data_6v5d_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6v5d _Structure_validation_residue.Date_analyzed 2019-12-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.273 0.559 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.51 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 119.651 -0.214 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.821 0.343 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 118.919 -0.562 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.597 -0.24 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.817 0.341 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.841 -0.059 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.451 0.167 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.884 0.374 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 111.306 0.114 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.603 -0.236 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt . . . . . 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.419 0.152 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.149 0.5 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.42 0.152 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 119.953 -0.07 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.074 0.027 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.222 0.058 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.54 0.21 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.804 0.335 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 119.718 -0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 119.54 -0.266 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp . . . . . 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.755 -0.164 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 110.855 -0.054 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.054 -0.022 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.387 0.137 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.351 0.119 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 0 0 . 1 . 129 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 0 0 . 1 . 129 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 119.694 -0.193 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 129 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.689 -0.196 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 0 0 . 1 . 133 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 0 0 . 1 . 133 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 133 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 0 0 . 1 . 134 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 0 0 . 1 . 134 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.041 0.448 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 134 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 0 0 . 1 . 139 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 0 0 . 1 . 139 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 139 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 0 0 . 1 . 143 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 0 0 . 1 . 143 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 143 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 0 0 . 1 . 144 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 144 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 0 0 . 1 . 145 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 0 0 . 1 . 145 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 118.839 -0.6 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 145 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 0 0 . 1 . 146 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 0 0 . 1 . 146 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 146 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 0 0 . 1 . 147 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 0 0 . 1 . 147 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 147 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 0 0 . 1 . 148 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 0 0 . 1 . 148 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 148 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 0 0 . 1 . 149 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 149 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 0 0 . 1 . 150 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 0 0 . 1 . 150 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 150 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 0 0 . 1 . 151 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 0 0 . 1 . 151 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 151 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 0 0 . 1 . 152 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 0 0 . 1 . 152 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 152 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 0 0 . 1 . 153 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 0 0 . 1 . 153 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.29 0.091 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 153 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 0 0 . 1 . 154 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 0 0 . 1 . 154 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 154 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 0 0 . 1 . 155 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 0 0 . 1 . 155 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 155 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 0 0 . 1 . 156 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 118.178 -0.915 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 156 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 0 0 . 1 . 157 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 0 0 . 1 . 157 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 157 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 0 0 . 1 . 158 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 0 0 . 1 . 158 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 158 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 0 0 . 1 . 159 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 0 0 . 1 . 159 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.329 0.109 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 159 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 0 0 . 1 . 160 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 0 0 . 1 . 160 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 160 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 0 0 . 1 . 161 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 0 0 . 1 . 161 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 161 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 0 0 . 1 . 162 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 0 0 . 1 . 162 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.611 0.243 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 162 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 0 0 . 1 . 163 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 0 0 . 1 . 163 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 163 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 0 0 . 1 . 164 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 0 0 . 1 . 164 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 164 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 0 0 . 1 . 165 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 0 0 . 1 . 165 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 165 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 0 0 . 1 . 166 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 0 0 . 1 . 166 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 166 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 0 0 . 1 . 167 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 0 0 . 1 . 167 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.602 0.239 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 167 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 0 0 . 1 . 168 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 0 0 . 1 . 168 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 119.802 -0.142 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 168 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 0 0 . 1 . 169 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 0 0 . 1 . 169 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 169 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 0 0 . 1 . 170 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 0 0 . 1 . 170 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 pttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 170 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 0 0 . 1 . 171 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 0 0 . 1 . 171 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 171 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 0 0 . 1 . 172 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 0 0 . 1 . 172 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 172 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 0 0 . 1 . 173 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 0 0 . 1 . 173 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.36 0.124 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 173 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 0 0 . 1 . 174 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 0 0 . 1 . 174 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 174 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 0 0 . 1 . 175 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 0 0 . 1 . 175 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 175 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 0 0 . 1 . 176 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 0 0 . 1 . 176 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 176 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -112.2 140.28 47.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -125.47 149.27 48.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.044 1.338 . . . . 0.0 111.462 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.4 mt -64.27 -11.97 36.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.819 1.647 . . . . 0.0 114.204 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -63.1 -13.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.586 1.154 . . . . 0.0 113.552 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.1 63.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 114.274 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -82.9 147.12 28.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.514 1.125 . . . . 0.0 112.367 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.51 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.72 142.1 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 130.93 45.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.756 1.222 . . . . 0.0 111.918 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.29 165.76 21.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.643 1.577 . . . . 0.0 113.146 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.63 -18.39 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.4 138.21 54.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.745 1.611 . . . . 0.0 113.995 -167.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.64 169.52 42.0 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.256 1.407 . . . . 0.0 112.998 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.297 . . . . 0.0 113.533 -176.293 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -102.86 127.78 49.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 p -94.32 164.05 13.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.427 1.491 . . . . 0.0 113.683 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.85 -20.35 65.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.695 0.798 . . . . 0.0 112.964 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.1 p -83.28 4.54 26.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.933 1.693 . . . . 0.0 114.065 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.04 35.08 54.44 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.224 0.916 . . . . 0.0 113.922 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -117.82 147.5 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.511 1.925 . . . . 0.0 109.771 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -132.35 154.17 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.7 mt -102.38 133.99 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.874 0.87 . . . . 0.0 111.546 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -64.31 135.53 56.29 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.202 1.401 . . . . 0.0 111.735 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.32 154.52 40.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.786 0.834 . . . . 0.0 112.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 58.17 13.26 2.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.362 2.265 . . . . 0.0 115.944 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.05 163.65 12.4 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.407 1.956 . . . . 0.0 112.809 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 116.861 -2.077 . . . . 0.0 114.51 -175.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -106.52 134.55 49.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -78.26 170.29 16.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.551 0.74 . . . . 0.0 111.679 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.84 -18.73 63.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.856 -1.152 . . . . 0.0 113.54 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -84.11 -6.06 59.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.44 1.496 . . . . 0.0 114.38 168.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.54 10.76 67.26 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.414 1.483 . . . . 0.0 115.98 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -71.44 143.92 49.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.392 1.596 . . . . 0.0 110.59 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.39 133.74 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -93.43 135.47 34.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.386 1.074 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -129.29 97.84 4.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.243 1.417 . . . . 0.0 109.964 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.52 -34.99 25.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.517 0.727 . . . . 0.0 111.822 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -58.95 150.76 23.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.854 1.261 . . . . 0.0 112.188 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 -159.35 50.81 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.139 0.875 . . . . 0.0 113.645 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 124.884 1.23 . . . . 0.0 113.387 -178.723 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.24 116.62 30.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -101.03 173.84 6.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.381 1.472 . . . . 0.0 113.809 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.29 -20.48 65.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -91.74 9.19 33.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.317 1.847 . . . . 0.0 113.837 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.71 80.93 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.202 -0.936 . . . . 0.0 114.401 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -75.32 149.91 38.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.948 2.099 . . . . 0.0 110.362 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.18 153.35 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -91.93 145.87 24.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.339 -0.85 . . . . 0.0 112.433 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -130.46 165.92 21.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.779 1.632 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.23 -28.52 3.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.508 1.923 . . . . 0.0 113.379 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -78.64 153.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 113.476 -173.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.46 -22.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 114.636 174.741 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.67 130.66 46.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.0 p -80.76 160.19 24.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.759 1.223 . . . . 0.0 112.152 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.28 -25.51 68.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.979 -1.075 . . . . 0.0 112.689 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -83.65 8.39 14.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.32 2.248 . . . . 0.0 114.002 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.05 -1.75 83.59 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.872 1.701 . . . . 0.0 117.21 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -78.61 142.39 37.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.78 . . . . 0.0 110.369 171.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.0 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -88.75 145.93 25.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.275 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -83.93 135.13 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.948 1.299 . . . . 0.0 111.358 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.76 -143.23 0.25 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.997 1.719 . . . . 0.0 109.743 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 56.08 25.0 8.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.074 2.15 . . . . 0.0 114.587 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.23 17.15 63.44 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.664 1.602 . . . . 0.0 115.075 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.478 1.99 . . . . 0.0 115.253 -169.109 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.14 151.91 21.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -122.97 164.49 18.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.529 1.131 . . . . 0.0 113.199 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.91 -23.95 61.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.169 1.388 . . . . 0.0 114.305 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -88.94 -1.89 58.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.115 1.366 . . . . 0.0 114.386 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.87 69.47 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.074 0.845 . . . . 0.0 114.766 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.74 144.56 35.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.772 1.286 . . . . 0.0 109.062 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t -90.77 116.97 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.13 94.9 9.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -67.2 117.42 9.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.363 1.065 . . . . 0.0 111.362 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.98 145.97 26.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.148 0.979 . . . . 0.0 111.794 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -112.85 143.72 43.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.983 1.313 . . . . 0.0 110.957 166.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.58 -154.02 13.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.169 0.89 . . . . 0.0 114.444 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.058 1.79 . . . . 0.0 114.089 175.622 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -87.01 122.68 31.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -81.01 175.66 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.367 1.467 . . . . 0.0 113.246 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.7 mt -63.21 -16.88 61.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.6 p -109.08 2.68 21.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.231 1.812 . . . . 0.0 113.919 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.95 82.32 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.27 149.81 49.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.401 1.6 . . . . 0.0 109.502 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.87 170.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.29 144.66 46.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.978 -1.076 . . . . 0.0 112.708 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -86.08 133.09 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.031 1.332 . . . . 0.0 109.681 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.55 140.34 48.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 111.249 -171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -155.16 149.87 26.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.85 -175.63 44.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.131 1.348 . . . . 0.0 114.158 164.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.506 2.003 . . . . 0.0 114.899 -179.006 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.21 148.21 52.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -122.34 160.67 24.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.474 1.509 . . . . 0.0 112.109 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 -19.37 63.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.743 1.217 . . . . 0.0 114.065 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -131.29 10.47 4.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.298 1.439 . . . . 0.0 114.468 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.98 158.55 24.76 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.531 1.062 . . . . 0.0 114.528 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -72.28 157.08 38.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.425 1.49 . . . . 0.0 112.009 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t -135.56 134.64 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.25 127.9 33.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.928 0.891 . . . . 0.0 112.041 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -46.47 137.94 6.17 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.22 2.208 . . . . 0.0 112.553 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.39 -43.6 92.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.032 1.333 . . . . 0.0 112.558 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -74.54 128.54 35.81 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.356 1.063 . . . . 0.0 110.165 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.81 -175.57 28.44 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.002 1.287 . . . . 0.0 114.09 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 125.824 1.678 . . . . 0.0 112.52 178.665 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -106.76 119.29 38.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -80.79 163.78 23.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.746 0.819 . . . . 0.0 111.929 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.88 -30.71 70.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 p -89.63 16.12 8.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.37 1.468 . . . . 0.0 113.396 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.18 3.2 85.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.242 1.401 . . . . 0.0 116.403 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -71.28 141.8 50.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.043 1.422 . . . . 0.0 110.959 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.19 147.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -121.41 134.75 55.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.198 0.599 . . . . 0.0 111.975 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -87.85 85.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 110.183 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.23 -26.44 68.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.655 1.582 . . . . 0.0 114.026 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -71.8 -13.71 61.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.77 -158.9 29.73 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.627 1.584 . . . . 0.0 114.579 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.699 1.618 . . . . 0.0 113.818 178.421 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.54 138.89 45.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 t -135.61 156.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.297 1.039 . . . . 0.0 113.481 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.55 -20.29 66.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.345 2.258 . . . . 0.0 115.601 -164.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -73.73 14.62 0.35 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.2 1.4 . . . . 0.0 114.434 168.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.32 14.17 82.82 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.512 1.53 . . . . 0.0 114.891 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -103.01 143.47 32.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.193 1.397 . . . . 0.0 111.624 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.46 145.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.98 151.82 33.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -96.74 176.28 6.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.087 1.755 . . . . 0.0 111.854 166.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.27 -51.56 0.95 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.068 1.347 . . . . 0.0 114.408 -168.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -71.62 -26.64 62.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.61 -7.24 82.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.314 1.435 . . . . 0.0 115.471 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.543 1.544 . . . . 0.0 112.464 170.617 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -115.19 150.96 35.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -102.85 167.13 10.06 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.406 1.482 . . . . 0.0 112.761 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.7 -32.31 73.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.947 -1.096 . . . . 0.0 111.831 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -73.77 -3.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.25 1.42 . . . . 0.0 113.896 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.87 82.85 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.065 1.793 . . . . 0.0 116.002 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -65.55 144.05 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.868 1.334 . . . . 0.0 110.523 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -100.29 145.77 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.7 mt -105.4 152.17 23.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.202 1.001 . . . . 0.0 112.993 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -138.78 69.56 1.38 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.393 1.877 . . . . 0.0 110.573 175.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -83.33 164.98 19.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.523 1.129 . . . . 0.0 111.489 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -78.76 142.04 37.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.557 0.743 . . . . 0.0 110.902 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.12 139.34 29.35 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.796 -0.565 . . . . 0.0 112.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 125.779 1.657 . . . . 0.0 113.842 -177.355 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.46 145.63 26.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -126.1 144.28 50.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.111 1.365 . . . . 0.0 112.354 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.25 -13.3 61.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.52 1.528 . . . . 0.0 113.231 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -71.34 -2.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.078 1.351 . . . . 0.0 113.35 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.82 46.14 5.5 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.671 1.129 . . . . 0.0 113.445 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -134.93 162.21 33.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 111.068 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.73 142.71 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -112.87 146.93 38.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.681 1.193 . . . . 0.0 111.984 -169.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -70.14 -31.72 69.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.21 12.68 36.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.793 1.237 . . . . 0.0 114.077 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -116.12 147.19 41.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.769 1.628 . . . . 0.0 111.271 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.44 3.42 47.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 119.04 1.42 . . . . 0.0 113.625 -173.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -127.64 123.93 36.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -78.0 157.23 29.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 121.672 -0.643 . . . . 0.0 110.785 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.48 -25.84 68.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.21 -0.931 . . . . 0.0 113.197 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -76.54 -21.19 56.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.698 1.199 . . . . 0.0 112.796 172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.24 -5.12 9.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -65.43 119.47 11.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.103 1.361 . . . . 0.0 108.923 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.77 136.22 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 tp -106.61 129.91 54.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.985 1.314 . . . . 0.0 111.739 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -85.09 149.25 25.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.852 1.261 . . . . 0.0 113.419 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.2 tp -132.72 124.88 28.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.275 1.83 . . . . 0.0 110.443 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 50.64 34.43 9.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.042 1.737 . . . . 0.0 113.295 -168.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.46 21.89 1.52 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.583 2.04 . . . . 0.0 113.809 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.093 1.806 . . . . 0.0 111.305 -173.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -82.68 126.34 32.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -77.1 150.54 35.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.117 0.967 . . . . 0.0 111.074 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.1 tp -64.32 -16.39 62.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.305 -0.872 . . . . 0.0 112.165 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -91.56 10.71 26.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.808 2.043 . . . . 0.0 114.089 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -17.49 56.18 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.252 1.406 . . . . 0.0 116.418 165.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -74.76 151.65 39.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.081 1.441 . . . . 0.0 111.129 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -135.68 129.6 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -75.98 130.81 39.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.647 0.779 . . . . 0.0 110.818 169.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -66.66 133.58 50.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.384 1.073 . . . . 0.0 111.724 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.8 mt -116.37 -133.41 0.33 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.895 1.678 . . . . 0.0 110.15 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 44.95 43.67 7.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.133 2.573 . . . . 0.0 114.841 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 146.16 8.1 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.965 -0.46 . . . . 0.0 113.833 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 126.119 1.819 . . . . 0.0 112.308 -178.074 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.76 113.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -81.41 169.22 17.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.677 0.791 . . . . 0.0 112.665 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.55 -40.45 91.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 111.893 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -81.58 12.25 3.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.066 1.747 . . . . 0.0 114.257 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.16 17.5 74.13 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.032 1.173 . . . . 0.0 116.032 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.07 147.34 31.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.229 1.515 . . . . 0.0 110.595 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' HD13 ' A' ' 73' ' ' LEU . 16.0 m -140.25 172.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.2 mt -42.07 133.12 3.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.512 1.925 . . . . 0.0 114.254 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 68.42 4.4 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.246 2.618 . . . . 0.0 117.554 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 70' ' ' VAL . 21.4 mt -72.42 88.24 1.2 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.559 1.144 . . . . 0.0 112.99 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -122.63 -139.29 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.242 2.217 . . . . 0.0 109.891 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.59 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.121 1.343 . . . . 0.0 114.751 -175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 C-N-CA 127.167 2.318 . . . . 0.0 113.132 -178.166 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -80.75 120.43 24.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.6 p -69.82 169.19 13.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.004 1.722 . . . . 0.0 112.407 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.45 -3.54 3.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -113.94 5.69 16.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.931 2.092 . . . . 0.0 114.014 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.27 -10.4 63.87 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.539 1.543 . . . . 0.0 116.256 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.49 149.09 50.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.994 1.718 . . . . 0.0 110.346 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.22 160.13 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.17 135.0 47.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 112.781 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -79.12 121.28 24.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.865 1.266 . . . . 0.0 112.102 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.24 120.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.555 1.142 . . . . 0.0 108.643 161.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -92.51 149.49 21.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.773 1.229 . . . . 0.0 110.89 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.18 177.38 48.38 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.148 -177.611 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.84 118.74 35.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -82.65 -176.96 6.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.676 0.791 . . . . 0.0 111.907 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.22 -31.79 72.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.934 -1.103 . . . . 0.0 113.368 -170.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.2 p -89.68 4.31 49.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.532 1.933 . . . . 0.0 114.147 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.53 5.24 89.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.967 -1.083 . . . . 0.0 114.826 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -57.02 139.56 51.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 118.338 1.069 . . . . 0.0 110.266 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.01 166.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.43 149.45 42.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.532 -0.73 . . . . 0.0 111.939 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -84.9 141.87 30.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.245 1.018 . . . . 0.0 109.956 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.87 2.07 44.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -164.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -69.06 159.37 33.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.604 1.562 . . . . 0.0 113.271 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.68 -160.28 33.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.223 0.916 . . . . 0.0 113.243 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.94 1.733 . . . . 0.0 113.927 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -100.69 135.28 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.9 p -91.93 164.66 13.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.124 1.37 . . . . 0.0 112.868 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -72.77 1.03 9.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 113.71 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 p -100.18 -0.86 37.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.094 1.757 . . . . 0.0 113.07 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 12.72 77.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 116.071 1.189 . . . . 0.0 116.071 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -88.28 142.03 28.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.678 1.239 . . . . 0.0 110.119 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.67 134.65 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -89.04 124.87 34.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.972 0.909 . . . . 0.0 110.625 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -76.51 74.24 3.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 111.562 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.84 153.06 42.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.789 1.635 . . . . 0.0 111.579 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 54.89 45.44 26.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.528 1.931 . . . . 0.0 113.715 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.16 5.83 0.04 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 117.561 1.784 . . . . 0.0 117.561 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-N 119.452 1.626 . . . . 0.0 112.967 178.49 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.64 133.56 42.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -96.1 165.04 12.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.249 1.02 . . . . 0.0 112.08 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.04 8.87 3.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.877 1.271 . . . . 0.0 113.409 165.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -112.01 11.83 20.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.133 2.173 . . . . 0.0 112.238 172.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.83 7.33 80.53 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.957 1.265 . . . . 0.0 115.625 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -82.47 147.19 28.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.995 1.397 . . . . 0.0 110.411 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.46 127.89 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 mp -91.33 138.6 31.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.016 0.526 . . . . 0.0 110.35 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -77.59 64.43 2.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.63 1.972 . . . . 0.0 111.807 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.89 135.85 53.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 58.71 51.54 7.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.678 1.991 . . . . 0.0 112.452 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.51 -51.3 0.07 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.862 1.22 . . . . 0.0 114.251 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.756 1.645 . . . . 0.0 113.514 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -125.23 125.98 44.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -81.09 144.6 31.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.274 0.559 . . . . 0.0 110.449 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.09 -3.89 11.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 114.408 -177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 p -85.52 -16.55 39.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.065 1.346 . . . . 0.0 113.533 168.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.55 -49.26 0.77 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.349 1.452 . . . . 0.0 114.819 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -58.66 130.22 45.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.314 1.057 . . . . 0.0 113.532 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.22 130.85 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.39 135.87 34.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.051 0.453 . . . . 0.0 109.804 166.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.8 141.1 57.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 0.0 109.717 162.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.85 -26.89 60.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -136.21 81.86 1.91 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.301 1.841 . . . . 0.0 109.705 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.11 6.39 28.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.104 1.811 . . . . 0.0 116.865 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 120.011 1.905 . . . . 0.0 114.382 178.605 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -109.8 146.5 34.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -119.41 155.85 31.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.859 1.263 . . . . 0.0 112.628 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.18 -16.52 63.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 112.571 172.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.2 p -69.17 0.37 4.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 113.608 164.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 4.35 88.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.293 1.425 . . . . 0.0 115.199 173.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -82.74 160.45 22.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.566 1.183 . . . . 0.0 111.833 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.45 154.81 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.94 131.4 52.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.891 0.877 . . . . 0.0 111.114 -171.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -62.35 -43.62 98.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.326 1.05 . . . . 0.0 113.117 -168.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.8 mt -80.48 9.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.337 1.455 . . . . 0.0 114.37 175.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.89 14.48 7.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.617 1.567 . . . . 0.0 113.305 177.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.15 -14.05 79.78 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.737 1.637 . . . . 0.0 113.826 177.484 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -103.6 123.22 46.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -75.89 162.26 28.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.818 0.847 . . . . 0.0 112.551 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.76 -19.98 60.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -90.56 -2.87 57.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.461 2.304 . . . . 0.0 115.011 173.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.4 63.95 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 175.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -78.88 134.67 36.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.363 1.082 . . . . 0.0 108.601 167.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.72 150.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.92 145.04 45.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.399 1.879 . . . . 0.0 112.754 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.983 1.713 . . . . 0.0 111.183 164.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -102.16 165.12 11.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.688 1.195 . . . . 0.0 113.884 -174.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.28 68.4 mtt180 63.97 25.52 13.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.051 2.54 . . . . 0.0 116.284 176.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.15 38.18 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.357 -0.839 . . . . 0.0 112.749 165.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.41 1.481 . . . . 0.0 114.247 177.635 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -123.92 145.65 49.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -130.04 166.82 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.107 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -50.24 -44.37 53.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.8 p -138.3 -20.47 1.07 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.92 169.45 52.71 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.216 0.916 . . . . 0.0 114.274 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.59 147.49 49.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.287 1.435 . . . . 0.0 112.341 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.61 151.48 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.19 149.33 42.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -160.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.07 151.78 22.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 109.355 173.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.28 44.24 25.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.066 1.746 . . . . 0.0 113.921 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -134.64 -21.45 1.73 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.299 1.84 . . . . 0.0 114.833 -178.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.96 -8.58 66.89 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.915 1.926 . . . . 0.0 117.915 -167.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-N 119.644 1.722 . . . . 0.0 116.168 -179.44 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -80.98 125.95 30.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.6 p -88.22 160.4 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.699 0.8 . . . . 0.0 111.56 171.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.79 -25.76 68.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.454 -0.779 . . . . 0.0 112.375 172.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -76.67 -9.39 58.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.163 1.785 . . . . 0.0 114.918 173.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.65 7.68 62.91 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.96 1.267 . . . . 0.0 115.645 177.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.85 152.11 31.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.548 1.174 . . . . 0.0 110.048 169.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.82 137.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 tp -85.26 138.39 32.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.414 1.886 . . . . 0.0 110.926 176.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -127.71 93.11 3.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.547 1.939 . . . . 0.0 111.139 -176.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -97.4 143.58 27.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.577 1.151 . . . . 0.0 112.469 179.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.02 132.71 52.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.888 1.275 . . . . 0.0 112.389 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 148.27 16.04 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.524 1.535 . . . . 0.0 112.264 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.506 -1.719 . . . . 0.0 113.424 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -91.2 121.76 33.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -89.12 163.83 15.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.808 0.843 . . . . 0.0 112.784 -173.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.95 -22.29 66.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.201 1.4 . . . . 0.0 113.645 -175.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -95.45 2.76 54.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.331 2.252 . . . . 0.0 113.957 173.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.39 61.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.414 1.483 . . . . 0.0 116.583 169.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.07 159.42 32.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.74 1.77 . . . . 0.0 111.173 174.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.97 166.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.73 139.89 46.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.696 1.199 . . . . 0.0 111.61 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -66.48 138.54 57.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.858 166.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.44 149.75 41.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.912 1.685 . . . . 0.0 111.196 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -139.72 154.24 47.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.328 1.451 . . . . 0.0 111.222 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.8 -119.91 0.88 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 C-N-CA 124.481 1.039 . . . . 0.0 110.65 155.985 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -99.76 145.37 27.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 m -120.19 153.12 36.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 110.18 173.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.04 -16.78 20.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -67.97 -8.37 36.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.999 2.519 . . . . 0.0 113.892 169.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.73 -11.1 57.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.922 1.725 . . . . 0.0 114.269 -169.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -63.5 136.28 57.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.168 1.484 . . . . 0.0 110.841 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.65 153.29 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.43 155.63 33.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.255 -0.903 . . . . 0.0 112.228 178.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -87.34 166.06 15.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.416 1.486 . . . . 0.0 111.383 165.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -52.23 150.43 4.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.678 1.191 . . . . 0.0 112.557 170.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 49.3 47.06 22.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.459 -162.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.93 -46.07 0.02 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.686 1.612 . . . . 0.0 112.428 -175.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.036 1.779 . . . . 0.0 113.136 168.763 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -99.99 112.8 25.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 p -78.12 171.73 14.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.199 1.0 . . . . 0.0 112.847 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -29.46 58.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.144 1.377 . . . . 0.0 114.392 174.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -88.86 -1.99 58.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.614 1.566 . . . . 0.0 113.678 178.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.25 5.7 89.06 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.558 1.075 . . . . 0.0 114.539 -174.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.94 143.31 57.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.028 1.414 . . . . 0.0 109.299 169.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.13 169.89 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.17 127.71 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.431 -0.793 . . . . 0.0 111.319 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -88.1 129.77 35.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.442 1.097 . . . . 0.0 111.704 173.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.55 146.26 42.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.243 1.417 . . . . 0.0 111.019 176.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -150.5 156.75 42.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.57 1.148 . . . . 0.0 112.726 172.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 159.62 49.11 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.289 0.947 . . . . 0.0 113.738 175.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.519 2.009 . . . . 0.0 113.045 -176.157 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -100.04 140.49 34.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.3 p -97.53 160.92 14.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.858 1.263 . . . . 0.0 112.148 168.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 mt -72.96 -6.41 45.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.755 1.222 . . . . 0.0 113.472 172.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -118.8 47.47 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.353 1.861 . . . . 0.0 110.672 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 -25.8 2.07 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 118.404 2.121 . . . . 0.0 118.404 165.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -78.39 135.22 37.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.085 1.942 . . . . 0.0 111.409 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.01 131.66 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.57 130.78 35.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.824 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.22 154.62 41.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.98 113.95 27.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.481 2.312 . . . . 0.0 108.717 174.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 55.45 28.48 11.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.044 2.138 . . . . 0.0 114.903 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.25 -6.9 9.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.895 1.712 . . . . 0.0 115.259 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 126.971 2.224 . . . . 0.0 111.994 -175.439 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -91.51 136.23 33.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.6 p -97.66 153.53 18.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.978 1.311 . . . . 0.0 112.272 169.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 tp -57.86 -35.89 71.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.475 1.11 . . . . 0.0 112.964 175.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -84.93 11.65 8.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.454 1.902 . . . . 0.0 115.535 176.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.18 55.86 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 160.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.53 147.5 24.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.698 1.599 . . . . 0.0 110.609 172.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t -119.47 133.02 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.94 128.91 40.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.537 0.735 . . . . 0.0 110.597 171.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -114.96 103.05 10.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.795 1.238 . . . . 0.0 111.397 179.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.14 149.25 42.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.245 1.818 . . . . 0.0 110.976 -176.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -72.27 165.34 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.613 0.765 . . . . 0.0 112.653 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 166.95 53.98 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.543 1.068 . . . . 0.0 114.22 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 125.839 1.685 . . . . 0.0 113.261 179.604 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -97.81 129.86 44.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -68.11 178.3 1.91 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.278 1.831 . . . . 0.0 112.843 -178.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.45 -18.06 63.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.927 -1.108 . . . . 0.0 113.725 172.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -98.39 5.68 47.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.865 1.266 . . . . 0.0 113.417 171.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.11 5.18 87.05 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.337 1.446 . . . . 0.0 115.689 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -73.63 138.84 45.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 118.757 1.279 . . . . 0.0 109.609 176.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 142.15 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -113.84 136.81 52.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.14 2.176 . . . . 0.0 110.797 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -70.05 106.31 3.19 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 109.826 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.0 89.57 5.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.239 1.415 . . . . 0.0 110.442 -174.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -63.53 150.01 44.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.994 1.318 . . . . 0.0 112.754 -173.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.33 172.02 38.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.157 0.884 . . . . 0.0 114.071 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 126.518 2.009 . . . . 0.0 113.174 179.023 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -127.29 133.34 50.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -90.06 151.51 21.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.433 0.693 . . . . 0.0 111.592 178.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.6 -8.35 46.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.681 0.792 . . . . 0.0 113.045 169.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.2 p -87.35 -3.91 59.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.209 1.804 . . . . 0.0 114.069 167.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.65 37.57 7.97 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.007 1.163 . . . . 0.0 116.007 172.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -116.54 143.97 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.605 1.962 . . . . 0.0 110.732 171.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.23 119.37 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.63 -38.95 77.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -65.14 -44.74 87.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.552 1.069 . . . . 0.0 112.021 -179.857 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -61.12 -25.38 66.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -67.13 -31.68 72.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.049 1.295 . . . . 0.0 112.715 174.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.72 -20.2 44.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.6 -1.111 . . . . 0.0 115.787 177.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-N 118.914 1.357 . . . . 0.0 114.519 -173.031 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -84.41 137.91 33.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -110.07 153.74 24.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.286 1.034 . . . . 0.0 111.994 174.328 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.14 -4.84 43.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.009 0.924 . . . . 0.0 112.469 166.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -83.79 -0.79 52.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.223 1.409 . . . . 0.0 113.587 165.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.24 38.34 10.15 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.41 -1.217 . . . . 0.0 115.994 170.171 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -130.56 162.46 29.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.519 1.659 . . . . 0.0 112.726 165.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.7 138.45 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt -94.65 142.37 27.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.414 0.685 . . . . 0.0 112.086 176.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -133.59 108.42 8.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.085 1.354 . . . . 0.0 111.984 176.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.48 151.04 22.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.069 177.156 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -60.53 133.8 56.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 110.248 172.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -178.07 54.08 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.267 1.413 . . . . 0.0 114.673 -176.092 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 C-N-CA 126.265 1.888 . . . . 0.0 113.56 -178.273 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -108.88 137.24 47.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -80.65 149.59 29.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.983 0.81 . . . . 0.0 110.345 163.031 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -68.81 -17.58 64.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.395 -0.815 . . . . 0.0 111.885 171.82 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -75.45 -10.97 59.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.848 1.659 . . . . 0.0 114.43 170.128 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.33 22.63 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 167.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.44 160.84 22.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.883 1.842 . . . . 0.0 112.093 177.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.89 145.05 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.6 148.54 33.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.791 1.236 . . . . 0.0 113.779 172.69 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -134.69 145.5 48.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.435 1.494 . . . . 0.0 111.583 -166.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.69 -40.44 5.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -169.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -77.98 37.06 0.24 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 -171.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.01 48.22 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.969 1.271 . . . . 0.0 114.264 178.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.691 1.615 . . . . 0.0 114.851 176.953 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -80.05 128.85 33.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -100.63 170.66 8.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.016 1.326 . . . . 0.0 113.388 -168.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.9 -22.83 64.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.039 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -91.96 1.51 57.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.309 1.844 . . . . 0.0 113.651 174.624 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.8 11.34 84.66 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.837 1.685 . . . . 0.0 114.384 -177.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.05 169.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.133 1.373 . . . . 0.0 110.568 169.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.59 143.02 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 tp -94.47 143.77 26.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.586 1.554 . . . . 0.0 111.135 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -73.87 63.2 0.89 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 113.019 170.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.86 119.53 10.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 161.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -85.28 132.26 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.713 1.205 . . . . 0.0 112.338 -170.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 151.17 2.36 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 122.676 1.153 . . . . 0.0 114.467 174.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.934 1.73 . . . . 0.0 111.68 -178.847 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -119.3 125.92 50.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -105.96 164.17 12.17 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.317 179.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.81 -25.81 61.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.715 2.006 . . . . 0.0 114.362 -172.66 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -71.89 -4.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.911 1.684 . . . . 0.0 114.061 175.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.5 -1.86 86.71 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.007 1.289 . . . . 0.0 114.403 -173.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.49 139.65 53.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.414 1.607 . . . . 0.0 110.891 175.134 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.4 139.79 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.77 141.81 28.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.216 1.006 . . . . 0.0 111.449 175.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -79.64 107.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 111.587 167.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.54 -28.99 70.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.775 1.23 . . . . 0.0 113.778 178.201 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -120.71 9.45 10.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 114.361 -177.833 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 147.53 49.75 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.878 164.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.678 -1.624 . . . . 0.0 112.829 -173.577 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.92 115.0 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -82.98 165.41 19.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.618 1.967 . . . . 0.0 112.579 -177.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.33 -12.09 61.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 -173.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -76.06 -9.31 58.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.132 1.333 . . . . 0.0 113.362 166.601 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.7 -14.94 64.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.744 1.64 . . . . 0.0 113.874 -168.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.91 129.21 39.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.204 1.502 . . . . 0.0 111.306 -177.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.79 164.66 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -110.52 -179.45 3.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.161 1.785 . . . . 0.0 110.747 -173.094 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -73.25 104.1 4.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.374 -0.829 . . . . 0.0 108.939 157.332 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -117.2 74.67 0.93 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.514 1.526 . . . . 0.0 110.722 -172.122 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -70.31 152.89 43.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.348 1.459 . . . . 0.0 112.508 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.45 143.08 5.28 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.014 1.293 . . . . 0.0 112.573 173.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.85 1.691 . . . . 0.0 112.765 177.563 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -91.33 126.12 36.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -90.72 157.4 17.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.227 1.411 . . . . 0.0 112.346 -176.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.88 -27.17 67.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.449 1.1 . . . . 0.0 113.357 176.57 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -92.5 12.7 22.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.535 2.334 . . . . 0.0 113.647 176.181 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.57 58.09 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 162.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -93.78 151.12 19.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.201 1.4 . . . . 0.0 110.606 170.323 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.62 165.82 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -50.73 -41.38 56.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 114.22 -173.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -80.97 12.61 3.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 178.665 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -123.1 6.47 9.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.778 2.431 . . . . 0.0 113.324 170.137 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -25.94 51.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.535 1.534 . . . . 0.0 113.08 -178.849 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.6 -36.68 32.79 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 121.052 -1.03 . . . . 0.0 112.624 167.339 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.148 -1.918 . . . . 0.0 114.171 175.705 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -110.89 130.87 55.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -74.1 165.74 24.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.173 0.589 . . . . 0.0 111.669 171.636 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.61 -27.61 67.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.991 -1.068 . . . . 0.0 113.031 169.677 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -80.87 3.06 23.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.781 2.032 . . . . 0.0 114.784 172.211 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.63 11.78 85.12 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.632 -1.293 . . . . 0.0 115.538 175.317 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -76.08 130.15 37.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.014 1.407 . . . . 0.0 108.896 171.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -124.96 148.86 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.56 129.44 37.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 110.295 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -123.29 81.21 1.86 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.714 2.006 . . . . 0.0 110.547 -176.456 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.4 mt -77.46 142.89 38.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.121 0.968 . . . . 0.0 111.41 -176.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -105.8 -17.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.217 1.407 . . . . 0.0 112.679 169.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 -170.69 30.17 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 118.703 0.683 . . . . 0.0 114.144 171.341 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.141 1.829 . . . . 0.0 113.361 179.735 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -113.44 132.27 55.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 p -81.96 162.41 22.69 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.518 0.727 . . . . 0.0 111.134 173.919 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.469 -1.395 . . . . 0.0 113.055 176.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -83.86 9.93 10.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.672 1.589 . . . . 0.0 114.711 172.066 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.12 -0.03 85.63 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 165.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -67.14 136.93 55.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.182 1.491 . . . . 0.0 109.703 172.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -119.28 136.8 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.79 139.35 42.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -78.9 157.46 28.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.622 1.569 . . . . 0.0 112.437 174.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.4 161.42 22.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.457 1.903 . . . . 0.0 111.888 178.789 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.3 mtt85 59.57 31.08 20.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.348 2.259 . . . . 0.0 114.633 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.05 -173.57 20.38 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.086 1.803 . . . . 0.0 114.928 -177.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.71 -1.605 . . . . 0.0 113.367 -179.071 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.95 125.68 52.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -93.31 148.14 22.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.119 0.968 . . . . 0.0 111.217 170.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.15 -25.79 64.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.16 0.984 . . . . 0.0 112.447 173.042 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -76.39 30.9 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.448 1.899 . . . . 0.0 113.022 174.403 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 43.18 93.22 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.62 -1.3 . . . . 0.0 116.085 164.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.82 144.12 31.64 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.629 1.215 . . . . 0.0 112.017 174.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.84 142.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.6 145.59 34.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.192 0.997 . . . . 0.0 110.956 172.687 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -62.08 146.79 49.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.353 -0.842 . . . . 0.0 112.064 167.252 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 tp -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.424 1.489 . . . . 0.0 112.722 -178.722 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -107.45 118.7 37.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.556 1.542 . . . . 0.0 108.335 162.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.12 171.37 44.41 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.229 0.919 . . . . 0.0 113.78 -177.529 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.233 1.397 . . . . 0.0 114.1 176.459 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -103.22 136.42 43.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -86.67 154.05 21.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.453 1.101 . . . . 0.0 110.919 171.165 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.19 -23.83 67.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.49 -1.381 . . . . 0.0 112.99 174.199 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -80.51 7.26 10.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.712 1.605 . . . . 0.0 114.067 173.441 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.18 38.45 9.13 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.048 -1.033 . . . . 0.0 115.335 163.948 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -123.96 143.07 50.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.369 1.468 . . . . 0.0 110.866 175.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.89 139.91 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.72 158.96 17.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.758 1.223 . . . . 0.0 111.472 175.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.5 mtt-85 -80.39 142.41 34.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 172.063 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.63 -33.29 3.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 113.575 -172.431 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -81.25 144.78 31.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.848 0.749 . . . . 0.0 112.663 176.679 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.54 3.74 0.11 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.329 1.442 . . . . 0.0 115.202 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.855 1.693 . . . . 0.0 113.931 175.93 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.13 139.43 30.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -102.57 163.8 12.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.995 175.262 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -56.01 -37.57 69.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.902 1.281 . . . . 0.0 112.212 166.852 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -71.65 -4.89 29.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.8 1.64 . . . . 0.0 114.686 178.759 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.16 74.1 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.332 0.969 . . . . 0.0 114.99 176.689 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -76.75 155.02 33.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.161 0.98 . . . . 0.0 110.1 171.149 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.05 127.24 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.17 138.11 35.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.631 0.773 . . . . 0.0 111.198 178.184 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -69.96 121.76 18.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.746 1.219 . . . . 0.0 110.083 166.679 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.65 151.5 39.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.569 174.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 54.95 31.63 16.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.091 1.756 . . . . 0.0 113.171 -166.465 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.94 8.52 6.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.214 1.864 . . . . 0.0 114.981 -177.479 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 126.198 1.856 . . . . 0.0 111.951 -175.328 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -96.91 139.64 32.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -107.0 156.66 18.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.747 1.219 . . . . 0.0 111.981 170.512 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.75 -37.68 82.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.32 1.048 . . . . 0.0 113.202 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -70.66 -3.14 16.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.846 1.658 . . . . 0.0 112.491 169.726 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 19.05 23.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 120.026 -1.671 . . . . 0.0 116.326 159.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -82.51 145.96 29.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.739 1.269 . . . . 0.0 110.03 169.719 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t -119.75 143.04 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.58 130.2 45.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.396 1.078 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -113.06 88.41 2.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.9 2.08 . . . . 0.0 109.185 -176.725 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 mt -113.46 133.33 55.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.455 1.502 . . . . 0.0 110.042 -169.624 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.4 mtt85 -107.56 136.86 46.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 110.74 174.939 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.36 -158.08 16.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.869 0.747 . . . . 0.0 113.143 -177.557 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 124.983 1.277 . . . . 0.0 114.067 177.649 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -96.24 106.04 18.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -89.77 163.27 15.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.186 1.395 . . . . 0.0 113.554 -172.843 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.57 -24.73 67.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -173.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -74.96 -4.98 41.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.059 1.344 . . . . 0.0 114.037 173.434 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.77 -16.24 58.68 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.751 1.643 . . . . 0.0 114.392 -170.487 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -62.7 128.75 37.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.817 1.808 . . . . 0.0 110.822 179.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -111.32 148.38 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.6 tp -87.01 -37.44 17.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.394 1.477 . . . . 0.0 113.863 -170.319 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -82.14 -56.61 3.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -171.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.72 56.78 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 169.483 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -63.85 -41.17 97.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -162.261 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 151.59 22.47 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 -169.673 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.557 2.503 . . . . 0.0 111.954 177.99 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.06 119.12 30.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -97.08 -179.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.659 1.584 . . . . 0.0 113.521 -166.295 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.6 mt -72.37 -10.07 59.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.516 -1.365 . . . . 0.0 114.412 -173.39 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -102.57 5.38 39.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 114.006 175.944 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.88 72.06 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.513 1.054 . . . . 0.0 114.984 -171.928 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -61.84 155.52 22.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.519 1.528 . . . . 0.0 111.116 171.769 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -122.1 139.22 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.0 tp -87.65 131.54 34.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 110.609 176.396 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -106.25 139.11 41.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 112.017 173.233 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.48 32.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.691 1.596 . . . . 0.0 113.383 -157.314 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -129.19 4.47 5.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.026 1.33 . . . . 0.0 113.671 -178.598 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.78 150.35 51.27 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.088 0.851 . . . . 0.0 113.295 179.03 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.493 1.52 . . . . 0.0 112.189 -174.822 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -135.96 135.21 39.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -87.18 162.31 17.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.751 0.821 . . . . 0.0 112.674 177.339 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.51 -26.13 68.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.117 -0.989 . . . . 0.0 111.379 168.191 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -80.81 16.67 1.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.069 2.148 . . . . 0.0 113.957 169.122 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.25 1.37 74.65 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 167.021 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -82.96 128.51 34.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.946 1.373 . . . . 0.0 110.388 -176.336 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -127.63 137.27 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 tp -85.88 132.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.355 172.585 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -124.67 16.31 8.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -169.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.93 24.2 0.95 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.454 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.74 109.78 16.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.208 1.403 . . . . 0.0 108.618 164.456 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.1 160.23 26.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.297 1.427 . . . . 0.0 115.073 -174.732 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.039 1.781 . . . . 0.0 115.223 178.942 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -102.12 129.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -89.13 174.99 7.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.247 1.419 . . . . 0.0 114.154 -171.855 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.55 -17.21 19.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.947 1.699 . . . . 0.0 115.286 175.591 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -111.34 9.02 21.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.434 1.894 . . . . 0.0 113.501 172.927 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.54 3.81 90.37 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.558 171.258 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -71.72 152.5 42.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.926 1.363 . . . . 0.0 110.058 175.949 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.12 162.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -105.72 123.84 48.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.117 1.767 . . . . 0.0 110.706 -170.931 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -70.62 99.84 1.73 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 113.034 -178.557 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt 58.94 -30.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.354 3.462 . . . . 0.0 118.965 172.505 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -83.27 44.92 0.98 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 121.246 1.839 . . . . 0.0 113.587 -177.975 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.54 -41.73 89.68 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.323 -0.86 . . . . 0.0 114.078 -175.278 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.679 179.282 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.47 149.21 50.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -113.7 162.0 16.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.884 1.673 . . . . 0.0 113.849 -179.094 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.8 -27.24 69.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.857 -1.152 . . . . 0.0 113.78 170.846 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -71.58 -4.59 27.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.893 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.72 13.06 78.9 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.767 1.175 . . . . 0.0 114.691 177.837 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -74.83 144.85 43.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.361 1.081 . . . . 0.0 109.539 171.699 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.35 163.46 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -100.53 157.27 16.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 112.631 -165.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -140.35 -177.72 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.828 1.251 . . . . 0.0 111.074 159.68 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.37 162.44 34.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.896 1.678 . . . . 0.0 111.39 172.711 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -107.4 -38.54 5.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.509 1.524 . . . . 0.0 111.979 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.73 132.0 11.04 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.739 1.162 . . . . 0.0 113.372 175.189 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.34 1.924 . . . . 0.0 115.511 179.664 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -89.31 138.74 31.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -99.12 166.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.48 1.512 . . . . 0.0 112.775 -175.275 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.15 -18.5 58.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 171.778 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.8 7.85 43.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.681 1.128 . . . . 0.0 113.352 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.39 -11.16 39.51 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.908 1.242 . . . . 0.0 115.079 179.366 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.15 140.89 58.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.415 1.608 . . . . 0.0 110.527 174.095 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -128.32 147.7 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -113.1 157.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -169.686 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -91.86 135.5 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.268 1.427 . . . . 0.0 109.126 167.557 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.02 146.44 31.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.984 0.914 . . . . 0.0 112.165 -170.534 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 50.38 43.67 26.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.716 1.606 . . . . 0.0 112.859 -172.554 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.66 72.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 117.047 1.579 . . . . 0.0 117.047 -170.192 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.281 1.541 . . . . 0.0 113.986 -179.571 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -125.15 136.88 54.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -100.94 162.4 12.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.99 1.316 . . . . 0.0 113.35 177.23 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.98 -12.48 61.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.545 1.538 . . . . 0.0 113.096 170.785 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -85.87 -0.97 56.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.178 1.791 . . . . 0.0 113.149 166.411 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.0 12.7 83.85 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.202 1.382 . . . . 0.0 115.261 175.331 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -83.0 142.61 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.405 1.482 . . . . 0.0 109.285 174.927 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -124.58 136.44 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.63 124.23 34.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.831 0.853 . . . . 0.0 109.623 175.692 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -100.61 126.75 47.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.716 1.606 . . . . 0.0 110.378 179.169 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.54 119.19 24.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.915 0.886 . . . . 0.0 110.631 -175.494 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -82.58 -31.97 28.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.209 1.404 . . . . 0.0 113.246 -177.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.8 -159.54 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.943 1.259 . . . . 0.0 114.601 178.677 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 C-N-CA 125.933 1.73 . . . . 0.0 112.617 -176.77 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -93.73 120.56 34.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -90.64 162.2 15.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 113.052 -172.912 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -75.91 -19.67 58.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.849 -1.157 . . . . 0.0 112.241 174.04 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -80.69 2.57 25.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.813 1.645 . . . . 0.0 113.724 165.839 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.6 49.13 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.563 1.385 . . . . 0.0 116.563 163.301 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -107.12 156.92 18.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.945 1.373 . . . . 0.0 111.246 168.136 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.3 152.65 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.39 143.06 27.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.309 1.444 . . . . 0.0 111.926 -178.7 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -75.58 119.54 19.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.824 0.849 . . . . 0.0 110.337 165.863 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.82 118.1 36.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.77 1.228 . . . . 0.0 110.359 -176.894 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -141.65 158.95 43.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 112.34 -173.511 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.42 -170.63 31.64 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.131 0.872 . . . . 0.0 114.491 176.363 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.933 -1.482 . . . . 0.0 113.207 176.621 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -92.35 132.52 36.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -98.31 159.37 14.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 112.415 177.711 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.09 -8.01 58.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.272 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -103.4 -28.07 12.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.566 1.546 . . . . 0.0 113.973 -172.232 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 -42.92 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 171.562 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.53 157.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.208 1.004 . . . . 0.0 113.134 -176.44 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.0 129.67 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 tp -88.17 129.9 35.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.073 0.949 . . . . 0.0 111.818 -179.732 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -67.9 158.11 33.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 111.811 175.182 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.24 162.39 14.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.245 1.418 . . . . 0.0 114.31 -168.282 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 65.1 mtt180 58.09 32.56 22.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.955 2.902 . . . . 0.0 115.948 172.912 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.73 18.14 22.47 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.727 2.108 . . . . 0.0 114.917 175.937 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.313 1.911 . . . . 0.0 112.917 -170.39 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -88.29 124.67 34.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.0 p -67.24 173.71 3.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.412 2.285 . . . . 0.0 112.78 177.955 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.29 -17.53 62.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.038 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -99.33 16.87 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.668 1.587 . . . . 0.0 113.415 173.152 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.62 -15.72 4.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.72 1.629 . . . . 0.0 115.831 176.811 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -67.79 140.55 56.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.151 1.38 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.33 176.29 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.99 151.64 29.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.81 1.244 . . . . 0.0 113.338 -172.501 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -138.1 126.39 23.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.94 1.296 . . . . 0.0 110.317 156.521 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.55 -32.63 1.29 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.635 1.174 . . . . 0.0 113.48 -174.302 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 169.85 18.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.74 1.216 . . . . 0.0 113.442 -179.233 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.14 29.5 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.337 1.446 . . . . 0.0 113.264 -174.58 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.16 -1.356 . . . . 0.0 111.796 179.708 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -124.75 143.91 50.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -124.18 162.64 23.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.77 1.228 . . . . 0.0 112.414 -173.324 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.91 -22.56 67.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.442 1.097 . . . . 0.0 113.922 -174.563 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -84.2 2.67 38.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.425 1.89 . . . . 0.0 114.554 171.844 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.23 7.44 88.42 Favored Glycine 0 CA--C 1.531 1.088 0 O-C-N 120.727 -1.233 . . . . 0.0 114.932 177.826 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.67 124.67 27.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.825 1.312 . . . . 0.0 109.24 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.88 134.74 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.12 131.33 37.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.615 -0.678 . . . . 0.0 110.13 -179.749 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -116.05 75.31 0.94 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.092 1.757 . . . . 0.0 109.542 176.958 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.62 153.01 37.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.456 1.102 . . . . 0.0 111.982 -179.073 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.92 162.82 13.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.226 1.811 . . . . 0.0 112.001 175.263 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.54 129.06 0.67 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.502 2.001 . . . . 0.0 113.373 179.036 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 124.258 0.932 . . . . 0.0 114.154 -178.722 . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -111.19 126.73 55.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -79.0 168.65 19.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 112.851 177.602 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.7 mt -59.94 -33.46 71.93 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.859 -1.151 . . . . 0.0 112.855 174.86 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -91.71 21.27 4.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.725 1.61 . . . . 0.0 113.52 173.748 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.4 28.02 73.6 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.902 1.239 . . . . 0.0 115.342 165.008 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -82.23 127.93 33.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.717 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.99 132.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.77 117.76 25.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.427 0.691 . . . . 0.0 111.266 170.646 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.43 62.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.556 2.342 . . . . 0.0 108.566 -176.861 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.44 -27.93 68.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.673 1.589 . . . . 0.0 113.355 -174.427 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -68.59 147.36 52.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.379 1.072 . . . . 0.0 112.884 -178.801 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.2 23.71 70.02 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.91 0.767 . . . . 0.0 114.834 174.375 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.057 1.313 . . . . 0.0 113.996 176.25 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.85 150.71 22.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 p -128.8 152.06 48.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.165 0.986 . . . . 0.0 112.94 -176.237 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.49 -29.75 70.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.42 1.088 . . . . 0.0 111.322 169.438 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -70.12 9.48 0.57 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.227 1.811 . . . . 0.0 114.416 173.779 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.7 9.68 68.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.181 1.372 . . . . 0.0 115.945 168.519 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -103.91 158.18 16.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.19 1.495 . . . . 0.0 112.618 -174.956 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.25 142.28 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.46 150.39 24.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.339 0.656 . . . . 0.0 111.093 175.325 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -75.41 140.42 42.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.457 1.103 . . . . 0.0 112.482 -176.206 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.7 mt -133.16 158.97 41.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.744 1.617 . . . . 0.0 110.369 174.995 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -100.6 168.82 9.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.117 1.767 . . . . 0.0 111.124 175.117 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.12 -152.75 5.87 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.24 0.924 . . . . 0.0 113.278 -179.513 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.434 -174.135 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -107.56 131.6 54.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -90.3 163.25 14.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.452 1.101 . . . . 0.0 112.052 179.567 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.32 -28.61 66.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -80.41 -11.95 59.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.158 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 5.74 56.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.416 1.484 . . . . 0.0 115.564 178.903 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.44 139.22 51.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.002 1.401 . . . . 0.0 109.429 169.341 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.91 145.77 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.14 151.47 26.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.427 1.091 . . . . 0.0 113.282 -177.623 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -93.53 75.98 4.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.317 1.847 . . . . 0.0 112.16 179.639 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 154.82 26.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.503 1.521 . . . . 0.0 111.946 175.868 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 54.58 16.17 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.276 2.23 . . . . 0.0 115.662 -175.047 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.36 -166.33 29.88 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.652 1.596 . . . . 0.0 113.573 -179.905 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.832 1.206 . . . . 0.0 112.284 170.661 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -108.76 133.55 52.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -78.51 169.37 18.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.73 0.812 . . . . 0.0 112.517 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -58.0 -21.86 46.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.978 1.311 . . . . 0.0 113.754 171.895 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -106.61 16.29 24.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.843 1.657 . . . . 0.0 113.873 172.587 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.32 7.42 88.56 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 165.515 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.13 138.98 50.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.615 1.707 . . . . 0.0 109.862 174.1 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.79 141.14 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.99 120.64 32.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.954 176.486 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 -64.2 -36.0 82.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 113.813 -175.437 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.68 22.28 1.97 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.412 1.085 . . . . 0.0 113.551 -177.495 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -136.66 156.0 49.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.633 1.973 . . . . 0.0 110.057 175.765 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.33 17.72 16.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.298 -176.562 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.483 1.992 . . . . 0.0 112.892 -177.517 . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -87.38 136.77 32.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -111.11 142.68 42.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.191 0.996 . . . . 0.0 110.288 163.335 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.0 mt -70.16 -15.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -161.149 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -77.63 -9.76 59.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 171.334 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.75 -40.43 1.41 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.818 165.731 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.99 152.37 41.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.562 1.681 . . . . 0.0 113.671 -168.083 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.21 132.83 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.86 149.68 28.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.988 0.515 . . . . 0.0 112.092 174.436 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 71.13 1.47 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.132 1.373 . . . . 0.0 110.338 172.905 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.42 143.16 53.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.439 1.096 . . . . 0.0 112.026 -176.207 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -73.05 -34.15 66.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -166.335 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.04 132.21 28.38 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 118.671 0.669 . . . . 0.0 114.025 -171.286 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.3 -1.278 . . . . 0.0 113.545 176.983 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -111.86 126.55 55.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -99.94 163.55 12.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.701 1.201 . . . . 0.0 113.509 -168.291 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 mt -73.94 -5.31 40.42 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.805 1.242 . . . . 0.0 113.318 170.675 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 p -92.17 6.69 45.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.121 1.768 . . . . 0.0 113.515 170.646 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.66 82.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.211 1.386 . . . . 0.0 114.465 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -93.28 153.87 18.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.414 1.886 . . . . 0.0 110.789 -176.208 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -119.1 120.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.6 tp -68.22 -47.87 66.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.634 0.774 . . . . 0.0 113.081 -171.352 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -61.61 -30.39 70.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.204 0.911 . . . . 0.0 112.318 179.408 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -72.86 -26.72 61.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.635 1.174 . . . . 0.0 113.078 174.773 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -74.5 -18.65 60.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.327 0.967 . . . . 0.0 113.136 170.375 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.27 152.13 44.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.165 0.888 . . . . 0.0 112.975 167.749 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.757 -1.579 . . . . 0.0 113.877 -178.369 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.74 115.9 19.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -83.79 -177.37 6.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.426 1.491 . . . . 0.0 113.541 -175.629 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.2 mt -69.33 -25.3 64.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.615 -1.303 . . . . 0.0 113.26 179.009 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -84.45 -0.67 53.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.93 1.292 . . . . 0.0 113.209 167.871 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 8.08 82.72 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.53 -1.356 . . . . 0.0 115.061 -176.049 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.28 138.73 57.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.46 1.63 . . . . 0.0 108.99 171.921 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.6 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.7 tp -88.24 140.27 29.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.801 1.24 . . . . 0.0 111.766 176.124 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm85 -134.77 149.58 50.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.562 1.945 . . . . 0.0 110.712 166.64 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.46 59.22 1.7 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.615 1.566 . . . . 0.0 111.909 -170.282 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -128.12 -3.22 5.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.4 2.28 . . . . 0.0 115.258 -178.444 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.83 -32.08 58.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 119.91 1.232 . . . . 0.0 114.231 179.066 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.946 -1.474 . . . . 0.0 113.942 166.775 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -104.03 132.97 49.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -82.62 168.09 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.352 1.061 . . . . 0.0 112.627 -176.611 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.31 -23.42 65.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.31 -0.869 . . . . 0.0 112.761 171.455 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -82.71 1.98 36.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.59 2.356 . . . . 0.0 114.459 167.909 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.06 4.41 90.26 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.349 -1.806 . . . . 0.0 117.073 169.302 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -84.28 149.66 25.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.827 2.314 . . . . 0.0 111.37 174.298 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t -121.5 132.87 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -90.03 121.16 31.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.809 170.11 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 106.01 18.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.61 1.564 . . . . 0.0 110.694 -170.361 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.56 137.64 36.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.877 1.271 . . . . 0.0 109.845 176.782 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -87.67 -57.16 3.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -167.039 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.33 -34.17 61.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.632 173.644 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.525 2.012 . . . . 0.0 111.48 -170.84 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -99.42 126.26 45.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -90.42 139.67 30.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.627 0.649 . . . . 0.0 109.798 167.285 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -74.92 -10.02 59.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.327 -0.858 . . . . 0.0 113.052 177.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -74.72 -2.85 28.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.715 2.006 . . . . 0.0 114.249 162.285 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 50.33 2.76 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.47 1.033 . . . . 0.0 115.186 167.646 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -136.35 151.07 49.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.492 1.517 . . . . 0.0 111.03 171.827 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.27 166.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.4 135.66 53.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.4 1.08 . . . . 0.0 113.224 -174.806 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -99.39 102.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.679 1.992 . . . . 0.0 109.281 174.653 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.31 132.17 56.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.639 1.176 . . . . 0.0 112.032 -166.902 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -70.52 -38.6 74.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.957 1.303 . . . . 0.0 114.057 -174.363 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.91 -149.78 48.25 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.738 0.699 . . . . 0.0 112.495 -169.777 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.11 1.814 . . . . 0.0 114.495 -177.941 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -104.79 147.6 27.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -109.87 164.61 12.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.352 1.861 . . . . 0.0 113.242 173.603 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -77.36 7.75 4.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.598 1.559 . . . . 0.0 113.934 169.399 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -110.65 11.54 22.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.949 2.1 . . . . 0.0 112.74 -179.391 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.9 86.62 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.605 1.098 . . . . 0.0 115.44 -177.734 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -94.53 142.29 27.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.879 1.34 . . . . 0.0 110.52 178.951 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.92 155.38 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.64 147.15 32.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.54 1.536 . . . . 0.0 111.572 -173.633 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.1 mtm105 -83.09 61.73 6.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 112.559 -175.833 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 tp -50.84 118.08 2.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.946 1.698 . . . . 0.0 111.543 178.505 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 63.61 -32.26 0.12 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.408 3.083 . . . . 0.0 117.731 -179.621 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.69 79.66 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.976 1.262 . . . . 0.0 114.504 173.636 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.438 1.971 . . . . 0.0 111.951 166.957 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -95.34 124.35 39.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -85.09 128.75 34.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 159.238 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -59.46 -24.84 63.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.152 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.5 p -72.58 -11.59 60.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.333 1.853 . . . . 0.0 114.378 176.496 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.01 -43.54 0.74 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.282 0.944 . . . . 0.0 115.207 167.636 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -62.97 125.96 25.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.498 1.149 . . . . 0.0 113.675 -166.281 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.71 146.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.58 164.13 27.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.203 -0.936 . . . . 0.0 112.274 171.761 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -110.2 144.24 39.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.226 1.81 . . . . 0.0 112.693 -177.102 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.16 149.95 26.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.07 0.948 . . . . 0.0 111.94 173.857 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 51.35 16.52 0.42 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.469 2.308 . . . . 0.0 116.034 -171.409 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.66 -38.29 77.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.985 -1.072 . . . . 0.0 112.911 174.625 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.266 -1.852 . . . . 0.0 114.411 175.189 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -112.27 130.43 55.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -89.33 172.87 8.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 112.992 -177.585 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.92 23.47 3.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.146 0.978 . . . . 0.0 113.038 164.919 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -130.81 6.38 4.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.0 1.72 . . . . 0.0 114.535 -173.614 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 32.11 17.71 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 120.981 -1.074 . . . . 0.0 114.812 179.324 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -129.91 143.05 50.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.268 1.427 . . . . 0.0 111.404 178.396 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t -125.06 121.73 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.4 tp -66.36 -31.36 72.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.359 1.063 . . . . 0.0 112.669 -175.681 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -64.73 -35.52 81.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.506 1.048 . . . . 0.0 113.106 172.728 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.44 -31.84 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.712 0.805 . . . . 0.0 112.775 176.739 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -77.69 -32.27 52.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.122 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.13 -44.78 90.51 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.147 0.879 . . . . 0.0 113.364 176.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.769 1.176 . . . . 0.0 113.052 174.28 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -107.42 151.69 25.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -114.65 162.14 17.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.208 1.003 . . . . 0.0 111.767 170.188 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.23 -13.3 61.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.725 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -83.74 -16.06 46.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.334 1.054 . . . . 0.0 112.224 166.852 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.5 11.91 37.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.621 1.581 . . . . 0.0 115.567 174.764 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.47 146.05 52.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.801 1.301 . . . . 0.0 110.137 173.836 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.19 142.2 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.67 143.4 27.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.914 0.886 . . . . 0.0 110.816 177.484 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -75.5 68.44 2.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.264 1.026 . . . . 0.0 110.421 166.015 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.67 142.0 58.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.509 1.524 . . . . 0.0 112.139 -175.022 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 50.91 52.31 15.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.624 1.57 . . . . 0.0 112.926 -178.384 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.37 -51.08 0.11 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.038 -0.868 . . . . 0.0 115.102 174.703 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.824 -1.542 . . . . 0.0 114.661 -177.754 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -105.09 134.89 47.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -104.94 165.94 10.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.463 1.505 . . . . 0.0 113.242 -178.491 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.8 tp -67.62 -31.07 70.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.462 -0.774 . . . . 0.0 112.362 168.607 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -68.67 -1.43 6.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.736 1.614 . . . . 0.0 115.195 177.539 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 26.89 40.24 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.25 -0.906 . . . . 0.0 114.142 178.774 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -108.1 148.37 29.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.581 1.552 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t -103.31 145.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.07 153.73 27.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.217 1.007 . . . . 0.0 113.586 -175.824 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -129.55 93.8 3.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.412 2.285 . . . . 0.0 108.924 171.836 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.5 mt -107.3 152.85 23.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.361 1.464 . . . . 0.0 112.529 -173.195 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -131.49 168.85 16.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.806 1.643 . . . . 0.0 112.227 -179.627 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.03 167.39 42.14 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.855 1.217 . . . . 0.0 114.237 -177.539 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 125.346 1.451 . . . . 0.0 115.001 -174.128 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.85 124.44 35.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -72.15 168.9 17.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 112.491 -179.355 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.62 -22.35 65.17 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.015 0.926 . . . . 0.0 113.189 169.553 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -90.07 4.74 49.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.288 1.835 . . . . 0.0 114.44 170.997 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 3.92 90.61 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.948 1.261 . . . . 0.0 116.085 175.883 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -77.91 140.05 39.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.666 1.586 . . . . 0.0 109.961 179.277 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.35 130.57 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -74.72 143.13 44.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 112.006 177.901 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -74.24 156.11 37.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.161 0.984 . . . . 0.0 113.572 172.851 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.66 148.15 52.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.29 1.436 . . . . 0.0 112.397 172.595 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 46.2 72.09 0.25 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.77 2.428 . . . . 0.0 114.511 179.049 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.11 165.95 20.21 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.944 1.259 . . . . 0.0 115.664 -179.08 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.902 1.715 . . . . 0.0 112.824 -171.016 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -94.48 126.82 40.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 p -94.3 162.28 13.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.207 1.003 . . . . 0.0 113.296 -178.567 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.97 -29.01 69.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.352 1.061 . . . . 0.0 112.392 169.145 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 p -80.29 10.06 5.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.077 2.151 . . . . 0.0 114.243 174.22 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.08 12.08 81.5 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.471 1.034 . . . . 0.0 115.532 173.94 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -86.43 164.11 17.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.359 1.863 . . . . 0.0 111.074 179.055 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.18 150.18 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.58 147.35 40.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.31 1.044 . . . . 0.0 111.291 -177.341 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -61.61 -21.98 64.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -172.843 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.91 -53.96 0.92 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.126 1.77 . . . . 0.0 112.177 174.136 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -76.93 149.07 36.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -162.639 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.53 17.42 59.93 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.819 1.2 . . . . 0.0 115.522 -178.977 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.479 1.514 . . . . 0.0 114.074 178.044 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -135.3 156.95 48.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -105.16 169.97 8.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.405 1.882 . . . . 0.0 113.231 179.949 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.24 -33.59 63.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.563 1.145 . . . . 0.0 113.783 169.685 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -79.29 -8.39 59.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.136 1.374 . . . . 0.0 114.188 176.237 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.39 -9.77 62.96 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.077 -1.402 . . . . 0.0 115.989 172.333 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -55.35 113.81 1.56 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.598 1.699 . . . . 0.0 110.149 178.061 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t -106.97 129.91 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.47 118.39 36.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.178 1.391 . . . . 0.0 110.97 -174.889 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -93.6 -9.1 39.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -166.779 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.1 tp -134.45 51.06 2.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.939 1.245 . . . . 0.0 113.388 -179.326 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -130.73 21.23 5.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.112 1.765 . . . . 0.0 114.288 178.39 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.3 164.16 20.13 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 114.808 173.956 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 117.424 -1.764 . . . . 0.0 110.849 176.074 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -92.96 121.13 33.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.2 p -83.03 160.58 21.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.247 1.819 . . . . 0.0 113.58 -177.039 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.63 -9.24 58.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.905 -1.122 . . . . 0.0 113.231 170.153 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -84.11 -0.76 53.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.669 1.987 . . . . 0.0 114.354 167.452 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 25.37 56.59 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.256 -0.903 . . . . 0.0 115.181 173.693 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -119.85 168.55 11.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.266 1.427 . . . . 0.0 111.062 175.56 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.81 151.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.35 128.83 54.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.686 1.194 . . . . 0.0 112.891 178.253 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -77.96 98.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.828 2.051 . . . . 0.0 110.723 175.232 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.6 mt -69.53 -23.8 63.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -173.301 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -107.23 -6.14 17.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.133 1.773 . . . . 0.0 113.389 171.265 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.55 -18.48 70.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.525 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-N 119.361 1.581 . . . . 0.0 114.591 176.618 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -96.48 128.53 43.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -78.29 165.5 23.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.532 1.133 . . . . 0.0 112.12 176.46 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -66.41 -26.82 67.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.471 -1.393 . . . . 0.0 112.644 179.918 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -87.13 13.21 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 113.615 169.731 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.42 9.96 82.76 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 165.139 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -77.07 135.46 38.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.838 1.819 . . . . 0.0 110.429 176.758 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.33 148.91 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.27 132.49 51.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.09 0.956 . . . . 0.0 111.862 -177.687 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -140.74 136.57 32.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.562 1.545 . . . . 0.0 110.058 177.588 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.86 100.65 10.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 111.963 -169.679 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -71.9 -28.14 63.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.058 1.343 . . . . 0.0 112.284 175.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 11.6 26.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.692 1.615 . . . . 0.0 116.031 172.812 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 C-N-CA 125.353 1.454 . . . . 0.0 112.792 178.667 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -122.04 137.48 54.79 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -92.28 162.12 14.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.345 1.058 . . . . 0.0 113.139 177.02 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.08 -43.99 78.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.743 1.217 . . . . 0.0 111.521 170.229 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -73.83 -4.57 35.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.876 1.671 . . . . 0.0 113.723 176.017 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.26 23.46 29.29 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 161.911 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -87.8 137.0 32.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.3 1.55 . . . . 0.0 109.431 166.624 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -133.71 138.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.46 142.21 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.754 0.821 . . . . 0.0 112.764 178.271 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.87 50.35 0.92 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.335 1.854 . . . . 0.0 112.303 -174.465 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.3 125.95 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.772 0.829 . . . . 0.0 111.517 -174.68 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.91 -29.91 62.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 113.43 -169.871 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 154.89 7.21 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.609 1.576 . . . . 0.0 113.934 -176.411 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.066 -1.964 . . . . 0.0 114.749 178.344 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -83.72 106.89 15.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -71.68 171.83 10.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.849 2.06 . . . . 0.0 112.274 -175.04 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -66.42 -19.4 65.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.978 -1.077 . . . . 0.0 113.488 -172.793 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -80.78 -11.85 59.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 113.714 173.951 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.53 -12.21 69.96 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.325 1.44 . . . . 0.0 114.942 -168.217 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.35 139.04 58.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.687 1.744 . . . . 0.0 110.29 174.324 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.79 163.87 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.6 tp -121.9 132.24 54.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.359 1.463 . . . . 0.0 112.721 -167.345 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.53 90.35 3.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.388 1.875 . . . . 0.0 109.94 177.807 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -69.83 -22.83 63.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -177.055 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -82.72 82.72 7.95 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 112.606 -178.646 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.71 -37.28 20.29 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 123.974 0.797 . . . . 0.0 113.37 171.21 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.712 -1.605 . . . . 0.0 112.721 -179.38 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -89.79 109.43 20.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.4 p -72.32 169.23 16.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.459 1.904 . . . . 0.0 113.437 -174.505 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.57 -16.14 62.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.644 1.177 . . . . 0.0 113.483 173.268 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -84.72 15.27 3.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.45 1.5 . . . . 0.0 113.055 164.057 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.12 -23.03 1.85 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.32 1.914 . . . . 0.0 115.631 171.931 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -85.12 166.93 16.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.702 1.601 . . . . 0.0 112.916 -177.857 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.33 144.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -86.41 136.86 32.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.152 1.381 . . . . 0.0 112.51 -179.006 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -94.9 140.17 30.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.48 1.112 . . . . 0.0 110.93 169.613 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.79 -23.24 1.81 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.162 1.385 . . . . 0.0 113.802 177.098 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 157.18 44.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.993 1.317 . . . . 0.0 112.099 173.078 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.56 -164.74 32.95 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.401 1.0 . . . . 0.0 113.132 -177.155 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.784 -1.564 . . . . 0.0 113.4 -179.16 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -128.97 146.3 51.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.8 1.64 . . . . 0.0 112.339 -179.27 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.03 -28.6 69.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.844 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 p -78.36 -1.45 33.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.097 1.759 . . . . 0.0 114.519 173.205 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 12.21 73.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.541 1.067 . . . . 0.0 115.634 174.949 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -79.24 129.91 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.351 1.46 . . . . 0.0 108.752 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.64 150.6 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.9 151.42 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.83 0.852 . . . . 0.0 112.612 -179.092 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -78.24 60.15 2.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.918 1.287 . . . . 0.0 110.619 166.642 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -61.15 122.18 14.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.535 1.934 . . . . 0.0 111.113 -178.352 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 56.87 28.86 15.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.873 2.069 . . . . 0.0 113.683 -177.348 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.03 15.6 0.12 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 -177.206 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-N 120.214 2.007 . . . . 0.0 115.232 174.767 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -111.18 153.3 25.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -137.41 148.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.69 1.196 . . . . 0.0 112.537 179.591 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -73.59 -14.28 61.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.24 -0.912 . . . . 0.0 112.583 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -80.56 2.64 24.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.587 1.155 . . . . 0.0 113.938 168.565 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.78 8.17 80.18 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.329 1.291 . . . . 0.0 116.329 167.489 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -90.71 142.02 28.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.153 1.477 . . . . 0.0 110.781 169.161 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.52 134.8 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.7 tp -81.77 130.97 35.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.321 1.448 . . . . 0.0 109.961 170.571 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -67.57 135.91 53.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 113.053 -178.791 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.7 mt -78.27 143.16 37.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 111.486 177.599 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 42.36 45.01 3.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.612 1.965 . . . . 0.0 112.429 -170.058 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.93 -25.46 69.32 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.83 -168.245 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.121 -1.377 . . . . 0.0 112.338 175.847 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -103.77 144.78 31.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -112.91 158.45 20.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 112.416 173.06 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.46 -18.45 61.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.562 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -78.93 -0.08 29.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.272 1.029 . . . . 0.0 113.757 164.159 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.83 3.83 55.88 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.642 -1.643 . . . . 0.0 116.724 163.834 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.22 140.97 38.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.554 2.177 . . . . 0.0 110.48 177.594 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.2 152.8 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.29 125.13 34.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 164.8 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -108.69 106.83 17.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.492 1.917 . . . . 0.0 108.092 176.021 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.8 mt -120.03 153.04 36.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.688 1.595 . . . . 0.0 112.484 -164.718 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 -122.68 -38.03 2.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.753 1.621 . . . . 0.0 114.329 -167.242 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.5 151.31 5.51 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.538 1.066 . . . . 0.0 115.017 178.406 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 125.502 1.525 . . . . 0.0 112.934 178.683 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -85.7 153.12 22.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 112.697 -175.883 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.17 -29.76 67.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 0.0 113.707 -175.726 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -80.5 -9.67 59.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.744 1.217 . . . . 0.0 113.972 178.097 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.65 -0.37 88.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.512 1.053 . . . . 0.0 114.785 -171.218 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -69.54 138.34 53.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.359 1.58 . . . . 0.0 109.719 170.559 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -106.84 137.36 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -95.75 133.97 39.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.77 0.828 . . . . 0.0 111.679 178.518 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mmt-85 -84.92 55.56 3.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.794 1.238 . . . . 0.0 111.352 169.408 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -127.24 142.75 51.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.863 2.065 . . . . 0.0 109.755 175.889 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -82.81 144.36 30.18 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -168.563 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.28 -2.16 80.46 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -172.288 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-N 118.628 1.214 . . . . 0.0 113.48 178.877 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -105.04 131.99 51.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.8 p -63.64 173.18 1.79 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.236 1.414 . . . . 0.0 112.295 165.504 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.76 -29.88 67.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.783 -1.198 . . . . 0.0 112.923 170.603 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -82.41 -5.16 58.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 114.344 174.492 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.95 89.57 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.125 1.345 . . . . 0.0 114.865 -177.798 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.63 134.34 55.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.039 1.42 . . . . 0.0 108.682 172.923 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.28 138.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.9 mt -60.44 -37.0 79.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.252 1.421 . . . . 0.0 113.39 -172.38 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -46.07 -38.21 7.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 113.234 171.715 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.72 -33.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.963 1.305 . . . . 0.0 113.352 -170.866 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.08 -71.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.759 2.824 . . . . 0.0 114.966 176.16 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.07 -25.25 0.04 OUTLIER Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 -178.61 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 119.236 1.518 . . . . 0.0 114.707 -173.551 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -121.85 151.62 40.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -99.9 162.88 12.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.833 1.653 . . . . 0.0 113.368 174.329 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.21 -19.42 64.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.535 1.534 . . . . 0.0 113.072 168.224 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -84.66 3.32 37.64 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.369 1.868 . . . . 0.0 113.88 169.318 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.32 -0.67 79.41 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.41 1.481 . . . . 0.0 115.709 176.458 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -69.42 140.27 54.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.591 1.157 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.33 139.43 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.68 132.1 35.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.964 -1.085 . . . . 0.0 111.208 177.915 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.22 -39.59 78.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.212 2.205 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 mt -136.43 132.96 36.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.381 1.472 . . . . 0.0 110.316 170.754 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -151.0 -11.33 0.23 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 169.399 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.48 161.87 18.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.837 1.684 . . . . 0.0 113.721 175.492 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.461 -1.744 . . . . 0.0 115.121 177.883 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -109.54 146.37 34.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -131.54 162.55 30.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.671 1.588 . . . . 0.0 114.028 -167.844 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 tp -62.17 -10.48 10.62 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.701 2.0 . . . . 0.0 114.713 178.098 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -108.6 2.13 21.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -178.743 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 27.26 73.87 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.11 -0.994 . . . . 0.0 113.89 -173.805 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -93.65 115.67 28.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.401 1.08 . . . . 0.0 109.051 168.725 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m -125.34 147.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.27 154.35 19.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.54 1.136 . . . . 0.0 112.565 -174.37 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -132.96 70.28 1.47 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.581 1.952 . . . . 0.0 109.965 175.901 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.84 153.95 39.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.236 1.415 . . . . 0.0 112.511 -174.475 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -80.59 140.15 35.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.051 1.341 . . . . 0.0 112.711 -168.077 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.49 135.48 2.84 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.432 1.492 . . . . 0.0 113.508 176.69 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.729 1.633 . . . . 0.0 114.2 -175.782 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -85.12 107.73 17.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -71.01 169.05 15.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.629 1.572 . . . . 0.0 113.199 -172.356 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.8 mt -58.64 -31.24 67.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.44 -1.413 . . . . 0.0 112.32 167.659 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -71.3 -0.72 10.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.238 2.215 . . . . 0.0 113.482 174.8 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.28 -33.88 1.77 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.193 1.854 . . . . 0.0 114.04 178.87 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.95 141.89 26.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 110.612 169.332 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.13 156.08 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 tp -92.66 150.45 20.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.343 -0.848 . . . . 0.0 111.548 170.988 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -132.87 145.48 50.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 111.725 162.444 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.2 mt -104.96 -32.8 8.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.197 1.799 . . . . 0.0 111.88 178.249 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -70.2 0.16 6.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -174.731 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.9 -25.47 45.23 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.495 175.465 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.187 1.851 . . . . 0.0 114.557 -178.127 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -101.73 126.26 48.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -89.28 163.71 15.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.699 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.6 -13.82 45.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 167.994 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 p -92.18 -0.12 57.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.0 113.412 174.951 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.09 89.66 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.383 1.468 . . . . 0.0 114.588 -179.004 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -84.82 170.59 13.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.06 1.744 . . . . 0.0 110.895 178.708 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.28 141.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.51 146.91 32.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mtm105 -72.76 -39.95 66.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.259 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 mt -109.36 7.66 25.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -168.999 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -141.39 151.43 43.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.479 1.911 . . . . 0.0 110.752 176.348 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.68 -75.12 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.449 1.5 . . . . 0.0 111.473 -179.123 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 C-N-CA 125.24 1.4 . . . . 0.0 113.266 179.224 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.4 134.69 36.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -119.51 161.17 21.02 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.094 1.358 . . . . 0.0 111.972 -173.471 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.29 -27.88 69.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.669 -1.269 . . . . 0.0 112.028 172.84 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -67.26 -7.02 20.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.813 1.645 . . . . 0.0 114.758 169.797 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.63 15.36 73.6 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.876 -1.14 . . . . 0.0 115.012 176.866 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -73.25 161.44 30.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.829 1.314 . . . . 0.0 111.595 174.428 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.53 147.39 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.72 129.86 56.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.633 1.573 . . . . 0.0 111.204 -175.249 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -76.57 -40.0 50.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.102 0.961 . . . . 0.0 113.361 -173.967 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 mt -92.09 19.7 6.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.394 1.477 . . . . 0.0 113.073 -168.792 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -143.4 132.27 22.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.989 2.116 . . . . 0.0 109.414 179.08 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.39 -144.75 39.71 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.557 0.617 . . . . 0.0 114.632 175.801 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.801 1.667 . . . . 0.0 112.619 -177.075 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.94 128.82 44.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 p -97.73 159.94 14.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.528 1.531 . . . . 0.0 112.54 177.536 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -77.51 4.17 11.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 114.466 176.862 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.8 p -128.84 33.3 4.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 177.235 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.02 52.48 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 162.383 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -115.19 141.98 47.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.705 1.753 . . . . 0.0 112.142 177.967 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.58 136.12 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.12 135.0 42.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.029 0.931 . . . . 0.0 111.027 179.997 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -82.11 77.67 8.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.286 1.434 . . . . 0.0 109.253 169.018 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.67 -26.47 68.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -172.231 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -68.41 -13.2 62.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 173.699 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.86 75.12 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.476 1.989 . . . . 0.0 116.84 -175.394 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 119.996 1.898 . . . . 0.0 115.719 179.679 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -123.35 136.7 54.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -82.24 136.1 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 111.075 165.195 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.22 -27.39 67.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.706 1.202 . . . . 0.0 114.24 -166.289 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -115.61 18.38 15.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.891 1.677 . . . . 0.0 113.162 177.688 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.13 -152.08 5.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.663 1.125 . . . . 0.0 115.236 -171.384 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -83.57 161.63 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.231 2.213 . . . . 0.0 112.997 -164.013 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.46 137.28 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.21 137.22 32.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.753 -0.592 . . . . 0.0 109.527 173.238 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.66 139.15 39.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.189 1.396 . . . . 0.0 112.087 -176.365 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.1 -41.04 74.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.2 1.0 . . . . 0.0 111.425 -178.642 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -63.42 122.06 15.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.203 1.401 . . . . 0.0 109.497 160.911 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.41 -179.55 23.11 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.908 1.242 . . . . 0.0 113.723 178.489 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.19 179.524 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -83.12 112.21 19.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.3 p -67.08 171.12 5.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.776 1.631 . . . . 0.0 113.187 -179.337 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.66 -9.53 44.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -179.626 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -93.24 -9.87 37.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.054 1.342 . . . . 0.0 113.469 170.334 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 -16.42 60.9 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.49 1.995 . . . . 0.0 115.065 -171.879 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.6 154.07 42.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.199 1.5 . . . . 0.0 111.585 177.46 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.98 137.88 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 tp -85.64 137.85 32.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 111.559 174.337 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -90.07 139.45 30.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.909 1.684 . . . . 0.0 111.997 172.043 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.35 7.05 9.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.614 1.566 . . . . 0.0 114.608 -174.996 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -132.09 107.96 8.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.057 1.343 . . . . 0.0 112.323 -176.482 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.66 -16.98 11.19 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.324 1.916 . . . . 0.0 116.528 170.618 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.751 2.12 . . . . 0.0 114.356 178.63 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.85 155.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.7 m -118.09 146.7 43.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.824 2.05 . . . . 0.0 109.954 -174.874 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.74 -19.74 62.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.207 -0.933 . . . . 0.0 113.516 179.022 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -67.95 -19.52 64.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.156 1.783 . . . . 0.0 114.966 171.057 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -12.52 40.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.888 1.709 . . . . 0.0 114.86 -174.159 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 145.47 55.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.066 1.433 . . . . 0.0 111.065 176.962 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.95 168.13 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -72.36 163.39 28.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.622 177.447 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -93.89 159.64 15.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.321 1.448 . . . . 0.0 111.312 158.542 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.84 133.9 25.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.981 0.912 . . . . 0.0 110.28 170.981 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 57.76 9.56 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.304 1.842 . . . . 0.0 115.194 -179.565 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 -9.67 83.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -168.777 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 119.654 1.727 . . . . 0.0 114.481 -176.993 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.1 123.42 33.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.8 p -87.73 170.96 10.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.187 1.395 . . . . 0.0 112.319 174.151 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.35 -20.51 64.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.45 -1.406 . . . . 0.0 114.034 -177.955 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -80.56 -1.89 43.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.888 1.275 . . . . 0.0 113.25 169.592 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.12 -1.22 87.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.02 1.771 . . . . 0.0 115.099 -179.607 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -67.37 139.13 57.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.845 1.822 . . . . 0.0 110.013 177.045 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.63 140.67 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tp -92.12 155.88 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.267 0.627 . . . . 0.0 111.272 178.575 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -126.0 151.41 47.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 111.452 161.419 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.12 143.98 36.84 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.509 0.723 . . . . 0.0 111.81 -177.542 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -133.56 -36.73 0.96 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.214 1.806 . . . . 0.0 112.288 178.687 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 159.96 34.72 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.078 1.323 . . . . 0.0 112.789 165.252 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.804 -175.638 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.76 135.05 54.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 p -76.36 160.39 29.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.974 -1.079 . . . . 0.0 111.738 174.897 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.95 -14.53 62.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.905 -1.122 . . . . 0.0 112.767 167.922 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -82.0 -6.56 59.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 114.368 165.956 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 16.14 57.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.548 1.547 . . . . 0.0 116.174 172.817 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -93.66 146.03 24.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.346 1.458 . . . . 0.0 110.064 176.33 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.47 125.38 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.4 tp -79.48 99.06 7.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 166.07 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -81.4 33.61 0.36 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.478 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.16 -23.13 24.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.728 1.211 . . . . 0.0 113.425 -177.011 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt-85 -134.24 154.16 51.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.351 1.86 . . . . 0.0 111.603 -175.375 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 119.57 1.41 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.467 1.508 . . . . 0.0 113.346 -177.336 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.047 1.784 . . . . 0.0 113.184 179.879 . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -124.64 143.67 50.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -103.31 156.83 17.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.38 1.472 . . . . 0.0 113.823 177.194 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.54 -5.99 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.236 1.814 . . . . 0.0 114.083 176.956 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -115.51 14.05 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.427 1.891 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.29 44.71 7.35 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.424 1.329 . . . . 0.0 116.424 165.366 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -114.42 135.61 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.489 1.116 . . . . 0.0 109.989 161.912 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 136.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.14 141.59 29.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.246 1.019 . . . . 0.0 112.029 -173.976 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 -95.49 -24.96 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.51 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.62 27.66 2.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.028 1.331 . . . . 0.0 112.804 -172.807 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -145.27 123.45 12.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.816 1.646 . . . . 0.0 109.708 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.73 127.6 0.94 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.761 1.172 . . . . 0.0 112.059 -167.247 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.24 1.4 . . . . 0.0 113.122 -173.571 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.51 138.6 46.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -96.52 151.2 19.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.722 1.209 . . . . 0.0 111.631 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -57.31 -35.71 70.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.897 -1.127 . . . . 0.0 112.939 -179.518 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -78.49 0.93 24.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.993 2.117 . . . . 0.0 115.294 176.777 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 25.45 10.74 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 164.041 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -89.96 148.57 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.321 1.56 . . . . 0.0 109.985 166.34 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.65 148.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -111.76 126.28 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.962 0.887 . . . . 0.0 112.615 -171.858 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -94.95 57.49 2.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 128.435 2.694 . . . . 0.0 110.297 -179.692 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 mt -77.32 137.98 39.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.827 1.251 . . . . 0.0 110.93 -176.288 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtp-105 -123.4 -20.78 5.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.373 1.469 . . . . 0.0 113.693 177.265 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.67 -158.95 31.68 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 119.363 0.983 . . . . 0.0 111.805 -164.383 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 C-N-CA 125.417 1.484 . . . . 0.0 113.342 175.453 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -82.48 116.02 21.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -76.72 179.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 113.505 -175.467 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.67 -29.86 70.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.317 . . . . 0.0 112.941 -179.294 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -92.9 6.45 47.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.581 1.952 . . . . 0.0 113.867 172.366 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.8 15.36 80.86 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.86 -1.15 . . . . 0.0 115.77 176.694 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -75.71 145.45 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.229 1.515 . . . . 0.0 108.868 168.49 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.71 167.08 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.59 141.41 51.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.135 -0.978 . . . . 0.0 111.506 173.422 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -90.02 112.56 24.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 176.025 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 mt -107.06 125.87 51.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.19 1.396 . . . . 0.0 111.204 -171.423 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.35 160.97 43.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.283 1.433 . . . . 0.0 113.52 -174.522 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 -164.49 1.53 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.233 0.92 . . . . 0.0 113.614 160.702 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.767 -1.574 . . . . 0.0 113.313 -177.925 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -102.22 159.06 15.73 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -150.32 160.2 43.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.929 1.691 . . . . 0.0 110.294 -176.36 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.69 -10.59 48.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.676 -1.265 . . . . 0.0 113.968 -178.237 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.8 p -79.81 -6.85 58.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.438 1.495 . . . . 0.0 113.953 167.963 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.37 5.91 86.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.409 1.48 . . . . 0.0 116.23 173.16 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 140.77 29.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.517 1.658 . . . . 0.0 110.455 174.512 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.12 144.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.18 136.62 32.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.494 0.718 . . . . 0.0 111.155 173.652 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -114.79 114.06 25.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 108.818 173.927 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.89 153.2 29.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.681 1.592 . . . . 0.0 109.863 -179.694 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -60.97 131.56 51.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.841 0.856 . . . . 0.0 109.999 171.224 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -135.61 20.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -163.575 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.482 174.334 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -91.19 130.75 37.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -85.28 167.47 15.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.684 1.194 . . . . 0.0 113.005 177.213 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.18 -15.0 62.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.006 -1.059 . . . . 0.0 113.55 178.7 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -103.92 17.97 22.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.585 1.954 . . . . 0.0 113.063 171.609 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.68 88.72 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 166.845 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -74.59 142.63 44.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.509 1.654 . . . . 0.0 110.618 178.036 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.62 150.6 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.43 127.56 33.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.446 1.498 . . . . 0.0 112.556 177.948 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -95.36 139.49 31.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.702 1.601 . . . . 0.0 112.439 173.778 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.85 174.92 8.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.153 1.781 . . . . 0.0 112.405 -170.032 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 58.54 31.99 21.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.259 2.224 . . . . 0.0 115.792 179.538 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.37 -9.1 67.62 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.873 1.225 . . . . 0.0 114.774 174.849 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 C-N-CA 125.773 1.654 . . . . 0.0 112.114 171.176 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.67 128.21 56.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 p -85.16 163.91 18.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.159 1.384 . . . . 0.0 111.948 175.913 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -64.02 -20.07 65.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.302 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -77.58 -13.5 59.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.318 1.417 . . . . 0.0 113.02 171.977 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.5 -13.64 39.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.354 1.931 . . . . 0.0 114.543 -176.642 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -64.9 141.37 58.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.84 1.256 . . . . 0.0 111.854 -175.214 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.44 150.07 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -92.16 160.78 15.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.769 -1.207 . . . . 0.0 113.415 -177.61 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 ttm105 -114.38 137.56 51.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.46 1.904 . . . . 0.0 110.248 169.695 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.81 162.46 26.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.183 2.193 . . . . 0.0 110.245 -171.735 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -68.08 119.08 12.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.015 -1.053 . . . . 0.0 110.168 173.634 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 14.96 74.43 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.781 -1.011 . . . . 0.0 115.072 -168.298 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.337 1.922 . . . . 0.0 113.277 -179.265 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -127.56 123.9 36.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.2 p -74.94 159.91 31.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.738 1.215 . . . . 0.0 112.894 -178.878 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.7 tp -57.48 -32.64 67.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.122 -0.986 . . . . 0.0 113.242 168.478 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -70.9 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.449 1.5 . . . . 0.0 114.097 173.954 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.07 59.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.823 1.678 . . . . 0.0 115.657 175.293 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.45 147.6 35.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.252 1.421 . . . . 0.0 109.941 174.43 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.29 132.0 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.02 106.93 3.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.131 1.372 . . . . 0.0 109.994 168.412 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 43.6 ptt85 -87.17 26.66 1.15 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.768 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -109.66 10.39 24.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.824 2.05 . . . . 0.0 112.749 169.16 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -135.53 158.49 44.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.961 2.105 . . . . 0.0 110.585 -179.12 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.42 68.18 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 176.281 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-N 118.928 1.364 . . . . 0.0 113.292 -176.292 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.49 148.32 30.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -130.25 163.27 27.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.8 1.24 . . . . 0.0 112.539 174.584 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.7 tp -56.92 -34.53 68.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.667 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -78.94 6.9 8.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.355 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.21 8.47 74.74 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 120.473 -1.392 . . . . 0.0 115.024 -179.868 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -90.49 118.88 30.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.839 1.656 . . . . 0.0 109.654 176.914 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.95 144.21 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -86.45 146.7 26.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.68 0.752 . . . . 0.0 112.794 175.277 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -134.53 62.05 1.66 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.437 1.895 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.44 131.71 41.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.208 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -62.71 134.22 55.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.226 0.61 . . . . 0.0 112.21 -170.506 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.59 131.37 10.33 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.211 166.342 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.399 1.476 . . . . 0.0 113.453 177.099 . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.97 148.25 22.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -111.29 158.05 19.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.186 0.994 . . . . 0.0 111.787 178.119 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.72 -21.16 66.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.889 -1.132 . . . . 0.0 112.126 169.142 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.4 p -76.85 1.48 17.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.759 1.624 . . . . 0.0 113.794 170.992 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.04 74.06 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 120.814 -1.179 . . . . 0.0 115.379 173.043 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -93.3 160.07 14.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.358 1.863 . . . . 0.0 109.985 178.791 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.97 133.57 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.5 tp -100.66 110.32 22.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.88 1.672 . . . . 0.0 109.11 172.692 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -74.82 116.37 15.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.099 0.408 . . . . 0.0 110.244 174.102 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.43 -47.41 8.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.234 1.014 . . . . 0.0 111.812 179.7 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -67.42 -50.07 61.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.388 0.54 . . . . 0.0 111.919 -179.148 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.31 7.41 78.65 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 -179.648 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 113.999 -174.991 . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -87.25 113.98 23.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -74.95 179.55 4.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.338 1.855 . . . . 0.0 113.669 -172.917 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -65.6 -21.63 66.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.906 -1.121 . . . . 0.0 113.207 178.233 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p -88.82 -3.48 58.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.939 1.296 . . . . 0.0 113.227 176.357 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.43 -2.02 86.15 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.554 1.55 . . . . 0.0 115.29 -173.803 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -65.11 144.8 56.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.816 1.808 . . . . 0.0 109.907 173.52 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.89 169.26 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.83 167.13 10.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 111.728 -177.94 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -75.43 138.42 41.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.243 1.017 . . . . 0.0 111.965 171.234 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -131.83 53.75 1.97 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.813 2.445 . . . . 0.0 109.566 174.866 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -76.27 147.73 38.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.409 -1.432 . . . . 0.0 111.131 -177.202 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.72 136.73 41.53 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.637 -0.664 . . . . 0.0 112.498 174.284 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.184 1.373 . . . . 0.0 113.534 -178.378 . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.4 143.12 51.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -108.46 151.82 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.757 1.623 . . . . 0.0 112.801 -179.363 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.64 -24.98 68.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.375 1.47 . . . . 0.0 112.703 179.641 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -81.72 11.79 4.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.332 1.453 . . . . 0.0 114.086 171.451 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.33 45.02 11.81 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.394 0.997 . . . . 0.0 114.693 165.229 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -118.6 148.97 42.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.425 1.09 . . . . 0.0 110.536 163.371 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.08 133.02 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.4 131.43 36.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.061 1.344 . . . . 0.0 111.412 -174.876 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -83.08 -31.38 27.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.701 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.0 tp -132.36 83.3 2.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 111.121 -171.983 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -135.69 38.75 2.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.569 1.947 . . . . 0.0 110.559 172.958 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.01 -168.87 26.88 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.514 1.531 . . . . 0.0 114.163 -174.847 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 127.133 2.301 . . . . 0.0 114.222 -179.041 . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -119.26 127.72 53.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -78.14 165.27 24.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.144 1.378 . . . . 0.0 112.884 178.138 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.1 -1.0 . . . . 0.0 111.559 167.869 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p -76.5 12.27 1.32 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.843 1.657 . . . . 0.0 114.189 172.371 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 1.45 57.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.357 1.456 . . . . 0.0 116.631 171.429 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.92 132.23 42.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.919 1.86 . . . . 0.0 109.174 177.066 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.01 146.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.37 136.14 33.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 171.516 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -93.09 141.42 28.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.402 -0.811 . . . . 0.0 110.338 162.062 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.85 155.23 25.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.686 0.794 . . . . 0.0 111.71 -175.184 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -143.32 7.44 1.55 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.002 1.721 . . . . 0.0 113.687 -172.5 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 177.42 44.75 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.724 2.107 . . . . 0.0 111.778 176.333 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.461 -1.188 . . . . 0.0 113.562 -179.958 . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -83.04 138.54 33.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -122.94 152.92 40.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.583 1.553 . . . . 0.0 111.37 169.579 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.91 -10.64 54.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -166.363 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.7 p -75.05 -5.24 43.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.373 1.469 . . . . 0.0 114.031 169.91 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.68 90.67 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.962 1.267 . . . . 0.0 113.888 -168.057 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.67 138.65 40.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.285 1.542 . . . . 0.0 110.413 169.255 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.26 157.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.68 138.91 31.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.489 0.716 . . . . 0.0 111.636 175.946 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -71.41 144.89 49.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.147 . . . . 0.0 112.829 176.701 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.21 136.44 50.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.34 1.456 . . . . 0.0 110.293 167.174 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 55.63 30.38 15.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.943 1.697 . . . . 0.0 115.058 177.755 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.87 9.05 78.6 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.571 1.558 . . . . 0.0 116.692 -170.649 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 126.046 1.784 . . . . 0.0 111.446 -174.402 . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -109.0 143.28 38.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 p -102.19 151.81 21.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.579 1.152 . . . . 0.0 111.678 167.474 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.66 -33.54 74.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.231 1.412 . . . . 0.0 110.81 169.353 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.1 p -68.75 -2.54 9.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.581 1.553 . . . . 0.0 114.613 173.382 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 15.64 27.1 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 162.729 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -99.46 144.62 28.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.396 1.598 . . . . 0.0 111.005 178.397 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.58 139.2 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.94 127.78 44.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.833 1.253 . . . . 0.0 110.212 -177.111 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -73.34 -25.24 60.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -165.844 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.3 mt -101.46 30.9 3.99 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.859 1.209 . . . . 0.0 113.606 -168.567 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -127.68 40.41 3.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.111 1.364 . . . . 0.0 114.211 -167.268 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.22 165.29 29.11 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.07 -1.019 . . . . 0.0 115.32 177.126 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 126.444 1.973 . . . . 0.0 114.034 -176.496 . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -90.23 127.51 36.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -89.48 175.93 7.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.05 1.34 . . . . 0.0 112.873 -179.451 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.4 -37.11 79.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.258 1.423 . . . . 0.0 113.177 -177.473 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -79.14 -0.19 30.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.703 . . . . 0.0 113.707 174.018 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.33 89.5 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.004 -1.06 . . . . 0.0 115.071 179.924 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.14 155.92 38.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.105 1.452 . . . . 0.0 110.586 169.825 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.28 144.74 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -86.83 133.61 33.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.054 0.942 . . . . 0.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -87.53 129.42 35.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.746 0.819 . . . . 0.0 111.168 168.081 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -130.94 -42.31 1.11 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.768 2.027 . . . . 0.0 110.452 177.179 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -67.18 160.52 26.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 112.478 167.422 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.51 -161.3 48.23 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.755 1.169 . . . . 0.0 114.431 -179.663 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 C-N-CA 126.78 2.133 . . . . 0.0 114.786 -173.489 . . . . . . . . 0 0 . 1 . 108 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.9 149.69 21.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -134.43 159.79 39.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -157.808 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.96 -20.32 66.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 113.532 173.15 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -86.9 10.45 16.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.588 1.555 . . . . 0.0 113.933 168.64 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.44 17.52 80.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.046 1.308 . . . . 0.0 115.804 164.108 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 158.92 30.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.449 1.5 . . . . 0.0 112.563 178.146 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.38 164.59 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.11 137.55 32.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.914 1.286 . . . . 0.0 111.73 -177.405 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -82.31 80.27 8.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.747 1.619 . . . . 0.0 110.811 176.88 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.6 mt 61.14 -56.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.601 2.76 . . . . 0.0 116.187 -176.406 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -79.65 123.01 27.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.549 1.94 . . . . 0.0 111.685 -176.853 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.01 24.58 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.183 1.373 . . . . 0.0 114.299 -179.122 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.156 1.836 . . . . 0.0 112.882 -174.645 . . . . . . . . 0 0 . 1 . 109 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -100.24 130.54 46.37 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -72.78 162.5 29.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.214 0.605 . . . . 0.0 111.04 164.619 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.17 -18.82 60.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.015 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -86.62 -11.54 51.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.598 1.559 . . . . 0.0 114.855 173.583 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.84 5.08 57.67 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -179.95 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.8 136.92 43.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.056 1.428 . . . . 0.0 110.256 174.675 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -124.21 137.03 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 150.46 20.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.426 0.69 . . . . 0.0 112.182 -178.256 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -86.05 130.61 34.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 157.757 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.3 mt -91.13 28.7 1.55 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -155.843 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -135.04 157.45 46.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.981 2.112 . . . . 0.0 111.927 171.73 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.99 -144.11 3.89 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.964 1.745 . . . . 0.0 113.172 178.68 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.338 1.447 . . . . 0.0 113.403 -177.717 . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -114.8 146.66 40.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -111.44 161.3 16.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.006 1.322 . . . . 0.0 113.892 -179.02 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.95 -31.42 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.13 0.972 . . . . 0.0 113.037 176.856 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -96.71 25.62 5.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.509 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.33 17.78 73.05 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.799 1.48 . . . . 0.0 116.799 160.061 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -83.21 134.59 34.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.076 1.438 . . . . 0.0 109.03 169.145 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -94.52 134.95 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.17 131.15 55.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.634 0.773 . . . . 0.0 112.259 -177.157 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -122.67 64.67 0.96 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.826 1.65 . . . . 0.0 111.204 -172.937 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.46 154.22 40.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.377 1.071 . . . . 0.0 112.392 -177.591 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.02 154.14 42.32 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.723 1.609 . . . . 0.0 112.771 -178.789 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.31 161.08 26.93 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.227 2.346 . . . . 0.0 112.225 -177.565 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.373 1.463 . . . . 0.0 114.441 -174.762 . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -89.46 117.21 28.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -80.63 165.5 21.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.126 1.371 . . . . 0.0 112.962 -176.894 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.27 -32.7 71.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.796 1.238 . . . . 0.0 113.618 -178.416 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -79.87 -11.86 59.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.485 1.514 . . . . 0.0 113.258 178.35 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 9.82 49.09 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.276 1.417 . . . . 0.0 115.602 176.856 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -85.04 171.0 12.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.376 1.588 . . . . 0.0 111.565 170.935 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.81 151.83 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -118.68 137.89 53.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.431 1.092 . . . . 0.0 110.637 -169.478 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.67 82.79 1.92 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.815 1.646 . . . . 0.0 109.064 -177.532 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.29 -6.13 44.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -169.893 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -114.82 101.52 9.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.706 1.602 . . . . 0.0 112.098 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 153.0 52.11 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.807 -0.558 . . . . 0.0 112.336 165.326 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 125.751 1.644 . . . . 0.0 114.16 178.537 . . . . . . . . 0 0 . 1 . 112 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -105.5 122.06 45.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -68.59 177.72 2.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.361 1.065 . . . . 0.0 112.845 177.039 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.39 -27.28 46.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 170.828 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -97.71 11.55 36.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.244 1.418 . . . . 0.0 113.232 175.674 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 6.83 71.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.801 1.191 . . . . 0.0 115.574 176.959 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -65.56 129.14 38.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.469 1.635 . . . . 0.0 109.881 177.576 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.55 144.47 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.12 -37.4 83.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.032 1.333 . . . . 0.0 114.055 -170.942 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -62.75 -18.65 62.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.788 1.235 . . . . 0.0 113.18 177.487 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -131.9 60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.58 2.352 . . . . 0.0 110.387 179.43 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -77.84 54.46 1.27 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 112.365 -177.467 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.28 -147.55 44.35 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.094 1.33 . . . . 0.0 113.633 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.819 1.676 . . . . 0.0 112.82 -174.783 . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -125.27 138.25 54.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -98.35 173.07 7.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.593 1.157 . . . . 0.0 113.258 -173.284 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.34 -16.62 64.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 176.075 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -88.82 1.6 55.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.466 1.106 . . . . 0.0 112.937 171.192 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.77 4.9 88.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.13 1.347 . . . . 0.0 114.721 -177.072 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.47 129.39 39.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.248 1.524 . . . . 0.0 109.492 175.348 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.39 154.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.3 mt -118.94 174.41 6.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.449 1.5 . . . . 0.0 111.85 -171.25 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.8 mtt-85 -96.99 141.17 30.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.888 1.275 . . . . 0.0 111.191 -179.062 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.6 mt -133.52 -17.07 2.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.03 1.332 . . . . 0.0 113.91 -165.687 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.27 146.76 49.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.938 1.695 . . . . 0.0 110.952 -172.201 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.93 22.11 61.99 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.848 0.737 . . . . 0.0 114.493 -173.712 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 C-N-CA 127.362 2.411 . . . . 0.0 110.099 -164.146 . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -103.0 127.1 50.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -109.05 134.69 51.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.409 1.484 . . . . 0.0 109.658 -179.021 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.58 -1.63 16.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -171.79 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -68.76 -5.2 19.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 114.064 161.732 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.73 32.33 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.636 1.589 . . . . 0.0 114.259 -175.239 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -122.22 127.29 49.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.248 1.419 . . . . 0.0 112.351 -173.376 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -106.09 150.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -98.87 136.57 38.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.531 0.732 . . . . 0.0 110.218 174.819 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -127.09 69.15 1.27 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -176.303 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.88 152.02 35.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.98 1.312 . . . . 0.0 114.325 -166.573 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -118.23 -41.04 2.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.268 2.227 . . . . 0.0 112.764 176.219 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.16 -179.95 25.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.283 1.897 . . . . 0.0 114.011 179.741 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.757 1.646 . . . . 0.0 113.723 -177.096 . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.2 136.66 33.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 p -95.63 165.43 12.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 112.369 175.89 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.0 mt -76.41 1.8 15.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.148 1.379 . . . . 0.0 113.49 165.938 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -116.29 29.18 8.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.474 2.71 . . . . 0.0 111.833 179.613 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 0.59 50.86 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 169.412 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -91.34 146.76 23.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.348 1.574 . . . . 0.0 110.906 -177.941 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.39 127.6 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.92 126.14 30.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.792 -1.193 . . . . 0.0 111.058 176.844 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -64.08 -26.03 68.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.805 2.042 . . . . 0.0 113.269 -178.775 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.41 4.48 17.94 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.228 1.411 . . . . 0.0 113.935 176.378 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.28 166.61 23.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.663 1.985 . . . . 0.0 109.764 176.25 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.96 31.33 69.73 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.331 -0.856 . . . . 0.0 114.989 178.858 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.574 1.559 . . . . 0.0 113.081 179.081 . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -84.69 117.89 24.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.4 p -76.58 173.89 11.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.036 1.335 . . . . 0.0 112.666 179.445 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.01 -20.68 66.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.859 -1.151 . . . . 0.0 113.443 179.295 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.4 p -102.47 16.64 25.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.971 1.708 . . . . 0.0 113.792 169.751 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.84 2.91 87.11 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.474 1.511 . . . . 0.0 116.361 169.676 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.74 146.01 51.82 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.943 1.371 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.32 177.2 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.77 150.7 24.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.743 -1.223 . . . . 0.0 113.601 -176.596 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.31 131.05 48.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.777 1.631 . . . . 0.0 110.96 168.292 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.5 116.4 30.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.663 0.785 . . . . 0.0 111.246 179.323 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -160.46 155.81 25.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.406 1.482 . . . . 0.0 113.101 -174.992 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.51 150.47 50.8 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.104 0.859 . . . . 0.0 114.556 -172.834 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.99 -1.45 . . . . 0.0 111.12 -178.959 . . . . . . . . 0 0 . 1 . 117 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -122.08 139.26 53.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -107.16 156.68 18.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.023 1.329 . . . . 0.0 113.22 173.746 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.3 -33.84 75.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.304 1.042 . . . . 0.0 113.18 178.402 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -89.11 5.13 45.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.463 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.37 24.36 10.31 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 159.764 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -86.44 134.98 33.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.654 1.227 . . . . 0.0 108.724 163.622 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.06 131.05 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.52 108.22 18.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.716 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -57.48 138.26 55.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.067 1.747 . . . . 0.0 112.205 -167.842 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.87 153.91 35.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.358 1.063 . . . . 0.0 112.35 -172.896 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -85.37 151.14 24.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.349 1.46 . . . . 0.0 112.016 -175.966 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.12 74.0 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.262 1.265 . . . . 0.0 116.262 -179.996 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.439 1.495 . . . . 0.0 113.879 179.884 . . . . . . . . 0 0 . 1 . 118 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -104.21 139.13 39.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -113.53 163.79 14.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.981 1.713 . . . . 0.0 113.775 -178.098 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -64.15 -22.66 67.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.054 1.342 . . . . 0.0 113.704 -169.84 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -77.31 2.11 16.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.571 2.348 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 2.08 90.55 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.062 -1.024 . . . . 0.0 114.829 -178.554 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -83.5 154.37 23.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.524 1.53 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.44 134.49 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.47 128.03 35.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.481 1.112 . . . . 0.0 111.18 -178.376 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -73.64 -62.85 1.34 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.028 1.331 . . . . 0.0 112.786 -179.52 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.97 105.61 8.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 109.881 -178.342 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -147.46 149.03 31.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.927 1.691 . . . . 0.0 111.05 166.895 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.49 144.2 4.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.418 1.485 . . . . 0.0 113.718 175.129 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.428 1.489 . . . . 0.0 113.371 -179.968 . . . . . . . . 0 0 . 1 . 119 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -86.09 117.7 25.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -72.5 149.43 44.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.227 0.611 . . . . 0.0 110.549 171.803 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.6 tp -68.85 -20.96 64.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.106 -0.996 . . . . 0.0 112.114 174.08 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -80.44 -29.49 37.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.525 1.53 . . . . 0.0 114.87 177.096 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.09 -62.01 0.2 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 170.562 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -74.73 166.61 23.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.412 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.03 143.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.68 137.57 39.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.424 -0.797 . . . . 0.0 110.148 172.615 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -110.72 111.33 22.44 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.409 1.084 . . . . 0.0 110.871 -178.925 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -111.49 159.2 18.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.805 1.642 . . . . 0.0 111.513 174.213 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -57.52 -38.84 75.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.589 1.155 . . . . 0.0 113.29 -178.396 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.93 157.86 14.82 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.664 1.602 . . . . 0.0 114.671 177.218 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 C-N-CA 125.89 1.71 . . . . 0.0 113.303 179.602 . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.63 134.39 52.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -90.79 170.28 10.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 113.337 178.182 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.8 mt -64.83 -29.65 70.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.206 -0.934 . . . . 0.0 112.119 169.126 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.11 5.57 9.8 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.387 1.875 . . . . 0.0 114.051 169.77 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.56 0.19 72.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.149 1.833 . . . . 0.0 115.882 174.819 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -64.17 144.68 56.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.545 1.938 . . . . 0.0 110.923 -177.452 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.75 132.95 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.96 127.55 33.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.031 0.933 . . . . 0.0 109.603 168.289 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 -126.27 100.76 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.488 1.515 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.4 mt -86.86 -42.29 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.643 0.777 . . . . 0.0 111.144 175.211 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -70.0 150.53 46.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.045 1.738 . . . . 0.0 113.765 -178.106 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.35 29.89 74.56 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.423 1.011 . . . . 0.0 115.481 173.14 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.515 1.531 . . . . 0.0 113.288 -179.255 . . . . . . . . 0 0 . 1 . 121 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -125.48 144.61 50.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -95.36 164.49 12.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.994 1.318 . . . . 0.0 112.502 178.834 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.12 -26.85 68.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.333 -0.854 . . . . 0.0 112.928 169.975 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -70.08 -6.96 37.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.796 1.238 . . . . 0.0 113.932 170.925 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.37 -2.6 74.63 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.97 1.748 . . . . 0.0 115.432 176.515 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -78.39 137.14 37.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.646 1.223 . . . . 0.0 111.024 -178.301 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.69 132.01 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 mt -104.89 149.23 25.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.105 0.962 . . . . 0.0 112.418 -175.183 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -84.45 124.09 30.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.883 0.873 . . . . 0.0 109.602 167.676 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 mp -109.13 99.29 8.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.951 1.3 . . . . 0.0 109.645 177.836 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -120.89 17.8 11.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.618 1.567 . . . . 0.0 113.554 -174.335 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.85 -15.43 71.45 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.925 1.25 . . . . 0.0 116.16 -173.715 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.22 1.867 . . . . 0.0 115.055 171.923 . . . . . . . . 0 0 . 1 . 122 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -81.02 118.44 22.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -83.27 173.2 11.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.165 1.786 . . . . 0.0 112.586 -178.819 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.79 -6.92 35.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.551 -1.343 . . . . 0.0 114.563 -173.87 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -103.02 9.03 38.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.723 2.009 . . . . 0.0 113.521 172.079 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.0 -15.48 6.36 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 120.289 -1.507 . . . . 0.0 115.255 -178.597 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -53.67 132.59 41.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.755 . . . . 0.0 110.105 165.958 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.57 157.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.26 129.88 35.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.854 0.862 . . . . 0.0 110.795 -176.472 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -88.12 137.38 32.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.112 2.165 . . . . 0.0 111.947 -178.857 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -133.95 149.95 51.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.3 1.44 . . . . 0.0 113.266 -162.251 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -154.2 163.22 40.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.213 1.405 . . . . 0.0 113.392 173.049 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.3 176.39 54.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.974 1.273 . . . . 0.0 114.535 173.108 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.428 1.489 . . . . 0.0 114.525 172.154 . . . . . . . . 0 0 . 1 . 123 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.87 131.65 37.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 p -89.61 154.71 19.76 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.762 0.791 . . . . 0.0 111.505 168.528 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.54 -6.63 54.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.655 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -138.48 -11.14 1.4 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.927 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -114.74 0.57 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.084 1.311 . . . . 0.0 114.812 -169.549 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -69.54 149.17 48.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.894 1.277 . . . . 0.0 112.5 -167.761 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.86 135.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.83 127.66 42.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.483 0.713 . . . . 0.0 112.26 -178.148 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -58.9 152.05 20.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.166 0.986 . . . . 0.0 112.153 173.604 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.07 161.37 29.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.785 1.234 . . . . 0.0 113.104 -171.112 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 52.53 25.17 3.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.958 2.503 . . . . 0.0 115.352 177.547 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.18 -13.14 62.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.704 1.145 . . . . 0.0 115.177 -174.53 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.692 1.615 . . . . 0.0 112.694 -178.396 . . . . . . . . 0 0 . 1 . 124 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -94.41 139.22 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -104.77 153.11 21.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.53 0.732 . . . . 0.0 111.527 174.017 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.49 -35.19 73.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.497 1.119 . . . . 0.0 112.954 -174.782 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -89.07 15.2 9.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 175.857 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 20.66 37.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 163.814 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm -85.02 155.76 21.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.353 1.077 . . . . 0.0 110.166 166.568 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.17 137.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.67 113.4 25.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 109.663 174.725 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.96 100.18 7.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.821 1.248 . . . . 0.0 109.81 -174.91 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.7 150.97 22.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.797 0.839 . . . . 0.0 111.713 -177.574 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -87.42 -25.38 23.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.904 1.682 . . . . 0.0 112.639 166.771 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.63 -166.38 37.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.704 1.145 . . . . 0.0 114.261 177.94 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.756 1.646 . . . . 0.0 112.428 -177.382 . . . . . . . . 0 0 . 1 . 125 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -126.62 130.85 51.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 p -83.87 167.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.715 1.606 . . . . 0.0 112.937 178.287 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.14 6.86 1.13 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 166.087 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -110.39 6.05 21.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.207 1.803 . . . . 0.0 112.851 168.389 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.98 4.25 71.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.974 1.273 . . . . 0.0 115.479 -178.618 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.28 122.09 17.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.911 1.355 . . . . 0.0 109.548 176.451 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m -133.32 166.11 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.5 mt -117.09 121.41 41.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.948 1.299 . . . . 0.0 110.811 -172.088 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -62.91 -21.88 66.34 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.906 1.282 . . . . 0.0 114.063 -178.783 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.27 3.35 53.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.413 1.485 . . . . 0.0 113.936 178.323 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -130.57 135.86 48.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.144 1.778 . . . . 0.0 111.288 179.082 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.04 -22.35 0.08 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.491 1.044 . . . . 0.0 115.619 -179.953 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.981 1.277 . . . . 0.0 113.927 174.16 . . . . . . . . 0 0 . 1 . 126 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -74.58 122.43 23.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -77.87 172.55 13.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.545 1.138 . . . . 0.0 112.671 -172.322 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tp -71.9 -21.55 61.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.409 170.606 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -84.15 4.57 29.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.871 2.068 . . . . 0.0 114.117 172.248 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.47 79.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.864 1.211 . . . . 0.0 115.635 178.011 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -90.48 -178.1 5.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.749 171.539 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.81 166.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -104.66 166.06 10.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.862 -1.149 . . . . 0.0 114.009 -170.802 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -116.39 147.66 41.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.013 2.125 . . . . 0.0 110.521 160.124 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.96 129.62 47.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.734 1.214 . . . . 0.0 112.251 178.535 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -79.03 168.91 19.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.502 1.521 . . . . 0.0 111.308 170.322 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.11 177.25 20.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.651 1.12 . . . . 0.0 115.161 -177.999 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.778 1.656 . . . . 0.0 113.55 -176.926 . . . . . . . . 0 0 . 1 . 127 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 148.25 27.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -124.06 154.82 39.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.324 1.45 . . . . 0.0 112.174 166.329 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -71.1 -19.09 62.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.832 -1.167 . . . . 0.0 113.032 173.867 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -69.36 -0.03 5.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.26 1.424 . . . . 0.0 113.955 164.299 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.35 14.49 71.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.412 1.482 . . . . 0.0 114.776 172.162 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -92.44 143.93 25.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.414 1.086 . . . . 0.0 110.256 177.181 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.73 132.04 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.4 124.25 39.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.721 0.409 . . . . 0.0 110.101 174.356 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -67.74 159.55 29.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.982 1.313 . . . . 0.0 114.435 -168.657 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -84.22 167.96 16.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.959 1.704 . . . . 0.0 111.893 169.702 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 47.67 46.09 18.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.886 2.074 . . . . 0.0 115.58 168.712 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.48 -4.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 177.339 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-N 120.254 2.027 . . . . 0.0 114.205 179.755 . . . . . . . . 0 0 . 1 . 128 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -117.49 133.16 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -82.06 159.42 23.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 112.42 178.626 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.68 -29.58 68.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.783 0.833 . . . . 0.0 112.121 167.692 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -72.57 -10.75 60.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.084 1.354 . . . . 0.0 114.232 173.232 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.08 12.36 52.43 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.448 1.499 . . . . 0.0 116.069 172.078 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -94.58 143.61 26.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.278 1.539 . . . . 0.0 111.173 178.792 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.34 132.04 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.87 171.63 9.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.254 1.022 . . . . 0.0 113.642 -179.815 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -134.11 66.64 1.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.093 2.157 . . . . 0.0 110.136 170.596 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -76.55 152.34 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.428 1.091 . . . . 0.0 112.159 179.972 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -115.84 149.37 38.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.471 1.909 . . . . 0.0 111.846 -170.381 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.95 47.29 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 175.948 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.216 1.865 . . . . 0.0 113.893 177.546 . . . . . . . . 0 0 . 1 . 129 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -89.63 144.86 25.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p -100.22 155.37 17.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.181 0.992 . . . . 0.0 110.763 167.131 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.47 -27.5 68.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.801 -1.187 . . . . 0.0 111.21 168.064 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -73.84 4.62 5.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.555 1.942 . . . . 0.0 114.239 173.892 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.19 19.46 52.86 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 166.195 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.57 155.94 17.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.376 1.47 . . . . 0.0 110.624 170.694 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.52 135.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.76 135.31 36.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.472 1.509 . . . . 0.0 109.864 172.102 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.37 144.7 56.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.791 0.836 . . . . 0.0 112.616 174.035 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.57 157.0 17.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.223 1.809 . . . . 0.0 112.955 -175.006 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 47.67 39.3 9.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.098 2.159 . . . . 0.0 112.657 -175.285 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.59 22.53 0.85 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.14 2.305 . . . . 0.0 117.675 -165.604 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.07 2.271 . . . . 0.0 111.244 178.266 . . . . . . . . 0 0 . 1 . 130 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.25 118.59 29.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -73.65 166.51 23.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.948 1.299 . . . . 0.0 112.587 -179.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.5 -31.64 70.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.293 -0.879 . . . . 0.0 112.087 167.56 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -72.83 3.35 5.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.634 1.573 . . . . 0.0 114.152 171.42 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.47 -10.97 57.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.36 1.933 . . . . 0.0 116.53 167.117 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -75.88 156.5 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.775 1.288 . . . . 0.0 111.28 175.924 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t -136.58 157.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.21 151.1 19.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.513 -1.367 . . . . 0.0 112.591 -177.716 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -73.34 154.04 40.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.186 0.994 . . . . 0.0 112.773 173.549 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -63.62 -36.15 82.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.55 1.54 . . . . 0.0 113.351 -174.212 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -128.42 157.05 42.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.452 1.901 . . . . 0.0 110.14 170.605 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.22 -18.19 3.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.453 1.501 . . . . 0.0 115.447 178.036 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.366 1.46 . . . . 0.0 114.051 -178.725 . . . . . . . . 0 0 . 1 . 131 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.82 148.3 50.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -90.48 161.19 15.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.53 1.132 . . . . 0.0 112.4 174.427 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.62 -24.89 65.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.797 -1.189 . . . . 0.0 113.064 176.182 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -79.73 3.76 18.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.054 1.741 . . . . 0.0 114.18 166.804 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.44 59.35 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 161.09 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -80.64 111.8 17.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.092 1.946 . . . . 0.0 111.195 -177.289 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.43 136.29 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.04 132.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.216 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -79.13 -24.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.891 0.876 . . . . 0.0 112.439 171.309 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 tt -152.9 135.52 15.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.27 1.428 . . . . 0.0 109.683 167.988 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -145.94 143.27 29.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.195 1.798 . . . . 0.0 110.147 167.232 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.4 -172.57 41.58 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.144 0.402 . . . . 0.0 113.422 -175.25 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.661 1.6 . . . . 0.0 114.159 -177.116 . . . . . . . . 0 0 . 1 . 132 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -119.63 132.9 55.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -90.36 161.03 15.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 111.684 166.542 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.12 -36.33 79.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.637 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -82.34 -1.31 49.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.641 1.176 . . . . 0.0 114.067 174.586 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.17 1.03 29.89 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.439 -1.756 . . . . 0.0 117.024 160.268 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -64.31 139.46 58.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.082 1.941 . . . . 0.0 110.016 177.588 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.45 163.26 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.31 128.3 54.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.752 1.221 . . . . 0.0 111.206 -178.017 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -92.04 119.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.808 1.643 . . . . 0.0 109.123 170.347 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.22 136.94 52.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.834 1.254 . . . . 0.0 112.062 -167.732 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.7 mmm-85 -119.58 -15.08 9.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.956 2.103 . . . . 0.0 113.533 173.28 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.33 -161.46 54.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.78 1.181 . . . . 0.0 114.465 176.622 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 C-N-CA 126.397 1.951 . . . . 0.0 111.965 -176.502 . . . . . . . . 0 0 . 1 . 133 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -89.83 129.65 36.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.3 p -106.65 151.91 24.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.157 0.983 . . . . 0.0 112.728 178.763 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.77 -12.52 60.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 112.897 173.527 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -72.93 -4.02 29.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.288 1.435 . . . . 0.0 113.334 163.721 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 47.33 7.15 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.944 1.259 . . . . 0.0 113.225 174.849 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -132.64 162.5 31.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.76 1.624 . . . . 0.0 110.948 -179.791 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.96 151.08 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.0 tp -102.24 136.16 42.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.79 1.236 . . . . 0.0 112.079 179.981 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -128.24 82.52 2.09 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.318 1.847 . . . . 0.0 109.99 178.745 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.66 -25.03 67.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.641 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -69.3 10.51 0.32 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 179.466 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.68 171.39 21.34 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.454 1.026 . . . . 0.0 113.6 167.399 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 C-N-CA 126.113 1.816 . . . . 0.0 112.189 178.604 . . . . . . . . 0 0 . 1 . 134 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -92.15 125.98 37.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -90.82 172.23 8.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.845 1.258 . . . . 0.0 111.99 -177.286 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.17 -25.84 67.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.731 -1.231 . . . . 0.0 113.49 179.378 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.2 p -87.29 2.53 49.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 113.932 178.181 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 1.2 89.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.972 1.273 . . . . 0.0 115.26 178.667 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -71.37 157.04 38.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.094 1.447 . . . . 0.0 111.148 171.015 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.98 144.1 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.46 151.51 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.231 1.012 . . . . 0.0 113.313 177.522 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 55.65 16.46 1.94 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.474 2.31 . . . . 0.0 116.403 175.875 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -129.16 37.41 4.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.653 1.981 . . . . 0.0 110.21 174.83 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -88.64 -34.86 17.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 0.0 113.409 -174.694 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -173.86 28.9 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.207 0.908 . . . . 0.0 114.048 -176.417 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.85 -2.084 . . . . 0.0 111.007 178.052 . . . . . . . . 0 0 . 1 . 135 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.75 147.72 46.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -116.8 162.35 17.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.335 1.454 . . . . 0.0 113.85 -173.81 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.49 -26.72 68.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.722 1.209 . . . . 0.0 112.8 169.715 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -72.65 1.31 8.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.222 1.409 . . . . 0.0 113.784 168.906 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.31 7.82 88.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.515 1.055 . . . . 0.0 115.124 172.47 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -83.47 145.04 29.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.787 1.293 . . . . 0.0 109.832 176.369 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.86 137.91 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.82 146.38 25.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 112.306 179.471 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -141.87 53.88 1.49 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.829 2.052 . . . . 0.0 112.281 -165.357 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.09 142.82 43.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.084 1.353 . . . . 0.0 112.378 -175.066 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -87.9 -13.85 40.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.009 1.724 . . . . 0.0 114.458 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 158.91 27.41 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.404 1.002 . . . . 0.0 113.423 172.541 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.336 1.446 . . . . 0.0 112.439 -172.143 . . . . . . . . 0 0 . 1 . 136 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.06 112.59 21.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -75.1 171.52 13.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.912 1.285 . . . . 0.0 112.853 -178.559 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.51 -13.09 60.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 167.526 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p -96.22 5.57 50.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.254 1.822 . . . . 0.0 113.495 172.06 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.42 0.42 46.67 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.9 1.238 . . . . 0.0 115.856 -178.566 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -66.31 148.8 51.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.407 1.883 . . . . 0.0 109.676 174.685 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -129.97 137.6 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.1 tp -89.01 133.51 34.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.096 1.359 . . . . 0.0 110.624 179.537 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -73.05 107.42 5.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.087 0.955 . . . . 0.0 108.526 164.977 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.39 -7.88 46.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -158.966 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -126.8 9.37 6.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.129 1.372 . . . . 0.0 114.101 174.913 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -28.52 69.76 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.429 1.332 . . . . 0.0 116.429 -171.836 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 119.163 1.481 . . . . 0.0 114.38 175.138 . . . . . . . . 0 0 . 1 . 137 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.73 139.05 49.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -92.37 163.74 13.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.226 176.353 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -75.07 -6.04 47.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 175.985 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -112.97 28.15 9.03 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.447 1.499 . . . . 0.0 112.506 168.204 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 30.0 64.44 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.619 1.408 . . . . 0.0 116.619 160.58 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.14 135.33 36.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.506 1.653 . . . . 0.0 109.543 163.34 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.11 135.03 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.05 113.83 27.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.944 0.898 . . . . 0.0 110.162 177.361 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -55.96 -42.84 76.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.57 0.748 . . . . 0.0 112.731 -178.622 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.83 31.94 4.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.016 1.327 . . . . 0.0 113.095 -168.742 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -136.91 21.12 3.05 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.778 1.231 . . . . 0.0 113.383 174.495 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 -179.18 26.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.361 1.458 . . . . 0.0 116.525 173.185 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.516 -179.749 . . . . . . . . 0 0 . 1 . 138 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -97.19 134.44 40.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -108.5 154.01 22.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.914 1.286 . . . . 0.0 112.948 172.506 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.48 -22.23 66.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.967 1.307 . . . . 0.0 114.376 -176.853 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.6 p -85.13 19.18 2.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.694 1.998 . . . . 0.0 113.95 171.473 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.46 89.61 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 167.848 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -81.21 152.94 27.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.987 1.394 . . . . 0.0 110.303 175.762 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.24 162.1 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.3 144.42 34.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.796 0.807 . . . . 0.0 111.17 173.706 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -80.0 137.93 36.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 110.275 177.706 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.18 154.69 21.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 111.423 176.33 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 54.51 39.16 30.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.089 1.756 . . . . 0.0 113.448 177.635 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.98 54.89 0.32 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 113.669 -169.761 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.746 1.641 . . . . 0.0 112.226 -175.574 . . . . . . . . 0 0 . 1 . 139 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -129.7 140.5 51.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.9 p -107.23 163.17 13.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.76 1.624 . . . . 0.0 112.901 179.376 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -27.37 69.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.885 -1.134 . . . . 0.0 112.348 169.3 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -65.11 -8.98 19.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 167.802 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 8.59 78.11 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.3 1.428 . . . . 0.0 116.041 172.286 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.34 135.77 37.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.426 1.613 . . . . 0.0 109.698 174.377 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -116.18 128.8 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.57 134.94 39.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.735 0.814 . . . . 0.0 110.228 178.753 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -85.17 64.88 8.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.098 179.06 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.16 129.44 34.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.564 178.757 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.54 -36.15 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.977 2.911 . . . . 0.0 116.975 -166.153 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.43 -24.35 76.43 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.497 1.499 . . . . 0.0 116.251 -176.372 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 126.552 2.025 . . . . 0.0 112.988 174.679 . . . . . . . . 0 0 . 1 . 140 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -116.35 154.11 30.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -125.39 155.54 40.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.284 1.433 . . . . 0.0 112.521 174.47 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.77 -19.52 65.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.597 1.159 . . . . 0.0 112.635 170.569 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -73.43 1.19 10.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.814 1.646 . . . . 0.0 113.659 168.54 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.81 25.69 68.95 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.851 -1.156 . . . . 0.0 114.456 174.813 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -96.01 142.89 27.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.299 1.049 . . . . 0.0 110.449 172.221 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.97 131.95 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.71 130.22 52.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.231 1.012 . . . . 0.0 111.75 179.859 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -100.53 151.44 21.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.064 1.746 . . . . 0.0 112.073 -167.632 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.06 -41.87 1.26 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.3 1.44 . . . . 0.0 112.789 179.863 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -72.15 150.67 43.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.448 1.022 . . . . 0.0 112.86 176.619 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.31 -2.94 12.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.52 1.534 . . . . 0.0 116.786 -179.01 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 126.54 2.019 . . . . 0.0 112.099 179.287 . . . . . . . . 0 0 . 1 . 141 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.38 129.58 55.24 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -84.36 176.62 8.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 113.292 -179.351 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.3 -22.93 65.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 177.535 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -85.83 -0.37 55.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.743 1.156 . . . . 0.0 113.69 170.599 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.94 8.81 86.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.583 1.087 . . . . 0.0 114.492 -177.515 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.57 138.22 50.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.951 1.375 . . . . 0.0 109.764 176.232 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.47 117.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.27 123.19 28.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.391 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -81.02 60.28 4.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.979 0.912 . . . . 0.0 113.122 -173.323 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.9 134.73 57.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 173.895 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 53.3 45.47 28.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.361 1.464 . . . . 0.0 113.492 -174.739 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.27 -37.72 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.762 1.172 . . . . 0.0 115.312 176.369 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 126.686 2.089 . . . . 0.0 113.364 175.43 . . . . . . . . 0 0 . 1 . 142 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.86 125.96 53.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -74.55 168.33 19.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.172 1.389 . . . . 0.0 113.704 -172.169 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -60.97 -16.54 43.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.328 1.451 . . . . 0.0 114.258 168.724 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.4 p -94.03 -5.05 48.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.849 1.659 . . . . 0.0 113.061 171.742 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 10.11 82.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.975 1.274 . . . . 0.0 115.281 -178.603 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.14 133.35 39.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.496 1.648 . . . . 0.0 109.592 174.977 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t -129.39 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.6 mt -109.04 155.75 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 112.528 -178.744 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -85.88 156.96 20.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -134.65 24.36 3.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.11 1.364 . . . . 0.0 113.836 -161.691 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.48 -43.82 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.521 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.73 -1.25 89.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.165 1.364 . . . . 0.0 116.27 -171.432 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.192 1.853 . . . . 0.0 112.878 176.757 . . . . . . . . 0 0 . 1 . 143 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.95 140.33 29.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -121.31 154.11 36.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.164 0.986 . . . . 0.0 111.004 174.741 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.6 tp -51.13 -38.58 52.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.095 1.758 . . . . 0.0 114.814 -166.22 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 p -73.8 -7.96 54.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.373 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.25 -18.41 36.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.573 1.559 . . . . 0.0 114.127 -177.885 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.3 140.4 58.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.978 1.711 . . . . 0.0 111.208 176.548 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.77 158.43 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.03 125.22 49.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.722 -0.611 . . . . 0.0 110.641 175.229 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -127.37 100.85 6.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 0.0 110.445 176.046 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.4 153.66 43.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.811 -179.644 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -105.3 -20.68 13.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.675 2.39 . . . . 0.0 111.941 174.304 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.18 -175.53 49.89 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.269 1.89 . . . . 0.0 113.755 177.608 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.338 -1.812 . . . . 0.0 112.979 174.748 . . . . . . . . 0 0 . 1 . 144 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 113.81 15.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -78.59 169.63 17.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.926 1.69 . . . . 0.0 114.21 -171.299 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.14 -22.29 64.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 176.394 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -93.61 -6.51 46.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 113.828 -176.848 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.22 -16.5 45.55 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.039 1.304 . . . . 0.0 115.501 176.414 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.46 170.95 15.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.163 1.482 . . . . 0.0 112.203 170.559 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.19 150.45 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.46 120.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.438 -0.789 . . . . 0.0 111.183 175.438 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -82.98 134.68 35.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.819 1.248 . . . . 0.0 110.278 171.575 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.25 -17.46 5.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.646 1.578 . . . . 0.0 113.309 -179.263 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -79.37 3.19 19.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 177.054 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 -23.38 51.64 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.612 1.096 . . . . 0.0 115.505 179.202 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.778 -179.283 . . . . . . . . 0 0 . 1 . 145 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -106.99 144.7 33.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -98.53 163.95 12.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.394 1.478 . . . . 0.0 113.745 171.729 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.74 -25.26 68.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.184 0.994 . . . . 0.0 112.355 166.547 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.8 p -76.72 0.88 18.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.9 1.28 . . . . 0.0 113.511 171.404 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.08 87.64 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.176 1.37 . . . . 0.0 115.773 174.005 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.92 138.94 32.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.358 1.463 . . . . 0.0 110.493 -177.995 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.48 137.01 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.6 mp -95.74 112.75 24.4 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.101 0.961 . . . . 0.0 108.596 170.065 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -60.22 112.65 2.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.167 0.987 . . . . 0.0 113.403 -167.668 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.1 130.15 42.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.56 1.144 . . . . 0.0 110.418 -178.585 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 58.21 17.14 4.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.933 1.693 . . . . 0.0 114.441 -169.769 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.56 173.45 19.65 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.835 1.683 . . . . 0.0 112.624 176.354 . . . . . . . . 1 1 . 1 . 145 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.737 -1.591 . . . . 0.0 113.854 179.499 . . . . . . . . 0 0 . 1 . 146 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -101.7 138.01 39.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.1 p -98.63 160.37 14.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.812 1.245 . . . . 0.0 112.812 179.265 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.69 -33.47 71.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.626 -0.671 . . . . 0.0 111.382 172.704 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.54 12.13 4.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.136 1.374 . . . . 0.0 113.688 176.817 . . . . . . . . 2 2 . 1 . 146 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.89 24.95 72.91 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.74 -1.225 . . . . 0.0 115.68 169.733 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -94.91 146.32 24.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.465 1.133 . . . . 0.0 108.955 168.805 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.25 128.41 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -84.03 131.34 34.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.94 -0.475 . . . . 0.0 110.315 173.168 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.96 89.86 2.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.276 1.83 . . . . 0.0 110.112 -175.398 . . . . . . . . 2 2 . 1 . 146 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -85.28 151.74 23.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.444 1.098 . . . . 0.0 111.494 -177.988 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -73.76 148.7 42.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.364 1.465 . . . . 0.0 112.238 -179.27 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.19 169.89 42.59 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.042 1.306 . . . . 0.0 115.445 178.638 . . . . . . . . 1 1 . 1 . 146 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.455 -1.747 . . . . 0.0 115.772 -174.349 . . . . . . . . 0 0 . 1 . 147 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -97.37 153.81 17.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -121.76 160.35 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.932 1.293 . . . . 0.0 112.21 178.639 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.1 mt -72.99 -12.83 61.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.2 -0.938 . . . . 0.0 112.486 171.248 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -80.04 3.73 19.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.444 1.498 . . . . 0.0 114.02 163.896 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 10.54 83.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.34 1.448 . . . . 0.0 116.244 170.669 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -80.14 165.1 22.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.711 1.756 . . . . 0.0 111.916 174.938 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.21 148.32 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -126.7 143.07 51.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.19 1.396 . . . . 0.0 112.416 -164.516 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -72.7 -39.23 67.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.942 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.8 mt -102.08 29.5 5.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.305 1.442 . . . . 0.0 114.249 -167.721 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -142.55 161.5 37.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.514 2.326 . . . . 0.0 111.134 178.736 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.85 111.18 2.23 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.927 1.727 . . . . 0.0 112.601 174.475 . . . . . . . . 1 1 . 1 . 147 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.967 1.27 . . . . 0.0 112.19 -171.12 . . . . . . . . 0 0 . 1 . 148 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -87.35 117.29 26.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 m -77.87 138.21 38.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 166.665 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.29 12.91 0.27 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 179.836 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 p -80.71 -12.75 59.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.917 1.687 . . . . 0.0 112.906 160.442 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -21.01 32.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 127.814 2.626 . . . . 0.0 114.146 -177.534 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -74.34 150.21 40.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.871 1.335 . . . . 0.0 112.442 179.348 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.2 153.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 2 2 . 1 . 148 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.39 143.25 57.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.918 0.887 . . . . 0.0 110.48 169.463 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -115.73 140.22 49.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.5 1.52 . . . . 0.0 112.562 179.109 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -74.69 164.59 26.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.697 1.999 . . . . 0.0 112.22 176.095 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 54.48 37.3 27.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.132 1.773 . . . . 0.0 114.143 -178.342 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.87 -15.35 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 178.356 . . . . . . . . 1 1 . 1 . 148 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.908 1.718 . . . . 0.0 112.204 178.326 . . . . . . . . 0 0 . 1 . 149 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.0 p -80.65 161.6 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.552 175.591 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.02 -22.95 67.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.174 -0.954 . . . . 0.0 112.435 169.309 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.5 p -79.21 -0.07 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 114.257 171.98 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.66 17.2 66.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.855 1.217 . . . . 0.0 116.015 173.111 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -98.14 135.9 39.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.511 1.524 . . . . 0.0 110.194 177.226 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.62 130.65 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.5 mt -81.76 140.29 34.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.96 0.504 . . . . 0.0 111.873 -175.858 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -75.83 158.02 32.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 112.135 165.541 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -88.34 141.54 28.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.469 1.508 . . . . 0.0 110.305 -179.427 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.02 44.01 25.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.002 1.721 . . . . 0.0 112.965 -175.609 . . . . . . . . 2 2 . 1 . 149 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.46 24.36 13.92 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.795 2.14 . . . . 0.0 114.779 -175.939 . . . . . . . . 1 1 . 1 . 149 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.856 1.693 . . . . 0.0 115.431 -172.963 . . . . . . . . 0 0 . 1 . 150 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.45 136.76 38.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -98.39 144.67 27.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.208 1.403 . . . . 0.0 111.923 175.124 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.06 -29.15 67.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.028 1.331 . . . . 0.0 114.26 -168.858 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -81.53 -15.11 55.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.945 1.698 . . . . 0.0 115.163 176.769 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.92 -32.86 0.88 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.961 1.944 . . . . 0.0 117.961 164.299 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -65.75 138.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.427 1.614 . . . . 0.0 112.708 -167.085 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.54 140.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mp -100.83 121.05 41.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.716 1.206 . . . . 0.0 110.288 -177.654 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 mtp-105 -86.62 137.04 32.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 112.965 175.346 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 tp -77.57 134.51 38.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.711 1.204 . . . . 0.0 111.173 177.746 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -106.01 -38.67 6.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.677 1.191 . . . . 0.0 113.191 173.123 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.26 -171.81 48.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.004 1.287 . . . . 0.0 116.256 171.817 . . . . . . . . 1 1 . 1 . 150 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 125.215 1.388 . . . . 0.0 113.26 177.877 . . . . . . . . 0 0 . 1 . 151 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -84.38 122.65 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -70.52 165.34 22.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 112.964 178.93 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.4 -25.03 66.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 112.471 166.822 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -84.09 4.3 30.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.996 1.718 . . . . 0.0 114.186 172.543 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.77 -1.79 88.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.573 . . . . 0.0 116.715 170.441 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -95.65 171.85 8.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.78 1.79 . . . . 0.0 112.5 178.896 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.6 165.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.13 157.18 19.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.245 1.018 . . . . 0.0 113.152 -177.053 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -125.72 156.99 38.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.218 1.807 . . . . 0.0 115.42 179.558 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt 60.59 -30.53 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 130.868 3.667 . . . . 0.0 120.407 155.759 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -122.6 154.79 37.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.142 1.337 . . . . 0.0 112.308 -165.533 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.27 160.32 25.79 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.498 1.047 . . . . 0.0 112.58 172.523 . . . . . . . . 1 1 . 1 . 151 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 117.691 -1.616 . . . . 0.0 112.933 177.058 . . . . . . . . 0 0 . 1 . 152 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.52 122.1 36.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -78.64 162.79 25.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.879 0.872 . . . . 0.0 112.12 173.285 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.22 -25.18 65.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.625 0.77 . . . . 0.0 112.425 170.891 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.6 p -86.93 7.84 25.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.109 2.163 . . . . 0.0 114.199 176.209 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.58 8.8 87.5 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.155 1.359 . . . . 0.0 115.893 174.482 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -77.29 138.25 39.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.663 1.185 . . . . 0.0 110.595 178.105 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -103.37 139.37 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 mt -101.15 143.85 30.75 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.769 -0.582 . . . . 0.0 110.95 165.468 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -114.86 76.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.309 1.444 . . . . 0.0 108.135 168.906 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.44 140.46 58.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.73 0.812 . . . . 0.0 110.185 178.481 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -73.49 143.21 46.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.807 1.243 . . . . 0.0 112.856 -166.154 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -152.49 34.75 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.28 0.943 . . . . 0.0 113.732 -176.3 . . . . . . . . 1 1 . 1 . 152 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 125.694 1.616 . . . . 0.0 112.66 -176.567 . . . . . . . . 0 0 . 1 . 153 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.59 143.53 43.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -122.9 157.43 32.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.696 1.598 . . . . 0.0 113.463 177.142 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -68.23 -20.68 64.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -175.041 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -72.98 -6.28 44.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.099 1.36 . . . . 0.0 114.202 168.212 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.93 9.54 57.17 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.876 1.227 . . . . 0.0 115.11 177.537 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -76.64 147.13 37.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.969 1.885 . . . . 0.0 110.988 174.423 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.23 149.11 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.55 154.16 19.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.239 1.016 . . . . 0.0 112.013 -172.081 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -121.58 47.95 1.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.064 1.746 . . . . 0.0 112.273 -179.07 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.56 134.68 36.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.553 1.141 . . . . 0.0 111.778 -175.941 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtp-105 -141.19 -3.15 1.22 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.898 1.679 . . . . 0.0 114.422 178.233 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.66 153.63 8.27 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.492 1.52 . . . . 0.0 114.794 179.944 . . . . . . . . 1 1 . 1 . 153 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 125.483 1.516 . . . . 0.0 112.666 -177.589 . . . . . . . . 0 0 . 1 . 154 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 148.93 26.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -152.17 148.27 27.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.05 1.34 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.96 5.74 2.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.981 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -99.68 36.82 1.71 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.158 1.783 . . . . 0.0 113.55 171.702 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.78 32.99 79.03 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 161.362 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -155.96 167.57 29.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.941 1.296 . . . . 0.0 112.333 179.333 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.48 136.1 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.51 137.9 31.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.303 1.041 . . . . 0.0 110.993 179.041 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -132.24 102.82 5.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.526 1.13 . . . . 0.0 110.523 179.295 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.75 164.54 15.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.685 1.994 . . . . 0.0 110.538 175.228 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -59.15 128.56 37.8 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.829 1.652 . . . . 0.0 112.949 -178.458 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.78 165.11 27.62 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.842 1.21 . . . . 0.0 114.473 179.182 . . . . . . . . 1 1 . 1 . 154 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.276 1.893 . . . . 0.0 115.172 -172.333 . . . . . . . . 0 0 . 1 . 155 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.81 116.12 16.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -93.54 173.24 7.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.895 1.278 . . . . 0.0 113.064 -177.208 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -66.49 -26.9 67.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -171.48 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -68.53 -21.76 64.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 171.306 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.09 -16.2 54.14 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.794 1.188 . . . . 0.0 113.543 -164.434 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -71.35 143.98 50.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.023 1.911 . . . . 0.0 111.49 177.306 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.35 155.57 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.6 tp -85.4 117.68 24.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.74 1.216 . . . . 0.0 108.115 166.252 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -114.25 122.16 45.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 110.505 -173.789 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.3 mt -142.37 -19.13 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.607 1.963 . . . . 0.0 114.91 -170.899 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -124.37 21.12 8.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.373 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.06 -21.52 61.59 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.587 1.089 . . . . 0.0 115.789 -176.013 . . . . . . . . 1 1 . 1 . 155 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.673 1.606 . . . . 0.0 112.565 175.125 . . . . . . . . 0 0 . 1 . 156 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 150.7 42.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 2 2 . 1 . 156 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.5 p -85.61 159.7 19.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.674 0.79 . . . . 0.0 111.027 166.835 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.19 0.35 6.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.479 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -111.83 20.35 17.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.78 2.432 . . . . 0.0 112.503 171.492 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.94 8.92 86.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 117.603 -1.665 . . . . 0.0 117.14 161.46 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -80.74 141.88 34.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.134 1.967 . . . . 0.0 109.825 167.195 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t -115.78 138.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.99 164.46 13.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 -179.912 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -98.98 -35.98 9.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 172.954 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.04 26.25 10.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.836 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -131.58 170.13 15.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.009 1.724 . . . . 0.0 112.492 179.521 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -91.08 1.03 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.401 1.001 . . . . 0.0 114.016 166.765 . . . . . . . . 1 1 . 1 . 156 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 116.639 -2.201 . . . . 0.0 114.816 -177.854 . . . . . . . . 0 0 . 1 . 157 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -110.41 127.34 55.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -73.49 166.89 22.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.551 1.54 . . . . 0.0 112.566 179.783 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.89 -24.37 67.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.955 -1.09 . . . . 0.0 112.515 169.964 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -81.35 -0.79 42.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.94 2.096 . . . . 0.0 114.033 171.051 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.25 10.34 86.28 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.678 1.609 . . . . 0.0 115.889 172.244 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -83.05 144.04 30.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.851 1.26 . . . . 0.0 109.591 171.933 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.33 146.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.13 147.21 23.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.029 -1.045 . . . . 0.0 110.22 176.761 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -135.98 101.41 4.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 110.827 170.628 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.31 163.79 23.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.084 0.945 . . . . 0.0 112.392 -175.006 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -100.53 5.49 44.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.726 2.01 . . . . 0.0 112.944 173.495 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.77 157.97 12.13 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.362 1.458 . . . . 0.0 113.111 176.949 . . . . . . . . 1 1 . 1 . 157 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.186 1.374 . . . . 0.0 115.69 179.749 . . . . . . . . 0 0 . 1 . 158 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -125.02 144.89 50.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -88.75 167.33 13.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.807 1.243 . . . . 0.0 112.088 -178.78 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.33 -33.84 74.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.623 -1.298 . . . . 0.0 111.312 169.834 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -74.96 1.93 11.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.287 2.235 . . . . 0.0 114.734 173.541 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.35 79.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 171.202 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -78.6 149.23 33.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.991 1.896 . . . . 0.0 111.723 176.497 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.51 151.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 132.87 34.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.599 -1.313 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 158 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -84.97 26.94 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.606 1.562 . . . . 0.0 114.923 -161.59 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt 54.24 38.29 29.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.589 1.556 . . . . 0.0 113.515 -179.685 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -105.91 -25.46 12.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.54 1.536 . . . . 0.0 113.138 -174.308 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.96 -145.82 7.17 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.04 2.257 . . . . 0.0 112.062 174.985 . . . . . . . . 1 1 . 1 . 158 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.812 -1.549 . . . . 0.0 113.894 177.498 . . . . . . . . 0 0 . 1 . 159 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -90.68 125.87 35.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -94.56 178.3 5.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.257 1.023 . . . . 0.0 113.172 179.13 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.54 -19.87 58.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.168 1.787 . . . . 0.0 115.667 -177.205 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -87.97 1.09 54.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.523 1.529 . . . . 0.0 113.69 172.473 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.95 40.56 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.687 1.137 . . . . 0.0 114.58 -170.551 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -66.28 142.85 57.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.775 1.787 . . . . 0.0 110.801 176.501 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.44 124.13 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.19 136.07 44.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.66 0.784 . . . . 0.0 111.989 -173.022 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -68.47 118.63 11.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.889 1.276 . . . . 0.0 110.807 171.117 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.4 tp -75.94 -46.72 28.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.917 0.887 . . . . 0.0 112.87 -172.227 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -83.1 40.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 112.066 175.622 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.14 -14.78 81.55 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.76 1.647 . . . . 0.0 115.806 -171.67 . . . . . . . . 1 1 . 1 . 159 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.861 -1.522 . . . . 0.0 113.054 -177.195 . . . . . . . . 0 0 . 1 . 160 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -112.61 137.91 50.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -113.15 155.36 25.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.394 1.478 . . . . 0.0 113.747 177.747 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.4 -35.71 81.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.046 1.338 . . . . 0.0 113.17 -175.829 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -78.86 7.95 6.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.47 1.108 . . . . 0.0 113.725 172.803 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.71 3.72 42.96 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.184 -1.342 . . . . 0.0 116.398 160.787 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -86.8 147.11 25.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.065 1.932 . . . . 0.0 112.34 -176.184 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.86 133.48 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -91.74 112.35 24.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.851 0.86 . . . . 0.0 109.143 173.302 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -79.91 64.3 4.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.468 1.907 . . . . 0.0 112.117 -179.574 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.79 164.48 12.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.274 2.229 . . . . 0.0 110.941 167.796 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -130.32 165.28 22.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.748 1.219 . . . . 0.0 112.385 -179.453 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.33 -152.29 11.9 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.669 1.128 . . . . 0.0 113.185 177.512 . . . . . . . . 1 1 . 1 . 160 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.701 -1.61 . . . . 0.0 113.003 176.325 . . . . . . . . 0 0 . 1 . 161 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.63 128.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -73.88 172.54 11.39 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.03 0.932 . . . . 0.0 113.168 178.892 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.53 -25.13 6.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.212 2.205 . . . . 0.0 114.45 169.869 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -104.82 8.13 34.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.154 1.781 . . . . 0.0 113.989 176.597 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.47 7.64 88.35 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.814 1.197 . . . . 0.0 115.564 175.074 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.39 131.87 46.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.343 1.571 . . . . 0.0 109.396 173.665 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.76 157.25 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.52 152.75 44.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.477 1.511 . . . . 0.0 112.97 171.621 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 57.58 -17.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 129.78 3.232 . . . . 0.0 118.624 173.299 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.27 92.74 3.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 108.982 172.066 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -116.41 -21.34 9.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 113.231 175.728 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.04 -158.53 32.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.166 1.841 . . . . 0.0 114.086 166.848 . . . . . . . . 1 1 . 1 . 161 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.965 1.745 . . . . 0.0 115.569 176.22 . . . . . . . . 0 0 . 1 . 162 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -90.98 117.87 29.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -91.16 156.23 18.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.655 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.17 -21.58 66.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.472 1.509 . . . . 0.0 112.834 170.658 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.5 p -79.44 -1.13 35.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.077 1.751 . . . . 0.0 113.904 172.305 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.13 19.46 55.5 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.515 -1.159 . . . . 0.0 115.853 170.276 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -114.77 163.65 15.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.283 1.433 . . . . 0.0 111.321 173.465 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.11 145.83 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 tp -92.0 143.05 26.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.471 1.109 . . . . 0.0 111.641 178.497 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -94.52 123.61 38.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.999 1.32 . . . . 0.0 110.651 165.532 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.9 -62.62 1.48 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.564 0.745 . . . . 0.0 111.797 178.123 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.05 157.59 34.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.603 1.161 . . . . 0.0 112.927 172.519 . . . . . . . . 2 2 . 1 . 162 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.5 155.75 25.87 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.811 1.196 . . . . 0.0 112.212 179.675 . . . . . . . . 1 1 . 1 . 162 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.935 -177.389 . . . . . . . . 0 0 . 1 . 163 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -127.81 141.89 51.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.7 p -129.24 153.59 47.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.673 1.189 . . . . 0.0 113.567 -179.632 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.93 -15.32 62.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.842 1.257 . . . . 0.0 112.855 173.286 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -68.71 -1.06 6.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.403 1.481 . . . . 0.0 114.036 164.351 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 31.11 9.74 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 161.371 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.48 139.67 52.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 111.76 178.435 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.55 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.44 143.07 27.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.026 0.93 . . . . 0.0 112.111 170.421 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -85.54 54.54 3.15 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.969 1.308 . . . . 0.0 114.185 174.02 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.47 -32.8 63.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.904 1.282 . . . . 0.0 114.162 -173.517 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -67.63 -14.26 62.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.051 1.34 . . . . 0.0 113.789 175.345 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.73 1.55 75.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.782 2.134 . . . . 0.0 114.997 169.001 . . . . . . . . 1 1 . 1 . 163 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.845 -1.53 . . . . 0.0 112.463 171.844 . . . . . . . . 0 0 . 1 . 164 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -107.87 132.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -107.53 155.89 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.525 1.13 . . . . 0.0 113.52 179.154 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.69 -12.1 56.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.967 1.307 . . . . 0.0 113.77 170.588 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -87.37 3.93 45.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.051 2.141 . . . . 0.0 113.529 170.024 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.71 16.42 77.48 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.744 -1.223 . . . . 0.0 115.756 172.568 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -92.21 145.26 24.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.439 1.096 . . . . 0.0 110.421 174.906 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.84 133.16 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.28 143.17 42.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 111.853 -178.655 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -99.85 82.88 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.994 1.718 . . . . 0.0 110.977 177.761 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.3 mt -107.42 142.13 37.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.629 1.171 . . . . 0.0 112.321 -171.458 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -68.44 152.55 45.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.216 1.407 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.81 173.33 45.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.085 1.802 . . . . 0.0 113.972 172.263 . . . . . . . . 1 1 . 1 . 164 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.567 1.556 . . . . 0.0 114.706 -176.917 . . . . . . . . 0 0 . 1 . 165 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -84.8 117.74 24.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -80.83 -174.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 112.696 -178.126 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.92 -21.63 66.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.379 -1.451 . . . . 0.0 113.743 -174.498 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -99.33 6.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.885 2.074 . . . . 0.0 113.412 174.098 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.6 1.64 66.67 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.777 -1.202 . . . . 0.0 115.231 -175.743 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.35 142.96 50.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.468 1.634 . . . . 0.0 109.825 172.647 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.36 154.15 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 tp -72.86 124.0 24.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.092 0.957 . . . . 0.0 111.103 -174.325 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -87.66 138.24 31.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.953 0.901 . . . . 0.0 110.14 172.242 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.24 146.92 41.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.826 1.25 . . . . 0.0 112.183 -171.544 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -148.31 164.6 33.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.93 1.692 . . . . 0.0 112.954 176.383 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 158.47 53.19 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.71 1.147 . . . . 0.0 114.259 177.198 . . . . . . . . 1 1 . 1 . 165 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.983 1.754 . . . . 0.0 115.81 -178.139 . . . . . . . . 0 0 . 1 . 166 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -96.01 130.16 43.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.4 p -78.08 161.91 27.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.865 0.866 . . . . 0.0 111.535 172.119 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.99 -41.5 83.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.927 -1.108 . . . . 0.0 111.867 175.704 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -81.84 15.72 2.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.159 1.383 . . . . 0.0 113.512 175.751 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.91 74.47 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 117.228 1.651 . . . . 0.0 117.228 161.138 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.41 136.4 36.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.552 1.676 . . . . 0.0 108.976 170.456 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.88 142.99 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.84 146.9 23.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.53 93.76 4.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.643 1.577 . . . . 0.0 109.767 174.753 . . . . . . . . 2 2 . 1 . 166 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.33 126.64 34.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.547 1.539 . . . . 0.0 109.505 -179.661 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.5 -50.05 55.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.664 1.186 . . . . 0.0 112.915 -173.032 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.94 -44.31 55.85 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.203 0.906 . . . . 0.0 111.046 170.368 . . . . . . . . 1 1 . 1 . 166 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.814 1.673 . . . . 0.0 113.865 -178.758 . . . . . . . . 0 0 . 1 . 167 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -114.21 141.15 47.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -121.84 158.63 28.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 113.144 -176.101 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.884 1.674 . . . . 0.0 113.909 172.683 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.8 p -84.51 7.06 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.634 1.174 . . . . 0.0 113.589 171.654 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 2.8 89.67 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 168.468 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -73.45 153.99 40.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.846 1.823 . . . . 0.0 111.521 165.84 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.31 137.83 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.57 141.65 46.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.279 1.032 . . . . 0.0 111.354 -175.631 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -77.32 90.23 3.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.151 0.98 . . . . 0.0 110.469 170.819 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.1 tp -58.98 -27.05 65.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.453 1.101 . . . . 0.0 113.939 -177.315 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -103.12 7.61 38.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.104 1.762 . . . . 0.0 113.948 175.536 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.97 31.49 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.213 1.863 . . . . 0.0 117.148 -174.091 . . . . . . . . 1 1 . 1 . 167 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.793 1.663 . . . . 0.0 115.949 -174.768 . . . . . . . . 0 0 . 1 . 168 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.3 153.54 29.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -128.71 172.24 11.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.96 1.304 . . . . 0.0 112.524 -174.807 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.65 -37.49 63.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.756 . . . . 0.0 114.592 -176.48 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -79.54 1.57 25.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.155 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 -7.9 63.32 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.503 1.525 . . . . 0.0 114.598 -175.3 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -64.23 143.06 58.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.999 1.32 . . . . 0.0 111.119 176.473 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.01 139.37 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.34 134.55 33.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.494 0.718 . . . . 0.0 110.946 177.168 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -63.05 149.03 46.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.569 1.148 . . . . 0.0 111.067 170.067 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.64 161.53 28.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.215 1.006 . . . . 0.0 111.892 -179.897 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 53.04 33.32 14.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.932 1.693 . . . . 0.0 114.8 171.836 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.69 -5.83 56.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.959 1.742 . . . . 0.0 116.544 -170.737 . . . . . . . . 1 1 . 1 . 168 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-N 119.53 1.665 . . . . 0.0 114.508 -178.727 . . . . . . . . 0 0 . 1 . 169 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -80.71 115.81 20.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.6 p -62.41 178.12 0.44 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.1 2.16 . . . . 0.0 113.654 -176.968 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -68.49 -4.83 16.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 174.322 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 p -129.7 22.77 5.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.814 2.046 . . . . 0.0 113.172 -175.431 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.11 -22.06 3.82 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.787 1.66 . . . . 0.0 116.348 173.452 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -64.72 145.96 55.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.727 1.764 . . . . 0.0 110.842 173.99 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.3 145.32 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.31 129.57 38.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.103 0.961 . . . . 0.0 109.976 175.609 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -66.63 122.1 16.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.633 -0.667 . . . . 0.0 110.093 170.913 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.4 -17.3 11.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.158 1.783 . . . . 0.0 112.868 -173.142 . . . . . . . . 2 2 . 1 . 169 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -116.0 147.34 41.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.804 1.642 . . . . 0.0 112.39 -172.337 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.16 79.88 0.11 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.24 1.4 . . . . 0.0 114.211 179.918 . . . . . . . . 1 1 . 1 . 169 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.428 1.489 . . . . 0.0 112.756 171.676 . . . . . . . . 0 0 . 1 . 170 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -104.39 141.35 36.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -114.19 161.68 17.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.526 1.13 . . . . 0.0 113.158 -173.428 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.64 -20.9 61.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 168.547 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -68.87 -0.36 5.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 161.517 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.16 -2.57 83.8 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.006 1.765 . . . . 0.0 116.404 166.05 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -91.63 160.9 15.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.347 1.574 . . . . 0.0 113.442 -176.356 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.67 153.23 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.93 141.29 38.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.773 1.229 . . . . 0.0 111.43 175.921 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -85.53 43.43 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.971 1.709 . . . . 0.0 112.729 -175.186 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.78 147.68 51.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 112.594 -173.201 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -100.72 151.67 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.399 1.479 . . . . 0.0 113.869 -170.505 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 175.47 46.38 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.116 1.341 . . . . 0.0 114.692 177.453 . . . . . . . . 1 1 . 1 . 170 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 127.415 2.436 . . . . 0.0 114.414 177.008 . . . . . . . . 0 0 . 1 . 171 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -99.5 139.04 35.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -96.54 164.26 12.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.154 1.382 . . . . 0.0 113.372 -177.625 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.29 -3.43 7.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.996 1.318 . . . . 0.0 114.431 168.859 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.6 p -107.49 4.26 25.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.203 2.201 . . . . 0.0 113.313 177.158 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.11 13.24 82.31 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 177.784 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -85.51 151.53 23.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 110.583 172.653 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.26 140.72 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -104.89 150.96 24.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.318 1.047 . . . . 0.0 111.828 -177.553 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -81.49 145.06 30.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.685 1.194 . . . . 0.0 112.346 176.406 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.49 -32.46 2.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -178.969 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.07 -25.56 65.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.61 1.096 . . . . 0.0 113.154 -171.914 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.1 -20.99 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.833 1.683 . . . . 0.0 115.23 177.814 . . . . . . . . 1 1 . 1 . 171 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.273 1.892 . . . . 0.0 114.598 -179.242 . . . . . . . . 0 0 . 1 . 172 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -126.83 139.44 53.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -94.85 154.04 17.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.779 0.832 . . . . 0.0 111.661 164.651 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.58 -26.88 68.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.603 -0.686 . . . . 0.0 112.657 171.039 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.2 p -70.93 -1.83 13.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.232 1.813 . . . . 0.0 115.506 168.277 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.64 4.24 63.94 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 170.746 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -72.74 139.88 47.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.53 1.665 . . . . 0.0 109.99 174.186 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.21 119.68 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.05 -35.37 80.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.523 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -63.55 -31.43 72.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 173.38 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.75 -34.98 62.6 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.148 0.579 . . . . 0.0 111.408 173.253 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -62.02 -26.09 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.314 0.961 . . . . 0.0 113.238 168.455 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.13 1.23 56.65 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.276 1.417 . . . . 0.0 115.793 169.23 . . . . . . . . 1 1 . 1 . 172 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-N 119.704 1.752 . . . . 0.0 113.134 178.397 . . . . . . . . 0 0 . 1 . 173 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -97.88 127.6 43.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -88.03 158.41 18.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.222 0.609 . . . . 0.0 111.119 171.096 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.94 -18.62 65.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.253 -0.904 . . . . 0.0 113.176 178.597 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -93.77 9.93 35.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.058 1.743 . . . . 0.0 113.935 173.571 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.36 -12.38 61.69 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 165.928 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.41 142.86 58.27 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.679 1.239 . . . . 0.0 111.092 -177.857 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t -116.66 153.75 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -131.08 138.8 49.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.141 0.976 . . . . 0.0 112.239 173.0 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 -84.69 119.78 25.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.533 1.133 . . . . 0.0 112.444 -174.487 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 mt -91.51 49.95 1.66 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.1 1.36 . . . . 0.0 112.561 -175.788 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.25 142.39 48.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.95 2.1 . . . . 0.0 110.241 179.101 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.51 -165.48 53.52 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.116 0.865 . . . . 0.0 113.768 -173.834 . . . . . . . . 1 1 . 1 . 173 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 C-N-CA 125.324 1.44 . . . . 0.0 113.531 176.975 . . . . . . . . 0 0 . 1 . 174 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -105.78 145.95 30.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -117.77 153.72 32.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 112.919 -175.545 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.55 -35.0 78.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.127 1.371 . . . . 0.0 112.569 178.978 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -70.37 -12.83 61.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.761 1.624 . . . . 0.0 112.966 176.014 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.99 38.26 4.41 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.352 0.901 . . . . 0.0 115.352 169.198 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -111.01 149.25 30.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.252 1.021 . . . . 0.0 109.845 163.77 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.56 142.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.5 113.49 27.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.701 1.2 . . . . 0.0 111.922 179.493 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.5 97.98 7.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.957 1.703 . . . . 0.0 110.305 178.214 . . . . . . . . 2 2 . 1 . 174 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.5 134.68 34.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 111.6 -176.882 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -80.97 23.23 0.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.881 2.072 . . . . 0.0 114.661 177.1 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.75 -143.53 7.38 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.761 2.124 . . . . 0.0 110.756 -174.113 . . . . . . . . 1 1 . 1 . 174 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.406 1.955 . . . . 0.0 112.553 172.965 . . . . . . . . 0 0 . 1 . 175 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.82 130.38 39.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -90.73 158.92 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.747 1.219 . . . . 0.0 112.094 173.636 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.78 -18.15 65.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.729 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -81.8 -2.69 51.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 167.223 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.6 70.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.138 1.351 . . . . 0.0 115.923 176.717 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 140.91 55.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.326 1.563 . . . . 0.0 110.593 176.865 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.09 137.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -86.63 144.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.178 1.391 . . . . 0.0 112.22 -178.926 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -81.07 140.67 34.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.374 168.142 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.02 -42.99 1.84 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.312 1.445 . . . . 0.0 111.543 172.955 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.1 116.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 154.824 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 25.17 61.66 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.223 -162.235 . . . . . . . . 1 1 . 1 . 175 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.547 1.546 . . . . 0.0 112.96 177.957 . . . . . . . . 0 0 . 1 . 176 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -118.01 127.45 53.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -92.08 158.83 15.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.895 1.278 . . . . 0.0 113.665 179.659 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.6 mt -69.82 -16.05 63.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.414 -0.804 . . . . 0.0 112.632 166.406 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.8 p -83.24 21.69 1.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.92 2.088 . . . . 0.0 113.887 171.579 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.63 14.78 81.74 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 166.137 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -111.01 146.21 37.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.971 1.708 . . . . 0.0 111.69 -177.586 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.68 142.17 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -71.17 133.71 46.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.482 0.713 . . . . 0.0 110.71 172.316 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -98.72 114.69 27.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.346 1.458 . . . . 0.0 109.957 171.419 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 125.03 22.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.671 1.588 . . . . 0.0 113.368 -169.105 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -136.04 136.2 40.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 112.216 -179.077 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.08 178.9 24.47 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.752 1.168 . . . . 0.0 114.433 -175.066 . . . . . . . . 1 1 . 1 . 176 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.086 1.803 . . . . 0.0 113.937 177.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.273 0.559 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 119.651 -0.214 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.821 0.343 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 118.919 -0.562 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.597 -0.24 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.817 0.341 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.841 -0.059 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.451 0.167 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.884 0.374 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 111.306 0.114 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.603 -0.236 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt . . . . . 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.419 0.152 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.149 0.5 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.42 0.152 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 119.953 -0.07 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.074 0.027 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.222 0.058 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.54 0.21 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.804 0.335 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 119.718 -0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 119.54 -0.266 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp . . . . . 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 HD12 ' A' ' 50' ' ' LEU . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 43' ' ' LEU . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 66' ' ' THR . 56.6 mtmt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HE2' ' A' ' 6' ' ' LYS . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.755 -0.164 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 110.855 -0.054 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.054 -0.022 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.387 0.137 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.351 0.119 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 0 0 . 1 . 129 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 0 0 . 1 . 129 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 119.694 -0.193 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 129 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 0 0 . 1 . 130 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 0 0 . 1 . 130 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 130 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.689 -0.196 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 0 0 . 1 . 134 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 0 0 . 1 . 134 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.041 0.448 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 134 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 0 0 . 1 . 139 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 0 0 . 1 . 139 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 139 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 0 0 . 1 . 143 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 0 0 . 1 . 143 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 143 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 0 0 . 1 . 144 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 144 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 0 0 . 1 . 145 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 0 0 . 1 . 145 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 118.839 -0.6 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 145 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 0 0 . 1 . 146 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 0 0 . 1 . 146 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 146 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 0 0 . 1 . 147 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 0 0 . 1 . 147 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 147 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 0 0 . 1 . 148 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 0 0 . 1 . 148 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 148 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 0 0 . 1 . 149 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 149 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 0 0 . 1 . 150 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 0 0 . 1 . 150 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 150 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 0 0 . 1 . 151 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 0 0 . 1 . 151 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 151 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 0 0 . 1 . 152 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 0 0 . 1 . 152 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 152 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 0 0 . 1 . 153 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 0 0 . 1 . 153 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.29 0.091 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 153 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 2 2 . 1 . 153 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 2 2 . 1 . 153 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 0 0 . 1 . 154 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 0 0 . 1 . 154 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 154 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 0 0 . 1 . 155 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 0 0 . 1 . 155 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 155 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 0 0 . 1 . 156 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 118.178 -0.915 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 156 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 0 0 . 1 . 157 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 0 0 . 1 . 157 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 157 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 0 0 . 1 . 158 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 0 0 . 1 . 158 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 158 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 0 0 . 1 . 159 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 0 0 . 1 . 159 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.329 0.109 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 159 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 0 0 . 1 . 160 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 0 0 . 1 . 160 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 160 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 0 0 . 1 . 161 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 0 0 . 1 . 161 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 161 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 0 0 . 1 . 162 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 0 0 . 1 . 162 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.611 0.243 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 162 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 0 0 . 1 . 163 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 0 0 . 1 . 163 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 163 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 0 0 . 1 . 164 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 0 0 . 1 . 164 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 164 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 2 2 . 1 . 164 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 2 2 . 1 . 164 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 0 0 . 1 . 165 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 0 0 . 1 . 165 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 165 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 0 0 . 1 . 166 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 0 0 . 1 . 166 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 166 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 0 0 . 1 . 167 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 0 0 . 1 . 167 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.602 0.239 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 167 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 0 0 . 1 . 168 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 0 0 . 1 . 168 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 119.802 -0.142 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 168 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 0 0 . 1 . 169 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 0 0 . 1 . 169 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 169 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 0 0 . 1 . 170 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 0 0 . 1 . 170 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 13' ' ' ILE . 56.4 pttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 . . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 ' HE3' ' A' ' 11' ' ' LYS . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 2 2 . 1 . 170 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 0 0 . 1 . 171 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 0 0 . 1 . 171 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 171 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 0 0 . 1 . 172 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 0 0 . 1 . 172 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 172 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 0 0 . 1 . 173 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 0 0 . 1 . 173 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.36 0.124 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 173 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 0 0 . 1 . 174 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 0 0 . 1 . 174 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 174 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 0 0 . 1 . 175 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 0 0 . 1 . 175 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 175 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 0 0 . 1 . 176 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 0 0 . 1 . 176 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 176 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -112.2 140.28 47.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -125.47 149.27 48.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.044 1.338 . . . . 0.0 111.462 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.4 mt -64.27 -11.97 36.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.819 1.647 . . . . 0.0 114.204 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -63.1 -13.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.586 1.154 . . . . 0.0 113.552 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.1 63.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 114.274 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -82.9 147.12 28.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.514 1.125 . . . . 0.0 112.367 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.72 142.1 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 130.93 45.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.756 1.222 . . . . 0.0 111.918 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.29 165.76 21.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.643 1.577 . . . . 0.0 113.146 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.63 -18.39 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.4 138.21 54.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.745 1.611 . . . . 0.0 113.995 -167.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.64 169.52 42.0 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.256 1.407 . . . . 0.0 112.998 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.297 . . . . 0.0 113.533 -176.293 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -102.86 127.78 49.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 p -94.32 164.05 13.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.427 1.491 . . . . 0.0 113.683 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.85 -20.35 65.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.695 0.798 . . . . 0.0 112.964 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.1 p -83.28 4.54 26.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.933 1.693 . . . . 0.0 114.065 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.04 35.08 54.44 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.224 0.916 . . . . 0.0 113.922 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -117.82 147.5 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.511 1.925 . . . . 0.0 109.771 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -132.35 154.17 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.7 mt -102.38 133.99 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.874 0.87 . . . . 0.0 111.546 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -64.31 135.53 56.29 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.202 1.401 . . . . 0.0 111.735 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.32 154.52 40.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.786 0.834 . . . . 0.0 112.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 58.17 13.26 2.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.362 2.265 . . . . 0.0 115.944 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.05 163.65 12.4 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.407 1.956 . . . . 0.0 112.809 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 116.861 -2.077 . . . . 0.0 114.51 -175.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -106.52 134.55 49.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -78.26 170.29 16.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.551 0.74 . . . . 0.0 111.679 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.84 -18.73 63.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.856 -1.152 . . . . 0.0 113.54 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -84.11 -6.06 59.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.44 1.496 . . . . 0.0 114.38 168.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.54 10.76 67.26 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.414 1.483 . . . . 0.0 115.98 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -71.44 143.92 49.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.392 1.596 . . . . 0.0 110.59 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.39 133.74 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -93.43 135.47 34.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.386 1.074 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -129.29 97.84 4.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.243 1.417 . . . . 0.0 109.964 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.52 -34.99 25.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.517 0.727 . . . . 0.0 111.822 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -58.95 150.76 23.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.854 1.261 . . . . 0.0 112.188 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 -159.35 50.81 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.139 0.875 . . . . 0.0 113.645 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 124.884 1.23 . . . . 0.0 113.387 -178.723 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.24 116.62 30.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -101.03 173.84 6.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.381 1.472 . . . . 0.0 113.809 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.29 -20.48 65.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -91.74 9.19 33.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.317 1.847 . . . . 0.0 113.837 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.71 80.93 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.202 -0.936 . . . . 0.0 114.401 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -75.32 149.91 38.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.948 2.099 . . . . 0.0 110.362 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.18 153.35 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -91.93 145.87 24.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.339 -0.85 . . . . 0.0 112.433 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -130.46 165.92 21.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.779 1.632 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.23 -28.52 3.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.508 1.923 . . . . 0.0 113.379 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -78.64 153.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 113.476 -173.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.46 -22.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 114.636 174.741 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.67 130.66 46.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.0 p -80.76 160.19 24.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.759 1.223 . . . . 0.0 112.152 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.28 -25.51 68.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.979 -1.075 . . . . 0.0 112.689 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -83.65 8.39 14.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.32 2.248 . . . . 0.0 114.002 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.05 -1.75 83.59 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.872 1.701 . . . . 0.0 117.21 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -78.61 142.39 37.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.78 . . . . 0.0 110.369 171.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.0 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -88.75 145.93 25.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.275 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -83.93 135.13 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.948 1.299 . . . . 0.0 111.358 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.76 -143.23 0.25 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.997 1.719 . . . . 0.0 109.743 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 56.08 25.0 8.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.074 2.15 . . . . 0.0 114.587 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.23 17.15 63.44 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.664 1.602 . . . . 0.0 115.075 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.478 1.99 . . . . 0.0 115.253 -169.109 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.14 151.91 21.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -122.97 164.49 18.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.529 1.131 . . . . 0.0 113.199 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.91 -23.95 61.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.169 1.388 . . . . 0.0 114.305 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -88.94 -1.89 58.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.115 1.366 . . . . 0.0 114.386 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.87 69.47 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.074 0.845 . . . . 0.0 114.766 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.74 144.56 35.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.772 1.286 . . . . 0.0 109.062 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t -90.77 116.97 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.13 94.9 9.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -67.2 117.42 9.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.363 1.065 . . . . 0.0 111.362 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.98 145.97 26.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.148 0.979 . . . . 0.0 111.794 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -112.85 143.72 43.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.983 1.313 . . . . 0.0 110.957 166.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.58 -154.02 13.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.169 0.89 . . . . 0.0 114.444 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.058 1.79 . . . . 0.0 114.089 175.622 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -87.01 122.68 31.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -81.01 175.66 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.367 1.467 . . . . 0.0 113.246 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.7 mt -63.21 -16.88 61.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.6 p -109.08 2.68 21.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.231 1.812 . . . . 0.0 113.919 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.95 82.32 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.27 149.81 49.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.401 1.6 . . . . 0.0 109.502 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.87 170.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.29 144.66 46.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.978 -1.076 . . . . 0.0 112.708 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -86.08 133.09 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.031 1.332 . . . . 0.0 109.681 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.55 140.34 48.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 111.249 -171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -155.16 149.87 26.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.85 -175.63 44.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.131 1.348 . . . . 0.0 114.158 164.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.506 2.003 . . . . 0.0 114.899 -179.006 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.21 148.21 52.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -122.34 160.67 24.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.474 1.509 . . . . 0.0 112.109 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 -19.37 63.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.743 1.217 . . . . 0.0 114.065 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -131.29 10.47 4.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.298 1.439 . . . . 0.0 114.468 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.98 158.55 24.76 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.531 1.062 . . . . 0.0 114.528 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -72.28 157.08 38.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.425 1.49 . . . . 0.0 112.009 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t -135.56 134.64 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.25 127.9 33.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.928 0.891 . . . . 0.0 112.041 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -46.47 137.94 6.17 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.22 2.208 . . . . 0.0 112.553 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.39 -43.6 92.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.032 1.333 . . . . 0.0 112.558 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -74.54 128.54 35.81 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.356 1.063 . . . . 0.0 110.165 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.81 -175.57 28.44 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.002 1.287 . . . . 0.0 114.09 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 125.824 1.678 . . . . 0.0 112.52 178.665 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -106.76 119.29 38.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -80.79 163.78 23.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.746 0.819 . . . . 0.0 111.929 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.88 -30.71 70.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 p -89.63 16.12 8.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.37 1.468 . . . . 0.0 113.396 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.18 3.2 85.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.242 1.401 . . . . 0.0 116.403 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -71.28 141.8 50.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.043 1.422 . . . . 0.0 110.959 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.19 147.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -121.41 134.75 55.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.198 0.599 . . . . 0.0 111.975 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -87.85 85.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 110.183 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.23 -26.44 68.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.655 1.582 . . . . 0.0 114.026 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -71.8 -13.71 61.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.77 -158.9 29.73 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.627 1.584 . . . . 0.0 114.579 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.699 1.618 . . . . 0.0 113.818 178.421 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.54 138.89 45.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 t -135.61 156.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.297 1.039 . . . . 0.0 113.481 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.55 -20.29 66.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.345 2.258 . . . . 0.0 115.601 -164.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -73.73 14.62 0.35 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.2 1.4 . . . . 0.0 114.434 168.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.32 14.17 82.82 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.512 1.53 . . . . 0.0 114.891 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -103.01 143.47 32.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.193 1.397 . . . . 0.0 111.624 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.46 145.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.98 151.82 33.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -96.74 176.28 6.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.087 1.755 . . . . 0.0 111.854 166.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.27 -51.56 0.95 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.068 1.347 . . . . 0.0 114.408 -168.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -71.62 -26.64 62.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.61 -7.24 82.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.314 1.435 . . . . 0.0 115.471 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.543 1.544 . . . . 0.0 112.464 170.617 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -115.19 150.96 35.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -102.85 167.13 10.06 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.406 1.482 . . . . 0.0 112.761 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.7 -32.31 73.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.947 -1.096 . . . . 0.0 111.831 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -73.77 -3.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.25 1.42 . . . . 0.0 113.896 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.87 82.85 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.065 1.793 . . . . 0.0 116.002 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -65.55 144.05 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.868 1.334 . . . . 0.0 110.523 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -100.29 145.77 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.7 mt -105.4 152.17 23.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.202 1.001 . . . . 0.0 112.993 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -138.78 69.56 1.38 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.393 1.877 . . . . 0.0 110.573 175.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -83.33 164.98 19.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.523 1.129 . . . . 0.0 111.489 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -78.76 142.04 37.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.557 0.743 . . . . 0.0 110.902 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.12 139.34 29.35 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.796 -0.565 . . . . 0.0 112.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 125.779 1.657 . . . . 0.0 113.842 -177.355 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.46 145.63 26.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -126.1 144.28 50.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.111 1.365 . . . . 0.0 112.354 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.25 -13.3 61.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.52 1.528 . . . . 0.0 113.231 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -71.34 -2.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.078 1.351 . . . . 0.0 113.35 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.82 46.14 5.5 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.671 1.129 . . . . 0.0 113.445 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -134.93 162.21 33.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 111.068 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.73 142.71 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -112.87 146.93 38.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.681 1.193 . . . . 0.0 111.984 -169.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -70.14 -31.72 69.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.21 12.68 36.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.793 1.237 . . . . 0.0 114.077 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -116.12 147.19 41.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.769 1.628 . . . . 0.0 111.271 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.44 3.42 47.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 119.04 1.42 . . . . 0.0 113.625 -173.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -127.64 123.93 36.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -78.0 157.23 29.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 121.672 -0.643 . . . . 0.0 110.785 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.48 -25.84 68.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.21 -0.931 . . . . 0.0 113.197 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -76.54 -21.19 56.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.698 1.199 . . . . 0.0 112.796 172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.24 -5.12 9.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -65.43 119.47 11.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.103 1.361 . . . . 0.0 108.923 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.77 136.22 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 tp -106.61 129.91 54.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.985 1.314 . . . . 0.0 111.739 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -85.09 149.25 25.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.852 1.261 . . . . 0.0 113.419 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.2 tp -132.72 124.88 28.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.275 1.83 . . . . 0.0 110.443 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 50.64 34.43 9.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.042 1.737 . . . . 0.0 113.295 -168.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.46 21.89 1.52 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.583 2.04 . . . . 0.0 113.809 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.093 1.806 . . . . 0.0 111.305 -173.878 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -82.68 126.34 32.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -77.1 150.54 35.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.117 0.967 . . . . 0.0 111.074 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.1 tp -64.32 -16.39 62.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.305 -0.872 . . . . 0.0 112.165 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -91.56 10.71 26.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.808 2.043 . . . . 0.0 114.089 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -17.49 56.18 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.252 1.406 . . . . 0.0 116.418 165.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -74.76 151.65 39.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.081 1.441 . . . . 0.0 111.129 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -135.68 129.6 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -75.98 130.81 39.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.647 0.779 . . . . 0.0 110.818 169.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -66.66 133.58 50.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.384 1.073 . . . . 0.0 111.724 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.8 mt -116.37 -133.41 0.33 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.895 1.678 . . . . 0.0 110.15 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 44.95 43.67 7.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.133 2.573 . . . . 0.0 114.841 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 146.16 8.1 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.965 -0.46 . . . . 0.0 113.833 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 126.119 1.819 . . . . 0.0 112.308 -178.074 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.76 113.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -81.41 169.22 17.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.677 0.791 . . . . 0.0 112.665 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.55 -40.45 91.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 111.893 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -81.58 12.25 3.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.066 1.747 . . . . 0.0 114.257 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.16 17.5 74.13 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.032 1.173 . . . . 0.0 116.032 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.07 147.34 31.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.229 1.515 . . . . 0.0 110.595 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' H ' HD12 ' A' ' 73' ' ' LEU . 16.0 m -140.25 172.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.2 mt -42.07 133.12 3.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.512 1.925 . . . . 0.0 114.254 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 68.42 4.4 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.246 2.618 . . . . 0.0 117.554 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 70' ' ' VAL . 21.4 mt -72.42 88.24 1.2 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.559 1.144 . . . . 0.0 112.99 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -122.63 -139.29 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.242 2.217 . . . . 0.0 109.891 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.59 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.121 1.343 . . . . 0.0 114.751 -175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 C-N-CA 127.167 2.318 . . . . 0.0 113.132 -178.166 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -80.75 120.43 24.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.6 p -69.82 169.19 13.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.004 1.722 . . . . 0.0 112.407 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.45 -3.54 3.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -113.94 5.69 16.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.931 2.092 . . . . 0.0 114.014 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.27 -10.4 63.87 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.539 1.543 . . . . 0.0 116.256 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.49 149.09 50.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.994 1.718 . . . . 0.0 110.346 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.22 160.13 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.17 135.0 47.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 112.781 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -79.12 121.28 24.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.865 1.266 . . . . 0.0 112.102 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.24 120.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.555 1.142 . . . . 0.0 108.643 161.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -92.51 149.49 21.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.773 1.229 . . . . 0.0 110.89 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.18 177.38 48.38 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.148 -177.611 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.84 118.74 35.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -82.65 -176.96 6.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.676 0.791 . . . . 0.0 111.907 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.22 -31.79 72.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.934 -1.103 . . . . 0.0 113.368 -170.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.2 p -89.68 4.31 49.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.532 1.933 . . . . 0.0 114.147 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.53 5.24 89.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.967 -1.083 . . . . 0.0 114.826 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -57.02 139.56 51.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 118.338 1.069 . . . . 0.0 110.266 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.01 166.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.43 149.45 42.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.532 -0.73 . . . . 0.0 111.939 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -84.9 141.87 30.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.245 1.018 . . . . 0.0 109.956 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.87 2.07 44.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -164.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -69.06 159.37 33.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.604 1.562 . . . . 0.0 113.271 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.68 -160.28 33.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.223 0.916 . . . . 0.0 113.243 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.94 1.733 . . . . 0.0 113.927 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -100.69 135.28 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.9 p -91.93 164.66 13.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.124 1.37 . . . . 0.0 112.868 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -72.77 1.03 9.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 113.71 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 p -100.18 -0.86 37.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.094 1.757 . . . . 0.0 113.07 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 12.72 77.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 116.071 1.189 . . . . 0.0 116.071 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -88.28 142.03 28.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.678 1.239 . . . . 0.0 110.119 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.67 134.65 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -89.04 124.87 34.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.972 0.909 . . . . 0.0 110.625 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -76.51 74.24 3.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 111.562 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.84 153.06 42.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.789 1.635 . . . . 0.0 111.579 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 54.89 45.44 26.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.528 1.931 . . . . 0.0 113.715 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.16 5.83 0.04 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 117.561 1.784 . . . . 0.0 117.561 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-N 119.452 1.626 . . . . 0.0 112.967 178.49 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.64 133.56 42.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -96.1 165.04 12.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.249 1.02 . . . . 0.0 112.08 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.04 8.87 3.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.877 1.271 . . . . 0.0 113.409 165.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -112.01 11.83 20.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.133 2.173 . . . . 0.0 112.238 172.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.83 7.33 80.53 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.957 1.265 . . . . 0.0 115.625 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -82.47 147.19 28.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.995 1.397 . . . . 0.0 110.411 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.46 127.89 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 mp -91.33 138.6 31.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.016 0.526 . . . . 0.0 110.35 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -77.59 64.43 2.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.63 1.972 . . . . 0.0 111.807 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.89 135.85 53.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 58.71 51.54 7.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.678 1.991 . . . . 0.0 112.452 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.51 -51.3 0.07 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.862 1.22 . . . . 0.0 114.251 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.756 1.645 . . . . 0.0 113.514 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -125.23 125.98 44.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -81.09 144.6 31.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.274 0.559 . . . . 0.0 110.449 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.09 -3.89 11.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 114.408 -177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 p -85.52 -16.55 39.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.065 1.346 . . . . 0.0 113.533 168.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.55 -49.26 0.77 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.349 1.452 . . . . 0.0 114.819 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -58.66 130.22 45.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.314 1.057 . . . . 0.0 113.532 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.22 130.85 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.39 135.87 34.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.051 0.453 . . . . 0.0 109.804 166.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.8 141.1 57.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 0.0 109.717 162.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.85 -26.89 60.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -136.21 81.86 1.91 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.301 1.841 . . . . 0.0 109.705 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.11 6.39 28.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.104 1.811 . . . . 0.0 116.865 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 120.011 1.905 . . . . 0.0 114.382 178.605 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -109.8 146.5 34.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -119.41 155.85 31.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.859 1.263 . . . . 0.0 112.628 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.18 -16.52 63.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 112.571 172.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.2 p -69.17 0.37 4.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 113.608 164.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 4.35 88.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.293 1.425 . . . . 0.0 115.199 173.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -82.74 160.45 22.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.566 1.183 . . . . 0.0 111.833 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.45 154.81 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.94 131.4 52.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.891 0.877 . . . . 0.0 111.114 -171.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -62.35 -43.62 98.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.326 1.05 . . . . 0.0 113.117 -168.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.8 mt -80.48 9.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.337 1.455 . . . . 0.0 114.37 175.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.89 14.48 7.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.617 1.567 . . . . 0.0 113.305 177.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.15 -14.05 79.78 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.737 1.637 . . . . 0.0 113.826 177.484 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -103.6 123.22 46.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -75.89 162.26 28.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.818 0.847 . . . . 0.0 112.551 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.76 -19.98 60.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -90.56 -2.87 57.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.461 2.304 . . . . 0.0 115.011 173.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.4 63.95 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 175.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -78.88 134.67 36.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.363 1.082 . . . . 0.0 108.601 167.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.72 150.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.92 145.04 45.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.399 1.879 . . . . 0.0 112.754 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.983 1.713 . . . . 0.0 111.183 164.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -102.16 165.12 11.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.688 1.195 . . . . 0.0 113.884 -174.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.28 68.4 mtt180 63.97 25.52 13.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.051 2.54 . . . . 0.0 116.284 176.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.15 38.18 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.357 -0.839 . . . . 0.0 112.749 165.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.41 1.481 . . . . 0.0 114.247 177.635 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -123.92 145.65 49.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -130.04 166.82 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.107 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -50.24 -44.37 53.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.8 p -138.3 -20.47 1.07 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.92 169.45 52.71 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.216 0.916 . . . . 0.0 114.274 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.59 147.49 49.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.287 1.435 . . . . 0.0 112.341 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.61 151.48 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.19 149.33 42.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -160.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.07 151.78 22.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 109.355 173.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.28 44.24 25.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.066 1.746 . . . . 0.0 113.921 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -134.64 -21.45 1.73 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.299 1.84 . . . . 0.0 114.833 -178.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.96 -8.58 66.89 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.915 1.926 . . . . 0.0 117.915 -167.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-N 119.644 1.722 . . . . 0.0 116.168 -179.44 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -80.98 125.95 30.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.6 p -88.22 160.4 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.699 0.8 . . . . 0.0 111.56 171.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.79 -25.76 68.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.454 -0.779 . . . . 0.0 112.375 172.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -76.67 -9.39 58.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.163 1.785 . . . . 0.0 114.918 173.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.65 7.68 62.91 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.96 1.267 . . . . 0.0 115.645 177.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.85 152.11 31.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.548 1.174 . . . . 0.0 110.048 169.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.82 137.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 tp -85.26 138.39 32.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.414 1.886 . . . . 0.0 110.926 176.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -127.71 93.11 3.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.547 1.939 . . . . 0.0 111.139 -176.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -97.4 143.58 27.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.577 1.151 . . . . 0.0 112.469 179.115 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.02 132.71 52.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.888 1.275 . . . . 0.0 112.389 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 148.27 16.04 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.524 1.535 . . . . 0.0 112.264 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.506 -1.719 . . . . 0.0 113.424 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -91.2 121.76 33.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -89.12 163.83 15.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.808 0.843 . . . . 0.0 112.784 -173.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.95 -22.29 66.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.201 1.4 . . . . 0.0 113.645 -175.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -95.45 2.76 54.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.331 2.252 . . . . 0.0 113.957 173.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.39 61.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.414 1.483 . . . . 0.0 116.583 169.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.07 159.42 32.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.74 1.77 . . . . 0.0 111.173 174.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.97 166.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.73 139.89 46.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.696 1.199 . . . . 0.0 111.61 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -66.48 138.54 57.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.858 166.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.44 149.75 41.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.912 1.685 . . . . 0.0 111.196 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -139.72 154.24 47.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.328 1.451 . . . . 0.0 111.222 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.8 -119.91 0.88 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 C-N-CA 124.481 1.039 . . . . 0.0 110.65 155.985 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -99.76 145.37 27.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 m -120.19 153.12 36.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 110.18 173.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.04 -16.78 20.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -67.97 -8.37 36.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.999 2.519 . . . . 0.0 113.892 169.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.73 -11.1 57.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.922 1.725 . . . . 0.0 114.269 -169.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -63.5 136.28 57.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.168 1.484 . . . . 0.0 110.841 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.65 153.29 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.43 155.63 33.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.255 -0.903 . . . . 0.0 112.228 178.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -87.34 166.06 15.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.416 1.486 . . . . 0.0 111.383 165.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -52.23 150.43 4.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.678 1.191 . . . . 0.0 112.557 170.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 49.3 47.06 22.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.459 -162.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.93 -46.07 0.02 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.686 1.612 . . . . 0.0 112.428 -175.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.036 1.779 . . . . 0.0 113.136 168.763 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -99.99 112.8 25.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 p -78.12 171.73 14.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.199 1.0 . . . . 0.0 112.847 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -29.46 58.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.144 1.377 . . . . 0.0 114.392 174.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -88.86 -1.99 58.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.614 1.566 . . . . 0.0 113.678 178.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.25 5.7 89.06 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.558 1.075 . . . . 0.0 114.539 -174.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.94 143.31 57.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.028 1.414 . . . . 0.0 109.299 169.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.13 169.89 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.17 127.71 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.431 -0.793 . . . . 0.0 111.319 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -88.1 129.77 35.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.442 1.097 . . . . 0.0 111.704 173.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.55 146.26 42.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.243 1.417 . . . . 0.0 111.019 176.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -150.5 156.75 42.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.57 1.148 . . . . 0.0 112.726 172.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 159.62 49.11 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.289 0.947 . . . . 0.0 113.738 175.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.519 2.009 . . . . 0.0 113.045 -176.157 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -100.04 140.49 34.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.3 p -97.53 160.92 14.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.858 1.263 . . . . 0.0 112.148 168.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 mt -72.96 -6.41 45.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.755 1.222 . . . . 0.0 113.472 172.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -118.8 47.47 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.353 1.861 . . . . 0.0 110.672 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 -25.8 2.07 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 118.404 2.121 . . . . 0.0 118.404 165.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -78.39 135.22 37.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.085 1.942 . . . . 0.0 111.409 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.01 131.66 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.57 130.78 35.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.824 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.22 154.62 41.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.98 113.95 27.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.481 2.312 . . . . 0.0 108.717 174.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 55.45 28.48 11.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.044 2.138 . . . . 0.0 114.903 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.25 -6.9 9.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.895 1.712 . . . . 0.0 115.259 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 126.971 2.224 . . . . 0.0 111.994 -175.439 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -91.51 136.23 33.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.6 p -97.66 153.53 18.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.978 1.311 . . . . 0.0 112.272 169.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 tp -57.86 -35.89 71.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.475 1.11 . . . . 0.0 112.964 175.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -84.93 11.65 8.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.454 1.902 . . . . 0.0 115.535 176.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.18 55.86 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 160.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.53 147.5 24.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.698 1.599 . . . . 0.0 110.609 172.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t -119.47 133.02 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.94 128.91 40.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.537 0.735 . . . . 0.0 110.597 171.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -114.96 103.05 10.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.795 1.238 . . . . 0.0 111.397 179.071 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.14 149.25 42.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.245 1.818 . . . . 0.0 110.976 -176.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -72.27 165.34 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.613 0.765 . . . . 0.0 112.653 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 166.95 53.98 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.543 1.068 . . . . 0.0 114.22 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 125.839 1.685 . . . . 0.0 113.261 179.604 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -97.81 129.86 44.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -68.11 178.3 1.91 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.278 1.831 . . . . 0.0 112.843 -178.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.45 -18.06 63.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.927 -1.108 . . . . 0.0 113.725 172.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -98.39 5.68 47.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.865 1.266 . . . . 0.0 113.417 171.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.11 5.18 87.05 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.337 1.446 . . . . 0.0 115.689 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -73.63 138.84 45.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 118.757 1.279 . . . . 0.0 109.609 176.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 142.15 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -113.84 136.81 52.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.14 2.176 . . . . 0.0 110.797 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -70.05 106.31 3.19 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 109.826 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.0 89.57 5.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.239 1.415 . . . . 0.0 110.442 -174.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -63.53 150.01 44.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.994 1.318 . . . . 0.0 112.754 -173.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.33 172.02 38.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.157 0.884 . . . . 0.0 114.071 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 126.518 2.009 . . . . 0.0 113.174 179.023 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -127.29 133.34 50.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -90.06 151.51 21.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.433 0.693 . . . . 0.0 111.592 178.188 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.6 -8.35 46.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.681 0.792 . . . . 0.0 113.045 169.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.2 p -87.35 -3.91 59.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.209 1.804 . . . . 0.0 114.069 167.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.65 37.57 7.97 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.007 1.163 . . . . 0.0 116.007 172.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -116.54 143.97 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.605 1.962 . . . . 0.0 110.732 171.96 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.23 119.37 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.63 -38.95 77.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -65.14 -44.74 87.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.552 1.069 . . . . 0.0 112.021 -179.857 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -61.12 -25.38 66.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.554 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -67.13 -31.68 72.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.049 1.295 . . . . 0.0 112.715 174.063 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.72 -20.2 44.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.6 -1.111 . . . . 0.0 115.787 177.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-N 118.914 1.357 . . . . 0.0 114.519 -173.031 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -84.41 137.91 33.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -110.07 153.74 24.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.286 1.034 . . . . 0.0 111.994 174.328 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.14 -4.84 43.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.009 0.924 . . . . 0.0 112.469 166.688 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -83.79 -0.79 52.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.223 1.409 . . . . 0.0 113.587 165.134 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.24 38.34 10.15 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.41 -1.217 . . . . 0.0 115.994 170.171 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -130.56 162.46 29.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.519 1.659 . . . . 0.0 112.726 165.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.7 138.45 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt -94.65 142.37 27.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.414 0.685 . . . . 0.0 112.086 176.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -133.59 108.42 8.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.085 1.354 . . . . 0.0 111.984 176.568 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.48 151.04 22.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.069 177.156 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -60.53 133.8 56.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 110.248 172.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -178.07 54.08 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.267 1.413 . . . . 0.0 114.673 -176.092 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 C-N-CA 126.265 1.888 . . . . 0.0 113.56 -178.273 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -108.88 137.24 47.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -80.65 149.59 29.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.983 0.81 . . . . 0.0 110.345 163.031 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -68.81 -17.58 64.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.395 -0.815 . . . . 0.0 111.885 171.82 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -75.45 -10.97 59.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.848 1.659 . . . . 0.0 114.43 170.128 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.33 22.63 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 167.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.44 160.84 22.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.883 1.842 . . . . 0.0 112.093 177.561 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.89 145.05 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.6 148.54 33.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.791 1.236 . . . . 0.0 113.779 172.69 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -134.69 145.5 48.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.435 1.494 . . . . 0.0 111.583 -166.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.69 -40.44 5.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -169.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -77.98 37.06 0.24 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 -171.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.01 48.22 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.969 1.271 . . . . 0.0 114.264 178.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.691 1.615 . . . . 0.0 114.851 176.953 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -80.05 128.85 33.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -100.63 170.66 8.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.016 1.326 . . . . 0.0 113.388 -168.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.9 -22.83 64.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.039 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -91.96 1.51 57.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.309 1.844 . . . . 0.0 113.651 174.624 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.8 11.34 84.66 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.837 1.685 . . . . 0.0 114.384 -177.702 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.05 169.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.133 1.373 . . . . 0.0 110.568 169.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.59 143.02 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 tp -94.47 143.77 26.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.586 1.554 . . . . 0.0 111.135 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -73.87 63.2 0.89 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 113.019 170.87 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.86 119.53 10.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 161.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -85.28 132.26 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.713 1.205 . . . . 0.0 112.338 -170.667 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 151.17 2.36 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 122.676 1.153 . . . . 0.0 114.467 174.638 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.934 1.73 . . . . 0.0 111.68 -178.847 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -119.3 125.92 50.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -105.96 164.17 12.17 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.317 179.306 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.81 -25.81 61.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.715 2.006 . . . . 0.0 114.362 -172.66 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -71.89 -4.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.911 1.684 . . . . 0.0 114.061 175.693 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.5 -1.86 86.71 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.007 1.289 . . . . 0.0 114.403 -173.386 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.49 139.65 53.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.414 1.607 . . . . 0.0 110.891 175.134 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.4 139.79 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.77 141.81 28.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.216 1.006 . . . . 0.0 111.449 175.696 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -79.64 107.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 111.587 167.647 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.54 -28.99 70.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.775 1.23 . . . . 0.0 113.778 178.201 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -120.71 9.45 10.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 114.361 -177.833 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 147.53 49.75 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.878 164.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.678 -1.624 . . . . 0.0 112.829 -173.577 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.92 115.0 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -82.98 165.41 19.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.618 1.967 . . . . 0.0 112.579 -177.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.33 -12.09 61.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 -173.136 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -76.06 -9.31 58.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.132 1.333 . . . . 0.0 113.362 166.601 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.7 -14.94 64.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.744 1.64 . . . . 0.0 113.874 -168.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.91 129.21 39.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.204 1.502 . . . . 0.0 111.306 -177.899 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.79 164.66 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -110.52 -179.45 3.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.161 1.785 . . . . 0.0 110.747 -173.094 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -73.25 104.1 4.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.374 -0.829 . . . . 0.0 108.939 157.332 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -117.2 74.67 0.93 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.514 1.526 . . . . 0.0 110.722 -172.122 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -70.31 152.89 43.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.348 1.459 . . . . 0.0 112.508 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.45 143.08 5.28 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.014 1.293 . . . . 0.0 112.573 173.117 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.85 1.691 . . . . 0.0 112.765 177.563 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -91.33 126.12 36.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -90.72 157.4 17.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.227 1.411 . . . . 0.0 112.346 -176.566 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.88 -27.17 67.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.449 1.1 . . . . 0.0 113.357 176.57 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -92.5 12.7 22.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.535 2.334 . . . . 0.0 113.647 176.181 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.57 58.09 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 162.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -93.78 151.12 19.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.201 1.4 . . . . 0.0 110.606 170.323 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.62 165.82 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -50.73 -41.38 56.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 114.22 -173.774 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -80.97 12.61 3.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 178.665 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -123.1 6.47 9.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.778 2.431 . . . . 0.0 113.324 170.137 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -25.94 51.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.535 1.534 . . . . 0.0 113.08 -178.849 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.6 -36.68 32.79 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 121.052 -1.03 . . . . 0.0 112.624 167.339 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.148 -1.918 . . . . 0.0 114.171 175.705 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -110.89 130.87 55.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -74.1 165.74 24.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.173 0.589 . . . . 0.0 111.669 171.636 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.61 -27.61 67.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.991 -1.068 . . . . 0.0 113.031 169.677 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -80.87 3.06 23.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.781 2.032 . . . . 0.0 114.784 172.211 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.63 11.78 85.12 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.632 -1.293 . . . . 0.0 115.538 175.317 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -76.08 130.15 37.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.014 1.407 . . . . 0.0 108.896 171.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -124.96 148.86 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.56 129.44 37.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 110.295 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -123.29 81.21 1.86 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.714 2.006 . . . . 0.0 110.547 -176.456 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.4 mt -77.46 142.89 38.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.121 0.968 . . . . 0.0 111.41 -176.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -105.8 -17.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.217 1.407 . . . . 0.0 112.679 169.547 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 -170.69 30.17 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 118.703 0.683 . . . . 0.0 114.144 171.341 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.141 1.829 . . . . 0.0 113.361 179.735 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -113.44 132.27 55.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 p -81.96 162.41 22.69 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.518 0.727 . . . . 0.0 111.134 173.919 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.469 -1.395 . . . . 0.0 113.055 176.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -83.86 9.93 10.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.672 1.589 . . . . 0.0 114.711 172.066 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.12 -0.03 85.63 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 165.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -67.14 136.93 55.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.182 1.491 . . . . 0.0 109.703 172.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -119.28 136.8 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.79 139.35 42.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.5 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -78.9 157.46 28.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.622 1.569 . . . . 0.0 112.437 174.341 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.4 161.42 22.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.457 1.903 . . . . 0.0 111.888 178.789 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.3 mtt85 59.57 31.08 20.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.348 2.259 . . . . 0.0 114.633 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.05 -173.57 20.38 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.086 1.803 . . . . 0.0 114.928 -177.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.71 -1.605 . . . . 0.0 113.367 -179.071 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.95 125.68 52.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -93.31 148.14 22.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.119 0.968 . . . . 0.0 111.217 170.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.15 -25.79 64.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.16 0.984 . . . . 0.0 112.447 173.042 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -76.39 30.9 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.448 1.899 . . . . 0.0 113.022 174.403 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 43.18 93.22 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.62 -1.3 . . . . 0.0 116.085 164.764 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.82 144.12 31.64 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.629 1.215 . . . . 0.0 112.017 174.87 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.84 142.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.6 145.59 34.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.192 0.997 . . . . 0.0 110.956 172.687 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -62.08 146.79 49.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.353 -0.842 . . . . 0.0 112.064 167.252 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 tp -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.424 1.489 . . . . 0.0 112.722 -178.722 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -107.45 118.7 37.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.556 1.542 . . . . 0.0 108.335 162.879 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.12 171.37 44.41 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.229 0.919 . . . . 0.0 113.78 -177.529 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.233 1.397 . . . . 0.0 114.1 176.459 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -103.22 136.42 43.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -86.67 154.05 21.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.453 1.101 . . . . 0.0 110.919 171.165 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.19 -23.83 67.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.49 -1.381 . . . . 0.0 112.99 174.199 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -80.51 7.26 10.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.712 1.605 . . . . 0.0 114.067 173.441 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.18 38.45 9.13 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.048 -1.033 . . . . 0.0 115.335 163.948 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -123.96 143.07 50.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.369 1.468 . . . . 0.0 110.866 175.918 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.89 139.91 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.72 158.96 17.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.758 1.223 . . . . 0.0 111.472 175.723 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.5 mtt-85 -80.39 142.41 34.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 172.063 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.63 -33.29 3.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 113.575 -172.431 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -81.25 144.78 31.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.848 0.749 . . . . 0.0 112.663 176.679 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.54 3.74 0.11 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.329 1.442 . . . . 0.0 115.202 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.855 1.693 . . . . 0.0 113.931 175.93 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.13 139.43 30.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -102.57 163.8 12.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.995 175.262 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -56.01 -37.57 69.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.902 1.281 . . . . 0.0 112.212 166.852 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -71.65 -4.89 29.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.8 1.64 . . . . 0.0 114.686 178.759 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.16 74.1 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.332 0.969 . . . . 0.0 114.99 176.689 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -76.75 155.02 33.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.161 0.98 . . . . 0.0 110.1 171.149 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.05 127.24 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.17 138.11 35.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.631 0.773 . . . . 0.0 111.198 178.184 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -69.96 121.76 18.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.746 1.219 . . . . 0.0 110.083 166.679 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.65 151.5 39.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.569 174.97 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 54.95 31.63 16.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.091 1.756 . . . . 0.0 113.171 -166.465 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.94 8.52 6.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.214 1.864 . . . . 0.0 114.981 -177.479 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 126.198 1.856 . . . . 0.0 111.951 -175.328 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -96.91 139.64 32.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -107.0 156.66 18.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.747 1.219 . . . . 0.0 111.981 170.512 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.75 -37.68 82.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.32 1.048 . . . . 0.0 113.202 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -70.66 -3.14 16.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.846 1.658 . . . . 0.0 112.491 169.726 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 19.05 23.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 120.026 -1.671 . . . . 0.0 116.326 159.664 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -82.51 145.96 29.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.739 1.269 . . . . 0.0 110.03 169.719 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t -119.75 143.04 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.58 130.2 45.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.396 1.078 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -113.06 88.41 2.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.9 2.08 . . . . 0.0 109.185 -176.725 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 mt -113.46 133.33 55.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.455 1.502 . . . . 0.0 110.042 -169.624 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.4 mtt85 -107.56 136.86 46.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 110.74 174.939 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.36 -158.08 16.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.869 0.747 . . . . 0.0 113.143 -177.557 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 124.983 1.277 . . . . 0.0 114.067 177.649 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -96.24 106.04 18.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -89.77 163.27 15.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.186 1.395 . . . . 0.0 113.554 -172.843 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.57 -24.73 67.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -173.646 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -74.96 -4.98 41.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.059 1.344 . . . . 0.0 114.037 173.434 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.77 -16.24 58.68 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.751 1.643 . . . . 0.0 114.392 -170.487 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -62.7 128.75 37.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.817 1.808 . . . . 0.0 110.822 179.633 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -111.32 148.38 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.6 tp -87.01 -37.44 17.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.394 1.477 . . . . 0.0 113.863 -170.319 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -82.14 -56.61 3.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -171.922 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.72 56.78 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 169.483 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -63.85 -41.17 97.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -162.261 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 151.59 22.47 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 -169.673 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.557 2.503 . . . . 0.0 111.954 177.99 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.06 119.12 30.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -97.08 -179.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.659 1.584 . . . . 0.0 113.521 -166.295 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.6 mt -72.37 -10.07 59.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.516 -1.365 . . . . 0.0 114.412 -173.39 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -102.57 5.38 39.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 114.006 175.944 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.88 72.06 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.513 1.054 . . . . 0.0 114.984 -171.928 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -61.84 155.52 22.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.519 1.528 . . . . 0.0 111.116 171.769 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -122.1 139.22 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.0 tp -87.65 131.54 34.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 110.609 176.396 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -106.25 139.11 41.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 112.017 173.233 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.48 32.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.691 1.596 . . . . 0.0 113.383 -157.314 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -129.19 4.47 5.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.026 1.33 . . . . 0.0 113.671 -178.598 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.78 150.35 51.27 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.088 0.851 . . . . 0.0 113.295 179.03 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.493 1.52 . . . . 0.0 112.189 -174.822 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -135.96 135.21 39.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -87.18 162.31 17.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.751 0.821 . . . . 0.0 112.674 177.339 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.51 -26.13 68.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.117 -0.989 . . . . 0.0 111.379 168.191 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -80.81 16.67 1.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.069 2.148 . . . . 0.0 113.957 169.122 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.25 1.37 74.65 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 167.021 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -82.96 128.51 34.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.946 1.373 . . . . 0.0 110.388 -176.336 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -127.63 137.27 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 tp -85.88 132.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.355 172.585 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -124.67 16.31 8.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -169.362 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.93 24.2 0.95 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.454 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.74 109.78 16.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.208 1.403 . . . . 0.0 108.618 164.456 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.1 160.23 26.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.297 1.427 . . . . 0.0 115.073 -174.732 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.039 1.781 . . . . 0.0 115.223 178.942 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -102.12 129.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -89.13 174.99 7.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.247 1.419 . . . . 0.0 114.154 -171.855 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.55 -17.21 19.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.947 1.699 . . . . 0.0 115.286 175.591 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -111.34 9.02 21.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.434 1.894 . . . . 0.0 113.501 172.927 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.54 3.81 90.37 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.558 171.258 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -71.72 152.5 42.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.926 1.363 . . . . 0.0 110.058 175.949 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.12 162.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -105.72 123.84 48.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.117 1.767 . . . . 0.0 110.706 -170.931 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -70.62 99.84 1.73 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 113.034 -178.557 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt 58.94 -30.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.354 3.462 . . . . 0.0 118.965 172.505 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -83.27 44.92 0.98 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 121.246 1.839 . . . . 0.0 113.587 -177.975 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.54 -41.73 89.68 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.323 -0.86 . . . . 0.0 114.078 -175.278 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.679 179.282 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.47 149.21 50.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -113.7 162.0 16.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.884 1.673 . . . . 0.0 113.849 -179.094 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.8 -27.24 69.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.857 -1.152 . . . . 0.0 113.78 170.846 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -71.58 -4.59 27.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.893 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.72 13.06 78.9 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.767 1.175 . . . . 0.0 114.691 177.837 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -74.83 144.85 43.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.361 1.081 . . . . 0.0 109.539 171.699 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.35 163.46 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -100.53 157.27 16.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 112.631 -165.845 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -140.35 -177.72 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.828 1.251 . . . . 0.0 111.074 159.68 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.37 162.44 34.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.896 1.678 . . . . 0.0 111.39 172.711 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -107.4 -38.54 5.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.509 1.524 . . . . 0.0 111.979 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.73 132.0 11.04 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.739 1.162 . . . . 0.0 113.372 175.189 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.34 1.924 . . . . 0.0 115.511 179.664 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -89.31 138.74 31.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -99.12 166.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.48 1.512 . . . . 0.0 112.775 -175.275 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.15 -18.5 58.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 171.778 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.8 7.85 43.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.681 1.128 . . . . 0.0 113.352 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.39 -11.16 39.51 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.908 1.242 . . . . 0.0 115.079 179.366 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.15 140.89 58.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.415 1.608 . . . . 0.0 110.527 174.095 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -128.32 147.7 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -113.1 157.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -169.686 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -91.86 135.5 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.268 1.427 . . . . 0.0 109.126 167.557 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.02 146.44 31.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.984 0.914 . . . . 0.0 112.165 -170.534 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 50.38 43.67 26.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.716 1.606 . . . . 0.0 112.859 -172.554 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.66 72.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 117.047 1.579 . . . . 0.0 117.047 -170.192 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.281 1.541 . . . . 0.0 113.986 -179.571 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -125.15 136.88 54.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -100.94 162.4 12.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.99 1.316 . . . . 0.0 113.35 177.23 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.98 -12.48 61.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.545 1.538 . . . . 0.0 113.096 170.785 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -85.87 -0.97 56.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.178 1.791 . . . . 0.0 113.149 166.411 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.0 12.7 83.85 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.202 1.382 . . . . 0.0 115.261 175.331 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -83.0 142.61 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.405 1.482 . . . . 0.0 109.285 174.927 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -124.58 136.44 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.63 124.23 34.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.831 0.853 . . . . 0.0 109.623 175.692 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -100.61 126.75 47.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.716 1.606 . . . . 0.0 110.378 179.169 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.54 119.19 24.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.915 0.886 . . . . 0.0 110.631 -175.494 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -82.58 -31.97 28.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.209 1.404 . . . . 0.0 113.246 -177.676 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.8 -159.54 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.943 1.259 . . . . 0.0 114.601 178.677 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 C-N-CA 125.933 1.73 . . . . 0.0 112.617 -176.77 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -93.73 120.56 34.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -90.64 162.2 15.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 113.052 -172.912 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -75.91 -19.67 58.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.849 -1.157 . . . . 0.0 112.241 174.04 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -80.69 2.57 25.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.813 1.645 . . . . 0.0 113.724 165.839 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.6 49.13 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.563 1.385 . . . . 0.0 116.563 163.301 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -107.12 156.92 18.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.945 1.373 . . . . 0.0 111.246 168.136 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.3 152.65 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.39 143.06 27.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.309 1.444 . . . . 0.0 111.926 -178.7 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -75.58 119.54 19.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.824 0.849 . . . . 0.0 110.337 165.863 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.82 118.1 36.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.77 1.228 . . . . 0.0 110.359 -176.894 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -141.65 158.95 43.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 112.34 -173.511 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.42 -170.63 31.64 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.131 0.872 . . . . 0.0 114.491 176.363 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.933 -1.482 . . . . 0.0 113.207 176.621 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -92.35 132.52 36.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -98.31 159.37 14.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 112.415 177.711 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.09 -8.01 58.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.272 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -103.4 -28.07 12.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.566 1.546 . . . . 0.0 113.973 -172.232 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 -42.92 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 171.562 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.53 157.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.208 1.004 . . . . 0.0 113.134 -176.44 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.0 129.67 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 tp -88.17 129.9 35.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.073 0.949 . . . . 0.0 111.818 -179.732 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -67.9 158.11 33.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 111.811 175.182 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.24 162.39 14.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.245 1.418 . . . . 0.0 114.31 -168.282 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 65.1 mtt180 58.09 32.56 22.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.955 2.902 . . . . 0.0 115.948 172.912 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.73 18.14 22.47 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.727 2.108 . . . . 0.0 114.917 175.937 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.313 1.911 . . . . 0.0 112.917 -170.39 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -88.29 124.67 34.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.0 p -67.24 173.71 3.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.412 2.285 . . . . 0.0 112.78 177.955 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.29 -17.53 62.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.038 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -99.33 16.87 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.668 1.587 . . . . 0.0 113.415 173.152 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.62 -15.72 4.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.72 1.629 . . . . 0.0 115.831 176.811 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -67.79 140.55 56.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.151 1.38 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.33 176.29 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.99 151.64 29.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.81 1.244 . . . . 0.0 113.338 -172.501 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -138.1 126.39 23.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.94 1.296 . . . . 0.0 110.317 156.521 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.55 -32.63 1.29 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.635 1.174 . . . . 0.0 113.48 -174.302 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 169.85 18.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.74 1.216 . . . . 0.0 113.442 -179.233 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.14 29.5 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.337 1.446 . . . . 0.0 113.264 -174.58 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.16 -1.356 . . . . 0.0 111.796 179.708 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -124.75 143.91 50.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -124.18 162.64 23.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.77 1.228 . . . . 0.0 112.414 -173.324 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.91 -22.56 67.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.442 1.097 . . . . 0.0 113.922 -174.563 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -84.2 2.67 38.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.425 1.89 . . . . 0.0 114.554 171.844 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.23 7.44 88.42 Favored Glycine 0 CA--C 1.531 1.088 0 O-C-N 120.727 -1.233 . . . . 0.0 114.932 177.826 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.67 124.67 27.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.825 1.312 . . . . 0.0 109.24 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.88 134.74 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.12 131.33 37.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.615 -0.678 . . . . 0.0 110.13 -179.749 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -116.05 75.31 0.94 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.092 1.757 . . . . 0.0 109.542 176.958 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.62 153.01 37.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.456 1.102 . . . . 0.0 111.982 -179.073 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.92 162.82 13.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.226 1.811 . . . . 0.0 112.001 175.263 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.54 129.06 0.67 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.502 2.001 . . . . 0.0 113.373 179.036 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 124.258 0.932 . . . . 0.0 114.154 -178.722 . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -111.19 126.73 55.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -79.0 168.65 19.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 112.851 177.602 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.7 mt -59.94 -33.46 71.93 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.859 -1.151 . . . . 0.0 112.855 174.86 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -91.71 21.27 4.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.725 1.61 . . . . 0.0 113.52 173.748 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.4 28.02 73.6 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.902 1.239 . . . . 0.0 115.342 165.008 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -82.23 127.93 33.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.717 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.99 132.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.77 117.76 25.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.427 0.691 . . . . 0.0 111.266 170.646 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.43 62.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.556 2.342 . . . . 0.0 108.566 -176.861 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.44 -27.93 68.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.673 1.589 . . . . 0.0 113.355 -174.427 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -68.59 147.36 52.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.379 1.072 . . . . 0.0 112.884 -178.801 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.2 23.71 70.02 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.91 0.767 . . . . 0.0 114.834 174.375 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.057 1.313 . . . . 0.0 113.996 176.25 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.85 150.71 22.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 p -128.8 152.06 48.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.165 0.986 . . . . 0.0 112.94 -176.237 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.49 -29.75 70.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.42 1.088 . . . . 0.0 111.322 169.438 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -70.12 9.48 0.57 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.227 1.811 . . . . 0.0 114.416 173.779 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.7 9.68 68.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.181 1.372 . . . . 0.0 115.945 168.519 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -103.91 158.18 16.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.19 1.495 . . . . 0.0 112.618 -174.956 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.25 142.28 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.46 150.39 24.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.339 0.656 . . . . 0.0 111.093 175.325 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -75.41 140.42 42.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.457 1.103 . . . . 0.0 112.482 -176.206 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.7 mt -133.16 158.97 41.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.744 1.617 . . . . 0.0 110.369 174.995 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -100.6 168.82 9.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.117 1.767 . . . . 0.0 111.124 175.117 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.12 -152.75 5.87 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.24 0.924 . . . . 0.0 113.278 -179.513 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.434 -174.135 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -107.56 131.6 54.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -90.3 163.25 14.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.452 1.101 . . . . 0.0 112.052 179.567 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.32 -28.61 66.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -80.41 -11.95 59.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.158 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 5.74 56.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.416 1.484 . . . . 0.0 115.564 178.903 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.44 139.22 51.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.002 1.401 . . . . 0.0 109.429 169.341 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.91 145.77 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.14 151.47 26.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.427 1.091 . . . . 0.0 113.282 -177.623 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -93.53 75.98 4.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.317 1.847 . . . . 0.0 112.16 179.639 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 154.82 26.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.503 1.521 . . . . 0.0 111.946 175.868 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 54.58 16.17 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.276 2.23 . . . . 0.0 115.662 -175.047 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.36 -166.33 29.88 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.652 1.596 . . . . 0.0 113.573 -179.905 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.832 1.206 . . . . 0.0 112.284 170.661 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -108.76 133.55 52.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -78.51 169.37 18.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.73 0.812 . . . . 0.0 112.517 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -58.0 -21.86 46.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.978 1.311 . . . . 0.0 113.754 171.895 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -106.61 16.29 24.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.843 1.657 . . . . 0.0 113.873 172.587 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.32 7.42 88.56 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 165.515 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.13 138.98 50.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.615 1.707 . . . . 0.0 109.862 174.1 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.79 141.14 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.99 120.64 32.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.954 176.486 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 -64.2 -36.0 82.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 113.813 -175.437 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.68 22.28 1.97 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.412 1.085 . . . . 0.0 113.551 -177.495 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -136.66 156.0 49.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.633 1.973 . . . . 0.0 110.057 175.765 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.33 17.72 16.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.298 -176.562 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.483 1.992 . . . . 0.0 112.892 -177.517 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -87.38 136.77 32.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -111.11 142.68 42.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.191 0.996 . . . . 0.0 110.288 163.335 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.0 mt -70.16 -15.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -161.149 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -77.63 -9.76 59.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 171.334 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.75 -40.43 1.41 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.818 165.731 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.99 152.37 41.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.562 1.681 . . . . 0.0 113.671 -168.083 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.21 132.83 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.86 149.68 28.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.988 0.515 . . . . 0.0 112.092 174.436 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 71.13 1.47 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.132 1.373 . . . . 0.0 110.338 172.905 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.42 143.16 53.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.439 1.096 . . . . 0.0 112.026 -176.207 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -73.05 -34.15 66.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -166.335 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.04 132.21 28.38 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 118.671 0.669 . . . . 0.0 114.025 -171.286 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.3 -1.278 . . . . 0.0 113.545 176.983 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -111.86 126.55 55.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -99.94 163.55 12.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.701 1.201 . . . . 0.0 113.509 -168.291 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 mt -73.94 -5.31 40.42 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.805 1.242 . . . . 0.0 113.318 170.675 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 p -92.17 6.69 45.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.121 1.768 . . . . 0.0 113.515 170.646 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.66 82.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.211 1.386 . . . . 0.0 114.465 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -93.28 153.87 18.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.414 1.886 . . . . 0.0 110.789 -176.208 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -119.1 120.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.6 tp -68.22 -47.87 66.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.634 0.774 . . . . 0.0 113.081 -171.352 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -61.61 -30.39 70.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.204 0.911 . . . . 0.0 112.318 179.408 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -72.86 -26.72 61.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.635 1.174 . . . . 0.0 113.078 174.773 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -74.5 -18.65 60.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.327 0.967 . . . . 0.0 113.136 170.375 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.27 152.13 44.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.165 0.888 . . . . 0.0 112.975 167.749 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.757 -1.579 . . . . 0.0 113.877 -178.369 . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.74 115.9 19.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -83.79 -177.37 6.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.426 1.491 . . . . 0.0 113.541 -175.629 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.2 mt -69.33 -25.3 64.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.615 -1.303 . . . . 0.0 113.26 179.009 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -84.45 -0.67 53.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.93 1.292 . . . . 0.0 113.209 167.871 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 8.08 82.72 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.53 -1.356 . . . . 0.0 115.061 -176.049 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.28 138.73 57.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.46 1.63 . . . . 0.0 108.99 171.921 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.6 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.7 tp -88.24 140.27 29.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.801 1.24 . . . . 0.0 111.766 176.124 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm85 -134.77 149.58 50.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.562 1.945 . . . . 0.0 110.712 166.64 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.46 59.22 1.7 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.615 1.566 . . . . 0.0 111.909 -170.282 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -128.12 -3.22 5.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.4 2.28 . . . . 0.0 115.258 -178.444 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.83 -32.08 58.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 119.91 1.232 . . . . 0.0 114.231 179.066 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.946 -1.474 . . . . 0.0 113.942 166.775 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -104.03 132.97 49.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -82.62 168.09 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.352 1.061 . . . . 0.0 112.627 -176.611 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.31 -23.42 65.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.31 -0.869 . . . . 0.0 112.761 171.455 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -82.71 1.98 36.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.59 2.356 . . . . 0.0 114.459 167.909 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.06 4.41 90.26 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.349 -1.806 . . . . 0.0 117.073 169.302 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -84.28 149.66 25.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.827 2.314 . . . . 0.0 111.37 174.298 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t -121.5 132.87 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -90.03 121.16 31.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.809 170.11 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 106.01 18.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.61 1.564 . . . . 0.0 110.694 -170.361 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.56 137.64 36.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.877 1.271 . . . . 0.0 109.845 176.782 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -87.67 -57.16 3.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -167.039 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.33 -34.17 61.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.632 173.644 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.525 2.012 . . . . 0.0 111.48 -170.84 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -99.42 126.26 45.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -90.42 139.67 30.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.627 0.649 . . . . 0.0 109.798 167.285 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -74.92 -10.02 59.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.327 -0.858 . . . . 0.0 113.052 177.865 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -74.72 -2.85 28.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.715 2.006 . . . . 0.0 114.249 162.285 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 50.33 2.76 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.47 1.033 . . . . 0.0 115.186 167.646 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -136.35 151.07 49.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.492 1.517 . . . . 0.0 111.03 171.827 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.27 166.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.4 135.66 53.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.4 1.08 . . . . 0.0 113.224 -174.806 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -99.39 102.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.679 1.992 . . . . 0.0 109.281 174.653 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.31 132.17 56.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.639 1.176 . . . . 0.0 112.032 -166.902 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -70.52 -38.6 74.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.957 1.303 . . . . 0.0 114.057 -174.363 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.91 -149.78 48.25 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.738 0.699 . . . . 0.0 112.495 -169.777 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.11 1.814 . . . . 0.0 114.495 -177.941 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -104.79 147.6 27.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -109.87 164.61 12.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.352 1.861 . . . . 0.0 113.242 173.603 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -77.36 7.75 4.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.598 1.559 . . . . 0.0 113.934 169.399 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -110.65 11.54 22.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.949 2.1 . . . . 0.0 112.74 -179.391 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.9 86.62 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.605 1.098 . . . . 0.0 115.44 -177.734 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -94.53 142.29 27.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.879 1.34 . . . . 0.0 110.52 178.951 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.92 155.38 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.64 147.15 32.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.54 1.536 . . . . 0.0 111.572 -173.633 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.1 mtm105 -83.09 61.73 6.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 112.559 -175.833 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 tp -50.84 118.08 2.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.946 1.698 . . . . 0.0 111.543 178.505 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 63.61 -32.26 0.12 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.408 3.083 . . . . 0.0 117.731 -179.621 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.69 79.66 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.976 1.262 . . . . 0.0 114.504 173.636 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.438 1.971 . . . . 0.0 111.951 166.957 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -95.34 124.35 39.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -85.09 128.75 34.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 159.238 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -59.46 -24.84 63.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.152 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.5 p -72.58 -11.59 60.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.333 1.853 . . . . 0.0 114.378 176.496 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.01 -43.54 0.74 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.282 0.944 . . . . 0.0 115.207 167.636 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -62.97 125.96 25.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.498 1.149 . . . . 0.0 113.675 -166.281 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.71 146.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.58 164.13 27.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.203 -0.936 . . . . 0.0 112.274 171.761 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -110.2 144.24 39.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.226 1.81 . . . . 0.0 112.693 -177.102 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.16 149.95 26.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.07 0.948 . . . . 0.0 111.94 173.857 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 51.35 16.52 0.42 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.469 2.308 . . . . 0.0 116.034 -171.409 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.66 -38.29 77.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.985 -1.072 . . . . 0.0 112.911 174.625 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.266 -1.852 . . . . 0.0 114.411 175.189 . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -112.27 130.43 55.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -89.33 172.87 8.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 112.992 -177.585 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.92 23.47 3.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.146 0.978 . . . . 0.0 113.038 164.919 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -130.81 6.38 4.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.0 1.72 . . . . 0.0 114.535 -173.614 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 32.11 17.71 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 120.981 -1.074 . . . . 0.0 114.812 179.324 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -129.91 143.05 50.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.268 1.427 . . . . 0.0 111.404 178.396 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t -125.06 121.73 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.4 tp -66.36 -31.36 72.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.359 1.063 . . . . 0.0 112.669 -175.681 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -64.73 -35.52 81.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.506 1.048 . . . . 0.0 113.106 172.728 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.44 -31.84 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.712 0.805 . . . . 0.0 112.775 176.739 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -77.69 -32.27 52.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.122 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.13 -44.78 90.51 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.147 0.879 . . . . 0.0 113.364 176.962 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.769 1.176 . . . . 0.0 113.052 174.28 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -107.42 151.69 25.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -114.65 162.14 17.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.208 1.003 . . . . 0.0 111.767 170.188 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.23 -13.3 61.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.725 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -83.74 -16.06 46.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.334 1.054 . . . . 0.0 112.224 166.852 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.5 11.91 37.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.621 1.581 . . . . 0.0 115.567 174.764 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.47 146.05 52.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.801 1.301 . . . . 0.0 110.137 173.836 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.19 142.2 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.67 143.4 27.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.914 0.886 . . . . 0.0 110.816 177.484 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -75.5 68.44 2.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.264 1.026 . . . . 0.0 110.421 166.015 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.67 142.0 58.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.509 1.524 . . . . 0.0 112.139 -175.022 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 50.91 52.31 15.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.624 1.57 . . . . 0.0 112.926 -178.384 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.37 -51.08 0.11 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.038 -0.868 . . . . 0.0 115.102 174.703 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.824 -1.542 . . . . 0.0 114.661 -177.754 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -105.09 134.89 47.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -104.94 165.94 10.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.463 1.505 . . . . 0.0 113.242 -178.491 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.8 tp -67.62 -31.07 70.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.462 -0.774 . . . . 0.0 112.362 168.607 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -68.67 -1.43 6.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.736 1.614 . . . . 0.0 115.195 177.539 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 26.89 40.24 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.25 -0.906 . . . . 0.0 114.142 178.774 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -108.1 148.37 29.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.581 1.552 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t -103.31 145.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.07 153.73 27.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.217 1.007 . . . . 0.0 113.586 -175.824 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -129.55 93.8 3.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.412 2.285 . . . . 0.0 108.924 171.836 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.5 mt -107.3 152.85 23.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.361 1.464 . . . . 0.0 112.529 -173.195 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -131.49 168.85 16.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.806 1.643 . . . . 0.0 112.227 -179.627 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.03 167.39 42.14 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.855 1.217 . . . . 0.0 114.237 -177.539 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 125.346 1.451 . . . . 0.0 115.001 -174.128 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.85 124.44 35.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -72.15 168.9 17.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 112.491 -179.355 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.62 -22.35 65.17 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.015 0.926 . . . . 0.0 113.189 169.553 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -90.07 4.74 49.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.288 1.835 . . . . 0.0 114.44 170.997 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 3.92 90.61 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.948 1.261 . . . . 0.0 116.085 175.883 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -77.91 140.05 39.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.666 1.586 . . . . 0.0 109.961 179.277 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.35 130.57 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -74.72 143.13 44.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 112.006 177.901 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -74.24 156.11 37.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.161 0.984 . . . . 0.0 113.572 172.851 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.66 148.15 52.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.29 1.436 . . . . 0.0 112.397 172.595 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 46.2 72.09 0.25 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.77 2.428 . . . . 0.0 114.511 179.049 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.11 165.95 20.21 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.944 1.259 . . . . 0.0 115.664 -179.08 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.902 1.715 . . . . 0.0 112.824 -171.016 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -94.48 126.82 40.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 p -94.3 162.28 13.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.207 1.003 . . . . 0.0 113.296 -178.567 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.97 -29.01 69.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.352 1.061 . . . . 0.0 112.392 169.145 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 p -80.29 10.06 5.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.077 2.151 . . . . 0.0 114.243 174.22 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.08 12.08 81.5 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.471 1.034 . . . . 0.0 115.532 173.94 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -86.43 164.11 17.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.359 1.863 . . . . 0.0 111.074 179.055 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.18 150.18 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.58 147.35 40.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.31 1.044 . . . . 0.0 111.291 -177.341 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -61.61 -21.98 64.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -172.843 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.91 -53.96 0.92 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.126 1.77 . . . . 0.0 112.177 174.136 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -76.93 149.07 36.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -162.639 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.53 17.42 59.93 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.819 1.2 . . . . 0.0 115.522 -178.977 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.479 1.514 . . . . 0.0 114.074 178.044 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -135.3 156.95 48.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -105.16 169.97 8.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.405 1.882 . . . . 0.0 113.231 179.949 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.24 -33.59 63.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.563 1.145 . . . . 0.0 113.783 169.685 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -79.29 -8.39 59.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.136 1.374 . . . . 0.0 114.188 176.237 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.39 -9.77 62.96 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.077 -1.402 . . . . 0.0 115.989 172.333 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -55.35 113.81 1.56 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.598 1.699 . . . . 0.0 110.149 178.061 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t -106.97 129.91 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.47 118.39 36.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.178 1.391 . . . . 0.0 110.97 -174.889 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -93.6 -9.1 39.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -166.779 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.1 tp -134.45 51.06 2.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.939 1.245 . . . . 0.0 113.388 -179.326 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -130.73 21.23 5.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.112 1.765 . . . . 0.0 114.288 178.39 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.3 164.16 20.13 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 114.808 173.956 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 117.424 -1.764 . . . . 0.0 110.849 176.074 . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -92.96 121.13 33.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.2 p -83.03 160.58 21.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.247 1.819 . . . . 0.0 113.58 -177.039 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.63 -9.24 58.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.905 -1.122 . . . . 0.0 113.231 170.153 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -84.11 -0.76 53.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.669 1.987 . . . . 0.0 114.354 167.452 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 25.37 56.59 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.256 -0.903 . . . . 0.0 115.181 173.693 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -119.85 168.55 11.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.266 1.427 . . . . 0.0 111.062 175.56 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.81 151.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.35 128.83 54.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.686 1.194 . . . . 0.0 112.891 178.253 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -77.96 98.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.828 2.051 . . . . 0.0 110.723 175.232 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.6 mt -69.53 -23.8 63.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -173.301 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -107.23 -6.14 17.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.133 1.773 . . . . 0.0 113.389 171.265 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.55 -18.48 70.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.525 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-N 119.361 1.581 . . . . 0.0 114.591 176.618 . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -96.48 128.53 43.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -78.29 165.5 23.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.532 1.133 . . . . 0.0 112.12 176.46 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -66.41 -26.82 67.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.471 -1.393 . . . . 0.0 112.644 179.918 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -87.13 13.21 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 113.615 169.731 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.42 9.96 82.76 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 165.139 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -77.07 135.46 38.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.838 1.819 . . . . 0.0 110.429 176.758 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.33 148.91 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.27 132.49 51.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.09 0.956 . . . . 0.0 111.862 -177.687 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -140.74 136.57 32.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.562 1.545 . . . . 0.0 110.058 177.588 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.86 100.65 10.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 111.963 -169.679 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -71.9 -28.14 63.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.058 1.343 . . . . 0.0 112.284 175.733 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 11.6 26.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.692 1.615 . . . . 0.0 116.031 172.812 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 C-N-CA 125.353 1.454 . . . . 0.0 112.792 178.667 . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -122.04 137.48 54.79 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -92.28 162.12 14.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.345 1.058 . . . . 0.0 113.139 177.02 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.08 -43.99 78.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.743 1.217 . . . . 0.0 111.521 170.229 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -73.83 -4.57 35.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.876 1.671 . . . . 0.0 113.723 176.017 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.26 23.46 29.29 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 161.911 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -87.8 137.0 32.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.3 1.55 . . . . 0.0 109.431 166.624 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -133.71 138.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.46 142.21 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.754 0.821 . . . . 0.0 112.764 178.271 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.87 50.35 0.92 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.335 1.854 . . . . 0.0 112.303 -174.465 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.3 125.95 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.772 0.829 . . . . 0.0 111.517 -174.68 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.91 -29.91 62.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 113.43 -169.871 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 154.89 7.21 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.609 1.576 . . . . 0.0 113.934 -176.411 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.066 -1.964 . . . . 0.0 114.749 178.344 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -83.72 106.89 15.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -71.68 171.83 10.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.849 2.06 . . . . 0.0 112.274 -175.04 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -66.42 -19.4 65.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.978 -1.077 . . . . 0.0 113.488 -172.793 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -80.78 -11.85 59.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 113.714 173.951 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.53 -12.21 69.96 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.325 1.44 . . . . 0.0 114.942 -168.217 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.35 139.04 58.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.687 1.744 . . . . 0.0 110.29 174.324 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.79 163.87 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.6 tp -121.9 132.24 54.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.359 1.463 . . . . 0.0 112.721 -167.345 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.53 90.35 3.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.388 1.875 . . . . 0.0 109.94 177.807 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -69.83 -22.83 63.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -177.055 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -82.72 82.72 7.95 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 112.606 -178.646 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.71 -37.28 20.29 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 123.974 0.797 . . . . 0.0 113.37 171.21 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.712 -1.605 . . . . 0.0 112.721 -179.38 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -89.79 109.43 20.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.4 p -72.32 169.23 16.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.459 1.904 . . . . 0.0 113.437 -174.505 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.57 -16.14 62.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.644 1.177 . . . . 0.0 113.483 173.268 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -84.72 15.27 3.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.45 1.5 . . . . 0.0 113.055 164.057 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.12 -23.03 1.85 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.32 1.914 . . . . 0.0 115.631 171.931 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -85.12 166.93 16.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.702 1.601 . . . . 0.0 112.916 -177.857 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.33 144.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -86.41 136.86 32.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.152 1.381 . . . . 0.0 112.51 -179.006 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -94.9 140.17 30.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.48 1.112 . . . . 0.0 110.93 169.613 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.79 -23.24 1.81 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.162 1.385 . . . . 0.0 113.802 177.098 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 157.18 44.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.993 1.317 . . . . 0.0 112.099 173.078 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.56 -164.74 32.95 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.401 1.0 . . . . 0.0 113.132 -177.155 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.784 -1.564 . . . . 0.0 113.4 -179.16 . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -128.97 146.3 51.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.8 1.64 . . . . 0.0 112.339 -179.27 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.03 -28.6 69.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.844 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 p -78.36 -1.45 33.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.097 1.759 . . . . 0.0 114.519 173.205 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 12.21 73.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.541 1.067 . . . . 0.0 115.634 174.949 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -79.24 129.91 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.351 1.46 . . . . 0.0 108.752 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.64 150.6 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.9 151.42 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.83 0.852 . . . . 0.0 112.612 -179.092 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -78.24 60.15 2.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.918 1.287 . . . . 0.0 110.619 166.642 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -61.15 122.18 14.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.535 1.934 . . . . 0.0 111.113 -178.352 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 56.87 28.86 15.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.873 2.069 . . . . 0.0 113.683 -177.348 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.03 15.6 0.12 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 -177.206 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-N 120.214 2.007 . . . . 0.0 115.232 174.767 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -111.18 153.3 25.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -137.41 148.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.69 1.196 . . . . 0.0 112.537 179.591 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -73.59 -14.28 61.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.24 -0.912 . . . . 0.0 112.583 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -80.56 2.64 24.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.587 1.155 . . . . 0.0 113.938 168.565 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.78 8.17 80.18 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.329 1.291 . . . . 0.0 116.329 167.489 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -90.71 142.02 28.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.153 1.477 . . . . 0.0 110.781 169.161 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.52 134.8 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.7 tp -81.77 130.97 35.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.321 1.448 . . . . 0.0 109.961 170.571 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -67.57 135.91 53.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 113.053 -178.791 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.7 mt -78.27 143.16 37.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 111.486 177.599 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 42.36 45.01 3.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.612 1.965 . . . . 0.0 112.429 -170.058 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.93 -25.46 69.32 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.83 -168.245 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.121 -1.377 . . . . 0.0 112.338 175.847 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -103.77 144.78 31.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -112.91 158.45 20.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 112.416 173.06 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.46 -18.45 61.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.562 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -78.93 -0.08 29.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.272 1.029 . . . . 0.0 113.757 164.159 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.83 3.83 55.88 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.642 -1.643 . . . . 0.0 116.724 163.834 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.22 140.97 38.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.554 2.177 . . . . 0.0 110.48 177.594 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.2 152.8 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.29 125.13 34.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 164.8 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -108.69 106.83 17.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.492 1.917 . . . . 0.0 108.092 176.021 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.8 mt -120.03 153.04 36.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.688 1.595 . . . . 0.0 112.484 -164.718 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 -122.68 -38.03 2.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.753 1.621 . . . . 0.0 114.329 -167.242 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.5 151.31 5.51 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.538 1.066 . . . . 0.0 115.017 178.406 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 125.502 1.525 . . . . 0.0 112.934 178.683 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -85.7 153.12 22.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 112.697 -175.883 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.17 -29.76 67.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 0.0 113.707 -175.726 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -80.5 -9.67 59.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.744 1.217 . . . . 0.0 113.972 178.097 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.65 -0.37 88.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.512 1.053 . . . . 0.0 114.785 -171.218 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -69.54 138.34 53.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.359 1.58 . . . . 0.0 109.719 170.559 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -106.84 137.36 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -95.75 133.97 39.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.77 0.828 . . . . 0.0 111.679 178.518 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mmt-85 -84.92 55.56 3.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.794 1.238 . . . . 0.0 111.352 169.408 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -127.24 142.75 51.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.863 2.065 . . . . 0.0 109.755 175.889 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -82.81 144.36 30.18 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -168.563 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.28 -2.16 80.46 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -172.288 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-N 118.628 1.214 . . . . 0.0 113.48 178.877 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -105.04 131.99 51.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.8 p -63.64 173.18 1.79 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.236 1.414 . . . . 0.0 112.295 165.504 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.76 -29.88 67.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.783 -1.198 . . . . 0.0 112.923 170.603 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -82.41 -5.16 58.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 114.344 174.492 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.95 89.57 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.125 1.345 . . . . 0.0 114.865 -177.798 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.63 134.34 55.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.039 1.42 . . . . 0.0 108.682 172.923 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.28 138.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.9 mt -60.44 -37.0 79.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.252 1.421 . . . . 0.0 113.39 -172.38 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -46.07 -38.21 7.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 113.234 171.715 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.72 -33.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.963 1.305 . . . . 0.0 113.352 -170.866 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.08 -71.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.759 2.824 . . . . 0.0 114.966 176.16 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.07 -25.25 0.04 OUTLIER Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 -178.61 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 119.236 1.518 . . . . 0.0 114.707 -173.551 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -121.85 151.62 40.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -99.9 162.88 12.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.833 1.653 . . . . 0.0 113.368 174.329 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.21 -19.42 64.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.535 1.534 . . . . 0.0 113.072 168.224 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -84.66 3.32 37.64 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.369 1.868 . . . . 0.0 113.88 169.318 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.32 -0.67 79.41 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.41 1.481 . . . . 0.0 115.709 176.458 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -69.42 140.27 54.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.591 1.157 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.33 139.43 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.68 132.1 35.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.964 -1.085 . . . . 0.0 111.208 177.915 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.22 -39.59 78.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.212 2.205 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 mt -136.43 132.96 36.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.381 1.472 . . . . 0.0 110.316 170.754 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -151.0 -11.33 0.23 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 169.399 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.48 161.87 18.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.837 1.684 . . . . 0.0 113.721 175.492 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.461 -1.744 . . . . 0.0 115.121 177.883 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -109.54 146.37 34.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -131.54 162.55 30.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.671 1.588 . . . . 0.0 114.028 -167.844 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 tp -62.17 -10.48 10.62 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.701 2.0 . . . . 0.0 114.713 178.098 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -108.6 2.13 21.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -178.743 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 27.26 73.87 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.11 -0.994 . . . . 0.0 113.89 -173.805 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -93.65 115.67 28.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.401 1.08 . . . . 0.0 109.051 168.725 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m -125.34 147.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.27 154.35 19.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.54 1.136 . . . . 0.0 112.565 -174.37 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -132.96 70.28 1.47 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.581 1.952 . . . . 0.0 109.965 175.901 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.84 153.95 39.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.236 1.415 . . . . 0.0 112.511 -174.475 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -80.59 140.15 35.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.051 1.341 . . . . 0.0 112.711 -168.077 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.49 135.48 2.84 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.432 1.492 . . . . 0.0 113.508 176.69 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.729 1.633 . . . . 0.0 114.2 -175.782 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -85.12 107.73 17.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -71.01 169.05 15.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.629 1.572 . . . . 0.0 113.199 -172.356 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.8 mt -58.64 -31.24 67.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.44 -1.413 . . . . 0.0 112.32 167.659 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -71.3 -0.72 10.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.238 2.215 . . . . 0.0 113.482 174.8 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.28 -33.88 1.77 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.193 1.854 . . . . 0.0 114.04 178.87 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.95 141.89 26.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 110.612 169.332 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.13 156.08 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 tp -92.66 150.45 20.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.343 -0.848 . . . . 0.0 111.548 170.988 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -132.87 145.48 50.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 111.725 162.444 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.2 mt -104.96 -32.8 8.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.197 1.799 . . . . 0.0 111.88 178.249 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -70.2 0.16 6.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -174.731 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.9 -25.47 45.23 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.495 175.465 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.187 1.851 . . . . 0.0 114.557 -178.127 . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -101.73 126.26 48.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -89.28 163.71 15.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.699 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.6 -13.82 45.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 167.994 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 p -92.18 -0.12 57.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.0 113.412 174.951 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.09 89.66 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.383 1.468 . . . . 0.0 114.588 -179.004 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -84.82 170.59 13.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.06 1.744 . . . . 0.0 110.895 178.708 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.28 141.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.51 146.91 32.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mtm105 -72.76 -39.95 66.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.259 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 mt -109.36 7.66 25.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -168.999 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -141.39 151.43 43.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.479 1.911 . . . . 0.0 110.752 176.348 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.68 -75.12 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.449 1.5 . . . . 0.0 111.473 -179.123 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 C-N-CA 125.24 1.4 . . . . 0.0 113.266 179.224 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.4 134.69 36.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -119.51 161.17 21.02 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.094 1.358 . . . . 0.0 111.972 -173.471 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.29 -27.88 69.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.669 -1.269 . . . . 0.0 112.028 172.84 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -67.26 -7.02 20.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.813 1.645 . . . . 0.0 114.758 169.797 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.63 15.36 73.6 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.876 -1.14 . . . . 0.0 115.012 176.866 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -73.25 161.44 30.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.829 1.314 . . . . 0.0 111.595 174.428 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.53 147.39 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.72 129.86 56.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.633 1.573 . . . . 0.0 111.204 -175.249 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -76.57 -40.0 50.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.102 0.961 . . . . 0.0 113.361 -173.967 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 mt -92.09 19.7 6.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.394 1.477 . . . . 0.0 113.073 -168.792 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -143.4 132.27 22.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.989 2.116 . . . . 0.0 109.414 179.08 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.39 -144.75 39.71 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.557 0.617 . . . . 0.0 114.632 175.801 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.801 1.667 . . . . 0.0 112.619 -177.075 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.94 128.82 44.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 p -97.73 159.94 14.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.528 1.531 . . . . 0.0 112.54 177.536 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -77.51 4.17 11.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 114.466 176.862 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.8 p -128.84 33.3 4.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 177.235 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.02 52.48 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 162.383 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -115.19 141.98 47.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.705 1.753 . . . . 0.0 112.142 177.967 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.58 136.12 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.12 135.0 42.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.029 0.931 . . . . 0.0 111.027 179.997 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -82.11 77.67 8.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.286 1.434 . . . . 0.0 109.253 169.018 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.67 -26.47 68.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -172.231 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -68.41 -13.2 62.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 173.699 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.86 75.12 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.476 1.989 . . . . 0.0 116.84 -175.394 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 119.996 1.898 . . . . 0.0 115.719 179.679 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -123.35 136.7 54.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -82.24 136.1 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 111.075 165.195 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.22 -27.39 67.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.706 1.202 . . . . 0.0 114.24 -166.289 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -115.61 18.38 15.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.891 1.677 . . . . 0.0 113.162 177.688 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.13 -152.08 5.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.663 1.125 . . . . 0.0 115.236 -171.384 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -83.57 161.63 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.231 2.213 . . . . 0.0 112.997 -164.013 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.46 137.28 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.21 137.22 32.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.753 -0.592 . . . . 0.0 109.527 173.238 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.66 139.15 39.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.189 1.396 . . . . 0.0 112.087 -176.365 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.1 -41.04 74.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.2 1.0 . . . . 0.0 111.425 -178.642 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -63.42 122.06 15.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.203 1.401 . . . . 0.0 109.497 160.911 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.41 -179.55 23.11 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.908 1.242 . . . . 0.0 113.723 178.489 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.19 179.524 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -83.12 112.21 19.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.3 p -67.08 171.12 5.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.776 1.631 . . . . 0.0 113.187 -179.337 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.66 -9.53 44.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -179.626 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -93.24 -9.87 37.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.054 1.342 . . . . 0.0 113.469 170.334 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 -16.42 60.9 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.49 1.995 . . . . 0.0 115.065 -171.879 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.6 154.07 42.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.199 1.5 . . . . 0.0 111.585 177.46 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.98 137.88 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 tp -85.64 137.85 32.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 111.559 174.337 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -90.07 139.45 30.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.909 1.684 . . . . 0.0 111.997 172.043 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.35 7.05 9.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.614 1.566 . . . . 0.0 114.608 -174.996 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -132.09 107.96 8.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.057 1.343 . . . . 0.0 112.323 -176.482 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.66 -16.98 11.19 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.324 1.916 . . . . 0.0 116.528 170.618 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.751 2.12 . . . . 0.0 114.356 178.63 . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.85 155.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.7 m -118.09 146.7 43.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.824 2.05 . . . . 0.0 109.954 -174.874 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.74 -19.74 62.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.207 -0.933 . . . . 0.0 113.516 179.022 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -67.95 -19.52 64.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.156 1.783 . . . . 0.0 114.966 171.057 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -12.52 40.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.888 1.709 . . . . 0.0 114.86 -174.159 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 145.47 55.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.066 1.433 . . . . 0.0 111.065 176.962 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.95 168.13 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -72.36 163.39 28.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.622 177.447 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -93.89 159.64 15.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.321 1.448 . . . . 0.0 111.312 158.542 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.84 133.9 25.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.981 0.912 . . . . 0.0 110.28 170.981 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 57.76 9.56 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.304 1.842 . . . . 0.0 115.194 -179.565 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 -9.67 83.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -168.777 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 119.654 1.727 . . . . 0.0 114.481 -176.993 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.1 123.42 33.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.8 p -87.73 170.96 10.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.187 1.395 . . . . 0.0 112.319 174.151 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.35 -20.51 64.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.45 -1.406 . . . . 0.0 114.034 -177.955 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -80.56 -1.89 43.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.888 1.275 . . . . 0.0 113.25 169.592 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.12 -1.22 87.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.02 1.771 . . . . 0.0 115.099 -179.607 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -67.37 139.13 57.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.845 1.822 . . . . 0.0 110.013 177.045 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.63 140.67 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tp -92.12 155.88 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.267 0.627 . . . . 0.0 111.272 178.575 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -126.0 151.41 47.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 111.452 161.419 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.12 143.98 36.84 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.509 0.723 . . . . 0.0 111.81 -177.542 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -133.56 -36.73 0.96 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.214 1.806 . . . . 0.0 112.288 178.687 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 159.96 34.72 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.078 1.323 . . . . 0.0 112.789 165.252 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.804 -175.638 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.76 135.05 54.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 p -76.36 160.39 29.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.974 -1.079 . . . . 0.0 111.738 174.897 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.95 -14.53 62.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.905 -1.122 . . . . 0.0 112.767 167.922 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -82.0 -6.56 59.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 114.368 165.956 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 16.14 57.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.548 1.547 . . . . 0.0 116.174 172.817 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -93.66 146.03 24.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.346 1.458 . . . . 0.0 110.064 176.33 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.47 125.38 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.4 tp -79.48 99.06 7.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 166.07 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -81.4 33.61 0.36 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.478 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.16 -23.13 24.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.728 1.211 . . . . 0.0 113.425 -177.011 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt-85 -134.24 154.16 51.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.351 1.86 . . . . 0.0 111.603 -175.375 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 119.57 1.41 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.467 1.508 . . . . 0.0 113.346 -177.336 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.047 1.784 . . . . 0.0 113.184 179.879 . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -124.64 143.67 50.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -103.31 156.83 17.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.38 1.472 . . . . 0.0 113.823 177.194 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.54 -5.99 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.236 1.814 . . . . 0.0 114.083 176.956 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -115.51 14.05 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.427 1.891 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.29 44.71 7.35 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.424 1.329 . . . . 0.0 116.424 165.366 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -114.42 135.61 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.489 1.116 . . . . 0.0 109.989 161.912 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 136.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.14 141.59 29.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.246 1.019 . . . . 0.0 112.029 -173.976 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 -95.49 -24.96 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.51 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.62 27.66 2.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.028 1.331 . . . . 0.0 112.804 -172.807 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -145.27 123.45 12.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.816 1.646 . . . . 0.0 109.708 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.73 127.6 0.94 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.761 1.172 . . . . 0.0 112.059 -167.247 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.24 1.4 . . . . 0.0 113.122 -173.571 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.51 138.6 46.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -96.52 151.2 19.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.722 1.209 . . . . 0.0 111.631 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -57.31 -35.71 70.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.897 -1.127 . . . . 0.0 112.939 -179.518 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -78.49 0.93 24.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.993 2.117 . . . . 0.0 115.294 176.777 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 25.45 10.74 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 164.041 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -89.96 148.57 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.321 1.56 . . . . 0.0 109.985 166.34 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.65 148.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -111.76 126.28 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.962 0.887 . . . . 0.0 112.615 -171.858 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -94.95 57.49 2.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 128.435 2.694 . . . . 0.0 110.297 -179.692 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 mt -77.32 137.98 39.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.827 1.251 . . . . 0.0 110.93 -176.288 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtp-105 -123.4 -20.78 5.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.373 1.469 . . . . 0.0 113.693 177.265 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.67 -158.95 31.68 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 119.363 0.983 . . . . 0.0 111.805 -164.383 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 C-N-CA 125.417 1.484 . . . . 0.0 113.342 175.453 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -82.48 116.02 21.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -76.72 179.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 113.505 -175.467 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.67 -29.86 70.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.317 . . . . 0.0 112.941 -179.294 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -92.9 6.45 47.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.581 1.952 . . . . 0.0 113.867 172.366 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.8 15.36 80.86 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.86 -1.15 . . . . 0.0 115.77 176.694 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -75.71 145.45 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.229 1.515 . . . . 0.0 108.868 168.49 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.71 167.08 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.59 141.41 51.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.135 -0.978 . . . . 0.0 111.506 173.422 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -90.02 112.56 24.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 176.025 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 mt -107.06 125.87 51.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.19 1.396 . . . . 0.0 111.204 -171.423 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.35 160.97 43.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.283 1.433 . . . . 0.0 113.52 -174.522 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 -164.49 1.53 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.233 0.92 . . . . 0.0 113.614 160.702 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.767 -1.574 . . . . 0.0 113.313 -177.925 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -102.22 159.06 15.73 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -150.32 160.2 43.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.929 1.691 . . . . 0.0 110.294 -176.36 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.69 -10.59 48.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.676 -1.265 . . . . 0.0 113.968 -178.237 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.8 p -79.81 -6.85 58.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.438 1.495 . . . . 0.0 113.953 167.963 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.37 5.91 86.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.409 1.48 . . . . 0.0 116.23 173.16 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 140.77 29.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.517 1.658 . . . . 0.0 110.455 174.512 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.12 144.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.18 136.62 32.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.494 0.718 . . . . 0.0 111.155 173.652 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -114.79 114.06 25.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 108.818 173.927 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.89 153.2 29.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.681 1.592 . . . . 0.0 109.863 -179.694 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -60.97 131.56 51.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.841 0.856 . . . . 0.0 109.999 171.224 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -135.61 20.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -163.575 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.482 174.334 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -91.19 130.75 37.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -85.28 167.47 15.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.684 1.194 . . . . 0.0 113.005 177.213 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.18 -15.0 62.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.006 -1.059 . . . . 0.0 113.55 178.7 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -103.92 17.97 22.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.585 1.954 . . . . 0.0 113.063 171.609 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.68 88.72 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 166.845 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -74.59 142.63 44.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.509 1.654 . . . . 0.0 110.618 178.036 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.62 150.6 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.43 127.56 33.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.446 1.498 . . . . 0.0 112.556 177.948 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -95.36 139.49 31.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.702 1.601 . . . . 0.0 112.439 173.778 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.85 174.92 8.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.153 1.781 . . . . 0.0 112.405 -170.032 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 58.54 31.99 21.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.259 2.224 . . . . 0.0 115.792 179.538 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.37 -9.1 67.62 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.873 1.225 . . . . 0.0 114.774 174.849 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 C-N-CA 125.773 1.654 . . . . 0.0 112.114 171.176 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.67 128.21 56.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 p -85.16 163.91 18.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.159 1.384 . . . . 0.0 111.948 175.913 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -64.02 -20.07 65.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.302 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -77.58 -13.5 59.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.318 1.417 . . . . 0.0 113.02 171.977 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.5 -13.64 39.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.354 1.931 . . . . 0.0 114.543 -176.642 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -64.9 141.37 58.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.84 1.256 . . . . 0.0 111.854 -175.214 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.44 150.07 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -92.16 160.78 15.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.769 -1.207 . . . . 0.0 113.415 -177.61 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 ttm105 -114.38 137.56 51.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.46 1.904 . . . . 0.0 110.248 169.695 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.81 162.46 26.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.183 2.193 . . . . 0.0 110.245 -171.735 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -68.08 119.08 12.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.015 -1.053 . . . . 0.0 110.168 173.634 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 14.96 74.43 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.781 -1.011 . . . . 0.0 115.072 -168.298 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.337 1.922 . . . . 0.0 113.277 -179.265 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -127.56 123.9 36.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.2 p -74.94 159.91 31.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.738 1.215 . . . . 0.0 112.894 -178.878 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.7 tp -57.48 -32.64 67.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.122 -0.986 . . . . 0.0 113.242 168.478 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -70.9 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.449 1.5 . . . . 0.0 114.097 173.954 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.07 59.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.823 1.678 . . . . 0.0 115.657 175.293 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.45 147.6 35.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.252 1.421 . . . . 0.0 109.941 174.43 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.29 132.0 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.02 106.93 3.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.131 1.372 . . . . 0.0 109.994 168.412 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 43.6 ptt85 -87.17 26.66 1.15 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.768 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -109.66 10.39 24.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.824 2.05 . . . . 0.0 112.749 169.16 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -135.53 158.49 44.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.961 2.105 . . . . 0.0 110.585 -179.12 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.42 68.18 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 176.281 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-N 118.928 1.364 . . . . 0.0 113.292 -176.292 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.49 148.32 30.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -130.25 163.27 27.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.8 1.24 . . . . 0.0 112.539 174.584 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.7 tp -56.92 -34.53 68.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.667 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -78.94 6.9 8.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.355 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.21 8.47 74.74 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 120.473 -1.392 . . . . 0.0 115.024 -179.868 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -90.49 118.88 30.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.839 1.656 . . . . 0.0 109.654 176.914 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.95 144.21 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -86.45 146.7 26.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.68 0.752 . . . . 0.0 112.794 175.277 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -134.53 62.05 1.66 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.437 1.895 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.44 131.71 41.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.208 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -62.71 134.22 55.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.226 0.61 . . . . 0.0 112.21 -170.506 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.59 131.37 10.33 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.211 166.342 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.399 1.476 . . . . 0.0 113.453 177.099 . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.97 148.25 22.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -111.29 158.05 19.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.186 0.994 . . . . 0.0 111.787 178.119 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.72 -21.16 66.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.889 -1.132 . . . . 0.0 112.126 169.142 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.4 p -76.85 1.48 17.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.759 1.624 . . . . 0.0 113.794 170.992 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.04 74.06 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 120.814 -1.179 . . . . 0.0 115.379 173.043 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -93.3 160.07 14.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.358 1.863 . . . . 0.0 109.985 178.791 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.97 133.57 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.5 tp -100.66 110.32 22.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.88 1.672 . . . . 0.0 109.11 172.692 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -74.82 116.37 15.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.099 0.408 . . . . 0.0 110.244 174.102 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.43 -47.41 8.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.234 1.014 . . . . 0.0 111.812 179.7 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -67.42 -50.07 61.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.388 0.54 . . . . 0.0 111.919 -179.148 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.31 7.41 78.65 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 -179.648 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 113.999 -174.991 . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -87.25 113.98 23.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -74.95 179.55 4.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.338 1.855 . . . . 0.0 113.669 -172.917 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -65.6 -21.63 66.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.906 -1.121 . . . . 0.0 113.207 178.233 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p -88.82 -3.48 58.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.939 1.296 . . . . 0.0 113.227 176.357 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.43 -2.02 86.15 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.554 1.55 . . . . 0.0 115.29 -173.803 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -65.11 144.8 56.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.816 1.808 . . . . 0.0 109.907 173.52 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.89 169.26 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.83 167.13 10.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 111.728 -177.94 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -75.43 138.42 41.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.243 1.017 . . . . 0.0 111.965 171.234 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -131.83 53.75 1.97 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.813 2.445 . . . . 0.0 109.566 174.866 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -76.27 147.73 38.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.409 -1.432 . . . . 0.0 111.131 -177.202 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.72 136.73 41.53 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.637 -0.664 . . . . 0.0 112.498 174.284 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.184 1.373 . . . . 0.0 113.534 -178.378 . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.4 143.12 51.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -108.46 151.82 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.757 1.623 . . . . 0.0 112.801 -179.363 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.64 -24.98 68.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.375 1.47 . . . . 0.0 112.703 179.641 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -81.72 11.79 4.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.332 1.453 . . . . 0.0 114.086 171.451 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.33 45.02 11.81 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.394 0.997 . . . . 0.0 114.693 165.229 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -118.6 148.97 42.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.425 1.09 . . . . 0.0 110.536 163.371 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.08 133.02 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.4 131.43 36.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.061 1.344 . . . . 0.0 111.412 -174.876 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -83.08 -31.38 27.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.701 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.0 tp -132.36 83.3 2.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 111.121 -171.983 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -135.69 38.75 2.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.569 1.947 . . . . 0.0 110.559 172.958 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.01 -168.87 26.88 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.514 1.531 . . . . 0.0 114.163 -174.847 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 127.133 2.301 . . . . 0.0 114.222 -179.041 . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -119.26 127.72 53.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -78.14 165.27 24.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.144 1.378 . . . . 0.0 112.884 178.138 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.1 -1.0 . . . . 0.0 111.559 167.869 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p -76.5 12.27 1.32 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.843 1.657 . . . . 0.0 114.189 172.371 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 1.45 57.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.357 1.456 . . . . 0.0 116.631 171.429 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.92 132.23 42.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.919 1.86 . . . . 0.0 109.174 177.066 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 HD12 ' A' ' 50' ' ' LEU . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 43' ' ' LEU . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.01 146.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.37 136.14 33.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 171.516 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -93.09 141.42 28.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.402 -0.811 . . . . 0.0 110.338 162.062 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.85 155.23 25.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.686 0.794 . . . . 0.0 111.71 -175.184 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -143.32 7.44 1.55 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.002 1.721 . . . . 0.0 113.687 -172.5 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 177.42 44.75 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.724 2.107 . . . . 0.0 111.778 176.333 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.461 -1.188 . . . . 0.0 113.562 -179.958 . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -83.04 138.54 33.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -122.94 152.92 40.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.583 1.553 . . . . 0.0 111.37 169.579 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.91 -10.64 54.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -166.363 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.7 p -75.05 -5.24 43.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.373 1.469 . . . . 0.0 114.031 169.91 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.68 90.67 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.962 1.267 . . . . 0.0 113.888 -168.057 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.67 138.65 40.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.285 1.542 . . . . 0.0 110.413 169.255 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.26 157.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.68 138.91 31.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.489 0.716 . . . . 0.0 111.636 175.946 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -71.41 144.89 49.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.147 . . . . 0.0 112.829 176.701 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.21 136.44 50.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.34 1.456 . . . . 0.0 110.293 167.174 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 55.63 30.38 15.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.943 1.697 . . . . 0.0 115.058 177.755 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.87 9.05 78.6 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.571 1.558 . . . . 0.0 116.692 -170.649 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 126.046 1.784 . . . . 0.0 111.446 -174.402 . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -109.0 143.28 38.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 p -102.19 151.81 21.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.579 1.152 . . . . 0.0 111.678 167.474 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.66 -33.54 74.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.231 1.412 . . . . 0.0 110.81 169.353 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.1 p -68.75 -2.54 9.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.581 1.553 . . . . 0.0 114.613 173.382 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 15.64 27.1 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 162.729 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -99.46 144.62 28.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.396 1.598 . . . . 0.0 111.005 178.397 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.58 139.2 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.94 127.78 44.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.833 1.253 . . . . 0.0 110.212 -177.111 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -73.34 -25.24 60.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -165.844 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.3 mt -101.46 30.9 3.99 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.859 1.209 . . . . 0.0 113.606 -168.567 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -127.68 40.41 3.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.111 1.364 . . . . 0.0 114.211 -167.268 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.22 165.29 29.11 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.07 -1.019 . . . . 0.0 115.32 177.126 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 126.444 1.973 . . . . 0.0 114.034 -176.496 . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -90.23 127.51 36.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -89.48 175.93 7.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.05 1.34 . . . . 0.0 112.873 -179.451 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.4 -37.11 79.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.258 1.423 . . . . 0.0 113.177 -177.473 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -79.14 -0.19 30.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.703 . . . . 0.0 113.707 174.018 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.33 89.5 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.004 -1.06 . . . . 0.0 115.071 179.924 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.14 155.92 38.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.105 1.452 . . . . 0.0 110.586 169.825 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.28 144.74 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -86.83 133.61 33.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.054 0.942 . . . . 0.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -87.53 129.42 35.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.746 0.819 . . . . 0.0 111.168 168.081 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -130.94 -42.31 1.11 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.768 2.027 . . . . 0.0 110.452 177.179 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -67.18 160.52 26.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 112.478 167.422 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.51 -161.3 48.23 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.755 1.169 . . . . 0.0 114.431 -179.663 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 C-N-CA 126.78 2.133 . . . . 0.0 114.786 -173.489 . . . . . . . . 0 0 . 1 . 108 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.9 149.69 21.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -134.43 159.79 39.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -157.808 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.96 -20.32 66.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 113.532 173.15 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -86.9 10.45 16.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.588 1.555 . . . . 0.0 113.933 168.64 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.44 17.52 80.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.046 1.308 . . . . 0.0 115.804 164.108 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 158.92 30.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.449 1.5 . . . . 0.0 112.563 178.146 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.38 164.59 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.11 137.55 32.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.914 1.286 . . . . 0.0 111.73 -177.405 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -82.31 80.27 8.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.747 1.619 . . . . 0.0 110.811 176.88 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.6 mt 61.14 -56.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.601 2.76 . . . . 0.0 116.187 -176.406 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -79.65 123.01 27.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.549 1.94 . . . . 0.0 111.685 -176.853 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.01 24.58 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.183 1.373 . . . . 0.0 114.299 -179.122 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.156 1.836 . . . . 0.0 112.882 -174.645 . . . . . . . . 0 0 . 1 . 109 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -100.24 130.54 46.37 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -72.78 162.5 29.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.214 0.605 . . . . 0.0 111.04 164.619 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.17 -18.82 60.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.015 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -86.62 -11.54 51.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.598 1.559 . . . . 0.0 114.855 173.583 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.84 5.08 57.67 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -179.95 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.8 136.92 43.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.056 1.428 . . . . 0.0 110.256 174.675 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -124.21 137.03 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 150.46 20.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.426 0.69 . . . . 0.0 112.182 -178.256 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -86.05 130.61 34.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 157.757 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.3 mt -91.13 28.7 1.55 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -155.843 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -135.04 157.45 46.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.981 2.112 . . . . 0.0 111.927 171.73 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.99 -144.11 3.89 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.964 1.745 . . . . 0.0 113.172 178.68 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.338 1.447 . . . . 0.0 113.403 -177.717 . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -114.8 146.66 40.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -111.44 161.3 16.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.006 1.322 . . . . 0.0 113.892 -179.02 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.95 -31.42 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.13 0.972 . . . . 0.0 113.037 176.856 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -96.71 25.62 5.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.509 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.33 17.78 73.05 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.799 1.48 . . . . 0.0 116.799 160.061 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -83.21 134.59 34.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.076 1.438 . . . . 0.0 109.03 169.145 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -94.52 134.95 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.17 131.15 55.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.634 0.773 . . . . 0.0 112.259 -177.157 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -122.67 64.67 0.96 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.826 1.65 . . . . 0.0 111.204 -172.937 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.46 154.22 40.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.377 1.071 . . . . 0.0 112.392 -177.591 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.02 154.14 42.32 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.723 1.609 . . . . 0.0 112.771 -178.789 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.31 161.08 26.93 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.227 2.346 . . . . 0.0 112.225 -177.565 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.373 1.463 . . . . 0.0 114.441 -174.762 . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -89.46 117.21 28.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -80.63 165.5 21.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.126 1.371 . . . . 0.0 112.962 -176.894 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.27 -32.7 71.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.796 1.238 . . . . 0.0 113.618 -178.416 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -79.87 -11.86 59.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.485 1.514 . . . . 0.0 113.258 178.35 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 9.82 49.09 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.276 1.417 . . . . 0.0 115.602 176.856 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -85.04 171.0 12.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.376 1.588 . . . . 0.0 111.565 170.935 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.81 151.83 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -118.68 137.89 53.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.431 1.092 . . . . 0.0 110.637 -169.478 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.67 82.79 1.92 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.815 1.646 . . . . 0.0 109.064 -177.532 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.29 -6.13 44.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -169.893 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -114.82 101.52 9.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.706 1.602 . . . . 0.0 112.098 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 153.0 52.11 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.807 -0.558 . . . . 0.0 112.336 165.326 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 125.751 1.644 . . . . 0.0 114.16 178.537 . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -105.5 122.06 45.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -68.59 177.72 2.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.361 1.065 . . . . 0.0 112.845 177.039 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.39 -27.28 46.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 170.828 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -97.71 11.55 36.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.244 1.418 . . . . 0.0 113.232 175.674 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 6.83 71.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.801 1.191 . . . . 0.0 115.574 176.959 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -65.56 129.14 38.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.469 1.635 . . . . 0.0 109.881 177.576 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.55 144.47 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.12 -37.4 83.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.032 1.333 . . . . 0.0 114.055 -170.942 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -62.75 -18.65 62.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.788 1.235 . . . . 0.0 113.18 177.487 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -131.9 60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.58 2.352 . . . . 0.0 110.387 179.43 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -77.84 54.46 1.27 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 112.365 -177.467 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.28 -147.55 44.35 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.094 1.33 . . . . 0.0 113.633 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.819 1.676 . . . . 0.0 112.82 -174.783 . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -125.27 138.25 54.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -98.35 173.07 7.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.593 1.157 . . . . 0.0 113.258 -173.284 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.34 -16.62 64.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 176.075 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -88.82 1.6 55.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.466 1.106 . . . . 0.0 112.937 171.192 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.77 4.9 88.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.13 1.347 . . . . 0.0 114.721 -177.072 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.47 129.39 39.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.248 1.524 . . . . 0.0 109.492 175.348 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.39 154.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.3 mt -118.94 174.41 6.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.449 1.5 . . . . 0.0 111.85 -171.25 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.8 mtt-85 -96.99 141.17 30.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.888 1.275 . . . . 0.0 111.191 -179.062 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.6 mt -133.52 -17.07 2.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.03 1.332 . . . . 0.0 113.91 -165.687 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.27 146.76 49.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.938 1.695 . . . . 0.0 110.952 -172.201 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.93 22.11 61.99 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.848 0.737 . . . . 0.0 114.493 -173.712 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 C-N-CA 127.362 2.411 . . . . 0.0 110.099 -164.146 . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 66' ' ' THR . 56.6 mtmt -103.0 127.1 50.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -109.05 134.69 51.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.409 1.484 . . . . 0.0 109.658 -179.021 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.58 -1.63 16.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -171.79 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -68.76 -5.2 19.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 114.064 161.732 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.73 32.33 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.636 1.589 . . . . 0.0 114.259 -175.239 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -122.22 127.29 49.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.248 1.419 . . . . 0.0 112.351 -173.376 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HE2' ' A' ' 6' ' ' LYS . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -106.09 150.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -98.87 136.57 38.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.531 0.732 . . . . 0.0 110.218 174.819 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -127.09 69.15 1.27 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -176.303 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.88 152.02 35.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.98 1.312 . . . . 0.0 114.325 -166.573 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -118.23 -41.04 2.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.268 2.227 . . . . 0.0 112.764 176.219 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.16 -179.95 25.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.283 1.897 . . . . 0.0 114.011 179.741 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.757 1.646 . . . . 0.0 113.723 -177.096 . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.2 136.66 33.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 p -95.63 165.43 12.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 112.369 175.89 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.0 mt -76.41 1.8 15.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.148 1.379 . . . . 0.0 113.49 165.938 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -116.29 29.18 8.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.474 2.71 . . . . 0.0 111.833 179.613 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 0.59 50.86 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 169.412 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -91.34 146.76 23.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.348 1.574 . . . . 0.0 110.906 -177.941 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.39 127.6 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.92 126.14 30.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.792 -1.193 . . . . 0.0 111.058 176.844 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -64.08 -26.03 68.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.805 2.042 . . . . 0.0 113.269 -178.775 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.41 4.48 17.94 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.228 1.411 . . . . 0.0 113.935 176.378 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.28 166.61 23.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.663 1.985 . . . . 0.0 109.764 176.25 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.96 31.33 69.73 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.331 -0.856 . . . . 0.0 114.989 178.858 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.574 1.559 . . . . 0.0 113.081 179.081 . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -84.69 117.89 24.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.4 p -76.58 173.89 11.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.036 1.335 . . . . 0.0 112.666 179.445 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.01 -20.68 66.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.859 -1.151 . . . . 0.0 113.443 179.295 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.4 p -102.47 16.64 25.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.971 1.708 . . . . 0.0 113.792 169.751 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.84 2.91 87.11 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.474 1.511 . . . . 0.0 116.361 169.676 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.74 146.01 51.82 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.943 1.371 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.32 177.2 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.77 150.7 24.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.743 -1.223 . . . . 0.0 113.601 -176.596 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.31 131.05 48.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.777 1.631 . . . . 0.0 110.96 168.292 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.5 116.4 30.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.663 0.785 . . . . 0.0 111.246 179.323 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -160.46 155.81 25.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.406 1.482 . . . . 0.0 113.101 -174.992 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.51 150.47 50.8 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.104 0.859 . . . . 0.0 114.556 -172.834 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.99 -1.45 . . . . 0.0 111.12 -178.959 . . . . . . . . 0 0 . 1 . 117 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -122.08 139.26 53.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -107.16 156.68 18.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.023 1.329 . . . . 0.0 113.22 173.746 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.3 -33.84 75.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.304 1.042 . . . . 0.0 113.18 178.402 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -89.11 5.13 45.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.463 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.37 24.36 10.31 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 159.764 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -86.44 134.98 33.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.654 1.227 . . . . 0.0 108.724 163.622 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.06 131.05 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.52 108.22 18.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.716 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -57.48 138.26 55.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.067 1.747 . . . . 0.0 112.205 -167.842 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.87 153.91 35.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.358 1.063 . . . . 0.0 112.35 -172.896 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -85.37 151.14 24.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.349 1.46 . . . . 0.0 112.016 -175.966 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.12 74.0 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.262 1.265 . . . . 0.0 116.262 -179.996 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.439 1.495 . . . . 0.0 113.879 179.884 . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -104.21 139.13 39.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -113.53 163.79 14.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.981 1.713 . . . . 0.0 113.775 -178.098 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -64.15 -22.66 67.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.054 1.342 . . . . 0.0 113.704 -169.84 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -77.31 2.11 16.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.571 2.348 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 2.08 90.55 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.062 -1.024 . . . . 0.0 114.829 -178.554 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -83.5 154.37 23.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.524 1.53 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.44 134.49 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.47 128.03 35.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.481 1.112 . . . . 0.0 111.18 -178.376 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -73.64 -62.85 1.34 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.028 1.331 . . . . 0.0 112.786 -179.52 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.97 105.61 8.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 109.881 -178.342 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -147.46 149.03 31.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.927 1.691 . . . . 0.0 111.05 166.895 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.49 144.2 4.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.418 1.485 . . . . 0.0 113.718 175.129 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.428 1.489 . . . . 0.0 113.371 -179.968 . . . . . . . . 0 0 . 1 . 119 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -86.09 117.7 25.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -72.5 149.43 44.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.227 0.611 . . . . 0.0 110.549 171.803 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.6 tp -68.85 -20.96 64.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.106 -0.996 . . . . 0.0 112.114 174.08 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -80.44 -29.49 37.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.525 1.53 . . . . 0.0 114.87 177.096 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.09 -62.01 0.2 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 170.562 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -74.73 166.61 23.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.412 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.03 143.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.68 137.57 39.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.424 -0.797 . . . . 0.0 110.148 172.615 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -110.72 111.33 22.44 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.409 1.084 . . . . 0.0 110.871 -178.925 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -111.49 159.2 18.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.805 1.642 . . . . 0.0 111.513 174.213 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -57.52 -38.84 75.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.589 1.155 . . . . 0.0 113.29 -178.396 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.93 157.86 14.82 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.664 1.602 . . . . 0.0 114.671 177.218 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 C-N-CA 125.89 1.71 . . . . 0.0 113.303 179.602 . . . . . . . . 0 0 . 1 . 120 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.63 134.39 52.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -90.79 170.28 10.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 113.337 178.182 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.8 mt -64.83 -29.65 70.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.206 -0.934 . . . . 0.0 112.119 169.126 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.11 5.57 9.8 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.387 1.875 . . . . 0.0 114.051 169.77 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.56 0.19 72.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.149 1.833 . . . . 0.0 115.882 174.819 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -64.17 144.68 56.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.545 1.938 . . . . 0.0 110.923 -177.452 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.75 132.95 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.96 127.55 33.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.031 0.933 . . . . 0.0 109.603 168.289 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 -126.27 100.76 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.488 1.515 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.4 mt -86.86 -42.29 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.643 0.777 . . . . 0.0 111.144 175.211 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -70.0 150.53 46.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.045 1.738 . . . . 0.0 113.765 -178.106 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.35 29.89 74.56 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.423 1.011 . . . . 0.0 115.481 173.14 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.515 1.531 . . . . 0.0 113.288 -179.255 . . . . . . . . 0 0 . 1 . 121 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -125.48 144.61 50.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -95.36 164.49 12.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.994 1.318 . . . . 0.0 112.502 178.834 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.12 -26.85 68.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.333 -0.854 . . . . 0.0 112.928 169.975 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -70.08 -6.96 37.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.796 1.238 . . . . 0.0 113.932 170.925 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.37 -2.6 74.63 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.97 1.748 . . . . 0.0 115.432 176.515 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -78.39 137.14 37.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.646 1.223 . . . . 0.0 111.024 -178.301 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.69 132.01 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 mt -104.89 149.23 25.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.105 0.962 . . . . 0.0 112.418 -175.183 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -84.45 124.09 30.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.883 0.873 . . . . 0.0 109.602 167.676 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 mp -109.13 99.29 8.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.951 1.3 . . . . 0.0 109.645 177.836 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -120.89 17.8 11.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.618 1.567 . . . . 0.0 113.554 -174.335 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.85 -15.43 71.45 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.925 1.25 . . . . 0.0 116.16 -173.715 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.22 1.867 . . . . 0.0 115.055 171.923 . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -81.02 118.44 22.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -83.27 173.2 11.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.165 1.786 . . . . 0.0 112.586 -178.819 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.79 -6.92 35.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.551 -1.343 . . . . 0.0 114.563 -173.87 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -103.02 9.03 38.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.723 2.009 . . . . 0.0 113.521 172.079 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.0 -15.48 6.36 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 120.289 -1.507 . . . . 0.0 115.255 -178.597 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -53.67 132.59 41.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.755 . . . . 0.0 110.105 165.958 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.57 157.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.26 129.88 35.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.854 0.862 . . . . 0.0 110.795 -176.472 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -88.12 137.38 32.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.112 2.165 . . . . 0.0 111.947 -178.857 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -133.95 149.95 51.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.3 1.44 . . . . 0.0 113.266 -162.251 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -154.2 163.22 40.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.213 1.405 . . . . 0.0 113.392 173.049 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.3 176.39 54.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.974 1.273 . . . . 0.0 114.535 173.108 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.428 1.489 . . . . 0.0 114.525 172.154 . . . . . . . . 0 0 . 1 . 123 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.87 131.65 37.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 p -89.61 154.71 19.76 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.762 0.791 . . . . 0.0 111.505 168.528 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.54 -6.63 54.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.655 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -138.48 -11.14 1.4 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.927 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -114.74 0.57 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.084 1.311 . . . . 0.0 114.812 -169.549 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -69.54 149.17 48.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.894 1.277 . . . . 0.0 112.5 -167.761 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.86 135.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.83 127.66 42.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.483 0.713 . . . . 0.0 112.26 -178.148 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -58.9 152.05 20.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.166 0.986 . . . . 0.0 112.153 173.604 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.07 161.37 29.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.785 1.234 . . . . 0.0 113.104 -171.112 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 52.53 25.17 3.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.958 2.503 . . . . 0.0 115.352 177.547 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.18 -13.14 62.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.704 1.145 . . . . 0.0 115.177 -174.53 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.692 1.615 . . . . 0.0 112.694 -178.396 . . . . . . . . 0 0 . 1 . 124 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -94.41 139.22 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -104.77 153.11 21.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.53 0.732 . . . . 0.0 111.527 174.017 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.49 -35.19 73.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.497 1.119 . . . . 0.0 112.954 -174.782 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -89.07 15.2 9.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 175.857 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 20.66 37.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 163.814 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm -85.02 155.76 21.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.353 1.077 . . . . 0.0 110.166 166.568 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.17 137.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.67 113.4 25.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 109.663 174.725 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.96 100.18 7.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.821 1.248 . . . . 0.0 109.81 -174.91 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.7 150.97 22.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.797 0.839 . . . . 0.0 111.713 -177.574 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -87.42 -25.38 23.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.904 1.682 . . . . 0.0 112.639 166.771 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.63 -166.38 37.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.704 1.145 . . . . 0.0 114.261 177.94 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.756 1.646 . . . . 0.0 112.428 -177.382 . . . . . . . . 0 0 . 1 . 125 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -126.62 130.85 51.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 p -83.87 167.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.715 1.606 . . . . 0.0 112.937 178.287 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.14 6.86 1.13 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 166.087 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -110.39 6.05 21.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.207 1.803 . . . . 0.0 112.851 168.389 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.98 4.25 71.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.974 1.273 . . . . 0.0 115.479 -178.618 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.28 122.09 17.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.911 1.355 . . . . 0.0 109.548 176.451 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m -133.32 166.11 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.5 mt -117.09 121.41 41.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.948 1.299 . . . . 0.0 110.811 -172.088 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -62.91 -21.88 66.34 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.906 1.282 . . . . 0.0 114.063 -178.783 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.27 3.35 53.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.413 1.485 . . . . 0.0 113.936 178.323 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -130.57 135.86 48.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.144 1.778 . . . . 0.0 111.288 179.082 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.04 -22.35 0.08 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.491 1.044 . . . . 0.0 115.619 -179.953 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.981 1.277 . . . . 0.0 113.927 174.16 . . . . . . . . 0 0 . 1 . 126 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -74.58 122.43 23.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -77.87 172.55 13.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.545 1.138 . . . . 0.0 112.671 -172.322 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tp -71.9 -21.55 61.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.409 170.606 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -84.15 4.57 29.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.871 2.068 . . . . 0.0 114.117 172.248 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.47 79.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.864 1.211 . . . . 0.0 115.635 178.011 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -90.48 -178.1 5.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.749 171.539 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.81 166.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -104.66 166.06 10.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.862 -1.149 . . . . 0.0 114.009 -170.802 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -116.39 147.66 41.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.013 2.125 . . . . 0.0 110.521 160.124 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.96 129.62 47.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.734 1.214 . . . . 0.0 112.251 178.535 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -79.03 168.91 19.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.502 1.521 . . . . 0.0 111.308 170.322 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.11 177.25 20.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.651 1.12 . . . . 0.0 115.161 -177.999 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.778 1.656 . . . . 0.0 113.55 -176.926 . . . . . . . . 0 0 . 1 . 127 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 148.25 27.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -124.06 154.82 39.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.324 1.45 . . . . 0.0 112.174 166.329 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -71.1 -19.09 62.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.832 -1.167 . . . . 0.0 113.032 173.867 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -69.36 -0.03 5.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.26 1.424 . . . . 0.0 113.955 164.299 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.35 14.49 71.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.412 1.482 . . . . 0.0 114.776 172.162 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -92.44 143.93 25.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.414 1.086 . . . . 0.0 110.256 177.181 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.73 132.04 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.4 124.25 39.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.721 0.409 . . . . 0.0 110.101 174.356 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -67.74 159.55 29.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.982 1.313 . . . . 0.0 114.435 -168.657 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -84.22 167.96 16.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.959 1.704 . . . . 0.0 111.893 169.702 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 47.67 46.09 18.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.886 2.074 . . . . 0.0 115.58 168.712 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.48 -4.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 177.339 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-N 120.254 2.027 . . . . 0.0 114.205 179.755 . . . . . . . . 0 0 . 1 . 128 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -117.49 133.16 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -82.06 159.42 23.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 112.42 178.626 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.68 -29.58 68.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.783 0.833 . . . . 0.0 112.121 167.692 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -72.57 -10.75 60.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.084 1.354 . . . . 0.0 114.232 173.232 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.08 12.36 52.43 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.448 1.499 . . . . 0.0 116.069 172.078 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -94.58 143.61 26.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.278 1.539 . . . . 0.0 111.173 178.792 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.34 132.04 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.87 171.63 9.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.254 1.022 . . . . 0.0 113.642 -179.815 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -134.11 66.64 1.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.093 2.157 . . . . 0.0 110.136 170.596 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -76.55 152.34 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.428 1.091 . . . . 0.0 112.159 179.972 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -115.84 149.37 38.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.471 1.909 . . . . 0.0 111.846 -170.381 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.95 47.29 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 175.948 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.216 1.865 . . . . 0.0 113.893 177.546 . . . . . . . . 0 0 . 1 . 129 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -89.63 144.86 25.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p -100.22 155.37 17.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.181 0.992 . . . . 0.0 110.763 167.131 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.47 -27.5 68.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.801 -1.187 . . . . 0.0 111.21 168.064 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -73.84 4.62 5.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.555 1.942 . . . . 0.0 114.239 173.892 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.19 19.46 52.86 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 166.195 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.57 155.94 17.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.376 1.47 . . . . 0.0 110.624 170.694 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.52 135.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.76 135.31 36.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.472 1.509 . . . . 0.0 109.864 172.102 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.37 144.7 56.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.791 0.836 . . . . 0.0 112.616 174.035 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.57 157.0 17.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.223 1.809 . . . . 0.0 112.955 -175.006 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 47.67 39.3 9.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.098 2.159 . . . . 0.0 112.657 -175.285 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.59 22.53 0.85 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.14 2.305 . . . . 0.0 117.675 -165.604 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.07 2.271 . . . . 0.0 111.244 178.266 . . . . . . . . 0 0 . 1 . 130 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.25 118.59 29.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -73.65 166.51 23.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.948 1.299 . . . . 0.0 112.587 -179.826 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.5 -31.64 70.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.293 -0.879 . . . . 0.0 112.087 167.56 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -72.83 3.35 5.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.634 1.573 . . . . 0.0 114.152 171.42 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.47 -10.97 57.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.36 1.933 . . . . 0.0 116.53 167.117 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -75.88 156.5 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.775 1.288 . . . . 0.0 111.28 175.924 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t -136.58 157.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.21 151.1 19.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.513 -1.367 . . . . 0.0 112.591 -177.716 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -73.34 154.04 40.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.186 0.994 . . . . 0.0 112.773 173.549 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -63.62 -36.15 82.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.55 1.54 . . . . 0.0 113.351 -174.212 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -128.42 157.05 42.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.452 1.901 . . . . 0.0 110.14 170.605 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.22 -18.19 3.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.453 1.501 . . . . 0.0 115.447 178.036 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.366 1.46 . . . . 0.0 114.051 -178.725 . . . . . . . . 0 0 . 1 . 131 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.82 148.3 50.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -90.48 161.19 15.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.53 1.132 . . . . 0.0 112.4 174.427 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.62 -24.89 65.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.797 -1.189 . . . . 0.0 113.064 176.182 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -79.73 3.76 18.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.054 1.741 . . . . 0.0 114.18 166.804 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.44 59.35 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 161.09 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -80.64 111.8 17.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.092 1.946 . . . . 0.0 111.195 -177.289 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.43 136.29 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.04 132.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.216 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -79.13 -24.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.891 0.876 . . . . 0.0 112.439 171.309 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 tt -152.9 135.52 15.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.27 1.428 . . . . 0.0 109.683 167.988 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -145.94 143.27 29.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.195 1.798 . . . . 0.0 110.147 167.232 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.4 -172.57 41.58 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.144 0.402 . . . . 0.0 113.422 -175.25 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.661 1.6 . . . . 0.0 114.159 -177.116 . . . . . . . . 0 0 . 1 . 132 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -119.63 132.9 55.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -90.36 161.03 15.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 111.684 166.542 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.12 -36.33 79.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.637 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -82.34 -1.31 49.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.641 1.176 . . . . 0.0 114.067 174.586 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.17 1.03 29.89 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.439 -1.756 . . . . 0.0 117.024 160.268 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -64.31 139.46 58.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.082 1.941 . . . . 0.0 110.016 177.588 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.45 163.26 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.31 128.3 54.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.752 1.221 . . . . 0.0 111.206 -178.017 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -92.04 119.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.808 1.643 . . . . 0.0 109.123 170.347 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.22 136.94 52.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.834 1.254 . . . . 0.0 112.062 -167.732 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.7 mmm-85 -119.58 -15.08 9.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.956 2.103 . . . . 0.0 113.533 173.28 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.33 -161.46 54.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.78 1.181 . . . . 0.0 114.465 176.622 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 C-N-CA 126.397 1.951 . . . . 0.0 111.965 -176.502 . . . . . . . . 0 0 . 1 . 133 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -89.83 129.65 36.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.3 p -106.65 151.91 24.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.157 0.983 . . . . 0.0 112.728 178.763 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.77 -12.52 60.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 112.897 173.527 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -72.93 -4.02 29.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.288 1.435 . . . . 0.0 113.334 163.721 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 47.33 7.15 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.944 1.259 . . . . 0.0 113.225 174.849 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -132.64 162.5 31.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.76 1.624 . . . . 0.0 110.948 -179.791 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.96 151.08 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.0 tp -102.24 136.16 42.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.79 1.236 . . . . 0.0 112.079 179.981 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -128.24 82.52 2.09 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.318 1.847 . . . . 0.0 109.99 178.745 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.66 -25.03 67.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.641 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -69.3 10.51 0.32 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 179.466 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.68 171.39 21.34 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.454 1.026 . . . . 0.0 113.6 167.399 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 C-N-CA 126.113 1.816 . . . . 0.0 112.189 178.604 . . . . . . . . 0 0 . 1 . 134 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -92.15 125.98 37.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -90.82 172.23 8.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.845 1.258 . . . . 0.0 111.99 -177.286 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.17 -25.84 67.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.731 -1.231 . . . . 0.0 113.49 179.378 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.2 p -87.29 2.53 49.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 113.932 178.181 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 1.2 89.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.972 1.273 . . . . 0.0 115.26 178.667 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -71.37 157.04 38.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.094 1.447 . . . . 0.0 111.148 171.015 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.98 144.1 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.46 151.51 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.231 1.012 . . . . 0.0 113.313 177.522 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 55.65 16.46 1.94 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.474 2.31 . . . . 0.0 116.403 175.875 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -129.16 37.41 4.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.653 1.981 . . . . 0.0 110.21 174.83 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -88.64 -34.86 17.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 0.0 113.409 -174.694 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -173.86 28.9 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.207 0.908 . . . . 0.0 114.048 -176.417 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.85 -2.084 . . . . 0.0 111.007 178.052 . . . . . . . . 0 0 . 1 . 135 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.75 147.72 46.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -116.8 162.35 17.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.335 1.454 . . . . 0.0 113.85 -173.81 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.49 -26.72 68.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.722 1.209 . . . . 0.0 112.8 169.715 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -72.65 1.31 8.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.222 1.409 . . . . 0.0 113.784 168.906 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.31 7.82 88.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.515 1.055 . . . . 0.0 115.124 172.47 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -83.47 145.04 29.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.787 1.293 . . . . 0.0 109.832 176.369 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.86 137.91 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.82 146.38 25.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 112.306 179.471 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -141.87 53.88 1.49 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.829 2.052 . . . . 0.0 112.281 -165.357 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.09 142.82 43.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.084 1.353 . . . . 0.0 112.378 -175.066 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -87.9 -13.85 40.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.009 1.724 . . . . 0.0 114.458 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 158.91 27.41 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.404 1.002 . . . . 0.0 113.423 172.541 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.336 1.446 . . . . 0.0 112.439 -172.143 . . . . . . . . 0 0 . 1 . 136 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.06 112.59 21.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -75.1 171.52 13.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.912 1.285 . . . . 0.0 112.853 -178.559 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.51 -13.09 60.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 167.526 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p -96.22 5.57 50.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.254 1.822 . . . . 0.0 113.495 172.06 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.42 0.42 46.67 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.9 1.238 . . . . 0.0 115.856 -178.566 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -66.31 148.8 51.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.407 1.883 . . . . 0.0 109.676 174.685 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -129.97 137.6 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.1 tp -89.01 133.51 34.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.096 1.359 . . . . 0.0 110.624 179.537 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -73.05 107.42 5.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.087 0.955 . . . . 0.0 108.526 164.977 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.39 -7.88 46.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -158.966 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -126.8 9.37 6.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.129 1.372 . . . . 0.0 114.101 174.913 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -28.52 69.76 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.429 1.332 . . . . 0.0 116.429 -171.836 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 119.163 1.481 . . . . 0.0 114.38 175.138 . . . . . . . . 0 0 . 1 . 137 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.73 139.05 49.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -92.37 163.74 13.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.226 176.353 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -75.07 -6.04 47.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 175.985 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -112.97 28.15 9.03 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.447 1.499 . . . . 0.0 112.506 168.204 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 30.0 64.44 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.619 1.408 . . . . 0.0 116.619 160.58 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.14 135.33 36.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.506 1.653 . . . . 0.0 109.543 163.34 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.11 135.03 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.05 113.83 27.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.944 0.898 . . . . 0.0 110.162 177.361 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -55.96 -42.84 76.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.57 0.748 . . . . 0.0 112.731 -178.622 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.83 31.94 4.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.016 1.327 . . . . 0.0 113.095 -168.742 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -136.91 21.12 3.05 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.778 1.231 . . . . 0.0 113.383 174.495 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 -179.18 26.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.361 1.458 . . . . 0.0 116.525 173.185 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.516 -179.749 . . . . . . . . 0 0 . 1 . 138 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -97.19 134.44 40.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -108.5 154.01 22.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.914 1.286 . . . . 0.0 112.948 172.506 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.48 -22.23 66.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.967 1.307 . . . . 0.0 114.376 -176.853 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.6 p -85.13 19.18 2.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.694 1.998 . . . . 0.0 113.95 171.473 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.46 89.61 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 167.848 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -81.21 152.94 27.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.987 1.394 . . . . 0.0 110.303 175.762 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.24 162.1 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.3 144.42 34.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.796 0.807 . . . . 0.0 111.17 173.706 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -80.0 137.93 36.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 110.275 177.706 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.18 154.69 21.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 111.423 176.33 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 54.51 39.16 30.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.089 1.756 . . . . 0.0 113.448 177.635 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.98 54.89 0.32 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 113.669 -169.761 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.746 1.641 . . . . 0.0 112.226 -175.574 . . . . . . . . 0 0 . 1 . 139 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -129.7 140.5 51.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.9 p -107.23 163.17 13.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.76 1.624 . . . . 0.0 112.901 179.376 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -27.37 69.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.885 -1.134 . . . . 0.0 112.348 169.3 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -65.11 -8.98 19.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 167.802 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 8.59 78.11 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.3 1.428 . . . . 0.0 116.041 172.286 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.34 135.77 37.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.426 1.613 . . . . 0.0 109.698 174.377 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -116.18 128.8 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.57 134.94 39.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.735 0.814 . . . . 0.0 110.228 178.753 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -85.17 64.88 8.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.098 179.06 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.16 129.44 34.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.564 178.757 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.54 -36.15 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.977 2.911 . . . . 0.0 116.975 -166.153 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.43 -24.35 76.43 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.497 1.499 . . . . 0.0 116.251 -176.372 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 126.552 2.025 . . . . 0.0 112.988 174.679 . . . . . . . . 0 0 . 1 . 140 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -116.35 154.11 30.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -125.39 155.54 40.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.284 1.433 . . . . 0.0 112.521 174.47 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.77 -19.52 65.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.597 1.159 . . . . 0.0 112.635 170.569 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -73.43 1.19 10.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.814 1.646 . . . . 0.0 113.659 168.54 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.81 25.69 68.95 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.851 -1.156 . . . . 0.0 114.456 174.813 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -96.01 142.89 27.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.299 1.049 . . . . 0.0 110.449 172.221 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.97 131.95 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.71 130.22 52.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.231 1.012 . . . . 0.0 111.75 179.859 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -100.53 151.44 21.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.064 1.746 . . . . 0.0 112.073 -167.632 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.06 -41.87 1.26 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.3 1.44 . . . . 0.0 112.789 179.863 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -72.15 150.67 43.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.448 1.022 . . . . 0.0 112.86 176.619 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.31 -2.94 12.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.52 1.534 . . . . 0.0 116.786 -179.01 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 126.54 2.019 . . . . 0.0 112.099 179.287 . . . . . . . . 0 0 . 1 . 141 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.38 129.58 55.24 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -84.36 176.62 8.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 113.292 -179.351 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.3 -22.93 65.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 177.535 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -85.83 -0.37 55.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.743 1.156 . . . . 0.0 113.69 170.599 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.94 8.81 86.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.583 1.087 . . . . 0.0 114.492 -177.515 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.57 138.22 50.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.951 1.375 . . . . 0.0 109.764 176.232 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.47 117.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.27 123.19 28.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.391 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -81.02 60.28 4.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.979 0.912 . . . . 0.0 113.122 -173.323 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.9 134.73 57.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 173.895 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 53.3 45.47 28.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.361 1.464 . . . . 0.0 113.492 -174.739 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.27 -37.72 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.762 1.172 . . . . 0.0 115.312 176.369 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 126.686 2.089 . . . . 0.0 113.364 175.43 . . . . . . . . 0 0 . 1 . 142 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.86 125.96 53.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -74.55 168.33 19.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.172 1.389 . . . . 0.0 113.704 -172.169 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -60.97 -16.54 43.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.328 1.451 . . . . 0.0 114.258 168.724 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.4 p -94.03 -5.05 48.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.849 1.659 . . . . 0.0 113.061 171.742 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 10.11 82.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.975 1.274 . . . . 0.0 115.281 -178.603 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.14 133.35 39.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.496 1.648 . . . . 0.0 109.592 174.977 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t -129.39 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.6 mt -109.04 155.75 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 112.528 -178.744 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -85.88 156.96 20.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -134.65 24.36 3.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.11 1.364 . . . . 0.0 113.836 -161.691 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.48 -43.82 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.521 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.73 -1.25 89.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.165 1.364 . . . . 0.0 116.27 -171.432 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.192 1.853 . . . . 0.0 112.878 176.757 . . . . . . . . 0 0 . 1 . 143 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.95 140.33 29.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -121.31 154.11 36.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.164 0.986 . . . . 0.0 111.004 174.741 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.6 tp -51.13 -38.58 52.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.095 1.758 . . . . 0.0 114.814 -166.22 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 p -73.8 -7.96 54.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.373 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.25 -18.41 36.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.573 1.559 . . . . 0.0 114.127 -177.885 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.3 140.4 58.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.978 1.711 . . . . 0.0 111.208 176.548 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.77 158.43 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.03 125.22 49.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.722 -0.611 . . . . 0.0 110.641 175.229 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -127.37 100.85 6.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 0.0 110.445 176.046 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.4 153.66 43.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.811 -179.644 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -105.3 -20.68 13.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.675 2.39 . . . . 0.0 111.941 174.304 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.18 -175.53 49.89 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.269 1.89 . . . . 0.0 113.755 177.608 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.338 -1.812 . . . . 0.0 112.979 174.748 . . . . . . . . 0 0 . 1 . 144 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 113.81 15.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -78.59 169.63 17.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.926 1.69 . . . . 0.0 114.21 -171.299 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.14 -22.29 64.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 176.394 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -93.61 -6.51 46.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 113.828 -176.848 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.22 -16.5 45.55 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.039 1.304 . . . . 0.0 115.501 176.414 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.46 170.95 15.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.163 1.482 . . . . 0.0 112.203 170.559 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.19 150.45 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.46 120.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.438 -0.789 . . . . 0.0 111.183 175.438 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -82.98 134.68 35.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.819 1.248 . . . . 0.0 110.278 171.575 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.25 -17.46 5.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.646 1.578 . . . . 0.0 113.309 -179.263 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -79.37 3.19 19.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 177.054 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 -23.38 51.64 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.612 1.096 . . . . 0.0 115.505 179.202 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.778 -179.283 . . . . . . . . 0 0 . 1 . 145 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -106.99 144.7 33.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -98.53 163.95 12.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.394 1.478 . . . . 0.0 113.745 171.729 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.74 -25.26 68.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.184 0.994 . . . . 0.0 112.355 166.547 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.8 p -76.72 0.88 18.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.9 1.28 . . . . 0.0 113.511 171.404 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.08 87.64 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.176 1.37 . . . . 0.0 115.773 174.005 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.92 138.94 32.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.358 1.463 . . . . 0.0 110.493 -177.995 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.48 137.01 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.6 mp -95.74 112.75 24.4 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.101 0.961 . . . . 0.0 108.596 170.065 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -60.22 112.65 2.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.167 0.987 . . . . 0.0 113.403 -167.668 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.1 130.15 42.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.56 1.144 . . . . 0.0 110.418 -178.585 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 58.21 17.14 4.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.933 1.693 . . . . 0.0 114.441 -169.769 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.56 173.45 19.65 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.835 1.683 . . . . 0.0 112.624 176.354 . . . . . . . . 1 1 . 1 . 145 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.737 -1.591 . . . . 0.0 113.854 179.499 . . . . . . . . 0 0 . 1 . 146 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -101.7 138.01 39.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.1 p -98.63 160.37 14.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.812 1.245 . . . . 0.0 112.812 179.265 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.69 -33.47 71.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.626 -0.671 . . . . 0.0 111.382 172.704 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.54 12.13 4.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.136 1.374 . . . . 0.0 113.688 176.817 . . . . . . . . 2 2 . 1 . 146 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.89 24.95 72.91 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.74 -1.225 . . . . 0.0 115.68 169.733 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -94.91 146.32 24.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.465 1.133 . . . . 0.0 108.955 168.805 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.25 128.41 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -84.03 131.34 34.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.94 -0.475 . . . . 0.0 110.315 173.168 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.96 89.86 2.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.276 1.83 . . . . 0.0 110.112 -175.398 . . . . . . . . 2 2 . 1 . 146 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -85.28 151.74 23.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.444 1.098 . . . . 0.0 111.494 -177.988 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -73.76 148.7 42.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.364 1.465 . . . . 0.0 112.238 -179.27 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.19 169.89 42.59 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.042 1.306 . . . . 0.0 115.445 178.638 . . . . . . . . 1 1 . 1 . 146 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.455 -1.747 . . . . 0.0 115.772 -174.349 . . . . . . . . 0 0 . 1 . 147 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -97.37 153.81 17.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -121.76 160.35 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.932 1.293 . . . . 0.0 112.21 178.639 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.1 mt -72.99 -12.83 61.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.2 -0.938 . . . . 0.0 112.486 171.248 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -80.04 3.73 19.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.444 1.498 . . . . 0.0 114.02 163.896 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 10.54 83.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.34 1.448 . . . . 0.0 116.244 170.669 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -80.14 165.1 22.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.711 1.756 . . . . 0.0 111.916 174.938 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.21 148.32 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -126.7 143.07 51.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.19 1.396 . . . . 0.0 112.416 -164.516 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -72.7 -39.23 67.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.942 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.8 mt -102.08 29.5 5.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.305 1.442 . . . . 0.0 114.249 -167.721 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -142.55 161.5 37.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.514 2.326 . . . . 0.0 111.134 178.736 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.85 111.18 2.23 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.927 1.727 . . . . 0.0 112.601 174.475 . . . . . . . . 1 1 . 1 . 147 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.967 1.27 . . . . 0.0 112.19 -171.12 . . . . . . . . 0 0 . 1 . 148 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -87.35 117.29 26.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 m -77.87 138.21 38.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 166.665 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.29 12.91 0.27 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 179.836 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 p -80.71 -12.75 59.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.917 1.687 . . . . 0.0 112.906 160.442 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -21.01 32.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 127.814 2.626 . . . . 0.0 114.146 -177.534 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -74.34 150.21 40.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.871 1.335 . . . . 0.0 112.442 179.348 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.2 153.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 2 2 . 1 . 148 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.39 143.25 57.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.918 0.887 . . . . 0.0 110.48 169.463 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -115.73 140.22 49.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.5 1.52 . . . . 0.0 112.562 179.109 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -74.69 164.59 26.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.697 1.999 . . . . 0.0 112.22 176.095 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 54.48 37.3 27.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.132 1.773 . . . . 0.0 114.143 -178.342 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.87 -15.35 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 178.356 . . . . . . . . 1 1 . 1 . 148 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.908 1.718 . . . . 0.0 112.204 178.326 . . . . . . . . 0 0 . 1 . 149 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.0 p -80.65 161.6 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.552 175.591 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.02 -22.95 67.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.174 -0.954 . . . . 0.0 112.435 169.309 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.5 p -79.21 -0.07 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 114.257 171.98 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.66 17.2 66.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.855 1.217 . . . . 0.0 116.015 173.111 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -98.14 135.9 39.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.511 1.524 . . . . 0.0 110.194 177.226 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.62 130.65 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.5 mt -81.76 140.29 34.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.96 0.504 . . . . 0.0 111.873 -175.858 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -75.83 158.02 32.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 112.135 165.541 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -88.34 141.54 28.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.469 1.508 . . . . 0.0 110.305 -179.427 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.02 44.01 25.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.002 1.721 . . . . 0.0 112.965 -175.609 . . . . . . . . 2 2 . 1 . 149 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.46 24.36 13.92 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.795 2.14 . . . . 0.0 114.779 -175.939 . . . . . . . . 1 1 . 1 . 149 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.856 1.693 . . . . 0.0 115.431 -172.963 . . . . . . . . 0 0 . 1 . 150 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.45 136.76 38.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -98.39 144.67 27.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.208 1.403 . . . . 0.0 111.923 175.124 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.06 -29.15 67.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.028 1.331 . . . . 0.0 114.26 -168.858 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -81.53 -15.11 55.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.945 1.698 . . . . 0.0 115.163 176.769 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.92 -32.86 0.88 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.961 1.944 . . . . 0.0 117.961 164.299 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -65.75 138.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.427 1.614 . . . . 0.0 112.708 -167.085 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.54 140.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mp -100.83 121.05 41.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.716 1.206 . . . . 0.0 110.288 -177.654 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 mtp-105 -86.62 137.04 32.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 112.965 175.346 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 tp -77.57 134.51 38.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.711 1.204 . . . . 0.0 111.173 177.746 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -106.01 -38.67 6.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.677 1.191 . . . . 0.0 113.191 173.123 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.26 -171.81 48.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.004 1.287 . . . . 0.0 116.256 171.817 . . . . . . . . 1 1 . 1 . 150 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 125.215 1.388 . . . . 0.0 113.26 177.877 . . . . . . . . 0 0 . 1 . 151 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -84.38 122.65 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -70.52 165.34 22.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 112.964 178.93 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.4 -25.03 66.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 112.471 166.822 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -84.09 4.3 30.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.996 1.718 . . . . 0.0 114.186 172.543 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.77 -1.79 88.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.573 . . . . 0.0 116.715 170.441 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -95.65 171.85 8.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.78 1.79 . . . . 0.0 112.5 178.896 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.6 165.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.13 157.18 19.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.245 1.018 . . . . 0.0 113.152 -177.053 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -125.72 156.99 38.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.218 1.807 . . . . 0.0 115.42 179.558 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt 60.59 -30.53 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 130.868 3.667 . . . . 0.0 120.407 155.759 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -122.6 154.79 37.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.142 1.337 . . . . 0.0 112.308 -165.533 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.27 160.32 25.79 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.498 1.047 . . . . 0.0 112.58 172.523 . . . . . . . . 1 1 . 1 . 151 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 117.691 -1.616 . . . . 0.0 112.933 177.058 . . . . . . . . 0 0 . 1 . 152 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.52 122.1 36.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -78.64 162.79 25.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.879 0.872 . . . . 0.0 112.12 173.285 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.22 -25.18 65.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.625 0.77 . . . . 0.0 112.425 170.891 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.6 p -86.93 7.84 25.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.109 2.163 . . . . 0.0 114.199 176.209 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.58 8.8 87.5 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.155 1.359 . . . . 0.0 115.893 174.482 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -77.29 138.25 39.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.663 1.185 . . . . 0.0 110.595 178.105 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -103.37 139.37 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 mt -101.15 143.85 30.75 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.769 -0.582 . . . . 0.0 110.95 165.468 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -114.86 76.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.309 1.444 . . . . 0.0 108.135 168.906 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.44 140.46 58.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.73 0.812 . . . . 0.0 110.185 178.481 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -73.49 143.21 46.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.807 1.243 . . . . 0.0 112.856 -166.154 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -152.49 34.75 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.28 0.943 . . . . 0.0 113.732 -176.3 . . . . . . . . 1 1 . 1 . 152 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 125.694 1.616 . . . . 0.0 112.66 -176.567 . . . . . . . . 0 0 . 1 . 153 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.59 143.53 43.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -122.9 157.43 32.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.696 1.598 . . . . 0.0 113.463 177.142 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -68.23 -20.68 64.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -175.041 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -72.98 -6.28 44.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.099 1.36 . . . . 0.0 114.202 168.212 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.93 9.54 57.17 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.876 1.227 . . . . 0.0 115.11 177.537 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -76.64 147.13 37.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.969 1.885 . . . . 0.0 110.988 174.423 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 2 2 . 1 . 153 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 2 2 . 1 . 153 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.23 149.11 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.55 154.16 19.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.239 1.016 . . . . 0.0 112.013 -172.081 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -121.58 47.95 1.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.064 1.746 . . . . 0.0 112.273 -179.07 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.56 134.68 36.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.553 1.141 . . . . 0.0 111.778 -175.941 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtp-105 -141.19 -3.15 1.22 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.898 1.679 . . . . 0.0 114.422 178.233 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.66 153.63 8.27 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.492 1.52 . . . . 0.0 114.794 179.944 . . . . . . . . 1 1 . 1 . 153 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 125.483 1.516 . . . . 0.0 112.666 -177.589 . . . . . . . . 0 0 . 1 . 154 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 148.93 26.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -152.17 148.27 27.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.05 1.34 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.96 5.74 2.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.981 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -99.68 36.82 1.71 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.158 1.783 . . . . 0.0 113.55 171.702 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.78 32.99 79.03 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 161.362 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -155.96 167.57 29.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.941 1.296 . . . . 0.0 112.333 179.333 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.48 136.1 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.51 137.9 31.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.303 1.041 . . . . 0.0 110.993 179.041 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -132.24 102.82 5.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.526 1.13 . . . . 0.0 110.523 179.295 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.75 164.54 15.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.685 1.994 . . . . 0.0 110.538 175.228 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -59.15 128.56 37.8 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.829 1.652 . . . . 0.0 112.949 -178.458 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.78 165.11 27.62 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.842 1.21 . . . . 0.0 114.473 179.182 . . . . . . . . 1 1 . 1 . 154 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.276 1.893 . . . . 0.0 115.172 -172.333 . . . . . . . . 0 0 . 1 . 155 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.81 116.12 16.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -93.54 173.24 7.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.895 1.278 . . . . 0.0 113.064 -177.208 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -66.49 -26.9 67.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -171.48 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -68.53 -21.76 64.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 171.306 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.09 -16.2 54.14 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.794 1.188 . . . . 0.0 113.543 -164.434 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -71.35 143.98 50.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.023 1.911 . . . . 0.0 111.49 177.306 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.35 155.57 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.6 tp -85.4 117.68 24.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.74 1.216 . . . . 0.0 108.115 166.252 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -114.25 122.16 45.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 110.505 -173.789 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.3 mt -142.37 -19.13 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.607 1.963 . . . . 0.0 114.91 -170.899 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -124.37 21.12 8.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.373 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.06 -21.52 61.59 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.587 1.089 . . . . 0.0 115.789 -176.013 . . . . . . . . 1 1 . 1 . 155 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.673 1.606 . . . . 0.0 112.565 175.125 . . . . . . . . 0 0 . 1 . 156 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 150.7 42.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 2 2 . 1 . 156 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.5 p -85.61 159.7 19.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.674 0.79 . . . . 0.0 111.027 166.835 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.19 0.35 6.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.479 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -111.83 20.35 17.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.78 2.432 . . . . 0.0 112.503 171.492 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.94 8.92 86.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 117.603 -1.665 . . . . 0.0 117.14 161.46 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -80.74 141.88 34.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.134 1.967 . . . . 0.0 109.825 167.195 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t -115.78 138.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.99 164.46 13.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 -179.912 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -98.98 -35.98 9.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 172.954 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.04 26.25 10.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.836 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -131.58 170.13 15.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.009 1.724 . . . . 0.0 112.492 179.521 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -91.08 1.03 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.401 1.001 . . . . 0.0 114.016 166.765 . . . . . . . . 1 1 . 1 . 156 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 116.639 -2.201 . . . . 0.0 114.816 -177.854 . . . . . . . . 0 0 . 1 . 157 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -110.41 127.34 55.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -73.49 166.89 22.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.551 1.54 . . . . 0.0 112.566 179.783 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.89 -24.37 67.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.955 -1.09 . . . . 0.0 112.515 169.964 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -81.35 -0.79 42.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.94 2.096 . . . . 0.0 114.033 171.051 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.25 10.34 86.28 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.678 1.609 . . . . 0.0 115.889 172.244 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -83.05 144.04 30.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.851 1.26 . . . . 0.0 109.591 171.933 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.33 146.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.13 147.21 23.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.029 -1.045 . . . . 0.0 110.22 176.761 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -135.98 101.41 4.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 110.827 170.628 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.31 163.79 23.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.084 0.945 . . . . 0.0 112.392 -175.006 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -100.53 5.49 44.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.726 2.01 . . . . 0.0 112.944 173.495 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.77 157.97 12.13 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.362 1.458 . . . . 0.0 113.111 176.949 . . . . . . . . 1 1 . 1 . 157 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.186 1.374 . . . . 0.0 115.69 179.749 . . . . . . . . 0 0 . 1 . 158 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -125.02 144.89 50.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -88.75 167.33 13.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.807 1.243 . . . . 0.0 112.088 -178.78 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.33 -33.84 74.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.623 -1.298 . . . . 0.0 111.312 169.834 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -74.96 1.93 11.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.287 2.235 . . . . 0.0 114.734 173.541 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.35 79.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 171.202 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -78.6 149.23 33.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.991 1.896 . . . . 0.0 111.723 176.497 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.51 151.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 132.87 34.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.599 -1.313 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 158 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -84.97 26.94 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.606 1.562 . . . . 0.0 114.923 -161.59 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt 54.24 38.29 29.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.589 1.556 . . . . 0.0 113.515 -179.685 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -105.91 -25.46 12.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.54 1.536 . . . . 0.0 113.138 -174.308 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.96 -145.82 7.17 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.04 2.257 . . . . 0.0 112.062 174.985 . . . . . . . . 1 1 . 1 . 158 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.812 -1.549 . . . . 0.0 113.894 177.498 . . . . . . . . 0 0 . 1 . 159 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -90.68 125.87 35.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -94.56 178.3 5.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.257 1.023 . . . . 0.0 113.172 179.13 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.54 -19.87 58.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.168 1.787 . . . . 0.0 115.667 -177.205 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -87.97 1.09 54.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.523 1.529 . . . . 0.0 113.69 172.473 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.95 40.56 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.687 1.137 . . . . 0.0 114.58 -170.551 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -66.28 142.85 57.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.775 1.787 . . . . 0.0 110.801 176.501 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.44 124.13 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.19 136.07 44.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.66 0.784 . . . . 0.0 111.989 -173.022 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -68.47 118.63 11.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.889 1.276 . . . . 0.0 110.807 171.117 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.4 tp -75.94 -46.72 28.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.917 0.887 . . . . 0.0 112.87 -172.227 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -83.1 40.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 112.066 175.622 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.14 -14.78 81.55 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.76 1.647 . . . . 0.0 115.806 -171.67 . . . . . . . . 1 1 . 1 . 159 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.861 -1.522 . . . . 0.0 113.054 -177.195 . . . . . . . . 0 0 . 1 . 160 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -112.61 137.91 50.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -113.15 155.36 25.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.394 1.478 . . . . 0.0 113.747 177.747 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.4 -35.71 81.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.046 1.338 . . . . 0.0 113.17 -175.829 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -78.86 7.95 6.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.47 1.108 . . . . 0.0 113.725 172.803 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.71 3.72 42.96 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.184 -1.342 . . . . 0.0 116.398 160.787 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -86.8 147.11 25.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.065 1.932 . . . . 0.0 112.34 -176.184 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.86 133.48 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -91.74 112.35 24.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.851 0.86 . . . . 0.0 109.143 173.302 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -79.91 64.3 4.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.468 1.907 . . . . 0.0 112.117 -179.574 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.79 164.48 12.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.274 2.229 . . . . 0.0 110.941 167.796 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -130.32 165.28 22.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.748 1.219 . . . . 0.0 112.385 -179.453 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.33 -152.29 11.9 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.669 1.128 . . . . 0.0 113.185 177.512 . . . . . . . . 1 1 . 1 . 160 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.701 -1.61 . . . . 0.0 113.003 176.325 . . . . . . . . 0 0 . 1 . 161 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.63 128.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -73.88 172.54 11.39 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.03 0.932 . . . . 0.0 113.168 178.892 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.53 -25.13 6.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.212 2.205 . . . . 0.0 114.45 169.869 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -104.82 8.13 34.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.154 1.781 . . . . 0.0 113.989 176.597 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.47 7.64 88.35 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.814 1.197 . . . . 0.0 115.564 175.074 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.39 131.87 46.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.343 1.571 . . . . 0.0 109.396 173.665 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.76 157.25 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.52 152.75 44.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.477 1.511 . . . . 0.0 112.97 171.621 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 57.58 -17.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 129.78 3.232 . . . . 0.0 118.624 173.299 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.27 92.74 3.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 108.982 172.066 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -116.41 -21.34 9.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 113.231 175.728 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.04 -158.53 32.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.166 1.841 . . . . 0.0 114.086 166.848 . . . . . . . . 1 1 . 1 . 161 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.965 1.745 . . . . 0.0 115.569 176.22 . . . . . . . . 0 0 . 1 . 162 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -90.98 117.87 29.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -91.16 156.23 18.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.655 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.17 -21.58 66.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.472 1.509 . . . . 0.0 112.834 170.658 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.5 p -79.44 -1.13 35.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.077 1.751 . . . . 0.0 113.904 172.305 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.13 19.46 55.5 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.515 -1.159 . . . . 0.0 115.853 170.276 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -114.77 163.65 15.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.283 1.433 . . . . 0.0 111.321 173.465 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.11 145.83 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 tp -92.0 143.05 26.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.471 1.109 . . . . 0.0 111.641 178.497 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -94.52 123.61 38.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.999 1.32 . . . . 0.0 110.651 165.532 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.9 -62.62 1.48 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.564 0.745 . . . . 0.0 111.797 178.123 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.05 157.59 34.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.603 1.161 . . . . 0.0 112.927 172.519 . . . . . . . . 2 2 . 1 . 162 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.5 155.75 25.87 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.811 1.196 . . . . 0.0 112.212 179.675 . . . . . . . . 1 1 . 1 . 162 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.935 -177.389 . . . . . . . . 0 0 . 1 . 163 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -127.81 141.89 51.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.7 p -129.24 153.59 47.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.673 1.189 . . . . 0.0 113.567 -179.632 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.93 -15.32 62.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.842 1.257 . . . . 0.0 112.855 173.286 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -68.71 -1.06 6.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.403 1.481 . . . . 0.0 114.036 164.351 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 31.11 9.74 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 161.371 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.48 139.67 52.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 111.76 178.435 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.55 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.44 143.07 27.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.026 0.93 . . . . 0.0 112.111 170.421 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -85.54 54.54 3.15 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.969 1.308 . . . . 0.0 114.185 174.02 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.47 -32.8 63.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.904 1.282 . . . . 0.0 114.162 -173.517 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -67.63 -14.26 62.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.051 1.34 . . . . 0.0 113.789 175.345 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.73 1.55 75.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.782 2.134 . . . . 0.0 114.997 169.001 . . . . . . . . 1 1 . 1 . 163 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.845 -1.53 . . . . 0.0 112.463 171.844 . . . . . . . . 0 0 . 1 . 164 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -107.87 132.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -107.53 155.89 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.525 1.13 . . . . 0.0 113.52 179.154 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.69 -12.1 56.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.967 1.307 . . . . 0.0 113.77 170.588 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -87.37 3.93 45.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.051 2.141 . . . . 0.0 113.529 170.024 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.71 16.42 77.48 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.744 -1.223 . . . . 0.0 115.756 172.568 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -92.21 145.26 24.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.439 1.096 . . . . 0.0 110.421 174.906 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 2 2 . 1 . 164 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 2 2 . 1 . 164 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.84 133.16 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.28 143.17 42.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 111.853 -178.655 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -99.85 82.88 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.994 1.718 . . . . 0.0 110.977 177.761 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.3 mt -107.42 142.13 37.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.629 1.171 . . . . 0.0 112.321 -171.458 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -68.44 152.55 45.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.216 1.407 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.81 173.33 45.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.085 1.802 . . . . 0.0 113.972 172.263 . . . . . . . . 1 1 . 1 . 164 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.567 1.556 . . . . 0.0 114.706 -176.917 . . . . . . . . 0 0 . 1 . 165 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -84.8 117.74 24.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -80.83 -174.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 112.696 -178.126 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.92 -21.63 66.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.379 -1.451 . . . . 0.0 113.743 -174.498 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -99.33 6.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.885 2.074 . . . . 0.0 113.412 174.098 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.6 1.64 66.67 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.777 -1.202 . . . . 0.0 115.231 -175.743 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.35 142.96 50.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.468 1.634 . . . . 0.0 109.825 172.647 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.36 154.15 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 tp -72.86 124.0 24.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.092 0.957 . . . . 0.0 111.103 -174.325 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -87.66 138.24 31.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.953 0.901 . . . . 0.0 110.14 172.242 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.24 146.92 41.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.826 1.25 . . . . 0.0 112.183 -171.544 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -148.31 164.6 33.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.93 1.692 . . . . 0.0 112.954 176.383 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 158.47 53.19 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.71 1.147 . . . . 0.0 114.259 177.198 . . . . . . . . 1 1 . 1 . 165 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.983 1.754 . . . . 0.0 115.81 -178.139 . . . . . . . . 0 0 . 1 . 166 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -96.01 130.16 43.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.4 p -78.08 161.91 27.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.865 0.866 . . . . 0.0 111.535 172.119 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.99 -41.5 83.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.927 -1.108 . . . . 0.0 111.867 175.704 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -81.84 15.72 2.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.159 1.383 . . . . 0.0 113.512 175.751 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.91 74.47 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 117.228 1.651 . . . . 0.0 117.228 161.138 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.41 136.4 36.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.552 1.676 . . . . 0.0 108.976 170.456 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.88 142.99 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.84 146.9 23.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.53 93.76 4.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.643 1.577 . . . . 0.0 109.767 174.753 . . . . . . . . 2 2 . 1 . 166 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.33 126.64 34.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.547 1.539 . . . . 0.0 109.505 -179.661 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.5 -50.05 55.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.664 1.186 . . . . 0.0 112.915 -173.032 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.94 -44.31 55.85 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.203 0.906 . . . . 0.0 111.046 170.368 . . . . . . . . 1 1 . 1 . 166 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.814 1.673 . . . . 0.0 113.865 -178.758 . . . . . . . . 0 0 . 1 . 167 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -114.21 141.15 47.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -121.84 158.63 28.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 113.144 -176.101 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.884 1.674 . . . . 0.0 113.909 172.683 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.8 p -84.51 7.06 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.634 1.174 . . . . 0.0 113.589 171.654 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 2.8 89.67 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 168.468 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -73.45 153.99 40.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.846 1.823 . . . . 0.0 111.521 165.84 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.31 137.83 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.57 141.65 46.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.279 1.032 . . . . 0.0 111.354 -175.631 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -77.32 90.23 3.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.151 0.98 . . . . 0.0 110.469 170.819 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.1 tp -58.98 -27.05 65.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.453 1.101 . . . . 0.0 113.939 -177.315 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -103.12 7.61 38.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.104 1.762 . . . . 0.0 113.948 175.536 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.97 31.49 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.213 1.863 . . . . 0.0 117.148 -174.091 . . . . . . . . 1 1 . 1 . 167 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.793 1.663 . . . . 0.0 115.949 -174.768 . . . . . . . . 0 0 . 1 . 168 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.3 153.54 29.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -128.71 172.24 11.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.96 1.304 . . . . 0.0 112.524 -174.807 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.65 -37.49 63.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.756 . . . . 0.0 114.592 -176.48 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -79.54 1.57 25.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.155 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 -7.9 63.32 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.503 1.525 . . . . 0.0 114.598 -175.3 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -64.23 143.06 58.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.999 1.32 . . . . 0.0 111.119 176.473 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.01 139.37 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.34 134.55 33.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.494 0.718 . . . . 0.0 110.946 177.168 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -63.05 149.03 46.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.569 1.148 . . . . 0.0 111.067 170.067 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.64 161.53 28.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.215 1.006 . . . . 0.0 111.892 -179.897 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 53.04 33.32 14.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.932 1.693 . . . . 0.0 114.8 171.836 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.69 -5.83 56.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.959 1.742 . . . . 0.0 116.544 -170.737 . . . . . . . . 1 1 . 1 . 168 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-N 119.53 1.665 . . . . 0.0 114.508 -178.727 . . . . . . . . 0 0 . 1 . 169 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -80.71 115.81 20.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.6 p -62.41 178.12 0.44 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.1 2.16 . . . . 0.0 113.654 -176.968 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -68.49 -4.83 16.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 174.322 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 p -129.7 22.77 5.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.814 2.046 . . . . 0.0 113.172 -175.431 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.11 -22.06 3.82 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.787 1.66 . . . . 0.0 116.348 173.452 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -64.72 145.96 55.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.727 1.764 . . . . 0.0 110.842 173.99 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.3 145.32 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.31 129.57 38.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.103 0.961 . . . . 0.0 109.976 175.609 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -66.63 122.1 16.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.633 -0.667 . . . . 0.0 110.093 170.913 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.4 -17.3 11.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.158 1.783 . . . . 0.0 112.868 -173.142 . . . . . . . . 2 2 . 1 . 169 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -116.0 147.34 41.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.804 1.642 . . . . 0.0 112.39 -172.337 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.16 79.88 0.11 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.24 1.4 . . . . 0.0 114.211 179.918 . . . . . . . . 1 1 . 1 . 169 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.428 1.489 . . . . 0.0 112.756 171.676 . . . . . . . . 0 0 . 1 . 170 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -104.39 141.35 36.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -114.19 161.68 17.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.526 1.13 . . . . 0.0 113.158 -173.428 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.64 -20.9 61.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 168.547 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -68.87 -0.36 5.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 161.517 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.16 -2.57 83.8 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.006 1.765 . . . . 0.0 116.404 166.05 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 13' ' ' ILE . 56.4 pttt -91.63 160.9 15.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.347 1.574 . . . . 0.0 113.442 -176.356 . . . . . . . . 2 2 . 1 . 170 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 ' HE3' ' A' ' 11' ' ' LYS . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 2 2 . 1 . 170 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.67 153.23 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.93 141.29 38.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.773 1.229 . . . . 0.0 111.43 175.921 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -85.53 43.43 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.971 1.709 . . . . 0.0 112.729 -175.186 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.78 147.68 51.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 112.594 -173.201 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -100.72 151.67 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.399 1.479 . . . . 0.0 113.869 -170.505 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 175.47 46.38 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.116 1.341 . . . . 0.0 114.692 177.453 . . . . . . . . 1 1 . 1 . 170 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 127.415 2.436 . . . . 0.0 114.414 177.008 . . . . . . . . 0 0 . 1 . 171 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -99.5 139.04 35.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -96.54 164.26 12.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.154 1.382 . . . . 0.0 113.372 -177.625 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.29 -3.43 7.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.996 1.318 . . . . 0.0 114.431 168.859 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.6 p -107.49 4.26 25.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.203 2.201 . . . . 0.0 113.313 177.158 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.11 13.24 82.31 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 177.784 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -85.51 151.53 23.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 110.583 172.653 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.26 140.72 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -104.89 150.96 24.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.318 1.047 . . . . 0.0 111.828 -177.553 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -81.49 145.06 30.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.685 1.194 . . . . 0.0 112.346 176.406 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.49 -32.46 2.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -178.969 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.07 -25.56 65.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.61 1.096 . . . . 0.0 113.154 -171.914 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.1 -20.99 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.833 1.683 . . . . 0.0 115.23 177.814 . . . . . . . . 1 1 . 1 . 171 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.273 1.892 . . . . 0.0 114.598 -179.242 . . . . . . . . 0 0 . 1 . 172 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -126.83 139.44 53.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -94.85 154.04 17.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.779 0.832 . . . . 0.0 111.661 164.651 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.58 -26.88 68.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.603 -0.686 . . . . 0.0 112.657 171.039 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.2 p -70.93 -1.83 13.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.232 1.813 . . . . 0.0 115.506 168.277 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.64 4.24 63.94 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 170.746 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -72.74 139.88 47.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.53 1.665 . . . . 0.0 109.99 174.186 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.21 119.68 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.05 -35.37 80.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.523 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -63.55 -31.43 72.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 173.38 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.75 -34.98 62.6 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.148 0.579 . . . . 0.0 111.408 173.253 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -62.02 -26.09 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.314 0.961 . . . . 0.0 113.238 168.455 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.13 1.23 56.65 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.276 1.417 . . . . 0.0 115.793 169.23 . . . . . . . . 1 1 . 1 . 172 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-N 119.704 1.752 . . . . 0.0 113.134 178.397 . . . . . . . . 0 0 . 1 . 173 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -97.88 127.6 43.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -88.03 158.41 18.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.222 0.609 . . . . 0.0 111.119 171.096 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.94 -18.62 65.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.253 -0.904 . . . . 0.0 113.176 178.597 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -93.77 9.93 35.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.058 1.743 . . . . 0.0 113.935 173.571 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.36 -12.38 61.69 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 165.928 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.41 142.86 58.27 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.679 1.239 . . . . 0.0 111.092 -177.857 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t -116.66 153.75 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -131.08 138.8 49.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.141 0.976 . . . . 0.0 112.239 173.0 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 -84.69 119.78 25.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.533 1.133 . . . . 0.0 112.444 -174.487 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 mt -91.51 49.95 1.66 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.1 1.36 . . . . 0.0 112.561 -175.788 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.25 142.39 48.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.95 2.1 . . . . 0.0 110.241 179.101 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.51 -165.48 53.52 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.116 0.865 . . . . 0.0 113.768 -173.834 . . . . . . . . 1 1 . 1 . 173 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 C-N-CA 125.324 1.44 . . . . 0.0 113.531 176.975 . . . . . . . . 0 0 . 1 . 174 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -105.78 145.95 30.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -117.77 153.72 32.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 112.919 -175.545 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.55 -35.0 78.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.127 1.371 . . . . 0.0 112.569 178.978 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -70.37 -12.83 61.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.761 1.624 . . . . 0.0 112.966 176.014 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.99 38.26 4.41 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.352 0.901 . . . . 0.0 115.352 169.198 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -111.01 149.25 30.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.252 1.021 . . . . 0.0 109.845 163.77 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.56 142.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.5 113.49 27.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.701 1.2 . . . . 0.0 111.922 179.493 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.5 97.98 7.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.957 1.703 . . . . 0.0 110.305 178.214 . . . . . . . . 2 2 . 1 . 174 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.5 134.68 34.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 111.6 -176.882 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -80.97 23.23 0.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.881 2.072 . . . . 0.0 114.661 177.1 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.75 -143.53 7.38 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.761 2.124 . . . . 0.0 110.756 -174.113 . . . . . . . . 1 1 . 1 . 174 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.406 1.955 . . . . 0.0 112.553 172.965 . . . . . . . . 0 0 . 1 . 175 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.82 130.38 39.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -90.73 158.92 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.747 1.219 . . . . 0.0 112.094 173.636 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.78 -18.15 65.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.729 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -81.8 -2.69 51.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 167.223 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.6 70.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.138 1.351 . . . . 0.0 115.923 176.717 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 140.91 55.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.326 1.563 . . . . 0.0 110.593 176.865 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.09 137.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -86.63 144.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.178 1.391 . . . . 0.0 112.22 -178.926 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -81.07 140.67 34.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.374 168.142 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.02 -42.99 1.84 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.312 1.445 . . . . 0.0 111.543 172.955 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.1 116.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 154.824 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 25.17 61.66 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.223 -162.235 . . . . . . . . 1 1 . 1 . 175 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.547 1.546 . . . . 0.0 112.96 177.957 . . . . . . . . 0 0 . 1 . 176 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -118.01 127.45 53.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -92.08 158.83 15.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.895 1.278 . . . . 0.0 113.665 179.659 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.6 mt -69.82 -16.05 63.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.414 -0.804 . . . . 0.0 112.632 166.406 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.8 p -83.24 21.69 1.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.92 2.088 . . . . 0.0 113.887 171.579 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.63 14.78 81.74 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 166.137 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -111.01 146.21 37.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.971 1.708 . . . . 0.0 111.69 -177.586 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.68 142.17 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -71.17 133.71 46.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.482 0.713 . . . . 0.0 110.71 172.316 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -98.72 114.69 27.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.346 1.458 . . . . 0.0 109.957 171.419 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 125.03 22.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.671 1.588 . . . . 0.0 113.368 -169.105 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -136.04 136.2 40.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 112.216 -179.077 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.08 178.9 24.47 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.752 1.168 . . . . 0.0 114.433 -175.066 . . . . . . . . 1 1 . 1 . 176 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.086 1.803 . . . . 0.0 113.937 177.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.273 0.559 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 119.651 -0.214 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.821 0.343 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 118.919 -0.562 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.597 -0.24 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.817 0.341 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.841 -0.059 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.451 0.167 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.884 0.374 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 111.306 0.114 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.603 -0.236 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt . . . . . 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.419 0.152 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.149 0.5 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.42 0.152 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 119.953 -0.07 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.074 0.027 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.222 0.058 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.54 0.21 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.804 0.335 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 119.718 -0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 119.54 -0.266 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp . . . . . 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 HD12 ' A' ' 50' ' ' LEU . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 43' ' ' LEU . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 66' ' ' THR . 56.6 mtmt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HE2' ' A' ' 6' ' ' LYS . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.755 -0.164 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 110.855 -0.054 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp . . . . . 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.054 -0.022 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.387 0.137 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.351 0.119 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 0 0 . 1 . 129 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 0 0 . 1 . 129 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 119.694 -0.193 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 129 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 0 0 . 1 . 130 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 0 0 . 1 . 130 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 130 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 119.689 -0.196 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 0 0 . 1 . 134 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 0 0 . 1 . 134 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.041 0.448 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 134 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 0 0 . 1 . 139 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 0 0 . 1 . 139 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 139 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 0 0 . 1 . 143 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 0 0 . 1 . 143 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 143 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 0 0 . 1 . 144 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 144 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 0 0 . 1 . 145 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 0 0 . 1 . 145 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 118.839 -0.6 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 145 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 0 0 . 1 . 146 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 0 0 . 1 . 146 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 146 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 0 0 . 1 . 147 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 0 0 . 1 . 147 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 147 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 0 0 . 1 . 148 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 0 0 . 1 . 148 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 148 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 0 0 . 1 . 149 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 149 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 0 0 . 1 . 150 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 0 0 . 1 . 150 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 150 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 0 0 . 1 . 151 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 0 0 . 1 . 151 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 151 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 0 0 . 1 . 152 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 0 0 . 1 . 152 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 152 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 0 0 . 1 . 153 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp . . . . . 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 0 0 . 1 . 153 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.29 0.091 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 153 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 2 2 . 1 . 153 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 2 2 . 1 . 153 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 0 0 . 1 . 154 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 0 0 . 1 . 154 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 154 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 0 0 . 1 . 155 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 0 0 . 1 . 155 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 155 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 0 0 . 1 . 156 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 118.178 -0.915 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 156 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 0 0 . 1 . 157 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 0 0 . 1 . 157 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 157 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 0 0 . 1 . 158 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 0 0 . 1 . 158 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 158 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 0 0 . 1 . 159 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 0 0 . 1 . 159 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.329 0.109 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 159 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 0 0 . 1 . 160 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp . . . . . 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 0 0 . 1 . 160 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 160 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 0 0 . 1 . 161 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 0 0 . 1 . 161 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 161 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 0 0 . 1 . 162 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 0 0 . 1 . 162 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.611 0.243 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 162 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 0 0 . 1 . 163 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 0 0 . 1 . 163 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 163 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 0 0 . 1 . 164 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 0 0 . 1 . 164 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 164 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 0 0 . 1 . 165 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 0 0 . 1 . 165 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 165 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 0 0 . 1 . 166 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 0 0 . 1 . 166 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 166 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 0 0 . 1 . 167 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 0 0 . 1 . 167 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.602 0.239 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 167 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 0 0 . 1 . 168 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 0 0 . 1 . 168 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 119.802 -0.142 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 168 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 0 0 . 1 . 169 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 0 0 . 1 . 169 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 169 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 0 0 . 1 . 170 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 0 0 . 1 . 170 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 13' ' ' ILE . 56.4 pttt . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 . . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 ' HE3' ' A' ' 11' ' ' LYS . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 2 2 . 1 . 170 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 0 0 . 1 . 171 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm . . . . . 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 0 0 . 1 . 171 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 171 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 0 0 . 1 . 172 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 0 0 . 1 . 172 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 172 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 0 0 . 1 . 173 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 0 0 . 1 . 173 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.36 0.124 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 173 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 0 0 . 1 . 174 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 0 0 . 1 . 174 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 174 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 0 0 . 1 . 175 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 0 0 . 1 . 175 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 175 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 0 0 . 1 . 176 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 0 0 . 1 . 176 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 176 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -106.7 132.83 52.23 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.03 178.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.797 1.639 . . . . 0.0 111.9 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.37 152.86 30.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 112.571 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.01 127.64 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.585 1.554 . . . . 0.0 108.678 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -112.2 140.28 47.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.01 1.324 . . . . 0.0 111.395 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -125.47 149.27 48.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.044 1.338 . . . . 0.0 111.462 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.4 mt -64.27 -11.97 36.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.819 1.647 . . . . 0.0 114.204 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -63.1 -13.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.586 1.154 . . . . 0.0 113.552 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.1 63.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 114.274 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -82.9 147.12 28.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.514 1.125 . . . . 0.0 112.367 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -123.54 141.14 52.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 110.18 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 mm -121.02 142.88 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 127.317 2.247 . . . . 0.0 108.623 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -114.94 139.78 49.54 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.897 0.879 . . . . 0.0 110.603 163.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -151.12 157.36 42.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -95.28 120.96 36.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.308 2.243 . . . . 0.0 111.659 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.18 162.19 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.615 2.366 . . . . 0.0 111.982 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -101.43 149.31 36.25 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 123.507 0.723 . . . . 0.0 111.928 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.7 -17.51 59.3 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.231 2.621 . . . . 0.0 114.599 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 p -87.63 -0.65 57.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.228 1.811 . . . . 0.0 114.436 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -69.31 127.61 33.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 120.001 1.273 . . . . 0.0 111.167 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.49 146.24 27.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 110.766 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.4 mm -65.82 -29.51 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.06 -22.24 64.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 121.309 1.868 . . . . 0.0 114.438 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.45 -34.87 63.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.504 -0.748 . . . . 0.0 111.521 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.29 -40.62 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 119.367 0.985 . . . . 0.0 110.717 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -56.96 -41.02 77.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.217 0.917 . . . . 0.0 112.366 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.03 72.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.645 -1.284 . . . . 0.0 111.598 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.79 -41.4 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.25 -39.5 79.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.582 1.083 . . . . 0.0 111.843 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.18 -30.85 68.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -86.18 -31.58 21.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -135.77 -1.23 2.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.51 -7.24 81.62 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -71.69 122.28 86.77 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.774 1.287 . . . . 0.0 111.499 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.06 129.27 28.04 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.938 2.425 . . . . 0.0 112.623 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -52.89 -35.17 69.51 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.692 2.928 . . . . 0.0 115.35 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.42 -17.94 64.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.031 1.287 . . . . 0.0 114.462 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -94.38 -12.02 28.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.257 1.023 . . . . 0.0 113.703 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.5 132.76 35.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.311 0.96 . . . . 0.0 111.119 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 49' ' ' GLN . 50.7 mtp180 -117.26 116.77 27.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.141 1.376 . . . . 0.0 109.022 162.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.0 mt -101.82 130.72 48.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.015 1.326 . . . . 0.0 111.198 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.57 137.42 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.666 1.986 . . . . 0.0 109.83 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -140.88 138.32 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.166 1.386 . . . . 0.0 110.27 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.06 50.4 5.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.397 1.479 . . . . 0.0 114.567 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 15.2 81.21 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.902 1.521 . . . . 0.0 116.902 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.89 153.46 43.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.156 1.978 . . . . 0.0 114.106 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 42' ' ' ARG . 61.7 mt-30 -71.27 148.37 47.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.265 0.626 . . . . 0.0 110.95 161.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.7 mt -92.61 144.7 25.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.995 0.918 . . . . 0.0 113.114 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.03 136.93 37.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.374 1.47 . . . . 0.0 110.277 168.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -78.55 -12.73 60.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.2 -7.21 62.7 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.586 -1.119 . . . . 0.0 115.146 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -120.86 161.29 21.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.77 1.628 . . . . 0.0 112.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -101.53 163.37 12.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.396 1.878 . . . . 0.0 113.6 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -51.79 -42.06 62.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -68.25 -30.71 69.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.45 -35.55 80.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.773 1.169 . . . . 0.0 111.637 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.54 3.93 34.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.159 1.784 . . . . 0.0 114.142 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.52 36.32 27.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.125 1.77 . . . . 0.0 115.111 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.14 132.9 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.809 1.644 . . . . 0.0 108.608 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -135.76 177.67 7.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.52 1.528 . . . . 0.0 110.598 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -52.83 144.21 15.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.376 -0.828 . . . . 0.0 112.671 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.23 2.84 3.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -71.7 158.15 36.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.044 -1.035 . . . . 0.0 112.376 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -119.27 128.91 54.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.303 1.441 . . . . 0.0 111.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.0 149.0 21.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.803 1.241 . . . . 0.0 110.701 164.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -110.02 135.05 51.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.436 0.694 . . . . 0.0 110.037 170.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.51 133.48 55.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.708 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.72 142.1 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.455 1.902 . . . . 0.0 109.774 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 130.93 45.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.756 1.222 . . . . 0.0 111.918 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.29 165.76 21.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.643 1.577 . . . . 0.0 113.146 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.63 -18.39 33.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.4 138.21 54.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.745 1.611 . . . . 0.0 113.995 -167.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.64 169.52 42.0 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.256 1.407 . . . . 0.0 112.998 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.297 . . . . 0.0 113.533 -176.293 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -94.23 145.81 24.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.783 0.833 . . . . 0.0 111.802 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.85 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.956 1.302 . . . . 0.0 110.197 160.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -117.52 116.18 26.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.1 0.96 . . . . 0.0 111.284 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.61 120.69 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.675 1.19 . . . . 0.0 110.46 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -102.86 127.78 49.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.129 1.371 . . . . 0.0 112.298 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 p -94.32 164.05 13.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.427 1.491 . . . . 0.0 113.683 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.85 -20.35 65.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.695 0.798 . . . . 0.0 112.964 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.1 p -83.28 4.54 26.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.933 1.693 . . . . 0.0 114.065 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.04 35.08 54.44 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.224 0.916 . . . . 0.0 113.922 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -117.82 147.5 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.511 1.925 . . . . 0.0 109.771 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.0 m -110.02 118.92 37.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mm -98.89 128.79 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.945 1.698 . . . . 0.0 110.264 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -96.99 135.28 39.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.593 0.757 . . . . 0.0 110.653 171.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -132.66 143.28 49.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.745 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -90.23 126.73 35.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 110.166 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.32 161.88 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.862 2.065 . . . . 0.0 111.463 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -103.04 151.25 38.41 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 121.017 -1.052 . . . . 0.0 111.008 163.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.02 -21.28 41.02 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.948 2.432 . . . . 0.0 115.749 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.1 p -76.8 -9.94 59.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.72 158.28 36.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.428 1.013 . . . . 0.0 112.736 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -96.44 165.14 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.825 1.25 . . . . 0.0 113.519 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.38 -31.02 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.608 0.763 . . . . 0.0 111.529 168.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -66.73 -37.28 84.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.503 -1.373 . . . . 0.0 113.66 171.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -62.55 -41.03 98.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.871 0.759 . . . . 0.0 111.277 170.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.34 -46.18 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -54.69 -43.54 72.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.48 1.036 . . . . 0.0 111.799 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.34 93.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -68.54 -41.16 80.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.221 1.008 . . . . 0.0 112.59 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.83 -41.73 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 111.239 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -60.38 -45.41 93.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.135 0.974 . . . . 0.0 111.915 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.94 -49.66 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.191 -0.943 . . . . 0.0 113.122 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.0 -32.41 59.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.542 1.137 . . . . 0.0 113.322 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -132.15 -5.49 3.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.08 9.19 87.14 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 120.67 1.577 . . . . 0.0 116.218 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.06 122.55 87.1 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 118.935 1.367 . . . . 0.0 109.236 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.44 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.991 2.461 . . . . 0.0 112.859 -168.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.06 -32.76 63.93 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.302 2.668 . . . . 0.0 114.772 -166.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.52 -17.26 64.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.573 1.079 . . . . 0.0 112.702 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -98.98 -8.76 24.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.585 1.954 . . . . 0.0 113.118 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.23 152.8 30.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.606 1.093 . . . . 0.0 112.613 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -120.33 144.04 48.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.12 1.768 . . . . 0.0 108.048 148.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -126.06 124.83 41.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.148 1.379 . . . . 0.0 109.273 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mt -121.85 131.1 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.554 1.142 . . . . 0.0 110.863 -164.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -131.71 137.85 48.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.455 1.502 . . . . 0.0 110.211 165.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 37.59 11.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.512 1.525 . . . . 0.0 114.007 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.54 17.48 77.93 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.011 -1.055 . . . . 0.0 115.696 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -121.01 124.69 45.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.677 1.591 . . . . 0.0 111.503 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.05 118.54 16.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.159 0.984 . . . . 0.0 110.719 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.77 135.96 33.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.537 1.535 . . . . 0.0 111.912 -171.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.75 136.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.197 1.399 . . . . 0.0 112.93 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -51.43 -35.89 41.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.31 2.244 . . . . 0.0 115.238 -169.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.8 -3.43 83.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 117.681 -1.622 . . . . 0.0 116.402 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -112.86 165.63 12.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.062 1.931 . . . . 0.0 113.884 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -106.06 151.86 24.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.654 1.582 . . . . 0.0 115.15 -171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.59 -40.7 96.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.093 0.957 . . . . 0.0 113.504 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.94 -39.62 94.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.029 0.932 . . . . 0.0 112.932 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -33.08 73.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.428 -0.795 . . . . 0.0 111.967 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.41 7.11 3.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.15 28.78 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.49 140.67 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -122.64 168.94 11.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.607 1.563 . . . . 0.0 112.772 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.9 138.23 43.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.871 1.268 . . . . 0.0 112.74 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 57.3 34.38 24.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.138 1.775 . . . . 0.0 115.3 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.2 m -82.02 153.65 26.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.674 -1.266 . . . . 0.0 112.902 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -106.38 135.3 48.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.456 1.102 . . . . 0.0 110.883 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.1 158.2 38.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.801 1.64 . . . . 0.0 110.188 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -118.51 141.35 48.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 110.893 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -106.42 134.44 49.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.025 1.33 . . . . 0.0 109.849 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -132.35 154.17 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.62 1.568 . . . . 0.0 109.091 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.7 mt -102.38 133.99 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.874 0.87 . . . . 0.0 111.546 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -64.31 135.53 56.29 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.202 1.401 . . . . 0.0 111.735 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.32 154.52 40.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.786 0.834 . . . . 0.0 112.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 58.17 13.26 2.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.362 2.265 . . . . 0.0 115.944 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.05 163.65 12.4 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.407 1.956 . . . . 0.0 112.809 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 116.861 -2.077 . . . . 0.0 114.51 -175.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttm . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.12 138.21 34.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.232 1.013 . . . . 0.0 111.457 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -133.76 159.48 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.336 1.054 . . . . 0.0 111.234 168.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.72 144.87 43.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.61 1.164 . . . . 0.0 111.106 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.44 128.91 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.288 1.435 . . . . 0.0 109.439 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -106.52 134.55 49.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.207 1.803 . . . . 0.0 111.625 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -78.26 170.29 16.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.551 0.74 . . . . 0.0 111.679 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.84 -18.73 63.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.856 -1.152 . . . . 0.0 113.54 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -84.11 -6.06 59.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.44 1.496 . . . . 0.0 114.38 168.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.54 10.76 67.26 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.414 1.483 . . . . 0.0 115.98 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -71.44 143.92 49.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.392 1.596 . . . . 0.0 110.59 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -115.2 136.67 52.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.09 0.956 . . . . 0.0 112.552 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.39 139.49 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.23 1.812 . . . . 0.0 109.806 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.2 m -114.52 132.49 56.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.07 1.348 . . . . 0.0 111.982 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.2 mt -125.38 147.39 49.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.645 1.178 . . . . 0.0 112.336 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -100.73 120.34 39.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.026 1.33 . . . . 0.0 109.476 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.01 148.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.91 1.684 . . . . 0.0 112.254 -170.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -77.46 149.93 79.07 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.087 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -61.82 -21.38 72.09 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.003 1.802 . . . . 0.0 112.616 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -93.49 5.08 52.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.856 1.662 . . . . 0.0 114.5 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.77 140.41 57.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 120.525 1.511 . . . . 0.0 110.307 171.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -75.44 160.14 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.779 1.231 . . . . 0.0 111.697 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.64 -32.62 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 120.859 -1.151 . . . . 0.0 111.259 168.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -57.33 -44.31 84.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.962 -1.086 . . . . 0.0 112.606 168.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -66.09 -38.45 88.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.395 -0.816 . . . . 0.0 111.992 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.02 -45.39 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 119.463 1.029 . . . . 0.0 111.056 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.41 -36.29 83.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.124 0.875 . . . . 0.0 112.257 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.57 81.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.565 0.746 . . . . 0.0 112.895 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -75.55 -27.44 58.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.832 1.253 . . . . 0.0 113.081 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.14 -40.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.217 1.007 . . . . 0.0 110.721 166.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.68 -40.06 90.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.254 0.933 . . . . 0.0 111.521 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.89 -40.77 85.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -76.18 -55.02 5.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.43 -8.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.949 1.3 . . . . 0.0 114.42 -163.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.7 8.66 68.22 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.35 118.13 68.42 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 118.957 1.379 . . . . 0.0 108.278 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.04 145.94 62.96 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.061 1.841 . . . . 0.0 111.643 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.76 -21.4 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.169 2.579 . . . . 0.0 114.31 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.93 -21.76 61.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.287 1.035 . . . . 0.0 113.007 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -87.34 -4.63 59.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.366 1.066 . . . . 0.0 113.019 173.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -101.32 142.78 32.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -131.8 134.19 45.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.365 1.066 . . . . 0.0 109.209 158.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.6 mt -104.88 144.95 31.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.58 137.32 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.515 1.926 . . . . 0.0 109.364 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -139.62 139.66 36.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.353 1.061 . . . . 0.0 111.425 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.6 45.57 17.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.216 1.407 . . . . 0.0 113.552 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 5.42 63.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.472 1.51 . . . . 0.0 116.803 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -113.2 133.63 54.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.032 1.916 . . . . 0.0 111.983 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.44 136.24 51.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.838 0.855 . . . . 0.0 109.941 165.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.0 mt -103.92 163.5 12.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.965 0.906 . . . . 0.0 112.39 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.24 142.18 34.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.679 1.191 . . . . 0.0 110.619 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.66 -25.35 53.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -162.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -14.6 81.61 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -81.85 154.46 25.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.151 1.476 . . . . 0.0 111.757 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 p -102.42 166.4 10.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.822 1.249 . . . . 0.0 114.367 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -58.3 -39.02 78.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.272 -0.893 . . . . 0.0 112.457 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -66.73 -22.17 66.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.95 -22.0 53.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.609 1.55 . . . . 0.0 113.009 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -108.81 7.49 26.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 53.92 37.23 26.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.719 1.207 . . . . 0.0 113.564 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.25 121.6 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.63 165.26 13.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.403 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -46.83 129.13 11.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.307 1.443 . . . . 0.0 111.348 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 58.89 26.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -64.03 158.74 21.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.504 1.122 . . . . 0.0 113.183 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -105.06 120.5 41.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 110.292 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.93 155.24 16.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 109.02 166.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -110.81 139.14 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.747 0.819 . . . . 0.0 110.104 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -112.38 121.18 44.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.166 1.786 . . . . 0.0 109.471 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.39 133.74 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.939 1.295 . . . . 0.0 109.036 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -93.43 135.47 34.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.386 1.074 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -129.29 97.84 4.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.243 1.417 . . . . 0.0 109.964 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.52 -34.99 25.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.517 0.727 . . . . 0.0 111.822 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -58.95 150.76 23.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.854 1.261 . . . . 0.0 112.188 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 -159.35 50.81 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.139 0.875 . . . . 0.0 113.645 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 124.884 1.23 . . . . 0.0 113.387 -178.723 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -85.5 137.19 33.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.952 2.101 . . . . 0.0 112.278 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -139.94 165.95 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.554 1.542 . . . . 0.0 111.048 165.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -125.49 139.02 53.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.472 1.109 . . . . 0.0 112.089 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.5 122.18 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.899 1.28 . . . . 0.0 110.386 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.24 116.62 30.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.315 1.846 . . . . 0.0 110.301 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -101.03 173.84 6.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.381 1.472 . . . . 0.0 113.809 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.29 -20.48 65.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -91.74 9.19 33.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.317 1.847 . . . . 0.0 113.837 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.71 80.93 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.202 -0.936 . . . . 0.0 114.401 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -75.32 149.91 38.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.948 2.099 . . . . 0.0 110.362 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -122.62 142.32 50.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.118 . . . . 0.0 109.656 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 pt -125.9 140.61 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.95 1.3 . . . . 0.0 111.144 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -89.46 125.61 35.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.733 0.813 . . . . 0.0 110.967 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.98 158.9 18.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.135 1.374 . . . . 0.0 112.281 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -119.98 129.98 54.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.467 1.507 . . . . 0.0 110.13 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -145.43 159.05 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.955 1.702 . . . . 0.0 111.842 -170.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.96 156.58 56.57 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.775 1.23 . . . . 0.0 110.867 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.87 -37.67 92.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.376 2.05 . . . . 0.0 114.799 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -95.79 10.73 36.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -77.95 159.87 28.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.966 0.907 . . . . 0.0 111.27 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -96.32 155.42 16.77 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.474 1.11 . . . . 0.0 113.943 -168.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -67.1 -30.93 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.026 0.931 . . . . 0.0 111.285 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.68 -39.52 88.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.874 -1.141 . . . . 0.0 112.48 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -68.36 -29.48 68.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -62.74 -47.62 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 119.732 1.151 . . . . 0.0 109.555 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.85 -36.19 83.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 -42.27 96.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.458 1.027 . . . . 0.0 112.612 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -64.61 -39.34 93.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 112.096 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -66.78 -36.51 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.864 1.266 . . . . 0.0 111.998 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.72 -42.93 99.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.248 1.386 . . . . 0.0 111.65 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.09 -37.79 81.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.701 0.682 . . . . 0.0 112.085 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -80.87 -38.77 27.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.46 2.02 3.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.295 1.838 . . . . 0.0 115.339 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.87 77.02 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 158.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -106.64 130.95 22.14 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.899 1.849 . . . . 0.0 108.468 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.61 145.25 57.39 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.37 2.047 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.63 -39.66 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.217 2.611 . . . . 0.0 115.848 -171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -67.63 -18.4 64.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.388 1.449 . . . . 0.0 113.893 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -94.23 -9.24 36.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.206 1.402 . . . . 0.0 114.274 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -84.65 121.41 27.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.603 1.092 . . . . 0.0 111.099 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -109.31 111.51 23.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 108.603 170.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.55 123.19 44.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.695 1.198 . . . . 0.0 110.876 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.65 128.17 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -124.66 108.74 12.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.044 1.737 . . . . 0.0 110.463 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.34 49.56 10.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.444 1.497 . . . . 0.0 113.982 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.68 -14.73 23.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -85.49 130.62 34.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.822 2.311 . . . . 0.0 111.496 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -78.78 130.81 36.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 110.869 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.27 121.99 40.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.065 0.946 . . . . 0.0 110.347 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -98.27 136.83 37.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.823 1.249 . . . . 0.0 111.949 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.95 -42.04 5.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.965 2.106 . . . . 0.0 115.609 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.6 17.99 5.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.091 1.805 . . . . 0.0 115.998 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -117.72 159.19 23.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.557 1.678 . . . . 0.0 111.834 172.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -90.84 163.59 14.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.012 1.325 . . . . 0.0 111.725 163.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.48 -34.18 75.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.087 -1.008 . . . . 0.0 112.598 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.42 -31.83 72.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.495 1.518 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.57 -16.73 64.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.349 0.977 . . . . 0.0 113.147 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -109.48 11.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 113.782 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 53.87 30.91 12.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.279 -1.513 . . . . 0.0 114.91 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.63 131.37 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 120.873 -1.142 . . . . 0.0 109.769 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -112.61 170.79 7.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.897 1.279 . . . . 0.0 112.307 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -56.71 156.4 6.49 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 62.66 20.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.554 1.942 . . . . 0.0 114.86 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -71.68 138.86 48.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.285 -0.884 . . . . 0.0 111.516 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.2 m -106.79 132.53 52.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 109.891 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.46 163.59 30.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.384 1.474 . . . . 0.0 111.752 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -116.45 150.23 38.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.687 1.195 . . . . 0.0 112.203 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.1 tp -112.85 135.76 53.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.628 1.571 . . . . 0.0 110.771 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.18 153.35 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.911 2.085 . . . . 0.0 108.428 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -91.93 145.87 24.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.339 -0.85 . . . . 0.0 112.433 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -130.46 165.92 21.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.779 1.632 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.23 -28.52 3.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.508 1.923 . . . . 0.0 113.379 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -78.64 153.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 113.476 -173.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.46 -22.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 114.636 174.741 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.815 0.34 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.45 143.28 26.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.162 0.585 . . . . 0.0 110.713 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -128.53 160.14 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.254 1.022 . . . . 0.0 109.972 162.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 151.4 29.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.902 0.881 . . . . 0.0 111.25 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.38 111.85 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.485 1.114 . . . . 0.0 109.025 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.67 130.66 46.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.326 1.85 . . . . 0.0 111.441 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.0 p -80.76 160.19 24.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.759 1.223 . . . . 0.0 112.152 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.28 -25.51 68.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.979 -1.075 . . . . 0.0 112.689 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -83.65 8.39 14.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.32 2.248 . . . . 0.0 114.002 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.05 -1.75 83.59 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.872 1.701 . . . . 0.0 117.21 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -78.61 142.39 37.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.78 . . . . 0.0 110.369 171.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -125.78 132.6 52.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.66 1.184 . . . . 0.0 112.817 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.51 143.62 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.202 2.201 . . . . 0.0 109.625 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -105.5 137.56 43.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.654 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -130.08 148.65 51.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.261 1.424 . . . . 0.0 111.795 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -102.83 121.54 42.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.516 1.526 . . . . 0.0 110.338 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.75 163.33 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.036 2.134 . . . . 0.0 111.261 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.78 159.12 30.39 Favored Pre-proline 0 N--CA 1.448 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 110.578 162.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -24.06 28.13 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.801 2.334 . . . . 0.0 114.864 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -82.03 -6.04 58.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.09 138.37 58.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.947 1.248 . . . . 0.0 111.103 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -79.69 161.02 26.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.02 -31.56 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.165 -0.96 . . . . 0.0 111.351 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.33 -39.08 89.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.661 1.119 . . . . 0.0 112.876 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -61.35 -40.05 92.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.912 0.778 . . . . 0.0 111.47 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.31 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.884 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.03 -40.63 90.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.592 1.087 . . . . 0.0 113.196 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -33.7 72.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.24 1.016 . . . . 0.0 112.685 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -71.6 -33.47 69.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.833 1.253 . . . . 0.0 112.181 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.82 -45.07 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.615 1.166 . . . . 0.0 110.554 167.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -57.16 -41.15 78.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 112.036 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.4 -26.44 68.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -102.8 -33.48 9.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.95 -20.7 13.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.31 39.82 35.25 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.999 1.272 . . . . 0.0 114.627 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.31 113.38 33.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 126.092 1.757 . . . . 0.0 108.999 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -56.83 152.29 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.563 2.842 . . . . 0.0 115.406 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.73 -28.55 68.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.352 2.701 . . . . 0.0 114.416 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.52 -9.4 58.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.316 1.447 . . . . 0.0 114.058 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.4 -2.85 51.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.817 1.247 . . . . 0.0 113.5 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.5 145.15 41.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.44 1.496 . . . . 0.0 111.956 -172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.75 140.88 49.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.32 1.048 . . . . 0.0 111.162 153.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -110.99 143.82 41.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.566 1.546 . . . . 0.0 111.747 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -129.57 140.71 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.082 2.153 . . . . 0.0 110.562 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -145.26 143.45 30.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.462 1.105 . . . . 0.0 110.888 165.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.28 43.78 15.3 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.689 1.595 . . . . 0.0 113.164 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.03 25.75 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.658 1.423 . . . . 0.0 116.658 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -111.81 144.01 41.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.136 1.774 . . . . 0.0 112.186 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -78.16 139.35 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.568 0.747 . . . . 0.0 112.649 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.31 138.25 39.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.402 1.481 . . . . 0.0 110.951 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -96.34 138.41 33.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.018 1.327 . . . . 0.0 113.056 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.6 -38.36 20.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.982 2.113 . . . . 0.0 114.861 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 -7.8 86.9 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.251 1.405 . . . . 0.0 116.477 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -98.79 164.96 12.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.98 1.89 . . . . 0.0 112.211 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -100.51 165.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.33 -37.46 72.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.733 -0.604 . . . . 0.0 111.825 168.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -69.04 -32.81 72.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.47 -26.23 68.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.299 1.409 . . . . 0.0 113.051 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -101.42 4.97 41.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.061 1.744 . . . . 0.0 113.567 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 50.98 43.4 28.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.319 2.248 . . . . 0.0 115.582 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -85.42 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.653 1.181 . . . . 0.0 109.643 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -74.31 165.0 25.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.712 0.805 . . . . 0.0 113.116 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.38 149.72 0.51 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.397 1.479 . . . . 0.0 114.494 166.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 58.7 11.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.409 1.884 . . . . 0.0 115.759 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 m -70.08 154.46 41.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.498 1.119 . . . . 0.0 112.056 169.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -111.08 117.58 33.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.216 1.006 . . . . 0.0 111.116 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.65 154.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.777 1.231 . . . . 0.0 109.257 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -107.14 138.5 43.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 110.098 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 tp -117.54 131.51 56.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 110.26 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.0 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.923 1.289 . . . . 0.0 109.648 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -88.75 145.93 25.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.275 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -83.93 135.13 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.948 1.299 . . . . 0.0 111.358 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.76 -143.23 0.25 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.997 1.719 . . . . 0.0 109.743 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 56.08 25.0 8.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.074 2.15 . . . . 0.0 114.587 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.23 17.15 63.44 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.664 1.602 . . . . 0.0 115.075 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.478 1.99 . . . . 0.0 115.253 -169.109 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.042 -0.504 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -90.7 142.98 27.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.734 0.697 . . . . 0.0 112.044 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.85 164.59 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.416 1.486 . . . . 0.0 110.964 166.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.24 147.83 43.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.52 1.128 . . . . 0.0 112.203 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.86 116.27 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.828 1.251 . . . . 0.0 110.283 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.14 151.91 21.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.435 1.494 . . . . 0.0 113.285 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -122.97 164.49 18.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.529 1.131 . . . . 0.0 113.199 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.91 -23.95 61.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.169 1.388 . . . . 0.0 114.305 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -88.94 -1.89 58.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.115 1.366 . . . . 0.0 114.386 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.87 69.47 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.074 0.845 . . . . 0.0 114.766 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.74 144.56 35.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.772 1.286 . . . . 0.0 109.062 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -122.44 106.98 11.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.218 1.007 . . . . 0.0 109.392 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -75.58 139.03 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.87 1.668 . . . . 0.0 108.087 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.7 m -114.63 131.61 56.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.358 1.063 . . . . 0.0 109.286 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.72 143.6 49.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.371 1.068 . . . . 0.0 111.532 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -96.2 114.2 25.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 108.602 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.94 161.28 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.617 1.167 . . . . 0.0 113.458 -170.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.33 154.23 44.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 109.899 163.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -53.74 -25.57 34.83 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.532 2.822 . . . . 0.0 115.647 174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.0 p -81.16 0.64 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.768 2.427 . . . . 0.0 115.166 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.13 128.31 36.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.136 1.334 . . . . 0.0 111.376 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p -76.27 159.54 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.972 -0.455 . . . . 0.0 112.086 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.69 -37.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 121.296 -0.878 . . . . 0.0 112.054 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.44 -39.19 93.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.365 1.439 . . . . 0.0 113.193 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -68.33 -33.63 74.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.691 -0.631 . . . . 0.0 111.719 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.08 -41.49 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.691 -1.256 . . . . 0.0 111.532 170.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.95 -34.86 75.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.422 1.01 . . . . 0.0 111.899 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -35.14 77.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.52 -34.05 76.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.526 1.057 . . . . 0.0 112.51 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.21 -42.85 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 110.661 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.16 -33.54 72.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.718 1.207 . . . . 0.0 112.766 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.69 -48.88 79.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.863 0.756 . . . . 0.0 112.962 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.19 -50.09 15.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -100.63 -17.76 16.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -165.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.84 9.74 83.31 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.45 119.77 77.33 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 119.143 1.471 . . . . 0.0 109.616 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 146.48 66.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.591 2.194 . . . . 0.0 111.916 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.77 -35.41 69.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.674 2.916 . . . . 0.0 115.164 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.15 -14.08 61.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.3 -17.32 26.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.651 1.581 . . . . 0.0 113.148 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -90.04 105.31 17.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.226 1.011 . . . . 0.0 112.167 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -99.16 117.04 32.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.724 1.21 . . . . 0.0 108.541 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.03 132.72 50.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.06 0.944 . . . . 0.0 111.545 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -120.44 138.7 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 111.539 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -132.7 114.85 14.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.89 1.676 . . . . 0.0 111.284 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 53.79 8.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.584 1.553 . . . . 0.0 112.767 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.26 -8.88 11.12 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -93.07 140.16 29.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.013 1.906 . . . . 0.0 112.157 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -77.78 137.87 38.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 111.285 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.42 125.32 37.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.975 . . . . 0.0 112.084 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.44 127.89 35.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.697 1.599 . . . . 0.0 113.537 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -43.26 -37.45 2.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.999 2.92 . . . . 0.0 117.271 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.85 -4.54 72.33 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.321 1.288 . . . . 0.0 116.321 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -98.09 172.43 7.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.248 1.524 . . . . 0.0 111.291 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 p -106.88 166.28 10.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.49 -43.5 65.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.844 0.858 . . . . 0.0 112.078 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -63.96 -29.38 70.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.9 -14.41 61.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.74 3.65 31.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.172 1.789 . . . . 0.0 113.639 167.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 54.85 35.83 25.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.795 1.238 . . . . 0.0 113.625 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.57 106.91 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.516 1.127 . . . . 0.0 108.053 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -94.51 175.75 6.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.831 1.253 . . . . 0.0 112.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -52.3 144.16 13.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.869 1.268 . . . . 0.0 112.218 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 58.55 18.13 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.839 1.656 . . . . 0.0 114.816 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -62.41 146.36 51.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.018 -1.051 . . . . 0.0 110.989 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -107.36 120.69 42.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.017 0.927 . . . . 0.0 109.505 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.25 168.09 10.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.085 1.754 . . . . 0.0 109.664 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -119.15 138.72 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.38 -0.825 . . . . 0.0 111.0 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -102.03 110.96 23.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.629 1.572 . . . . 0.0 109.188 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.4 t -90.77 116.97 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 165.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.13 94.9 9.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -67.2 117.42 9.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.363 1.065 . . . . 0.0 111.362 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.98 145.97 26.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.148 0.979 . . . . 0.0 111.794 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -112.85 143.72 43.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.983 1.313 . . . . 0.0 110.957 166.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.58 -154.02 13.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.169 0.89 . . . . 0.0 114.444 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.058 1.79 . . . . 0.0 114.089 175.622 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -88.86 143.19 27.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 110.721 172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -144.37 144.74 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.73 1.212 . . . . 0.0 111.558 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -95.12 156.18 16.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.89 0.876 . . . . 0.0 113.291 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.17 131.8 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.28 1.032 . . . . 0.0 109.863 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -87.01 122.68 31.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.138 0.975 . . . . 0.0 110.005 167.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -81.01 175.66 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.367 1.467 . . . . 0.0 113.246 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.7 mt -63.21 -16.88 61.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.6 p -109.08 2.68 21.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.231 1.812 . . . . 0.0 113.919 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.95 82.32 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.27 149.81 49.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.401 1.6 . . . . 0.0 109.502 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -102.22 127.29 49.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.405 0.682 . . . . 0.0 109.539 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 pt -106.85 146.06 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.162 0.985 . . . . 0.0 110.109 166.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 m -110.54 112.86 25.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.067 1.347 . . . . 0.0 109.823 -176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -103.71 160.39 14.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.839 1.255 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.41 129.26 45.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.097 0.959 . . . . 0.0 112.146 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -148.02 -179.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.987 2.115 . . . . 0.0 111.596 -165.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -121.95 161.68 41.11 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.298 1.439 . . . . 0.0 109.772 163.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -58.35 -30.39 91.01 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.994 2.463 . . . . 0.0 114.652 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -78.51 -4.73 50.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.58 150.82 41.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.982 1.719 . . . . 0.0 112.283 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -94.76 157.9 15.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -164.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -66.29 -34.07 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.528 -0.732 . . . . 0.0 111.739 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.17 -34.88 77.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.169 1.35 . . . . 0.0 112.773 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -66.89 -41.31 87.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.213 0.605 . . . . 0.0 111.385 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.18 -45.26 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 118.986 0.812 . . . . 0.0 111.23 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.82 -35.97 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.697 1.135 . . . . 0.0 112.825 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.28 87.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.306 -0.871 . . . . 0.0 112.924 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -64.6 -28.99 70.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.766 1.626 . . . . 0.0 112.888 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.24 -48.3 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.141 0.976 . . . . 0.0 110.509 169.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.28 -37.59 78.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.293 1.406 . . . . 0.0 112.269 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.32 -12.11 19.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.462 1.905 . . . . 0.0 115.554 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -120.34 -38.36 2.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -107.21 -8.25 16.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.121 1.768 . . . . 0.0 114.132 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -4.14 37.48 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.686 1.435 . . . . 0.0 116.686 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -78.14 123.39 86.03 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.162 1.481 . . . . 0.0 111.976 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.31 139.9 92.07 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.159 2.573 . . . . 0.0 113.013 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.13 -30.23 59.66 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.674 2.916 . . . . 0.0 115.907 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.44 -9.81 57.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -105.76 -2.18 23.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.842 1.657 . . . . 0.0 113.688 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -92.47 132.56 36.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.957 1.253 . . . . 0.0 111.755 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -124.96 121.84 35.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 107.901 167.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.54 126.19 54.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.919 0.887 . . . . 0.0 111.941 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.6 136.95 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.437 1.495 . . . . 0.0 110.945 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -149.59 127.21 11.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.061 1.745 . . . . 0.0 110.657 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.86 40.14 15.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.397 1.479 . . . . 0.0 114.393 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.15 -2.22 52.52 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.475 1.512 . . . . 0.0 116.117 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.58 149.35 22.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.78 2.032 . . . . 0.0 111.259 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -99.37 133.92 42.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.144 0.978 . . . . 0.0 111.133 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.5 mt -87.11 111.55 21.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.39 160.72 14.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.278 1.431 . . . . 0.0 114.136 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.27 147.11 27.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.273 1.429 . . . . 0.0 110.464 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.84 80.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.617 1.103 . . . . 0.0 114.2 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -101.37 164.89 11.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.036 1.735 . . . . 0.0 112.994 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 p -107.28 165.11 11.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.778 1.231 . . . . 0.0 112.536 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.44 -36.76 76.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -63.08 -32.51 73.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -70.02 -13.86 62.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.65 0.18 20.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.789 1.636 . . . . 0.0 114.398 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 56.28 51.37 11.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.649 1.113 . . . . 0.0 113.19 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.21 133.89 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 108.932 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.46 165.4 13.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.066 1.346 . . . . 0.0 113.173 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -36.42 125.24 0.81 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.036 2.134 . . . . 0.0 113.311 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.284 39.0 mt-10 58.75 21.7 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.197 2.199 . . . . 0.0 115.903 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.32 153.29 19.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.164 -0.96 . . . . 0.0 111.155 157.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -109.64 136.9 48.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.571 1.148 . . . . 0.0 110.701 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -105.41 153.1 22.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 109.39 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -111.62 131.12 55.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.95 131.47 40.86 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.87 170.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.402 1.881 . . . . 0.0 109.328 163.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.29 144.66 46.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.978 -1.076 . . . . 0.0 112.708 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -86.08 133.09 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.031 1.332 . . . . 0.0 109.681 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.55 140.34 48.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 111.249 -171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -155.16 149.87 26.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.85 -175.63 44.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.131 1.348 . . . . 0.0 114.158 164.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.506 2.003 . . . . 0.0 114.899 -179.006 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.748 -0.168 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -85.21 140.33 30.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.573 0.749 . . . . 0.0 111.974 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -132.36 168.37 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.762 1.625 . . . . 0.0 110.955 167.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -126.2 147.19 49.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.592 1.557 . . . . 0.0 111.477 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.08 134.57 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.919 1.688 . . . . 0.0 109.757 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.21 148.21 52.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.828 1.651 . . . . 0.0 111.827 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -122.34 160.67 24.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.474 1.509 . . . . 0.0 112.109 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 -19.37 63.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.743 1.217 . . . . 0.0 114.065 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -131.29 10.47 4.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.298 1.439 . . . . 0.0 114.468 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.98 158.55 24.76 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.531 1.062 . . . . 0.0 114.528 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -72.28 157.08 38.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.425 1.49 . . . . 0.0 112.009 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -58.58 144.32 43.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.642 1.577 . . . . 0.0 112.796 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.31 138.41 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 127.326 2.25 . . . . 0.0 109.003 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -108.24 143.9 36.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 113.342 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -138.7 149.36 45.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.063 1.345 . . . . 0.0 111.533 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.31 129.21 53.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 109.79 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.72 170.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.932 2.093 . . . . 0.0 111.142 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.3 148.0 39.17 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 124.65 1.18 . . . . 0.0 111.173 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.02 -15.95 52.15 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.148 2.566 . . . . 0.0 114.352 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -81.32 -8.6 59.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.536 1.534 . . . . 0.0 114.302 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -71.34 139.99 50.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.717 1.144 . . . . 0.0 112.812 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -72.29 149.06 44.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.206 1.402 . . . . 0.0 112.686 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.41 -34.23 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.895 0.878 . . . . 0.0 111.433 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.37 -43.74 68.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.611 1.165 . . . . 0.0 112.948 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -76.79 -17.19 59.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.92 -42.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.597 0.759 . . . . 0.0 110.164 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -58.55 -34.95 71.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.205 0.911 . . . . 0.0 112.666 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.33 90.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -69.42 -30.92 68.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.86 0.864 . . . . 0.0 112.52 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.43 -36.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.081 0.952 . . . . 0.0 111.724 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.79 -39.88 90.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.097 -1.002 . . . . 0.0 110.813 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.52 -32.38 72.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 172.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -82.36 -38.27 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -126.55 -9.23 6.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.13 11.12 81.78 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.555 1.07 . . . . 0.0 115.433 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.46 122.09 73.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.014 1.325 . . . . 0.0 109.333 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.7 136.07 68.22 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.571 2.181 . . . . 0.0 112.796 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -47.19 -33.12 15.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 125.281 3.987 . . . . 0.0 116.07 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.55 -17.49 62.93 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -98.19 -11.65 22.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.569 1.947 . . . . 0.0 113.317 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -83.51 123.03 29.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.124 0.874 . . . . 0.0 110.288 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -103.84 130.05 51.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.603 1.161 . . . . 0.0 108.41 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.97 121.6 44.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.986 0.914 . . . . 0.0 110.458 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -117.09 134.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.046 1.738 . . . . 0.0 110.644 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -149.71 137.84 20.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.783 1.233 . . . . 0.0 110.371 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.61 44.31 21.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.844 1.257 . . . . 0.0 113.56 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.13 -1.5 59.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.244 1.402 . . . . 0.0 116.492 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -126.69 147.94 49.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.593 1.696 . . . . 0.0 112.396 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -84.89 131.27 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.755 0.822 . . . . 0.0 111.595 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.7 139.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.461 1.504 . . . . 0.0 111.165 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -95.35 134.98 37.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.85 -35.38 66.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 114.339 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.24 3.68 61.43 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.942 1.734 . . . . 0.0 115.653 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -112.37 178.01 4.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.545 1.672 . . . . 0.0 112.364 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -113.74 169.5 8.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.814 2.046 . . . . 0.0 113.206 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.84 -38.03 84.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.381 -0.824 . . . . 0.0 112.442 170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.37 -25.88 62.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -57.95 -20.01 34.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.738 1.608 . . . . 0.0 113.262 168.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.02 4.76 12.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.391 1.476 . . . . 0.0 114.05 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 49.9 47.55 23.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.274 1.429 . . . . 0.0 113.225 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.17 128.53 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -121.29 -175.18 3.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.507 1.523 . . . . 0.0 112.178 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -51.79 147.18 7.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.998 0.919 . . . . 0.0 112.919 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 57.89 23.0 9.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.338 1.855 . . . . 0.0 114.599 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -80.35 140.53 36.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.028 -1.045 . . . . 0.0 112.051 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -94.5 129.61 41.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.696 1.199 . . . . 0.0 109.48 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.58 145.64 38.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.786 1.635 . . . . 0.0 109.227 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.1 132.9 49.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.67 -0.643 . . . . 0.0 110.539 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -105.27 137.65 42.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.703 1.601 . . . . 0.0 109.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t -135.56 134.64 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.546 1.538 . . . . 0.0 109.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.25 127.9 33.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.928 0.891 . . . . 0.0 112.041 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -46.47 137.94 6.17 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.22 2.208 . . . . 0.0 112.553 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.39 -43.6 92.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.032 1.333 . . . . 0.0 112.558 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -74.54 128.54 35.81 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.356 1.063 . . . . 0.0 110.165 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.81 -175.57 28.44 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.002 1.287 . . . . 0.0 114.09 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 125.824 1.678 . . . . 0.0 112.52 178.665 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -82.45 146.18 29.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.149 0.886 . . . . 0.0 113.232 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -131.17 165.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.632 . . . . 0.0 109.643 159.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -113.86 148.07 37.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.788 0.835 . . . . 0.0 110.902 168.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.64 126.07 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.297 1.439 . . . . 0.0 109.42 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -106.76 119.29 38.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.511 1.524 . . . . 0.0 111.476 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -80.79 163.78 23.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.746 0.819 . . . . 0.0 111.929 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.88 -30.71 70.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 p -89.63 16.12 8.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.37 1.468 . . . . 0.0 113.396 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.18 3.2 85.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.242 1.401 . . . . 0.0 116.403 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -71.28 141.8 50.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.043 1.422 . . . . 0.0 110.959 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -116.68 115.22 25.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 111.396 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -116.54 125.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.284 1.434 . . . . 0.0 109.642 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -90.79 132.43 35.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.936 0.894 . . . . 0.0 110.387 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -122.61 146.28 47.59 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.399 1.08 . . . . 0.0 111.717 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -106.06 111.06 23.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.851 1.66 . . . . 0.0 109.849 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.14 154.64 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.917 2.087 . . . . 0.0 111.369 -167.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.51 149.45 35.73 Favored Pre-proline 0 N--CA 1.449 -0.483 0 O-C-N 121.07 -1.019 . . . . 0.0 111.539 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.16 -15.24 22.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.087 2.525 . . . . 0.0 116.337 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -118.36 12.85 13.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.989 1.716 . . . . 0.0 114.322 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.46 153.19 43.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.35 0.977 . . . . 0.0 110.171 160.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -84.18 157.8 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.447 -0.783 . . . . 0.0 112.668 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.47 -37.06 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.476 -0.765 . . . . 0.0 111.024 168.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.11 -43.38 91.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.21 0.913 . . . . 0.0 113.076 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.57 -37.11 86.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.838 0.855 . . . . 0.0 112.779 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.97 -39.11 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 112.115 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -56.06 -37.88 69.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.289 0.95 . . . . 0.0 112.287 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.65 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.99 -37.08 86.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.895 0.878 . . . . 0.0 112.034 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.62 -32.47 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.842 0.857 . . . . 0.0 111.555 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.01 -36.39 82.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.113 1.324 . . . . 0.0 112.36 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.6 -51.65 58.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.514 1.052 . . . . 0.0 112.643 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -78.39 -35.3 47.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -122.51 -4.21 8.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.802 1.241 . . . . 0.0 113.864 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.6 -2.15 64.21 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 120.049 -1.657 . . . . 0.0 116.274 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.86 123.77 88.37 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 119.455 1.628 . . . . 0.0 108.945 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.35 143.11 42.6 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.241 1.961 . . . . 0.0 111.876 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.01 -29.94 66.37 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.634 2.889 . . . . 0.0 113.854 -164.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.76 -21.83 64.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.512 1.125 . . . . 0.0 113.365 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -97.65 -12.92 21.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.014 1.325 . . . . 0.0 113.912 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -72.37 142.47 48.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.484 1.038 . . . . 0.0 111.681 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -137.73 133.1 33.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.71 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.91 143.07 49.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 0.0 112.655 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.25 131.54 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.553 1.541 . . . . 0.0 111.905 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.17 136.56 28.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.519 1.527 . . . . 0.0 111.62 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.12 38.58 13.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.838 1.655 . . . . 0.0 114.386 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -9.54 28.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.574 1.559 . . . . 0.0 115.87 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -90.74 134.6 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 110.69 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.93 109.94 21.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.372 1.469 . . . . 0.0 108.525 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -78.91 138.84 38.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -158.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -106.49 152.23 23.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.857 1.663 . . . . 0.0 112.739 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.93 -31.69 51.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 120.849 -1.157 . . . . 0.0 113.71 -161.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.77 16.18 47.86 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.663 2.078 . . . . 0.0 115.097 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -117.33 163.69 15.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.831 1.652 . . . . 0.0 112.219 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -106.29 165.76 11.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 112.582 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.94 -35.78 73.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.219 -0.925 . . . . 0.0 112.838 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -66.91 -22.0 65.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -72.22 -13.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.602 1.092 . . . . 0.0 113.676 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -120.12 12.32 11.85 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.631 1.572 . . . . 0.0 113.974 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 57.27 31.81 20.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.293 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.45 133.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -120.51 179.9 4.18 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.239 1.816 . . . . 0.0 111.983 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -54.54 122.13 9.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.702 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 58.1 26.64 13.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.297 1.439 . . . . 0.0 114.133 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 m -59.71 147.08 39.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.854 1.261 . . . . 0.0 111.566 165.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.0 m -102.38 122.01 43.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.524 0.73 . . . . 0.0 111.02 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.95 143.6 26.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.372 1.469 . . . . 0.0 108.791 166.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -101.68 136.85 40.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.705 -0.622 . . . . 0.0 110.365 170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.07 138.57 46.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.78 1.632 . . . . 0.0 110.751 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.19 147.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.638 2.375 . . . . 0.0 107.755 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -121.41 134.75 55.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.198 0.599 . . . . 0.0 111.975 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -87.85 85.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 110.183 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.23 -26.44 68.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.655 1.582 . . . . 0.0 114.026 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -71.8 -13.71 61.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.77 -158.9 29.73 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.627 1.584 . . . . 0.0 114.579 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.699 1.618 . . . . 0.0 113.818 178.421 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.39 137.21 33.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.607 0.763 . . . . 0.0 111.34 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.33 171.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.711 1.604 . . . . 0.0 111.35 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -129.59 154.41 47.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.703 1.201 . . . . 0.0 112.414 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.59 126.31 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.511 1.125 . . . . 0.0 109.473 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.54 138.89 45.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.691 1.596 . . . . 0.0 110.913 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 t -135.61 156.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.297 1.039 . . . . 0.0 113.481 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.55 -20.29 66.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.345 2.258 . . . . 0.0 115.601 -164.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -73.73 14.62 0.35 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.2 1.4 . . . . 0.0 114.434 168.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.32 14.17 82.82 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.512 1.53 . . . . 0.0 114.891 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -103.01 143.47 32.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.193 1.397 . . . . 0.0 111.624 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.6 m -128.53 132.52 48.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.94 1.296 . . . . 0.0 109.995 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.8 pt -121.86 157.7 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.085 1.754 . . . . 0.0 111.654 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.7 m -116.76 141.25 48.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.754 1.622 . . . . 0.0 111.283 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.36 157.1 47.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.255 1.422 . . . . 0.0 112.537 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.53 111.11 17.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.672 1.989 . . . . 0.0 109.338 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.64 176.5 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.114 1.766 . . . . 0.0 113.277 -163.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.22 148.52 43.9 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 124.802 1.241 . . . . 0.0 112.336 172.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -57.29 -24.87 62.18 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.624 2.883 . . . . 0.0 115.475 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 p -80.02 -8.48 59.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.87 1.668 . . . . 0.0 114.683 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.36 156.49 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.573 1.533 . . . . 0.0 112.542 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -109.3 151.25 26.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.813 1.245 . . . . 0.0 113.288 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.3 -34.56 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.488 -0.758 . . . . 0.0 112.301 -160.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.84 -27.24 68.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.278 -0.889 . . . . 0.0 113.131 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.1 -36.03 64.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.365 -0.835 . . . . 0.0 111.897 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.196 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -58.96 -42.2 89.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.759 1.163 . . . . 0.0 112.048 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.03 82.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -67.57 -34.97 78.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.047 -1.033 . . . . 0.0 112.984 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.19 -34.71 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 120.909 -1.119 . . . . 0.0 111.331 171.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -63.79 -40.71 97.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.169 0.895 . . . . 0.0 112.505 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.18 -51.56 68.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.334 0.97 . . . . 0.0 112.211 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.99 -42.29 85.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.18 -0.914 . . . . 0.0 113.374 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -124.02 -12.5 7.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.01 44.23 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 120.357 1.435 . . . . 0.0 115.487 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.92 117.54 57.42 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 125.276 1.43 . . . . 0.0 109.065 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.55 144.17 97.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.98 2.453 . . . . 0.0 114.137 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.9 -28.15 67.04 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.037 3.158 . . . . 0.0 113.961 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.12 -12.41 59.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.23 -19.58 23.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.882 1.273 . . . . 0.0 112.507 171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.14 139.24 31.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.027 1.331 . . . . 0.0 112.704 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -125.27 128.42 48.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.656 1.583 . . . . 0.0 109.69 163.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.75 129.11 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.508 1.123 . . . . 0.0 112.023 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.69 138.48 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.477 . . . . 0.0 110.764 -168.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -142.62 127.84 18.69 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.033 1.733 . . . . 0.0 110.83 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.62 34.83 16.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.825 1.25 . . . . 0.0 113.243 -171.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.32 -0.73 15.58 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.029 1.299 . . . . 0.0 115.438 -174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.8 135.99 34.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.552 1.541 . . . . 0.0 109.612 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -84.48 140.91 31.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.571 0.748 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.53 102.95 15.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 111.274 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.39 124.71 24.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.737 -0.602 . . . . 0.0 109.97 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.57 -7.64 53.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -161.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.4 8.56 6.84 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 115.986 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -130.36 177.05 7.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.191 1.796 . . . . 0.0 112.232 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -107.71 167.26 10.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.361 1.464 . . . . 0.0 112.89 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.77 -41.3 77.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.55 -0.719 . . . . 0.0 112.505 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -65.12 -33.73 76.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 113.594 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.88 -18.19 63.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 120.07 1.304 . . . . 0.0 113.281 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -109.17 9.54 26.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.739 1.616 . . . . 0.0 114.326 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.38 30.02 19.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 113.079 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -81.9 127.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -130.25 176.68 7.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.699 1.6 . . . . 0.0 110.976 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -51.67 153.42 2.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 112.984 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 62.01 9.17 2.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.416 1.486 . . . . 0.0 114.801 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 m -83.72 147.38 27.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.9 -1.125 . . . . 0.0 111.949 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -93.83 137.72 32.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.265 1.026 . . . . 0.0 110.347 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.05 147.52 27.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.713 1.605 . . . . 0.0 109.606 159.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -102.6 129.17 49.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.259 0.623 . . . . 0.0 110.389 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.91 134.49 41.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.189 175.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.46 145.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.849 2.459 . . . . 0.0 107.846 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.98 151.82 33.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -96.74 176.28 6.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.087 1.755 . . . . 0.0 111.854 166.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.27 -51.56 0.95 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.068 1.347 . . . . 0.0 114.408 -168.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -71.62 -26.64 62.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.61 -7.24 82.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.314 1.435 . . . . 0.0 115.471 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.543 1.544 . . . . 0.0 112.464 170.617 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.815 -0.136 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -94.76 143.89 26.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.99 163.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.454 1.502 . . . . 0.0 110.952 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.87 155.63 32.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -137.3 138.72 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.719 1.608 . . . . 0.0 109.126 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -115.19 150.96 35.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.17 1.388 . . . . 0.0 112.194 172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -102.85 167.13 10.06 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.406 1.482 . . . . 0.0 112.761 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.7 -32.31 73.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.947 -1.096 . . . . 0.0 111.831 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -73.77 -3.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.25 1.42 . . . . 0.0 113.896 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.87 82.85 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.065 1.793 . . . . 0.0 116.002 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -65.55 144.05 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.868 1.334 . . . . 0.0 110.523 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -111.0 132.63 54.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.014 1.326 . . . . 0.0 110.069 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.4 mt -124.86 135.04 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 127.0 2.12 . . . . 0.0 108.024 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.7 m -111.99 129.22 56.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.242 1.017 . . . . 0.0 110.622 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.76 152.05 38.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.285 1.434 . . . . 0.0 110.267 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -116.74 126.7 53.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.714 0.806 . . . . 0.0 110.299 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.43 166.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.266 1.826 . . . . 0.0 111.113 -164.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -112.66 161.44 26.41 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 124.164 0.986 . . . . 0.0 109.207 159.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -56.46 -19.72 30.24 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.61 2.206 . . . . 0.0 114.691 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -77.61 -8.58 58.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.66 134.97 55.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.896 1.68 . . . . 0.0 110.997 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -77.72 160.63 28.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.428 0.691 . . . . 0.0 111.777 174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -60.65 -30.58 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.26 -0.9 . . . . 0.0 111.471 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.9 -39.66 93.87 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.615 -1.303 . . . . 0.0 113.55 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -61.74 -41.0 97.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.492 1.042 . . . . 0.0 111.896 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.2 -47.38 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.271 1.029 . . . . 0.0 111.145 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -58.77 -38.78 79.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.191 0.905 . . . . 0.0 112.614 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.42 77.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.049 0.84 . . . . 0.0 112.847 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -66.28 -29.08 69.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.001 -1.062 . . . . 0.0 112.639 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.22 -44.12 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.605 1.162 . . . . 0.0 111.109 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -56.17 -42.56 77.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 112.113 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -57.47 -25.68 60.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -103.05 -41.47 6.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.638 1.175 . . . . 0.0 114.052 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.34 -15.24 14.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.63 -4.63 77.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.26 126.46 76.69 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 119.613 1.706 . . . . 0.0 110.278 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.06 153.48 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.686 2.257 . . . . 0.0 112.867 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.04 -35.7 51.66 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.737 3.625 . . . . 0.0 117.288 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.08 -4.08 39.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.29 2.99 14.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.226 1.811 . . . . 0.0 112.042 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -102.53 147.57 26.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 111.395 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -140.5 118.58 11.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.102 1.761 . . . . 0.0 109.537 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.4 129.33 46.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.458 0.703 . . . . 0.0 111.823 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.17 143.07 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.019 1.728 . . . . 0.0 110.831 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -139.33 104.27 4.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 110.712 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.12 13.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.077 1.751 . . . . 0.0 113.714 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.72 -13.56 17.29 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.026 1.298 . . . . 0.0 116.125 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -85.7 130.79 34.47 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.792 1.796 . . . . 0.0 111.201 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.34 141.23 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.564 0.62 . . . . 0.0 110.974 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.59 138.05 33.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.418 1.087 . . . . 0.0 110.978 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.0 135.4 49.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.575 1.55 . . . . 0.0 112.526 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -56.87 -32.13 65.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.404 2.281 . . . . 0.0 114.611 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 7.02 49.64 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.469 1.509 . . . . 0.0 116.318 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -119.22 173.87 6.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.642 1.977 . . . . 0.0 113.22 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -120.35 165.16 15.25 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.356 1.863 . . . . 0.0 113.447 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.3 -41.84 89.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.324 0.649 . . . . 0.0 112.285 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 p -63.36 -43.02 98.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.203 1.001 . . . . 0.0 112.782 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.99 -33.8 74.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.077 0.853 . . . . 0.0 112.83 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.46 -2.62 58.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 51.81 47.52 24.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.226 1.41 . . . . 0.0 113.63 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.1 112.41 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.456 1.502 . . . . 0.0 107.313 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -105.17 174.51 5.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.985 1.314 . . . . 0.0 111.874 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -53.09 138.43 31.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.888 0.875 . . . . 0.0 113.244 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 43.6 mt-10 60.43 22.69 12.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -65.27 156.14 32.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.496 0.718 . . . . 0.0 111.157 158.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -122.68 119.34 30.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.464 1.106 . . . . 0.0 112.285 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.8 mt -86.43 162.11 18.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.273 1.029 . . . . 0.0 112.026 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -108.62 140.81 41.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.106 0.962 . . . . 0.0 110.98 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.61 116.24 31.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.468 1.507 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -100.29 145.77 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.344 1.857 . . . . 0.0 108.442 170.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.7 mt -105.4 152.17 23.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.202 1.001 . . . . 0.0 112.993 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -138.78 69.56 1.38 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.393 1.877 . . . . 0.0 110.573 175.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -83.33 164.98 19.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.523 1.129 . . . . 0.0 111.489 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -78.76 142.04 37.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.557 0.743 . . . . 0.0 110.902 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.12 139.34 29.35 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.796 -0.565 . . . . 0.0 112.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 125.779 1.657 . . . . 0.0 113.842 -177.355 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -95.24 139.5 31.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.398 0.679 . . . . 0.0 111.88 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -122.83 157.11 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.292 1.437 . . . . 0.0 110.506 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -114.23 116.78 29.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.461 1.104 . . . . 0.0 110.664 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.4 t -107.12 127.73 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.913 1.285 . . . . 0.0 110.522 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.46 145.63 26.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.224 1.81 . . . . 0.0 111.665 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.1 p -126.1 144.28 50.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.111 1.365 . . . . 0.0 112.354 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.25 -13.3 61.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.52 1.528 . . . . 0.0 113.231 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -71.34 -2.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.078 1.351 . . . . 0.0 113.35 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.82 46.14 5.5 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.671 1.129 . . . . 0.0 113.445 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -134.93 162.21 33.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 111.068 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 m -132.12 137.67 47.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 108.906 166.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.15 129.12 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.79 1.636 . . . . 0.0 110.008 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -82.14 140.98 33.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.656 -0.652 . . . . 0.0 111.28 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 tp -133.73 140.34 46.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.842 0.857 . . . . 0.0 111.577 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -98.21 119.14 36.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.408 1.083 . . . . 0.0 111.12 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.87 167.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.691 1.596 . . . . 0.0 111.984 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -111.46 153.82 44.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.748 1.619 . . . . 0.0 110.079 165.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.76 -22.69 62.86 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.118 2.546 . . . . 0.0 113.68 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -88.33 3.25 50.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.647 1.979 . . . . 0.0 114.888 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -72.21 140.2 48.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 121.42 1.918 . . . . 0.0 112.206 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.5 p -92.21 160.28 15.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 112.768 171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -56.38 -39.82 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.142 1.377 . . . . 0.0 112.772 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.51 -32.86 74.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.976 -1.078 . . . . 0.0 112.426 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -73.78 -32.32 63.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.769 -0.582 . . . . 0.0 112.189 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.57 -45.14 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 121.764 -0.585 . . . . 0.0 109.981 171.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.89 -41.11 90.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.982 0.81 . . . . 0.0 113.046 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.81 91.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.77 -36.5 84.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.017 1.327 . . . . 0.0 112.064 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.2 mt -69.12 -39.36 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.004 . . . . 0.0 111.354 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -61.08 -44.27 97.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.509 1.504 . . . . 0.0 111.896 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.1 -28.02 68.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -97.51 -64.53 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.153 1.381 . . . . 0.0 113.402 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.62 -9.02 55.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.858 1.663 . . . . 0.0 114.885 -172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.16 10.74 86.1 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.851 1.205 . . . . 0.0 115.276 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.8 122.46 72.97 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.097 1.448 . . . . 0.0 109.568 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.4 135.09 32.85 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.562 2.175 . . . . 0.0 112.325 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.21 -24.65 50.99 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.894 3.062 . . . . 0.0 114.228 -167.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.44 -26.51 67.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.127 0.876 . . . . 0.0 112.6 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -90.84 -9.0 48.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.78 135.21 33.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 112.372 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -123.58 119.56 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.847 1.259 . . . . 0.0 110.236 162.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -94.24 139.69 30.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.058 0.943 . . . . 0.0 112.287 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -128.22 135.92 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.96 1.704 . . . . 0.0 111.215 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.84 139.91 23.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.542 1.537 . . . . 0.0 110.107 169.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.67 42.22 22.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.182 1.393 . . . . 0.0 114.188 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.55 0.06 45.56 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -93.92 130.75 39.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.016 1.908 . . . . 0.0 110.952 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -72.83 123.41 23.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 151.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.79 154.79 24.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.458 -170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -126.57 154.43 43.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.264 -170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.93 149.09 45.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.992 -1.068 . . . . 0.0 113.751 -164.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.92 -3.91 55.26 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.352 1.453 . . . . 0.0 115.21 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.08 139.14 31.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.428 1.491 . . . . 0.0 108.813 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -84.8 167.27 16.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -54.0 -41.89 68.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.053 0.541 . . . . 0.0 111.235 166.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -61.95 -39.97 93.93 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.487 1.115 . . . . 0.0 113.941 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -63.89 -21.96 66.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.85 -1.156 . . . . 0.0 113.57 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -101.68 5.15 41.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.233 1.813 . . . . 0.0 114.334 171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.7 t30 57.04 32.13 21.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.563 1.545 . . . . 0.0 114.575 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -81.77 136.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.291 1.437 . . . . 0.0 108.814 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -135.78 171.47 14.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.411 -167.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -50.68 129.08 22.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.427 1.491 . . . . 0.0 111.992 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 67.47 14.73 9.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.915 1.686 . . . . 0.0 115.48 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 m -66.38 147.04 53.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.897 -1.127 . . . . 0.0 111.636 167.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -107.47 133.13 52.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.747 1.219 . . . . 0.0 110.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.38 166.01 18.67 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.121 2.168 . . . . 0.0 110.621 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -126.39 150.14 48.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.049 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.0 tp -130.11 126.06 36.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 0.0 109.348 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.73 142.71 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.301 1.04 . . . . 0.0 110.785 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -112.87 146.93 38.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.681 1.193 . . . . 0.0 111.984 -169.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -70.14 -31.72 69.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.21 12.68 36.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.793 1.237 . . . . 0.0 114.077 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -116.12 147.19 41.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.769 1.628 . . . . 0.0 111.271 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.44 3.42 47.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 119.04 1.42 . . . . 0.0 113.625 -173.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -95.02 145.66 24.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.845 0.748 . . . . 0.0 112.078 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.75 161.86 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.526 1.53 . . . . 0.0 110.75 165.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -104.47 145.32 30.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.837 1.255 . . . . 0.0 110.138 169.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.06 127.15 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.636 1.174 . . . . 0.0 109.048 170.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -127.64 123.93 36.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.022 1.729 . . . . 0.0 110.613 -167.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -78.0 157.23 29.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 121.672 -0.643 . . . . 0.0 110.785 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.48 -25.84 68.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.21 -0.931 . . . . 0.0 113.197 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -76.54 -21.19 56.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.698 1.199 . . . . 0.0 112.796 172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.24 -5.12 9.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -65.43 119.47 11.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.103 1.361 . . . . 0.0 108.923 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.96 126.85 46.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.73 0.812 . . . . 0.0 112.575 -167.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.22 159.55 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.778 . . . . 0.0 111.218 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -112.55 144.2 42.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.869 1.268 . . . . 0.0 110.943 169.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -129.09 143.62 50.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.475 1.11 . . . . 0.0 110.839 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -91.89 118.19 30.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.232 1.015 . . . . 0.0 109.986 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.27 161.36 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.274 1.83 . . . . 0.0 111.727 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.63 156.5 55.88 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 124.529 1.132 . . . . 0.0 111.451 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -53.12 -27.73 38.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.85 3.034 . . . . 0.0 115.758 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -97.34 7.99 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.391 1.476 . . . . 0.0 114.746 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.93 137.03 53.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.572 1.533 . . . . 0.0 110.84 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -82.54 150.16 27.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 112.34 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -60.07 -37.97 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 121.402 -0.811 . . . . 0.0 111.606 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.22 -48.58 68.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 112.254 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.09 -26.72 56.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.68 -37.57 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 120.224 1.375 . . . . 0.0 111.441 169.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.4 -34.95 73.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.978 1.263 . . . . 0.0 112.171 167.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.32 60.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.18 -40.21 46.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.928 1.291 . . . . 0.0 111.627 167.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.62 -42.68 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.064 0.946 . . . . 0.0 110.197 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.16 -38.69 77.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.956 0.902 . . . . 0.0 113.124 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.86 -35.01 79.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.332 0.969 . . . . 0.0 113.476 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -84.72 -34.39 22.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -118.3 -13.48 9.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -171.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.1 78.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.62 -1.3 . . . . 0.0 115.51 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.1 mt -78.02 122.38 85.35 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.787 1.235 . . . . 0.0 108.841 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.63 134.41 30.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.87 -37.46 28.91 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.543 3.495 . . . . 0.0 115.405 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -60.74 -24.6 65.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -92.04 -5.88 52.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.98 1.312 . . . . 0.0 113.278 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.67 141.88 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.521 1.529 . . . . 0.0 112.479 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -127.39 142.54 51.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.171 1.788 . . . . 0.0 110.386 161.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -119.07 126.94 52.84 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.463 1.105 . . . . 0.0 111.375 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -117.12 133.6 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.928 1.691 . . . . 0.0 109.666 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -153.66 138.03 16.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.33 48.14 19.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.293 1.837 . . . . 0.0 113.668 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 8.86 86.28 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -142.7 155.5 44.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.896 1.348 . . . . 0.0 113.905 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -82.24 138.44 34.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.788 1.635 . . . . 0.0 111.362 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.92 123.73 37.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.54 1.536 . . . . 0.0 110.863 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -89.2 137.94 31.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.019 1.327 . . . . 0.0 111.827 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.9 -29.49 60.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.483 2.313 . . . . 0.0 115.681 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.85 -10.74 80.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 117.287 1.675 . . . . 0.0 117.287 -173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -122.9 163.57 20.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.462 2.131 . . . . 0.0 112.953 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -91.96 161.97 14.59 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.806 1.242 . . . . 0.0 113.499 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -53.83 -37.52 63.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -75.88 -23.86 55.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.51 -26.71 68.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 121.169 1.804 . . . . 0.0 111.736 166.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.68 7.43 45.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 114.179 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 53.05 30.7 9.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.88 119.37 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 120.625 -1.297 . . . . 0.0 109.369 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -93.73 162.83 13.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.109 1.364 . . . . 0.0 112.682 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -52.49 151.68 4.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.955 1.302 . . . . 0.0 113.242 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 62.97 19.6 11.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 114.044 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -77.3 154.22 33.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.905 1.282 . . . . 0.0 111.533 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 115.92 28.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.101 1.76 . . . . 0.0 110.133 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.18 144.27 26.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.709 1.204 . . . . 0.0 110.581 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -93.54 134.81 35.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 118.519 0.6 . . . . 0.0 111.827 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.6 tp -109.93 124.45 51.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.225 1.41 . . . . 0.0 110.735 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.77 136.22 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.713 2.005 . . . . 0.0 109.811 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 tp -106.61 129.91 54.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.985 1.314 . . . . 0.0 111.739 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -85.09 149.25 25.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.852 1.261 . . . . 0.0 113.419 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.2 tp -132.72 124.88 28.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.275 1.83 . . . . 0.0 110.443 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 50.64 34.43 9.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.042 1.737 . . . . 0.0 113.295 -168.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.46 21.89 1.52 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.583 2.04 . . . . 0.0 113.809 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.093 1.806 . . . . 0.0 111.305 -173.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -110.0 143.04 40.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.944 1.298 . . . . 0.0 111.349 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -138.73 151.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.345 1.458 . . . . 0.0 111.313 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -96.68 133.43 41.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.647 0.779 . . . . 0.0 111.032 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -116.6 109.02 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.2 1.0 . . . . 0.0 108.972 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -82.68 126.34 32.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.976 0.91 . . . . 0.0 110.131 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -77.1 150.54 35.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.117 0.967 . . . . 0.0 111.074 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.1 tp -64.32 -16.39 62.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.305 -0.872 . . . . 0.0 112.165 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -91.56 10.71 26.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.808 2.043 . . . . 0.0 114.089 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -17.49 56.18 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.252 1.406 . . . . 0.0 116.418 165.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -74.76 151.65 39.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.081 1.441 . . . . 0.0 111.129 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -118.15 128.68 54.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.065 0.946 . . . . 0.0 110.669 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -101.68 123.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.119 1.368 . . . . 0.0 108.75 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -89.23 121.54 31.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -114.7 136.9 52.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.96 0.904 . . . . 0.0 111.273 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -104.21 127.54 51.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.4 164.37 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 110.834 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -94.42 147.74 33.8 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.662 -0.649 . . . . 0.0 110.931 161.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -13.06 36.03 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.569 2.179 . . . . 0.0 114.411 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -87.38 -6.41 58.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -72.63 153.31 41.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.081 1.309 . . . . 0.0 112.578 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.3 p -84.11 161.4 20.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.174 0.989 . . . . 0.0 113.19 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.01 -31.53 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 111.988 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -65.75 -39.21 90.85 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.098 1.317 . . . . 0.0 112.333 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -62.81 -33.66 75.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.448 1.022 . . . . 0.0 112.72 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.15 -48.78 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.948 0.899 . . . . 0.0 110.677 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.64 -32.73 74.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.558 0.743 . . . . 0.0 112.634 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -37.27 86.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.895 0.878 . . . . 0.0 113.016 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.85 -32.25 70.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.916 -1.115 . . . . 0.0 112.331 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.06 -35.95 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.166 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -62.2 -41.54 98.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.484 1.493 . . . . 0.0 111.411 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.81 -33.09 74.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.18 -31.7 16.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -125.45 -6.93 6.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 115.148 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.27 7.97 87.77 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 120.878 1.672 . . . . 0.0 116.957 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -92.43 124.9 57.97 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.382 1.473 . . . . 0.0 110.459 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.23 134.97 62.57 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.102 2.534 . . . . 0.0 113.865 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.97 -39.02 59.85 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.757 2.971 . . . . 0.0 115.17 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -13.98 62.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.08 1.309 . . . . 0.0 114.045 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -91.09 -7.39 51.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.192 1.397 . . . . 0.0 112.983 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -100.13 123.81 44.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.754 1.222 . . . . 0.0 113.34 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -96.19 131.21 42.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.396 1.079 . . . . 0.0 110.592 160.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 138.64 48.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.38 134.77 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.346 1.058 . . . . 0.0 110.226 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -129.09 121.67 28.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.729 1.612 . . . . 0.0 111.249 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 47.89 13.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.707 1.603 . . . . 0.0 113.934 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -14.62 32.01 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.037 1.779 . . . . 0.0 117.088 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -89.77 126.71 35.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.161 1.981 . . . . 0.0 112.128 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.47 120.55 23.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.41 147.98 24.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.697 0.799 . . . . 0.0 112.678 -169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.38 144.05 42.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.648 1.179 . . . . 0.0 112.579 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -72.38 -26.94 62.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -162.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.46 -4.58 75.14 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.574 -1.125 . . . . 0.0 115.057 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -106.33 168.8 8.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.4 1.48 . . . . 0.0 114.005 -173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -112.39 159.45 18.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.591 2.356 . . . . 0.0 112.062 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.77 -37.97 80.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 p -68.05 -24.03 65.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.62 -24.27 67.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.502 1.501 . . . . 0.0 112.372 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.91 5.21 40.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.661 1.584 . . . . 0.0 114.054 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.5 t30 54.82 41.84 31.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 113.762 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.66 123.82 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -124.19 166.13 16.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.242 1.817 . . . . 0.0 110.95 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 139.21 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 3.0 mp0 58.77 29.82 19.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.724 2.009 . . . . 0.0 115.403 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -67.37 153.77 42.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.126 -0.984 . . . . 0.0 112.232 160.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -111.5 135.88 51.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.905 1.282 . . . . 0.0 110.027 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.17 161.42 23.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.09 2.156 . . . . 0.0 110.089 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -107.32 145.61 32.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.417 1.087 . . . . 0.0 110.72 170.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.77 143.47 33.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.327 1.851 . . . . 0.0 109.851 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -135.68 129.6 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.976 1.31 . . . . 0.0 109.552 168.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -75.98 130.81 39.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.647 0.779 . . . . 0.0 110.818 169.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -66.66 133.58 50.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.384 1.073 . . . . 0.0 111.724 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.8 mt -116.37 -133.41 0.33 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.895 1.678 . . . . 0.0 110.15 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 44.95 43.67 7.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.133 2.573 . . . . 0.0 114.841 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 146.16 8.1 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.965 -0.46 . . . . 0.0 113.833 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 126.119 1.819 . . . . 0.0 112.308 -178.074 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.05 140.61 29.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.206 0.603 . . . . 0.0 112.329 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.63 165.04 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.928 1.691 . . . . 0.0 109.494 159.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.3 149.35 48.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.921 0.889 . . . . 0.0 112.187 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 131.81 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.634 0.774 . . . . 0.0 110.675 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.76 113.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.114 2.165 . . . . 0.0 109.66 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -81.41 169.22 17.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.677 0.791 . . . . 0.0 112.665 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.55 -40.45 91.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 111.893 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -81.58 12.25 3.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.066 1.747 . . . . 0.0 114.257 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.16 17.5 74.13 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.032 1.173 . . . . 0.0 116.032 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.07 147.34 31.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.229 1.515 . . . . 0.0 110.595 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -109.53 116.35 31.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.941 0.897 . . . . 0.0 110.381 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.93 139.1 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.762 1.225 . . . . 0.0 112.033 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -96.36 127.39 42.32 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 mt -119.63 127.69 53.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.622 1.169 . . . . 0.0 110.911 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -87.69 127.93 35.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.71 0.804 . . . . 0.0 110.112 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -145.68 164.0 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.932 1.693 . . . . 0.0 112.166 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -120.45 159.15 49.15 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.172 1.389 . . . . 0.0 109.98 161.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.79 -19.69 64.46 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.81 1.673 . . . . 0.0 115.51 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -79.71 -5.41 55.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.855 1.662 . . . . 0.0 114.718 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 136.12 54.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.553 1.069 . . . . 0.0 110.946 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.87 161.65 27.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 112.262 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.4 -32.3 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.44 -37.22 84.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.112 -0.992 . . . . 0.0 113.236 171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.61 -42.88 99.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.146 1.339 . . . . 0.0 111.877 170.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.91 -43.78 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.021 -1.049 . . . . 0.0 111.186 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -60.19 -36.58 77.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.551 0.74 . . . . 0.0 112.766 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.4 71.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.24 0.927 . . . . 0.0 113.479 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.9 -37.44 72.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.148 0.886 . . . . 0.0 111.967 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.1 mt -65.17 -33.78 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.892 0.877 . . . . 0.0 110.593 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -65.43 -37.35 86.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.222 -0.924 . . . . 0.0 112.549 170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.48 -47.97 83.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.024 1.284 . . . . 0.0 112.091 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -77.35 -45.16 26.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -173.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -124.48 2.48 8.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.827 1.251 . . . . 0.0 114.142 -170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.29 4.87 89.94 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 166.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.84 125.4 75.47 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.396 1.598 . . . . 0.0 110.227 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.33 148.81 77.53 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.93 2.42 . . . . 0.0 113.437 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.74 -32.8 46.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.044 1.829 . . . . 0.0 113.333 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.35 -4.78 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 173.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.04 22.5 15.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.482 1.913 . . . . 0.0 112.521 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -129.53 152.76 48.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.728 1.611 . . . . 0.0 111.291 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -142.49 144.63 33.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.077 1.351 . . . . 0.0 109.81 153.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.65 139.38 50.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.64 135.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.152 1.781 . . . . 0.0 110.478 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -143.17 139.45 30.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.308 1.843 . . . . 0.0 109.724 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.2 45.11 12.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 113.832 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.46 8.96 63.81 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.17 153.01 48.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.867 1.834 . . . . 0.0 112.711 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -88.45 144.15 26.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.924 0.89 . . . . 0.0 113.067 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -104.81 159.49 15.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.119 1.368 . . . . 0.0 112.138 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.0 136.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.648 1.179 . . . . 0.0 114.18 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.62 -34.06 57.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.101 2.16 . . . . 0.0 116.555 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.09 -15.03 81.18 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.834 1.317 . . . . 0.0 111.82 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -105.58 161.8 14.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.338 1.455 . . . . 0.0 112.409 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.04 -33.51 65.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -67.05 -31.81 72.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -64.07 -25.59 68.17 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.329 1.422 . . . . 0.0 112.92 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -101.48 3.35 40.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.139 1.776 . . . . 0.0 113.278 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.21 47.03 25.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.217 1.807 . . . . 0.0 113.789 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.35 106.77 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 109.391 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -100.89 -175.08 2.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.148 1.779 . . . . 0.0 112.645 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -39.17 129.76 1.66 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.069 2.148 . . . . 0.0 116.016 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 56.98 26.6 12.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -67.67 151.32 47.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.81 1.244 . . . . 0.0 112.169 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -119.51 135.12 54.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 111.161 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.5 157.42 25.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.02 2.128 . . . . 0.0 110.46 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -126.77 148.85 49.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.496 1.118 . . . . 0.0 112.446 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -129.42 138.58 51.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.809 1.644 . . . . 0.0 109.537 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' H ' HD12 ' A' ' 73' ' ' LEU . 16.0 m -140.25 172.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.166 2.187 . . . . 0.0 111.401 -174.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.2 mt -42.07 133.12 3.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.512 1.925 . . . . 0.0 114.254 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 68.42 4.4 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.246 2.618 . . . . 0.0 117.554 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 70' ' ' VAL . 21.4 mt -72.42 88.24 1.2 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.559 1.144 . . . . 0.0 112.99 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -122.63 -139.29 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.242 2.217 . . . . 0.0 109.891 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.59 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.121 1.343 . . . . 0.0 114.751 -175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 C-N-CA 127.167 2.318 . . . . 0.0 113.132 -178.166 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.421 0.153 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.92 139.12 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.36 . . . . 0.0 111.462 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -139.04 162.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.457 1.103 . . . . 0.0 110.538 167.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -119.36 144.82 46.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.095 0.958 . . . . 0.0 112.633 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.63 127.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.95 1.3 . . . . 0.0 109.793 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -80.75 120.43 24.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.928 0.891 . . . . 0.0 110.514 172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.6 p -69.82 169.19 13.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.004 1.722 . . . . 0.0 112.407 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.45 -3.54 3.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -113.94 5.69 16.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.931 2.092 . . . . 0.0 114.014 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.27 -10.4 63.87 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.539 1.543 . . . . 0.0 116.256 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.49 149.09 50.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.994 1.718 . . . . 0.0 110.346 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 p -103.61 126.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.973 1.261 . . . . 0.0 111.944 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.86 152.69 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.654 1.981 . . . . 0.0 110.969 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.8 m -104.26 142.53 34.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.919 1.288 . . . . 0.0 112.757 -172.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.9 mt -123.67 162.64 22.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 0.0 112.073 169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -115.27 125.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.351 1.461 . . . . 0.0 108.545 162.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.54 155.99 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.092 1.357 . . . . 0.0 111.527 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -105.45 145.14 30.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 108.942 164.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.02 -17.12 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.386 2.058 . . . . 0.0 115.429 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -76.98 -11.95 59.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.75 139.69 57.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.064 1.302 . . . . 0.0 111.86 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.7 p -80.54 160.98 25.01 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.529 0.732 . . . . 0.0 111.405 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -56.5 -29.98 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 O-C-N 121.551 -0.718 . . . . 0.0 112.68 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.46 -30.79 66.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.417 1.462 . . . . 0.0 112.885 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.36 -41.61 69.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.582 -0.698 . . . . 0.0 111.342 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 -42.96 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.411 -0.805 . . . . 0.0 111.31 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -59.57 -35.6 74.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.176 0.991 . . . . 0.0 112.934 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.24 77.91 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.314 0.646 . . . . 0.0 112.714 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -63.6 -28.49 69.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.037 0.935 . . . . 0.0 113.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -74.8 -47.15 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.612 1.165 . . . . 0.0 110.795 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.08 -32.37 68.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.339 0.972 . . . . 0.0 113.373 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.56 -25.1 65.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -119.82 -24.45 6.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -103.51 -21.67 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.72 15.7 77.89 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -91.68 127.11 51.58 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 119.381 1.59 . . . . 0.0 109.858 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.11 145.67 85.08 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.42 2.747 . . . . 0.0 114.176 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.6 -25.46 34.53 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.638 2.225 . . . . 0.0 113.203 -170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.96 -16.54 59.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.32 -21.82 21.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.558 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -78.2 124.35 27.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.978 0.911 . . . . 0.0 111.523 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -106.47 134.31 49.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.303 153.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.62 126.98 53.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.921 0.888 . . . . 0.0 110.826 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.9 mm -119.44 134.82 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.495 1.518 . . . . 0.0 109.943 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -150.44 139.66 21.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.011 1.324 . . . . 0.0 111.905 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.79 37.84 10.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.62 1.568 . . . . 0.0 114.216 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.94 88.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.117 1.818 . . . . 0.0 116.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.06 154.98 40.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.195 1.997 . . . . 0.0 112.454 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.29 135.14 38.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.953 0.901 . . . . 0.0 111.963 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.18 123.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.43 1.492 . . . . 0.0 109.826 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -94.74 139.29 31.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -161.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.56 108.84 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.102 0.961 . . . . 0.0 111.491 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.25 -22.79 17.34 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 127.556 2.503 . . . . 0.0 115.543 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -76.83 158.01 31.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.734 1.767 . . . . 0.0 111.461 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 p -107.07 151.14 25.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.261 1.425 . . . . 0.0 114.292 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.19 -38.65 83.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.846 0.859 . . . . 0.0 113.155 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -63.0 -36.96 85.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.687 1.195 . . . . 0.0 113.179 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.55 -28.6 67.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.726 1.148 . . . . 0.0 112.731 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -84.02 0.45 48.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.677 1.591 . . . . 0.0 114.656 169.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.58 37.76 29.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.81 1.644 . . . . 0.0 114.24 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.46 147.53 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.325 1.45 . . . . 0.0 110.771 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.56 165.27 19.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.479 1.511 . . . . 0.0 113.278 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 148.54 49.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -174.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 58.28 10.86 1.4 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.43 2.692 . . . . 0.0 114.786 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -69.37 153.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.725 1.21 . . . . 0.0 112.739 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -102.74 137.11 41.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 110.797 171.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.91 169.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.746 1.618 . . . . 0.0 110.652 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -119.09 136.23 54.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.42 -0.8 . . . . 0.0 112.314 -166.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.8 tp -92.97 130.38 38.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.61 1.164 . . . . 0.0 109.729 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.22 160.13 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.362 1.465 . . . . 0.0 110.28 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.17 135.0 47.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 112.781 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -79.12 121.28 24.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.865 1.266 . . . . 0.0 112.102 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.24 120.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.555 1.142 . . . . 0.0 108.643 161.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -92.51 149.49 21.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.773 1.229 . . . . 0.0 110.89 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.18 177.38 48.38 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.148 -177.611 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.178 0.037 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -87.33 140.2 29.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.556 1.143 . . . . 0.0 111.166 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.37 168.13 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.238 1.415 . . . . 0.0 110.946 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -117.03 141.99 47.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.993 1.317 . . . . 0.0 112.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.22 137.03 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.708 1.203 . . . . 0.0 109.876 169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.84 118.74 35.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 109.289 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -82.65 -176.96 6.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.676 0.791 . . . . 0.0 111.907 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.22 -31.79 72.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.934 -1.103 . . . . 0.0 113.368 -170.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.2 p -89.68 4.31 49.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.532 1.933 . . . . 0.0 114.147 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.53 5.24 89.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.967 -1.083 . . . . 0.0 114.826 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -57.02 139.56 51.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 118.338 1.069 . . . . 0.0 110.266 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -100.05 128.76 46.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.704 0.801 . . . . 0.0 109.768 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.5 pt -129.21 139.69 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.378 1.071 . . . . 0.0 110.894 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -87.72 137.56 32.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.789 1.236 . . . . 0.0 111.496 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -116.59 147.95 41.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.963 0.905 . . . . 0.0 110.659 167.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -105.61 121.0 43.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.571 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.96 158.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.266 1.426 . . . . 0.0 111.669 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -105.14 154.04 39.1 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 123.363 0.665 . . . . 0.0 110.323 162.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.79 -9.44 21.09 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.601 2.2 . . . . 0.0 114.457 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -87.4 -11.05 50.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.789 2.036 . . . . 0.0 114.701 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -64.15 156.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.421 1.464 . . . . 0.0 111.6 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -102.12 167.6 9.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.995 0.918 . . . . 0.0 113.205 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.69 -33.34 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.737 -0.602 . . . . 0.0 111.766 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.89 -37.25 83.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.357 -0.839 . . . . 0.0 112.833 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.8 -38.56 86.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.052 0.842 . . . . 0.0 111.626 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -48.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.711 1.141 . . . . 0.0 110.534 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -62.1 -40.91 97.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.513 0.725 . . . . 0.0 112.286 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.46 -31.8 72.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.351 1.06 . . . . 0.0 113.262 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.69 -28.15 50.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.8 1.24 . . . . 0.0 112.918 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.64 -44.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.408 1.083 . . . . 0.0 110.878 168.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.29 -35.23 67.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.33 1.052 . . . . 0.0 112.425 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.23 -25.24 67.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -108.34 -27.11 10.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -122.14 -3.92 9.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.872 1.215 . . . . 0.0 113.933 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -17.77 5.05 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.344 -1.472 . . . . 0.0 116.683 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.88 122.98 84.87 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 119.432 1.616 . . . . 0.0 111.782 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 148.46 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.606 2.204 . . . . 0.0 112.625 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -49.92 -36.83 44.87 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.747 3.632 . . . . 0.0 116.238 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.23 -8.35 49.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.07 -7.4 23.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.049 1.739 . . . . 0.0 113.746 167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -93.74 142.71 27.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.769 1.168 . . . . 0.0 112.795 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -133.41 129.24 37.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.299 1.84 . . . . 0.0 108.357 165.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.08 134.44 54.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.103 0.961 . . . . 0.0 113.421 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 mm -122.09 131.95 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.139 1.775 . . . . 0.0 110.654 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -136.62 123.02 20.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 110.944 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.32 48.49 10.42 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.232 1.413 . . . . 0.0 113.649 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 -4.55 33.22 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.048 1.785 . . . . 0.0 116.272 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -101.92 129.57 48.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.779 1.79 . . . . 0.0 111.227 -174.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.92 128.95 36.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.708 0.803 . . . . 0.0 110.318 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.11 121.04 28.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.907 0.883 . . . . 0.0 110.721 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -108.38 168.16 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -74.35 135.16 42.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.897 0.879 . . . . 0.0 113.081 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.36 -3.13 63.74 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.867 . . . . 0.0 115.463 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -75.96 151.12 37.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.971 1.386 . . . . 0.0 111.126 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -93.99 166.18 12.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.619 0.768 . . . . 0.0 112.846 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.88 -36.68 75.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.224 166.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -60.04 -36.89 78.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.758 0.823 . . . . 0.0 112.777 173.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.04 -8.56 50.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.75 1.15 11.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.193 1.397 . . . . 0.0 113.853 166.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 51.54 48.51 22.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.417 1.887 . . . . 0.0 114.55 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.45 128.17 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.036 0.934 . . . . 0.0 108.589 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -134.07 168.64 18.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.83 116.66 14.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.266 2.226 . . . . 0.0 112.537 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 142.6 30.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.481 3.512 . . . . 0.0 109.738 -23.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -125.89 159.69 31.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.211 1.804 . . . . 0.0 112.068 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -115.76 140.66 49.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.398 1.479 . . . . 0.0 111.515 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.53 163.73 31.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.067 1.347 . . . . 0.0 111.938 171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.06 142.26 45.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.056 1.342 . . . . 0.0 112.019 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.14 137.57 35.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 110.094 166.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.01 166.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.304 1.841 . . . . 0.0 110.017 168.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.43 149.45 42.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.532 -0.73 . . . . 0.0 111.939 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -84.9 141.87 30.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.245 1.018 . . . . 0.0 109.956 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.87 2.07 44.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -164.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -69.06 159.37 33.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.604 1.562 . . . . 0.0 113.271 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.68 -160.28 33.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.223 0.916 . . . . 0.0 113.243 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.94 1.733 . . . . 0.0 113.927 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.12 146.0 29.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.503 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.69 156.02 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.223 1.009 . . . . 0.0 110.091 156.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.56 127.76 51.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.616 1.166 . . . . 0.0 111.336 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.12 116.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.063 0.945 . . . . 0.0 110.58 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -100.69 135.28 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.152 1.781 . . . . 0.0 112.424 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.9 p -91.93 164.66 13.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.124 1.37 . . . . 0.0 112.868 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -72.77 1.03 9.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 113.71 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 p -100.18 -0.86 37.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.094 1.757 . . . . 0.0 113.07 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 12.72 77.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 116.071 1.189 . . . . 0.0 116.071 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -88.28 142.03 28.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.678 1.239 . . . . 0.0 110.119 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -110.25 134.7 51.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.624 1.17 . . . . 0.0 110.933 167.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 mm -108.03 133.44 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.368 1.867 . . . . 0.0 109.396 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.7 m -103.03 121.06 41.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.119 1.368 . . . . 0.0 110.31 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -115.26 141.02 48.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.877 1.271 . . . . 0.0 110.979 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -99.36 121.39 41.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.245 1.018 . . . . 0.0 109.885 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -145.11 157.13 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.666 1.586 . . . . 0.0 110.883 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.7 161.75 23.41 Favored Pre-proline 0 N--CA 1.45 -0.471 0 O-C-N 120.567 -1.333 . . . . 0.0 109.538 162.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.28 -25.67 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.826 2.351 . . . . 0.0 114.443 168.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -78.31 -9.26 59.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.225 1.81 . . . . 0.0 115.803 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 136.2 56.78 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 120.473 1.488 . . . . 0.0 110.462 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -76.17 156.58 33.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.288 0.635 . . . . 0.0 111.361 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -62.76 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.092 -1.005 . . . . 0.0 111.443 171.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.541 1.064 . . . . 0.0 111.873 166.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -62.14 -38.74 90.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.752 1.16 . . . . 0.0 112.146 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.09 -49.64 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 121.286 -0.884 . . . . 0.0 111.253 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.79 -34.28 77.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.321 0.648 . . . . 0.0 112.299 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.94 90.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.277 1.031 . . . . 0.0 112.875 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.19 -35.7 78.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.534 1.133 . . . . 0.0 111.975 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.75 -36.93 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.403 -0.811 . . . . 0.0 111.378 170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.58 -37.42 86.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.467 1.03 . . . . 0.0 111.635 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -61.92 -43.54 98.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.918 1.235 . . . . 0.0 112.52 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -84.38 -27.92 27.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -130.92 -6.55 3.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.38 20.32 79.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 120.303 1.411 . . . . 0.0 116.192 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.02 127.41 53.79 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 110.118 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.42 126.76 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.961 2.441 . . . . 0.0 112.149 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.85 -26.46 57.65 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 124.074 3.182 . . . . 0.0 116.689 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.34 -9.74 58.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -111.99 1.46 16.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.819 1.247 . . . . 0.0 113.321 170.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.44 113.51 22.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.363 0.983 . . . . 0.0 110.789 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -99.72 123.08 43.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.131 0.572 . . . . 0.0 110.806 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -109.75 128.47 55.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.687 1.195 . . . . 0.0 111.661 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.7 mt -125.14 131.77 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.811 1.244 . . . . 0.0 110.562 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -136.3 122.85 20.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.27 1.828 . . . . 0.0 110.303 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 44.22 25.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 114.174 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.97 6.64 64.47 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.378 1.311 . . . . 0.0 116.378 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -98.87 128.36 45.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.368 1.467 . . . . 0.0 111.228 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -80.88 110.28 16.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 108.912 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.0 143.78 31.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.315 -0.865 . . . . 0.0 111.686 -173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.63 134.47 54.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 113.76 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -29.82 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.035 2.534 . . . . 0.0 115.071 -164.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.86 -6.97 88.88 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.465 1.507 . . . . 0.0 116.386 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -110.64 165.99 11.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.523 1.661 . . . . 0.0 111.814 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -98.75 165.38 11.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.77 -33.53 70.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.425 -0.797 . . . . 0.0 112.464 168.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.9 p -69.93 -28.37 65.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.0 -29.09 70.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.598 1.544 . . . . 0.0 112.351 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -100.42 3.09 42.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 114.289 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 49.47 52.8 13.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.238 1.415 . . . . 0.0 112.868 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -90.13 133.29 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 108.728 173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -118.98 170.12 9.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.875 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 141.3 15.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.933 1.293 . . . . 0.0 113.862 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.08 20.36 5.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.062 1.745 . . . . 0.0 115.413 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -66.9 145.25 55.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 112.41 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -103.45 140.29 37.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.549 1.14 . . . . 0.0 110.83 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.69 164.96 24.78 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.982 2.513 . . . . 0.0 109.778 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -114.26 148.68 37.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.93 0.892 . . . . 0.0 112.178 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.66 122.2 39.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.072 2.149 . . . . 0.0 110.907 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.67 134.65 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.995 1.318 . . . . 0.0 109.167 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -89.04 124.87 34.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.972 0.909 . . . . 0.0 110.625 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -76.51 74.24 3.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 111.562 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.84 153.06 42.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.789 1.635 . . . . 0.0 111.579 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 54.89 45.44 26.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.528 1.931 . . . . 0.0 113.715 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.16 5.83 0.04 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 117.561 1.784 . . . . 0.0 117.561 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-N 119.452 1.626 . . . . 0.0 112.967 178.49 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.92 131.73 52.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.229 1.012 . . . . 0.0 112.162 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -130.28 157.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.086 0.954 . . . . 0.0 110.481 164.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.3 143.85 33.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.724 0.81 . . . . 0.0 111.395 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.51 120.92 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.43 1.092 . . . . 0.0 109.612 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.64 133.56 42.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.733 1.613 . . . . 0.0 110.325 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -96.1 165.04 12.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.249 1.02 . . . . 0.0 112.08 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.04 8.87 3.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.877 1.271 . . . . 0.0 113.409 165.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -112.01 11.83 20.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.133 2.173 . . . . 0.0 112.238 172.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.83 7.33 80.53 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.957 1.265 . . . . 0.0 115.625 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -82.47 147.19 28.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.995 1.397 . . . . 0.0 110.411 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -126.39 114.05 17.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.051 0.94 . . . . 0.0 109.587 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -105.75 154.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 124.523 1.129 . . . . 0.0 111.067 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -103.22 145.9 29.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.878 0.871 . . . . 0.0 111.336 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -121.33 154.0 36.99 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.85 1.26 . . . . 0.0 111.608 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.7 110.51 22.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 109.607 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.77 161.87 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.665 1.986 . . . . 0.0 110.751 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -79.8 153.11 75.36 Favored Pre-proline 0 N--CA 1.45 -0.475 0 O-C-N 121.035 -1.041 . . . . 0.0 111.39 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.53 -33.26 47.08 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.424 2.749 . . . . 0.0 114.113 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.8 m -118.26 44.55 2.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.958 2.103 . . . . 0.0 112.682 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 149.51 34.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.854 1.261 . . . . 0.0 113.024 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 p -78.77 154.84 29.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -59.41 -33.39 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.381 -0.825 . . . . 0.0 112.203 171.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.08 -39.9 93.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 -33.69 76.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.564 0.62 . . . . 0.0 111.96 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.23 -44.95 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.052 -1.03 . . . . 0.0 111.212 172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.22 -39.22 78.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.937 1.244 . . . . 0.0 112.473 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.99 88.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -69.27 -27.97 65.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.06 0.944 . . . . 0.0 112.871 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.55 -41.68 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.094 0.958 . . . . 0.0 110.922 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -63.14 -41.44 99.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 119.067 0.849 . . . . 0.0 112.427 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.71 -28.78 50.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -100.18 -45.41 5.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.75 5.05 10.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -167.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.1 17.29 80.26 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 162.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 121.53 69.69 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 119.066 1.433 . . . . 0.0 110.197 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.1 136.83 77.4 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.319 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.21 -21.49 35.99 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.089 2.526 . . . . 0.0 113.858 -167.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.41 -18.71 63.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.426 1.012 . . . . 0.0 112.904 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -93.78 -2.32 53.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.737 1.615 . . . . 0.0 112.827 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -101.7 136.87 40.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.857 1.263 . . . . 0.0 112.653 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -123.03 127.86 49.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.665 1.586 . . . . 0.0 109.655 164.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.24 119.44 38.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.779 0.831 . . . . 0.0 110.251 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.61 132.34 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 110.168 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.86 136.26 28.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.166 1.387 . . . . 0.0 111.11 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.99 39.5 7.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.835 1.654 . . . . 0.0 115.384 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.86 77.46 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.38 1.467 . . . . 0.0 116.137 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -139.37 150.15 44.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.744 1.772 . . . . 0.0 113.222 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -75.21 135.65 41.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.234 1.013 . . . . 0.0 110.529 166.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 mt -95.0 139.52 31.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.461 1.104 . . . . 0.0 111.165 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -100.17 140.78 33.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.674 1.589 . . . . 0.0 112.465 -173.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.88 -29.66 65.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -169.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.32 0.23 49.28 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -134.51 165.53 24.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.246 1.523 . . . . 0.0 112.748 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -102.69 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 114.165 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.2 mt -52.72 -41.97 64.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.975 0.91 . . . . 0.0 111.908 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -71.85 -30.82 65.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -61.82 -39.94 93.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.288 1.403 . . . . 0.0 110.579 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -80.74 6.47 12.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.73 1.612 . . . . 0.0 114.672 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 59.28 26.25 15.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -87.09 114.35 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.245 1.418 . . . . 0.0 109.609 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -89.02 164.9 14.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.079 1.352 . . . . 0.0 112.429 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 149.01 1.93 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.491 1.516 . . . . 0.0 114.823 175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.96 22.59 4.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.728 2.011 . . . . 0.0 114.956 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -67.5 155.61 38.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 156.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 m -112.5 132.58 55.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.572 1.149 . . . . 0.0 109.712 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.75 140.98 45.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.888 1.275 . . . . 0.0 108.992 171.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -90.85 144.45 25.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.241 -0.912 . . . . 0.0 111.299 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -110.81 113.48 26.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.853 1.661 . . . . 0.0 109.866 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.46 127.89 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.821 1.249 . . . . 0.0 108.874 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 mp -91.33 138.6 31.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.016 0.526 . . . . 0.0 110.35 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -77.59 64.43 2.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.63 1.972 . . . . 0.0 111.807 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.89 135.85 53.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 58.71 51.54 7.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.678 1.991 . . . . 0.0 112.452 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.51 -51.3 0.07 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.862 1.22 . . . . 0.0 114.251 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.756 1.645 . . . . 0.0 113.514 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.05 141.6 28.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.795 -0.566 . . . . 0.0 111.732 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -135.41 179.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.765 1.626 . . . . 0.0 111.742 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -124.84 143.87 50.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.68 1.192 . . . . 0.0 112.302 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.66 126.37 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.017 1.327 . . . . 0.0 108.919 166.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -125.23 125.98 44.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.443 1.097 . . . . 0.0 111.583 -172.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -81.09 144.6 31.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.274 0.559 . . . . 0.0 110.449 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.09 -3.89 11.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 114.408 -177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 p -85.52 -16.55 39.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.065 1.346 . . . . 0.0 113.533 168.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.55 -49.26 0.77 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.349 1.452 . . . . 0.0 114.819 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -58.66 130.22 45.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.314 1.057 . . . . 0.0 113.532 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -102.39 139.91 37.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.689 1.596 . . . . 0.0 111.032 167.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mm -115.63 130.14 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.268 2.227 . . . . 0.0 108.36 169.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.4 m -88.51 126.05 35.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 109.733 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -116.4 156.8 26.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.402 1.081 . . . . 0.0 112.805 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.76 116.7 24.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.494 1.918 . . . . 0.0 109.297 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.63 154.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.346 1.459 . . . . 0.0 111.691 -166.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -88.52 149.52 44.52 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.098 164.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.59 -20.48 68.91 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.345 2.03 . . . . 0.0 113.532 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -87.13 -0.88 57.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.456 1.902 . . . . 0.0 114.93 172.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -64.05 135.09 56.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.55 1.523 . . . . 0.0 110.148 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 t -84.75 154.67 22.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.905 0.882 . . . . 0.0 111.757 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 mm -62.96 -36.12 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.943 -1.098 . . . . 0.0 112.19 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.47 -22.66 65.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -76.58 -33.22 58.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.819 -0.551 . . . . 0.0 111.609 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.83 -39.26 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.947 -1.095 . . . . 0.0 110.725 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -59.32 -40.63 86.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 118.978 0.808 . . . . 0.0 112.599 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.67 77.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.238 1.015 . . . . 0.0 113.385 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.85 -39.54 83.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.985 1.314 . . . . 0.0 111.733 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.3 -42.55 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.558 0.743 . . . . 0.0 110.825 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -61.85 -39.37 91.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.044 0.938 . . . . 0.0 112.164 173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.63 -36.45 82.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.44 -43.2 16.09 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -116.86 -8.62 11.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 -7.73 69.31 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.92 115.87 35.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 C-N-CA 125.458 1.503 . . . . 0.0 110.89 -170.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -61.4 140.01 85.51 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.032 2.488 . . . . 0.0 112.886 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.32 -31.09 55.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.085 3.19 . . . . 0.0 114.885 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.96 -5.57 35.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -98.59 -12.12 21.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.888 1.275 . . . . 0.0 113.003 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -95.45 135.95 36.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.865 1.266 . . . . 0.0 111.631 -171.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -129.57 123.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.63 1.172 . . . . 0.0 110.141 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 133.0 52.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.696 1.198 . . . . 0.0 111.482 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.36 129.61 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.39 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -137.03 142.33 42.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.407 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 37.54 3.42 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.984 1.714 . . . . 0.0 114.018 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.68 1.99 55.12 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.161 1.839 . . . . 0.0 116.672 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -93.79 129.27 40.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.739 1.769 . . . . 0.0 110.494 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -72.67 118.65 15.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 166.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.9 mt -79.52 125.11 29.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.53 0.681 . . . . 0.0 112.348 -164.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.46 144.65 33.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.283 1.033 . . . . 0.0 110.792 164.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.54 -16.15 37.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -167.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 31.3 0.84 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.122 1.328 . . . . 0.0 115.38 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -141.6 168.67 19.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.535 2.334 . . . . 0.0 111.178 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -103.44 165.61 10.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.486 1.114 . . . . 0.0 112.401 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.0 mt -53.32 -40.8 65.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.428 0.691 . . . . 0.0 112.324 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 p -64.37 -29.27 70.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -74.13 -16.82 60.99 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.683 1.128 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -96.84 5.35 50.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.316 1.447 . . . . 0.0 113.563 167.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 56.98 36.31 27.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.411 1.484 . . . . 0.0 113.996 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.26 141.92 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.391 1.076 . . . . 0.0 109.035 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.9 175.43 8.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.081 1.752 . . . . 0.0 111.628 -170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -56.32 136.49 53.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.355 -0.841 . . . . 0.0 110.845 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 51.5 mt-10 56.64 16.37 2.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.006 2.122 . . . . 0.0 115.945 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.2 m -64.65 149.61 48.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.068 -1.02 . . . . 0.0 112.282 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.51 117.09 29.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.086 1.355 . . . . 0.0 112.074 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -97.36 139.01 33.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.716 1.607 . . . . 0.0 108.829 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -96.17 136.02 37.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.005 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -111.73 115.54 29.25 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.267 1.427 . . . . 0.0 109.308 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.22 130.85 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 166.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -84.39 135.87 34.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.051 0.453 . . . . 0.0 109.804 166.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.8 141.1 57.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 0.0 109.717 162.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.85 -26.89 60.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -136.21 81.86 1.91 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.301 1.841 . . . . 0.0 109.705 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.11 6.39 28.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.104 1.811 . . . . 0.0 116.865 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 120.011 1.905 . . . . 0.0 114.382 178.605 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -82.59 144.51 30.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.391 172.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.19 157.26 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.777 1.231 . . . . 0.0 111.668 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -97.97 139.99 32.99 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.973 0.909 . . . . 0.0 111.79 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.25 124.7 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.23 1.412 . . . . 0.0 109.106 167.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -109.8 146.5 34.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.029 1.331 . . . . 0.0 112.429 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -119.41 155.85 31.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.859 1.263 . . . . 0.0 112.628 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.18 -16.52 63.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 112.571 172.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.2 p -69.17 0.37 4.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 113.608 164.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 4.35 88.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.293 1.425 . . . . 0.0 115.199 173.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -82.74 160.45 22.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.566 1.183 . . . . 0.0 111.833 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -128.94 135.0 48.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.838 1.255 . . . . 0.0 110.245 163.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.3 mt -122.26 141.81 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 107.945 -172.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -110.26 139.11 45.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.827 0.74 . . . . 0.0 112.017 173.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.4 145.99 50.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.87 115.59 30.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.687 1.195 . . . . 0.0 110.003 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.49 168.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.815 1.246 . . . . 0.0 113.489 -168.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -119.73 148.14 45.53 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 110.084 171.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.04 -28.68 41.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.293 2.662 . . . . 0.0 114.781 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -87.94 -0.27 56.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -64.57 136.14 56.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.256 1.389 . . . . 0.0 111.038 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -79.52 160.23 26.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.442 0.697 . . . . 0.0 112.347 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.77 -33.58 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.462 -0.773 . . . . 0.0 112.009 177.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -63.22 -36.16 82.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.035 1.289 . . . . 0.0 112.644 170.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.02 -44.78 68.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.117 0.567 . . . . 0.0 111.915 175.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -32.5 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.296 -1.503 . . . . 0.0 113.141 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.34 -38.85 92.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.768 0.713 . . . . 0.0 112.445 169.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.21 69.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 173.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.07 -33.78 75.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.93 -1.106 . . . . 0.0 112.714 172.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.9 mt -67.79 -41.81 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.145 0.978 . . . . 0.0 111.047 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.08 -47.24 85.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -58.39 -36.54 73.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.254 1.021 . . . . 0.0 113.005 175.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -76.99 -50.03 14.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 113.315 -178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -117.4 -7.41 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.54 16.9 67.41 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.3 mt -112.4 121.09 39.9 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 109.559 -175.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 154.4 45.52 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.139 2.559 . . . . 0.0 113.298 -173.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -47.89 -40.6 32.53 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 115.644 -177.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.38 -22.87 65.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -85.65 -13.94 47.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.087 . . . . 0.0 112.8 175.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -90.24 152.77 20.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.042 1.737 . . . . 0.0 111.744 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -137.74 140.96 40.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.53 0.732 . . . . 0.0 110.211 147.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.09 137.39 51.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.744 1.218 . . . . 0.0 111.388 -172.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.4 mt -122.33 139.53 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.636 1.574 . . . . 0.0 110.399 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -130.63 121.45 25.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 166.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.71 52.21 9.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.277 1.431 . . . . 0.0 113.625 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.07 -5.53 48.73 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.99 1.757 . . . . 0.0 117.135 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.99 140.35 39.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.41 2.105 . . . . 0.0 111.239 179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.05 139.15 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.073 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.36 122.26 30.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.147 0.979 . . . . 0.0 110.591 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.26 144.98 32.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.557 1.143 . . . . 0.0 113.755 -168.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.68 146.15 54.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.305 1.042 . . . . 0.0 111.195 -174.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.16 -17.87 53.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.312 1.434 . . . . 0.0 115.738 -175.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -91.99 171.86 8.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.565 1.546 . . . . 0.0 111.478 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -118.01 160.5 21.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.322 1.449 . . . . 0.0 112.772 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.61 -39.64 73.95 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.834 0.854 . . . . 0.0 113.054 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.7 p -62.42 -29.24 70.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.41 -21.55 65.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.831 1.65 . . . . 0.0 112.597 178.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -98.25 5.66 48.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.098 1.759 . . . . 0.0 113.924 173.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 55.69 34.71 23.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.212 1.405 . . . . 0.0 114.087 -173.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.42 126.94 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.057 . . . . 0.0 108.97 172.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -128.73 168.89 15.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.48 1.912 . . . . 0.0 111.927 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -46.22 125.16 6.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.772 2.029 . . . . 0.0 112.758 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 34.2 mt-10 61.45 20.83 11.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.429 2.292 . . . . 0.0 115.475 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -70.22 156.87 38.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.592 0.757 . . . . 0.0 112.435 162.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.1 m -108.4 123.82 49.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.931 1.292 . . . . 0.0 112.21 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.48 162.61 13.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.06 2.144 . . . . 0.0 109.735 170.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -121.52 137.63 54.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.332 1.053 . . . . 0.0 110.964 176.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.85 126.73 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.106 1.762 . . . . 0.0 109.052 176.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.45 154.81 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.732 1.213 . . . . 0.0 110.575 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.94 131.4 52.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.891 0.877 . . . . 0.0 111.114 -171.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -62.35 -43.62 98.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.326 1.05 . . . . 0.0 113.117 -168.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.8 mt -80.48 9.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.337 1.455 . . . . 0.0 114.37 175.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.89 14.48 7.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.617 1.567 . . . . 0.0 113.305 177.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.15 -14.05 79.78 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.737 1.637 . . . . 0.0 113.826 177.484 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -98.08 141.42 31.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.699 0.681 . . . . 0.0 112.329 168.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.03 169.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.064 1.745 . . . . 0.0 109.87 167.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -126.73 149.86 49.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.071 0.948 . . . . 0.0 111.573 178.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.52 126.95 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.409 1.084 . . . . 0.0 109.616 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -103.6 123.22 46.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.94 1.296 . . . . 0.0 112.301 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -75.89 162.26 28.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.818 0.847 . . . . 0.0 112.551 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.76 -19.98 60.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -90.56 -2.87 57.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.461 2.304 . . . . 0.0 115.011 173.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.4 63.95 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 175.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -78.88 134.67 36.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.363 1.082 . . . . 0.0 108.601 167.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -107.18 104.13 13.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.354 1.062 . . . . 0.0 109.305 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -80.0 136.87 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.095 1.758 . . . . 0.0 109.007 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.0 m -112.2 127.82 56.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.782 1.233 . . . . 0.0 110.412 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.31 136.17 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.396 0.998 . . . . 0.0 112.881 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -85.3 127.41 34.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.336 1.455 . . . . 0.0 110.852 169.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.98 171.03 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.39 1.876 . . . . 0.0 111.933 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.4 153.83 47.6 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 124.915 1.286 . . . . 0.0 110.08 157.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.19 -19.51 57.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.952 2.435 . . . . 0.0 114.934 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -82.95 -3.39 57.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 114.847 175.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.65 144.32 51.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.127 -0.983 . . . . 0.0 111.306 172.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -88.7 162.03 16.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -177.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.49 -33.6 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.25 -39.59 93.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.988 -1.07 . . . . 0.0 112.458 172.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -60.99 -26.79 67.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.6 t -80.53 -48.82 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.37 0.668 . . . . 0.0 110.163 174.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.78 -38.31 81.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.87 87.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.746 0.819 . . . . 0.0 112.981 175.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -67.16 -33.84 76.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.189 -0.945 . . . . 0.0 112.617 174.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.44 -37.37 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.877 0.871 . . . . 0.0 111.302 169.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -65.86 -43.98 86.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.704 -1.248 . . . . 0.0 112.526 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.71 -30.27 70.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.54 -41.32 15.41 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -115.59 -20.69 10.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 14.33 78.99 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.746 1.059 . . . . 0.0 115.746 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.22 118.25 70.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.404 1.082 . . . . 0.0 109.191 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.63 127.4 16.27 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.539 2.159 . . . . 0.0 112.594 -173.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.58 -35.22 76.27 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.276 3.317 . . . . 0.0 114.863 -176.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.96 -10.93 57.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.45 1.03 21.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.599 1.56 . . . . 0.0 113.793 173.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -93.99 130.59 40.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -108.14 136.27 48.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.704 1.602 . . . . 0.0 109.322 159.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.7 mt -115.35 139.64 49.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 111.119 172.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -131.77 136.26 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.765 1.626 . . . . 0.0 110.686 -171.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.36 143.34 30.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.786 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 35.96 18.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.571 1.148 . . . . 0.0 113.107 -170.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.39 43.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.107 1.813 . . . . 0.0 115.869 -178.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -117.29 142.71 46.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.177 1.791 . . . . 0.0 111.052 -170.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -73.95 152.31 40.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 111.938 -176.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.96 130.11 56.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.804 1.242 . . . . 0.0 111.952 -173.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.53 135.14 34.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.775 1.23 . . . . 0.0 113.433 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.16 -33.88 71.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 114.84 -173.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.32 -3.95 78.19 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.176 1.369 . . . . 0.0 115.32 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -101.46 165.37 11.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.639 1.72 . . . . 0.0 112.411 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -91.88 162.55 14.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.079 0.951 . . . . 0.0 112.681 172.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -55.79 -39.02 70.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.722 0.809 . . . . 0.0 112.182 169.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.6 p -65.43 -30.22 71.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 176.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.37 -18.32 63.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.346 0.975 . . . . 0.0 113.071 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -109.45 15.61 22.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.291 1.836 . . . . 0.0 113.643 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 55.11 35.38 24.63 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.169 1.388 . . . . 0.0 114.599 178.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.0 mt -81.59 122.85 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 120.678 -1.264 . . . . 0.0 108.683 176.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -117.59 -179.65 3.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 111.457 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.22 17.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.064 -1.022 . . . . 0.0 112.543 175.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 59.02 25.46 13.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.618 1.567 . . . . 0.0 115.044 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -80.55 138.21 36.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 171.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.4 m -103.54 124.1 48.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.642 1.177 . . . . 0.0 110.735 170.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.6 151.7 19.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.013 1.725 . . . . 0.0 109.36 170.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -102.82 133.24 48.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.456 0.702 . . . . 0.0 110.189 170.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.9 tp -97.81 133.9 41.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.734 1.614 . . . . 0.0 109.76 173.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.72 150.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.376 1.47 . . . . 0.0 110.551 -173.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.92 145.04 45.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.399 1.879 . . . . 0.0 112.754 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.983 1.713 . . . . 0.0 111.183 164.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -102.16 165.12 11.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.688 1.195 . . . . 0.0 113.884 -174.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.28 68.4 mtt180 63.97 25.52 13.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.051 2.54 . . . . 0.0 116.284 176.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.15 38.18 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.357 -0.839 . . . . 0.0 112.749 165.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.41 1.481 . . . . 0.0 114.247 177.635 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -103.87 133.53 48.7 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.167 1.387 . . . . 0.0 111.706 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.17 148.1 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 112.039 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -94.12 161.4 14.29 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.648 1.179 . . . . 0.0 113.042 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.88 136.45 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.114 1.366 . . . . 0.0 110.062 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -123.92 145.65 49.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 110.651 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -130.04 166.82 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.107 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -50.24 -44.37 53.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.8 p -138.3 -20.47 1.07 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.92 169.45 52.71 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.216 0.916 . . . . 0.0 114.274 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.59 147.49 49.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.287 1.435 . . . . 0.0 112.341 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -72.48 141.57 48.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.439 1.096 . . . . 0.0 109.816 174.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 pt -124.86 162.79 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.402 1.081 . . . . 0.0 112.818 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -117.05 136.78 52.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.558 1.543 . . . . 0.0 111.528 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.02 154.32 41.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.83 1.652 . . . . 0.0 111.486 173.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.99 129.58 49.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.392 1.077 . . . . 0.0 111.412 176.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -149.41 167.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.696 2.399 . . . . 0.0 111.532 -163.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.15 150.06 39.97 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 124.432 1.093 . . . . 0.0 110.666 164.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -54.7 -25.77 43.69 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.299 2.666 . . . . 0.0 116.255 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -85.18 0.23 52.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 175.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.06 146.26 49.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.391 1.45 . . . . 0.0 111.378 171.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -93.11 157.04 16.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.61 -34.54 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.498 -0.751 . . . . 0.0 112.504 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.65 -27.59 69.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.164 1.347 . . . . 0.0 113.796 173.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.33 -34.83 63.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.41 0.684 . . . . 0.0 111.532 173.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.02 -44.43 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.502 0.721 . . . . 0.0 109.954 173.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.93 -36.62 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 174.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.83 80.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 176.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -69.02 -35.53 76.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.976 -1.077 . . . . 0.0 112.474 171.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.54 -36.96 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.594 0.758 . . . . 0.0 111.284 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -63.22 -39.28 94.17 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.804 1.184 . . . . 0.0 111.495 172.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.85 -44.1 67.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -76.38 -39.39 53.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -114.05 -7.91 13.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.76 84.2 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.895 1.118 . . . . 0.0 115.895 177.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -96.46 119.99 63.07 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.896 1.279 . . . . 0.0 110.125 -171.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.71 141.94 98.18 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.404 2.736 . . . . 0.0 113.19 175.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.63 -23.21 43.01 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.206 2.604 . . . . 0.0 114.501 -168.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.21 -23.53 60.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.963 0.801 . . . . 0.0 112.967 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -82.37 -13.84 56.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -88.16 129.74 35.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.433 1.093 . . . . 0.0 111.955 -175.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -115.11 123.92 50.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.239 1.416 . . . . 0.0 109.603 164.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.82 132.44 54.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.077 0.951 . . . . 0.0 111.759 -178.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.8 mt -126.21 140.47 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.381 1.873 . . . . 0.0 110.66 -175.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -142.61 127.94 18.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.242 1.417 . . . . 0.0 111.232 171.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.04 45.2 22.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.985 1.314 . . . . 0.0 113.697 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.73 -7.08 28.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.37 1.938 . . . . 0.0 116.522 -177.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -96.89 128.8 44.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.378 1.589 . . . . 0.0 111.375 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -78.28 135.16 37.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.515 0.726 . . . . 0.0 110.219 171.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -96.34 156.56 16.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.911 1.284 . . . . 0.0 112.245 -171.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -113.5 135.99 53.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.197 1.399 . . . . 0.0 112.95 -173.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.46 -37.99 68.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.118 1.767 . . . . 0.0 114.683 -165.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.55 -7.85 68.68 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -86.24 160.9 19.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.737 1.768 . . . . 0.0 111.642 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -93.7 159.86 15.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.253 1.021 . . . . 0.0 113.363 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.56 -34.35 72.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 174.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 t -62.51 -33.66 75.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.941 1.296 . . . . 0.0 113.551 172.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -66.98 -14.46 62.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.27 -0.894 . . . . 0.0 112.936 176.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.91 9.21 18.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.033 1.733 . . . . 0.0 113.831 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.54 35.29 23.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.635 -1.291 . . . . 0.0 114.324 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.57 119.41 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 120.893 -1.13 . . . . 0.0 109.463 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -111.16 173.06 6.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.851 1.66 . . . . 0.0 113.292 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -44.78 147.5 0.63 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.96 2.104 . . . . 0.0 115.777 178.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 59.91 8.8 1.5 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.994 2.118 . . . . 0.0 115.269 175.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 m -68.25 158.29 33.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.53 1.532 . . . . 0.0 111.233 167.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 m -120.88 121.96 39.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.602 1.161 . . . . 0.0 110.929 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -82.89 146.96 28.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.797 1.239 . . . . 0.0 109.759 168.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -112.17 133.04 54.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.875 0.87 . . . . 0.0 109.511 176.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.3 128.1 54.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.705 1.202 . . . . 0.0 109.413 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.61 151.48 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.547 1.539 . . . . 0.0 109.315 171.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.19 149.33 42.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -160.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.07 151.78 22.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 109.355 173.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.28 44.24 25.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.066 1.746 . . . . 0.0 113.921 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -134.64 -21.45 1.73 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.299 1.84 . . . . 0.0 114.833 -178.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.96 -8.58 66.89 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.915 1.926 . . . . 0.0 117.915 -167.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-N 119.644 1.722 . . . . 0.0 116.168 -179.44 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -93.55 140.72 29.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.254 0.622 . . . . 0.0 110.813 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.59 167.11 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.874 1.27 . . . . 0.0 111.841 171.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -124.81 152.83 43.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.395 1.478 . . . . 0.0 112.614 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -130.67 118.49 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.01 0.924 . . . . 0.0 111.229 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -80.98 125.95 30.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.813 2.045 . . . . 0.0 110.244 174.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.6 p -88.22 160.4 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.699 0.8 . . . . 0.0 111.56 171.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.3 tp -64.79 -25.76 68.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.454 -0.779 . . . . 0.0 112.375 172.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -76.67 -9.39 58.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.163 1.785 . . . . 0.0 114.918 173.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.65 7.68 62.91 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.96 1.267 . . . . 0.0 115.645 177.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.85 152.11 31.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.548 1.174 . . . . 0.0 110.048 169.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 m -126.06 119.73 28.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.178 0.991 . . . . 0.0 110.393 176.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 mt -98.89 121.98 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 109.328 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -96.36 134.19 39.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 111.303 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -143.73 151.67 40.32 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.866 1.266 . . . . 0.0 111.409 178.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -95.24 138.22 33.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.052 0.941 . . . . 0.0 110.692 169.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.37 163.95 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.846 1.658 . . . . 0.0 110.811 178.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -106.19 159.85 28.25 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.631 -0.668 . . . . 0.0 109.243 155.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.82 -15.66 39.4 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.982 1.788 . . . . 0.0 114.379 175.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -76.66 -11.06 59.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.51 1.924 . . . . 0.0 115.654 171.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 139.21 58.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.959 1.709 . . . . 0.0 110.623 175.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -82.71 158.99 22.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.687 -0.633 . . . . 0.0 111.424 169.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -59.93 -31.2 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.697 -0.627 . . . . 0.0 112.05 172.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -59.37 -41.75 90.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.18 0.9 . . . . 0.0 112.692 169.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -68.51 -39.34 81.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.581 0.628 . . . . 0.0 111.928 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.6 -45.53 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.286 -0.883 . . . . 0.0 111.413 174.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -59.87 -36.74 77.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.266 -0.896 . . . . 0.0 112.598 174.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.4 -27.07 63.06 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.505 1.122 . . . . 0.0 113.768 175.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -77.21 -37.59 53.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 111.892 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.66 -45.68 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 110.292 169.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -36.62 75.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.525 1.13 . . . . 0.0 112.788 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.77 -51.15 70.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.984 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 19.1 ptpt -94.45 -32.49 13.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.394 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.62 -12.44 16.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 19.88 78.61 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 170.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.4 119.85 71.77 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 119.38 1.59 . . . . 0.0 109.514 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.6 145.16 96.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.24 2.627 . . . . 0.0 112.737 177.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.93 -33.14 33.86 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.646 2.231 . . . . 0.0 113.513 -165.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -71.71 -14.29 61.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -89.6 -9.82 48.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.626 1.17 . . . . 0.0 113.33 172.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -93.71 138.3 32.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.662 1.119 . . . . 0.0 111.352 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -132.6 134.64 45.16 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.578 1.151 . . . . 0.0 110.811 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.83 140.42 48.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.177 1.391 . . . . 0.0 113.11 -174.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.88 132.71 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.35 1.86 . . . . 0.0 111.444 -174.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -144.22 137.54 27.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.819 2.048 . . . . 0.0 111.626 176.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.08 43.31 22.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.903 1.281 . . . . 0.0 113.855 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.94 44.53 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.249 1.88 . . . . 0.0 116.609 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -122.31 156.13 34.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.664 1.585 . . . . 0.0 112.159 -172.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -88.4 156.24 19.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.053 0.941 . . . . 0.0 112.171 -174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.83 133.98 55.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.015 1.326 . . . . 0.0 111.347 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -114.01 135.42 54.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.384 1.473 . . . . 0.0 112.664 -170.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.02 -32.63 4.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.777 2.431 . . . . 0.0 117.063 -172.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.88 -19.74 78.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -105.43 156.34 18.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.768 1.284 . . . . 0.0 112.378 -167.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.7 p -98.92 157.66 16.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.444 1.498 . . . . 0.0 114.008 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.28 -38.3 83.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.03 0.932 . . . . 0.0 113.371 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.6 p -63.96 -42.57 97.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.218 0.917 . . . . 0.0 112.501 174.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.48 -12.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.44 0.34 45.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.5 m120 56.46 40.23 29.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.081 1.353 . . . . 0.0 113.86 -174.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.0 mt -88.2 135.71 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.887 0.875 . . . . 0.0 108.935 174.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.77 171.02 8.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.383 -167.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -47.02 139.01 6.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.565 1.146 . . . . 0.0 111.489 165.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 57.93 12.94 1.92 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -63.08 150.67 42.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.924 0.89 . . . . 0.0 112.042 173.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -116.09 119.45 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.014 1.326 . . . . 0.0 109.151 176.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.52 158.4 18.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.448 1.099 . . . . 0.0 108.687 168.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -108.77 143.85 37.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.386 -0.821 . . . . 0.0 109.301 167.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -118.67 137.94 52.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.585 1.554 . . . . 0.0 110.304 -178.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.82 137.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.519 1.127 . . . . 0.0 110.917 169.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 tp -85.26 138.39 32.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.414 1.886 . . . . 0.0 110.926 176.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -127.71 93.11 3.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.547 1.939 . . . . 0.0 111.139 -176.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -97.4 143.58 27.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.577 1.151 . . . . 0.0 112.469 179.115 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.02 132.71 52.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.888 1.275 . . . . 0.0 112.389 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 148.27 16.04 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.524 1.535 . . . . 0.0 112.264 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.506 -1.719 . . . . 0.0 113.424 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.975 0.417 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.0 139.41 31.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 111.562 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.0 pt -138.66 165.72 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.205 1.402 . . . . 0.0 110.778 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -117.23 142.38 47.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.083 0.953 . . . . 0.0 112.092 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.4 t -119.69 123.08 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.405 1.082 . . . . 0.0 109.408 175.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -91.2 121.76 33.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.073 1.749 . . . . 0.0 108.785 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -89.12 163.83 15.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.808 0.843 . . . . 0.0 112.784 -173.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.95 -22.29 66.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.201 1.4 . . . . 0.0 113.645 -175.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -95.45 2.76 54.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.331 2.252 . . . . 0.0 113.957 173.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.39 61.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.414 1.483 . . . . 0.0 116.583 169.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.07 159.42 32.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.74 1.77 . . . . 0.0 111.173 174.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -116.15 136.54 52.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.529 0.732 . . . . 0.0 110.467 165.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.38 154.11 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.401 1.88 . . . . 0.0 111.276 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.2 m -114.13 120.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.578 1.151 . . . . 0.0 111.609 -170.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.7 163.1 16.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.285 1.434 . . . . 0.0 112.78 -173.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -125.74 126.98 45.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.727 1.611 . . . . 0.0 110.392 174.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 155.29 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.95 1.7 . . . . 0.0 111.4 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -96.67 142.85 25.14 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.05 167.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.46 -20.01 54.56 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.331 2.021 . . . . 0.0 115.938 -178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.5 p -88.09 -2.13 58.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.15 158.81 30.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.682 1.128 . . . . 0.0 111.145 170.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -103.31 174.32 5.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.478 -1.389 . . . . 0.0 114.292 -176.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mm -50.44 -37.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.877 1.271 . . . . 0.0 112.067 171.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.85 -32.21 70.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.098 -1.001 . . . . 0.0 112.919 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -69.78 -47.76 61.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.538 0.735 . . . . 0.0 111.874 175.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.35 -35.61 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.277 -0.89 . . . . 0.0 112.264 176.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -58.1 -41.63 83.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.812 1.187 . . . . 0.0 112.236 169.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.75 72.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.304 0.956 . . . . 0.0 113.02 177.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.47 -30.79 61.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.169 0.988 . . . . 0.0 113.577 172.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.26 -38.04 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.111 0.964 . . . . 0.0 110.36 167.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -63.73 -38.8 92.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.053 -1.03 . . . . 0.0 111.817 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.74 -41.06 90.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -79.05 -53.69 6.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -106.79 -12.1 15.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.83 14.26 82.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.01 123.07 66.98 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.017 1.327 . . . . 0.0 109.06 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -65.37 135.57 43.37 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.493 2.129 . . . . 0.0 115.224 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.58 -29.76 51.74 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 125.012 3.808 . . . . 0.0 116.127 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.17 -15.68 61.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 175.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -101.27 -29.53 12.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.349 1.46 . . . . 0.0 112.733 174.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.12 141.15 58.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.539 1.063 . . . . 0.0 111.579 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -131.45 144.48 51.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.575 -0.703 . . . . 0.0 110.631 154.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -110.28 135.75 50.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.156 0.983 . . . . 0.0 111.747 -175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mt -120.57 125.65 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.24 1.416 . . . . 0.0 108.793 179.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -131.42 125.95 33.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.642 1.177 . . . . 0.0 110.986 178.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.43 51.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.973 1.309 . . . . 0.0 112.574 -177.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 -14.27 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.807 2.146 . . . . 0.0 116.671 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.97 130.92 41.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.859 1.829 . . . . 0.0 111.335 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -82.13 116.85 21.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.236 0.615 . . . . 0.0 109.921 170.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.63 135.31 33.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.442 1.097 . . . . 0.0 112.462 -168.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -99.85 146.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.112 1.365 . . . . 0.0 112.711 178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.98 162.71 21.4 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.425 1.49 . . . . 0.0 114.468 -176.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -18.44 56.93 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 116.198 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -100.1 152.24 20.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.464 1.506 . . . . 0.0 112.285 176.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 p -83.55 161.81 21.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.995 0.918 . . . . 0.0 113.396 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.57 -34.43 76.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.734 0.813 . . . . 0.0 113.158 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.7 p -70.68 -32.95 70.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.321 0.964 . . . . 0.0 112.727 173.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.51 -25.06 65.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.819 0.848 . . . . 0.0 113.06 173.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -94.55 3.19 55.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 113.882 168.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 t30 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.77 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.35 163.45 23.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.489 1.116 . . . . 0.0 112.243 -177.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -46.14 125.17 6.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.141 1.776 . . . . 0.0 112.268 174.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 77.5 mt-10 64.52 22.84 12.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.82 2.448 . . . . 0.0 116.143 -177.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 m -72.67 156.65 38.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.923 0.889 . . . . 0.0 112.685 166.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.6 m -115.04 135.21 54.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.962 1.305 . . . . 0.0 110.145 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.23 162.07 26.28 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.708 1.203 . . . . 0.0 111.61 169.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -110.82 146.0 37.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.569 1.548 . . . . 0.0 111.542 -172.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.87 131.98 54.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.583 1.553 . . . . 0.0 111.586 178.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.97 166.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.191 1.797 . . . . 0.0 110.938 170.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.73 139.89 46.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.696 1.199 . . . . 0.0 111.61 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -66.48 138.54 57.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.858 166.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.44 149.75 41.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.912 1.685 . . . . 0.0 111.196 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -139.72 154.24 47.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.328 1.451 . . . . 0.0 111.222 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.8 -119.91 0.88 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 C-N-CA 124.481 1.039 . . . . 0.0 110.65 155.985 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.657 -0.127 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -76.0 137.97 40.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.47 155.47 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.214 1.806 . . . . 0.0 111.398 171.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.17 142.07 40.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.209 1.404 . . . . 0.0 111.451 174.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 t -130.21 121.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.916 0.886 . . . . 0.0 111.572 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -99.76 145.37 27.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.802 2.041 . . . . 0.0 111.946 -177.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 m -120.19 153.12 36.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 110.18 173.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.04 -16.78 20.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -67.97 -8.37 36.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.999 2.519 . . . . 0.0 113.892 169.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.73 -11.1 57.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.922 1.725 . . . . 0.0 114.269 -169.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -63.5 136.28 57.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.168 1.484 . . . . 0.0 110.841 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.15 151.37 37.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.479 1.112 . . . . 0.0 111.301 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.9 pt -136.86 147.41 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.458 1.503 . . . . 0.0 110.176 173.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 p -105.19 131.58 52.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 111.989 174.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.94 156.0 31.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.461 1.504 . . . . 0.0 110.377 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.7 111.79 15.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.16 1.784 . . . . 0.0 109.509 173.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.52 166.23 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.481 1.512 . . . . 0.0 111.817 -168.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.49 151.96 43.11 Favored Pre-proline 0 N--CA 1.449 -0.499 0 O-C-N 121.207 -0.933 . . . . 0.0 112.049 169.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.38 -28.57 21.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.635 2.89 . . . . 0.0 115.561 167.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.3 p -85.15 -1.47 56.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 115.428 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.06 135.39 39.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.79 -1.194 . . . . 0.0 110.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 p -77.0 168.56 19.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.006 0.922 . . . . 0.0 113.166 -176.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -36.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 121.419 -0.801 . . . . 0.0 110.022 169.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.04 -34.94 64.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.823 -1.173 . . . . 0.0 114.044 176.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.74 -38.35 75.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.257 0.935 . . . . 0.0 111.105 169.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.94 -47.4 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.463 174.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -55.87 -39.92 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.136 1.335 . . . . 0.0 112.502 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.35 64.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -74.74 -37.15 62.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.177 -0.952 . . . . 0.0 111.603 173.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.46 -36.32 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.454 1.502 . . . . 0.0 110.791 170.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -60.59 -47.13 87.57 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.117 0.871 . . . . 0.0 111.649 170.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.5 -37.92 87.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.284 0.947 . . . . 0.0 112.916 175.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -73.91 -54.15 8.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.368 1.467 . . . . 0.0 114.042 -177.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -112.23 -14.86 13.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.31 1.844 . . . . 0.0 114.319 -169.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.81 51.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.666 1.426 . . . . 0.0 116.666 174.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 tp -103.98 124.16 38.51 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.303 1.441 . . . . 0.0 111.807 -175.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -61.18 136.03 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.062 2.508 . . . . 0.0 114.828 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.45 -36.46 88.04 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 124.14 3.227 . . . . 0.0 115.908 179.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.04 -31.24 66.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.751 1.16 . . . . 0.0 113.659 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -101.5 13.89 33.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.28 139.19 35.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.208 1.003 . . . . 0.0 111.268 171.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -124.17 118.12 26.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.747 1.619 . . . . 0.0 109.185 168.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 130.16 43.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.623 1.169 . . . . 0.0 110.727 -170.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.74 142.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.816 1.646 . . . . 0.0 111.0 -169.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -139.77 122.39 16.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.907 1.283 . . . . 0.0 110.556 172.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 53.33 11.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.586 1.554 . . . . 0.0 113.511 177.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.4 -2.88 60.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.391 1.948 . . . . 0.0 116.423 178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.93 129.78 56.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.537 1.668 . . . . 0.0 111.267 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -77.84 131.08 37.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.79 -0.569 . . . . 0.0 110.591 173.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 mt -95.46 150.85 19.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.723 1.209 . . . . 0.0 112.359 -174.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -90.58 138.02 31.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 113.993 -169.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.82 -34.92 70.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 115.064 -172.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.88 -4.9 81.79 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.61 167.34 11.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.578 1.551 . . . . 0.0 112.004 -178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -123.58 167.36 14.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.597 1.959 . . . . 0.0 112.451 -173.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.3 mt -56.8 -36.02 69.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 173.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -63.8 -36.16 82.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.172 0.989 . . . . 0.0 113.235 176.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.77 -29.29 69.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.312 -0.868 . . . . 0.0 112.24 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -98.51 3.29 48.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.123 2.169 . . . . 0.0 114.502 175.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m120 57.28 35.97 26.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.342 1.857 . . . . 0.0 114.416 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.7 mt -83.48 133.95 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.93 1.292 . . . . 0.0 110.039 -175.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -107.05 173.43 6.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 114.836 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.9 141.53 49.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.658 1.583 . . . . 0.0 112.268 171.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 10.3 tt0 61.15 24.85 14.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.185 2.194 . . . . 0.0 114.226 -176.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.2 p -74.03 161.19 30.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.14 -0.975 . . . . 0.0 112.066 169.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -128.42 138.39 52.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.444 1.097 . . . . 0.0 110.735 178.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.31 175.37 9.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.072 2.149 . . . . 0.0 110.471 -172.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -128.69 158.18 39.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.335 1.854 . . . . 0.0 111.942 176.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.75 155.64 47.35 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 153.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.65 153.29 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.114 2.166 . . . . 0.0 108.584 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.43 155.63 33.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.255 -0.903 . . . . 0.0 112.228 178.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -87.34 166.06 15.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.416 1.486 . . . . 0.0 111.383 165.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -52.23 150.43 4.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.678 1.191 . . . . 0.0 112.557 170.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 49.3 47.06 22.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.459 -162.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.93 -46.07 0.02 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.686 1.612 . . . . 0.0 112.428 -175.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.036 1.779 . . . . 0.0 113.136 168.763 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -84.81 145.81 27.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.8 pt -130.37 158.38 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.251 1.42 . . . . 0.0 110.461 159.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -118.07 122.69 43.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.461 1.104 . . . . 0.0 111.149 -177.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.49 124.09 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.442 -0.786 . . . . 0.0 110.53 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -99.99 112.8 25.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.819 2.048 . . . . 0.0 111.099 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 p -78.12 171.73 14.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.199 1.0 . . . . 0.0 112.847 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -29.46 58.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.144 1.377 . . . . 0.0 114.392 174.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -88.86 -1.99 58.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.614 1.566 . . . . 0.0 113.678 178.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.25 5.7 89.06 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.558 1.075 . . . . 0.0 114.539 -174.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.94 143.31 57.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.028 1.414 . . . . 0.0 109.299 169.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -120.0 131.72 55.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.713 0.805 . . . . 0.0 111.535 -179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -116.33 138.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.813 0.845 . . . . 0.0 110.715 169.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m -89.03 134.88 33.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.219 1.008 . . . . 0.0 108.374 169.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.11 132.62 50.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.889 0.876 . . . . 0.0 110.415 172.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -81.66 124.14 29.31 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.601 0.76 . . . . 0.0 109.211 169.04 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.78 162.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.641 1.576 . . . . 0.0 111.216 -174.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -110.88 149.14 39.98 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.476 162.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.75 -30.47 46.75 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.914 2.409 . . . . 0.0 114.844 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.0 p -80.37 1.72 27.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -66.87 136.17 54.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.07 -1.019 . . . . 0.0 110.589 171.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -70.78 153.81 42.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.357 0.663 . . . . 0.0 111.502 175.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.32 -37.34 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.595 -0.691 . . . . 0.0 110.109 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.83 -41.57 91.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.769 1.627 . . . . 0.0 113.147 174.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -73.75 -32.53 63.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 176.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.73 -38.13 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 119.102 0.864 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.54 -33.37 75.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.292 -0.88 . . . . 0.0 112.173 171.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.13 87.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.238 168.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -63.38 -35.11 79.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.145 1.339 . . . . 0.0 112.378 172.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -66.43 -46.88 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.977 0.911 . . . . 0.0 111.561 172.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -56.82 -37.25 70.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.445 1.021 . . . . 0.0 111.389 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.17 -17.64 64.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -111.42 -31.99 6.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -123.69 1.79 8.84 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.581 1.152 . . . . 0.0 113.893 -168.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.13 -24.94 1.95 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -62.82 123.62 80.37 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 118.547 1.174 . . . . 0.0 111.384 177.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.87 153.46 53.12 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.515 2.144 . . . . 0.0 112.95 -175.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.95 -42.61 37.67 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.039 3.16 . . . . 0.0 115.635 -175.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.21 -10.93 60.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -94.68 -4.23 47.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.637 1.575 . . . . 0.0 112.673 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.53 130.21 45.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.993 -1.067 . . . . 0.0 110.983 -177.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -120.56 125.78 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.648 1.579 . . . . 0.0 109.084 172.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -118.79 123.38 44.65 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.062 0.945 . . . . 0.0 111.934 -166.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -120.01 132.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.154 1.382 . . . . 0.0 110.711 -176.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -145.98 134.95 22.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.482 1.513 . . . . 0.0 111.247 176.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.14 12.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -176.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.03 16.34 76.65 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.06 1.314 . . . . 0.0 114.464 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -126.77 144.07 51.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.062 2.145 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -81.63 138.91 35.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.775 0.83 . . . . 0.0 112.479 178.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.51 116.08 23.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.382 1.073 . . . . 0.0 110.531 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -92.14 143.22 26.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.938 0.895 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.04 147.82 52.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 172.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.92 10.32 60.06 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.762 1.172 . . . . 0.0 113.902 -169.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -121.23 174.77 6.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.264 2.225 . . . . 0.0 111.513 177.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -111.69 170.77 7.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.899 1.68 . . . . 0.0 112.76 169.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.5 mt -60.04 -39.72 86.89 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.288 -0.883 . . . . 0.0 112.342 169.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -63.22 -35.69 81.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 113.474 175.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -58.52 -31.23 67.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.493 1.042 . . . . 0.0 113.223 174.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.7 14.24 31.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.279 1.432 . . . . 0.0 114.12 177.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.7 34.65 22.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -83.76 137.25 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 121.045 -1.034 . . . . 0.0 109.638 175.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -140.18 -176.33 4.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.578 1.551 . . . . 0.0 113.856 -165.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.94 126.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.152 1.381 . . . . 0.0 112.496 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 56.68 39.08 29.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.355 1.862 . . . . 0.0 114.22 -177.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.5 m -76.28 148.53 37.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.635 -0.665 . . . . 0.0 112.183 169.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.5 m -99.82 140.08 34.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 169.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.23 138.28 47.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.81 2.044 . . . . 0.0 110.133 -176.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -107.97 130.56 55.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.58 0.752 . . . . 0.0 111.669 -173.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -110.31 132.28 54.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.058 1.743 . . . . 0.0 111.619 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.13 169.89 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.186 1.795 . . . . 0.0 111.006 172.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.17 127.71 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.431 -0.793 . . . . 0.0 111.319 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -88.1 129.77 35.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.442 1.097 . . . . 0.0 111.704 173.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.55 146.26 42.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.243 1.417 . . . . 0.0 111.019 176.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -150.5 156.75 42.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.57 1.148 . . . . 0.0 112.726 172.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 159.62 49.11 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.289 0.947 . . . . 0.0 113.738 175.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.519 2.009 . . . . 0.0 113.045 -176.157 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.06 139.98 37.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.132 1.373 . . . . 0.0 111.647 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.03 170.7 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.79 1.236 . . . . 0.0 112.088 171.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.2 151.26 41.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.844 1.258 . . . . 0.0 112.166 174.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.3 119.96 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.625 1.17 . . . . 0.0 109.604 174.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -100.04 140.49 34.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.658 1.583 . . . . 0.0 111.659 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.3 p -97.53 160.92 14.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.858 1.263 . . . . 0.0 112.148 168.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 mt -72.96 -6.41 45.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.755 1.222 . . . . 0.0 113.472 172.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -118.8 47.47 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.353 1.861 . . . . 0.0 110.672 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 -25.8 2.07 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 118.404 2.121 . . . . 0.0 118.404 165.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -78.39 135.22 37.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.085 1.942 . . . . 0.0 111.409 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.6 m -122.77 134.76 54.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.043 1.337 . . . . 0.0 109.55 168.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 pt -117.92 164.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.785 1.634 . . . . 0.0 111.448 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -124.47 149.77 46.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 113.088 172.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.94 154.44 50.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.699 1.6 . . . . 0.0 111.458 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -92.07 135.49 33.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.495 165.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.43 170.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.959 2.103 . . . . 0.0 112.076 -171.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.27 150.95 52.65 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.202 1.801 . . . . 0.0 111.006 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.68 -29.96 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.597 2.865 . . . . 0.0 115.971 175.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -85.42 -0.0 53.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -72.25 136.71 46.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.313 0.961 . . . . 0.0 112.198 -177.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -85.56 148.01 26.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.089 1.356 . . . . 0.0 113.298 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -62.75 -31.22 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.503 -0.748 . . . . 0.0 112.418 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.42 -40.74 79.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.328 1.051 . . . . 0.0 112.296 171.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -78.01 -34.55 50.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.71 -48.49 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.503 1.047 . . . . 0.0 110.716 169.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.2 -39.2 89.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.422 0.689 . . . . 0.0 112.616 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.67 93.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 175.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -66.84 -29.78 69.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.988 -1.07 . . . . 0.0 112.584 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -68.51 -30.09 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.839 1.256 . . . . 0.0 112.001 169.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -66.84 -44.14 81.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.529 1.513 . . . . 0.0 112.219 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.82 -38.29 90.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.764 1.166 . . . . 0.0 111.959 175.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -74.16 -43.86 55.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -119.46 -6.72 10.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -172.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.3 81.64 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 120.875 1.67 . . . . 0.0 115.598 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.3 mt -94.57 118.83 66.87 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.41 1.484 . . . . 0.0 109.463 -176.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.37 137.94 73.41 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.622 2.215 . . . . 0.0 112.932 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -55.71 -31.6 80.6 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.483 2.789 . . . . 0.0 115.609 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -73.72 -8.55 56.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -94.84 -14.64 24.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.667 1.587 . . . . 0.0 112.78 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -94.45 113.93 25.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.958 1.254 . . . . 0.0 112.744 -172.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -96.04 136.95 35.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.564 0.745 . . . . 0.0 109.705 159.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -121.71 131.62 54.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.653 0.781 . . . . 0.0 111.647 -178.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.88 138.86 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.818 2.047 . . . . 0.0 110.011 -171.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -144.66 131.58 20.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.787 0.835 . . . . 0.0 112.501 171.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.18 52.64 14.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.809 1.244 . . . . 0.0 112.714 -174.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -24.58 3.11 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.705 2.098 . . . . 0.0 116.547 175.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 152.81 21.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.314 1.557 . . . . 0.0 114.778 -175.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.17 147.89 42.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.662 1.185 . . . . 0.0 111.912 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -105.91 148.03 28.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.478 1.511 . . . . 0.0 112.114 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.1 144.7 32.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.853 2.061 . . . . 0.0 112.05 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.636 1.974 . . . . 0.0 115.35 -167.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -8.53 86.5 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.28 1.272 . . . . 0.0 116.28 -168.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -94.24 159.53 15.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.435 1.117 . . . . 0.0 111.814 -177.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.65 162.96 13.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.304 1.042 . . . . 0.0 113.334 -174.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.02 -37.65 74.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.292 -0.88 . . . . 0.0 113.206 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.2 p -65.63 -31.97 73.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.74 -13.32 59.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.015 0.926 . . . . 0.0 113.363 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -113.24 5.12 16.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 113.621 173.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 53.82 39.85 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.987 1.315 . . . . 0.0 114.333 -172.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.6 mt -77.32 138.82 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 171.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -137.64 168.76 19.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.661 1.584 . . . . 0.0 111.482 -174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -50.73 138.38 18.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.276 1.031 . . . . 0.0 113.65 177.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.38 9.5 3.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.424 2.29 . . . . 0.0 115.997 -178.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -66.5 147.36 53.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.845 -1.159 . . . . 0.0 111.828 169.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -106.19 120.81 42.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.46 1.104 . . . . 0.0 110.989 175.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.13 1.372 . . . . 0.0 108.686 168.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -106.31 131.88 53.02 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.873 -1.142 . . . . 0.0 110.066 173.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 tp -108.07 121.97 45.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.32 1.848 . . . . 0.0 109.889 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.01 131.66 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.336 1.454 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.57 130.78 35.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.824 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.22 154.62 41.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.98 113.95 27.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.481 2.312 . . . . 0.0 108.717 174.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 55.45 28.48 11.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.044 2.138 . . . . 0.0 114.903 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.25 -6.9 9.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.895 1.712 . . . . 0.0 115.259 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 126.971 2.224 . . . . 0.0 111.994 -175.439 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 111.334 0.124 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.23 141.58 29.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.65 0.78 . . . . 0.0 111.303 168.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.8 pt -127.08 153.71 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.24 1.016 . . . . 0.0 109.919 159.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.49 149.39 31.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.727 0.811 . . . . 0.0 112.074 -177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.22 120.15 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.027 0.931 . . . . 0.0 111.141 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -91.51 136.23 33.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.477 1.911 . . . . 0.0 111.666 -178.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.6 p -97.66 153.53 18.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.978 1.311 . . . . 0.0 112.272 169.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 tp -57.86 -35.89 71.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.475 1.11 . . . . 0.0 112.964 175.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -84.93 11.65 8.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.454 1.902 . . . . 0.0 115.535 176.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.18 55.86 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 160.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.53 147.5 24.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.698 1.599 . . . . 0.0 110.609 172.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -123.58 115.65 21.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.466 1.106 . . . . 0.0 109.899 172.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.78 138.6 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.155 2.182 . . . . 0.0 108.008 179.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -110.79 129.9 55.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.058 0.943 . . . . 0.0 108.911 173.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.4 mt -121.13 127.79 51.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.533 -177.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -84.78 113.59 21.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.39 0.676 . . . . 0.0 109.425 170.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.28 164.46 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.363 1.865 . . . . 0.0 111.307 -171.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.36 150.06 59.59 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.592 1.157 . . . . 0.0 110.6 167.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.43 -18.26 24.46 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.604 2.87 . . . . 0.0 117.354 -175.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 p -86.51 -5.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.086 1.754 . . . . 0.0 114.847 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -69.43 139.87 54.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.839 1.2 . . . . 0.0 111.947 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.99 154.63 35.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.322 1.049 . . . . 0.0 111.89 175.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mt -68.1 -30.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.055 -1.028 . . . . 0.0 111.178 176.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.48 -43.07 83.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.182 -0.949 . . . . 0.0 112.598 167.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -70.39 -34.96 73.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.226 -0.921 . . . . 0.0 112.512 174.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.35 -38.17 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 120.325 -1.484 . . . . 0.0 111.636 174.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.7 -36.79 79.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.144 -0.973 . . . . 0.0 112.312 168.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.02 81.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.235 0.614 . . . . 0.0 112.558 174.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -65.35 -33.02 74.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.668 1.187 . . . . 0.0 112.27 173.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.1 -50.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.319 1.047 . . . . 0.0 110.66 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -55.62 -38.96 70.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.852 0.861 . . . . 0.0 112.386 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.56 -41.76 73.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 113.759 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.69 -19.83 13.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -111.47 -13.35 13.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 11.24 85.16 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 120.138 1.335 . . . . 0.0 116.311 176.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -91.98 115.57 64.88 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 109.975 -174.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.03 145.93 97.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.114 2.542 . . . . 0.0 114.03 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -66.27 -27.71 48.0 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.319 2.679 . . . . 0.0 113.995 -170.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.86 -16.96 62.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.218 1.007 . . . . 0.0 113.205 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.69 -14.92 41.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 112.334 175.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.4 137.94 32.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.864 1.266 . . . . 0.0 112.493 -171.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -124.58 136.65 54.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.419 1.487 . . . . 0.0 109.943 157.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 136.28 53.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.56 1.144 . . . . 0.0 112.425 -175.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.66 135.45 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.142 1.777 . . . . 0.0 111.088 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -132.51 118.09 18.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.956 1.702 . . . . 0.0 110.891 169.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.87 56.95 6.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.971 1.308 . . . . 0.0 113.481 -176.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 -29.14 1.1 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.114 1.816 . . . . 0.0 116.338 -178.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -75.5 135.51 40.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.096 1.448 . . . . 0.0 111.765 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -82.02 151.46 27.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.745 0.818 . . . . 0.0 112.21 169.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.56 128.29 56.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.283 1.433 . . . . 0.0 112.375 -171.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -96.55 135.68 38.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.15 -32.3 54.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.564 2.346 . . . . 0.0 115.661 -168.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.75 -16.58 79.19 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.728 1.633 . . . . 0.0 115.804 -177.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.53 165.25 14.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.018 1.327 . . . . 0.0 111.351 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.78 163.21 12.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.319 1.048 . . . . 0.0 112.782 170.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.8 p -70.94 -30.5 66.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -62.45 -37.9 87.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.239 1.381 . . . . 0.0 111.602 172.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -85.65 6.35 27.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.34 48.97 13.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.954 1.302 . . . . 0.0 113.45 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.9 mt -101.25 124.72 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 109.754 176.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -108.01 166.18 10.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.901 1.68 . . . . 0.0 113.029 176.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -44.6 147.66 0.58 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.121 2.168 . . . . 0.0 114.602 173.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 63.56 1.77 1.1 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 0.0 116.094 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -59.63 140.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.863 0.865 . . . . 0.0 111.247 168.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -102.84 133.27 48.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.524 1.129 . . . . 0.0 109.725 169.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -114.2 164.55 13.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.086 2.154 . . . . 0.0 109.63 175.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -116.49 139.13 50.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 111.212 178.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -104.15 129.47 51.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.117 1.367 . . . . 0.0 110.402 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t -119.47 133.02 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.063 1.345 . . . . 0.0 108.814 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.94 128.91 40.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.537 0.735 . . . . 0.0 110.597 171.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -114.96 103.05 10.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.795 1.238 . . . . 0.0 111.397 179.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.14 149.25 42.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.245 1.818 . . . . 0.0 110.976 -176.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -72.27 165.34 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.613 0.765 . . . . 0.0 112.653 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 166.95 53.98 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.543 1.068 . . . . 0.0 114.22 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 125.839 1.685 . . . . 0.0 113.261 179.604 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -89.53 140.98 29.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.855 0.862 . . . . 0.0 111.066 -178.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -136.17 172.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.087 1.755 . . . . 0.0 110.037 167.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.38 146.63 47.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.967 0.907 . . . . 0.0 111.988 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.54 137.48 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.72 1.208 . . . . 0.0 108.66 173.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -97.81 129.86 44.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.762 0.825 . . . . 0.0 111.884 169.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -68.11 178.3 1.91 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.278 1.831 . . . . 0.0 112.843 -178.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.45 -18.06 63.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.927 -1.108 . . . . 0.0 113.725 172.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -98.39 5.68 47.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.865 1.266 . . . . 0.0 113.417 171.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.11 5.18 87.05 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.337 1.446 . . . . 0.0 115.689 177.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -73.63 138.84 45.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 118.757 1.279 . . . . 0.0 109.609 176.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -79.27 139.18 37.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.067 0.849 . . . . 0.0 111.207 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 pt -127.86 147.67 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.765 2.026 . . . . 0.0 110.181 165.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 m -89.21 146.54 24.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -179.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -134.11 153.91 51.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.352 1.061 . . . . 0.0 111.238 172.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -123.62 124.71 43.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.702 1.201 . . . . 0.0 111.047 175.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -145.1 161.47 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.123 1.769 . . . . 0.0 111.942 -167.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -107.24 142.69 25.62 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 110.351 172.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -56.46 -18.84 26.72 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.099 2.533 . . . . 0.0 116.581 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.78 -7.36 58.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.579 1.552 . . . . 0.0 114.868 175.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.57 143.79 48.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.363 1.065 . . . . 0.0 112.702 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -73.66 157.53 36.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.57 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.43 -21.12 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.034 -1.041 . . . . 0.0 112.111 176.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -63.26 -35.33 79.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.117 -1.614 . . . . 0.0 112.665 169.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -63.61 -34.65 78.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.918 -0.489 . . . . 0.0 111.921 173.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.27 -47.66 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.975 0.91 . . . . 0.0 109.97 174.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -40.13 95.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.825 0.85 . . . . 0.0 112.749 178.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.31 82.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.455 0.702 . . . . 0.0 112.888 174.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -71.59 -29.22 64.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.648 -1.283 . . . . 0.0 113.362 174.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.43 1.092 . . . . 0.0 111.087 169.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -55.2 -39.58 69.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.241 1.016 . . . . 0.0 112.54 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.62 -10.5 46.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.27 -14.5 5.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 176.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -119.74 -11.65 9.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 5.17 75.7 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.998 1.559 . . . . 0.0 116.998 172.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.8 124.66 63.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 125.138 1.375 . . . . 0.0 109.477 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.48 150.36 63.71 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.294 -177.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -54.84 -35.32 88.34 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.205 2.603 . . . . 0.0 116.05 -170.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -63.68 -25.68 68.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.288 1.404 . . . . 0.0 114.205 178.357 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.17 -16.0 48.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.749 0.82 . . . . 0.0 112.933 174.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -91.31 122.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.138 0.881 . . . . 0.0 111.681 -177.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -119.21 139.61 51.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.138 0.575 . . . . 0.0 109.904 159.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.71 121.0 39.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.661 1.184 . . . . 0.0 110.854 -168.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.17 134.83 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.12 1.368 . . . . 0.0 110.391 -177.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -143.25 128.54 18.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.964 1.706 . . . . 0.0 110.599 178.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 41.49 7.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 173.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.1 12.51 79.17 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -128.35 143.73 51.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.266 1.826 . . . . 0.0 111.298 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.24 119.96 27.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.966 0.506 . . . . 0.0 110.385 165.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.72 127.85 34.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.15 0.98 . . . . 0.0 110.741 178.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -76.34 165.26 25.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.596 1.159 . . . . 0.0 112.668 177.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.65 -36.76 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.324 -0.86 . . . . 0.0 112.71 -176.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.4 22.52 8.58 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.275 1.417 . . . . 0.0 116.189 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -133.45 167.79 19.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.028 1.731 . . . . 0.0 111.638 -172.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -106.94 165.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 178.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.06 -39.18 71.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 113.057 175.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.1 p -78.14 -18.92 54.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 174.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -66.86 -30.11 70.19 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.623 1.556 . . . . 0.0 112.143 166.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -93.05 -2.32 55.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.33 1.452 . . . . 0.0 114.779 169.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 48.82 46.51 21.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.558 1.543 . . . . 0.0 114.06 -175.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.73 114.12 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.073 . . . . 0.0 108.9 178.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -80.44 163.64 23.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.616 1.566 . . . . 0.0 112.123 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -58.07 143.19 44.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.204 1.002 . . . . 0.0 112.68 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 58.1 23.29 9.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.929 2.092 . . . . 0.0 114.702 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -71.84 155.98 39.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 111.712 165.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -112.9 123.92 51.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 111.914 -178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.33 154.48 18.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.904 2.082 . . . . 0.0 109.798 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -121.62 129.43 52.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.096 178.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -85.91 136.05 33.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.692 1.197 . . . . 0.0 111.225 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 142.15 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.426 1.491 . . . . 0.0 111.358 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -113.84 136.81 52.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.14 2.176 . . . . 0.0 110.797 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -70.05 106.31 3.19 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 109.826 168.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.0 89.57 5.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.239 1.415 . . . . 0.0 110.442 -174.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -63.53 150.01 44.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.994 1.318 . . . . 0.0 112.754 -173.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.33 172.02 38.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.157 0.884 . . . . 0.0 114.071 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 126.518 2.009 . . . . 0.0 113.174 179.023 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.82 144.55 42.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.94 164.97 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 110.517 170.145 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.18 134.77 55.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.405 0.682 . . . . 0.0 111.855 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.13 125.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 155.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -127.29 133.34 50.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.237 1.015 . . . . 0.0 110.714 -174.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -90.06 151.51 21.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.433 0.693 . . . . 0.0 111.592 178.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.6 -8.35 46.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.681 0.792 . . . . 0.0 113.045 169.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.2 p -87.35 -3.91 59.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.209 1.804 . . . . 0.0 114.069 167.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.65 37.57 7.97 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 116.007 1.163 . . . . 0.0 116.007 172.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -116.54 143.97 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.605 1.962 . . . . 0.0 110.732 171.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -124.93 140.57 52.8 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.733 1.213 . . . . 0.0 112.955 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.42 115.18 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.074 2.149 . . . . 0.0 108.399 171.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -86.67 126.75 34.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.861 1.264 . . . . 0.0 110.604 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -125.1 131.2 53.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.303 1.041 . . . . 0.0 110.547 -176.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -97.76 125.6 42.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.16 0.984 . . . . 0.0 109.727 178.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.54 170.18 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.35 1.86 . . . . 0.0 111.455 -164.347 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -129.74 156.44 78.86 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.365 1.466 . . . . 0.0 109.181 168.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.62 -29.06 88.11 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.284 1.989 . . . . 0.0 116.597 -176.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -88.72 14.37 10.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 172.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -86.9 153.47 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.698 -1.251 . . . . 0.0 111.312 169.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -108.86 158.29 17.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -167.049 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.63 -32.6 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.892 0.877 . . . . 0.0 112.16 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.38 -41.79 94.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.62 1.1 . . . . 0.0 111.947 171.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.41 -38.51 77.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.222 0.464 . . . . 0.0 111.776 174.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -55.96 -47.63 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.057 -1.027 . . . . 0.0 111.177 172.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -66.12 -36.82 84.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.755 0.822 . . . . 0.0 112.984 176.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.08 -33.37 73.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 113.16 174.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -68.56 -36.13 78.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.182 1.393 . . . . 0.0 111.22 171.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.4 -33.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.778 0.831 . . . . 0.0 111.93 171.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.29 -41.17 81.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.461 1.482 . . . . 0.0 111.873 173.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.02 -36.94 68.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 172.109 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.83 -67.44 0.67 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 171.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -111.32 0.57 16.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -160.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 14.71 77.46 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 168.525 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.24 126.67 78.63 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 119.092 1.446 . . . . 0.0 109.474 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.77 130.65 41.58 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.124 2.55 . . . . 0.0 112.02 176.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.27 -27.97 85.93 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.231 1.954 . . . . 0.0 115.234 -174.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.25 -16.12 63.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -90.55 -16.49 28.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.218 1.807 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.97 105.46 15.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.559 -1.338 . . . . 0.0 111.241 -175.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -107.13 130.78 54.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.321 1.048 . . . . 0.0 110.551 170.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -130.77 143.71 50.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.476 1.511 . . . . 0.0 112.017 -175.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.2 138.78 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 110.63 -178.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -145.83 144.22 30.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.074 1.35 . . . . 0.0 110.827 165.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.52 43.97 12.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.557 1.543 . . . . 0.0 113.924 -177.513 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 7.67 58.95 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.534 1.54 . . . . 0.0 116.285 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -114.15 139.13 49.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.22 1.808 . . . . 0.0 110.93 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -79.68 122.86 27.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 110.04 172.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -80.36 142.17 34.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.73 0.812 . . . . 0.0 112.271 -171.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -113.93 141.57 47.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.564 1.546 . . . . 0.0 113.077 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -58.34 -41.1 83.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.227 1.811 . . . . 0.0 114.841 -164.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.99 -12.55 84.29 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 -174.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -87.79 152.56 22.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.534 1.667 . . . . 0.0 112.36 -172.832 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -85.99 157.79 20.03 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.952 0.501 . . . . 0.0 112.138 175.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.22 -40.29 67.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.142 0.577 . . . . 0.0 111.94 170.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.8 p -66.29 -27.13 67.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -70.99 -30.16 66.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.799 1.181 . . . . 0.0 111.903 176.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -87.85 2.88 50.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.069 1.348 . . . . 0.0 113.52 169.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 53.26 37.17 24.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.997 1.719 . . . . 0.0 114.151 -173.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.32 108.54 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 120.895 -1.128 . . . . 0.0 109.311 -177.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -91.69 169.53 10.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.622 1.569 . . . . 0.0 111.983 176.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -55.73 146.55 20.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 56.49 22.74 6.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.848 2.059 . . . . 0.0 115.085 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.4 m -55.75 142.35 34.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.221 1.008 . . . . 0.0 111.069 163.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -109.78 109.15 19.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.246 1.418 . . . . 0.0 110.101 -178.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.6 137.23 32.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.412 1.485 . . . . 0.0 109.587 -179.084 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -114.29 164.0 14.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.164 1.385 . . . . 0.0 112.584 -173.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.72 143.82 31.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.793 1.237 . . . . 0.0 112.083 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.23 119.37 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.191 1.397 . . . . 0.0 108.931 176.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.63 -38.95 77.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -65.14 -44.74 87.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.552 1.069 . . . . 0.0 112.021 -179.857 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -61.12 -25.38 66.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -67.13 -31.68 72.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.049 1.295 . . . . 0.0 112.715 174.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.72 -20.2 44.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.6 -1.111 . . . . 0.0 115.787 177.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-N 118.914 1.357 . . . . 0.0 114.519 -173.031 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 119.368 -0.349 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.54 142.52 29.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.139 0.976 . . . . 0.0 110.984 167.519 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.02 168.66 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.017 157.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -116.04 151.86 34.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 175.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.94 115.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.742 1.217 . . . . 0.0 109.794 171.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -84.41 137.91 33.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.256 1.022 . . . . 0.0 111.169 174.621 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -110.07 153.74 24.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.286 1.034 . . . . 0.0 111.994 174.328 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.14 -4.84 43.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.009 0.924 . . . . 0.0 112.469 166.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -83.79 -0.79 52.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.223 1.409 . . . . 0.0 113.587 165.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.24 38.34 10.15 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.41 -1.217 . . . . 0.0 115.994 170.171 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -130.56 162.46 29.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.519 1.659 . . . . 0.0 112.726 165.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.0 m -121.08 99.22 6.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.538 1.535 . . . . 0.0 109.177 174.384 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.09 126.2 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.372 1.869 . . . . 0.0 109.294 -175.223 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -77.8 140.71 39.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.723 1.147 . . . . 0.0 110.613 166.211 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -130.52 144.28 51.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.281 1.032 . . . . 0.0 110.734 169.661 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -104.17 108.65 20.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.261 1.024 . . . . 0.0 110.964 175.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.16 -177.36 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 127.15 2.18 . . . . 0.0 112.107 -168.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -124.96 154.74 71.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.076 1.35 . . . . 0.0 111.572 168.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.71 -29.6 34.15 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.24 3.293 . . . . 0.0 115.617 175.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 6.42 47.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.398 1.479 . . . . 0.0 114.968 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -71.4 158.42 36.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.764 1.165 . . . . 0.0 112.494 -178.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.4 p -97.51 149.9 21.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.7 1.2 . . . . 0.0 112.866 -171.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.03 -40.7 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.611 -0.681 . . . . 0.0 111.639 -173.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.62 64.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.572 1.078 . . . . 0.0 113.464 176.384 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.83 -27.6 62.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.735 -1.228 . . . . 0.0 112.876 171.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.99 -39.95 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.048 -1.033 . . . . 0.0 111.025 169.015 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -56.8 -38.46 72.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.388 0.995 . . . . 0.0 111.942 167.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -35.88 78.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.971 0.908 . . . . 0.0 113.168 176.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -65.23 -35.3 80.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.834 -1.166 . . . . 0.0 112.804 171.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.61 -37.76 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.919 0.888 . . . . 0.0 110.594 171.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.98 -40.48 96.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.113 -0.992 . . . . 0.0 112.636 174.406 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.17 -44.68 75.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 176.117 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -79.9 -38.68 32.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -175.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -120.5 -8.4 9.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.488 1.515 . . . . 0.0 114.35 -172.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.16 4.67 89.64 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.999 1.272 . . . . 0.0 116.025 176.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -82.65 120.64 76.96 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 118.963 1.382 . . . . 0.0 110.9 -169.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.57 147.15 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.16 2.573 . . . . 0.0 113.996 -176.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.42 -29.8 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.47 2.78 . . . . 0.0 115.977 -161.676 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -69.01 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.436 1.017 . . . . 0.0 112.809 178.41 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -100.95 -1.93 33.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.028 1.731 . . . . 0.0 112.699 -176.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.59 140.67 29.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.475 1.51 . . . . 0.0 111.402 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -128.08 119.49 25.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.086 1.354 . . . . 0.0 109.49 163.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.66 140.56 33.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.997 0.919 . . . . 0.0 111.838 -178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.32 138.21 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.167 1.787 . . . . 0.0 110.233 -177.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -138.12 139.28 39.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.697 1.599 . . . . 0.0 111.113 167.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.07 43.59 14.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.583 1.553 . . . . 0.0 113.623 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.1 -5.96 38.35 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -179.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -108.02 141.19 40.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.957 1.879 . . . . 0.0 111.862 179.65 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.72 144.82 36.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.68 0.792 . . . . 0.0 111.186 175.149 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.89 132.37 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.655 1.582 . . . . 0.0 110.812 -172.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.3 136.3 36.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 112.246 -176.102 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -51.68 -39.15 57.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.764 1.626 . . . . 0.0 114.876 -171.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.7 2.45 59.0 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.795 1.664 . . . . 0.0 116.819 -176.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -112.25 174.08 6.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.468 1.907 . . . . 0.0 113.112 -173.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 p -110.01 158.93 17.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.931 1.693 . . . . 0.0 113.164 -179.299 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.19 -38.18 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.218 1.007 . . . . 0.0 111.886 170.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 p -62.83 -25.71 68.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.774 1.63 . . . . 0.0 114.902 173.717 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.2 -15.49 61.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.053 1.297 . . . . 0.0 112.54 174.345 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.87 4.23 13.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.271 1.829 . . . . 0.0 114.822 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 58.09 37.01 26.42 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.54 120.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.169 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.82 177.42 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.864 1.666 . . . . 0.0 112.265 -173.53 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -52.2 145.21 11.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.351 1.06 . . . . 0.0 112.838 174.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 61.08 14.18 5.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.899 1.68 . . . . 0.0 115.297 179.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -73.16 156.54 38.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.627 1.171 . . . . 0.0 112.084 175.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -115.56 121.8 43.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.527 1.531 . . . . 0.0 111.192 175.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 mt -91.57 161.96 14.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.337 1.455 . . . . 0.0 109.901 166.062 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -115.13 144.47 43.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 109.966 164.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -115.41 120.14 38.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.609 1.564 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.7 138.45 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.567 1.547 . . . . 0.0 108.883 171.037 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt -94.65 142.37 27.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.414 0.685 . . . . 0.0 112.086 176.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -133.59 108.42 8.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.085 1.354 . . . . 0.0 111.984 176.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.48 151.04 22.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.069 177.156 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -60.53 133.8 56.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 110.248 172.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -178.07 54.08 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.267 1.413 . . . . 0.0 114.673 -176.092 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 C-N-CA 126.265 1.888 . . . . 0.0 113.56 -178.273 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.73 137.47 35.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.503 0.721 . . . . 0.0 112.468 -169.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.87 167.21 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.868 1.667 . . . . 0.0 111.127 173.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.31 146.61 43.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.35 1.06 . . . . 0.0 110.814 177.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.88 124.15 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.522 0.729 . . . . 0.0 109.569 172.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -108.88 137.24 47.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 111.941 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -80.65 149.59 29.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.983 0.81 . . . . 0.0 110.345 163.031 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -68.81 -17.58 64.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.395 -0.815 . . . . 0.0 111.885 171.82 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -75.45 -10.97 59.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.848 1.659 . . . . 0.0 114.43 170.128 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.33 22.63 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 167.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.44 160.84 22.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.883 1.842 . . . . 0.0 112.093 177.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -127.02 151.99 47.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.006 1.722 . . . . 0.0 111.163 168.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -137.99 155.69 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 127.047 2.139 . . . . 0.0 110.665 160.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -113.79 135.7 53.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 109.514 177.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 tt -138.99 138.92 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.234 0.924 . . . . 0.0 111.304 -164.752 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -109.81 128.33 55.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.391 1.477 . . . . 0.0 111.614 -175.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.41 165.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.587 1.555 . . . . 0.0 112.806 -172.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.12 161.13 33.98 Favored Pre-proline 0 N--CA 1.448 -0.531 0 O-C-N 121.019 -1.051 . . . . 0.0 109.37 149.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -55.15 -17.3 14.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.677 2.252 . . . . 0.0 114.275 164.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m -86.13 -7.54 58.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.986 2.114 . . . . 0.0 115.093 177.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.97 132.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 120.729 1.604 . . . . 0.0 110.678 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -74.58 156.93 36.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 122.046 -0.409 . . . . 0.0 111.584 170.302 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.09 -35.6 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.55 -0.719 . . . . 0.0 111.159 170.12 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.24 -46.6 79.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.488 1.04 . . . . 0.0 112.511 169.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.04 -37.33 81.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.66 -44.41 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 118.936 0.789 . . . . 0.0 110.941 173.545 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -63.14 -32.91 74.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 112.49 174.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.28 82.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.512 -0.743 . . . . 0.0 112.657 173.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -65.61 -35.35 80.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.706 0.802 . . . . 0.0 112.246 171.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.76 -37.18 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.813 0.845 . . . . 0.0 111.058 172.241 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.35 -42.68 98.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.368 1.44 . . . . 0.0 111.594 171.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.33 -47.73 84.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.656 1.116 . . . . 0.0 112.785 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -67.64 -54.04 22.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.296 1.039 . . . . 0.0 113.307 178.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -110.15 -11.59 14.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -160.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 11.0 84.49 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 179.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -84.86 120.81 74.18 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 119.049 1.424 . . . . 0.0 108.596 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.4 137.23 54.6 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.041 1.827 . . . . 0.0 112.087 179.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.23 -25.74 72.22 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.553 2.835 . . . . 0.0 115.388 -169.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.09 -20.25 65.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.829 1.195 . . . . 0.0 112.801 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -97.81 -7.78 29.8 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.182 2.193 . . . . 0.0 113.088 178.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -91.44 150.42 21.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.097 1.359 . . . . 0.0 111.584 175.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -136.37 140.87 43.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.652 1.581 . . . . 0.0 110.813 161.03 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.8 mt -112.77 139.37 48.44 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.404 1.082 . . . . 0.0 112.336 177.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.55 137.75 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.739 2.015 . . . . 0.0 109.49 -177.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.96 137.65 23.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.046 0.938 . . . . 0.0 111.807 171.759 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.51 51.98 11.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.241 1.416 . . . . 0.0 113.712 -178.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.65 2.36 80.48 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.41 1.957 . . . . 0.0 116.682 175.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -133.05 144.72 50.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.596 1.698 . . . . 0.0 111.661 -167.406 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.83 142.22 27.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.625 0.77 . . . . 0.0 111.455 -177.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.2 156.63 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.215 1.406 . . . . 0.0 112.681 -169.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.38 137.66 54.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.792 1.237 . . . . 0.0 113.7 -171.572 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.91 -33.39 56.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 115.298 -170.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 -13.02 83.68 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.18 . . . . 0.0 115.494 -176.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -95.4 163.17 13.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.493 1.517 . . . . 0.0 112.403 -174.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -104.55 161.49 14.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.391 1.477 . . . . 0.0 113.338 175.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -57.64 -29.3 64.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 173.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.0 m -69.14 -29.65 67.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 171.008 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.87 -31.15 71.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.552 1.524 . . . . 0.0 112.187 175.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -101.13 -1.26 34.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.081 1.353 . . . . 0.0 114.223 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.77 54.06 11.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 0.0 114.121 -174.312 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.16 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 160.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -126.06 173.52 9.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.222 1.809 . . . . 0.0 111.067 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.55 137.38 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 112.401 174.088 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 63.54 19.18 11.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.038 1.735 . . . . 0.0 115.319 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 m -69.05 142.03 54.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.178 -0.951 . . . . 0.0 111.328 167.289 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -106.22 119.93 40.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.953 0.901 . . . . 0.0 111.127 170.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.0 154.5 17.27 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.588 172.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -110.13 135.04 51.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 110.073 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -112.27 125.94 54.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.886 1.674 . . . . 0.0 110.204 -176.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.89 145.05 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.446 1.898 . . . . 0.0 109.759 174.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.6 148.54 33.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.791 1.236 . . . . 0.0 113.779 172.69 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -134.69 145.5 48.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.435 1.494 . . . . 0.0 111.583 -166.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.69 -40.44 5.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -169.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -77.98 37.06 0.24 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 -171.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.01 48.22 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.969 1.271 . . . . 0.0 114.264 178.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.691 1.615 . . . . 0.0 114.851 176.953 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -81.84 140.81 33.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.487 0.715 . . . . 0.0 111.014 171.295 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -127.97 166.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.303 . . . . 0.0 110.28 159.568 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -115.86 143.09 45.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.135 1.374 . . . . 0.0 110.981 175.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.92 125.76 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 170.511 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -80.05 128.85 33.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.202 1.401 . . . . 0.0 109.757 173.03 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -100.63 170.66 8.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.016 1.326 . . . . 0.0 113.388 -168.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.9 -22.83 64.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.039 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -91.96 1.51 57.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.309 1.844 . . . . 0.0 113.651 174.624 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.8 11.34 84.66 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.837 1.685 . . . . 0.0 114.384 -177.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.05 169.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.133 1.373 . . . . 0.0 110.568 169.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.8 m -123.85 127.24 47.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.939 0.896 . . . . 0.0 111.319 176.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -101.32 142.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.151 1.381 . . . . 0.0 111.183 170.634 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -92.39 142.35 27.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.729 0.812 . . . . 0.0 109.999 169.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.74 140.61 47.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.273 1.029 . . . . 0.0 110.187 172.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -99.76 111.96 24.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.258 1.023 . . . . 0.0 109.574 177.171 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.56 173.06 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.438 1.895 . . . . 0.0 111.996 -169.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -125.77 144.77 49.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.477 1.511 . . . . 0.0 110.475 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.47 -19.14 21.77 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.272 2.648 . . . . 0.0 115.871 176.279 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.0 p -87.43 -4.97 59.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.419 2.288 . . . . 0.0 115.51 175.13 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -72.13 140.39 48.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.168 1.349 . . . . 0.0 111.464 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -88.03 164.37 15.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.006 0.522 . . . . 0.0 111.447 165.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mm -59.06 -32.44 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.854 0.861 . . . . 0.0 112.457 -172.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.94 -38.76 68.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.368 1.467 . . . . 0.0 112.867 174.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -66.92 -32.06 73.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.68 -41.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 123.847 0.859 . . . . 0.0 110.401 177.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.76 -35.15 72.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.568 0.747 . . . . 0.0 112.436 175.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.434 0.693 . . . . 0.0 112.685 173.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.12 -29.94 63.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.987 -1.071 . . . . 0.0 112.12 178.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.68 -33.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.523 -0.736 . . . . 0.0 111.554 171.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.06 -41.15 97.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.083 1.31 . . . . 0.0 111.961 172.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.2 -44.65 96.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 112.142 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -82.26 -42.3 19.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -177.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -110.29 -11.61 14.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -170.431 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 34.33 56.58 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.448 1.022 . . . . 0.0 115.105 176.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.09 117.97 42.94 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.359 1.464 . . . . 0.0 108.318 -179.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.4 Cg_exo -57.63 135.71 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.037 2.492 . . . . 0.0 113.001 176.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 28.4 Cg_exo -55.56 -28.26 64.1 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.872 3.048 . . . . 0.0 117.165 -173.221 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -69.88 -15.91 63.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.849 1.204 . . . . 0.0 114.05 174.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -93.24 -6.59 47.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.868 1.667 . . . . 0.0 113.607 177.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.06 135.36 35.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.884 0.874 . . . . 0.0 112.781 -173.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.72 127.13 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.612 1.165 . . . . 0.0 110.234 165.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.4 129.57 55.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.625 1.17 . . . . 0.0 111.512 178.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.07 139.09 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.186 1.394 . . . . 0.0 109.494 -176.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -129.48 122.52 29.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.688 1.595 . . . . 0.0 109.328 175.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 39.48 10.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.753 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.5 -9.24 59.25 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.281 1.672 . . . . 0.0 117.281 -178.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -104.03 143.39 32.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.874 2.337 . . . . 0.0 112.775 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.83 143.15 34.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.503 -0.748 . . . . 0.0 112.391 -176.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.7 mt -90.49 101.94 14.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.85 1.26 . . . . 0.0 109.558 173.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -83.92 134.49 34.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.165 0.986 . . . . 0.0 111.766 178.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.19 153.05 15.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.476 . . . . 0.0 114.578 -173.144 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.13 -21.87 11.19 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.567 1.556 . . . . 0.0 115.631 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -83.13 153.11 24.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.369 1.584 . . . . 0.0 110.848 164.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -86.15 162.25 18.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.27 -39.52 72.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.087 -1.008 . . . . 0.0 112.503 174.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 p -66.37 -29.04 69.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.261 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.55 -14.36 62.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.729 1.149 . . . . 0.0 113.415 172.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -107.67 12.82 27.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.056 1.742 . . . . 0.0 113.749 171.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.52 31.74 20.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.114 1.366 . . . . 0.0 114.339 178.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.31 113.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.28 1.032 . . . . 0.0 108.492 179.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -87.9 169.37 12.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.559 1.144 . . . . 0.0 112.614 178.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -41.71 128.18 3.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.204 1.802 . . . . 0.0 111.442 161.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 62.91 28.07 16.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.373 1.869 . . . . 0.0 115.867 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -65.81 150.86 47.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.128 -0.983 . . . . 0.0 112.953 168.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -113.17 124.87 53.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.643 1.177 . . . . 0.0 111.427 172.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -107.42 159.67 16.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.949 2.1 . . . . 0.0 111.039 177.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.9 136.32 53.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.966 1.306 . . . . 0.0 111.083 177.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -100.66 142.4 32.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 111.816 178.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.59 143.02 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.722 1.609 . . . . 0.0 109.77 171.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 tp -94.47 143.77 26.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.586 1.554 . . . . 0.0 111.135 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -73.87 63.2 0.89 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 113.019 170.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.86 119.53 10.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 161.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -85.28 132.26 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.713 1.205 . . . . 0.0 112.338 -170.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 151.17 2.36 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 122.676 1.153 . . . . 0.0 114.467 174.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.934 1.73 . . . . 0.0 111.68 -178.847 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -108.03 136.67 47.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.614 0.766 . . . . 0.0 112.568 -177.82 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -130.31 175.6 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.166 1.386 . . . . 0.0 111.899 -178.151 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -117.11 149.24 40.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.624 1.17 . . . . 0.0 112.388 171.165 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.7 134.08 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.303 1.441 . . . . 0.0 109.968 171.121 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -119.3 125.92 50.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.391 1.876 . . . . 0.0 111.611 -178.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -105.96 164.17 12.17 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.317 179.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.81 -25.81 61.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.715 2.006 . . . . 0.0 114.362 -172.66 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -71.89 -4.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.911 1.684 . . . . 0.0 114.061 175.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.5 -1.86 86.71 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.007 1.289 . . . . 0.0 114.403 -173.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.49 139.65 53.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.414 1.607 . . . . 0.0 110.891 175.134 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.5 m -115.56 135.42 54.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.053 1.741 . . . . 0.0 110.018 176.809 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 mm -121.39 137.97 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.352 2.261 . . . . 0.0 108.992 -172.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -97.22 130.22 44.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 173.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tp -130.26 147.88 52.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.246 1.019 . . . . 0.0 112.045 -176.736 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -116.74 120.41 38.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 110.384 178.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.95 167.78 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.815 2.046 . . . . 0.0 111.6 -168.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.12 156.54 57.03 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 124.339 1.055 . . . . 0.0 111.933 169.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.33 -23.62 55.74 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.572 2.848 . . . . 0.0 116.269 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.2 p -84.11 -5.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.795 1.638 . . . . 0.0 114.967 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.49 143.63 57.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.409 1.459 . . . . 0.0 111.159 -178.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -97.35 160.69 14.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.952 176.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.02 -34.29 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.285 -0.884 . . . . 0.0 112.094 -175.664 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.58 -28.4 69.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.28 0.945 . . . . 0.0 113.069 175.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -77.21 -37.52 53.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.661 -0.649 . . . . 0.0 112.721 173.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.55 -42.21 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.65 0.659 . . . . 0.0 111.078 173.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.18 -44.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.273 0.629 . . . . 0.0 112.131 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.98 92.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -63.1 -38.2 90.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 111.932 175.524 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.4 -40.12 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.2 174.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -59.54 -42.84 93.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.155 0.889 . . . . 0.0 111.721 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.65 -42.37 92.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -87.08 -33.89 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -125.19 -11.11 7.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.72 81.39 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 171.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.0 mt -78.66 119.97 79.26 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.019 1.41 . . . . 0.0 109.014 -177.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.45 137.75 47.93 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.127 1.885 . . . . 0.0 113.096 -172.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.32 -29.32 72.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.674 2.916 . . . . 0.0 114.201 -170.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.39 -13.53 59.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.152 1.381 . . . . 0.0 114.207 173.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -99.7 -10.4 21.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.136 1.374 . . . . 0.0 112.882 175.516 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -79.37 144.41 34.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.781 1.232 . . . . 0.0 112.586 174.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -127.28 136.25 51.71 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.061 1.744 . . . . 0.0 108.955 155.742 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.55 129.96 54.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.841 1.256 . . . . 0.0 110.867 -174.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -127.79 129.93 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.849 1.66 . . . . 0.0 110.51 -171.063 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -128.76 128.56 44.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.803 1.241 . . . . 0.0 110.966 174.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.15 44.22 19.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.326 1.05 . . . . 0.0 113.241 -175.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 -0.12 27.96 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.041 1.781 . . . . 0.0 117.476 -177.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -97.09 134.49 40.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.321 1.561 . . . . 0.0 110.528 178.078 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -80.68 142.24 34.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.715 1.143 . . . . 0.0 112.093 171.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.58 132.2 47.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.881 0.873 . . . . 0.0 113.288 -168.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -111.2 135.36 51.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.434 1.893 . . . . 0.0 112.451 -174.206 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.08 14.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.979 2.112 . . . . 0.0 115.603 -168.004 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.66 -4.24 65.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.739 1.162 . . . . 0.0 114.543 168.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -135.61 160.99 36.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.506 1.522 . . . . 0.0 111.931 -177.007 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.036 1.735 . . . . 0.0 113.47 -171.236 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.09 -40.39 67.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.38 1.072 . . . . 0.0 113.712 -179.104 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.9 p -62.14 -34.43 76.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 172.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -67.33 -17.72 64.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.154 0.888 . . . . 0.0 112.382 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -106.33 6.25 30.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.344 1.858 . . . . 0.0 113.333 176.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 55.48 33.19 20.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.58 1.552 . . . . 0.0 114.064 -175.573 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.29 127.69 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.765 -1.209 . . . . 0.0 108.411 173.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -143.2 167.03 23.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 110.908 -173.521 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -42.14 140.5 1.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.227 1.811 . . . . 0.0 114.681 178.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 61.72 1.73 0.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 178.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -71.16 156.14 39.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.95 1.3 . . . . 0.0 112.308 173.47 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -113.82 129.6 56.57 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.183 1.393 . . . . 0.0 112.527 -178.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.4 tp -104.62 141.4 36.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.632 2.373 . . . . 0.0 109.561 175.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.55 123.38 47.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 110.942 177.749 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.3 tt -98.6 137.6 37.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.662 1.585 . . . . 0.0 110.593 178.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -130.4 139.79 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.697 1.599 . . . . 0.0 109.557 179.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.77 141.81 28.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.216 1.006 . . . . 0.0 111.449 175.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -79.64 107.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 111.587 167.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.54 -28.99 70.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.775 1.23 . . . . 0.0 113.778 178.201 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -120.71 9.45 10.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 114.361 -177.833 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 147.53 49.75 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.878 164.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.678 -1.624 . . . . 0.0 112.829 -173.577 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -94.63 139.49 31.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.621 0.769 . . . . 0.0 111.94 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.54 162.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 161.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -101.87 149.52 24.11 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.875 0.87 . . . . 0.0 110.748 167.198 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -130.72 125.31 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.212 1.405 . . . . 0.0 108.867 171.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.92 115.0 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 176.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -82.98 165.41 19.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.618 1.967 . . . . 0.0 112.579 -177.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.33 -12.09 61.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 -173.136 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -76.06 -9.31 58.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.132 1.333 . . . . 0.0 113.362 166.601 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.7 -14.94 64.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.744 1.64 . . . . 0.0 113.874 -168.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.91 129.21 39.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.204 1.502 . . . . 0.0 111.306 -177.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -96.87 127.64 43.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.685 1.194 . . . . 0.0 110.195 174.193 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.47 156.92 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.872 1.669 . . . . 0.0 111.698 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.1 p -94.87 146.02 24.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.831 1.252 . . . . 0.0 112.169 176.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.43 138.58 36.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.62 1.168 . . . . 0.0 111.26 171.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -88.97 122.61 32.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 111.766 175.373 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.6 157.48 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.655 1.582 . . . . 0.0 113.079 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.06 141.48 23.91 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 126.349 1.86 . . . . 0.0 108.886 167.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.31 -13.92 22.34 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.06 2.507 . . . . 0.0 116.699 -178.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 p -90.36 -2.5 57.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.87 1.668 . . . . 0.0 114.897 173.294 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -67.37 139.61 57.18 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.873 1.215 . . . . 0.0 110.993 175.824 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.3 p -81.29 159.62 24.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.498 0.719 . . . . 0.0 112.191 177.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -62.45 -33.69 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 118.797 -0.62 . . . . 0.0 111.3 172.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.14 -35.48 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.222 1.374 . . . . 0.0 113.727 174.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.68 -44.61 73.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.078 0.854 . . . . 0.0 111.816 172.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.43 -42.91 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.079 -1.013 . . . . 0.0 111.409 175.892 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.4 -40.04 89.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.012 0.925 . . . . 0.0 112.563 174.029 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.06 92.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.78 -34.81 77.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.582 0.753 . . . . 0.0 112.659 174.448 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -66.4 -45.09 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 118.902 0.774 . . . . 0.0 110.712 171.605 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -55.96 -39.16 71.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.124 -0.985 . . . . 0.0 112.288 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -58.08 -21.12 44.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 114.688 -179.234 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -128.34 -14.15 4.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -113.9 -13.92 12.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.953 1.701 . . . . 0.0 115.354 177.733 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 -1.81 83.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 171.035 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.81 125.92 53.58 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.435 1.617 . . . . 0.0 110.293 -178.542 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.2 150.24 85.53 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.497 2.798 . . . . 0.0 114.901 177.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.0 -39.74 59.47 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.037 3.158 . . . . 0.0 116.324 -178.483 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.38 -19.64 61.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.112 -0.992 . . . . 0.0 113.561 178.25 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.15 -7.83 50.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.606 1.562 . . . . 0.0 113.246 174.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.15 119.47 30.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.071 0.948 . . . . 0.0 110.876 173.629 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -103.29 111.69 24.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.881 0.872 . . . . 0.0 108.864 163.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.16 131.36 42.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.786 0.835 . . . . 0.0 111.447 -175.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -119.53 130.91 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 126.134 1.774 . . . . 0.0 110.307 -175.263 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -140.0 138.95 35.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.375 1.47 . . . . 0.0 109.413 170.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.48 41.39 16.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.92 -4.12 47.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.027 1.775 . . . . 0.0 116.739 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -116.73 150.93 37.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.3 1.84 . . . . 0.0 112.686 -174.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -86.77 143.98 27.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 111.67 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.3 mt -95.59 152.25 18.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -105.16 146.82 28.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.027 1.731 . . . . 0.0 112.613 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.36 -36.19 83.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.366 1.066 . . . . 0.0 113.6 -173.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.85 2.07 65.71 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 116.556 1.382 . . . . 0.0 116.556 -178.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -102.61 167.55 9.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.278 1.539 . . . . 0.0 113.848 -173.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -114.86 159.63 20.43 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.669 1.588 . . . . 0.0 112.705 173.56 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.05 -37.96 75.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -176.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p -64.38 -32.61 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.223 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -63.66 -27.71 69.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.393 0.997 . . . . 0.0 111.886 177.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -96.01 1.26 52.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 114.448 175.674 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 51.47 50.3 19.14 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.725 1.148 . . . . 0.0 112.586 -172.366 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.42 123.55 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.438 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.47 173.3 10.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.526 1.53 . . . . 0.0 112.48 -168.429 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -53.76 134.84 42.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.4 17.26 9.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.228 2.211 . . . . 0.0 116.371 -177.786 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 m -73.83 147.66 43.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.87 -1.144 . . . . 0.0 112.557 167.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.8 m -102.61 121.87 43.26 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.837 1.255 . . . . 0.0 113.0 178.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -93.27 147.82 22.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.823 2.449 . . . . 0.0 110.13 172.071 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -121.91 155.16 36.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.925 1.29 . . . . 0.0 111.932 175.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.3 tp -117.91 135.57 54.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.463 1.505 . . . . 0.0 110.147 174.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.79 164.66 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.555 1.542 . . . . 0.0 110.068 163.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -110.52 -179.45 3.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.161 1.785 . . . . 0.0 110.747 -173.094 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -73.25 104.1 4.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.374 -0.829 . . . . 0.0 108.939 157.332 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -117.2 74.67 0.93 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.514 1.526 . . . . 0.0 110.722 -172.122 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -70.31 152.89 43.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.348 1.459 . . . . 0.0 112.508 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.45 143.08 5.28 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.014 1.293 . . . . 0.0 112.573 173.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.85 1.691 . . . . 0.0 112.765 177.563 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tmm? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -115.46 138.86 50.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.423 1.089 . . . . 0.0 112.629 -170.444 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -138.59 157.72 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 111.056 171.563 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.7 135.4 53.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.983 1.313 . . . . 0.0 112.37 -178.977 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -122.69 119.12 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.092 178.308 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -91.33 126.12 36.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.675 1.59 . . . . 0.0 111.788 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -90.72 157.4 17.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.227 1.411 . . . . 0.0 112.346 -176.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.88 -27.17 67.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.449 1.1 . . . . 0.0 113.357 176.57 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -92.5 12.7 22.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.535 2.334 . . . . 0.0 113.647 176.181 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.57 58.09 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 162.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -93.78 151.12 19.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.201 1.4 . . . . 0.0 110.606 170.323 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -113.5 105.12 12.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.067 0.947 . . . . 0.0 109.452 168.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.3 mt -75.36 138.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.181 1.792 . . . . 0.0 108.672 176.361 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -110.38 124.47 51.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 109.385 171.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.05 155.59 22.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.313 1.045 . . . . 0.0 112.69 -177.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.847 1.659 . . . . 0.0 109.072 167.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.2 176.24 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.459 1.904 . . . . 0.0 111.62 -171.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.6 159.29 71.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.773 1.629 . . . . 0.0 111.394 159.124 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -56.68 -20.58 35.35 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.911 3.074 . . . . 0.0 116.986 -173.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -94.13 4.97 53.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 114.3 177.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.24 135.25 54.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.674 1.124 . . . . 0.0 110.383 170.46 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -78.52 164.75 24.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.048 0.939 . . . . 0.0 112.196 176.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -65.51 -26.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 120.541 -1.35 . . . . 0.0 111.362 170.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -60.02 -42.93 95.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.12 -0.987 . . . . 0.0 111.783 165.813 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -66.52 -35.78 81.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.038 -1.039 . . . . 0.0 112.863 172.951 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.71 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 119.814 1.188 . . . . 0.0 110.983 173.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -58.51 -42.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.149 0.886 . . . . 0.0 112.422 172.594 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 177.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -71.48 -31.05 66.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.889 1.276 . . . . 0.0 112.814 175.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.82 -39.57 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 111.038 169.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.59 -40.51 97.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.813 1.188 . . . . 0.0 111.521 170.853 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -62.44 -39.69 94.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.461 1.104 . . . . 0.0 113.516 175.847 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.69 -53.67 6.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -118.71 -4.58 10.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -164.525 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.61 12.83 82.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.821 172.708 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -82.17 125.44 76.99 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 119.45 1.625 . . . . 0.0 109.585 -178.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.9 Cg_exo -67.73 147.18 75.08 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.266 1.977 . . . . 0.0 114.827 -178.54 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.8 Cg_exo -56.29 -39.65 89.89 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.353 3.369 . . . . 0.0 115.903 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 6.1 p30 -81.44 5.49 17.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -113.4 24.01 12.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.744 1.617 . . . . 0.0 113.072 178.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -157.02 152.1 26.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.571 1.548 . . . . 0.0 112.527 -178.535 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 mtt85 -135.56 160.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.036 1.735 . . . . 0.0 110.612 158.518 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.8 mt -125.37 149.65 47.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.533 1.133 . . . . 0.0 112.644 -174.177 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.93 137.82 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 111.799 179.298 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -148.59 139.98 23.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.263 1.425 . . . . 0.0 110.933 172.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 44.35 25.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 170.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.92 74.35 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.004 1.288 . . . . 0.0 115.613 -178.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -121.79 121.76 37.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.8 1.64 . . . . 0.0 110.306 -173.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -79.54 124.48 28.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.685 0.794 . . . . 0.0 108.953 169.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -90.63 133.48 35.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -160.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -98.51 141.31 31.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.396 1.479 . . . . 0.0 113.92 -175.02 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -62.38 -30.51 71.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.257 1.423 . . . . 0.0 113.331 -176.275 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.96 18.39 27.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.605 2.05 . . . . 0.0 115.418 174.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -129.51 165.48 21.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 112.115 175.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -114.41 168.53 9.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.794 1.637 . . . . 0.0 114.088 -174.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.08 -46.18 68.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.674 0.79 . . . . 0.0 111.666 169.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.89 -29.64 66.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.15 -33.69 72.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.434 1.47 . . . . 0.0 112.741 171.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -100.04 8.73 43.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 114.56 177.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 56.87 34.4 24.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.381 1.472 . . . . 0.0 114.922 -177.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -82.72 84.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.213 1.405 . . . . 0.0 109.091 -179.714 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -69.44 172.95 6.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.404 1.482 . . . . 0.0 113.48 177.835 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -47.81 142.62 4.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.734 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 45.6 mt-10 56.13 24.52 8.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.496 2.318 . . . . 0.0 114.619 178.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -67.44 148.49 51.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.4 1.08 . . . . 0.0 112.709 168.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -113.04 126.69 55.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 110.558 174.715 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.921 1.689 . . . . 0.0 112.125 176.047 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -130.16 158.63 39.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -164.698 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tt -114.1 142.0 46.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.763 1.625 . . . . 0.0 109.507 153.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.62 165.82 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.619 1.967 . . . . 0.0 110.774 176.793 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -50.73 -41.38 56.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 114.22 -173.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -80.97 12.61 3.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 178.665 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -123.1 6.47 9.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.778 2.431 . . . . 0.0 113.324 170.137 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -25.94 51.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.535 1.534 . . . . 0.0 113.08 -178.849 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.6 -36.68 32.79 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 121.052 -1.03 . . . . 0.0 112.624 167.339 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.148 -1.918 . . . . 0.0 114.171 175.705 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptt? . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.866 -0.111 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.36 141.95 27.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.503 0.721 . . . . 0.0 111.602 174.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.38 161.3 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.724 1.609 . . . . 0.0 110.054 167.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -111.25 143.01 42.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.798 0.839 . . . . 0.0 112.424 177.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.19 127.71 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.931 1.292 . . . . 0.0 109.306 169.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -110.89 130.87 55.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.468 1.507 . . . . 0.0 112.206 178.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -74.1 165.74 24.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.173 0.589 . . . . 0.0 111.669 171.636 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.61 -27.61 67.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.991 -1.068 . . . . 0.0 113.031 169.677 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -80.87 3.06 23.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.781 2.032 . . . . 0.0 114.784 172.211 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.63 11.78 85.12 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.632 -1.293 . . . . 0.0 115.538 175.317 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -76.08 130.15 37.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.014 1.407 . . . . 0.0 108.896 171.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -108.38 137.59 46.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.327 1.051 . . . . 0.0 111.618 -176.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.86 120.84 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.905 2.082 . . . . 0.0 109.565 -179.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -80.2 130.87 35.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.52 0.728 . . . . 0.0 110.338 170.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.43 138.13 52.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.375 1.47 . . . . 0.0 110.273 174.099 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.84 119.75 38.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.698 0.799 . . . . 0.0 109.627 173.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.02 163.07 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.696 1.598 . . . . 0.0 111.77 -167.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 40.9 tt0 -101.85 151.14 37.9 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.293 1.437 . . . . 0.0 108.24 164.219 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.52 -31.7 94.93 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 CA-C-N 122.094 1.783 . . . . 0.0 112.89 172.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 3.6 m -71.66 -3.76 23.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.857 1.663 . . . . 0.0 115.043 172.803 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -77.05 147.37 36.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.118 1.327 . . . . 0.0 111.905 -176.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.7 p -90.15 151.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.527 1.131 . . . . 0.0 113.159 -169.141 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -64.76 -36.4 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.367 -0.833 . . . . 0.0 111.869 -179.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.66 -31.9 73.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.227 -1.546 . . . . 0.0 113.194 172.689 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.1 -35.56 64.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.126 -0.984 . . . . 0.0 113.009 171.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.51 -44.54 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.192 -0.943 . . . . 0.0 110.588 169.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -61.15 -37.1 81.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 112.661 173.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -34.39 74.27 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.35 -37.66 77.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.009 1.324 . . . . 0.0 112.108 173.103 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.64 -43.32 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.302 . . . . 0.0 110.303 170.69 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -62.6 -40.0 95.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.935 0.789 . . . . 0.0 112.295 176.499 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 -39.29 91.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 112.305 175.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -83.1 -49.28 9.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.96 1.304 . . . . 0.0 114.381 -177.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -108.34 -17.52 13.98 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.144 1.377 . . . . 0.0 114.632 -171.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.77 1.03 89.12 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -178.101 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -69.18 121.45 81.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.418 1.109 . . . . 0.0 108.747 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -64.36 137.7 57.01 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.338 2.025 . . . . 0.0 113.326 -174.138 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -23.92 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.389 2.726 . . . . 0.0 114.88 -172.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -79.3 -14.11 59.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.979 1.263 . . . . 0.0 113.621 172.435 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -98.32 -20.62 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.64 1.576 . . . . 0.0 112.392 173.735 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.98 144.92 55.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.994 -1.066 . . . . 0.0 111.603 171.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.92 133.47 31.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.376 1.871 . . . . 0.0 109.817 161.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.46 128.9 55.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.616 1.166 . . . . 0.0 111.253 -174.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -122.7 131.68 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.174 1.789 . . . . 0.0 111.39 -173.818 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -144.69 139.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.64 1.576 . . . . 0.0 110.857 171.549 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.96 39.82 11.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.962 1.305 . . . . 0.0 113.958 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.07 14.52 63.76 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -177.155 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -126.0 142.86 51.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.783 2.033 . . . . 0.0 110.938 -174.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -80.72 141.71 34.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.877 0.871 . . . . 0.0 112.144 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -88.95 150.26 22.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 112.8 177.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.58 137.35 39.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.704 2.001 . . . . 0.0 112.737 178.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.91 -34.1 75.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -168.42 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.51 -15.94 78.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.311 0.957 . . . . 0.0 115.264 -176.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -88.77 -178.36 5.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.131 1.372 . . . . 0.0 112.328 -170.097 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -127.84 158.52 37.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.914 1.686 . . . . 0.0 113.1 -173.829 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.21 -32.65 74.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.707 0.803 . . . . 0.0 112.904 -178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 p -66.79 -39.58 87.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.129 1.371 . . . . 0.0 112.739 173.282 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.84 -34.57 78.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.66 0.664 . . . . 0.0 111.748 173.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -77.83 0.5 23.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 t30 58.43 41.62 22.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.681 1.592 . . . . 0.0 114.584 171.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.2 mt -97.83 127.89 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.428 1.491 . . . . 0.0 110.647 -177.539 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -85.01 161.07 19.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -55.95 151.13 12.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.236 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 59.73 31.86 21.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.106 1.762 . . . . 0.0 114.258 -175.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.5 m -93.1 159.64 15.2 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.671 1.188 . . . . 0.0 112.002 171.107 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.7 m -112.73 137.03 51.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.341 1.456 . . . . 0.0 111.019 178.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.28 164.08 15.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.461 1.904 . . . . 0.0 109.966 168.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -110.09 148.71 31.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.816 0.846 . . . . 0.0 112.309 175.1 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -124.17 126.2 45.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.06 2.144 . . . . 0.0 109.368 177.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 m -124.96 148.86 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.224 1.01 . . . . 0.0 111.169 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.56 129.44 37.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 110.295 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -123.29 81.21 1.86 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.714 2.006 . . . . 0.0 110.547 -176.456 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.4 mt -77.46 142.89 38.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.121 0.968 . . . . 0.0 111.41 -176.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -105.8 -17.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.217 1.407 . . . . 0.0 112.679 169.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 -170.69 30.17 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 118.703 0.683 . . . . 0.0 114.144 171.341 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.141 1.829 . . . . 0.0 113.361 179.735 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.03 142.73 27.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.759 0.823 . . . . 0.0 111.402 -179.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.33 161.94 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.763 1.225 . . . . 0.0 110.785 161.292 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -114.18 136.52 52.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.27 124.56 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.764 1.226 . . . . 0.0 109.422 177.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -113.44 132.27 55.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.958 1.703 . . . . 0.0 111.964 -174.414 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 p -81.96 162.41 22.69 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.518 0.727 . . . . 0.0 111.134 173.919 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.469 -1.395 . . . . 0.0 113.055 176.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -83.86 9.93 10.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.672 1.589 . . . . 0.0 114.711 172.066 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.12 -0.03 85.63 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 165.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -67.14 136.93 55.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.182 1.491 . . . . 0.0 109.703 172.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -117.43 147.72 42.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.456 1.025 . . . . 0.0 113.009 -179.049 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -126.3 125.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.874 2.07 . . . . 0.0 107.36 178.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -86.95 135.42 33.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.429 0.691 . . . . 0.0 109.194 170.018 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.3 141.93 51.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.861 174.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.0 113.15 21.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.336 . . . . 0.0 108.818 170.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -146.77 159.38 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.452 1.501 . . . . 0.0 111.807 -174.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -85.91 147.28 45.31 Favored Pre-proline 0 N--CA 1.449 -0.477 0 O-C-N 121.403 -0.811 . . . . 0.0 111.449 172.933 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.74 -16.33 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.869 2.379 . . . . 0.0 115.549 -172.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -86.34 -2.08 58.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 174.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.79 147.39 48.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.985 1.266 . . . . 0.0 110.731 176.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -97.02 151.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.572 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.3 -47.35 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.982 0.913 . . . . 0.0 112.154 -171.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.09 -24.73 60.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.593 -1.317 . . . . 0.0 113.632 -177.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.07 -32.16 64.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.952 -1.092 . . . . 0.0 112.507 167.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.78 -41.56 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.446 1.021 . . . . 0.0 111.259 172.105 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.22 -37.99 73.05 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.258 1.023 . . . . 0.0 112.444 171.573 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.21 71.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 173.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -66.78 -33.68 76.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.748 -1.22 . . . . 0.0 112.083 171.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.44 -44.2 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.934 0.893 . . . . 0.0 110.368 169.418 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -55.29 -44.51 75.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.581 1.082 . . . . 0.0 112.635 175.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -64.26 -19.6 65.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -110.81 -36.42 5.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -118.19 -2.92 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.306 1.442 . . . . 0.0 114.035 -176.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.81 -1.42 78.72 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 170.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.4 mt -79.18 119.62 77.78 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 119.6 1.7 . . . . 0.0 109.55 -178.828 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 147.37 70.14 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 112.526 -178.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.5 -32.61 59.16 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.193 2.596 . . . . 0.0 113.506 -167.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.4 -10.63 56.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.336 1.454 . . . . 0.0 114.32 175.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.03 -17.06 33.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.183 . . . . 0.0 113.211 169.309 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.79 122.73 38.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.108 0.963 . . . . 0.0 113.114 -167.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -98.99 127.24 44.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.715 1.206 . . . . 0.0 108.663 158.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -110.57 134.76 52.11 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.759 0.823 . . . . 0.0 110.824 176.274 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mp -132.5 138.53 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.109 1.363 . . . . 0.0 109.802 -172.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -122.21 120.49 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.917 0.887 . . . . 0.0 109.903 163.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.67 47.69 14.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.485 1.114 . . . . 0.0 113.856 177.327 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.51 35.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.235 1.398 . . . . 0.0 116.483 -178.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -83.97 114.57 21.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.139 1.97 . . . . 0.0 109.723 170.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.04 130.73 42.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.609 0.641 . . . . 0.0 110.049 169.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.8 129.98 41.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.622 1.169 . . . . 0.0 110.856 -169.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -86.81 137.49 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.194 0.998 . . . . 0.0 113.684 -168.603 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -60.89 -28.71 69.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.478 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.36 3.3 81.91 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.241 1.401 . . . . 0.0 116.097 177.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -105.66 168.1 9.33 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.564 1.682 . . . . 0.0 112.962 -175.358 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.51 166.12 12.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.13 174.336 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.49 -35.71 80.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.578 -0.702 . . . . 0.0 112.045 166.067 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 p -64.28 -24.54 67.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 177.337 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.94 -20.46 65.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.633 1.106 . . . . 0.0 112.881 171.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.17 2.68 23.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.185 1.794 . . . . 0.0 112.96 174.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 48.42 42.81 18.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.013 2.125 . . . . 0.0 114.454 -178.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.62 116.77 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 109.308 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -83.31 162.09 21.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 111.673 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 144.96 15.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.493 1.117 . . . . 0.0 113.133 177.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 58.08 24.47 11.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.702 2.001 . . . . 0.0 114.879 177.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.5 m -74.33 160.11 31.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 112.948 168.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -115.8 134.89 54.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.07 1.348 . . . . 0.0 111.7 176.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.8 165.03 14.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.36 2.664 . . . . 0.0 110.486 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -111.71 150.15 30.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.968 173.394 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 tp -121.89 122.17 38.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.719 2.008 . . . . 0.0 110.245 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -119.28 136.8 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.183 1.793 . . . . 0.0 109.315 177.115 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.79 139.35 42.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -78.9 157.46 28.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.622 1.569 . . . . 0.0 112.437 174.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.4 161.42 22.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.457 1.903 . . . . 0.0 111.888 178.789 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.3 mtt85 59.57 31.08 20.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.348 2.259 . . . . 0.0 114.633 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.05 -173.57 20.38 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.086 1.803 . . . . 0.0 114.928 -177.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.71 -1.605 . . . . 0.0 113.367 -179.071 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -94.01 135.66 35.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 111.353 -177.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.79 166.1 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.043 1.337 . . . . 0.0 111.306 170.034 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.74 139.77 51.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.173 0.989 . . . . 0.0 110.642 176.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.05 123.01 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.102 171.453 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.95 125.68 52.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 111.294 178.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -93.31 148.14 22.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.119 0.968 . . . . 0.0 111.217 170.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.15 -25.79 64.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.16 0.984 . . . . 0.0 112.447 173.042 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -76.39 30.9 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.448 1.899 . . . . 0.0 113.022 174.403 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 43.18 93.22 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 120.62 -1.3 . . . . 0.0 116.085 164.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.82 144.12 31.64 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.629 1.215 . . . . 0.0 112.017 174.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -121.38 132.93 55.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.229 1.411 . . . . 0.0 111.062 169.096 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.0 pt -121.15 143.81 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 110.87 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -106.99 115.43 30.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.597 1.159 . . . . 0.0 111.191 -173.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.0 159.44 17.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.442 1.497 . . . . 0.0 112.45 -174.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -108.13 128.99 55.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.504 1.522 . . . . 0.0 110.419 172.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.25 173.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.636 1.974 . . . . 0.0 110.851 -173.687 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -130.41 160.53 65.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.313 1.445 . . . . 0.0 111.135 169.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.31 -28.79 85.88 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.848 2.365 . . . . 0.0 115.127 173.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 p -90.57 2.24 55.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.315 1.446 . . . . 0.0 114.149 171.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -75.45 154.29 37.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.919 -1.113 . . . . 0.0 110.889 173.519 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -104.81 146.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.144 1.378 . . . . 0.0 112.915 -170.28 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.3 mm -62.52 -36.23 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 121.353 -0.842 . . . . 0.0 112.007 -176.573 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -63.21 -27.39 69.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.535 -1.353 . . . . 0.0 114.38 173.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -75.17 -36.47 61.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.691 0.796 . . . . 0.0 111.185 171.042 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.19 -42.09 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 120.548 -1.345 . . . . 0.0 111.02 170.35 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -65.0 -38.1 89.84 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 112.817 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.44 71.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 172.028 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -75.38 -36.3 60.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.561 1.145 . . . . 0.0 112.368 173.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.98 -39.35 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 120.81 -1.181 . . . . 0.0 111.273 169.494 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.54 -42.6 96.86 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.035 0.934 . . . . 0.0 112.367 172.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.29 -42.42 96.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.404 -0.81 . . . . 0.0 112.513 175.452 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -71.1 -53.89 13.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.8 1.24 . . . . 0.0 113.339 -179.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -122.99 -2.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.136 1.774 . . . . 0.0 115.06 -166.672 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.21 86.34 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.726 1.85 . . . . 0.0 117.726 167.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.57 128.52 91.01 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 120.214 2.007 . . . . 0.0 110.264 -178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.93 130.47 36.79 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.863 2.375 . . . . 0.0 111.772 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -48.9 -41.81 38.8 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.891 3.06 . . . . 0.0 115.359 -177.629 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.7 -22.3 66.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 178.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -87.16 -9.02 56.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.792 1.237 . . . . 0.0 113.38 174.023 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -88.46 139.26 30.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.491 1.116 . . . . 0.0 111.546 175.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -119.23 131.5 55.81 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.484 1.514 . . . . 0.0 109.984 164.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.6 mt -110.3 134.71 52.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.889 0.875 . . . . 0.0 112.21 177.433 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -128.13 125.27 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.424 1.49 . . . . 0.0 110.687 -172.394 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -124.35 119.74 30.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.522 1.129 . . . . 0.0 112.316 176.012 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.77 49.87 16.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.449 1.5 . . . . 0.0 113.585 -179.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -12.29 48.75 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.452 1.501 . . . . 0.0 116.375 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -95.7 134.34 38.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.973 1.387 . . . . 0.0 112.18 -177.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -77.7 119.42 21.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.765 0.826 . . . . 0.0 109.865 171.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.06 128.27 33.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.845 0.458 . . . . 0.0 112.068 -178.565 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.96 139.06 42.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.195 1.798 . . . . 0.0 109.946 163.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.07 -28.3 21.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -151.966 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.39 26.21 5.84 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.761 -1.212 . . . . 0.0 115.483 -178.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.13 158.58 29.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.196 2.198 . . . . 0.0 110.877 -174.725 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 p -93.17 157.22 16.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.558 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -55.34 -38.72 69.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.031 0.932 . . . . 0.0 113.232 -178.738 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -62.44 -32.36 73.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.987 1.315 . . . . 0.0 113.779 174.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -66.63 -19.59 65.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 120.023 1.283 . . . . 0.0 112.972 177.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -112.66 8.17 18.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.417 1.887 . . . . 0.0 114.328 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 55.46 41.82 30.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.048 1.339 . . . . 0.0 114.141 -175.62 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.76 136.58 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.065 -1.022 . . . . 0.0 108.482 168.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -129.16 174.78 9.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.131 1.772 . . . . 0.0 110.936 -172.185 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.45 151.43 4.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.606 -0.684 . . . . 0.0 111.33 164.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 60.57 15.05 5.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 176.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -80.56 147.95 30.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 120.7 -1.25 . . . . 0.0 111.385 174.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -104.06 138.58 40.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.226 1.01 . . . . 0.0 110.025 168.389 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 tp -122.01 135.32 54.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.883 1.673 . . . . 0.0 109.481 178.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -98.09 134.63 40.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.188 0.449 . . . . 0.0 111.28 -174.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.21 125.77 53.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.146 1.778 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.84 142.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.933 1.693 . . . . 0.0 109.595 -180.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.6 145.59 34.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.192 0.997 . . . . 0.0 110.956 172.687 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -62.08 146.79 49.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.353 -0.842 . . . . 0.0 112.064 167.252 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 tp -62.51 -27.25 69.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.424 1.489 . . . . 0.0 112.722 -178.722 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -107.45 118.7 37.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.556 1.542 . . . . 0.0 108.335 162.879 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.12 171.37 44.41 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.229 0.919 . . . . 0.0 113.78 -177.529 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.233 1.397 . . . . 0.0 114.1 176.459 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.079 0.029 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.31 139.83 30.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.264 1.026 . . . . 0.0 111.732 172.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.37 160.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.007 0.923 . . . . 0.0 111.027 161.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -105.04 144.28 32.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.96 0.904 . . . . 0.0 112.843 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.63 128.11 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.732 1.613 . . . . 0.0 109.141 174.02 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -103.22 136.42 43.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.421 1.488 . . . . 0.0 111.93 174.377 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -86.67 154.05 21.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.453 1.101 . . . . 0.0 110.919 171.165 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.19 -23.83 67.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.49 -1.381 . . . . 0.0 112.99 174.199 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -80.51 7.26 10.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.712 1.605 . . . . 0.0 114.067 173.441 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.18 38.45 9.13 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.048 -1.033 . . . . 0.0 115.335 163.948 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -123.96 143.07 50.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.369 1.468 . . . . 0.0 110.866 175.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -101.91 142.76 32.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.912 1.285 . . . . 0.0 111.82 176.299 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.11 140.56 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.864 2.466 . . . . 0.0 108.378 179.753 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -107.18 138.2 43.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.319 1.448 . . . . 0.0 110.387 169.595 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -132.34 150.9 52.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.524 0.729 . . . . 0.0 112.834 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -95.8 122.62 38.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.127 1.771 . . . . 0.0 111.391 178.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.85 161.83 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.455 1.902 . . . . 0.0 111.51 -174.845 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -101.6 160.35 26.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 160.115 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.23 -15.42 28.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.574 2.183 . . . . 0.0 115.554 175.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -86.0 -6.94 58.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.546 1.938 . . . . 0.0 115.058 174.468 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.91 136.52 57.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.099 1.318 . . . . 0.0 111.016 179.202 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -85.02 158.04 20.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.436 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.31 -37.69 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.37 0.668 . . . . 0.0 111.231 176.099 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.35 -33.87 76.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.048 -1.032 . . . . 0.0 112.963 174.702 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -67.46 -39.11 85.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.352 -0.843 . . . . 0.0 112.564 170.684 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.13 -37.2 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 119.495 1.043 . . . . 0.0 111.286 176.396 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.77 -39.36 88.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.167 0.894 . . . . 0.0 112.454 170.381 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.16 -20.04 64.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 174.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -84.4 -38.6 20.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.17 1.388 . . . . 0.0 112.572 172.942 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.93 -45.13 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.9 0.88 . . . . 0.0 110.054 167.181 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -56.79 -41.65 78.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.294 1.038 . . . . 0.0 112.617 175.194 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.29 -52.3 59.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.354 -0.832 . . . . 0.0 112.609 -178.83 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -87.46 -43.8 11.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -176.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -90.98 -16.06 28.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.417 1.008 . . . . 0.0 113.493 -176.711 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.98 15.14 78.08 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.011 1.164 . . . . 0.0 116.011 175.444 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.75 127.73 48.95 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 118.934 1.367 . . . . 0.0 110.684 -171.409 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.38 125.24 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.437 2.758 . . . . 0.0 112.78 -177.296 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -52.42 -35.01 63.83 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 124.383 3.389 . . . . 0.0 117.139 -173.922 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.28 -18.06 63.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.975 1.261 . . . . 0.0 113.209 -179.434 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -89.73 -14.21 35.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.504 1.122 . . . . 0.0 113.185 172.113 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.88 140.76 31.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.238 1.015 . . . . 0.0 112.211 -176.054 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -134.84 124.82 25.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.187 1.395 . . . . 0.0 109.612 171.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.68 127.42 53.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.717 0.807 . . . . 0.0 111.961 -175.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.05 139.75 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.644 1.978 . . . . 0.0 109.907 -172.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -138.68 124.84 20.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 110.409 172.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.03 59.73 3.32 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.14 1.376 . . . . 0.0 113.714 177.398 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -1.94 52.01 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 177.097 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.13 150.37 51.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.186 1.993 . . . . 0.0 112.746 -176.005 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -76.62 157.85 31.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.632 1.173 . . . . 0.0 112.387 177.426 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.9 mt -108.69 136.44 48.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.03 1.332 . . . . 0.0 112.384 -179.699 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -77.75 126.46 30.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.163 1.785 . . . . 0.0 112.241 -179.05 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.83 -34.66 65.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.18 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.07 -10.34 86.31 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 177.889 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -99.83 165.17 11.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.606 1.703 . . . . 0.0 113.109 -172.303 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -96.24 164.26 12.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.511 1.525 . . . . 0.0 113.124 -176.959 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.56 -38.51 74.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.93 -1.106 . . . . 0.0 112.302 167.964 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.8 m -63.91 -21.46 66.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 175.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.23 -26.36 68.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.272 1.396 . . . . 0.0 113.296 173.513 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -117.92 11.05 13.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.793 1.637 . . . . 0.0 114.596 -167.076 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 56.35 37.17 28.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.774 1.23 . . . . 0.0 113.701 -174.198 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.05 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.197 -0.94 . . . . 0.0 108.637 173.136 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -133.83 173.32 11.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 111.03 -165.081 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -57.39 127.21 30.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.892 -1.13 . . . . 0.0 110.201 173.859 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 65.22 22.0 12.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.009 1.724 . . . . 0.0 115.047 -177.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -66.67 155.22 38.55 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.881 -1.137 . . . . 0.0 112.037 158.322 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -118.7 129.6 55.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 111.962 178.697 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.63 167.52 10.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.317 2.247 . . . . 0.0 110.587 175.055 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -120.92 140.95 51.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.39 1.076 . . . . 0.0 111.578 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.2 tp -108.52 115.28 29.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.772 1.629 . . . . 0.0 110.158 176.523 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.89 139.91 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.284 1.834 . . . . 0.0 108.857 176.271 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.72 158.96 17.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.758 1.223 . . . . 0.0 111.472 175.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.5 mtt-85 -80.39 142.41 34.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 172.063 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.63 -33.29 3.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 113.575 -172.431 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -81.25 144.78 31.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.848 0.749 . . . . 0.0 112.663 176.679 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.54 3.74 0.11 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.329 1.442 . . . . 0.0 115.202 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.855 1.693 . . . . 0.0 113.931 175.93 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.88 140.95 30.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.228 0.467 . . . . 0.0 111.064 170.615 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.1 156.44 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.407 1.483 . . . . 0.0 109.897 161.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -122.48 127.02 49.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.234 0.613 . . . . 0.0 112.52 -170.817 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -116.72 114.96 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.543 0.737 . . . . 0.0 111.172 -176.388 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.13 139.43 30.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.822 2.049 . . . . 0.0 112.639 -175.855 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -102.57 163.8 12.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.995 175.262 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -56.01 -37.57 69.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.902 1.281 . . . . 0.0 112.212 166.852 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -71.65 -4.89 29.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.8 1.64 . . . . 0.0 114.686 178.759 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.16 74.1 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.332 0.969 . . . . 0.0 114.99 176.689 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -76.75 155.02 33.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.161 0.98 . . . . 0.0 110.1 171.149 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 p -129.94 111.81 12.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.436 1.095 . . . . 0.0 109.6 169.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.97 123.92 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.622 1.569 . . . . 0.0 108.872 -175.957 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -91.7 120.38 32.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.825 0.85 . . . . 0.0 110.554 179.205 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 mt -112.42 135.2 53.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.827 1.251 . . . . 0.0 111.337 179.438 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -98.16 110.98 23.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.426 1.09 . . . . 0.0 109.726 175.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.15 165.06 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.544 1.538 . . . . 0.0 111.91 -167.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -116.93 154.3 49.6 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.035 0.934 . . . . 0.0 109.979 165.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.0 -26.74 51.02 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.043 2.495 . . . . 0.0 115.484 178.429 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -78.24 -6.77 55.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 174.513 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.5 147.17 53.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.847 1.203 . . . . 0.0 110.585 174.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -109.0 157.14 18.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.629 1.172 . . . . 0.0 112.607 -178.511 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.69 -35.3 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -169.659 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -72.61 -28.04 62.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 113.566 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.28 -38.11 60.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.061 0.944 . . . . 0.0 112.184 171.257 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.97 -37.88 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.978 -1.076 . . . . 0.0 110.617 173.824 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.92 -37.13 86.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.29 -0.881 . . . . 0.0 113.123 170.661 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.56 78.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.079 0.854 . . . . 0.0 112.882 172.683 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.99 -31.54 72.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.415 1.086 . . . . 0.0 112.206 172.32 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -70.95 -40.25 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.885 1.274 . . . . 0.0 111.533 171.473 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -58.58 -35.92 73.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.795 1.179 . . . . 0.0 111.258 175.095 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.05 -18.9 64.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.665 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -108.14 -42.16 4.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.257 1.823 . . . . 0.0 114.948 -179.111 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -111.31 -15.49 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.118 1.367 . . . . 0.0 114.371 -175.161 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.15 -4.17 72.91 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 177.565 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.25 123.42 89.33 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.318 1.559 . . . . 0.0 110.501 -179.427 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -61.85 143.79 96.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.0 -24.7 66.86 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.277 2.651 . . . . 0.0 114.225 -170.671 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.92 -17.4 62.09 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.906 1.23 . . . . 0.0 113.638 176.691 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -87.57 -19.06 28.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.421 1.088 . . . . 0.0 112.645 173.251 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -85.55 121.17 27.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.36 -0.837 . . . . 0.0 112.793 -171.178 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -92.96 140.16 29.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.476 0.71 . . . . 0.0 109.416 155.641 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.3 mt -115.72 140.81 48.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.318 0.647 . . . . 0.0 110.367 168.399 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.2 mt -131.3 132.33 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.749 1.219 . . . . 0.0 110.384 -176.703 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -138.65 130.09 27.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.415 1.486 . . . . 0.0 110.739 177.537 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.04 37.07 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 0.0 114.007 -176.023 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.75 -6.25 48.27 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.645 1.593 . . . . 0.0 116.443 -175.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.42 126.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.919 1.86 . . . . 0.0 110.403 177.356 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -75.62 114.78 14.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 165.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.66 149.29 31.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.325 0.65 . . . . 0.0 111.879 -170.364 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -114.44 143.81 44.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.901 1.68 . . . . 0.0 111.476 -175.456 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.72 -18.22 62.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -163.039 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -3.3 90.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -177.692 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -110.97 155.05 23.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.465 1.632 . . . . 0.0 114.089 -165.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -80.58 161.59 24.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.291 1.036 . . . . 0.0 113.111 171.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.6 mt -59.64 -38.61 81.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.338 -0.851 . . . . 0.0 111.604 167.484 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.4 p -67.38 -32.4 73.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 175.28 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.28 -39.57 94.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.607 1.094 . . . . 0.0 111.381 171.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -80.14 1.13 29.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 170.433 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t30 55.17 37.06 28.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.434 1.494 . . . . 0.0 113.991 -178.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.47 141.95 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 109.142 175.323 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -135.71 168.85 18.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.853 1.261 . . . . 0.0 111.947 -160.993 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.52 126.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.993 1.317 . . . . 0.0 111.702 177.768 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 67.29 14.58 9.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.018 2.127 . . . . 0.0 115.528 -176.21 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 m -63.02 148.34 48.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.039 -1.038 . . . . 0.0 113.007 173.771 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.4 p -113.57 141.22 47.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.299 1.44 . . . . 0.0 112.262 -174.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.48 165.25 26.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.791 2.036 . . . . 0.0 111.295 -174.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -107.38 141.63 38.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.518 162.493 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -95.31 133.83 38.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.879 1.272 . . . . 0.0 108.718 160.427 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.05 127.24 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.512 0.725 . . . . 0.0 109.568 172.345 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.17 138.11 35.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.631 0.773 . . . . 0.0 111.198 178.184 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -69.96 121.76 18.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.746 1.219 . . . . 0.0 110.083 166.679 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.65 151.5 39.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.569 174.97 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 54.95 31.63 16.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.091 1.756 . . . . 0.0 113.171 -166.465 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.94 8.52 6.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.214 1.864 . . . . 0.0 114.981 -177.479 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 126.198 1.856 . . . . 0.0 111.951 -175.328 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -81.9 142.67 32.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.4 0.68 . . . . 0.0 112.001 -178.339 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -136.19 162.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.065 1.346 . . . . 0.0 110.617 160.314 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -120.77 136.83 54.78 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.351 1.06 . . . . 0.0 111.168 177.224 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.09 123.77 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.695 1.198 . . . . 0.0 110.33 178.73 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -96.91 139.64 32.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.958 2.103 . . . . 0.0 112.338 -177.734 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -107.0 156.66 18.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.747 1.219 . . . . 0.0 111.981 170.512 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.75 -37.68 82.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.32 1.048 . . . . 0.0 113.202 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -70.66 -3.14 16.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.846 1.658 . . . . 0.0 112.491 169.726 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 19.05 23.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 120.026 -1.671 . . . . 0.0 116.326 159.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -82.51 145.96 29.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.739 1.269 . . . . 0.0 110.03 169.719 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.2 m -119.09 128.61 54.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.144 0.973 . . . . 0.0 109.483 169.378 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.21 118.81 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.244 1.818 . . . . 0.0 107.777 -168.361 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.6 m -92.14 131.25 37.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 177.155 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -128.52 146.02 50.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.581 1.152 . . . . 0.0 111.182 178.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.44 126.68 40.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.505 0.722 . . . . 0.0 110.164 161.596 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.46 159.78 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.598 1.959 . . . . 0.0 112.137 -175.605 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -108.47 152.38 42.03 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.542 1.137 . . . . 0.0 109.926 168.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.51 -24.13 77.25 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.561 2.174 . . . . 0.0 114.059 176.519 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.6 p -77.98 -6.99 56.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.175 1.79 . . . . 0.0 115.099 173.39 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.37 131.01 45.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.67 1.123 . . . . 0.0 110.867 178.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -75.23 159.78 31.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.701 168.765 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.46 -29.27 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 O-C-N 121.407 -0.808 . . . . 0.0 111.171 173.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.6 -37.92 85.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.878 -1.138 . . . . 0.0 113.491 169.107 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -67.59 -40.5 84.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.008 0.822 . . . . 0.0 111.4 173.101 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.96 -42.89 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.178 -0.951 . . . . 0.0 110.988 175.564 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.52 -37.99 76.79 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.427 0.691 . . . . 0.0 112.665 172.619 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.08 76.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.995 0.816 . . . . 0.0 113.124 177.645 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.7 -38.42 83.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.182 -0.949 . . . . 0.0 111.864 173.941 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.01 -36.62 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.364 1.065 . . . . 0.0 111.757 174.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.32 -38.29 73.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.232 1.013 . . . . 0.0 111.047 174.734 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.83 -56.12 11.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.073 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.291 19.3 ptpt -86.03 -12.29 50.64 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.864 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -119.06 -18.92 8.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.384 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.84 20.66 79.76 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.606 1.093 . . . . 0.0 115.177 -178.946 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mt -92.78 121.97 64.91 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 118.741 1.27 . . . . 0.0 109.437 -178.333 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -55.97 136.21 73.62 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.023 2.482 . . . . 0.0 113.135 176.414 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.57 -37.0 73.3 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.358 2.705 . . . . 0.0 115.902 -178.357 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.16 -17.91 61.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 176.503 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -93.42 -3.05 53.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.936 1.694 . . . . 0.0 112.875 174.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.97 139.57 31.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.585 1.154 . . . . 0.0 111.522 174.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.59 123.59 31.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.205 1.402 . . . . 0.0 109.098 168.074 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.42 138.76 46.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.902 1.281 . . . . 0.0 111.689 -171.895 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.58 143.84 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.287 1.835 . . . . 0.0 110.688 -171.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -142.61 133.34 25.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.804 1.241 . . . . 0.0 111.461 164.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.28 48.24 13.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.406 1.482 . . . . 0.0 113.074 -176.291 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.47 -5.47 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.072 1.796 . . . . 0.0 116.292 178.873 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -106.09 135.73 47.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.954 1.877 . . . . 0.0 111.619 -178.677 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.83 131.67 34.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.015 1.326 . . . . 0.0 111.221 -172.592 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -99.67 133.32 44.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.75 1.22 . . . . 0.0 111.554 -164.014 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -99.17 141.22 32.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -169.261 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.65 -29.18 58.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -168.212 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.17 -11.47 61.23 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.677 1.132 . . . . 0.0 115.379 178.069 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.251 1.821 . . . . 0.0 111.526 -176.35 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -116.3 159.48 21.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -174.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.85 -42.48 84.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.46 0.704 . . . . 0.0 112.867 175.348 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 p -63.2 -41.43 99.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.226 1.01 . . . . 0.0 113.235 175.974 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.31 -36.07 82.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.97 0.805 . . . . 0.0 112.176 177.276 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -77.41 7.14 5.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 169.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 57.56 24.56 10.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.042 1.737 . . . . 0.0 115.206 -178.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.91 118.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 120.261 -1.524 . . . . 0.0 109.604 -176.312 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.12 169.72 8.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.309 1.443 . . . . 0.0 112.621 -176.399 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.86 148.48 7.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.537 1.135 . . . . 0.0 114.062 -177.488 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 62.44 14.26 6.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.804 2.041 . . . . 0.0 115.006 177.298 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.0 m -64.85 152.24 43.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.074 1.35 . . . . 0.0 112.767 172.001 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -107.32 124.01 49.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.615 1.166 . . . . 0.0 111.138 170.455 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.67 174.75 6.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.114 2.565 . . . . 0.0 110.206 -178.732 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -128.04 157.09 41.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.57 1.148 . . . . 0.0 113.832 179.422 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -129.97 132.39 46.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.096 2.158 . . . . 0.0 109.954 174.853 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.6 t -119.75 143.04 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.778 2.031 . . . . 0.0 109.434 172.534 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.58 130.2 45.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.396 1.078 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -113.06 88.41 2.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.9 2.08 . . . . 0.0 109.185 -176.725 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 mt -113.46 133.33 55.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.455 1.502 . . . . 0.0 110.042 -169.624 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.4 mtt85 -107.56 136.86 46.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 110.74 174.939 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.36 -158.08 16.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.869 0.747 . . . . 0.0 113.143 -177.557 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 124.983 1.277 . . . . 0.0 114.067 177.649 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 tmm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.97 130.53 37.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.15 0.98 . . . . 0.0 113.372 -175.517 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.17 159.71 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.401 1.48 . . . . 0.0 111.832 167.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.84 135.05 54.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.606 1.562 . . . . 0.0 110.259 173.185 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.16 109.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 109.249 -173.557 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -96.24 106.04 18.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.193 1.397 . . . . 0.0 111.822 -176.023 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -89.77 163.27 15.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.186 1.395 . . . . 0.0 113.554 -172.843 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.57 -24.73 67.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -173.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -74.96 -4.98 41.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.059 1.344 . . . . 0.0 114.037 173.434 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.77 -16.24 58.68 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.751 1.643 . . . . 0.0 114.392 -170.487 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -62.7 128.75 37.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.817 1.808 . . . . 0.0 110.822 179.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -97.4 119.36 35.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.684 1.194 . . . . 0.0 108.781 171.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.5 mt -95.11 128.44 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.707 1.203 . . . . 0.0 108.32 173.499 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.1 m -105.16 120.66 42.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 108.221 175.337 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.317 0.647 . . . . 0.0 111.626 -174.473 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -108.76 109.36 20.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 109.289 174.74 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -127.15 150.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.536 1.534 . . . . 0.0 112.053 -163.579 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.47 129.31 55.71 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.232 170.708 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -59.73 -18.02 46.08 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.574 2.183 . . . . 0.0 115.652 -179.929 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -86.32 0.86 52.97 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.318 1.447 . . . . 0.0 113.954 176.192 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.01 152.11 23.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.993 1.269 . . . . 0.0 112.474 179.304 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -81.73 154.57 25.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -171.87 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.16 -30.48 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 121.003 -1.06 . . . . 0.0 111.727 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.64 -45.41 81.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.218 -0.926 . . . . 0.0 111.199 168.565 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -66.69 -38.3 86.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.59 0.756 . . . . 0.0 112.837 175.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.28 -45.86 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.803 1.183 . . . . 0.0 111.289 173.848 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.42 -38.85 92.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.497 1.044 . . . . 0.0 112.951 175.328 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.81 85.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.739 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.36 -42.47 87.98 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.346 1.059 . . . . 0.0 112.332 171.986 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.33 -37.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 111.152 176.389 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -63.06 -45.69 90.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.775 0.83 . . . . 0.0 111.869 172.125 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.01 -24.19 67.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -78.83 -60.22 2.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 113.912 169.328 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -118.47 6.41 11.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -164.875 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.3 -8.03 54.52 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 120.402 -1.436 . . . . 0.0 116.492 170.334 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 pt -75.37 124.87 89.3 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.641 1.221 . . . . 0.0 111.747 -179.04 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 144.23 32.41 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.643 2.229 . . . . 0.0 112.589 -172.507 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.93 -31.78 64.71 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.555 3.503 . . . . 0.0 116.046 -177.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -69.06 -6.75 30.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.664 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -121.91 27.68 7.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.628 2.371 . . . . 0.0 112.501 175.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -125.67 122.84 37.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.226 1.811 . . . . 0.0 110.925 172.769 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -115.12 124.6 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.746 1.218 . . . . 0.0 109.523 162.323 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.46 116.61 31.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.589 1.156 . . . . 0.0 110.753 -176.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -116.03 124.05 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.94 1.296 . . . . 0.0 110.889 -179.015 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -126.85 121.26 31.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.893 1.677 . . . . 0.0 110.834 176.081 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.42 52.1 9.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.264 1.425 . . . . 0.0 114.63 172.606 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.31 3.67 62.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.295 1.426 . . . . 0.0 116.622 -177.144 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -108.35 128.55 54.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.851 1.826 . . . . 0.0 110.81 177.365 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -79.55 133.94 36.47 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 163.872 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.34 113.41 25.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 110.649 -178.397 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.27 139.89 41.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 178.458 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -55.69 -35.83 66.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.289 1.836 . . . . 0.0 113.206 178.55 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 16.11 3.75 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.469 1.985 . . . . 0.0 115.864 178.723 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -132.28 169.16 16.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.315 1.557 . . . . 0.0 112.009 177.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.6 p -103.23 164.82 11.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.147 . . . . 0.0 112.524 171.315 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.41 -40.28 74.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.804 0.842 . . . . 0.0 112.824 177.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.4 p -71.6 -28.63 63.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 177.174 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.66 -35.12 79.85 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.446 1.476 . . . . 0.0 111.97 171.993 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.31 4.67 30.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.75 1.22 . . . . 0.0 114.227 172.001 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 m120 51.67 44.92 28.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.761 1.624 . . . . 0.0 113.771 -177.113 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mm -82.65 127.68 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.3 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.63 -178.44 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.206 1.402 . . . . 0.0 112.748 -178.447 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -43.86 138.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.708 1.603 . . . . 0.0 115.252 178.078 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 56.08 33.45 21.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.33 1.852 . . . . 0.0 113.937 177.558 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -79.94 130.79 35.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.175 -0.953 . . . . 0.0 112.089 174.381 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.9 m -106.15 121.47 44.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 111.186 177.053 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -117.86 159.19 23.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.499 1.52 . . . . 0.0 111.612 174.68 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -120.3 152.75 37.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.874 1.27 . . . . 0.0 111.45 -177.529 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 mp -99.09 138.72 35.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 109.153 163.63 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -111.32 148.38 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.061 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.6 tp -87.01 -37.44 17.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.394 1.477 . . . . 0.0 113.863 -170.319 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -82.14 -56.61 3.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -171.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.72 56.78 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 169.483 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -63.85 -41.17 97.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -162.261 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 151.59 22.47 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 -169.673 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.557 2.503 . . . . 0.0 111.954 177.99 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 119.965 -0.064 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -92.28 138.37 31.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.911 1.284 . . . . 0.0 112.031 174.819 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.79 172.25 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.706 1.203 . . . . 0.0 110.373 164.836 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.23 153.54 44.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 111.042 175.204 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 t -132.13 124.93 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.956 0.903 . . . . 0.0 110.173 175.497 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.06 119.12 30.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 109.795 176.416 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -97.08 -179.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.659 1.584 . . . . 0.0 113.521 -166.295 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.6 mt -72.37 -10.07 59.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.516 -1.365 . . . . 0.0 114.412 -173.39 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -102.57 5.38 39.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 114.006 175.944 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.88 72.06 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.513 1.054 . . . . 0.0 114.984 -171.928 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -61.84 155.52 22.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.519 1.528 . . . . 0.0 111.116 171.769 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 m -117.34 141.76 47.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.478 1.111 . . . . 0.0 109.711 165.765 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -118.28 152.02 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.088 1.755 . . . . 0.0 110.788 170.46 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.3 m -101.24 131.86 47.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.233 1.413 . . . . 0.0 110.217 175.528 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.57 152.39 35.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.052 1.341 . . . . 0.0 111.383 177.992 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -108.25 126.37 52.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.711 1.205 . . . . 0.0 109.735 166.879 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.57 157.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.158 1.383 . . . . 0.0 111.817 -172.071 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -96.22 150.57 37.34 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.23 165.476 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.38 -26.7 45.22 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.573 2.182 . . . . 0.0 114.112 165.843 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -82.87 -0.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.467 1.907 . . . . 0.0 115.708 172.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.6 136.62 47.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.955 1.707 . . . . 0.0 110.28 172.483 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -71.87 161.68 30.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.726 1.21 . . . . 0.0 111.938 171.906 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.1 -31.58 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.748 -1.22 . . . . 0.0 110.123 167.456 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.51 -48.48 74.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.333 0.97 . . . . 0.0 112.58 166.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -62.69 -37.2 85.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 112.677 176.9 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.68 -45.14 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 118.94 0.791 . . . . 0.0 111.341 176.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -58.34 -37.74 75.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.179 0.9 . . . . 0.0 112.252 172.576 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.04 85.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.74 0.816 . . . . 0.0 112.29 175.159 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -62.22 -34.77 77.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.185 -0.947 . . . . 0.0 112.598 172.311 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 -40.36 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.595 1.558 . . . . 0.0 111.569 172.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.84 -47.87 84.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.076 1.307 . . . . 0.0 110.63 173.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.24 -29.66 69.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.24 1.016 . . . . 0.0 113.209 176.697 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -86.87 -45.24 11.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.282 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -125.94 -1.78 7.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -165.753 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.27 66.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.774 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.2 mt -102.73 122.99 44.01 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.408 1.604 . . . . 0.0 110.221 -177.624 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -57.46 129.35 33.47 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.862 3.041 . . . . 0.0 114.627 178.928 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -52.66 -30.27 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.826 3.684 . . . . 0.0 116.595 179.778 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.05 -12.74 61.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.566 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -101.89 -12.33 18.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 112.635 175.066 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -85.5 146.89 26.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.626 1.171 . . . . 0.0 111.152 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -133.35 144.6 49.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.532 -0.73 . . . . 0.0 111.65 147.17 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -109.16 137.67 46.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.904 1.282 . . . . 0.0 111.542 -176.563 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -114.19 135.26 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.87 1.668 . . . . 0.0 110.608 -177.298 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -140.55 135.86 32.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.016 1.326 . . . . 0.0 112.32 169.097 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.32 39.21 11.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.415 1.486 . . . . 0.0 113.344 -175.539 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.86 -15.77 45.77 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.483 1.992 . . . . 0.0 116.213 -179.39 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.81 141.17 36.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.202 2.001 . . . . 0.0 112.573 -171.747 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -78.19 137.05 37.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.396 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.68 158.67 15.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.126 1.37 . . . . 0.0 112.367 -173.616 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -114.44 144.9 42.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.748 1.619 . . . . 0.0 112.933 -179.511 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.81 -33.7 70.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.575 1.95 . . . . 0.0 115.772 -166.488 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.03 -13.27 81.41 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -172.864 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.44 160.51 14.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.198 1.499 . . . . 0.0 112.293 179.234 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.0 p -104.24 167.96 9.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.983 1.713 . . . . 0.0 113.886 -178.536 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.39 -41.07 68.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.048 0.539 . . . . 0.0 112.106 176.316 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -65.74 -32.27 73.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 175.307 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.79 -15.58 63.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.133 0.878 . . . . 0.0 113.174 176.448 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -111.46 -8.76 14.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.461 1.905 . . . . 0.0 114.689 172.804 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 54.95 50.36 15.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.487 1.915 . . . . 0.0 114.606 -167.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.65 109.2 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.126 -0.984 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -78.96 159.96 27.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.33 1.052 . . . . 0.0 113.008 -178.059 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -57.35 149.27 20.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.238 1.015 . . . . 0.0 112.536 174.435 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 48.72 55.74 8.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.455 1.502 . . . . 0.0 113.032 -171.643 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.79 151.79 24.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.477 1.511 . . . . 0.0 111.37 169.596 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -101.77 126.06 48.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.766 0.826 . . . . 0.0 110.162 171.442 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.2 mt -94.85 151.15 19.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.563 1.545 . . . . 0.0 109.437 166.769 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -112.65 133.01 54.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.927 -0.483 . . . . 0.0 110.286 172.789 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.86 130.84 38.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.128 0.971 . . . . 0.0 110.156 176.232 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -122.1 139.22 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.991 1.317 . . . . 0.0 108.898 172.142 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.0 tp -87.65 131.54 34.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 110.609 176.396 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -106.25 139.11 41.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.409 1.084 . . . . 0.0 112.017 173.233 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.48 32.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.691 1.596 . . . . 0.0 113.383 -157.314 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -129.19 4.47 5.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.026 1.33 . . . . 0.0 113.671 -178.598 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.78 150.35 51.27 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.088 0.851 . . . . 0.0 113.295 179.03 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.493 1.52 . . . . 0.0 112.189 -174.822 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.2 137.56 32.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.042 0.937 . . . . 0.0 111.444 173.276 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.83 157.41 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 109.921 166.755 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -110.43 149.14 30.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.582 0.753 . . . . 0.0 112.125 177.244 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.28 124.61 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.871 1.268 . . . . 0.0 108.745 173.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -135.96 135.21 39.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.069 1.348 . . . . 0.0 113.146 -167.472 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -87.18 162.31 17.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.751 0.821 . . . . 0.0 112.674 177.339 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.51 -26.13 68.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.117 -0.989 . . . . 0.0 111.379 168.191 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -80.81 16.67 1.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.069 2.148 . . . . 0.0 113.957 169.122 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.25 1.37 74.65 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 167.021 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -82.96 128.51 34.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.946 1.373 . . . . 0.0 110.388 -176.336 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 140.25 52.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.333 1.453 . . . . 0.0 111.769 -170.677 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.3 153.15 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.044 1.338 . . . . 0.0 111.139 167.059 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -99.58 145.03 27.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.416 1.086 . . . . 0.0 110.243 171.388 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.6 mt -120.94 164.61 16.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.51 1.524 . . . . 0.0 112.133 173.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -118.84 118.9 32.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.681 1.993 . . . . 0.0 108.978 172.134 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.12 171.8 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.25 1.82 . . . . 0.0 111.242 -171.829 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -134.3 160.21 69.34 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.744 1.217 . . . . 0.0 109.835 157.521 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -62.2 -24.1 75.94 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 117.386 2.033 . . . . 0.0 117.386 -160.84 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 m -78.79 3.18 17.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.83 135.02 49.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.777 1.626 . . . . 0.0 112.061 175.299 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -74.91 154.32 38.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.0 111.936 176.383 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.4 -35.98 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.761 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -69.65 -33.23 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.07 1.304 . . . . 0.0 113.667 174.459 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -63.6 -39.6 94.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.745 1.157 . . . . 0.0 111.73 170.474 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.06 -45.18 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.651 0.78 . . . . 0.0 111.504 171.766 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -58.98 -40.0 83.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.521 1.055 . . . . 0.0 112.851 173.584 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.96 71.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.304 0.956 . . . . 0.0 113.081 175.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -73.83 -38.02 64.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 120.765 -1.21 . . . . 0.0 111.396 173.794 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.46 -39.29 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.29 1.036 . . . . 0.0 110.452 168.242 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -64.33 -45.45 87.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.15 -0.969 . . . . 0.0 112.301 176.937 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.44 -42.09 91.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.329 0.968 . . . . 0.0 112.368 174.352 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -73.22 -44.7 59.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -123.25 -6.74 8.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -165.494 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 39.09 55.84 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.809 -1.182 . . . . 0.0 115.215 175.315 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.36 108.31 41.96 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 108.988 -178.026 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.54 140.98 94.1 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.912 2.408 . . . . 0.0 114.607 -179.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -48.63 -32.08 20.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 125.174 3.916 . . . . 0.0 117.787 -176.659 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -76.7 -22.73 53.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 178.367 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -83.52 -23.35 32.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.401 1.08 . . . . 0.0 113.145 -179.601 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -99.14 130.89 45.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.105 1.362 . . . . 0.0 112.87 -177.359 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -102.6 127.96 49.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 109.855 169.102 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.3 126.31 54.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 110.811 177.937 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.51 134.37 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 126.044 1.738 . . . . 0.0 111.325 -170.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -144.95 148.12 33.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.033 1.733 . . . . 0.0 110.041 172.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.08 36.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.139 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.93 12.5 83.18 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -178.532 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -132.3 156.89 45.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.539 1.67 . . . . 0.0 113.366 178.991 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.59 145.82 43.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.644 1.177 . . . . 0.0 110.084 165.546 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.52 147.19 25.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.951 0.901 . . . . 0.0 112.231 176.686 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.292 1.437 . . . . 0.0 110.924 -176.46 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.42 -30.98 71.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.77 1.228 . . . . 0.0 114.064 -172.82 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.43 -6.58 68.2 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.783 1.658 . . . . 0.0 116.08 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -87.41 168.09 13.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 119.113 1.457 . . . . 0.0 111.453 174.006 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -117.47 170.57 8.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.801 1.64 . . . . 0.0 113.246 -177.231 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.14 -37.49 77.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.69 -0.631 . . . . 0.0 111.843 173.927 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.2 m -61.85 -38.93 90.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.22 -29.2 69.68 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.678 1.126 . . . . 0.0 112.436 178.129 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -104.92 5.96 33.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.066 1.346 . . . . 0.0 114.477 179.261 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.97 35.06 25.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.366 1.467 . . . . 0.0 114.32 179.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.33 143.42 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.903 1.281 . . . . 0.0 109.256 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -137.41 165.34 26.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.148 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -37.89 124.87 1.16 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.123 2.569 . . . . 0.0 113.679 179.191 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 82.9 mt-10 60.09 21.93 11.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.138 1.775 . . . . 0.0 115.587 177.545 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 m -69.26 154.02 42.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.642 -0.661 . . . . 0.0 111.407 162.646 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -105.78 138.3 42.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.365 170.488 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.7 tp -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.736 2.415 . . . . 0.0 109.294 178.382 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -88.15 134.84 33.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.842 0.746 . . . . 0.0 112.006 -179.962 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -115.91 124.84 51.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.836 1.654 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -127.63 137.27 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.67 1.588 . . . . 0.0 109.543 176.535 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 tp -85.88 132.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.355 172.585 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -124.67 16.31 8.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -169.362 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.93 24.2 0.95 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.454 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.74 109.78 16.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.208 1.403 . . . . 0.0 108.618 164.456 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.1 160.23 26.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.297 1.427 . . . . 0.0 115.073 -174.732 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.039 1.781 . . . . 0.0 115.223 178.942 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.77 139.78 31.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.464 1.105 . . . . 0.0 111.13 173.36 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.74 167.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 110.314 167.842 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -115.18 138.12 51.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.329 1.052 . . . . 0.0 112.454 -177.794 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.1 136.59 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.346 1.059 . . . . 0.0 109.575 173.277 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -102.12 129.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.437 1.495 . . . . 0.0 111.282 175.098 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -89.13 174.99 7.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.247 1.419 . . . . 0.0 114.154 -171.855 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.55 -17.21 19.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.947 1.699 . . . . 0.0 115.286 175.591 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -111.34 9.02 21.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.434 1.894 . . . . 0.0 113.501 172.927 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.54 3.81 90.37 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.558 171.258 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -71.72 152.5 42.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.926 1.363 . . . . 0.0 110.058 175.949 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -91.4 141.19 29.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.103 0.561 . . . . 0.0 111.584 172.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.1 pt -129.66 150.82 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.785 1.634 . . . . 0.0 111.106 167.839 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -100.14 134.9 42.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.899 1.28 . . . . 0.0 112.807 -175.384 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -127.35 135.41 50.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.647 1.179 . . . . 0.0 110.85 179.092 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.26 114.86 29.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.659 1.184 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.55 149.85 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.597 1.559 . . . . 0.0 111.435 -172.254 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.84 148.94 52.48 Favored Pre-proline 0 N--CA 1.448 -0.534 0 O-C-N 121.333 -0.854 . . . . 0.0 110.75 173.234 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.39 -24.6 16.5 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.776 2.984 . . . . 0.0 115.971 178.565 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -99.5 8.65 44.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.546 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.23 153.43 41.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.041 1.291 . . . . 0.0 113.848 -178.841 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -90.15 160.0 16.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.357 1.463 . . . . 0.0 111.812 176.843 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -60.34 -34.41 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.457 -0.777 . . . . 0.0 111.297 171.425 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.96 -42.42 89.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.265 -0.897 . . . . 0.0 112.037 172.734 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.32 -38.62 81.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.083 0.553 . . . . 0.0 111.992 178.401 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.28 -49.4 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.58 0.752 . . . . 0.0 110.603 172.15 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -61.95 -37.91 86.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.121 0.968 . . . . 0.0 113.033 178.528 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.1 84.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.553 0.741 . . . . 0.0 112.133 176.269 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -37.14 86.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.002 -1.061 . . . . 0.0 112.07 175.499 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.9 -36.7 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.755 1.222 . . . . 0.0 112.232 173.335 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -61.47 -36.85 81.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.591 1.087 . . . . 0.0 111.689 173.169 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.03 -36.47 77.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.46 -1.4 . . . . 0.0 113.691 172.136 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.31 -53.64 22.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.781 1.173 . . . . 0.0 113.218 175.642 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.18 -15.29 14.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.355 1.462 . . . . 0.0 114.706 -163.402 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 15.41 78.53 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.723 1.147 . . . . 0.0 115.952 177.437 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -96.02 117.57 66.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.444 1.498 . . . . 0.0 108.592 174.09 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -59.58 149.45 82.2 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.116 2.544 . . . . 0.0 114.313 -177.839 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.51 -24.46 78.16 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.73 2.953 . . . . 0.0 115.712 -171.948 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -83.56 -9.11 59.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.174 1.352 . . . . 0.0 114.09 174.386 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.6 -20.96 13.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.393 1.877 . . . . 0.0 111.87 179.148 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -67.26 140.08 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.418 1.487 . . . . 0.0 111.693 165.71 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -123.95 130.63 52.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.763 1.225 . . . . 0.0 108.842 154.871 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -113.17 128.49 56.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.666 1.186 . . . . 0.0 110.89 -177.436 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.2 mm -118.24 131.76 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.33 1.452 . . . . 0.0 110.346 -178.767 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.72 132.05 25.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.347 1.459 . . . . 0.0 111.238 175.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 45.19 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.497 1.519 . . . . 0.0 114.227 177.96 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.25 23.97 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.915 1.722 . . . . 0.0 116.678 -177.511 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.52 144.96 28.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.524 1.662 . . . . 0.0 112.041 -178.953 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.17 130.28 36.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.813 -0.555 . . . . 0.0 110.492 164.687 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.37 121.86 26.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.159 0.983 . . . . 0.0 109.916 175.353 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.77 135.48 53.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.84 1.256 . . . . 0.0 112.238 -176.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.82 157.37 1.67 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.706 2.802 . . . . 0.0 115.862 -172.664 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.01 -1.31 80.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 127.193 2.33 . . . . 0.0 114.324 -179.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.07 169.25 10.69 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.508 1.923 . . . . 0.0 112.946 178.471 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -109.06 167.24 10.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.107 1.763 . . . . 0.0 113.699 -170.35 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.05 -41.52 64.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.005 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -69.07 -27.42 65.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.46 -16.13 63.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.141 0.882 . . . . 0.0 112.845 175.35 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.19 6.87 13.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.827 1.651 . . . . 0.0 113.804 173.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 50.81 51.55 16.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.058 1.743 . . . . 0.0 114.196 -175.383 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.48 115.25 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 109.247 176.148 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.18 174.21 5.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.804 2.042 . . . . 0.0 111.792 -175.098 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.8 144.74 56.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.059 -1.026 . . . . 0.0 113.246 178.645 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.61 8.24 1.66 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.528 1.931 . . . . 0.0 115.541 -174.335 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -73.06 156.96 38.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.354 0.979 . . . . 0.0 112.857 174.726 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 m -119.41 127.93 53.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.708 1.203 . . . . 0.0 111.682 -170.756 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -123.48 158.65 30.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.257 1.423 . . . . 0.0 112.277 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.09 140.64 47.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.537 1.135 . . . . 0.0 112.215 -172.979 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -111.11 130.57 55.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.36 1.464 . . . . 0.0 110.774 176.256 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.12 162.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.588 1.555 . . . . 0.0 111.535 170.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -105.72 123.84 48.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.117 1.767 . . . . 0.0 110.706 -170.931 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -70.62 99.84 1.73 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 113.034 -178.557 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt 58.94 -30.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.354 3.462 . . . . 0.0 118.965 172.505 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -83.27 44.92 0.98 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 121.246 1.839 . . . . 0.0 113.587 -177.975 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.54 -41.73 89.68 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.323 -0.86 . . . . 0.0 114.078 -175.278 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.679 179.282 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.97 144.7 49.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.509 1.124 . . . . 0.0 112.946 -174.912 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -136.92 162.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.62 1.568 . . . . 0.0 112.145 173.622 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.8 152.76 19.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.358 1.463 . . . . 0.0 112.724 173.231 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -132.39 140.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.15 1.38 . . . . 0.0 110.076 167.265 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.47 149.21 50.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.897 1.679 . . . . 0.0 113.847 -170.983 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -113.7 162.0 16.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.884 1.673 . . . . 0.0 113.849 -179.094 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.8 -27.24 69.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.857 -1.152 . . . . 0.0 113.78 170.846 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -71.58 -4.59 27.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.893 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.72 13.06 78.9 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.767 1.175 . . . . 0.0 114.691 177.837 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -74.83 144.85 43.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.361 1.081 . . . . 0.0 109.539 171.699 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -133.63 131.25 39.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.554 0.742 . . . . 0.0 110.801 175.979 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.43 157.71 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.829 1.652 . . . . 0.0 111.365 -175.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 p -109.88 144.81 37.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.943 1.297 . . . . 0.0 112.527 173.957 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.5 148.87 52.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.963 1.705 . . . . 0.0 110.504 175.152 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.43 128.11 56.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.001 1.32 . . . . 0.0 110.737 176.697 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.78 164.84 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.158 1.783 . . . . 0.0 111.879 -164.11 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -106.36 153.22 40.58 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.728 1.211 . . . . 0.0 110.325 160.875 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.75 -17.4 35.83 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.086 2.524 . . . . 0.0 115.517 174.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -89.39 -0.4 57.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.444 2.298 . . . . 0.0 114.617 174.973 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -77.61 146.68 36.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.864 -1.148 . . . . 0.0 111.411 173.003 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -85.18 152.54 23.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.374 1.47 . . . . 0.0 113.01 -176.628 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.19 -33.76 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.955 -1.09 . . . . 0.0 111.646 -179.096 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -64.52 -29.95 70.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.968 -1.082 . . . . 0.0 113.74 172.578 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -72.22 -42.57 65.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.403 -0.811 . . . . 0.0 110.903 170.41 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.52 -44.26 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 120.757 -1.215 . . . . 0.0 111.757 173.323 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.84 -37.8 85.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.068 -1.02 . . . . 0.0 112.663 174.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -32.62 66.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 176.691 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -64.07 -35.63 81.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.299 1.44 . . . . 0.0 111.698 169.962 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.97 -45.58 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.06 0.944 . . . . 0.0 110.345 170.062 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -57.29 -40.14 77.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.525 1.057 . . . . 0.0 111.909 176.388 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.95 -16.06 63.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.123 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.66 -35.79 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.936 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -103.74 -9.67 18.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.209 1.368 . . . . 0.0 114.463 -179.753 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.93 1.7 68.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 176.586 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.75 119.79 77.21 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 119.639 1.719 . . . . 0.0 109.156 -178.033 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.65 130.81 18.83 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.199 1.933 . . . . 0.0 111.819 -177.176 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.42 -36.09 57.2 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.94 3.76 . . . . 0.0 115.614 -178.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.85 -24.98 25.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.353 1.061 . . . . 0.0 113.437 174.215 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.85 2.33 32.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.968 1.707 . . . . 0.0 113.715 -179.374 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.83 124.13 43.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.876 1.27 . . . . 0.0 112.482 -178.345 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -117.28 121.92 42.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.772 1.629 . . . . 0.0 108.788 170.058 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.87 137.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.884 0.874 . . . . 0.0 112.69 -172.106 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.97 140.0 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.693 1.597 . . . . 0.0 110.626 -176.138 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -140.09 124.7 18.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.386 1.875 . . . . 0.0 110.57 177.29 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.862 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.87 -10.5 13.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.975 1.75 . . . . 0.0 116.476 -175.502 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -92.88 131.53 37.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.607 1.704 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.13 141.59 35.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.903 0.481 . . . . 0.0 111.768 176.014 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.66 119.7 35.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.117 0.967 . . . . 0.0 112.064 -174.223 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -77.88 138.18 38.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.988 1.315 . . . . 0.0 112.414 176.177 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.64 -34.37 74.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.471 1.509 . . . . 0.0 113.727 -175.265 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.23 4.76 84.49 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.149 1.833 . . . . 0.0 115.817 -177.91 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -100.73 168.35 9.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.015 1.326 . . . . 0.0 111.393 175.363 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -103.22 160.63 14.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.64 1.576 . . . . 0.0 112.134 175.719 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -54.53 -40.32 68.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 174.711 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 p -68.43 -23.52 64.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 176.234 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.77 -24.99 66.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 120.495 1.498 . . . . 0.0 112.635 171.026 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.48 12.46 33.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.627 1.571 . . . . 0.0 113.514 173.706 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 54.33 30.57 12.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.651 1.18 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.93 97.18 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 120.908 -1.12 . . . . 0.0 107.99 179.448 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -89.26 165.16 14.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.324 1.45 . . . . 0.0 110.779 175.219 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -47.53 144.62 2.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.938 1.695 . . . . 0.0 114.986 179.184 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 23.7 mt-10 66.4 7.38 4.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.022 2.529 . . . . 0.0 116.587 177.617 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -60.89 158.76 12.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.839 1.655 . . . . 0.0 112.985 166.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -116.73 125.79 52.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 110.822 173.086 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.85 152.79 18.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.278 1.431 . . . . 0.0 110.593 170.68 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -114.77 139.08 50.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.442 1.097 . . . . 0.0 111.199 179.397 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.57 130.98 57.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.764 1.226 . . . . 0.0 111.448 -175.93 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.35 163.46 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.296 1.838 . . . . 0.0 111.372 169.019 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -100.53 157.27 16.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 112.631 -165.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -140.35 -177.72 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.828 1.251 . . . . 0.0 111.074 159.68 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.37 162.44 34.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.896 1.678 . . . . 0.0 111.39 172.711 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -107.4 -38.54 5.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.509 1.524 . . . . 0.0 111.979 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.73 132.0 11.04 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.739 1.162 . . . . 0.0 113.372 175.189 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.34 1.924 . . . . 0.0 115.511 179.664 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -88.38 136.87 32.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.376 0.67 . . . . 0.0 111.284 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -137.81 164.22 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 166.114 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.68 144.17 46.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 111.724 178.577 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.25 116.26 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.309 1.044 . . . . 0.0 110.084 174.288 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -89.31 138.74 31.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.507 1.123 . . . . 0.0 111.889 176.929 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -99.12 166.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.48 1.512 . . . . 0.0 112.775 -175.275 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.15 -18.5 58.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 171.778 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.8 7.85 43.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.681 1.128 . . . . 0.0 113.352 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.39 -11.16 39.51 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.908 1.242 . . . . 0.0 115.079 179.366 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.15 140.89 58.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.415 1.608 . . . . 0.0 110.527 174.095 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -112.96 127.93 56.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.919 0.888 . . . . 0.0 111.905 177.318 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -97.98 126.98 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.229 1.811 . . . . 0.0 109.476 -179.741 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -94.22 127.47 40.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.3 1.04 . . . . 0.0 110.027 174.352 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.15 160.8 20.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.234 1.414 . . . . 0.0 112.377 -176.942 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -119.64 121.64 39.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 109.509 167.052 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.91 165.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.021 1.729 . . . . 0.0 112.072 -170.825 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -110.95 142.97 27.33 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.797 1.639 . . . . 0.0 111.124 168.434 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -55.11 -25.08 43.75 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 123.273 2.649 . . . . 0.0 115.816 173.248 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 p -78.35 -9.35 59.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 173.924 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -73.69 145.98 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.554 1.07 . . . . 0.0 112.499 -177.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.72 152.05 35.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.616 1.566 . . . . 0.0 112.286 176.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.8 -33.73 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.024 -1.047 . . . . 0.0 111.89 176.104 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.25 -27.75 65.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 174.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -69.09 -35.8 76.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.08 0.854 . . . . 0.0 111.499 171.093 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.77 -43.65 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 118.884 0.766 . . . . 0.0 110.882 172.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.01 -38.6 76.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.802 0.728 . . . . 0.0 112.778 171.511 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.96 63.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 177.272 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.38 -33.24 71.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.703 -1.248 . . . . 0.0 112.023 169.529 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.46 -32.26 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 169.487 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -65.64 -40.88 92.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.056 1.298 . . . . 0.0 112.153 170.338 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.23 -39.83 94.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.959 1.254 . . . . 0.0 112.703 174.542 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -75.43 -43.08 51.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.079 1.351 . . . . 0.0 113.958 -178.563 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -130.85 -2.44 4.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -165.596 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.36 78.78 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 174.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.7 mm -79.92 120.93 81.44 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 119.383 1.591 . . . . 0.0 110.534 -175.34 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.79 140.4 85.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.485 2.124 . . . . 0.0 112.893 179.185 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.53 -37.91 63.5 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.082 3.188 . . . . 0.0 114.881 -179.159 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.83 -17.21 60.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.06 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -87.35 -13.88 42.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.52 1.055 . . . . 0.0 113.387 174.677 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -99.93 143.92 29.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.988 1.315 . . . . 0.0 113.801 -167.049 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -134.58 142.87 47.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.606 1.162 . . . . 0.0 111.725 155.604 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -113.02 135.25 53.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 111.618 -173.544 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.9 mt -124.16 137.98 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 110.187 -172.938 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -138.27 125.09 21.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.746 1.618 . . . . 0.0 110.62 178.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.62 45.93 14.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.723 1.209 . . . . 0.0 113.832 -174.87 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.88 -12.4 8.85 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.074 1.797 . . . . 0.0 117.185 -175.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -95.84 144.1 26.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.2 1.8 . . . . 0.0 111.72 -173.229 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.17 132.64 35.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.695 0.68 . . . . 0.0 111.624 178.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.98 142.12 27.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 176.182 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.58 134.33 54.77 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.218 1.007 . . . . 0.0 113.394 -169.325 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.3 -34.42 64.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.574 1.95 . . . . 0.0 115.376 -166.868 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.08 -10.87 85.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.349 1.452 . . . . 0.0 115.684 179.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -100.81 170.65 8.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.911 1.284 . . . . 0.0 111.846 -176.982 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 p -117.09 159.13 23.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.712 1.205 . . . . 0.0 113.4 -176.699 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.21 -40.02 73.38 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.833 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -66.11 -28.44 68.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.01 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -64.24 -34.61 78.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.24 1.382 . . . . 0.0 111.367 175.877 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -88.11 1.19 54.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.937 1.695 . . . . 0.0 114.436 174.723 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 56.66 34.54 24.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.248 1.419 . . . . 0.0 114.566 -173.667 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.89 135.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 109.6 175.402 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -133.84 174.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 112.303 -168.947 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -45.18 129.85 7.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.439 1.496 . . . . 0.0 112.892 175.863 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 61.11 25.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.381 1.872 . . . . 0.0 114.641 -179.707 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -64.77 146.66 54.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.549 -1.344 . . . . 0.0 111.179 162.034 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.7 m -112.6 127.89 56.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 110.654 173.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.71 165.46 12.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.316 2.247 . . . . 0.0 109.131 175.058 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -123.88 142.18 51.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 110.349 175.041 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -102.17 131.51 48.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.004 1.722 . . . . 0.0 109.506 176.181 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.4 t -128.32 147.7 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 126.052 1.741 . . . . 0.0 108.089 174.112 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -113.1 157.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -169.686 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -91.86 135.5 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.268 1.427 . . . . 0.0 109.126 167.557 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.02 146.44 31.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.984 0.914 . . . . 0.0 112.165 -170.534 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 50.38 43.67 26.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.716 1.606 . . . . 0.0 112.859 -172.554 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.66 72.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 117.047 1.579 . . . . 0.0 117.047 -170.192 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.281 1.541 . . . . 0.0 113.986 -179.571 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -107.63 139.36 42.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.118 0.967 . . . . 0.0 110.721 178.975 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.1 pt -127.69 159.6 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 174.355 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.26 152.13 24.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.452 1.101 . . . . 0.0 110.814 173.871 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.55 132.07 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.177 0.991 . . . . 0.0 108.945 168.662 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -125.15 136.88 54.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.043 1.737 . . . . 0.0 111.832 -171.776 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -100.94 162.4 12.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.99 1.316 . . . . 0.0 113.35 177.23 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.98 -12.48 61.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.545 1.538 . . . . 0.0 113.096 170.785 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -85.87 -0.97 56.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.178 1.791 . . . . 0.0 113.149 166.411 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.0 12.7 83.85 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.202 1.382 . . . . 0.0 115.261 175.331 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -83.0 142.61 31.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.405 1.482 . . . . 0.0 109.285 174.927 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -130.41 150.47 51.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.783 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.79 158.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.906 1.682 . . . . 0.0 110.344 175.822 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -112.09 140.28 46.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.471 1.508 . . . . 0.0 111.857 173.478 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mp -123.2 144.59 49.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.78 1.632 . . . . 0.0 109.532 171.051 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.73 120.63 42.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.734 1.214 . . . . 0.0 110.093 174.077 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.1 162.7 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.187 1.795 . . . . 0.0 111.431 -163.564 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.33 155.71 36.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.269 1.028 . . . . 0.0 111.179 170.291 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.16 -18.94 39.25 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.197 2.598 . . . . 0.0 116.196 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 p -92.45 -3.05 55.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.397 1.879 . . . . 0.0 115.027 176.116 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.05 147.19 48.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.806 1.185 . . . . 0.0 110.931 175.501 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.04 158.93 20.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.62 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -62.72 -32.38 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 121.354 -0.841 . . . . 0.0 111.652 170.044 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -58.24 -45.28 88.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.997 -1.064 . . . . 0.0 112.257 169.534 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -65.9 -37.17 85.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.805 174.56 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.84 -51.27 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.797 1.181 . . . . 0.0 111.141 173.16 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.93 -37.1 78.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.873 0.76 . . . . 0.0 112.378 176.269 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.79 81.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 177.172 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -67.11 -31.76 72.45 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 112.406 173.862 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.92 -49.3 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.885 0.874 . . . . 0.0 110.524 169.956 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -56.79 -37.41 71.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.571 1.078 . . . . 0.0 112.25 176.691 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.03 -32.79 71.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 176.264 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.268 17.4 ptpt -113.74 -6.26 13.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -179.022 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -132.85 -8.74 3.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 177.157 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 9.07 72.94 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 121.169 1.804 . . . . 0.0 116.656 174.231 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.85 123.59 80.05 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 118.933 1.367 . . . . 0.0 108.815 -179.884 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.43 130.89 21.94 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.293 1.995 . . . . 0.0 111.94 -178.078 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -49.24 -33.07 27.1 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 125.123 3.882 . . . . 0.0 116.391 179.763 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.45 -24.39 67.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.328 0.967 . . . . 0.0 113.464 175.138 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.39 -3.07 31.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.817 1.647 . . . . 0.0 114.095 174.962 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.44 128.02 34.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.19 0.904 . . . . 0.0 111.169 174.69 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -122.75 111.66 16.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.829 1.652 . . . . 0.0 109.644 171.589 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 mt -103.99 129.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.132 1.373 . . . . 0.0 111.39 -176.897 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mm -118.03 136.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.526 1.531 . . . . 0.0 110.844 177.299 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -145.42 140.2 27.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.783 165.996 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.58 31.71 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -176.86 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.11 -10.68 33.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.179 1.847 . . . . 0.0 115.785 -174.535 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -93.08 142.25 27.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.755 1.778 . . . . 0.0 111.713 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -87.21 117.87 26.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.218 1.407 . . . . 0.0 109.78 176.593 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.52 132.71 36.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.972 0.909 . . . . 0.0 111.393 -167.845 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.62 141.42 45.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -48.17 -32.76 7.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.165 2.586 . . . . 0.0 117.797 -165.078 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.06 -10.36 58.66 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.092 1.329 . . . . 0.0 115.713 -177.396 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -81.74 163.07 22.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.916 1.358 . . . . 0.0 111.368 174.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -106.32 168.61 9.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 111.677 176.322 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -56.33 -38.2 71.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.333 -0.855 . . . . 0.0 112.586 174.019 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -69.12 -18.58 63.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.008 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.51 -11.91 60.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.715 1.143 . . . . 0.0 113.66 172.295 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -123.86 6.99 8.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.428 1.491 . . . . 0.0 113.849 178.256 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 6.5 t-20 53.2 41.91 32.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.563 1.545 . . . . 0.0 114.322 -174.979 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -76.8 138.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.795 1.238 . . . . 0.0 108.074 167.119 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -133.63 179.08 6.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.299 1.04 . . . . 0.0 113.484 -169.697 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -51.42 128.01 21.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.13 1.372 . . . . 0.0 112.462 171.321 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.1 25.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.384 1.873 . . . . 0.0 115.572 -174.646 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -70.26 154.16 42.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.745 -1.222 . . . . 0.0 111.591 164.826 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -115.85 130.79 56.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.48 1.512 . . . . 0.0 110.395 175.275 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.8 mt -100.23 144.28 29.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.191 1.396 . . . . 0.0 110.461 173.849 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -95.9 114.78 26.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.876 0.87 . . . . 0.0 109.178 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.6 tp -95.41 134.79 37.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.422 0.689 . . . . 0.0 110.501 174.61 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -124.58 136.44 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.377 1.871 . . . . 0.0 108.41 172.563 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.63 124.23 34.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.831 0.853 . . . . 0.0 109.623 175.692 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -100.61 126.75 47.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.716 1.606 . . . . 0.0 110.378 179.169 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.54 119.19 24.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.915 0.886 . . . . 0.0 110.631 -175.494 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -82.58 -31.97 28.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.209 1.404 . . . . 0.0 113.246 -177.676 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.8 -159.54 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.943 1.259 . . . . 0.0 114.601 178.677 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 C-N-CA 125.933 1.73 . . . . 0.0 112.617 -176.77 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.21 141.35 38.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.924 0.89 . . . . 0.0 112.865 178.782 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -135.8 176.43 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.624 1.969 . . . . 0.0 109.848 163.005 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -129.34 156.3 44.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.06 1.344 . . . . 0.0 112.571 177.356 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -130.77 134.89 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.894 1.278 . . . . 0.0 110.095 173.991 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -93.73 120.56 34.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.819 1.647 . . . . 0.0 109.182 168.472 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -90.64 162.2 15.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 113.052 -172.912 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -75.91 -19.67 58.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.849 -1.157 . . . . 0.0 112.241 174.04 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -80.69 2.57 25.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.813 1.645 . . . . 0.0 113.724 165.839 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.6 49.13 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.563 1.385 . . . . 0.0 116.563 163.301 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -107.12 156.92 18.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.945 1.373 . . . . 0.0 111.246 168.136 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.4 m -92.2 130.18 37.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.978 0.911 . . . . 0.0 108.735 157.378 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -127.2 150.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.445 1.498 . . . . 0.0 111.681 177.948 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.7 p -84.72 151.59 24.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.857 0.863 . . . . 0.0 112.207 175.126 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -135.66 160.38 38.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.756 1.222 . . . . 0.0 110.81 159.107 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -115.49 126.85 54.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 109.474 170.692 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.18 161.1 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 112.349 -174.993 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -100.38 142.86 25.43 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 125.052 1.341 . . . . 0.0 110.418 170.845 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.09 -22.52 64.53 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.733 2.289 . . . . 0.0 115.325 -179.395 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -88.92 -3.46 58.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.326 2.25 . . . . 0.0 114.619 179.618 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -72.38 154.85 40.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.245 1.018 . . . . 0.0 112.188 179.575 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -90.72 165.38 13.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 112.853 -179.868 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.04 -35.64 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 112.434 169.895 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.11 -20.4 64.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.021 1.282 . . . . 0.0 114.14 174.269 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -74.68 -49.87 19.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.517 1.053 . . . . 0.0 111.766 170.248 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.05 -34.24 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.237 -0.914 . . . . 0.0 112.107 -179.938 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -59.82 -42.08 92.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.106 0.866 . . . . 0.0 112.227 169.288 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.42 75.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 175.893 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.81 -31.18 64.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.92 -1.112 . . . . 0.0 113.094 172.037 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.32 -41.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.165 -0.959 . . . . 0.0 111.004 170.065 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.67 -37.29 78.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 111.93 174.91 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.58 -29.64 66.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.031 0.932 . . . . 0.0 113.321 175.441 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -108.12 -28.2 9.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -175.189 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -125.34 -1.92 7.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.536 1.534 . . . . 0.0 114.8 -176.181 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.04 -16.17 4.7 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.746 1.859 . . . . 0.0 117.746 169.931 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -67.83 126.36 92.52 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 120.121 1.96 . . . . 0.0 109.449 179.055 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 143.52 44.64 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.722 2.281 . . . . 0.0 112.61 -178.539 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -47.16 -39.17 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 125.223 3.948 . . . . 0.0 117.077 -176.515 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.07 -10.44 59.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 179.459 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -101.52 -9.26 21.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.999 1.319 . . . . 0.0 112.653 170.317 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -83.3 136.32 34.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.095 0.861 . . . . 0.0 111.747 173.902 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -118.84 143.32 47.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 109.664 154.466 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.52 142.48 47.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.092 0.957 . . . . 0.0 112.227 -176.265 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.46 136.28 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.287 1.835 . . . . 0.0 109.91 -179.916 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -139.18 127.31 22.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.72 1.608 . . . . 0.0 111.154 177.668 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 47.14 14.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.877 1.671 . . . . 0.0 113.329 -178.02 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.56 4.25 80.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.554 1.549 . . . . 0.0 116.798 179.244 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -120.77 138.46 54.0 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.293 2.046 . . . . 0.0 112.619 177.523 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -79.62 137.87 37.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.994 1.318 . . . . 0.0 110.995 178.451 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -102.19 163.69 12.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.886 1.674 . . . . 0.0 111.981 -174.689 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.43 154.47 45.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.067 1.747 . . . . 0.0 112.224 -177.825 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.01 166.86 14.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.609 0.763 . . . . 0.0 111.484 172.069 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.39 -1.26 84.11 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 175.646 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.93 161.25 28.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.63 1.972 . . . . 0.0 112.56 -179.364 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -100.27 157.91 16.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.344 1.458 . . . . 0.0 114.381 -174.352 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.08 -41.66 98.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.298 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 p -66.39 -32.17 73.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 174.44 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.57 -29.35 69.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.33 0.968 . . . . 0.0 112.743 174.183 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -82.28 1.19 37.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.073 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.59 36.37 27.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.667 1.587 . . . . 0.0 113.451 -173.115 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -80.8 103.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 172.944 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.89 170.67 12.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.643 1.577 . . . . 0.0 112.445 -179.104 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -55.19 141.79 33.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.77 0.828 . . . . 0.0 111.476 170.529 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.96 6.57 2.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.872 2.469 . . . . 0.0 117.271 -174.183 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -62.43 152.94 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.472 1.033 . . . . 0.0 113.03 174.448 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -117.68 126.07 51.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.33 1.452 . . . . 0.0 111.212 -178.559 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.17 148.35 24.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.905 1.682 . . . . 0.0 110.94 174.587 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -110.31 141.44 43.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 110.277 170.084 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.68 133.63 51.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.64 1.576 . . . . 0.0 110.633 -178.103 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.3 152.65 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 125.233 1.413 . . . . 0.0 111.446 170.836 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.39 143.06 27.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.309 1.444 . . . . 0.0 111.926 -178.7 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -75.58 119.54 19.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.824 0.849 . . . . 0.0 110.337 165.863 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.82 118.1 36.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.77 1.228 . . . . 0.0 110.359 -176.894 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -141.65 158.95 43.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 112.34 -173.511 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.42 -170.63 31.64 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.131 0.872 . . . . 0.0 114.491 176.363 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.933 -1.482 . . . . 0.0 113.207 176.621 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -91.63 144.03 25.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.589 0.756 . . . . 0.0 111.151 171.628 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -129.9 158.24 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.879 1.272 . . . . 0.0 110.818 165.155 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -108.74 139.14 43.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.315 1.046 . . . . 0.0 111.608 178.264 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.23 111.22 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.857 1.263 . . . . 0.0 109.616 177.272 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -92.35 132.52 36.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.967 1.707 . . . . 0.0 111.341 -171.02 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -98.31 159.37 14.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 112.415 177.711 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.09 -8.01 58.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.272 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -103.4 -28.07 12.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.566 1.546 . . . . 0.0 113.973 -172.232 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 -42.92 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 171.562 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -69.53 157.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.208 1.004 . . . . 0.0 113.134 -176.44 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -127.37 120.02 27.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.984 1.714 . . . . 0.0 108.589 161.715 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.41 129.51 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.861 1.264 . . . . 0.0 109.072 -176.189 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -99.53 130.44 45.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.426 0.69 . . . . 0.0 109.298 175.957 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -129.64 136.2 49.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 111.308 -173.159 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -89.31 123.58 33.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.649 1.18 . . . . 0.0 110.073 172.112 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -147.12 173.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 127.183 2.193 . . . . 0.0 111.094 -168.647 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.6 157.6 77.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 120.79 -1.194 . . . . 0.0 111.244 172.301 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -51.95 -32.34 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.71 2.94 . . . . 0.0 115.13 173.09 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -86.48 2.62 47.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.924 1.69 . . . . 0.0 114.274 177.028 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -86.7 142.78 27.94 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.1 1.318 . . . . 0.0 111.976 -175.276 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -91.24 151.87 20.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.86 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.55 -37.07 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.3 1.04 . . . . 0.0 113.491 -175.85 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.29 -36.47 84.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.715 1.598 . . . . 0.0 112.744 175.961 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -68.25 -29.41 68.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.045 0.838 . . . . 0.0 112.946 173.048 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.17 -46.82 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 120.922 -1.111 . . . . 0.0 110.226 170.139 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -61.93 -38.39 88.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.687 175.334 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -30.51 71.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.031 -1.043 . . . . 0.0 113.05 174.084 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.86 -21.02 48.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.05 -1.031 . . . . 0.0 113.301 173.873 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.35 -45.42 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.279 1.032 . . . . 0.0 110.584 164.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -52.07 -42.9 63.53 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.633 1.173 . . . . 0.0 111.166 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.35 -7.78 34.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -179.474 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -111.03 -48.72 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.555 1.142 . . . . 0.0 113.013 170.76 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -103.55 -10.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -168.475 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.62 79.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.732 1.151 . . . . 0.0 114.682 -179.564 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -93.58 118.61 67.53 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.932 1.293 . . . . 0.0 108.094 177.075 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -63.74 149.16 91.45 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.47 2.113 . . . . 0.0 114.587 -179.247 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -58.3 -29.41 87.85 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.441 2.761 . . . . 0.0 115.242 178.883 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.39 -27.55 63.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.251 0.932 . . . . 0.0 113.134 -179.608 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -84.29 -5.47 59.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.797 1.239 . . . . 0.0 113.672 -172.597 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -125.59 132.48 52.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.189 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.69 135.67 35.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.781 1.633 . . . . 0.0 109.479 170.089 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.44 135.74 49.98 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.081 0.952 . . . . 0.0 110.056 166.76 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.25 138.46 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 109.636 -173.378 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -145.92 139.74 26.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.754 1.222 . . . . 0.0 110.587 172.45 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 40.98 8.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.878 1.671 . . . . 0.0 114.755 -179.666 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 23.04 78.6 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.324 0.964 . . . . 0.0 115.316 178.396 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -134.3 133.78 41.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.156 1.783 . . . . 0.0 111.53 179.278 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -73.31 138.36 45.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.967 0.907 . . . . 0.0 110.708 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.45 131.57 42.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.295 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.51 135.4 33.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.011 1.324 . . . . 0.0 112.277 -169.487 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.29 -29.83 67.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.959 1.704 . . . . 0.0 115.431 -164.542 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.95 -7.5 57.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.811 1.672 . . . . 0.0 115.438 177.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -87.81 168.74 12.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.436 1.618 . . . . 0.0 111.166 176.08 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.7 p -111.31 161.85 15.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 113.266 -168.495 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.64 -33.22 71.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.402 -0.811 . . . . 0.0 113.059 173.968 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -24.67 64.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.015 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -65.48 -20.84 66.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.441 1.473 . . . . 0.0 112.674 168.704 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -111.71 6.5 19.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.396 1.478 . . . . 0.0 113.718 178.107 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 t30 53.24 39.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.003 1.321 . . . . 0.0 114.093 -176.93 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.75 119.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 120.723 -1.236 . . . . 0.0 108.646 178.785 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -117.56 178.98 4.19 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.107 1.763 . . . . 0.0 112.423 174.822 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.33 142.16 1.63 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.997 1.719 . . . . 0.0 115.508 -173.702 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 62.75 7.91 2.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.652 1.981 . . . . 0.0 116.13 175.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.5 m -60.96 150.82 32.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.095 1.358 . . . . 0.0 112.397 167.61 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -114.02 127.33 55.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.257 1.023 . . . . 0.0 111.24 177.658 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.89 163.22 13.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.101 2.16 . . . . 0.0 109.964 176.958 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -110.81 141.11 44.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.635 1.174 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.19 135.38 54.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.422 1.489 . . . . 0.0 111.282 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.0 129.67 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.535 1.134 . . . . 0.0 110.059 173.994 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 tp -88.17 129.9 35.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.073 0.949 . . . . 0.0 111.818 -179.732 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -67.9 158.11 33.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 111.811 175.182 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.24 162.39 14.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.245 1.418 . . . . 0.0 114.31 -168.282 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 65.1 mtt180 58.09 32.56 22.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.955 2.902 . . . . 0.0 115.948 172.912 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.73 18.14 22.47 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.727 2.108 . . . . 0.0 114.917 175.937 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.313 1.911 . . . . 0.0 112.917 -170.39 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -99.69 142.08 31.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 176.212 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.89 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.777 1.231 . . . . 0.0 109.977 167.488 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.84 130.25 55.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 111.225 -176.051 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.88 123.12 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.348 178.072 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -88.29 124.67 34.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.742 0.817 . . . . 0.0 110.905 171.334 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.0 p -67.24 173.71 3.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.412 2.285 . . . . 0.0 112.78 177.955 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.29 -17.53 62.63 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.038 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -99.33 16.87 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.668 1.587 . . . . 0.0 113.415 173.152 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.62 -15.72 4.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.72 1.629 . . . . 0.0 115.831 176.811 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -67.79 140.55 56.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.151 1.38 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -95.38 144.74 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.831 0.852 . . . . 0.0 112.899 -173.874 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 pt -122.38 153.0 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.263 1.825 . . . . 0.0 110.834 164.629 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 m -104.96 127.99 53.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.666 1.186 . . . . 0.0 110.537 176.713 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -109.51 160.59 16.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.996 1.318 . . . . 0.0 112.066 177.871 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -109.57 120.98 44.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.148 1.379 . . . . 0.0 111.118 172.528 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.9 177.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.805 2.042 . . . . 0.0 111.038 -171.499 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -132.05 162.42 56.78 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.565 1.546 . . . . 0.0 109.779 164.988 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -54.5 -32.93 76.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.509 2.806 . . . . 0.0 115.53 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.2 m -85.68 2.72 44.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.119 1.368 . . . . 0.0 114.454 176.303 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -71.45 132.33 44.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.88 -1.137 . . . . 0.0 110.662 -178.049 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -81.31 147.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.954 0.901 . . . . 0.0 112.189 -174.542 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.85 -27.84 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.125 -0.985 . . . . 0.0 112.251 -176.559 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.65 -36.49 78.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.532 1.06 . . . . 0.0 112.244 170.956 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.71 -38.41 67.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.175 -0.953 . . . . 0.0 112.31 173.701 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.58 -44.14 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 121.305 -0.872 . . . . 0.0 111.207 173.492 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -60.53 -40.82 92.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 112.591 173.57 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.15 -36.46 84.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 175.779 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -67.79 -33.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.076 1.351 . . . . 0.0 112.541 174.405 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.9 mt -66.41 -33.21 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 121.41 -0.806 . . . . 0.0 111.268 172.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -68.68 -40.21 80.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.614 1.097 . . . . 0.0 112.082 168.65 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.65 -46.55 84.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.096 0.862 . . . . 0.0 112.385 176.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -93.24 -29.6 15.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -173.454 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -126.98 1.42 6.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.214 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.63 6.36 71.24 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.296 -1.503 . . . . 0.0 115.919 172.909 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -68.38 120.11 72.76 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 119.433 1.617 . . . . 0.0 109.366 -179.027 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.6 124.98 14.6 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.25 1.966 . . . . 0.0 110.93 -178.815 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -56.8 -27.78 73.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.215 2.61 . . . . 0.0 115.781 -172.922 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.0 -13.78 62.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.193 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -105.44 2.39 28.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.816 2.046 . . . . 0.0 113.319 179.68 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -96.38 130.67 43.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.536 1.134 . . . . 0.0 113.097 -173.628 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -117.71 135.51 53.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.839 1.256 . . . . 0.0 109.367 159.138 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.7 mt -112.25 136.31 51.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.845 1.258 . . . . 0.0 110.944 177.118 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.85 136.38 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.298 1.439 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -131.26 130.87 43.39 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.905 1.282 . . . . 0.0 110.502 165.432 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.05 43.89 25.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.701 1.6 . . . . 0.0 114.376 178.606 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.72 -7.97 51.72 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.842 1.687 . . . . 0.0 116.731 -178.094 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -109.7 133.31 53.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.908 1.683 . . . . 0.0 112.758 -174.466 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -81.26 138.65 35.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.073 1.349 . . . . 0.0 112.732 -176.557 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -102.22 134.33 45.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.22 1.408 . . . . 0.0 111.704 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -166.84 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.48 -18.15 37.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.15 1.78 . . . . 0.0 114.797 179.03 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.28 -2.19 71.14 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.421 1.486 . . . . 0.0 115.595 174.042 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -117.05 167.7 10.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.155 1.782 . . . . 0.0 112.865 -173.032 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -112.18 166.49 11.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.857 1.663 . . . . 0.0 112.662 178.287 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.6 -39.0 70.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.84 0.856 . . . . 0.0 113.016 174.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -56.71 -37.91 71.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 113.75 173.801 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -73.95 -12.37 60.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.161 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.11 11.36 21.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.276 1.83 . . . . 0.0 113.493 170.398 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.65 33.02 20.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.086 1.355 . . . . 0.0 114.057 178.664 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.52 98.96 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 120.788 -1.195 . . . . 0.0 109.182 -177.921 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -83.93 171.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.385 1.474 . . . . 0.0 111.798 172.923 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -44.14 149.02 0.37 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.684 1.594 . . . . 0.0 114.054 170.498 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.315 9.1 pt-20 52.35 23.46 2.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.932 2.093 . . . . 0.0 116.449 179.799 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -79.13 152.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.384 1.073 . . . . 0.0 111.136 166.659 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -111.11 132.51 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.91 1.284 . . . . 0.0 110.505 174.64 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.77 168.09 18.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 111.493 176.307 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -111.34 142.58 43.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 113.599 -174.591 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -101.51 129.65 47.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 108.301 164.867 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.33 176.29 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.44 1.896 . . . . 0.0 111.365 178.538 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.99 151.64 29.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.81 1.244 . . . . 0.0 113.338 -172.501 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -138.1 126.39 23.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.94 1.296 . . . . 0.0 110.317 156.521 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.55 -32.63 1.29 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.635 1.174 . . . . 0.0 113.48 -174.302 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 169.85 18.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.74 1.216 . . . . 0.0 113.442 -179.233 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.14 29.5 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.337 1.446 . . . . 0.0 113.264 -174.58 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.16 -1.356 . . . . 0.0 111.796 179.708 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -92.29 137.09 32.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.902 0.881 . . . . 0.0 111.874 170.964 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.17 157.73 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.959 1.304 . . . . 0.0 109.79 165.576 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.66 149.47 27.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.714 0.805 . . . . 0.0 111.713 -179.993 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.54 129.76 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.011 1.325 . . . . 0.0 108.538 170.571 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -124.75 143.91 50.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.778 1.231 . . . . 0.0 111.698 -179.899 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -124.18 162.64 23.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.77 1.228 . . . . 0.0 112.414 -173.324 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.91 -22.56 67.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.442 1.097 . . . . 0.0 113.922 -174.563 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -84.2 2.67 38.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.425 1.89 . . . . 0.0 114.554 171.844 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.23 7.44 88.42 Favored Glycine 0 CA--C 1.531 1.088 0 O-C-N 120.727 -1.233 . . . . 0.0 114.932 177.826 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.67 124.67 27.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.825 1.312 . . . . 0.0 109.24 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -106.17 139.86 40.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.207 1.803 . . . . 0.0 110.532 175.386 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.36 144.66 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.024 2.13 . . . . 0.0 108.383 -178.844 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.1 m -108.93 134.03 52.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.03 0.832 . . . . 0.0 110.272 170.505 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -112.66 148.38 34.76 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.719 1.208 . . . . 0.0 110.228 172.754 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.36 124.33 49.36 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.857 0.863 . . . . 0.0 110.064 166.576 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -141.63 159.44 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.403 1.481 . . . . 0.0 112.561 -168.898 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -105.22 148.87 36.96 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 124.448 1.099 . . . . 0.0 108.884 160.791 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.01 -22.48 39.06 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.534 2.156 . . . . 0.0 115.902 175.045 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.2 p -79.55 -3.05 45.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.551 1.541 . . . . 0.0 115.022 173.887 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.53 133.63 48.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.994 1.27 . . . . 0.0 111.228 175.489 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 p -72.31 155.09 40.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 112.036 173.907 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.71 -31.09 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.232 -0.917 . . . . 0.0 111.736 173.824 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.29 -42.79 78.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.85 -1.156 . . . . 0.0 113.338 167.161 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.47 -34.01 67.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 176.546 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.6 -45.28 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.164 -0.96 . . . . 0.0 110.491 171.661 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.03 -38.66 79.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.794 0.725 . . . . 0.0 112.659 171.528 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.62 71.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.841 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.49 -40.36 70.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.594 1.158 . . . . 0.0 111.67 172.571 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -64.41 -40.83 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 124.042 0.937 . . . . 0.0 111.049 173.311 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.99 -36.19 82.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.159 0.983 . . . . 0.0 111.989 175.708 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.0 -51.7 65.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.162 0.892 . . . . 0.0 112.498 172.333 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -74.96 -43.64 52.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.335 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.55 -18.36 12.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.033 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.97 80.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 177.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.11 123.88 84.74 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.468 1.634 . . . . 0.0 110.306 -177.092 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.01 143.37 99.26 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.442 2.095 . . . . 0.0 113.553 179.41 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.36 -28.88 71.95 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 123.114 2.543 . . . . 0.0 114.381 -171.882 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -77.56 -6.9 55.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.675 1.19 . . . . 0.0 113.953 177.59 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -100.51 -12.86 18.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.998 1.319 . . . . 0.0 112.8 171.736 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -86.75 126.98 34.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.16 0.984 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -121.93 125.86 47.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.083 1.353 . . . . 0.0 109.446 167.56 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.15 124.65 52.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 -169.395 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mm -117.29 133.34 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.881 1.672 . . . . 0.0 112.158 -172.156 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -148.47 137.45 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.714 1.606 . . . . 0.0 111.709 169.036 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.37 38.34 21.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.357 1.463 . . . . 0.0 113.948 -179.955 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.75 6.68 67.67 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.09 179.663 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -113.4 151.18 31.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.467 1.907 . . . . 0.0 110.645 174.989 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -92.26 147.61 22.79 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.975 0.91 . . . . 0.0 111.021 169.086 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.1 mt -102.03 127.46 48.9 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.86 135.08 35.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.41 1.084 . . . . 0.0 113.224 -174.213 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.83 -28.06 63.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.225 1.81 . . . . 0.0 114.423 -176.7 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.27 8.34 80.06 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.658 2.075 . . . . 0.0 116.76 176.448 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -117.55 167.88 10.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.939 1.87 . . . . 0.0 112.364 174.921 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -101.01 166.26 10.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.852 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -55.92 -38.84 70.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.489 0.716 . . . . 0.0 112.832 169.352 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 p -65.25 -33.75 76.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 176.986 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -66.21 -20.85 66.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.916 0.887 . . . . 0.0 113.141 179.13 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -104.12 3.37 33.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.232 1.413 . . . . 0.0 114.123 172.952 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.0 t30 54.45 52.59 12.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.106 1.363 . . . . 0.0 112.833 -174.225 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.95 135.88 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.447 1.099 . . . . 0.0 110.043 174.345 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -125.76 164.23 21.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.341 1.457 . . . . 0.0 112.36 -164.988 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -58.97 155.46 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.204 1.002 . . . . 0.0 112.635 178.726 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 57.46 17.01 3.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -178.57 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.6 m -110.14 161.56 15.43 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.055 1.342 . . . . 0.0 111.494 -173.861 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -112.66 136.66 51.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 112.956 -166.244 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.1 mt -99.04 140.23 33.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.056 1.343 . . . . 0.0 109.456 158.813 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -96.22 130.28 43.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 167.341 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -104.98 106.89 17.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.287 1.435 . . . . 0.0 108.841 -179.796 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.88 134.74 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 107.968 174.239 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.12 131.33 37.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.615 -0.678 . . . . 0.0 110.13 -179.749 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -116.05 75.31 0.94 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.092 1.757 . . . . 0.0 109.542 176.958 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.62 153.01 37.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.456 1.102 . . . . 0.0 111.982 -179.073 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.92 162.82 13.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.226 1.811 . . . . 0.0 112.001 175.263 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.54 129.06 0.67 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.502 2.001 . . . . 0.0 113.373 179.036 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 124.258 0.932 . . . . 0.0 114.154 -178.722 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -103.15 132.34 49.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.711 1.204 . . . . 0.0 111.797 -171.015 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -130.55 156.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.623 0.769 . . . . 0.0 111.199 168.051 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.0 137.7 53.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.187 0.995 . . . . 0.0 110.829 175.601 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.05 125.47 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.103 0.961 . . . . 0.0 109.915 177.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -111.19 126.73 55.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 113.065 -177.407 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -79.0 168.65 19.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 112.851 177.602 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.7 mt -59.94 -33.46 71.93 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.859 -1.151 . . . . 0.0 112.855 174.86 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -91.71 21.27 4.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.725 1.61 . . . . 0.0 113.52 173.748 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.4 28.02 73.6 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.902 1.239 . . . . 0.0 115.342 165.008 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -82.23 127.93 33.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.717 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -105.83 124.44 49.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.037 0.935 . . . . 0.0 110.236 -178.548 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -111.61 121.74 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 108.514 -175.728 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 m -97.76 120.72 38.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.508 1.523 . . . . 0.0 109.988 -179.666 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -118.61 148.36 42.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.056 0.942 . . . . 0.0 111.876 -178.462 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -104.93 116.57 32.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.115 1.366 . . . . 0.0 108.707 170.142 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.18 159.52 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.867 1.667 . . . . 0.0 111.504 -174.35 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -101.59 139.4 20.36 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.604 170.445 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.38 -27.27 48.0 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.04 2.493 . . . . 0.0 116.92 -173.284 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 m -91.25 5.91 47.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.472 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.21 157.51 22.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.593 1.088 . . . . 0.0 113.022 -178.134 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -84.35 155.67 22.24 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.632 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.28 -36.92 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.638 -0.664 . . . . 0.0 110.413 172.429 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.89 -42.73 69.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.254 1.422 . . . . 0.0 112.905 170.839 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.25 -26.27 64.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 174.695 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.13 -41.92 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 119.354 0.979 . . . . 0.0 110.491 168.442 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -60.74 -34.15 73.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.513 1.051 . . . . 0.0 112.859 174.093 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.76 -35.27 78.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 175.055 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.63 -40.94 80.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.629 0.772 . . . . 0.0 111.426 170.981 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.06 -37.4 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.378 -0.826 . . . . 0.0 111.335 174.69 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.97 -46.6 88.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.15 -0.968 . . . . 0.0 111.341 173.271 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.4 -42.98 97.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.582 0.753 . . . . 0.0 112.71 176.275 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -72.0 -51.37 22.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 113.429 -178.836 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -111.49 -15.42 13.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -165.342 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.98 31.35 64.49 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.915 1.234 . . . . 0.0 115.053 -178.799 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.11 120.06 52.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.938 1.295 . . . . 0.0 108.224 173.586 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.1 Cg_exo -58.43 139.76 91.87 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.751 2.301 . . . . 0.0 113.37 -179.893 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -56.25 -25.4 55.87 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.922 3.082 . . . . 0.0 117.112 -174.788 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.42 -18.6 41.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.655 1.582 . . . . 0.0 113.583 175.221 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -95.12 3.64 54.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.855 2.062 . . . . 0.0 112.243 173.963 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -94.7 150.51 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.394 1.478 . . . . 0.0 111.139 171.372 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -136.76 115.29 11.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.606 1.562 . . . . 0.0 110.204 166.725 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -99.76 137.63 37.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.905 1.282 . . . . 0.0 112.512 178.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.84 134.29 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.036 1.734 . . . . 0.0 110.213 -178.954 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -139.04 133.62 31.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.507 1.123 . . . . 0.0 111.428 172.434 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.01 35.57 5.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 113.834 -175.542 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 -5.96 63.47 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.079 1.8 . . . . 0.0 115.945 -176.624 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -87.75 126.49 35.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.85 1.825 . . . . 0.0 111.455 -178.912 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.58 121.15 20.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.354 0.979 . . . . 0.0 109.946 166.356 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.2 146.11 30.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -169.056 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.67 169.34 18.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.761 1.224 . . . . 0.0 110.404 161.773 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.09 -48.49 5.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.61 -1.307 . . . . 0.0 114.061 -170.201 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -8.88 87.23 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.711 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -76.82 157.35 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.807 1.303 . . . . 0.0 111.888 -179.64 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 p -82.68 158.87 22.77 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.119 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -54.6 -43.0 71.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.296 1.038 . . . . 0.0 111.772 168.81 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -64.3 -33.36 75.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.538 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.85 -18.53 62.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.541 1.064 . . . . 0.0 113.208 175.523 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -96.54 8.99 42.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.519 1.528 . . . . 0.0 113.719 166.629 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 54.43 31.38 14.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.509 1.523 . . . . 0.0 114.223 -177.386 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.78 128.58 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.525 -1.36 . . . . 0.0 109.515 -179.123 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -118.67 170.17 9.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.345 1.858 . . . . 0.0 112.274 -172.312 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -54.41 138.87 38.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.655 0.782 . . . . 0.0 112.664 176.915 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.01 17.87 5.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.546 1.938 . . . . 0.0 115.791 -174.592 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -62.55 138.06 58.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 121.085 -1.009 . . . . 0.0 110.995 168.629 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 m -101.92 123.59 46.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.551 1.14 . . . . 0.0 110.236 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.14 154.93 19.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.161 1.784 . . . . 0.0 108.904 171.546 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -105.96 148.91 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 110.621 169.124 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -122.52 128.9 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.968 1.707 . . . . 0.0 108.715 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.99 132.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.689 1.595 . . . . 0.0 108.473 167.842 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.77 117.76 25.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.427 0.691 . . . . 0.0 111.266 170.646 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.43 62.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.556 2.342 . . . . 0.0 108.566 -176.861 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.44 -27.93 68.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.673 1.589 . . . . 0.0 113.355 -174.427 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -68.59 147.36 52.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.379 1.072 . . . . 0.0 112.884 -178.801 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.2 23.71 70.02 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.91 0.767 . . . . 0.0 114.834 174.375 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.057 1.313 . . . . 0.0 113.996 176.25 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.715 0.293 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -80.25 140.83 36.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.385 1.074 . . . . 0.0 111.134 173.409 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -136.82 167.88 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.947 1.699 . . . . 0.0 111.242 168.51 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.41 144.52 48.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.676 1.19 . . . . 0.0 110.836 174.775 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.47 121.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.788 0.835 . . . . 0.0 109.548 172.031 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.85 150.71 22.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.131 1.372 . . . . 0.0 111.967 -179.642 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 p -128.8 152.06 48.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.165 0.986 . . . . 0.0 112.94 -176.237 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.49 -29.75 70.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.42 1.088 . . . . 0.0 111.322 169.438 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -70.12 9.48 0.57 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.227 1.811 . . . . 0.0 114.416 173.779 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.7 9.68 68.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.181 1.372 . . . . 0.0 115.945 168.519 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -103.91 158.18 16.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.19 1.495 . . . . 0.0 112.618 -174.956 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -130.37 113.49 14.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 108.336 163.036 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -101.13 139.07 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.246 1.018 . . . . 0.0 111.193 179.178 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 m -108.14 127.58 53.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.117 -174.552 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 mt -131.82 142.41 49.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.737 1.215 . . . . 0.0 111.748 -173.635 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -95.26 124.11 39.13 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.098 0.959 . . . . 0.0 110.075 166.133 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 m -137.49 157.58 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.306 -177.647 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 20' ' ' SER . 53.3 tp10 -105.68 142.31 24.51 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.272 1.029 . . . . 0.0 110.083 174.224 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -58.56 -16.83 31.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.351 2.034 . . . . 0.0 115.981 176.607 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 12.0 m -75.49 -13.47 60.37 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.398 1.879 . . . . 0.0 114.581 172.309 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -71.35 153.29 42.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.747 1.219 . . . . 0.0 112.187 -178.117 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -100.5 171.61 7.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.23 1.012 . . . . 0.0 112.606 175.57 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.58 -39.16 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.528 0.731 . . . . 0.0 111.238 179.994 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.25 -31.65 72.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.393 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -66.24 -49.37 67.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.693 1.133 . . . . 0.0 111.634 176.059 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -35.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.824 -179.715 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.57 -36.66 81.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.882 1.219 . . . . 0.0 113.157 173.949 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.4 75.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 173.805 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.369 174.643 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.93 -41.41 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.049 1.34 . . . . 0.0 110.466 167.999 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -61.61 -37.93 85.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.403 -0.811 . . . . 0.0 111.933 173.111 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.36 -33.3 74.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 172.72 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -75.74 -47.31 26.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.794 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.43 -9.51 11.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -165.798 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 30.66 64.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 119.787 1.176 . . . . 0.0 114.432 -178.614 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.38 114.7 52.82 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 126.152 1.781 . . . . 0.0 108.725 -175.381 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.5 152.35 78.65 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.555 2.837 . . . . 0.0 112.083 -175.324 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -66.62 -30.77 42.03 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.759 2.306 . . . . 0.0 112.342 -169.437 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.78 7.67 2.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 172.87 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -110.96 -7.56 14.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.654 1.982 . . . . 0.0 113.151 165.997 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -98.25 149.46 22.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.673 1.589 . . . . 0.0 113.039 -177.255 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -136.74 141.45 43.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.969 1.707 . . . . 0.0 109.963 154.478 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.25 143.63 44.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.187 0.995 . . . . 0.0 112.569 -175.892 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 141.32 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.741 2.016 . . . . 0.0 110.39 -175.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -143.4 124.26 14.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.533 177.604 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.02 50.33 11.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.678 1.591 . . . . 0.0 113.512 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.13 58.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 117.13 1.612 . . . . 0.0 117.13 -179.676 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -114.13 142.83 45.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.722 1.761 . . . . 0.0 112.075 178.418 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -69.86 135.32 49.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.873 0.869 . . . . 0.0 111.893 172.667 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.73 91.69 8.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.35 1.46 . . . . 0.0 109.721 171.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.49 139.6 36.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.913 0.885 . . . . 0.0 111.732 179.73 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.22 155.84 27.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.382 1.473 . . . . 0.0 113.742 -176.227 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.93 51.4 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.004 1.288 . . . . 0.0 115.43 -178.438 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -133.15 165.58 24.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.515 2.326 . . . . 0.0 111.386 174.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.1 p -92.18 162.68 14.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.844 1.258 . . . . 0.0 113.761 176.894 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.63 -32.9 73.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.418 -0.801 . . . . 0.0 112.191 172.59 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.9 p -70.01 -36.75 75.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.909 171.236 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -60.31 -35.23 75.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 121.174 1.806 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -86.1 2.24 47.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.324 1.45 . . . . 0.0 114.505 173.676 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.38 49.59 10.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.28 1.432 . . . . 0.0 114.256 171.623 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.07 136.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.242 177.55 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.96 169.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.154 1.782 . . . . 0.0 114.168 179.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.93 136.73 57.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.324 1.849 . . . . 0.0 112.488 175.168 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.9 mt-10 61.58 20.43 11.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.247 2.219 . . . . 0.0 115.782 -174.98 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.4 m -66.91 147.84 52.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.051 -1.031 . . . . 0.0 112.516 170.332 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.8 m -100.64 122.96 44.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.63 1.172 . . . . 0.0 110.74 169.052 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.37 160.8 14.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.643 1.577 . . . . 0.0 109.272 167.369 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -120.45 139.68 52.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.311 1.044 . . . . 0.0 110.365 177.729 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.71 136.37 45.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.301 1.44 . . . . 0.0 110.093 173.589 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.25 142.28 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.453 1.101 . . . . 0.0 109.725 161.839 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.46 150.39 24.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.339 0.656 . . . . 0.0 111.093 175.325 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -75.41 140.42 42.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.457 1.103 . . . . 0.0 112.482 -176.206 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.7 mt -133.16 158.97 41.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.744 1.617 . . . . 0.0 110.369 174.995 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -100.6 168.82 9.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.117 1.767 . . . . 0.0 111.124 175.117 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.12 -152.75 5.87 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.24 0.924 . . . . 0.0 113.278 -179.513 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.434 -174.135 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -121.59 149.66 42.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.234 1.014 . . . . 0.0 113.21 172.167 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.67 166.15 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.892 1.677 . . . . 0.0 109.693 160.43 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.13 127.43 47.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.083 0.953 . . . . 0.0 111.029 -174.828 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -108.12 123.5 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.338 1.055 . . . . 0.0 110.425 -178.155 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -107.56 131.6 54.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.053 1.741 . . . . 0.0 112.396 -177.071 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -90.3 163.25 14.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.452 1.101 . . . . 0.0 112.052 179.567 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.32 -28.61 66.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 p -80.41 -11.95 59.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.158 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 5.74 56.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.416 1.484 . . . . 0.0 115.564 178.903 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.44 139.22 51.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.002 1.401 . . . . 0.0 109.429 169.341 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.7 m -123.05 137.78 54.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.029 0.532 . . . . 0.0 110.53 175.198 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -122.81 137.51 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.168 1.387 . . . . 0.0 111.045 178.876 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -82.96 141.84 31.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.205 1.002 . . . . 0.0 110.514 171.866 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -133.75 140.83 47.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.433 1.093 . . . . 0.0 112.0 175.014 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -86.74 118.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.142 0.977 . . . . 0.0 110.762 177.498 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.21 175.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.365 1.866 . . . . 0.0 111.51 -174.179 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -133.69 161.08 65.93 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.759 1.624 . . . . 0.0 110.232 173.265 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -58.26 -26.73 78.02 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.737 2.291 . . . . 0.0 115.002 179.28 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -99.42 16.75 22.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.171 1.788 . . . . 0.0 113.374 176.457 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -87.66 143.56 27.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.353 -1.467 . . . . 0.0 111.107 177.201 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -89.77 158.37 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.07 0.948 . . . . 0.0 113.418 -170.944 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.32 -34.86 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 O-C-N 121.414 -0.804 . . . . 0.0 111.044 169.505 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.14 -36.41 77.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.971 172.215 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.7 -34.29 62.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.389 -0.819 . . . . 0.0 113.017 175.926 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.37 -46.43 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 118.591 0.632 . . . . 0.0 110.807 172.446 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -59.94 -38.34 82.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.351 0.978 . . . . 0.0 112.845 178.636 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.84 86.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 171.865 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -72.74 -22.96 60.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.817 -1.177 . . . . 0.0 113.853 177.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.36 -47.64 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.032 1.333 . . . . 0.0 110.338 165.339 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -57.05 -42.48 80.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.794 0.838 . . . . 0.0 111.543 176.608 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.66 -13.06 58.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 179.514 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.97 -58.22 1.92 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.621 1.169 . . . . 0.0 112.895 170.94 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -98.01 -6.77 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.74 1.216 . . . . 0.0 114.136 -167.948 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.19 -5.74 58.64 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 176.245 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.01 119.49 70.19 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.978 1.389 . . . . 0.0 109.355 -175.618 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.2 137.4 74.88 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.899 2.399 . . . . 0.0 112.352 -177.253 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.13 -31.07 83.04 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 113.735 -173.945 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.53 -15.13 63.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 172.92 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -94.86 -10.93 29.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.208 1.803 . . . . 0.0 113.433 176.468 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -94.96 147.03 23.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.955 1.302 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -132.52 138.45 47.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.251 1.42 . . . . 0.0 110.109 154.305 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.6 134.97 51.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.915 1.286 . . . . 0.0 112.077 -177.536 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.9 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.852 1.661 . . . . 0.0 110.496 -176.222 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.13 130.42 46.4 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.684 1.194 . . . . 0.0 111.473 171.844 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.73 42.07 8.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.28 1.832 . . . . 0.0 113.716 -177.152 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.42 0.16 86.25 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.525 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -113.53 138.13 50.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.265 2.033 . . . . 0.0 112.311 -179.389 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -75.73 141.65 42.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.105 1.362 . . . . 0.0 111.529 179.932 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.47 140.82 39.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.897 1.279 . . . . 0.0 111.337 -175.351 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -113.5 137.98 50.77 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.443 1.497 . . . . 0.0 113.106 -178.997 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.76 -54.76 2.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.543 3.137 . . . . 0.0 116.718 -173.904 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.46 8.37 41.26 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 -164.74 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -124.56 158.74 32.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.618 1.709 . . . . 0.0 112.191 -178.56 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.7 p -92.19 161.51 14.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.266 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -53.8 -40.16 66.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.967 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -66.34 -31.23 71.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -69.86 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.607 1.094 . . . . 0.0 113.687 173.881 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.57 7.23 26.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.553 1.541 . . . . 0.0 113.016 169.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 66.8 m-80 54.46 36.23 25.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.243 1.417 . . . . 0.0 114.381 -176.052 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.12 107.41 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 108.446 176.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.41 168.59 19.77 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.346 1.458 . . . . 0.0 112.365 -179.674 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 143.76 8.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.863 0.865 . . . . 0.0 112.977 166.635 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 62.43 1.56 0.76 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.417 2.287 . . . . 0.0 117.108 -177.992 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -54.79 146.97 15.89 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.622 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -104.78 125.74 51.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 110.5 -179.718 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.55 157.79 45.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.841 1.256 . . . . 0.0 112.119 179.592 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -114.27 141.18 47.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.968 0.907 . . . . 0.0 113.0 -162.289 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.59 112.33 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.724 1.61 . . . . 0.0 111.722 -177.207 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.91 145.77 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.217 1.807 . . . . 0.0 109.695 177.847 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.14 151.47 26.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.427 1.091 . . . . 0.0 113.282 -177.623 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -93.53 75.98 4.42 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.317 1.847 . . . . 0.0 112.16 179.639 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 154.82 26.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.503 1.521 . . . . 0.0 111.946 175.868 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 54.58 16.17 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.276 2.23 . . . . 0.0 115.662 -175.047 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.36 -166.33 29.88 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.652 1.596 . . . . 0.0 113.573 -179.905 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.832 1.206 . . . . 0.0 112.284 170.661 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.19 147.63 26.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 111.549 179.074 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -135.35 161.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.459 1.104 . . . . 0.0 109.09 153.669 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.09 145.66 46.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.738 1.215 . . . . 0.0 111.13 -179.36 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.44 127.83 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.322 1.049 . . . . 0.0 110.326 177.272 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -108.76 133.55 52.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 112.206 179.674 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -78.51 169.37 18.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.73 0.812 . . . . 0.0 112.517 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -58.0 -21.86 46.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.978 1.311 . . . . 0.0 113.754 171.895 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -106.61 16.29 24.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.843 1.657 . . . . 0.0 113.873 172.587 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.32 7.42 88.56 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 165.515 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.13 138.98 50.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.615 1.707 . . . . 0.0 109.862 174.1 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -117.07 125.2 50.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.884 0.873 . . . . 0.0 112.38 -168.2 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mm -114.31 125.19 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.319 1.848 . . . . 0.0 109.195 -177.778 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 m -94.23 133.31 37.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.427 1.091 . . . . 0.0 110.381 176.531 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.73 166.14 12.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.264 1.425 . . . . 0.0 112.437 179.957 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -119.88 119.34 33.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.678 171.519 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.14 166.81 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.589 1.556 . . . . 0.0 111.496 -169.798 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -129.96 165.37 33.96 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 110.089 161.878 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.87 -18.46 27.69 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.396 2.731 . . . . 0.0 116.469 -175.456 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 p -77.87 -13.96 59.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.879 2.072 . . . . 0.0 115.594 174.293 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.97 130.71 45.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.263 1.392 . . . . 0.0 111.665 179.33 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -78.11 164.29 25.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.772 0.829 . . . . 0.0 112.963 173.75 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.35 -35.58 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.848 -0.532 . . . . 0.0 109.851 171.5 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.72 -41.28 97.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.069 -1.019 . . . . 0.0 112.614 173.767 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.14 -43.51 98.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.394 0.543 . . . . 0.0 111.971 174.361 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.2 -43.51 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.086 179.082 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.39 -39.51 87.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.21 0.913 . . . . 0.0 112.824 175.162 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.58 73.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.111 0.964 . . . . 0.0 113.361 175.661 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.31 -37.67 74.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.603 1.161 . . . . 0.0 112.126 174.197 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.94 -46.2 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.348 1.459 . . . . 0.0 110.619 170.297 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.71 -44.46 85.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 111.521 176.496 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.05 -43.99 97.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.09 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -81.14 -44.36 18.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -174.175 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.36 -14.65 13.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.586 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.14 34.23 21.39 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.443 1.02 . . . . 0.0 115.397 175.501 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.32 117.73 61.51 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 118.56 1.18 . . . . 0.0 110.2 -179.322 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.85 131.98 49.26 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.311 2.674 . . . . 0.0 113.287 -179.542 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -26.77 10.57 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.416 2.744 . . . . 0.0 113.321 -162.719 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.28 -7.66 56.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.545 1.138 . . . . 0.0 113.721 -176.347 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.27 3.4 18.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 172.455 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.52 117.18 21.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.517 1.053 . . . . 0.0 110.509 178.61 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -92.89 116.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.192 0.997 . . . . 0.0 108.808 160.985 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.8 133.09 47.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.033 0.933 . . . . 0.0 111.307 175.455 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -133.84 136.14 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.723 1.209 . . . . 0.0 111.245 -166.538 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -145.12 129.31 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 111.476 169.703 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.47 11.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.003 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.04 -2.5 86.8 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.877 1.227 . . . . 0.0 116.058 -177.633 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 131.94 38.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.486 1.643 . . . . 0.0 109.992 171.317 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -83.19 133.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 159.274 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.92 127.11 40.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.814 0.846 . . . . 0.0 110.008 -170.334 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -100.14 144.83 28.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -167.427 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.64 -33.23 71.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -166.511 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 -7.47 71.47 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 176.424 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -107.31 169.0 8.84 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.908 1.683 . . . . 0.0 112.428 -171.292 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 p -114.6 171.34 7.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.935 2.094 . . . . 0.0 113.977 -178.911 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.1 mt -55.42 -40.45 71.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.686 -0.634 . . . . 0.0 112.102 166.652 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 p -69.23 -25.68 64.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 176.896 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.26 -28.25 67.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.849 1.204 . . . . 0.0 112.952 171.82 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.0 11.99 27.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.763 1.625 . . . . 0.0 113.402 177.166 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.82 35.9 25.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.212 1.405 . . . . 0.0 114.262 175.914 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mm -80.89 121.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.33 1.052 . . . . 0.0 109.32 178.09 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.31 178.19 5.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.8 1.64 . . . . 0.0 112.426 176.941 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -47.17 154.66 0.36 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.199 1.4 . . . . 0.0 113.049 172.546 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 60.7 11.96 3.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.609 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -69.33 144.36 53.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 112.455 179.372 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 m -104.72 132.31 51.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.863 0.865 . . . . 0.0 110.229 169.465 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -117.06 160.45 20.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.356 2.262 . . . . 0.0 109.455 177.073 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -110.93 149.29 30.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.994 0.918 . . . . 0.0 112.453 175.672 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -121.26 142.21 50.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.931 2.092 . . . . 0.0 110.266 176.173 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.79 141.14 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 109.014 167.188 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.99 120.64 32.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.954 176.486 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 -64.2 -36.0 82.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 113.813 -175.437 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.68 22.28 1.97 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.412 1.085 . . . . 0.0 113.551 -177.495 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -136.66 156.0 49.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.633 1.973 . . . . 0.0 110.057 175.765 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.33 17.72 16.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.298 -176.562 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.483 1.992 . . . . 0.0 112.892 -177.517 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.78 140.19 35.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.277 1.031 . . . . 0.0 111.92 -179.37 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.52 151.68 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.045 1.338 . . . . 0.0 110.691 159.756 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -98.14 152.62 19.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.546 1.138 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -132.37 121.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.735 1.214 . . . . 0.0 109.244 169.671 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -87.38 136.77 32.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 110.361 170.136 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -111.11 142.68 42.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.191 0.996 . . . . 0.0 110.288 163.335 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.0 mt -70.16 -15.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -161.149 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -77.63 -9.76 59.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 171.334 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.75 -40.43 1.41 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.818 165.731 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.99 152.37 41.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.562 1.681 . . . . 0.0 113.671 -168.083 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -108.72 143.87 37.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.396 1.479 . . . . 0.0 109.789 173.771 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 mt -123.91 147.95 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.294 2.637 . . . . 0.0 108.164 -174.92 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -119.18 136.81 54.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.439 1.096 . . . . 0.0 112.385 174.346 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.2 149.24 49.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.125 1.37 . . . . 0.0 110.774 174.43 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -102.58 127.78 49.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.168 0.987 . . . . 0.0 110.385 167.407 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 175.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.287 1.835 . . . . 0.0 111.71 -175.951 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -123.15 153.76 64.8 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 125.966 1.707 . . . . 0.0 109.46 161.694 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.66 -13.58 40.5 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.665 2.243 . . . . 0.0 114.348 -175.0 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 p -79.63 -8.67 59.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 171.842 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -68.05 156.64 36.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.659 1.118 . . . . 0.0 112.802 -176.918 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 p -106.07 150.11 26.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.266 1.827 . . . . 0.0 112.48 -174.016 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.47 -37.57 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.338 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -36.99 85.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.905 1.229 . . . . 0.0 112.003 176.018 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.77 -27.87 62.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.703 0.801 . . . . 0.0 112.368 177.42 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.01 -38.42 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 120.975 -1.078 . . . . 0.0 111.488 169.322 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.75 -35.11 73.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.105 1.321 . . . . 0.0 112.095 167.379 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.89 -28.13 64.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 174.81 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.04 -39.72 75.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.983 1.265 . . . . 0.0 111.715 168.85 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.13 -41.85 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.493 171.388 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -61.1 -40.83 95.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.234 -0.916 . . . . 0.0 112.503 173.717 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.75 -43.87 91.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.774 176.446 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -84.62 -32.48 23.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.205 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.85 -11.28 8.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.457 1.503 . . . . 0.0 114.965 -172.813 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.18 -6.69 78.58 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 177.968 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.36 120.97 82.9 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.825 1.25 . . . . 0.0 110.531 -170.516 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.57 133.04 49.23 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.983 2.455 . . . . 0.0 112.472 176.532 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.57 -29.22 59.38 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.458 2.772 . . . . 0.0 115.651 -179.535 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.49 -21.88 64.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.703 1.138 . . . . 0.0 113.765 176.328 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.13 -2.73 58.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.516 1.926 . . . . 0.0 113.382 171.686 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.11 142.54 33.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.075 1.35 . . . . 0.0 111.995 179.874 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -136.07 133.81 37.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.445 1.498 . . . . 0.0 109.423 161.094 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.44 144.69 38.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.953 0.901 . . . . 0.0 112.903 -172.372 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.43 138.38 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.925 1.69 . . . . 0.0 110.933 178.853 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -139.82 138.49 35.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.577 1.551 . . . . 0.0 110.078 163.467 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.84 34.74 5.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.964 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.04 0.3 69.44 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.766 1.65 . . . . 0.0 116.457 -176.329 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.45 126.87 38.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.371 1.868 . . . . 0.0 110.56 -179.45 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -75.19 114.97 14.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 109.65 171.639 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 mt -79.9 124.82 29.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.747 0.819 . . . . 0.0 112.699 -165.57 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -86.32 129.87 34.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.645 1.578 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.1 -28.31 62.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -170.265 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 -3.71 89.75 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.45 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -104.97 163.48 12.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.611 1.706 . . . . 0.0 113.233 -172.454 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -98.6 160.31 14.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 113.953 176.616 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.95 -40.85 94.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.412 1.085 . . . . 0.0 113.039 177.429 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.0 p -63.35 -43.62 97.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.623 176.605 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.78 -37.54 76.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.746 0.818 . . . . 0.0 111.737 173.047 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -80.78 3.54 22.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.579 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 61.09 28.45 18.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.843 1.656 . . . . 0.0 114.544 -178.266 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.12 137.73 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.85 -1.156 . . . . 0.0 109.248 175.456 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -135.16 172.69 12.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.994 1.718 . . . . 0.0 112.342 -173.419 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -52.44 135.79 32.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 168.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 63.36 30.39 15.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.815 1.646 . . . . 0.0 114.931 -177.301 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 m -81.02 150.51 28.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.186 -1.571 . . . . 0.0 112.186 167.932 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -108.51 119.28 39.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.096 0.958 . . . . 0.0 110.773 168.913 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -86.28 158.1 19.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.367 1.467 . . . . 0.0 110.472 165.258 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -118.01 132.29 56.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.872 0.869 . . . . 0.0 109.817 168.574 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 tp -101.24 127.76 47.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.831 1.653 . . . . 0.0 109.136 175.397 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.21 132.83 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.516 1.526 . . . . 0.0 108.098 169.879 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.86 149.68 28.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.988 0.515 . . . . 0.0 112.092 174.436 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 71.13 1.47 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.132 1.373 . . . . 0.0 110.338 172.905 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.42 143.16 53.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.439 1.096 . . . . 0.0 112.026 -176.207 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -73.05 -34.15 66.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -166.335 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.04 132.21 28.38 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 118.671 0.669 . . . . 0.0 114.025 -171.286 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.3 -1.278 . . . . 0.0 113.545 176.983 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.34 147.37 25.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.42 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 165.65 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.598 1.159 . . . . 0.0 111.661 158.881 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -115.7 135.63 53.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.167 . . . . 0.0 112.559 -175.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -108.56 127.15 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.536 1.135 . . . . 0.0 109.248 164.275 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -111.86 126.55 55.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.311 1.044 . . . . 0.0 112.127 -175.843 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -99.94 163.55 12.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.701 1.201 . . . . 0.0 113.509 -168.291 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 mt -73.94 -5.31 40.42 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.805 1.242 . . . . 0.0 113.318 170.675 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 p -92.17 6.69 45.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.121 1.768 . . . . 0.0 113.515 170.646 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.66 82.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.211 1.386 . . . . 0.0 114.465 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -93.28 153.87 18.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.414 1.886 . . . . 0.0 110.789 -176.208 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.8 m -122.03 123.38 41.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.223 1.009 . . . . 0.0 110.162 165.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.48 125.52 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.899 1.28 . . . . 0.0 108.043 171.693 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -101.15 132.88 46.41 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.372 1.069 . . . . 0.0 109.645 178.728 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.1 mt -129.2 116.15 18.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 109.825 -170.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.41 124.46 39.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.24 1.416 . . . . 0.0 110.352 178.579 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -151.74 164.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.01 2.124 . . . . 0.0 111.607 -164.602 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -104.75 150.24 38.4 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.053 0.941 . . . . 0.0 110.476 162.289 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.78 -20.92 72.45 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.993 2.462 . . . . 0.0 114.905 -174.609 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -81.62 -4.52 56.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.016 1.726 . . . . 0.0 114.47 173.93 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.48 147.16 49.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 111.685 173.694 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.7 p -71.99 157.25 38.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.252 -0.905 . . . . 0.0 112.936 179.046 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.38 -26.14 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.503 -1.373 . . . . 0.0 110.865 167.523 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.83 -32.74 74.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.787 -1.82 . . . . 0.0 113.161 167.809 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -70.55 -37.95 74.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 120.973 -1.079 . . . . 0.0 111.014 173.382 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.53 -49.5 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 111.368 169.645 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.27 -42.45 86.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.453 1.024 . . . . 0.0 112.624 174.57 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.6 93.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.99 0.916 . . . . 0.0 112.938 179.572 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -66.13 -25.15 66.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.394 1.078 . . . . 0.0 113.315 175.093 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.1 -47.06 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.779 0.832 . . . . 0.0 110.535 167.831 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -55.98 -40.06 72.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.215 1.006 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.59 -22.37 55.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 114.925 175.009 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.33 -36.14 8.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.885 1.674 . . . . 0.0 113.771 174.62 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -117.15 -14.12 10.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -160.953 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.64 3.8 59.76 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 176.073 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.85 119.79 76.09 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 119.144 1.472 . . . . 0.0 108.536 176.62 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.88 155.73 53.13 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.305 2.003 . . . . 0.0 112.569 -176.592 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.19 -30.79 89.17 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.737 2.291 . . . . 0.0 114.411 -169.048 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.258 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.12 -23.16 16.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.899 1.28 . . . . 0.0 112.865 172.777 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -79.85 116.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.445 -0.784 . . . . 0.0 110.718 -178.049 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -118.39 132.03 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.534 1.134 . . . . 0.0 110.678 167.873 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.94 138.35 50.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.94 1.296 . . . . 0.0 112.334 -170.443 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.99 140.36 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.403 1.881 . . . . 0.0 110.1 -177.272 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.77 126.86 31.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.09 1.756 . . . . 0.0 109.84 172.487 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.59 50.91 10.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 113.397 177.659 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.71 10.47 71.73 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 179.156 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -125.28 140.23 53.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.211 1.804 . . . . 0.0 111.832 -176.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -81.76 144.21 31.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.095 0.958 . . . . 0.0 112.305 -179.072 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -104.28 112.53 25.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.9 1.28 . . . . 0.0 111.113 -176.907 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -93.32 135.64 34.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 113.116 -176.73 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.79 -15.09 63.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -168.753 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -14.61 82.4 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.522 1.055 . . . . 0.0 114.942 170.073 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -94.8 175.9 6.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.327 1.851 . . . . 0.0 111.937 -178.203 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -113.63 167.98 10.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.99 1.716 . . . . 0.0 112.713 178.034 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.38 -37.13 72.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.654 . . . . 0.0 111.989 169.244 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.28 -32.14 73.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 178.192 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.22 -33.47 72.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.607 1.094 . . . . 0.0 112.795 178.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.43 8.03 43.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.414 1.486 . . . . 0.0 113.612 -179.547 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 49.29 52.76 13.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.675 1.19 . . . . 0.0 112.499 -175.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -85.54 134.14 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.505 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -125.16 165.06 18.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.066 1.746 . . . . 0.0 110.999 -173.006 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 139.14 7.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.533 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.33 21.36 9.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.505 1.922 . . . . 0.0 115.042 176.503 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -64.04 147.12 52.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.839 0.856 . . . . 0.0 111.661 165.533 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 p -104.94 131.22 52.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.229 1.012 . . . . 0.0 112.127 174.297 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.75 144.71 41.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.334 2.254 . . . . 0.0 109.878 179.74 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.08 168.25 16.36 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.708 1.603 . . . . 0.0 112.322 -169.547 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.94 156.31 44.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.508 1.123 . . . . 0.0 113.332 -177.486 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -119.1 120.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 109.071 172.275 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.6 tp -68.22 -47.87 66.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.634 0.774 . . . . 0.0 113.081 -171.352 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -61.61 -30.39 70.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.204 0.911 . . . . 0.0 112.318 179.408 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -72.86 -26.72 61.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.635 1.174 . . . . 0.0 113.078 174.773 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -74.5 -18.65 60.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.327 0.967 . . . . 0.0 113.136 170.375 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.27 152.13 44.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.165 0.888 . . . . 0.0 112.975 167.749 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.757 -1.579 . . . . 0.0 113.877 -178.369 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -80.31 132.34 35.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 111.8 173.063 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -135.39 171.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 111.268 173.051 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -124.52 146.86 48.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.271 1.028 . . . . 0.0 112.216 178.368 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -127.71 125.03 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 110.753 174.615 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.74 115.9 19.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.789 1.236 . . . . 0.0 109.006 168.628 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -83.79 -177.37 6.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.426 1.491 . . . . 0.0 113.541 -175.629 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.2 mt -69.33 -25.3 64.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.615 -1.303 . . . . 0.0 113.26 179.009 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -84.45 -0.67 53.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.93 1.292 . . . . 0.0 113.209 167.871 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 8.08 82.72 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.53 -1.356 . . . . 0.0 115.061 -176.049 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.28 138.73 57.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.46 1.63 . . . . 0.0 108.99 171.921 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -97.66 96.67 8.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.196 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 pt -90.35 140.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.393 1.077 . . . . 0.0 111.887 -177.096 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -100.32 113.47 26.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 111.038 -170.769 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mp -107.69 164.22 12.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 111.723 -176.684 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.36 127.97 51.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.59 1.156 . . . . 0.0 110.425 167.146 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.24 152.91 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.5 -176.752 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.29 131.11 25.7 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 125.178 1.391 . . . . 0.0 111.205 170.223 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -53.46 -26.49 36.21 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 123.528 2.819 . . . . 0.0 116.432 176.779 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -74.68 -13.5 60.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 177.325 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -75.83 154.66 36.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.806 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.1 p -84.0 147.95 27.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 112.44 179.349 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -57.49 -36.67 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.951 0.9 . . . . 0.0 110.864 174.635 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.33 -35.35 71.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.75 -1.219 . . . . 0.0 113.639 -179.407 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -68.22 -34.87 77.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.778 0.717 . . . . 0.0 111.695 172.313 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.7 -37.02 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 111.737 171.675 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -61.17 -37.55 83.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.314 1.416 . . . . 0.0 113.13 170.656 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.99 93.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 118.74 0.7 . . . . 0.0 112.815 172.088 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -73.22 -27.92 61.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.434 1.094 . . . . 0.0 112.738 178.535 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.62 -38.56 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.376 1.071 . . . . 0.0 111.316 168.155 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -60.61 -46.35 90.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.906 1.23 . . . . 0.0 111.014 171.04 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.17 -39.76 93.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.031 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -72.73 -49.19 32.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.097 1.359 . . . . 0.0 113.912 -178.054 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -114.68 -12.06 12.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.699 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 22.29 65.43 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.289 0.95 . . . . 0.0 114.968 -178.415 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 mt -107.45 111.93 62.75 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.692 1.597 . . . . 0.0 108.555 179.87 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -66.1 152.74 80.5 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.421 2.081 . . . . 0.0 114.912 -176.283 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -55.34 -32.75 82.69 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.59 2.86 . . . . 0.0 115.296 -174.712 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.24 -15.41 61.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 177.96 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.99 -14.33 24.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.036 1.334 . . . . 0.0 113.887 173.595 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.49 141.59 33.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.613 0.765 . . . . 0.0 111.881 -175.338 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -131.46 139.13 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.863 2.065 . . . . 0.0 108.222 162.563 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 131.11 49.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.533 0.733 . . . . 0.0 112.288 -167.858 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.77 137.81 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.387 1.475 . . . . 0.0 111.342 -177.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.64 105.7 8.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.083 2.153 . . . . 0.0 109.671 172.021 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.77 60.53 3.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.016 1.727 . . . . 0.0 112.88 -176.765 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.17 -20.18 1.21 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 -176.086 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -83.45 130.2 35.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.282 2.041 . . . . 0.0 111.262 178.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.7 138.62 41.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.737 -0.602 . . . . 0.0 111.597 173.359 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.53 139.14 30.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.585 1.154 . . . . 0.0 111.589 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -109.37 144.11 38.0 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.895 1.678 . . . . 0.0 111.613 -177.269 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.42 -33.9 77.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.259 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.47 19.57 3.81 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.718 1.447 . . . . 0.0 116.718 -179.102 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.44 165.01 12.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.75 1.775 . . . . 0.0 113.328 179.486 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -105.32 164.42 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.455 1.502 . . . . 0.0 111.245 165.06 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.71 -33.19 74.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.971 -1.08 . . . . 0.0 112.663 179.402 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -63.26 -31.81 73.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.454 1.101 . . . . 0.0 113.651 172.898 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.11 -22.25 66.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.959 1.254 . . . . 0.0 112.882 174.175 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -101.15 2.76 40.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.815 1.246 . . . . 0.0 113.761 173.496 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 55.26 36.44 27.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.522 1.129 . . . . 0.0 113.822 178.033 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.29 136.09 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.217 1.407 . . . . 0.0 109.229 179.67 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -127.59 177.42 6.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.482 1.113 . . . . 0.0 113.107 175.408 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -42.56 142.31 0.86 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.217 1.807 . . . . 0.0 114.384 169.604 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 63.82 13.66 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.895 2.078 . . . . 0.0 116.032 -179.748 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.3 m -72.79 150.04 43.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.735 -1.228 . . . . 0.0 112.263 171.367 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 m -109.36 141.11 42.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.052 1.341 . . . . 0.0 110.483 172.371 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.38 160.04 24.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.991 2.117 . . . . 0.0 110.191 171.666 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.7 133.6 52.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.761 0.824 . . . . 0.0 111.285 -179.629 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 tp -101.77 135.7 42.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.296 1.439 . . . . 0.0 111.086 179.631 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.6 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.764 2.026 . . . . 0.0 109.366 -176.465 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.7 tp -88.24 140.27 29.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.801 1.24 . . . . 0.0 111.766 176.124 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm85 -134.77 149.58 50.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.562 1.945 . . . . 0.0 110.712 166.64 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.46 59.22 1.7 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.615 1.566 . . . . 0.0 111.909 -170.282 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -128.12 -3.22 5.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.4 2.28 . . . . 0.0 115.258 -178.444 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.83 -32.08 58.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 119.91 1.232 . . . . 0.0 114.231 179.066 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.946 -1.474 . . . . 0.0 113.942 166.775 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.31 139.84 30.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.292 1.037 . . . . 0.0 112.134 179.58 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -131.35 162.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.967 1.307 . . . . 0.0 111.45 170.097 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.46 145.38 44.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.769 1.228 . . . . 0.0 111.783 177.348 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -131.42 115.8 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.942 1.297 . . . . 0.0 108.892 176.104 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -104.03 132.97 49.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.539 1.136 . . . . 0.0 111.68 -177.335 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -82.62 168.09 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.352 1.061 . . . . 0.0 112.627 -176.611 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.31 -23.42 65.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.31 -0.869 . . . . 0.0 112.761 171.455 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -82.71 1.98 36.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.59 2.356 . . . . 0.0 114.459 167.909 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.06 4.41 90.26 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.349 -1.806 . . . . 0.0 117.073 169.302 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -84.28 149.66 25.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.827 2.314 . . . . 0.0 111.37 174.298 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.4 m -105.0 132.6 51.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.408 1.083 . . . . 0.0 111.525 179.524 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.46 142.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 128.076 2.55 . . . . 0.0 107.578 169.67 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.2 m -119.88 134.75 55.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.532 1.133 . . . . 0.0 110.459 -178.648 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.21 148.92 48.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.368 1.067 . . . . 0.0 112.679 -177.375 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -102.68 115.37 30.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 110.202 172.911 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.1 171.51 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 126.5 1.92 . . . . 0.0 112.668 -170.499 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -106.81 158.06 33.73 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 123.846 0.858 . . . . 0.0 111.635 163.845 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.51 -22.44 66.42 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.696 2.264 . . . . 0.0 114.016 170.563 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -78.21 -10.47 59.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.026 2.13 . . . . 0.0 114.756 176.081 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 132.38 47.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.954 1.252 . . . . 0.0 111.125 178.571 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -70.41 159.65 33.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.822 1.249 . . . . 0.0 111.822 174.76 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.23 -28.27 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.225 -0.922 . . . . 0.0 111.156 170.917 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.37 -46.34 90.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.546 1.066 . . . . 0.0 112.354 167.68 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -63.56 -37.23 86.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.335 -0.853 . . . . 0.0 112.706 174.794 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.91 -44.25 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 119.158 0.89 . . . . 0.0 110.841 178.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -57.1 -38.28 73.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.827 0.739 . . . . 0.0 111.774 171.388 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.22 70.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 177.065 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.66 -37.36 62.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.865 1.211 . . . . 0.0 112.62 172.228 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.2 -40.02 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.69 0.796 . . . . 0.0 110.282 171.086 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.09 -35.29 80.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 112.414 172.922 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.5 -45.42 93.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.051 -1.031 . . . . 0.0 112.969 175.656 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -84.72 -42.74 14.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -113.03 -4.47 13.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.714 1.205 . . . . 0.0 114.029 -169.738 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.24 74.68 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 116.469 1.348 . . . . 0.0 116.469 171.644 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -77.24 125.28 86.7 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 119.201 1.5 . . . . 0.0 110.64 -173.039 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.52 140.49 94.23 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.276 2.651 . . . . 0.0 113.823 176.494 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -55.44 -40.9 82.98 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.223 2.615 . . . . 0.0 115.592 -176.16 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.87 -5.93 54.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.387 0.994 . . . . 0.0 113.065 178.73 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.62 -2.57 53.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.215 1.406 . . . . 0.0 113.548 162.129 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.11 140.41 30.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.182 1.81 . . . . 0.0 111.272 175.048 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.36 130.27 49.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.647 1.579 . . . . 0.0 109.085 161.452 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -124.29 128.76 49.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.842 1.257 . . . . 0.0 111.292 -171.75 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.82 141.4 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.554 1.941 . . . . 0.0 111.341 -172.631 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -146.3 145.15 30.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.773 1.229 . . . . 0.0 111.625 162.965 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.32 8.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.308 1.443 . . . . 0.0 114.069 -178.171 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.46 13.96 77.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.153 1.358 . . . . 0.0 115.82 179.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -124.69 140.9 52.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.492 1.646 . . . . 0.0 112.111 -179.642 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -73.21 131.98 42.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.288 1.035 . . . . 0.0 111.126 171.225 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -94.28 149.91 20.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.965 1.306 . . . . 0.0 111.3 -176.231 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -124.09 142.03 51.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -165.038 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.08 -20.9 63.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.665 1.986 . . . . 0.0 115.756 -167.495 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.67 7.82 63.51 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.098 1.332 . . . . 0.0 114.821 178.522 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -123.5 166.12 15.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.788 1.635 . . . . 0.0 111.721 177.097 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -111.21 166.29 11.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.682 1.593 . . . . 0.0 112.86 -173.734 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.44 -38.46 66.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 172.909 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -66.72 -25.91 66.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.773 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.77 -17.92 64.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 120.324 1.42 . . . . 0.0 113.016 173.153 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -109.33 11.89 25.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.714 1.606 . . . . 0.0 113.535 178.427 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 55.72 30.55 15.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.313 1.445 . . . . 0.0 114.05 -177.775 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -75.6 137.93 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 110.113 179.106 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.89 176.09 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.947 1.699 . . . . 0.0 112.305 -171.357 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -63.24 137.55 58.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.622 -0.674 . . . . 0.0 110.877 167.154 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.88 14.76 6.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.468 1.907 . . . . 0.0 116.133 -174.633 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.1 m -61.71 146.8 48.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.779 -1.2 . . . . 0.0 111.519 161.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -113.11 120.66 42.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.103 0.961 . . . . 0.0 110.656 174.977 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.51 156.7 16.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.346 1.858 . . . . 0.0 109.792 174.812 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -114.1 135.69 53.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.284 -0.885 . . . . 0.0 112.524 178.345 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.6 tp -116.02 134.18 55.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.553 1.541 . . . . 0.0 111.186 -173.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.2 t -121.5 132.87 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.689 1.596 . . . . 0.0 108.968 170.339 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -90.03 121.16 31.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.809 170.11 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 106.01 18.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.61 1.564 . . . . 0.0 110.694 -170.361 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.56 137.64 36.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.877 1.271 . . . . 0.0 109.845 176.782 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -87.67 -57.16 3.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -167.039 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.33 -34.17 61.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.632 173.644 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.525 2.012 . . . . 0.0 111.48 -170.84 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.49 137.92 34.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.396 0.678 . . . . 0.0 111.779 173.496 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 pt -136.78 159.3 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.667 1.587 . . . . 0.0 111.641 167.086 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -116.86 148.62 41.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.317 1.447 . . . . 0.0 111.434 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -131.12 127.54 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 110.032 173.126 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -99.42 126.26 45.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.362 1.865 . . . . 0.0 110.72 178.839 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -90.42 139.67 30.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.627 0.649 . . . . 0.0 109.798 167.285 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -74.92 -10.02 59.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.327 -0.858 . . . . 0.0 113.052 177.865 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -74.72 -2.85 28.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.715 2.006 . . . . 0.0 114.249 162.285 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 50.33 2.76 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.47 1.033 . . . . 0.0 115.186 167.646 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -136.35 151.07 49.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.492 1.517 . . . . 0.0 111.03 171.827 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -114.84 123.38 49.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.102 1.361 . . . . 0.0 110.438 175.523 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -106.36 138.74 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.692 1.997 . . . . 0.0 108.073 179.121 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -124.69 126.05 45.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 110.431 -178.159 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -129.6 148.18 51.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.471 1.108 . . . . 0.0 112.115 -175.865 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.54 108.06 15.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 109.955 172.629 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.37 165.27 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.584 1.954 . . . . 0.0 112.99 -162.991 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.62 146.18 40.96 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 121.502 -0.749 . . . . 0.0 111.366 171.955 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.72 -25.39 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.064 2.509 . . . . 0.0 114.493 168.631 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -92.74 4.88 52.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 114.558 179.683 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -71.58 145.02 49.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.062 1.301 . . . . 0.0 111.534 170.362 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -83.32 159.71 21.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.974 0.91 . . . . 0.0 112.338 176.973 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm -66.75 -32.57 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 O-C-N 121.221 -0.924 . . . . 0.0 110.712 173.954 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.29 -44.03 83.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.766 1.227 . . . . 0.0 112.342 170.073 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -65.87 -46.29 78.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 173.646 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.58 -40.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.646 -1.284 . . . . 0.0 111.688 175.333 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 55.0 mtpt -64.3 -35.87 82.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 112.484 173.66 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.66 -30.39 65.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 174.066 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -66.46 -46.01 77.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.07 0.948 . . . . 0.0 110.686 169.502 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.15 -35.38 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.409 1.084 . . . . 0.0 111.624 176.498 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.79 -43.32 98.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 111.614 172.407 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.36 -39.54 85.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.532 -0.73 . . . . 0.0 112.778 176.299 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -79.16 -40.33 31.18 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.12 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -117.29 -9.09 11.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 114.108 -171.025 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.65 83.44 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.645 1.111 . . . . 0.0 115.643 -179.277 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.3 121.41 72.52 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 119.222 1.511 . . . . 0.0 109.246 -176.96 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.83 141.86 41.84 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.603 2.202 . . . . 0.0 113.371 -176.035 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.63 -26.44 23.5 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.437 2.758 . . . . 0.0 114.218 -164.653 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.46 -19.23 63.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.635 1.107 . . . . 0.0 113.07 177.396 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -91.51 -32.91 15.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.845 1.258 . . . . 0.0 112.604 174.471 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.8 mt-30 -64.09 135.36 56.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.336 0.971 . . . . 0.0 112.429 179.926 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -133.79 125.47 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.548 1.539 . . . . 0.0 111.556 167.212 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.08 130.56 36.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.141 0.976 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.85 131.24 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.227 1.811 . . . . 0.0 109.579 178.934 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -144.57 125.54 14.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.779 1.232 . . . . 0.0 111.054 176.071 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.45 54.03 9.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.361 1.864 . . . . 0.0 113.521 -178.55 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.09 -13.07 40.45 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 176.785 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -108.09 143.94 36.15 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.759 1.779 . . . . 0.0 112.781 -174.021 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -85.72 131.35 34.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.715 1.206 . . . . 0.0 110.707 170.579 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.52 147.15 27.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.563 0.745 . . . . 0.0 112.174 -177.337 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.2 -177.33 6.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.158 1.783 . . . . 0.0 111.545 172.438 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -94.11 -56.44 2.85 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.377 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.26 90.12 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 -170.27 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -82.4 154.24 25.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 111.215 179.757 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.8 p -93.08 156.05 17.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.897 1.279 . . . . 0.0 114.163 -175.005 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.58 -40.48 75.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.924 0.889 . . . . 0.0 112.753 178.615 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -62.66 -34.86 77.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.293 1.037 . . . . 0.0 113.69 175.14 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.092 0.86 . . . . 0.0 112.987 178.105 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -84.92 5.71 27.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.156 1.382 . . . . 0.0 114.404 166.747 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 58.52 38.6 25.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.54 1.536 . . . . 0.0 113.636 179.061 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.52 116.35 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.671 1.188 . . . . 0.0 108.506 175.622 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -113.94 -178.61 3.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.394 1.478 . . . . 0.0 111.699 -176.316 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -48.96 143.26 5.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.941 1.296 . . . . 0.0 113.614 176.985 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.86 30.17 19.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.46 1.504 . . . . 0.0 114.401 177.512 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.8 m -83.93 151.24 25.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.726 -1.234 . . . . 0.0 112.127 174.794 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.5 m -114.23 128.2 56.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.07 1.348 . . . . 0.0 110.734 170.645 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -111.8 162.26 15.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.71 2.004 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -114.06 143.15 45.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 176.091 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -121.7 117.71 27.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.576 1.55 . . . . 0.0 111.341 -178.835 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.27 166.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 126.235 1.814 . . . . 0.0 111.11 176.547 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.4 135.66 53.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.4 1.08 . . . . 0.0 113.224 -174.806 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -99.39 102.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.679 1.992 . . . . 0.0 109.281 174.653 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.31 132.17 56.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.639 1.176 . . . . 0.0 112.032 -166.902 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -70.52 -38.6 74.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.957 1.303 . . . . 0.0 114.057 -174.363 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.91 -149.78 48.25 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.738 0.699 . . . . 0.0 112.495 -169.777 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.11 1.814 . . . . 0.0 114.495 -177.941 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.74 135.64 35.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.545 1.138 . . . . 0.0 112.954 -171.712 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.02 176.3 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.313 1.445 . . . . 0.0 112.119 166.471 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.63 154.01 47.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.847 1.259 . . . . 0.0 112.657 177.536 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.78 131.26 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.341 1.456 . . . . 0.0 110.502 -179.905 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -104.79 147.6 27.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.227 1.811 . . . . 0.0 112.408 173.074 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -109.87 164.61 12.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.352 1.861 . . . . 0.0 113.242 173.603 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -77.36 7.75 4.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.598 1.559 . . . . 0.0 113.934 169.399 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -110.65 11.54 22.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.949 2.1 . . . . 0.0 112.74 -179.391 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.9 86.62 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.605 1.098 . . . . 0.0 115.44 -177.734 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -94.53 142.29 27.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.879 1.34 . . . . 0.0 110.52 178.951 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -130.3 137.0 49.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.419 1.088 . . . . 0.0 109.211 166.352 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.48 158.16 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.067 1.747 . . . . 0.0 111.414 -176.49 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -106.01 148.82 27.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.28 1.032 . . . . 0.0 111.729 172.238 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.24 150.68 48.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.544 1.138 . . . . 0.0 111.573 -176.503 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -96.85 126.62 42.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.987 0.899 . . . . 0.0 111.658 173.251 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.52 163.66 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.4 1.88 . . . . 0.0 110.275 -178.523 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -96.12 149.23 35.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.579 164.529 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.68 -28.39 46.48 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.897 2.398 . . . . 0.0 115.388 176.095 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -114.37 36.92 3.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.329 1.852 . . . . 0.0 113.589 171.256 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.4 148.42 33.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.647 -1.283 . . . . 0.0 112.0 170.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -80.29 142.74 34.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.107 1.363 . . . . 0.0 110.474 -177.999 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.12 -36.62 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.279 -0.888 . . . . 0.0 112.454 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.03 -35.05 68.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.542 1.065 . . . . 0.0 113.238 171.412 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -73.03 -34.2 66.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.253 -0.905 . . . . 0.0 112.291 177.738 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.36 -48.69 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 172.137 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.04 -37.48 85.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.586 1.154 . . . . 0.0 112.456 177.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.15 98.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.47 -0.769 . . . . 0.0 111.76 174.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -69.24 -25.18 64.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.784 -1.197 . . . . 0.0 113.767 175.192 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.58 -28.52 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.372 1.069 . . . . 0.0 112.035 168.951 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -58.96 -39.18 80.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.803 1.638 . . . . 0.0 111.8 175.031 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.18 -39.52 86.76 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.287 0.635 . . . . 0.0 112.195 178.845 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -86.92 -37.96 17.14 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -177.996 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -110.58 -9.13 14.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -171.979 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.53 20.22 79.63 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 174.702 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -120.41 127.5 26.28 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.854 1.661 . . . . 0.0 110.748 -175.043 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -59.28 151.15 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.702 2.268 . . . . 0.0 113.265 -178.519 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.36 -34.06 93.75 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.569 2.179 . . . . 0.0 113.146 178.471 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.51 -11.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.848 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -97.57 -0.71 45.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.535 1.534 . . . . 0.0 112.834 175.627 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -112.71 160.08 18.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.828 1.651 . . . . 0.0 112.468 -175.712 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -136.84 140.95 42.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.07 2.148 . . . . 0.0 109.428 158.686 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.8 mt -103.38 135.96 44.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.749 0.82 . . . . 0.0 111.753 173.194 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 mm -117.93 131.72 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.824 2.05 . . . . 0.0 108.926 -176.353 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.67 147.85 27.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.877 1.271 . . . . 0.0 110.069 174.615 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.09 37.12 13.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.217 1.007 . . . . 0.0 113.538 -174.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.55 61.06 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 116.366 1.306 . . . . 0.0 116.366 179.668 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 153.33 44.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.932 1.693 . . . . 0.0 112.516 -178.022 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.31 138.86 43.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.901 -0.499 . . . . 0.0 110.2 172.546 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.1 mt -86.53 135.73 33.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.526 173.482 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.38 130.2 40.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.824 1.25 . . . . 0.0 110.742 167.338 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.19 -24.07 64.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -167.447 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.18 3.56 80.17 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.215 1.388 . . . . 0.0 116.203 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -98.51 168.66 10.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.11 1.455 . . . . 0.0 111.384 173.263 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 p -106.2 158.9 16.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.322 1.449 . . . . 0.0 113.009 179.778 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.38 -33.64 65.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.66 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 p -73.22 -17.61 61.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 173.837 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -74.56 -18.24 60.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.545 1.066 . . . . 0.0 111.946 169.034 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.5 -2.86 21.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.821 1.649 . . . . 0.0 113.792 174.005 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 52.32 46.88 25.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.189 1.796 . . . . 0.0 113.392 -172.983 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.3 mt -90.92 107.76 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.358 1.063 . . . . 0.0 109.036 176.274 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -101.91 166.02 10.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.889 1.676 . . . . 0.0 113.432 -177.324 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -46.15 139.54 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -168.98 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 43.1 mt-10 63.17 17.93 10.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.503 2.321 . . . . 0.0 114.587 177.538 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -66.96 155.64 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.908 1.283 . . . . 0.0 112.779 162.957 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -115.01 132.59 56.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.328 1.451 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.06 163.35 13.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.86 1.664 . . . . 0.0 110.687 174.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -111.52 145.47 39.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.175 0.99 . . . . 0.0 110.891 170.76 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -116.21 130.25 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.152 1.381 . . . . 0.0 111.401 -176.332 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.92 155.38 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 111.467 172.099 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.64 147.15 32.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.54 1.536 . . . . 0.0 111.572 -173.633 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.1 mtm105 -83.09 61.73 6.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 112.559 -175.833 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 tp -50.84 118.08 2.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.946 1.698 . . . . 0.0 111.543 178.505 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 63.61 -32.26 0.12 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.408 3.083 . . . . 0.0 117.731 -179.621 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.69 79.66 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.976 1.262 . . . . 0.0 114.504 173.636 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.438 1.971 . . . . 0.0 111.951 166.957 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 120.772 0.32 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -98.35 134.34 41.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.711 1.604 . . . . 0.0 111.311 177.813 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -136.48 172.38 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.01 1.724 . . . . 0.0 111.235 176.132 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.17 158.44 18.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.515 1.126 . . . . 0.0 112.785 174.976 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.66 122.91 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.12 1.368 . . . . 0.0 110.003 169.148 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -95.34 124.35 39.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.741 1.616 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -85.09 128.75 34.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 159.238 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -59.46 -24.84 63.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.152 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.5 p -72.58 -11.59 60.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.333 1.853 . . . . 0.0 114.378 176.496 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.01 -43.54 0.74 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.282 0.944 . . . . 0.0 115.207 167.636 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -62.97 125.96 25.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.498 1.149 . . . . 0.0 113.675 -166.281 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 m -90.98 135.7 33.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.164 0.985 . . . . 0.0 109.888 158.603 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.2 pt -123.27 160.19 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.382 1.473 . . . . 0.0 110.436 164.612 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -92.24 147.63 22.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.38 0.672 . . . . 0.0 111.751 169.969 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tp -131.25 152.19 50.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.689 1.196 . . . . 0.0 110.027 167.87 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -128.0 126.69 41.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.246 1.019 . . . . 0.0 110.309 178.282 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -152.78 163.22 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.581 1.952 . . . . 0.0 110.744 -162.098 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -100.76 155.18 36.63 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 121.213 -0.929 . . . . 0.0 110.442 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.11 -14.11 26.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.706 2.27 . . . . 0.0 115.635 175.449 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -94.2 -3.78 50.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.389 2.275 . . . . 0.0 114.744 175.856 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.54 143.13 57.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.541 1.518 . . . . 0.0 111.252 173.262 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -82.85 165.48 19.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.759 0.824 . . . . 0.0 112.298 176.075 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.06 -29.99 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 121.2 -0.938 . . . . 0.0 111.796 169.432 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.08 -34.16 72.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.44 -1.412 . . . . 0.0 113.182 173.651 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -66.4 -36.92 84.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.655 0.382 . . . . 0.0 111.276 171.089 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.01 -47.44 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.077 -1.014 . . . . 0.0 111.263 172.377 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.15 -39.79 83.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.792 0.723 . . . . 0.0 112.418 177.371 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.77 83.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.8 0.84 . . . . 0.0 113.071 176.215 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -66.11 -33.42 75.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.971 1.308 . . . . 0.0 112.705 174.403 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.87 -36.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.726 1.21 . . . . 0.0 111.157 172.596 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.76 -36.52 83.33 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.398 1.454 . . . . 0.0 111.191 170.265 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.45 -50.36 65.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.236 -0.915 . . . . 0.0 112.788 173.45 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -86.41 -24.86 25.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -170.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -120.73 -15.6 8.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.106 1.763 . . . . 0.0 115.181 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.52 31.44 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 120.802 1.637 . . . . 0.0 115.537 176.349 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.47 121.69 36.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.835 1.654 . . . . 0.0 110.75 178.05 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.72 142.86 90.85 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.774 2.316 . . . . 0.0 115.623 -175.583 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -50.89 -41.78 54.27 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.452 3.435 . . . . 0.0 115.558 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.93 -1.92 16.15 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -172.632 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -123.79 10.03 8.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 171.759 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.03 149.5 24.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.207 170.59 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -130.31 121.59 26.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 110.07 162.979 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.7 mt -103.03 136.76 42.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.145 1.378 . . . . 0.0 112.264 -179.68 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.21 139.04 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.2 1.8 . . . . 0.0 110.734 -177.256 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -140.28 133.69 29.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 112.283 168.737 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.41 39.61 6.78 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.687 1.595 . . . . 0.0 113.64 -172.819 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.94 -1.98 71.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.302 1.43 . . . . 0.0 116.61 -178.964 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -99.19 135.39 40.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.948 1.874 . . . . 0.0 111.745 178.77 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.5 137.35 33.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.887 0.875 . . . . 0.0 110.572 173.375 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.9 mt -99.46 157.36 16.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -162.437 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -103.85 147.07 27.74 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 0.0 111.667 178.047 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.82 -31.91 57.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -163.675 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.09 -9.21 85.48 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.314 -0.866 . . . . 0.0 115.133 175.835 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -89.07 153.98 20.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.061 1.745 . . . . 0.0 112.003 -171.984 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -108.89 160.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.095 0.958 . . . . 0.0 113.27 -178.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.52 -40.65 79.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.393 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 p -63.71 -27.62 69.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.53 1.132 . . . . 0.0 113.769 176.39 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.55 -39.65 73.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.485 1.038 . . . . 0.0 112.183 178.623 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -83.05 1.98 37.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.897 1.279 . . . . 0.0 113.257 175.653 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 57.63 39.76 27.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.975 1.31 . . . . 0.0 112.957 -174.56 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -79.18 104.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.835 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.26 162.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.995 1.318 . . . . 0.0 112.145 -173.184 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -47.12 139.92 5.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.979 1.311 . . . . 0.0 111.45 167.682 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 66.5 -4.88 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.834 2.054 . . . . 0.0 116.374 179.682 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.7 p -71.36 162.15 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.826 1.194 . . . . 0.0 112.478 170.713 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -109.09 132.73 53.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.914 0.885 . . . . 0.0 112.703 176.339 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.39 164.54 23.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.164 0.986 . . . . 0.0 109.654 157.881 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -120.1 143.55 48.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.909 1.283 . . . . 0.0 110.123 164.324 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.11 129.32 47.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 110.061 -177.587 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.71 146.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.306 1.443 . . . . 0.0 109.294 177.428 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.58 164.13 27.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.203 -0.936 . . . . 0.0 112.274 171.761 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -110.2 144.24 39.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.226 1.81 . . . . 0.0 112.693 -177.102 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.16 149.95 26.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.07 0.948 . . . . 0.0 111.94 173.857 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 51.35 16.52 0.42 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.469 2.308 . . . . 0.0 116.034 -171.409 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.66 -38.29 77.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.985 -1.072 . . . . 0.0 112.911 174.625 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.266 -1.852 . . . . 0.0 114.411 175.189 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -92.1 147.78 22.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.319 0.509 . . . . 0.0 112.27 174.911 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.27 165.2 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.508 1.523 . . . . 0.0 109.748 168.654 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -125.88 142.23 51.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.279 1.032 . . . . 0.0 112.596 -175.072 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -118.67 124.32 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.875 1.27 . . . . 0.0 109.782 174.189 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -112.27 130.43 55.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.487 1.515 . . . . 0.0 111.355 -170.485 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -89.33 172.87 8.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 112.992 -177.585 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.92 23.47 3.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.146 0.978 . . . . 0.0 113.038 164.919 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -130.81 6.38 4.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.0 1.72 . . . . 0.0 114.535 -173.614 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 32.11 17.71 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 120.981 -1.074 . . . . 0.0 114.812 179.324 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -129.91 143.05 50.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.268 1.427 . . . . 0.0 111.404 178.396 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -124.15 135.82 53.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.918 1.287 . . . . 0.0 110.132 168.531 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.24 130.18 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.559 1.543 . . . . 0.0 109.432 176.795 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -94.08 133.67 37.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.176 173.726 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.2 mt -120.45 164.3 16.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.539 1.536 . . . . 0.0 111.511 176.799 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -113.98 133.36 55.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.628 1.171 . . . . 0.0 109.821 165.635 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.49 174.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.188 1.795 . . . . 0.0 110.872 -175.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.96 161.22 63.96 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.597 1.559 . . . . 0.0 108.838 162.489 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.51 -30.88 89.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.081 1.854 . . . . 0.0 115.079 -178.013 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -77.62 -1.15 29.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.787 1.635 . . . . 0.0 115.218 175.843 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -77.39 149.47 35.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.04 0.924 . . . . 0.0 111.358 179.395 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -89.87 146.25 24.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -170.909 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.67 -37.14 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 121.466 -0.771 . . . . 0.0 111.01 177.291 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -58.37 -44.76 88.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.633 1.173 . . . . 0.0 112.826 172.044 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.2 -38.05 84.68 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.371 0.987 . . . . 0.0 112.466 174.035 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.31 -42.81 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.673 1.124 . . . . 0.0 111.373 173.424 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -65.51 -38.6 90.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.183 -0.948 . . . . 0.0 112.154 175.244 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.35 70.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 173.413 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.31 -36.47 77.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.706 1.602 . . . . 0.0 112.251 174.327 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.37 -47.21 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.465 171.162 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -53.87 -45.7 71.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.255 0.934 . . . . 0.0 112.095 175.908 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.47 -22.41 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.386 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -96.67 -41.66 8.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.086 1.354 . . . . 0.0 113.377 175.686 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -119.06 -2.62 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -164.44 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.94 -13.45 4.32 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 173.02 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.51 119.37 77.18 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.103 1.361 . . . . 0.0 108.924 177.042 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.74 157.87 43.57 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.605 2.87 . . . . 0.0 114.297 -166.76 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.38 -34.53 89.27 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.739 2.959 . . . . 0.0 116.729 -172.026 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.03 -12.77 61.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 177.091 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -96.82 -16.21 20.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.509 1.523 . . . . 0.0 112.0 168.565 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -79.98 69.69 6.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.497 1.519 . . . . 0.0 112.277 -179.857 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -80.19 135.33 36.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.761 166.639 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.0 mt -136.7 137.38 39.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.174 1.39 . . . . 0.0 111.157 -169.483 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.87 134.76 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.15 1.78 . . . . 0.0 110.524 -178.904 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -117.3 119.24 34.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.591 1.556 . . . . 0.0 110.033 166.838 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 46.18 11.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.02 1.328 . . . . 0.0 114.049 178.761 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.47 0.28 89.77 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 -179.981 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -111.8 135.61 52.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 120.451 2.126 . . . . 0.0 112.638 176.678 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.71 148.22 46.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.403 0.681 . . . . 0.0 112.083 177.072 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.7 mt -105.69 127.5 53.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.447 1.499 . . . . 0.0 111.828 179.146 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -98.13 133.82 42.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 113.814 -178.096 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -42.25 -47.13 4.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.338 1.855 . . . . 0.0 115.245 178.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.12 4.63 23.5 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.184 1.374 . . . . 0.0 116.482 -174.62 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -107.62 176.83 5.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.605 1.562 . . . . 0.0 113.101 -179.208 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.02 162.71 13.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.318 1.847 . . . . 0.0 112.3 168.335 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -56.03 -36.8 68.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.68 -0.637 . . . . 0.0 112.173 168.495 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 p -67.01 -25.22 66.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 175.54 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -64.53 -29.19 70.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.695 1.589 . . . . 0.0 112.755 173.048 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.75 8.23 39.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.021 1.728 . . . . 0.0 113.025 178.379 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 52.59 37.32 22.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.181 1.392 . . . . 0.0 114.487 -177.67 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -76.21 133.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.204 1.002 . . . . 0.0 109.051 175.001 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -125.77 176.24 7.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.223 1.809 . . . . 0.0 110.943 -171.07 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -51.61 149.7 4.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 177.381 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 63.05 2.83 1.11 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.268 1.827 . . . . 0.0 115.452 179.711 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -63.62 147.93 50.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.458 -1.401 . . . . 0.0 113.116 -176.903 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 p -107.01 139.29 41.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.236 1.414 . . . . 0.0 111.47 176.497 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.63 143.91 45.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.229 1.812 . . . . 0.0 109.981 175.348 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -120.59 165.44 15.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.833 1.653 . . . . 0.0 111.852 -172.921 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -129.06 159.53 35.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.613 1.165 . . . . 0.0 112.495 172.652 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.8 t -125.06 121.73 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.231 1.812 . . . . 0.0 108.221 173.525 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.4 tp -66.36 -31.36 72.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.359 1.063 . . . . 0.0 112.669 -175.681 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -64.73 -35.52 81.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.506 1.048 . . . . 0.0 113.106 172.728 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.44 -31.84 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.712 0.805 . . . . 0.0 112.775 176.739 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -77.69 -32.27 52.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.122 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.13 -44.78 90.51 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.147 0.879 . . . . 0.0 113.364 176.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.769 1.176 . . . . 0.0 113.052 174.28 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 132.63 35.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -163.59 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.02 163.22 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 111.379 169.63 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -115.5 148.29 39.64 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.877 1.271 . . . . 0.0 110.389 168.257 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.13 130.95 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.305 1.042 . . . . 0.0 109.392 169.49 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -107.42 151.69 25.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.831 2.052 . . . . 0.0 110.248 172.647 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -114.65 162.14 17.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.208 1.003 . . . . 0.0 111.767 170.188 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.23 -13.3 61.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.725 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -83.74 -16.06 46.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.334 1.054 . . . . 0.0 112.224 166.852 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.5 11.91 37.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.621 1.581 . . . . 0.0 115.567 174.764 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.47 146.05 52.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.801 1.301 . . . . 0.0 110.137 173.836 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -127.54 133.72 49.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.163 1.385 . . . . 0.0 110.608 -178.039 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -144.5 151.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.566 1.146 . . . . 0.0 110.976 179.17 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 t -125.57 141.45 52.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.23 1.012 . . . . 0.0 113.146 178.228 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -134.22 147.44 50.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.592 -175.891 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -96.01 122.09 38.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.905 0.882 . . . . 0.0 109.227 167.262 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.23 171.66 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.935 2.094 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -112.71 145.69 33.51 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 111.694 175.152 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.99 -28.54 69.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.656 2.904 . . . . 0.0 115.291 175.347 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -92.09 8.43 37.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.813 1.245 . . . . 0.0 114.127 176.535 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -81.9 151.31 27.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.859 1.209 . . . . 0.0 111.848 176.298 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 156.31 19.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.322 1.049 . . . . 0.0 112.853 -177.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.22 -34.48 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.627 172.087 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.52 -44.81 81.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.899 170.569 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -70.11 -40.39 74.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.498 0.719 . . . . 0.0 112.511 178.232 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.61 -36.13 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.249 0.931 . . . . 0.0 111.427 175.394 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.77 -40.65 88.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.818 1.19 . . . . 0.0 112.2 168.914 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.16 81.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.798 0.726 . . . . 0.0 112.882 175.781 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.82 -42.09 91.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.427 1.091 . . . . 0.0 111.928 172.261 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -61.38 -34.79 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.531 1.132 . . . . 0.0 111.449 171.082 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -68.4 -33.97 75.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.631 1.105 . . . . 0.0 112.602 174.82 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.78 -29.64 70.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.707 1.14 . . . . 0.0 113.366 172.635 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.94 -55.45 4.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.254 1.021 . . . . 0.0 112.882 172.885 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -114.87 -8.93 12.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -161.868 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.06 76.28 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.16 1.224 . . . . 0.0 116.16 178.435 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.04 125.44 70.42 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 118.743 1.272 . . . . 0.0 109.24 179.729 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.36 137.86 83.53 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.75 2.3 . . . . 0.0 112.443 177.316 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -57.69 -32.33 94.35 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.746 2.297 . . . . 0.0 113.267 -179.896 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.51 -14.27 61.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 114.698 174.45 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -94.83 -18.78 20.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.395 1.478 . . . . 0.0 112.264 170.962 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.41 140.48 34.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.093 -179.942 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -127.36 137.23 52.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.067 2.147 . . . . 0.0 109.69 162.366 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 mt -116.89 124.35 49.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.357 1.063 . . . . 0.0 111.205 177.91 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -108.84 132.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.892 1.677 . . . . 0.0 110.728 -177.155 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -153.91 140.8 19.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.827 1.651 . . . . 0.0 111.35 176.721 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.54 36.95 21.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.111 1.364 . . . . 0.0 114.482 -176.339 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.99 6.57 89.08 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.016 1.293 . . . . 0.0 115.536 177.365 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -141.95 163.06 33.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.242 1.417 . . . . 0.0 112.916 -175.787 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -88.74 131.35 35.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.977 1.311 . . . . 0.0 111.476 -176.289 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.5 mt -74.95 152.51 38.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.113 1.365 . . . . 0.0 110.864 175.928 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -117.3 140.03 50.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.344 1.057 . . . . 0.0 112.38 -177.369 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.23 -30.3 64.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.137 2.175 . . . . 0.0 115.194 -170.624 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.88 1.53 87.92 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 118.104 2.001 . . . . 0.0 118.104 -171.689 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtm-85 -132.87 170.65 15.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.117 1.958 . . . . 0.0 113.015 -179.324 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 p -97.53 162.76 13.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.85 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.72 -35.09 65.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 178.782 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.4 p -70.69 -29.86 66.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 173.835 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.77 -15.72 63.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.058 169.252 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -105.7 4.94 30.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.692 1.597 . . . . 0.0 113.868 172.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 55.56 37.46 28.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 113.81 179.754 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -75.54 131.4 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 109.419 179.128 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -108.64 166.73 10.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.833 2.053 . . . . 0.0 111.526 -174.353 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 143.79 57.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.967 -1.083 . . . . 0.0 112.203 175.041 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.18 27.34 11.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.831 1.653 . . . . 0.0 114.225 -168.38 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -68.97 148.19 50.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.806 -1.184 . . . . 0.0 111.481 164.09 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.6 m -107.99 132.49 53.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.678 0.791 . . . . 0.0 110.612 170.707 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.05 148.69 33.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.503 1.521 . . . . 0.0 109.317 173.871 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.66 119.17 38.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.786 -0.571 . . . . 0.0 110.837 -178.796 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 tp -95.33 123.38 38.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.598 1.559 . . . . 0.0 110.362 -175.262 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.19 142.2 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 108.684 -178.476 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.67 143.4 27.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.914 0.886 . . . . 0.0 110.816 177.484 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -75.5 68.44 2.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.264 1.026 . . . . 0.0 110.421 166.015 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.67 142.0 58.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.509 1.524 . . . . 0.0 112.139 -175.022 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 50.91 52.31 15.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.624 1.57 . . . . 0.0 112.926 -178.384 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.37 -51.08 0.11 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.038 -0.868 . . . . 0.0 115.102 174.703 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.824 -1.542 . . . . 0.0 114.661 -177.754 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -100.54 148.58 24.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.015 0.926 . . . . 0.0 113.263 176.724 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.44 155.57 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 110.061 165.015 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -119.58 122.91 42.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 111.896 -174.946 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -103.45 126.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.307 1.043 . . . . 0.0 110.639 -179.077 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -105.09 134.89 47.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.724 1.61 . . . . 0.0 112.34 178.793 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -104.94 165.94 10.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.463 1.505 . . . . 0.0 113.242 -178.491 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.8 tp -67.62 -31.07 70.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.462 -0.774 . . . . 0.0 112.362 168.607 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -68.67 -1.43 6.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.736 1.614 . . . . 0.0 115.195 177.539 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.76 26.89 40.24 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.25 -0.906 . . . . 0.0 114.142 178.774 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -108.1 148.37 29.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.581 1.552 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -121.34 130.5 53.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.476 1.51 . . . . 0.0 108.709 171.764 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.12 124.27 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.418 1.487 . . . . 0.0 109.849 -177.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -83.49 127.91 34.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.256 1.023 . . . . 0.0 110.076 172.139 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -118.66 147.77 43.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.511 1.124 . . . . 0.0 112.078 174.42 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.48 118.0 35.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.933 1.693 . . . . 0.0 110.338 177.941 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.55 160.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 113.16 -170.622 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -112.65 154.2 44.79 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.558 1.543 . . . . 0.0 110.913 164.164 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.17 -27.93 39.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.819 3.013 . . . . 0.0 116.273 178.906 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 -1.08 57.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 178.432 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.38 139.69 51.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.762 1.165 . . . . 0.0 110.853 176.619 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.1 p -83.71 158.94 21.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.434 0.694 . . . . 0.0 112.657 -179.697 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.86 -33.72 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.399 -0.813 . . . . 0.0 111.94 173.951 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.36 -27.33 66.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.895 1.225 . . . . 0.0 113.589 172.926 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.57 -37.81 65.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.276 -0.89 . . . . 0.0 111.743 169.49 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.41 -43.18 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 119.056 0.844 . . . . 0.0 110.895 174.082 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -58.28 -40.55 82.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 112.548 172.279 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.99 82.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.392 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -65.9 -32.58 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.253 1.021 . . . . 0.0 112.544 173.351 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -69.24 -45.63 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.788 1.235 . . . . 0.0 111.032 170.342 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -55.96 -34.57 65.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.333 1.053 . . . . 0.0 112.075 175.657 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.65 -2.91 35.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.588 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -121.93 -40.25 2.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.265 0.939 . . . . 0.0 113.023 172.561 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.18 -8.31 18.46 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -175.468 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.3 0.21 65.71 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 177.023 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -82.32 121.47 78.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 118.926 1.363 . . . . 0.0 109.841 -173.656 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.66 148.07 92.41 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.354 2.036 . . . . 0.0 114.089 179.901 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -61.47 -23.99 77.56 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.96 3.106 . . . . 0.0 114.389 -176.624 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.4 -16.25 64.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.888 1.275 . . . . 0.0 113.332 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.43 7.02 17.43 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.492 1.917 . . . . 0.0 113.137 -171.488 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.26 150.24 36.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.554 1.942 . . . . 0.0 111.891 -178.538 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -138.98 137.04 36.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.295 1.838 . . . . 0.0 108.792 159.711 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -103.55 141.43 36.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.661 0.784 . . . . 0.0 111.9 179.185 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mm -124.75 131.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.859 1.663 . . . . 0.0 109.644 178.814 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -137.22 129.19 29.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.89 0.876 . . . . 0.0 112.672 172.388 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.89 44.1 14.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.452 1.501 . . . . 0.0 112.938 -174.989 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.87 -6.03 28.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.501 1.524 . . . . 0.0 116.782 -177.375 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -91.44 131.26 37.02 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.664 1.732 . . . . 0.0 111.419 -178.172 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.6 130.91 43.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 109.987 173.994 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.09 126.06 51.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.615 0.766 . . . . 0.0 111.875 -176.579 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.36 145.64 37.17 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.405 1.482 . . . . 0.0 112.956 -170.76 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.35 -24.92 67.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -155.489 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -16.01 63.07 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 -178.584 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.46 159.06 16.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.933 1.367 . . . . 0.0 112.598 -175.034 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -95.11 164.34 12.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.747 1.219 . . . . 0.0 113.575 -179.223 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -54.65 -37.23 65.45 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.903 -0.498 . . . . 0.0 112.086 167.757 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -66.68 -34.04 76.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.019 1.328 . . . . 0.0 113.823 174.85 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -68.88 -13.7 62.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 173.613 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -113.03 4.02 16.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.252 1.821 . . . . 0.0 113.326 170.536 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 51.16 41.06 27.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.74 2.016 . . . . 0.0 114.571 -177.355 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.26 102.36 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.829 1.252 . . . . 0.0 108.761 -179.497 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -89.56 178.38 6.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.477 1.511 . . . . 0.0 112.51 -176.939 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -52.57 144.09 14.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.206 1.402 . . . . 0.0 114.756 -177.104 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 58.4 40.08 24.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.983 1.713 . . . . 0.0 113.63 177.675 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -88.29 143.42 27.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.209 1.404 . . . . 0.0 112.298 174.049 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -108.2 128.37 54.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.937 1.695 . . . . 0.0 110.376 178.226 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.38 164.6 26.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.361 1.864 . . . . 0.0 111.349 -178.143 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -118.9 140.84 49.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.639 0.776 . . . . 0.0 111.222 -175.168 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -100.57 119.36 38.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.047 1.339 . . . . 0.0 110.178 176.805 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.6 t -103.31 145.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.655 1.982 . . . . 0.0 109.238 171.151 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 mt -113.07 153.73 27.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.217 1.007 . . . . 0.0 113.586 -175.824 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -129.55 93.8 3.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.412 2.285 . . . . 0.0 108.924 171.836 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.5 mt -107.3 152.85 23.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.361 1.464 . . . . 0.0 112.529 -173.195 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -131.49 168.85 16.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.806 1.643 . . . . 0.0 112.227 -179.627 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.03 167.39 42.14 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.855 1.217 . . . . 0.0 114.237 -177.539 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 C-N-CA 125.346 1.451 . . . . 0.0 115.001 -174.128 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.62 131.75 35.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.386 0.674 . . . . 0.0 111.814 170.632 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.96 156.01 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.766 1.226 . . . . 0.0 111.189 171.496 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -102.06 144.32 30.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.468 0.707 . . . . 0.0 112.554 -178.739 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.48 120.53 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.496 1.119 . . . . 0.0 109.855 171.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.85 124.44 35.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.928 1.291 . . . . 0.0 110.503 179.704 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -72.15 168.9 17.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.798 1.239 . . . . 0.0 112.491 -179.355 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.62 -22.35 65.17 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.015 0.926 . . . . 0.0 113.189 169.553 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -90.07 4.74 49.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.288 1.835 . . . . 0.0 114.44 170.997 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 3.92 90.61 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.948 1.261 . . . . 0.0 116.085 175.883 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -77.91 140.05 39.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.666 1.586 . . . . 0.0 109.961 179.277 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.5 m -101.99 106.49 17.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.244 1.384 . . . . 0.0 112.411 -177.786 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -75.3 147.16 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.821 2.049 . . . . 0.0 109.04 171.501 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -121.45 122.76 40.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.657 1.183 . . . . 0.0 109.839 174.162 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.78 143.91 43.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -176.483 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -96.74 118.74 33.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.272 1.029 . . . . 0.0 110.413 170.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.16 162.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.651 1.58 . . . . 0.0 111.994 -171.296 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.4 152.69 43.44 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.801 159.605 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.54 -23.8 58.42 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.563 2.175 . . . . 0.0 115.628 -178.053 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -79.49 -4.76 52.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 176.032 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.16 135.8 56.66 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 120.118 1.326 . . . . 0.0 111.673 179.769 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -73.13 153.54 40.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.788 0.435 . . . . 0.0 111.927 176.649 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.22 -33.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.157 -0.965 . . . . 0.0 111.325 176.29 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.91 -45.81 92.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.045 -1.034 . . . . 0.0 112.416 169.979 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -65.59 -32.9 74.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.329 -0.857 . . . . 0.0 112.841 176.18 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.15 -41.14 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 121.067 -1.021 . . . . 0.0 111.165 171.391 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.27 -36.26 81.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.567 1.076 . . . . 0.0 112.27 171.579 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.48 86.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.353 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.85 -30.14 70.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.106 0.962 . . . . 0.0 112.5 171.871 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.4 mt -71.94 -35.14 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.388 1.075 . . . . 0.0 111.579 170.687 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -61.87 -37.19 83.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.495 1.498 . . . . 0.0 111.444 172.533 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.49 -40.7 97.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 171.918 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -84.74 -32.82 23.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.902 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -124.35 -12.54 7.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.98 84.1 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.5 mm -78.57 122.52 85.01 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.793 1.796 . . . . 0.0 110.109 179.157 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.2 Cg_exo -64.95 147.56 89.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.429 2.086 . . . . 0.0 113.739 178.933 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -54.89 -36.11 90.81 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.193 2.595 . . . . 0.0 115.063 -176.037 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -61.63 -14.48 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.751 1.621 . . . . 0.0 114.645 177.808 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.8 -3.44 17.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.231 1.412 . . . . 0.0 113.413 -177.845 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.59 137.23 38.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.526 1.53 . . . . 0.0 113.172 -177.371 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.54 127.25 51.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.171 1.389 . . . . 0.0 109.689 167.553 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.09 140.97 47.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.175 0.99 . . . . 0.0 113.101 -176.666 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.25 138.55 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.126 1.771 . . . . 0.0 110.534 -178.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -132.36 133.87 44.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.882 1.273 . . . . 0.0 109.746 163.18 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.05 46.04 6.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 113.592 -177.053 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.66 8.82 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.342 1.697 . . . . 0.0 117.342 -178.521 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -88.42 128.24 35.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.803 1.802 . . . . 0.0 110.907 173.462 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -76.37 125.73 29.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.173 0.589 . . . . 0.0 110.05 171.076 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.42 127.07 36.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.702 0.801 . . . . 0.0 112.106 -164.115 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.18 127.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.795 0.838 . . . . 0.0 112.183 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 -36.28 46.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.735 1.614 . . . . 0.0 113.067 177.938 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 1.81 62.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.601 2.048 . . . . 0.0 117.28 178.14 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -111.42 172.67 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.663 1.585 . . . . 0.0 111.664 178.594 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.18 164.23 13.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.761 1.224 . . . . 0.0 112.869 -179.11 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -54.11 -40.58 67.43 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.529 0.732 . . . . 0.0 112.806 170.636 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.2 p -63.65 -35.52 80.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.435 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.88 -36.72 85.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.429 1.013 . . . . 0.0 111.918 -179.203 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -89.75 9.42 27.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.823 1.649 . . . . 0.0 114.296 175.741 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.1 t30 56.45 40.77 29.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.762 1.625 . . . . 0.0 114.568 178.901 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -83.36 126.94 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 121.303 -0.873 . . . . 0.0 109.149 175.655 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.898 2.079 . . . . 0.0 111.547 -178.602 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -44.75 136.09 4.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.777 2.031 . . . . 0.0 112.879 174.551 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.29 11.92 3.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.052 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.0 m -76.12 155.46 34.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.527 -1.358 . . . . 0.0 111.482 161.977 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -117.17 129.46 55.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.458 1.503 . . . . 0.0 112.211 -175.489 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.09 160.5 14.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.337 1.855 . . . . 0.0 110.171 171.058 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.71 141.68 47.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.17 0.988 . . . . 0.0 111.064 173.064 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.75 133.48 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.084 1.754 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.35 130.57 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.967 1.307 . . . . 0.0 110.527 172.219 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -74.72 143.13 44.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 112.006 177.901 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -74.24 156.11 37.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.161 0.984 . . . . 0.0 113.572 172.851 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.66 148.15 52.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.29 1.436 . . . . 0.0 112.397 172.595 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 46.2 72.09 0.25 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.77 2.428 . . . . 0.0 114.511 179.049 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.11 165.95 20.21 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.944 1.259 . . . . 0.0 115.664 -179.08 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.902 1.715 . . . . 0.0 112.824 -171.016 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 119.62 -0.229 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -86.28 146.27 26.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.605 0.762 . . . . 0.0 112.296 171.392 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.59 166.42 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.667 1.987 . . . . 0.0 110.864 170.308 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -118.08 142.08 47.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.262 1.425 . . . . 0.0 112.071 177.575 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.06 1.344 . . . . 0.0 110.074 171.247 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -94.48 126.82 40.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.107 2.163 . . . . 0.0 110.872 179.357 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 p -94.3 162.28 13.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.207 1.003 . . . . 0.0 113.296 -178.567 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.97 -29.01 69.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.352 1.061 . . . . 0.0 112.392 169.145 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 p -80.29 10.06 5.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.077 2.151 . . . . 0.0 114.243 174.22 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.08 12.08 81.5 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.471 1.034 . . . . 0.0 115.532 173.94 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -86.43 164.11 17.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.359 1.863 . . . . 0.0 111.074 179.055 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -129.22 118.04 21.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.363 1.065 . . . . 0.0 110.713 171.611 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 99.1 mt -101.18 125.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.775 1.23 . . . . 0.0 108.582 176.971 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.9 p -83.52 139.55 32.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.475 0.579 . . . . 0.0 110.388 168.136 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.43 150.05 50.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.361 1.064 . . . . 0.0 110.307 170.788 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -117.71 114.05 22.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.299 1.44 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.96 160.11 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.829 1.652 . . . . 0.0 112.239 -164.412 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -111.95 144.96 31.75 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.022 1.329 . . . . 0.0 111.202 175.974 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -58.59 -20.6 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.26 2.64 . . . . 0.0 117.309 -172.506 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -87.23 -4.08 59.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 174.478 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.36 154.05 40.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.819 1.191 . . . . 0.0 112.161 178.49 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -81.34 163.4 22.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -173.772 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -72.45 -37.71 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.62 172.553 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.38 -28.43 69.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.132 -0.98 . . . . 0.0 112.4 175.926 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.72 -36.85 84.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.654 170.608 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.7 -47.35 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 172.632 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -62.94 -34.35 77.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.061 0.944 . . . . 0.0 111.882 179.963 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.58 73.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.628 1.171 . . . . 0.0 113.423 174.493 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -67.52 -39.99 85.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.298 -0.876 . . . . 0.0 111.477 172.292 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.32 -41.05 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.271 1.028 . . . . 0.0 111.176 171.807 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -61.04 -46.76 89.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.393 -0.817 . . . . 0.0 111.84 176.867 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.96 -44.83 88.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.743 0.701 . . . . 0.0 112.694 177.512 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.8 -39.22 52.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.738 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -112.41 -11.08 13.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -173.986 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 34.31 52.86 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.395 1.452 . . . . 0.0 115.032 178.198 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -111.19 115.72 52.16 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 125.396 1.478 . . . . 0.0 109.668 -175.537 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.96 139.5 89.88 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.195 2.597 . . . . 0.0 113.098 -179.847 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.48 -29.06 31.51 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.057 2.505 . . . . 0.0 112.744 -165.769 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.13 -12.79 61.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.87 1.268 . . . . 0.0 113.394 177.971 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -92.68 -11.53 33.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.954 1.301 . . . . 0.0 113.052 175.608 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.22 138.76 31.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.148 1.379 . . . . 0.0 111.677 -175.567 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -121.11 122.1 39.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.979 2.112 . . . . 0.0 108.363 162.787 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.86 137.91 33.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.855 0.752 . . . . 0.0 110.754 171.221 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.4 mt -124.26 136.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.397 1.479 . . . . 0.0 109.844 179.906 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -148.5 127.07 12.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.163 1.385 . . . . 0.0 111.755 -177.113 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.54 48.89 6.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.272 1.829 . . . . 0.0 115.109 167.567 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.07 7.58 77.06 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 177.792 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -133.58 157.14 46.45 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.584 1.692 . . . . 0.0 112.634 176.687 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -95.12 133.08 39.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.65 0.78 . . . . 0.0 109.567 165.209 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.99 148.83 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.805 0.842 . . . . 0.0 111.335 177.16 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.44 174.39 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.486 1.915 . . . . 0.0 110.073 174.147 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -93.45 159.99 15.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.98 -1.075 . . . . 0.0 111.503 -176.104 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 27.31 26.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.125 0.869 . . . . 0.0 114.243 175.434 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -131.82 172.86 11.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.184 2.193 . . . . 0.0 111.299 179.356 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -111.13 160.67 16.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.985 1.714 . . . . 0.0 112.751 170.984 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.1 mt -55.75 -39.8 71.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.495 1.118 . . . . 0.0 113.447 -178.998 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -65.19 -32.75 74.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 175.498 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -65.71 -33.25 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.097 0.862 . . . . 0.0 112.164 176.58 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -91.16 10.65 26.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.496 1.518 . . . . 0.0 114.292 177.384 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 57.7 35.05 25.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 175.751 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.1 mt -82.41 144.37 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.562 1.145 . . . . 0.0 108.91 175.505 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -132.49 174.66 10.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.503 1.521 . . . . 0.0 113.213 -167.433 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.06 128.9 38.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.695 -0.628 . . . . 0.0 110.547 173.005 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 49.9 mt-10 60.2 25.71 15.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.63 1.972 . . . . 0.0 114.8 -175.401 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 m -61.84 148.8 42.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.144 0.978 . . . . 0.0 112.196 165.379 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.1 m -122.47 115.2 21.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.543 1.537 . . . . 0.0 110.592 -179.136 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.38 153.69 22.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.166 1.786 . . . . 0.0 110.791 -177.56 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -104.34 135.75 45.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.668 1.187 . . . . 0.0 111.145 173.558 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.36 123.31 43.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.361 1.064 . . . . 0.0 110.006 167.83 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.18 150.18 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.453 1.901 . . . . 0.0 108.689 175.336 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.58 147.35 40.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.31 1.044 . . . . 0.0 111.291 -177.341 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -61.61 -21.98 64.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -172.843 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.91 -53.96 0.92 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.126 1.77 . . . . 0.0 112.177 174.136 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -76.93 149.07 36.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -162.639 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.53 17.42 59.93 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.819 1.2 . . . . 0.0 115.522 -178.977 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.479 1.514 . . . . 0.0 114.074 178.044 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -86.7 142.25 28.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.325 0.65 . . . . 0.0 110.906 174.706 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -133.7 162.86 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.196 1.398 . . . . 0.0 109.557 162.948 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.63 144.22 45.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.581 0.753 . . . . 0.0 111.161 178.98 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.41 125.96 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.8 0.84 . . . . 0.0 110.37 178.349 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -135.3 156.95 48.09 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -176.072 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -105.16 169.97 8.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.405 1.882 . . . . 0.0 113.231 179.949 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.24 -33.59 63.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.563 1.145 . . . . 0.0 113.783 169.685 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -79.29 -8.39 59.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.136 1.374 . . . . 0.0 114.188 176.237 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.39 -9.77 62.96 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.077 -1.402 . . . . 0.0 115.989 172.333 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -55.35 113.81 1.56 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.598 1.699 . . . . 0.0 110.149 178.061 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -116.26 133.72 55.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.439 1.096 . . . . 0.0 110.988 -175.515 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.12 144.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.459 1.504 . . . . 0.0 111.325 178.134 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -100.96 125.32 47.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 110.108 177.61 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 mt -113.63 143.39 44.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.612 1.165 . . . . 0.0 111.148 -179.273 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -102.1 113.22 26.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.048 1.339 . . . . 0.0 108.784 173.214 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 157.73 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.664 1.586 . . . . 0.0 112.157 -168.316 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -98.77 148.65 34.85 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 123.439 0.695 . . . . 0.0 110.655 164.015 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.22 -19.5 16.77 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.386 2.724 . . . . 0.0 115.494 170.72 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.4 p -93.21 -4.49 51.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.797 2.039 . . . . 0.0 115.47 175.9 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.22 134.35 51.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.409 1.459 . . . . 0.0 110.349 176.711 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -85.96 162.92 18.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.478 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.51 -40.67 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 121.051 -1.03 . . . . 0.0 112.377 -169.198 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.44 -26.3 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.829 -1.169 . . . . 0.0 113.072 179.34 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.23 -25.99 33.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.691 1.196 . . . . 0.0 112.943 174.611 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.67 -36.42 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.824 168.353 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.51 -32.65 71.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.909 -1.119 . . . . 0.0 112.601 168.804 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.8 67.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 169.514 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.1 -31.17 62.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.341 -1.475 . . . . 0.0 111.961 171.518 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.04 -39.74 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.633 1.173 . . . . 0.0 110.957 168.414 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -59.28 -42.49 91.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.117 0.871 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.09 -23.91 67.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.082 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -85.81 -59.33 2.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.401 1.08 . . . . 0.0 113.074 172.028 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -105.19 -14.34 15.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -164.614 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.32 9.61 79.18 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -178.031 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.84 121.89 74.46 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.139 1.375 . . . . 0.0 110.082 -172.83 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.9 Cg_exo -61.34 138.4 76.53 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.698 2.265 . . . . 0.0 112.858 178.97 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 83.4 Cg_exo -54.89 -33.88 83.7 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.381 2.721 . . . . 0.0 116.636 -174.582 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.46 -18.37 64.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.426 1.466 . . . . 0.0 112.976 178.209 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -89.0 4.03 49.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.21 1.404 . . . . 0.0 113.374 178.422 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.42 136.33 53.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.201 1.801 . . . . 0.0 111.912 -176.426 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -127.74 136.9 52.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 110.291 164.068 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -112.48 139.33 48.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.15 0.98 . . . . 0.0 112.343 -174.181 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.07 137.66 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.053 1.741 . . . . 0.0 110.221 -177.78 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -136.79 134.13 36.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.174 1.39 . . . . 0.0 110.595 169.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.3 42.2 13.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.934 1.294 . . . . 0.0 114.355 -179.671 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 -14.27 23.36 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.326 1.917 . . . . 0.0 116.69 -176.075 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.99 131.19 41.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.652 1.581 . . . . 0.0 111.962 -173.91 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -82.73 128.2 34.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.551 0.741 . . . . 0.0 111.299 176.43 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.27 128.17 34.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 111.595 -170.242 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -84.54 122.08 28.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.469 1.107 . . . . 0.0 113.343 -178.534 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.35 138.24 46.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.749 0.82 . . . . 0.0 111.727 172.99 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.73 -19.12 53.32 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.663 -1.631 . . . . 0.0 115.686 -166.123 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -92.7 159.55 15.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.672 2.236 . . . . 0.0 112.461 171.343 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 p -95.2 168.59 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.852 1.661 . . . . 0.0 113.643 -176.65 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.1 -38.91 80.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.568 -0.707 . . . . 0.0 112.694 166.242 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -63.39 -32.59 74.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.113 0.965 . . . . 0.0 113.354 176.474 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -67.28 -17.34 64.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 176.239 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.91 10.45 14.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.625 1.57 . . . . 0.0 114.285 178.842 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.13 34.23 23.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.107 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.1 mt -90.64 96.46 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.805 -1.184 . . . . 0.0 108.237 -179.061 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -94.96 172.48 8.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.186 1.395 . . . . 0.0 112.364 -176.293 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -44.15 132.46 5.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.522 1.929 . . . . 0.0 114.997 179.921 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 92.8 mt-10 62.49 22.84 13.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.573 2.749 . . . . 0.0 115.904 -178.368 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 m -69.6 152.06 45.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.447 -0.783 . . . . 0.0 112.47 166.342 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -112.94 126.8 55.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.075 1.35 . . . . 0.0 111.325 176.681 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.25 152.08 23.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.23 1.812 . . . . 0.0 110.549 178.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -102.59 133.47 47.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.875 1.27 . . . . 0.0 110.554 176.386 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.13 124.94 53.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.725 1.61 . . . . 0.0 110.607 -176.428 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.9 t -106.97 129.91 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.747 1.619 . . . . 0.0 109.063 175.761 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.47 118.39 36.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.178 1.391 . . . . 0.0 110.97 -174.889 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -93.6 -9.1 39.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -166.779 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.1 tp -134.45 51.06 2.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.939 1.245 . . . . 0.0 113.388 -179.326 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -130.73 21.23 5.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.112 1.765 . . . . 0.0 114.288 178.39 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.3 164.16 20.13 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 114.808 173.956 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 117.424 -1.764 . . . . 0.0 110.849 176.074 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 119.12 -0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -132.07 154.09 49.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.613 1.097 . . . . 0.0 113.245 178.873 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.22 163.15 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 165.777 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -115.09 143.08 45.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.549 1.54 . . . . 0.0 112.08 -178.95 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -128.68 121.99 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.188 1.395 . . . . 0.0 110.394 -179.787 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -92.96 121.13 33.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.846 1.658 . . . . 0.0 112.919 -179.218 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.2 p -83.03 160.58 21.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.247 1.819 . . . . 0.0 113.58 -177.039 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.63 -9.24 58.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.905 -1.122 . . . . 0.0 113.231 170.153 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -84.11 -0.76 53.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.669 1.987 . . . . 0.0 114.354 167.452 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 25.37 56.59 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.256 -0.903 . . . . 0.0 115.181 173.693 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -119.85 168.55 11.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.266 1.427 . . . . 0.0 111.062 175.56 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.7 m -118.3 132.85 56.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.462 1.105 . . . . 0.0 111.178 179.465 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.38 136.71 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 109.252 177.477 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -109.92 136.46 49.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.796 1.238 . . . . 0.0 110.556 179.695 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.65 134.89 31.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.225 1.01 . . . . 0.0 112.89 -179.013 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -81.08 127.32 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.714 1.605 . . . . 0.0 111.698 171.919 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.47 157.76 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.76 2.024 . . . . 0.0 112.499 -174.038 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -94.56 154.2 40.16 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 124.509 1.124 . . . . 0.0 109.768 157.324 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.82 -16.7 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.21 2.606 . . . . 0.0 115.609 168.941 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 p -98.49 1.39 46.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 114.976 176.654 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -73.17 145.35 46.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.089 1.313 . . . . 0.0 111.252 173.52 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -82.02 153.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -178.117 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.1 -37.42 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.929 0.892 . . . . 0.0 110.904 170.568 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.97 -51.81 62.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.419 1.488 . . . . 0.0 112.935 172.061 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.0 -37.91 82.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.156 0.582 . . . . 0.0 112.393 178.081 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.37 -49.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.28 0.946 . . . . 0.0 111.24 174.268 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -63.64 -35.21 79.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.769 0.828 . . . . 0.0 112.575 176.72 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.25 72.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.17 0.988 . . . . 0.0 113.544 173.477 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.45 -30.08 61.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.346 1.058 . . . . 0.0 112.661 171.657 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.31 -39.27 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 110.617 169.659 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.07 -43.4 95.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.343 0.974 . . . . 0.0 111.261 168.928 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.64 -44.71 95.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.196 -0.94 . . . . 0.0 113.284 179.868 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -89.44 -36.66 15.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -174.772 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.36 -10.82 14.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 113.876 -175.723 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.69 18.39 79.49 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.1 -1.625 . . . . 0.0 116.008 175.604 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.1 mt -85.52 126.59 66.19 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 118.941 1.371 . . . . 0.0 109.357 179.204 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.9 129.3 29.91 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.32 2.014 . . . . 0.0 112.772 179.575 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.78 -14.91 30.03 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.237 2.625 . . . . 0.0 113.737 -173.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.68 -16.16 39.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.49 1.916 . . . . 0.0 113.168 169.569 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.07 -42.02 15.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.799 0.727 . . . . 0.0 111.301 163.38 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.33 143.47 39.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 179.154 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -117.89 165.35 13.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.738 1.615 . . . . 0.0 110.502 148.786 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.5 mt -122.9 138.22 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.805 1.242 . . . . 0.0 110.534 155.425 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.29 136.39 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.523 1.529 . . . . 0.0 109.254 179.13 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -151.22 140.48 21.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.513 1.125 . . . . 0.0 111.924 178.62 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 32.02 5.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.809 1.644 . . . . 0.0 114.471 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.3 87.94 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.989 1.281 . . . . 0.0 116.142 179.737 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -114.67 136.97 52.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.858 1.329 . . . . 0.0 112.579 177.051 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -68.68 137.81 54.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.939 0.896 . . . . 0.0 109.633 165.076 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.76 122.74 40.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.184 0.594 . . . . 0.0 111.102 -174.32 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -81.03 139.99 35.42 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.818 1.247 . . . . 0.0 111.608 -179.308 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 -41.24 87.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.656 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.63 -2.55 85.5 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 116.161 1.224 . . . . 0.0 116.161 -173.396 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -97.33 158.5 15.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.421 1.488 . . . . 0.0 111.514 -178.205 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 p -100.2 162.45 12.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.269 1.028 . . . . 0.0 112.648 179.509 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.88 -44.09 73.77 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 112.792 178.704 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.6 p -65.1 -29.17 70.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 176.602 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.13 -29.52 69.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.23 1.377 . . . . 0.0 112.204 176.182 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -91.62 1.24 57.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.409 1.483 . . . . 0.0 114.254 168.961 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t30 55.04 42.04 31.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 0.0 114.305 -173.153 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -87.11 114.43 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.06 1.344 . . . . 0.0 107.651 175.31 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.0 173.66 6.21 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 112.652 -174.329 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -54.75 138.72 41.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.779 1.232 . . . . 0.0 113.505 -179.084 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.03 30.59 18.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.76 . . . . 0.0 115.663 -173.642 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -68.76 152.01 45.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.049 -1.032 . . . . 0.0 112.097 164.265 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.1 m -117.82 117.31 28.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.9 1.28 . . . . 0.0 111.056 174.357 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.0 165.61 11.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.738 2.415 . . . . 0.0 109.902 -178.023 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -118.19 142.42 47.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.815 0.846 . . . . 0.0 112.8 175.234 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -103.2 135.7 44.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.669 1.988 . . . . 0.0 110.332 175.68 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.81 151.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.552 1.541 . . . . 0.0 109.722 174.808 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.35 128.83 54.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.686 1.194 . . . . 0.0 112.891 178.253 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -77.96 98.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.828 2.051 . . . . 0.0 110.723 175.232 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.6 mt -69.53 -23.8 63.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -173.301 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -107.23 -6.14 17.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.133 1.773 . . . . 0.0 113.389 171.265 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.55 -18.48 70.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.525 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-N 119.361 1.581 . . . . 0.0 114.591 176.618 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.36 0.124 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -83.28 140.47 32.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.621 1.169 . . . . 0.0 110.901 174.533 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -136.78 166.77 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.715 1.206 . . . . 0.0 110.946 164.323 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.08 149.08 43.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.4 1.08 . . . . 0.0 111.349 174.475 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.51 120.0 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.106 1.363 . . . . 0.0 108.864 173.862 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -96.48 128.53 43.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.071 0.948 . . . . 0.0 111.467 178.069 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 p -78.29 165.5 23.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.532 1.133 . . . . 0.0 112.12 176.46 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -66.41 -26.82 67.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.471 -1.393 . . . . 0.0 112.644 179.918 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -87.13 13.21 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 113.615 169.731 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.42 9.96 82.76 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 165.139 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -77.07 135.46 38.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.838 1.819 . . . . 0.0 110.429 176.758 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -95.59 110.99 23.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.11 0.868 . . . . 0.0 110.712 174.631 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mt -84.88 127.29 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.876 1.27 . . . . 0.0 108.046 167.572 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.7 m -97.28 132.11 43.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 109.723 171.586 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.3 mt -125.03 149.7 47.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.766 1.226 . . . . 0.0 111.207 178.928 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.13 127.56 53.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.293 0.637 . . . . 0.0 109.782 161.73 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.22 160.28 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.43 1.892 . . . . 0.0 110.823 -172.833 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -93.47 150.52 39.05 Favored Pre-proline 0 N--CA 1.449 -0.514 0 O-C-N 121.413 -0.804 . . . . 0.0 110.189 159.056 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -61.57 -19.69 65.77 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.878 1.719 . . . . 0.0 112.822 170.918 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.1 p -80.11 -9.7 59.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.094 1.758 . . . . 0.0 114.969 172.758 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.443 1.474 . . . . 0.0 111.649 177.874 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.9 p -77.53 163.38 26.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.067 0.547 . . . . 0.0 112.415 178.299 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.52 -31.5 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 121.338 -0.851 . . . . 0.0 111.985 170.404 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.01 -34.16 68.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.754 -1.216 . . . . 0.0 113.08 173.827 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -63.99 -38.09 89.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.966 0.803 . . . . 0.0 111.318 169.753 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.47 -42.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.28 -0.888 . . . . 0.0 111.489 174.305 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.36 -36.77 78.79 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 118.994 0.815 . . . . 0.0 112.795 173.812 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.49 77.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 174.426 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -67.17 -32.43 73.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.857 -1.152 . . . . 0.0 112.638 174.829 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.85 -39.34 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.119 1.368 . . . . 0.0 111.407 170.285 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -61.32 -36.04 79.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.507 0.723 . . . . 0.0 112.507 173.313 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.5 -49.56 68.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.438 -0.789 . . . . 0.0 112.441 172.972 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -67.9 -45.51 74.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.61 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.48 -1.34 8.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.96 89.73 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.246 -1.534 . . . . 0.0 115.922 173.624 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.74 120.14 78.18 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 125.317 1.447 . . . . 0.0 110.205 -172.381 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.94 134.79 58.89 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.972 2.448 . . . . 0.0 112.905 177.936 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -50.44 -36.67 49.34 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.972 3.115 . . . . 0.0 116.069 179.584 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -64.29 -17.51 63.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.21 -19.24 30.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 173.714 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -88.19 130.4 35.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.104 0.961 . . . . 0.0 112.659 -166.663 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -118.94 126.04 50.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 109.683 168.627 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -121.07 131.2 54.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.09 0.956 . . . . 0.0 112.299 -166.025 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.12 140.71 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.841 1.657 . . . . 0.0 110.884 -173.073 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -130.33 133.68 46.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.339 1.055 . . . . 0.0 110.985 163.493 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 38.44 5.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.542 1.537 . . . . 0.0 113.991 -177.847 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.79 58.44 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -176.069 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -90.27 127.3 36.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.405 2.102 . . . . 0.0 110.747 177.178 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.18 126.85 31.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.051 0.842 . . . . 0.0 110.926 171.266 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -89.92 136.09 33.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.01 0.924 . . . . 0.0 111.71 -168.124 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -80.29 143.1 33.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 112.305 -179.373 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.17 -32.4 68.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.487 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.65 18.58 5.66 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.715 -179.422 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -134.12 163.48 29.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.755 1.622 . . . . 0.0 112.362 -166.954 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.38 167.67 10.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.362 1.465 . . . . 0.0 114.157 178.331 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -59.52 -35.2 73.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.578 -0.701 . . . . 0.0 112.545 168.124 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -65.42 -39.32 91.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.952 1.301 . . . . 0.0 112.858 172.875 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.98 -25.17 66.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 113.661 173.086 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.17 6.91 47.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.409 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.16 34.09 24.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.787 1.176 . . . . 0.0 113.287 176.828 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.24 127.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.742 1.217 . . . . 0.0 109.003 -178.314 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -101.71 169.89 8.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.948 1.299 . . . . 0.0 112.721 -177.745 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -56.51 145.87 26.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.804 1.241 . . . . 0.0 113.221 176.88 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.256 43.9 mt-10 58.39 25.95 13.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.955 1.702 . . . . 0.0 114.375 -179.583 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -68.09 149.52 49.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.482 1.113 . . . . 0.0 112.257 165.348 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -107.42 127.42 53.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.571 1.148 . . . . 0.0 110.564 167.207 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.16 160.85 15.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.382 1.873 . . . . 0.0 109.684 175.139 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -112.45 139.99 47.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.913 1.285 . . . . 0.0 111.049 175.7 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -123.48 134.62 53.88 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.901 1.68 . . . . 0.0 109.394 179.895 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.33 148.91 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.828 1.251 . . . . 0.0 109.767 167.746 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -105.27 132.49 51.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.09 0.956 . . . . 0.0 111.862 -177.687 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -140.74 136.57 32.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.562 1.545 . . . . 0.0 110.058 177.588 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.86 100.65 10.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.685 1.194 . . . . 0.0 111.963 -169.679 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -71.9 -28.14 63.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.058 1.343 . . . . 0.0 112.284 175.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 11.6 26.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.692 1.615 . . . . 0.0 116.031 172.812 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 C-N-CA 125.353 1.454 . . . . 0.0 112.792 178.667 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -114.43 145.91 41.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.955 1.302 . . . . 0.0 110.832 171.378 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -132.89 161.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.79 1.636 . . . . 0.0 110.376 174.196 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -102.05 151.05 22.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 111.171 174.053 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.49 130.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.92 0.888 . . . . 0.0 109.147 165.313 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -122.04 137.48 54.79 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.325 1.85 . . . . 0.0 110.51 -176.441 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -92.28 162.12 14.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.345 1.058 . . . . 0.0 113.139 177.02 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.08 -43.99 78.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.743 1.217 . . . . 0.0 111.521 170.229 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -73.83 -4.57 35.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.876 1.671 . . . . 0.0 113.723 176.017 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.26 23.46 29.29 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 161.911 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -87.8 137.0 32.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.3 1.55 . . . . 0.0 109.431 166.624 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -121.5 129.6 53.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.924 0.89 . . . . 0.0 111.131 179.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.87 161.37 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.889 2.076 . . . . 0.0 111.292 179.865 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.5 p -107.6 140.15 41.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 110.771 173.067 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -125.21 138.29 54.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.024 1.33 . . . . 0.0 110.0 171.511 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.72 123.25 48.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.985 0.914 . . . . 0.0 109.61 178.257 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.02 162.35 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.128 1.371 . . . . 0.0 112.94 -160.496 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -100.31 143.42 26.48 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.654 1.582 . . . . 0.0 110.378 167.605 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.99 -30.81 71.46 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.979 2.453 . . . . 0.0 115.486 175.882 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -89.23 7.61 34.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.639 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -77.94 152.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.498 1.044 . . . . 0.0 111.71 173.659 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -100.82 155.56 17.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.212 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -57.64 -36.54 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.606 1.162 . . . . 0.0 112.315 179.121 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -56.68 -44.91 81.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.72 1.146 . . . . 0.0 112.384 172.376 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -74.22 -31.58 62.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.6 178.856 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.56 -41.59 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 119.553 1.069 . . . . 0.0 111.015 170.133 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.27 -38.65 91.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 112.374 171.323 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.73 64.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.745 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -74.36 -35.85 63.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.652 1.581 . . . . 0.0 112.158 172.267 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.55 -44.8 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.221 1.009 . . . . 0.0 110.052 169.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.94 -42.83 80.76 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.812 1.245 . . . . 0.0 111.698 173.166 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.84 -48.69 79.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.773 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.58 -34.11 11.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -174.675 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -100.77 -13.37 18.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.571 1.532 . . . . 0.0 114.112 -178.771 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.62 22.56 78.28 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.887 -1.133 . . . . 0.0 115.06 177.263 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.47 117.16 65.07 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.224 1.409 . . . . 0.0 108.489 178.046 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.63 154.91 31.21 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.226 1.951 . . . . 0.0 112.588 -176.454 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -52.77 -29.92 44.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.368 3.378 . . . . 0.0 116.698 -177.752 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.22 -37.51 23.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.515 1.526 . . . . 0.0 113.091 169.596 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -96.35 -6.83 36.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.26 134.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.012 -1.055 . . . . 0.0 112.02 -174.961 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.02 103.88 5.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.174 0.99 . . . . 0.0 109.441 167.715 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.96 127.54 37.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.556 1.542 . . . . 0.0 111.921 177.89 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.54 139.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.936 2.094 . . . . 0.0 109.613 175.657 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -142.19 136.22 29.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.836 1.255 . . . . 0.0 109.932 171.613 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 47.37 17.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.135 1.374 . . . . 0.0 113.659 -177.178 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.06 -3.77 27.68 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.857 1.694 . . . . 0.0 116.995 -178.267 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.98 133.5 53.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.019 1.728 . . . . 0.0 111.891 -170.956 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -80.59 125.21 29.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.912 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.51 142.06 30.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -168.046 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.68 145.85 26.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.52 1.128 . . . . 0.0 113.695 -177.112 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.17 -30.0 67.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -163.756 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.65 -14.22 80.21 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.891 -0.949 . . . . 0.0 115.116 176.362 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.62 150.45 31.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.956 1.378 . . . . 0.0 112.446 -174.952 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.2 p -86.18 163.22 17.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.55 0.74 . . . . 0.0 112.273 173.164 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.28 -37.28 74.69 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.266 -0.897 . . . . 0.0 111.613 166.914 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -66.03 -29.53 69.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.192 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.82 -33.16 73.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.053 1.751 . . . . 0.0 112.562 173.155 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.38 7.62 45.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.496 1.518 . . . . 0.0 113.828 173.611 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.19 35.66 23.08 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.205 1.402 . . . . 0.0 113.531 -178.754 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -79.03 134.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 109.019 179.275 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.89 170.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.599 1.56 . . . . 0.0 111.914 -167.714 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -43.22 131.59 4.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 175.578 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 66.14 13.65 9.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 116.614 179.472 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 m -64.92 149.74 49.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.153 -0.967 . . . . 0.0 112.13 171.568 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -104.61 130.27 52.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.871 1.268 . . . . 0.0 111.062 169.533 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.62 144.11 29.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.901 1.28 . . . . 0.0 110.261 165.411 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -98.41 127.08 44.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.476 0.71 . . . . 0.0 110.593 178.414 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.2 mt -87.71 145.64 26.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 109.748 161.064 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -133.71 138.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.839 1.256 . . . . 0.0 110.431 -177.299 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.46 142.21 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.754 0.821 . . . . 0.0 112.764 178.271 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.87 50.35 0.92 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.335 1.854 . . . . 0.0 112.303 -174.465 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.3 125.95 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.772 0.829 . . . . 0.0 111.517 -174.68 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.91 -29.91 62.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 113.43 -169.871 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 154.89 7.21 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.609 1.576 . . . . 0.0 113.934 -176.411 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.066 -1.964 . . . . 0.0 114.749 178.344 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -91.81 144.59 25.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.217 1.007 . . . . 0.0 111.912 174.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.77 140.68 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.596 1.559 . . . . 0.0 111.538 175.851 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -105.96 103.96 13.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 111.283 -176.913 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.67 115.95 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.064 -1.023 . . . . 0.0 110.457 -176.306 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -83.72 106.89 15.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.178 0.991 . . . . 0.0 109.944 175.963 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -71.68 171.83 10.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.849 2.06 . . . . 0.0 112.274 -175.04 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -66.42 -19.4 65.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.978 -1.077 . . . . 0.0 113.488 -172.793 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -80.78 -11.85 59.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 113.714 173.951 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.53 -12.21 69.96 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.325 1.44 . . . . 0.0 114.942 -168.217 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.35 139.04 58.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.687 1.744 . . . . 0.0 110.29 174.324 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -111.66 122.23 47.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.905 0.775 . . . . 0.0 111.143 -176.393 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 pt -107.27 134.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.113 1.365 . . . . 0.0 111.535 -178.449 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -87.05 122.18 30.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.034 0.934 . . . . 0.0 110.305 174.644 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -124.43 158.17 33.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.551 1.54 . . . . 0.0 110.644 174.487 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -124.04 129.39 50.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.758 0.823 . . . . 0.0 111.993 -171.858 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.09 156.11 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.213 2.205 . . . . 0.0 111.593 -170.46 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -121.64 155.96 59.18 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.147 1.379 . . . . 0.0 111.709 174.111 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.64 -28.89 17.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.703 3.602 . . . . 0.0 117.863 -173.203 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -92.36 -5.63 51.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.255 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.42 150.54 46.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 175.36 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -89.13 159.76 17.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.64 -0.663 . . . . 0.0 112.78 173.102 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 mm -61.51 -34.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.047 176.235 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.32 -32.08 73.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 120.188 1.358 . . . . 0.0 113.292 173.4 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -60.94 -34.33 74.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.977 1.262 . . . . 0.0 111.862 172.32 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -72.73 -46.78 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 118.92 0.782 . . . . 0.0 110.901 175.748 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -61.79 -31.93 72.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.416 -0.802 . . . . 0.0 112.846 177.438 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.634 0.773 . . . . 0.0 112.482 171.588 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.27 -34.32 77.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.641 1.11 . . . . 0.0 112.629 174.126 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.79 -30.81 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.672 1.189 . . . . 0.0 111.765 174.724 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.69 -36.37 84.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.773 1.624 . . . . 0.0 112.261 176.849 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.12 -22.29 64.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 174.141 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -90.26 -46.98 8.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 114.302 175.328 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -114.12 -10.9 12.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -167.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.76 72.6 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.873 0.76 . . . . 0.0 114.617 178.16 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -96.76 122.18 57.58 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 108.264 175.843 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.31 134.08 50.0 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 176.603 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -32.7 69.94 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.566 2.844 . . . . 0.0 116.091 -174.341 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -72.86 -5.21 36.69 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.884 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.0 -14.33 14.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.645 1.578 . . . . 0.0 113.969 166.893 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.63 144.17 41.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.395 0.998 . . . . 0.0 110.815 173.079 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.304 1.041 . . . . 0.0 111.022 157.655 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.89 138.1 52.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.51 178.317 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mt -122.01 123.86 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.154 1.382 . . . . 0.0 109.837 -176.659 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -129.13 138.39 51.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.287 2.235 . . . . 0.0 109.764 178.238 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 34.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.987 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 -9.26 57.87 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 117.421 -1.766 . . . . 0.0 116.26 -176.246 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.81 148.44 39.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.989 2.394 . . . . 0.0 113.595 -176.543 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -73.99 145.44 44.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.142 0.977 . . . . 0.0 111.634 177.263 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.82 162.54 13.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 112.508 177.337 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -126.96 144.63 50.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.447 1.899 . . . . 0.0 112.846 -177.181 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -76.55 -33.9 58.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -154.871 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.99 -11.47 73.22 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.703 1.144 . . . . 0.0 114.966 -177.248 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -79.04 152.85 30.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.654 1.182 . . . . 0.0 110.728 -178.993 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -86.71 158.84 19.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.34 0.656 . . . . 0.0 111.674 173.857 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tp -54.37 -39.69 67.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.506 -0.746 . . . . 0.0 112.188 176.544 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 p -62.87 -14.47 46.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.316 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -79.11 -6.06 55.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 113.64 176.623 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -119.51 1.87 11.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -171.709 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 54.31 54.09 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.723 1.601 . . . . 0.0 112.756 -175.321 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -95.06 101.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.983 1.713 . . . . 0.0 108.105 178.735 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -110.97 141.72 44.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.282 1.033 . . . . 0.0 113.659 -167.096 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp 50.55 -67.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 130.398 3.479 . . . . 0.0 117.709 176.051 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -156.53 133.26 10.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.251 1.821 . . . . 0.0 108.43 -176.277 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -141.03 163.89 31.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.411 1.085 . . . . 0.0 113.72 -172.696 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.9 t -128.78 150.16 50.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.03 1.332 . . . . 0.0 111.589 167.11 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.32 163.8 27.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.93 1.692 . . . . 0.0 110.81 -177.457 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -112.17 150.21 31.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.764 1.225 . . . . 0.0 110.982 166.417 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.16 136.63 49.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.054 1.342 . . . . 0.0 111.419 173.506 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.79 163.87 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 111.874 171.231 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.6 tp -121.9 132.24 54.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.359 1.463 . . . . 0.0 112.721 -167.345 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.53 90.35 3.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.388 1.875 . . . . 0.0 109.94 177.807 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -69.83 -22.83 63.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -177.055 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -82.72 82.72 7.95 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 112.606 -178.646 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.71 -37.28 20.29 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 123.974 0.797 . . . . 0.0 113.37 171.21 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.712 -1.605 . . . . 0.0 112.721 -179.38 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -94.83 140.33 30.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 176.602 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -129.07 172.8 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.398 1.479 . . . . 0.0 110.377 165.958 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -124.37 145.9 49.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.13 0.972 . . . . 0.0 112.819 -178.132 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.95 127.59 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.836 1.254 . . . . 0.0 109.984 -179.772 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -89.79 109.43 20.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.049 1.34 . . . . 0.0 110.622 178.259 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.4 p -72.32 169.23 16.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.459 1.904 . . . . 0.0 113.437 -174.505 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.57 -16.14 62.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.644 1.177 . . . . 0.0 113.483 173.268 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -84.72 15.27 3.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.45 1.5 . . . . 0.0 113.055 164.057 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.12 -23.03 1.85 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.32 1.914 . . . . 0.0 115.631 171.931 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -85.12 166.93 16.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.702 1.601 . . . . 0.0 112.916 -177.857 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -92.74 148.33 22.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.931 0.892 . . . . 0.0 112.906 -176.033 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.16 153.07 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.992 1.717 . . . . 0.0 110.659 157.948 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -98.3 141.14 31.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.185 1.394 . . . . 0.0 110.559 178.274 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -129.88 141.27 50.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.0 111.748 -178.94 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -103.08 120.06 39.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.632 1.173 . . . . 0.0 111.29 -178.691 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.06 159.63 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.357 1.463 . . . . 0.0 112.343 -169.218 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -94.49 154.47 40.18 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.298 1.039 . . . . 0.0 110.788 162.334 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.35 -28.86 82.0 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.203 1.936 . . . . 0.0 113.801 169.527 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -81.82 2.5 29.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.535 1.534 . . . . 0.0 114.317 177.075 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.71 137.64 37.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.714 1.143 . . . . 0.0 112.467 -172.392 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.47 148.46 27.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.536 1.535 . . . . 0.0 111.915 -177.451 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.91 -31.51 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.291 -0.881 . . . . 0.0 113.33 -175.492 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.85 -38.08 77.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.309 1.413 . . . . 0.0 113.09 174.011 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -70.63 -34.67 72.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.136 -0.978 . . . . 0.0 112.161 174.456 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 -43.15 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.712 0.805 . . . . 0.0 110.535 172.69 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.48 -41.11 93.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.662 0.785 . . . . 0.0 112.874 175.908 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.63 78.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.385 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.81 -35.33 78.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.766 1.226 . . . . 0.0 112.867 170.933 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.24 -39.06 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.979 0.911 . . . . 0.0 111.233 172.616 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -57.74 -38.49 75.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.485 1.039 . . . . 0.0 112.132 176.654 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.1 -42.46 76.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.952 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.13 -44.67 11.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.377 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.62 -4.4 15.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -168.219 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.86 -14.68 24.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 117.007 1.563 . . . . 0.0 117.007 167.865 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.17 125.7 91.94 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.605 1.703 . . . . 0.0 110.75 -177.035 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -57.61 144.5 92.46 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.181 2.588 . . . . 0.0 113.469 176.211 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -62.75 -29.77 77.46 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.901 2.4 . . . . 0.0 114.051 -172.132 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.17 -19.7 64.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.719 -1.238 . . . . 0.0 113.651 174.03 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.1 8.05 45.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.674 1.59 . . . . 0.0 113.668 178.413 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -105.35 136.48 44.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.617 1.167 . . . . 0.0 112.354 177.209 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -121.61 135.71 54.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.377 1.071 . . . . 0.0 109.374 163.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.8 mt -111.61 130.15 55.85 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.018 0.927 . . . . 0.0 110.669 -179.858 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.46 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.263 1.025 . . . . 0.0 111.331 -173.965 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.33 126.72 16.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.35 1.46 . . . . 0.0 110.876 177.273 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.38 39.56 20.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.205 1.402 . . . . 0.0 113.662 -176.482 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 -11.98 11.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.471 1.986 . . . . 0.0 116.259 -173.877 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.71 133.43 35.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.67 1.735 . . . . 0.0 111.149 -177.729 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.17 129.97 38.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.946 0.498 . . . . 0.0 109.908 167.512 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.38 121.98 36.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 109.375 178.062 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -101.19 146.37 27.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.966 1.306 . . . . 0.0 112.738 -164.52 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.4 -38.79 92.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -157.034 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.36 -6.98 87.2 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.647 1.118 . . . . 0.0 114.592 176.805 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.15 164.66 14.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.941 1.37 . . . . 0.0 111.206 175.847 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -114.81 163.49 15.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.53 1.132 . . . . 0.0 113.626 -175.214 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.13 -36.52 68.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.22 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -64.66 -37.33 87.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.344 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -62.75 -28.89 70.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.26 0.936 . . . . 0.0 112.395 176.999 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.97 6.24 47.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 114.567 174.084 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 53.37 41.12 32.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.531 -178.521 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -89.33 105.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.781 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -84.69 169.98 13.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.708 1.203 . . . . 0.0 111.778 172.168 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.04 148.58 1.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.085 2.154 . . . . 0.0 113.458 171.507 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 62.45 5.08 1.49 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 177.885 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -66.99 148.96 51.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.389 1.076 . . . . 0.0 111.894 167.118 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 m -109.5 138.9 45.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.237 1.415 . . . . 0.0 110.34 174.963 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.16 159.5 34.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 112.127 172.581 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.84 136.47 35.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.385 1.074 . . . . 0.0 111.789 -178.083 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.4 tp -96.98 131.34 43.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.944 1.298 . . . . 0.0 110.19 168.164 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.33 144.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.184 1.794 . . . . 0.0 110.182 -177.946 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -86.41 136.86 32.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.152 1.381 . . . . 0.0 112.51 -179.006 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -94.9 140.17 30.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.48 1.112 . . . . 0.0 110.93 169.613 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.79 -23.24 1.81 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.162 1.385 . . . . 0.0 113.802 177.098 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 157.18 44.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.993 1.317 . . . . 0.0 112.099 173.078 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.56 -164.74 32.95 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.401 1.0 . . . . 0.0 113.132 -177.155 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.784 -1.564 . . . . 0.0 113.4 -179.16 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.69 135.26 35.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.068 0.849 . . . . 0.0 112.384 -176.167 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -134.66 177.48 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.806 1.242 . . . . 0.0 111.038 161.214 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.42 157.67 41.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.691 1.196 . . . . 0.0 112.215 176.15 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.12 134.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.506 1.122 . . . . 0.0 109.474 173.456 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -128.97 146.3 51.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.835 -177.637 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.8 1.64 . . . . 0.0 112.339 -179.27 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.03 -28.6 69.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.844 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 p -78.36 -1.45 33.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.097 1.759 . . . . 0.0 114.519 173.205 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 12.21 73.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.541 1.067 . . . . 0.0 115.634 174.949 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -79.24 129.91 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.351 1.46 . . . . 0.0 108.752 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -138.16 136.65 36.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.34 1.056 . . . . 0.0 111.303 -169.846 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -135.71 159.97 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.593 1.557 . . . . 0.0 112.31 -177.1 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 t -111.15 151.65 27.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.669 1.188 . . . . 0.0 112.04 165.283 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.4 mt -130.63 161.03 32.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.603 1.561 . . . . 0.0 111.129 178.075 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -104.74 129.62 52.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.964 0.906 . . . . 0.0 110.517 158.336 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -138.33 177.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.17 2.588 . . . . 0.0 109.904 179.938 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -131.67 158.75 74.51 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.75 1.22 . . . . 0.0 110.302 172.38 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.51 -37.74 82.79 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.129 2.553 . . . . 0.0 115.652 176.257 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.48 12.69 17.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.394 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -78.42 143.4 36.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.593 -1.317 . . . . 0.0 111.773 176.619 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -87.12 159.36 18.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.763 0.825 . . . . 0.0 113.177 -173.318 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.01 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.03 -1.044 . . . . 0.0 112.276 170.62 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -67.96 -34.62 76.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.025 1.284 . . . . 0.0 112.274 172.596 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.4 -38.86 74.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.996 -1.065 . . . . 0.0 112.205 174.489 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.77 -48.86 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.56 170.96 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -37.77 82.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.308 0.958 . . . . 0.0 113.259 177.621 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.06 -29.64 63.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 176.836 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -77.53 -27.74 51.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.988 -1.07 . . . . 0.0 113.218 172.28 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.71 -44.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.494 1.118 . . . . 0.0 110.093 163.52 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.0 -40.09 79.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.057 0.844 . . . . 0.0 112.375 176.784 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.75 -18.55 65.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 176.713 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.55 -34.39 6.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -177.712 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -120.55 -2.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.711 1.205 . . . . 0.0 114.028 -176.367 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 -2.28 49.62 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 177.24 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -74.13 119.35 75.9 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.691 1.245 . . . . 0.0 108.981 -173.613 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 146.66 70.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.3 2.0 . . . . 0.0 111.524 -178.33 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.89 -30.51 90.18 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.365 2.71 . . . . 0.0 112.688 -172.104 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 8.23 9.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.167 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -100.26 -20.03 16.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.5 1.12 . . . . 0.0 113.487 157.672 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.67 128.11 35.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.57 1.077 . . . . 0.0 112.577 -167.647 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -113.41 127.85 56.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.396 1.478 . . . . 0.0 109.632 160.763 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.55 128.13 54.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.66 1.184 . . . . 0.0 111.983 -179.522 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -120.68 139.11 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.332 1.853 . . . . 0.0 109.888 -171.939 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -153.8 132.65 12.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.424 0.689 . . . . 0.0 112.725 175.202 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.73 53.66 12.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.488 1.515 . . . . 0.0 114.113 172.529 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.35 87.69 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.079 -1.4 . . . . 0.0 116.356 174.323 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -144.93 159.15 43.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.889 1.845 . . . . 0.0 114.255 178.385 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.18 146.34 35.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 111.75 171.293 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -105.79 138.71 41.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.1 1.76 . . . . 0.0 110.185 172.235 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -115.4 152.87 32.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.385 1.474 . . . . 0.0 112.908 177.037 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.18 -24.74 63.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 128.223 2.609 . . . . 0.0 116.678 -171.487 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.28 13.31 3.65 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 -177.078 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -143.86 156.26 44.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.147 1.779 . . . . 0.0 112.208 -174.365 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -90.22 165.56 13.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.516 1.126 . . . . 0.0 113.107 175.476 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.28 -34.75 68.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.336 -0.852 . . . . 0.0 112.797 173.147 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -76.95 -26.96 54.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.71 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.38 -33.9 74.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.824 1.647 . . . . 0.0 111.654 165.041 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -86.35 -2.01 58.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 114.059 171.633 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 55.43 39.41 31.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.261 1.824 . . . . 0.0 114.827 -177.743 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.5 mt -86.16 141.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.844 1.658 . . . . 0.0 110.58 179.923 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -120.52 162.88 18.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.29 1.836 . . . . 0.0 113.201 -173.029 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -55.49 149.21 13.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 114.166 -177.862 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 59.69 11.64 2.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.228 2.211 . . . . 0.0 116.642 -175.353 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -72.22 150.08 44.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.813 -1.18 . . . . 0.0 112.092 170.02 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 121.89 44.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.476 1.511 . . . . 0.0 110.819 176.775 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.81 152.73 24.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.968 1.307 . . . . 0.0 110.388 166.101 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -102.78 138.81 39.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.37 -0.831 . . . . 0.0 110.918 165.938 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.2 tp -110.3 127.08 54.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.966 1.306 . . . . 0.0 109.491 174.624 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.64 150.6 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.737 1.215 . . . . 0.0 110.601 167.267 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.9 151.42 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.83 0.852 . . . . 0.0 112.612 -179.092 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -78.24 60.15 2.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.918 1.287 . . . . 0.0 110.619 166.642 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -61.15 122.18 14.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.535 1.934 . . . . 0.0 111.113 -178.352 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 56.87 28.86 15.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.873 2.069 . . . . 0.0 113.683 -177.348 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.03 15.6 0.12 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 -177.206 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-N 120.214 2.007 . . . . 0.0 115.232 174.767 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.633 0.254 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.39 142.38 37.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.4 0.68 . . . . 0.0 110.35 172.677 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.84 164.95 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.616 1.566 . . . . 0.0 109.903 166.07 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.66 146.26 47.62 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.112 0.965 . . . . 0.0 111.014 174.061 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.25 129.8 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.407 1.083 . . . . 0.0 109.281 171.69 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -111.18 153.3 25.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 112.952 -179.143 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -137.41 148.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.69 1.196 . . . . 0.0 112.537 179.591 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -73.59 -14.28 61.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.24 -0.912 . . . . 0.0 112.583 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -80.56 2.64 24.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.587 1.155 . . . . 0.0 113.938 168.565 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.78 8.17 80.18 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.329 1.291 . . . . 0.0 116.329 167.489 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -90.71 142.02 28.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.153 1.477 . . . . 0.0 110.781 169.161 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 m -119.24 145.34 46.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.209 1.003 . . . . 0.0 109.411 168.716 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -127.52 108.26 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.54 1.136 . . . . 0.0 108.787 -178.582 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 m -85.09 124.01 31.27 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 109.251 168.238 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 tp -134.96 139.03 44.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.164 0.985 . . . . 0.0 112.326 -177.167 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -94.35 115.94 28.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.696 1.198 . . . . 0.0 110.398 172.926 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -126.93 174.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.331 1.852 . . . . 0.0 112.571 -174.031 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -109.2 146.45 33.92 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 162.459 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.19 -14.3 43.7 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.832 2.354 . . . . 0.0 114.047 178.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -87.35 -1.83 58.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.519 1.528 . . . . 0.0 115.08 171.964 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -69.31 149.26 48.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.629 1.104 . . . . 0.0 110.964 174.839 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -78.92 154.23 29.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.402 -0.811 . . . . 0.0 112.977 175.995 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -58.98 -41.21 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.906 -0.496 . . . . 0.0 110.581 172.604 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -59.05 -40.42 85.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.888 1.675 . . . . 0.0 113.155 174.409 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.6 -40.35 92.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.697 -0.627 . . . . 0.0 112.404 176.984 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.77 -41.22 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.311 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.77 -41.98 87.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.946 1.248 . . . . 0.0 112.498 172.868 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.59 82.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.625 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -69.56 -36.98 76.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.42 1.088 . . . . 0.0 112.134 174.323 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.68 -37.27 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.828 0.851 . . . . 0.0 111.225 171.639 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.8 -51.75 60.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.68 1.127 . . . . 0.0 112.304 171.752 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.22 -41.0 78.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.413 0.685 . . . . 0.0 112.595 -179.285 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.19 -52.24 8.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.769 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -118.67 -4.09 10.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -164.768 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 15.92 65.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 168.179 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -92.54 118.11 67.88 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 119.379 1.59 . . . . 0.0 109.668 -177.514 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.3 129.76 29.58 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.041 2.494 . . . . 0.0 113.66 -175.225 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.49 -31.81 20.98 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.371 2.714 . . . . 0.0 113.733 -165.825 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -76.75 0.41 20.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.528 174.305 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.47 6.24 20.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.349 1.46 . . . . 0.0 113.724 167.032 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -94.0 135.55 35.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.443 1.474 . . . . 0.0 112.248 177.712 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.13 135.07 54.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.407 1.483 . . . . 0.0 110.275 160.969 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -118.16 129.53 55.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.37 1.468 . . . . 0.0 110.408 177.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.47 127.3 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.279 1.432 . . . . 0.0 110.571 -171.369 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -153.91 142.82 21.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.417 1.487 . . . . 0.0 112.315 -178.66 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.58 45.94 8.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.037 1.735 . . . . 0.0 115.133 170.661 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.75 5.86 89.02 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.775 175.523 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -130.82 153.2 49.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.982 1.713 . . . . 0.0 112.761 -177.07 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -77.73 134.23 38.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 156.007 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.56 124.49 29.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.074 0.95 . . . . 0.0 110.732 178.625 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -97.32 128.4 44.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.748 1.219 . . . . 0.0 113.531 -171.544 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.64 -35.54 9.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.776 2.43 . . . . 0.0 116.619 -173.733 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.7 -7.87 87.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.906 1.123 . . . . 0.0 115.906 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mmm-85 -100.65 169.16 9.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.106 1.762 . . . . 0.0 112.046 -175.951 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.9 p -109.67 159.8 16.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.354 1.462 . . . . 0.0 113.001 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.12 -38.27 70.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 112.995 -176.455 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 p -65.77 -27.32 68.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.647 1.179 . . . . 0.0 113.913 176.418 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.02 -21.47 65.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 119.953 1.251 . . . . 0.0 112.833 174.462 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.57 10.27 37.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.363 1.465 . . . . 0.0 113.329 170.38 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.31 33.39 23.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 114.131 176.541 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -72.32 114.99 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.419 1.088 . . . . 0.0 108.949 179.925 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -95.91 173.03 7.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.539 1.536 . . . . 0.0 112.799 -178.161 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 134.44 56.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.034 -1.041 . . . . 0.0 112.483 175.802 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 50.7 mt-10 59.61 30.66 20.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.104 2.162 . . . . 0.0 114.981 -176.791 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.7 m -65.1 151.16 46.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.275 0.63 . . . . 0.0 111.814 162.407 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 m -113.79 123.69 50.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.457 1.103 . . . . 0.0 110.557 173.695 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -102.85 152.12 21.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.243 1.817 . . . . 0.0 110.301 177.139 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -106.01 136.51 45.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 173.868 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.25 137.81 51.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.442 1.497 . . . . 0.0 111.044 -179.538 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.52 134.8 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.193 1.797 . . . . 0.0 110.334 176.776 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.7 tp -81.77 130.97 35.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.321 1.448 . . . . 0.0 109.961 170.571 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -67.57 135.91 53.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 113.053 -178.791 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.7 mt -78.27 143.16 37.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 111.486 177.599 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 42.36 45.01 3.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.612 1.965 . . . . 0.0 112.429 -170.058 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.93 -25.46 69.32 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.83 -168.245 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.121 -1.377 . . . . 0.0 112.338 175.847 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.44 145.14 25.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.194 0.998 . . . . 0.0 111.72 179.354 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.67 162.85 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.303 1.441 . . . . 0.0 111.684 170.028 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -112.58 151.51 29.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.273 1.029 . . . . 0.0 112.107 175.435 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -138.16 123.05 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.523 1.529 . . . . 0.0 110.266 178.003 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -103.77 144.78 31.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.896 1.279 . . . . 0.0 112.777 -178.565 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -112.91 158.45 20.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 112.416 173.06 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.46 -18.45 61.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.562 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -78.93 -0.08 29.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.272 1.029 . . . . 0.0 113.757 164.159 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.83 3.83 55.88 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.642 -1.643 . . . . 0.0 116.724 163.834 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.22 140.97 38.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 120.554 2.177 . . . . 0.0 110.48 177.594 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -110.16 111.67 23.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.129 0.972 . . . . 0.0 109.942 167.835 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mt -92.29 149.56 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 128.105 2.562 . . . . 0.0 108.592 179.748 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -119.19 136.57 54.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.155 1.782 . . . . 0.0 109.694 177.894 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -133.12 152.74 51.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 112.581 -178.97 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -102.86 126.25 49.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.035 171.286 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.41 -177.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.814 2.046 . . . . 0.0 111.204 -174.185 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 20' ' ' SER . 7.5 pt-20 -133.16 168.36 18.3 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.892 1.277 . . . . 0.0 110.212 155.989 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -57.42 -23.07 53.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.372 2.048 . . . . 0.0 115.649 -179.207 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 15.6 m -96.22 10.54 37.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.102 1.761 . . . . 0.0 114.824 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 131.78 51.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.44 1.096 . . . . 0.0 110.885 167.08 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -80.92 150.7 28.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.37 0.668 . . . . 0.0 111.984 172.211 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -68.07 -38.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.697 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -58.28 -35.93 72.52 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.665 -1.272 . . . . 0.0 112.65 172.943 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -38.38 80.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.478 1.111 . . . . 0.0 113.217 171.02 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.44 -38.36 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 120.666 -1.271 . . . . 0.0 110.339 176.879 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.53 -36.87 85.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.645 -0.66 . . . . 0.0 112.636 171.172 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.54 79.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.216 0.916 . . . . 0.0 113.103 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.24 -35.74 81.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.604 1.162 . . . . 0.0 112.418 172.484 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.9 mt -67.96 -42.47 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.22 1.008 . . . . 0.0 110.868 171.637 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.36 -42.99 92.85 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.104 -0.997 . . . . 0.0 111.499 175.459 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.03 -24.86 67.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 176.279 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -100.65 -36.68 9.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.908 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -128.4 -8.66 5.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.555 1.542 . . . . 0.0 114.813 -168.031 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.11 10.16 84.2 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 171.553 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.87 126.48 68.09 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 119.39 1.595 . . . . 0.0 110.153 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -65.1 133.06 34.04 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.44 2.093 . . . . 0.0 114.318 -178.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.18 -18.1 50.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 124.057 3.172 . . . . 0.0 115.9 -172.885 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -74.28 -28.11 61.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.694 1.134 . . . . 0.0 112.128 171.938 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.86 -37.37 24.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.662 1.185 . . . . 0.0 111.754 176.133 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.36 140.49 58.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.622 0.769 . . . . 0.0 112.859 179.396 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.297 1.439 . . . . 0.0 111.353 160.991 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.85 138.31 36.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.146 0.979 . . . . 0.0 111.551 178.033 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.72 138.37 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.77 2.028 . . . . 0.0 109.571 -178.463 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -139.89 119.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.535 1.134 . . . . 0.0 110.521 175.689 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.71 48.33 8.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.115 1.366 . . . . 0.0 113.454 -170.387 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.24 -10.05 11.67 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.37 1.462 . . . . 0.0 116.1 -178.819 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -84.4 124.65 31.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.959 1.88 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -77.64 121.8 24.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.641 0.655 . . . . 0.0 110.932 174.384 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.66 134.39 46.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.838 1.255 . . . . 0.0 111.503 -178.28 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.85 131.08 39.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.813 0.845 . . . . 0.0 111.294 173.296 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.86 -11.25 60.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.083 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.99 4.36 67.9 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.949 1.738 . . . . 0.0 116.019 174.943 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 mtp85 -105.52 -172.12 2.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.791 1.636 . . . . 0.0 112.727 -177.562 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -124.71 159.74 30.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 113.079 -179.039 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.22 -38.95 74.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.663 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -65.53 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.576 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.29 -24.39 67.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.882 1.219 . . . . 0.0 112.61 173.704 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.53 12.76 36.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.027 1.731 . . . . 0.0 112.073 174.83 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 t30 54.64 30.47 13.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.903 1.681 . . . . 0.0 114.352 -178.774 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.0 mt -77.39 134.77 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.294 1.038 . . . . 0.0 108.747 179.255 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -137.62 177.9 7.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.536 1.934 . . . . 0.0 110.285 -166.386 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.77 131.24 48.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.869 -1.144 . . . . 0.0 111.765 178.901 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 57.43 24.06 9.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.377 1.871 . . . . 0.0 114.854 -176.501 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -67.06 150.27 49.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.116 -0.99 . . . . 0.0 111.105 158.848 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.2 m -115.68 123.74 49.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.706 1.202 . . . . 0.0 110.365 -179.892 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.38 163.81 12.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.404 1.481 . . . . 0.0 109.474 170.189 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.81 147.75 37.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.091 0.956 . . . . 0.0 109.829 166.547 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.23 130.09 51.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.473 1.509 . . . . 0.0 109.649 -174.711 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.2 152.8 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.133 0.973 . . . . 0.0 112.087 173.762 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.29 125.13 34.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 164.8 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -108.69 106.83 17.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.492 1.917 . . . . 0.0 108.092 176.021 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.8 mt -120.03 153.04 36.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.688 1.595 . . . . 0.0 112.484 -164.718 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 -122.68 -38.03 2.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.753 1.621 . . . . 0.0 114.329 -167.242 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.5 151.31 5.51 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.538 1.066 . . . . 0.0 115.017 178.406 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 125.502 1.525 . . . . 0.0 112.934 178.683 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.03 145.69 26.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.57 0.748 . . . . 0.0 111.752 172.593 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.24 153.75 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.826 1.251 . . . . 0.0 110.145 168.332 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.86 126.77 53.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.328 0.651 . . . . 0.0 111.221 -170.136 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.81 114.31 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.861 1.264 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -85.7 153.12 22.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.296 1.438 . . . . 0.0 111.411 174.836 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 112.697 -175.883 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.17 -29.76 67.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 0.0 113.707 -175.726 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -80.5 -9.67 59.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.744 1.217 . . . . 0.0 113.972 178.097 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.65 -0.37 88.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.512 1.053 . . . . 0.0 114.785 -171.218 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -69.54 138.34 53.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.359 1.58 . . . . 0.0 109.719 170.559 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -124.72 125.99 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 110.615 -176.669 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.82 128.94 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.576 1.55 . . . . 0.0 109.155 -173.887 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -97.65 130.0 44.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.163 0.585 . . . . 0.0 110.42 176.608 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.79 148.94 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.526 1.53 . . . . 0.0 111.558 177.974 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -105.85 117.83 35.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.463 1.505 . . . . 0.0 109.854 173.899 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -142.25 154.61 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.543 1.137 . . . . 0.0 111.696 -174.723 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -98.28 158.24 33.03 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 123.711 0.804 . . . . 0.0 109.15 159.214 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.04 -15.71 18.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.334 2.022 . . . . 0.0 115.449 172.734 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.1 p -80.3 -11.53 59.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.972 1.709 . . . . 0.0 115.596 173.475 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.43 149.54 48.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 119.621 1.101 . . . . 0.0 111.675 177.564 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -94.27 168.77 10.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.1 0.952 . . . . 0.0 113.22 173.165 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.52 -26.39 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.562 -0.711 . . . . 0.0 111.867 168.236 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.33 -35.01 77.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 120.481 -1.387 . . . . 0.0 114.069 167.23 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -65.43 -41.57 93.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.181 0.9 . . . . 0.0 110.898 169.499 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.6 -47.72 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.071 173.584 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.05 -42.54 94.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 176.5 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.01 84.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.626 0.648 . . . . 0.0 112.34 177.856 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -73.01 -38.63 66.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.799 1.24 . . . . 0.0 112.443 179.496 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.93 -40.61 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.878 1.271 . . . . 0.0 110.829 169.902 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -59.12 -38.45 79.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.89 0.768 . . . . 0.0 111.682 175.062 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.05 -37.08 75.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.87 -32.97 59.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 114.337 -178.676 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -126.85 -11.56 6.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -170.18 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.81 16.88 80.16 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.953 1.251 . . . . 0.0 115.288 -178.566 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.62 120.05 62.74 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 110.523 -178.149 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.46 152.44 47.28 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 124.722 3.615 . . . . 0.0 115.221 178.44 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.73 -40.37 74.16 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.672 2.915 . . . . 0.0 115.168 -178.04 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.89 -24.43 63.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -83.52 -8.97 59.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.305 1.042 . . . . 0.0 112.87 -178.637 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.85 124.26 39.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.066 1.346 . . . . 0.0 110.632 179.06 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -110.7 117.15 32.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.455 1.102 . . . . 0.0 109.55 165.069 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.39 117.41 34.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.938 0.895 . . . . 0.0 111.248 -171.153 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.18 138.13 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.68 1.592 . . . . 0.0 111.353 -177.106 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -148.74 140.48 23.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.715 1.606 . . . . 0.0 109.513 168.242 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.43 38.62 7.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.068 1.347 . . . . 0.0 113.842 -174.138 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 15.44 65.86 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 -178.401 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -128.61 152.33 48.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.198 1.799 . . . . 0.0 111.15 -178.511 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.52 133.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.359 0.663 . . . . 0.0 111.939 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.29 130.78 34.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.791 1.236 . . . . 0.0 110.659 173.131 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -97.84 127.67 43.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -171.653 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.97 -34.98 1.86 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.182 2.993 . . . . 0.0 115.927 -175.479 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.65 -16.89 80.37 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 179.777 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mtt-85 -100.02 161.19 13.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.578 1.689 . . . . 0.0 113.67 -167.639 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -95.62 157.68 15.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.18 1.392 . . . . 0.0 114.047 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.93 -45.1 95.16 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.761 0.824 . . . . 0.0 112.872 176.261 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -59.57 -40.83 88.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.164 0.985 . . . . 0.0 112.714 174.407 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.65 -24.3 66.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.422 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -89.8 4.65 49.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.888 1.675 . . . . 0.0 114.969 167.32 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.6 t30 55.61 35.09 24.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.447 -1.408 . . . . 0.0 114.292 -175.144 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.6 138.97 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.037 0.935 . . . . 0.0 108.574 173.443 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -132.92 172.74 12.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.122 1.769 . . . . 0.0 111.571 -165.975 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.73 136.08 40.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.732 0.813 . . . . 0.0 112.314 176.844 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 55.38 32.73 19.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.732 1.613 . . . . 0.0 115.206 -179.105 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -71.8 147.23 47.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.862 0.865 . . . . 0.0 112.661 169.21 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 m -98.7 125.92 44.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.39 1.476 . . . . 0.0 111.443 173.026 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 161.27 19.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 109.998 175.996 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -122.93 142.56 50.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 177.374 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -119.5 123.6 44.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.328 1.451 . . . . 0.0 110.826 177.686 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -106.84 137.36 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.418 1.887 . . . . 0.0 108.453 171.757 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -95.75 133.97 39.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.77 0.828 . . . . 0.0 111.679 178.518 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mmt-85 -84.92 55.56 3.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.794 1.238 . . . . 0.0 111.352 169.408 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -127.24 142.75 51.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.863 2.065 . . . . 0.0 109.755 175.889 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -82.81 144.36 30.18 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -168.563 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.28 -2.16 80.46 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -172.288 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-N 118.628 1.214 . . . . 0.0 113.48 178.877 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -112.76 134.14 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.12 1.327 . . . . 0.0 113.323 -169.751 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -129.92 171.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.92 1.688 . . . . 0.0 111.319 -179.083 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -122.66 157.61 31.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.473 1.509 . . . . 0.0 110.81 172.745 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -135.8 134.83 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.161 0.984 . . . . 0.0 110.419 175.497 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -105.04 131.99 51.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.801 1.64 . . . . 0.0 112.455 173.275 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.8 p -63.64 173.18 1.79 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.236 1.414 . . . . 0.0 112.295 165.504 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.76 -29.88 67.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.783 -1.198 . . . . 0.0 112.923 170.603 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -82.41 -5.16 58.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 114.344 174.492 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.95 89.57 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.125 1.345 . . . . 0.0 114.865 -177.798 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.63 134.34 55.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.039 1.42 . . . . 0.0 108.682 172.923 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m -113.11 138.97 49.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.717 0.807 . . . . 0.0 112.03 -165.938 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.53 157.51 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.711 1.605 . . . . 0.0 111.439 168.446 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.6 m -107.99 137.4 46.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.558 1.543 . . . . 0.0 110.342 175.185 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.43 137.79 42.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.54 1.136 . . . . 0.0 112.741 178.032 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -100.59 124.21 45.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.563 175.446 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.48 177.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 127.477 2.311 . . . . 0.0 111.815 -166.507 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.16 150.95 37.35 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 125.027 1.331 . . . . 0.0 111.58 166.294 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.75 -26.64 83.39 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.391 2.061 . . . . 0.0 113.652 171.919 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -93.02 8.21 40.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.21 1.404 . . . . 0.0 114.24 174.299 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.18 142.18 57.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.771 1.623 . . . . 0.0 111.746 174.329 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -76.18 159.06 31.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.949 0.9 . . . . 0.0 111.93 172.778 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.86 -29.41 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.125 169.126 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.58 -46.82 87.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.742 1.155 . . . . 0.0 112.583 169.525 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -62.4 -39.28 92.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.813 0.733 . . . . 0.0 112.262 175.478 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -43.25 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 121.039 -1.038 . . . . 0.0 111.718 178.168 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -59.89 -34.0 72.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 111.661 173.224 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.03 -36.0 81.13 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.94 -31.05 56.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.269 -0.894 . . . . 0.0 113.271 174.972 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.03 -43.15 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.851 0.86 . . . . 0.0 110.623 167.77 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -59.71 -41.87 91.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.562 1.145 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.53 -48.63 66.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 178.702 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -73.02 -43.87 61.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.94 -12.17 12.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.369 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.98 17.4 63.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 119.774 1.17 . . . . 0.0 115.307 174.914 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -85.16 120.09 73.09 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 119.108 1.454 . . . . 0.0 109.802 -175.898 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 134.3 49.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.211 2.607 . . . . 0.0 112.955 -176.784 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -55.98 -26.96 61.46 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 124.0 3.133 . . . . 0.0 116.925 -176.162 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -82.4 -3.5 55.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 120.029 1.286 . . . . 0.0 114.236 174.221 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -115.3 1.39 13.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.572 2.349 . . . . 0.0 113.721 -178.622 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.52 129.0 53.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.229 1.412 . . . . 0.0 111.29 173.341 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -137.66 133.11 33.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.45 1.5 . . . . 0.0 110.166 177.996 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -123.98 153.82 40.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -163.324 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mm -129.77 147.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 128.807 2.843 . . . . 0.0 110.558 175.684 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -140.4 129.99 24.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.652 1.581 . . . . 0.0 109.901 163.51 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 37.33 10.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.201 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.47 -10.39 12.02 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.854 1.692 . . . . 0.0 116.235 -172.983 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -73.12 132.34 43.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.366 1.583 . . . . 0.0 111.568 -178.568 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -71.26 117.07 12.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.367 171.632 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.11 120.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.492 1.117 . . . . 0.0 111.091 -177.152 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.45 142.81 51.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.417 1.087 . . . . 0.0 113.198 -168.294 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.88 -31.19 62.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.172 1.789 . . . . 0.0 114.974 -165.767 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.35 4.63 83.39 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.992 1.758 . . . . 0.0 117.251 -179.982 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -128.59 167.3 17.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.73 1.765 . . . . 0.0 113.156 179.78 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -113.64 163.51 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -166.536 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.6 mt -58.48 -37.65 75.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.638 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 p -69.08 -28.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 172.891 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.58 -34.93 79.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.984 1.265 . . . . 0.0 111.332 173.251 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.11 3.54 53.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 177.007 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 52.01 39.39 26.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.698 1.199 . . . . 0.0 113.753 -175.096 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.44 138.62 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.192 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -130.62 -177.67 4.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 112.086 -175.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 144.42 21.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 175.434 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 59.56 15.76 4.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.838 1.655 . . . . 0.0 114.636 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -70.92 139.01 50.57 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.8 -1.187 . . . . 0.0 111.174 173.459 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -96.79 127.08 42.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.822 0.849 . . . . 0.0 109.98 168.85 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -95.39 140.83 29.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.765 1.226 . . . . 0.0 109.314 168.683 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -117.12 128.54 55.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.662 -172.142 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.32 136.09 40.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 153.343 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.28 138.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 112.279 -176.787 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.9 mt -60.44 -37.0 79.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.252 1.421 . . . . 0.0 113.39 -172.38 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -46.07 -38.21 7.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 113.234 171.715 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.72 -33.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.963 1.305 . . . . 0.0 113.352 -170.866 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.08 -71.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.759 2.824 . . . . 0.0 114.966 176.16 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.07 -25.25 0.04 OUTLIER Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 -178.61 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 119.236 1.518 . . . . 0.0 114.707 -173.551 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.015 -0.041 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -122.35 151.54 41.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.293 1.437 . . . . 0.0 111.305 178.994 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -134.72 159.89 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 111.129 172.704 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.83 137.06 37.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.884 165.992 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.9 t -120.46 129.82 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.009 1.324 . . . . 0.0 109.114 172.991 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -121.85 151.62 40.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 179.846 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -99.9 162.88 12.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.833 1.653 . . . . 0.0 113.368 174.329 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.21 -19.42 64.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.535 1.534 . . . . 0.0 113.072 168.224 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -84.66 3.32 37.64 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.369 1.868 . . . . 0.0 113.88 169.318 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.32 -0.67 79.41 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.41 1.481 . . . . 0.0 115.709 176.458 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -69.42 140.27 54.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.591 1.157 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.18 138.9 54.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.944 -173.009 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.96 138.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.081 1.752 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -93.95 134.4 36.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.908 1.283 . . . . 0.0 112.008 175.544 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tp -125.83 139.96 53.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -176.659 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.53 124.29 38.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.447 0.699 . . . . 0.0 111.458 172.474 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -140.32 158.93 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.197 1.399 . . . . 0.0 112.335 -171.618 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -126.47 153.75 75.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 124.779 1.232 . . . . 0.0 111.113 178.194 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.5 -23.74 49.43 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.103 2.535 . . . . 0.0 116.304 -176.529 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p -84.68 -8.83 58.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.355 1.862 . . . . 0.0 115.13 176.656 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.35 130.15 42.69 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.759 1.163 . . . . 0.0 110.627 -177.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 p -72.79 163.38 28.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 111.164 170.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.23 -35.75 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.059 -1.026 . . . . 0.0 110.566 170.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -73.54 -28.74 62.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.472 -1.393 . . . . 0.0 113.952 176.693 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -64.85 -43.47 92.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.597 -1.314 . . . . 0.0 111.788 167.302 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.27 -41.07 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 118.956 0.798 . . . . 0.0 111.369 178.299 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.93 -40.22 83.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.889 0.768 . . . . 0.0 112.863 171.449 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -30.62 64.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.236 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.02 -39.11 83.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.362 -1.461 . . . . 0.0 111.686 169.857 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.13 -38.49 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.338 1.055 . . . . 0.0 111.158 170.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -58.32 -32.86 68.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.728 1.149 . . . . 0.0 113.155 176.371 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -74.5 -22.56 58.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.399 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.7 -39.05 8.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.564 1.146 . . . . 0.0 113.955 179.94 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -109.81 -15.79 14.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.046 1.738 . . . . 0.0 114.303 -174.471 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.11 5.48 80.84 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 116.579 1.391 . . . . 0.0 116.579 177.92 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.85 124.84 81.29 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 119.762 1.781 . . . . 0.0 110.441 -178.627 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.7 133.13 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.932 2.421 . . . . 0.0 113.614 177.099 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -53.75 -27.47 42.98 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.339 3.359 . . . . 0.0 115.906 179.972 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.56 -22.8 66.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.224 0.92 . . . . 0.0 113.461 179.267 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.16 17.1 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 174.605 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.13 149.99 24.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.331 1.052 . . . . 0.0 112.868 175.265 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -130.86 148.86 52.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.528 2.731 . . . . 0.0 109.895 165.988 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.75 141.22 52.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 112.41 175.054 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.23 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.429 1.891 . . . . 0.0 110.846 -178.76 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -140.35 139.72 35.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.819 1.248 . . . . 0.0 112.078 169.555 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 43.07 13.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.592 1.557 . . . . 0.0 113.544 -178.401 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.35 -5.66 42.23 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.466 1.508 . . . . 0.0 116.769 -178.221 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -106.87 146.57 30.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.057 1.928 . . . . 0.0 112.345 -175.39 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -80.26 138.29 36.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.505 1.122 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.86 152.99 23.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.712 1.205 . . . . 0.0 111.857 -176.765 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -117.23 139.38 50.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.013 1.325 . . . . 0.0 114.286 -170.463 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.67 -24.5 63.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -173.807 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.81 -9.63 85.02 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.819 -0.989 . . . . 0.0 115.497 174.175 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -114.81 168.58 9.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.298 1.839 . . . . 0.0 112.237 -169.775 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.97 167.18 12.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.166 1.787 . . . . 0.0 114.134 -172.226 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.09 -40.89 70.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.463 -0.773 . . . . 0.0 112.663 172.814 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.0 p -72.6 -23.69 60.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 177.532 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -63.18 -41.14 99.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.014 1.733 . . . . 0.0 111.629 167.353 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -90.67 4.36 51.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.62 1.168 . . . . 0.0 113.891 -177.766 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 56.81 38.16 29.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.991 1.316 . . . . 0.0 113.533 -178.345 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.73 115.58 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.365 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -110.29 174.64 5.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.31 1.444 . . . . 0.0 111.92 -175.879 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.6 150.17 0.72 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.654 1.982 . . . . 0.0 115.791 -174.494 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 63.97 -1.41 0.67 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.032 2.533 . . . . 0.0 117.148 179.468 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -61.5 156.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.787 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.2 m -106.98 126.21 52.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.335 1.454 . . . . 0.0 111.071 177.692 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.57 155.19 29.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.342 1.857 . . . . 0.0 110.478 177.963 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.38 133.58 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.555 0.742 . . . . 0.0 111.32 176.563 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -100.0 129.32 46.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.713 1.605 . . . . 0.0 109.926 176.165 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.33 139.43 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.64 1.176 . . . . 0.0 109.219 177.173 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.68 132.1 35.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.964 -1.085 . . . . 0.0 111.208 177.915 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.22 -39.59 78.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.212 2.205 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 mt -136.43 132.96 36.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.381 1.472 . . . . 0.0 110.316 170.754 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -151.0 -11.33 0.23 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 169.399 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.48 161.87 18.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.837 1.684 . . . . 0.0 113.721 175.492 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 117.461 -1.744 . . . . 0.0 115.121 177.883 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.73 142.81 31.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.062 0.945 . . . . 0.0 112.263 175.323 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -131.71 157.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.023 1.329 . . . . 0.0 110.587 167.552 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -116.11 146.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 112.512 -174.691 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.19 133.95 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 110.728 178.667 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -109.54 146.37 34.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.462 1.905 . . . . 0.0 113.071 179.517 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -131.54 162.55 30.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.671 1.588 . . . . 0.0 114.028 -167.844 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 tp -62.17 -10.48 10.62 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.701 2.0 . . . . 0.0 114.713 178.098 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -108.6 2.13 21.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -178.743 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.26 27.26 73.87 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.11 -0.994 . . . . 0.0 113.89 -173.805 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -93.65 115.67 28.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.401 1.08 . . . . 0.0 109.051 168.725 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -80.93 136.36 36.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.707 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.8 mt -123.13 138.19 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.058 1.343 . . . . 0.0 108.278 179.054 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -115.8 134.19 55.26 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.566 1.147 . . . . 0.0 110.011 -179.817 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.03 135.49 54.46 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.109 0.964 . . . . 0.0 111.744 -176.878 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.71 117.95 24.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.489 1.116 . . . . 0.0 109.585 169.691 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.15 161.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.928 1.291 . . . . 0.0 112.691 -173.69 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -102.19 152.71 38.3 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 158.773 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -29.14 56.91 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.854 2.369 . . . . 0.0 113.76 169.493 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 p -77.43 -4.36 45.01 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.29 1.836 . . . . 0.0 115.054 176.086 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -74.45 150.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.38 1.445 . . . . 0.0 111.477 172.668 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.5 p -96.76 163.27 13.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.364 1.066 . . . . 0.0 112.704 178.704 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.59 -30.78 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.018 0.527 . . . . 0.0 111.523 173.644 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.7 -45.7 91.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.654 1.182 . . . . 0.0 111.378 172.677 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -69.84 -32.56 71.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.782 175.306 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.05 -44.65 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.101 -1.0 . . . . 0.0 111.065 174.901 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.98 -37.37 79.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.139 0.881 . . . . 0.0 112.398 174.154 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -41.69 92.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.353 0.661 . . . . 0.0 112.658 175.72 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.14 -27.57 67.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.8 1.24 . . . . 0.0 112.947 175.358 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -74.57 -42.73 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.276 1.43 . . . . 0.0 111.76 170.444 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.29 -38.03 76.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.173 -0.954 . . . . 0.0 112.056 175.081 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.34 -18.0 60.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.31 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.23 -51.43 3.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 113.539 175.743 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -102.6 -8.43 20.98 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.222 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.95 6.6 73.78 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 175.849 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.5 mm -88.72 124.26 65.99 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 118.866 1.333 . . . . 0.0 109.916 178.914 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.07 151.8 72.95 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.726 2.284 . . . . 0.0 112.077 -178.334 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.74 -36.7 82.94 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.305 2.67 . . . . 0.0 116.549 -170.584 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.34 -15.32 62.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.304 . . . . 0.0 114.386 179.918 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -91.64 2.93 56.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.256 1.422 . . . . 0.0 113.174 172.92 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -105.97 141.51 37.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.64 1.576 . . . . 0.0 111.373 177.819 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -129.5 118.06 21.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.547 1.539 . . . . 0.0 109.199 167.985 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.15 135.03 42.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.994 1.317 . . . . 0.0 111.035 -178.649 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.0 mm -122.5 134.56 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.214 1.806 . . . . 0.0 111.361 -173.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -149.95 146.42 27.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.781 2.033 . . . . 0.0 109.705 169.854 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.82 20.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.86 1.264 . . . . 0.0 113.607 -178.348 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.56 60.9 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.534 1.54 . . . . 0.0 116.45 -178.279 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -137.27 161.35 36.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.797 1.799 . . . . 0.0 113.589 -170.373 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -55.53 145.43 23.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.411 1.484 . . . . 0.0 112.972 175.463 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.41 130.09 45.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.929 1.692 . . . . 0.0 110.139 162.986 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -104.52 143.8 32.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.181 1.392 . . . . 0.0 113.443 -171.946 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -61.21 -30.02 70.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.714 1.606 . . . . 0.0 115.222 -168.782 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.18 54.08 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.817 -1.546 . . . . 0.0 116.886 -173.343 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -127.04 152.45 47.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.126 1.963 . . . . 0.0 112.478 -175.377 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 p -80.19 159.38 26.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.552 1.141 . . . . 0.0 113.329 174.39 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.49 -38.5 74.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.583 -0.698 . . . . 0.0 111.875 166.392 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.8 p -63.0 -28.9 70.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.04 1.336 . . . . 0.0 114.33 173.157 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.63 -50.01 66.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.996 1.271 . . . . 0.0 110.479 173.57 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -73.87 1.51 10.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 t30 55.36 37.6 29.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.896 1.679 . . . . 0.0 113.73 -176.105 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.7 mt -87.21 86.14 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 107.731 178.83 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -79.47 177.05 9.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.707 1.603 . . . . 0.0 113.037 -179.08 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -45.02 137.75 4.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.881 1.672 . . . . 0.0 113.648 173.019 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.215 1.806 . . . . 0.0 115.766 -178.246 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -78.24 153.98 31.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.732 -1.23 . . . . 0.0 112.548 170.206 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.17 1.388 . . . . 0.0 112.222 177.985 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.6 mt -125.71 170.3 11.68 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.613 2.365 . . . . 0.0 110.419 178.605 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -121.12 151.45 39.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.031 -1.043 . . . . 0.0 112.118 173.311 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -129.16 129.82 45.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.39 1.876 . . . . 0.0 110.419 178.442 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.1 m -125.34 147.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.968 1.307 . . . . 0.0 110.353 168.475 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.27 154.35 19.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.54 1.136 . . . . 0.0 112.565 -174.37 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -132.96 70.28 1.47 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.581 1.952 . . . . 0.0 109.965 175.901 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.84 153.95 39.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.236 1.415 . . . . 0.0 112.511 -174.475 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -80.59 140.15 35.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.051 1.341 . . . . 0.0 112.711 -168.077 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.49 135.48 2.84 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.432 1.492 . . . . 0.0 113.508 176.69 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 C-N-CA 125.729 1.633 . . . . 0.0 114.2 -175.782 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.9 135.97 33.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.297 0.498 . . . . 0.0 111.414 169.031 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.84 176.48 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.732 1.613 . . . . 0.0 110.549 174.102 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -118.31 133.91 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.889 1.275 . . . . 0.0 111.755 175.314 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.61 118.74 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.843 1.257 . . . . 0.0 109.237 173.841 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -85.12 107.73 17.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.068 1.347 . . . . 0.0 108.826 174.79 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -71.01 169.05 15.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.629 1.572 . . . . 0.0 113.199 -172.356 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.8 mt -58.64 -31.24 67.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.44 -1.413 . . . . 0.0 112.32 167.659 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -71.3 -0.72 10.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.238 2.215 . . . . 0.0 113.482 174.8 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.28 -33.88 1.77 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.193 1.854 . . . . 0.0 114.04 178.87 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.95 141.89 26.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 110.612 169.332 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -105.75 137.52 43.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.166 0.986 . . . . 0.0 110.842 -176.957 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.91 148.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.508 1.523 . . . . 0.0 111.775 -179.676 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -92.25 131.42 37.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.067 1.347 . . . . 0.0 110.446 178.351 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.77 137.73 48.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.019 1.328 . . . . 0.0 111.515 -176.922 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -88.83 129.23 35.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.928 173.221 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.83 156.96 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.015 1.726 . . . . 0.0 112.11 179.47 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.6 137.17 19.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.673 164.903 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.85 -31.95 64.67 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.964 2.443 . . . . 0.0 114.581 171.433 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -85.54 -0.92 56.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 178.79 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -83.33 156.31 23.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.072 1.305 . . . . 0.0 112.004 177.138 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -88.78 151.04 22.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 112.994 -174.217 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.97 -33.72 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.064 -178.213 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.76 -35.42 81.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.551 1.523 . . . . 0.0 114.311 174.463 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.47 -39.5 77.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.562 0.619 . . . . 0.0 110.849 176.32 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.66 -40.17 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 111.266 174.449 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.2 -41.54 88.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.747 1.158 . . . . 0.0 112.788 170.533 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.84 85.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.241 0.928 . . . . 0.0 111.85 177.474 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -71.34 -34.36 70.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.177 -0.952 . . . . 0.0 112.672 174.986 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -70.19 -32.04 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.148 1.379 . . . . 0.0 111.534 170.56 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.1 -45.88 91.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 119.977 1.262 . . . . 0.0 110.455 174.643 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.73 -40.44 95.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 177.1 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.01 -46.58 56.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -179.596 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -111.99 -15.72 13.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -169.467 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 31.94 46.98 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.744 1.156 . . . . 0.0 115.16 176.288 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -112.5 127.51 26.75 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 118.61 1.205 . . . . 0.0 109.617 175.52 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.55 137.09 78.33 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.187 2.591 . . . . 0.0 112.934 176.368 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.03 -30.21 39.27 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 123.739 2.96 . . . . 0.0 116.032 178.669 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.91 -9.45 59.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.617 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -103.5 -24.63 13.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.33 1.052 . . . . 0.0 113.727 167.489 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.82 120.76 12.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.678 1.127 . . . . 0.0 111.566 175.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -112.95 130.27 56.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.349 1.059 . . . . 0.0 109.384 163.153 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -108.61 132.08 54.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.535 1.134 . . . . 0.0 110.385 177.719 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.76 131.59 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.105 1.362 . . . . 0.0 110.016 175.991 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -129.91 123.79 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 111.599 172.389 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.05 44.08 7.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.478 1.511 . . . . 0.0 113.621 -176.132 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.83 -13.49 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.967 1.746 . . . . 0.0 117.009 -179.225 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -92.17 130.94 37.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.431 2.115 . . . . 0.0 111.483 -179.616 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -74.69 127.91 34.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.352 1.461 . . . . 0.0 110.888 175.7 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.2 157.57 17.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.227 1.011 . . . . 0.0 112.463 -176.183 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 144.2 42.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -178.894 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -24.05 27.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 128.587 2.755 . . . . 0.0 116.722 -165.123 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.15 55.63 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -88.09 168.38 12.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.928 1.364 . . . . 0.0 113.025 -170.714 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -98.85 159.8 14.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.766 1.226 . . . . 0.0 112.477 173.793 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.146 -0.972 . . . . 0.0 113.285 178.878 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -65.41 -29.22 69.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.693 1.597 . . . . 0.0 113.0 174.845 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.98 -21.13 63.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.577 1.081 . . . . 0.0 112.762 172.829 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -110.37 6.57 22.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.531 1.532 . . . . 0.0 113.826 179.053 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.9 m120 59.22 39.73 22.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.451 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.93 127.93 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.223 1.009 . . . . 0.0 109.144 172.995 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -136.58 177.67 7.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.427 1.891 . . . . 0.0 111.95 -176.689 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -56.42 140.6 45.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.554 -1.341 . . . . 0.0 112.852 -177.082 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.85 25.59 10.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -172.441 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.9 m -72.8 146.14 46.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.286 -1.509 . . . . 0.0 111.766 165.448 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 m -109.84 128.49 55.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.746 1.219 . . . . 0.0 110.533 171.823 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -125.37 158.8 33.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.732 1.213 . . . . 0.0 110.942 170.485 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -113.66 141.28 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.492 -172.026 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.83 122.69 47.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.36 1.464 . . . . 0.0 109.738 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.13 156.08 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.783 2.433 . . . . 0.0 108.976 -176.52 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 tp -92.66 150.45 20.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.343 -0.848 . . . . 0.0 111.548 170.988 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -132.87 145.48 50.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 111.725 162.444 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.2 mt -104.96 -32.8 8.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.197 1.799 . . . . 0.0 111.88 178.249 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -70.2 0.16 6.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -174.731 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.9 -25.47 45.23 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.495 175.465 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.187 1.851 . . . . 0.0 114.557 -178.127 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -88.33 149.89 23.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.963 0.801 . . . . 0.0 112.446 170.218 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -137.39 153.32 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.61 1.564 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.55 148.24 43.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.13 126.19 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.658 1.183 . . . . 0.0 109.906 173.943 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -101.73 126.26 48.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.764 1.626 . . . . 0.0 112.024 -175.875 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -89.28 163.71 15.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.699 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -63.6 -13.82 45.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 167.994 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 p -92.18 -0.12 57.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.0 113.412 174.951 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.09 89.66 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.383 1.468 . . . . 0.0 114.588 -179.004 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -84.82 170.59 13.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.06 1.744 . . . . 0.0 110.895 178.708 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.103 174.266 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.42 134.75 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.809 2.044 . . . . 0.0 107.7 172.345 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.3 m -120.21 133.15 55.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.823 1.249 . . . . 0.0 110.193 -176.406 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -140.81 163.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.458 1.503 . . . . 0.0 111.661 -179.163 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.0 128.32 49.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 110.666 -179.972 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.58 167.41 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 110.808 -166.967 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.7 157.8 47.05 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 124.38 1.072 . . . . 0.0 111.318 168.756 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -61.06 -17.83 54.31 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.684 2.256 . . . . 0.0 116.798 -168.633 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 p -92.09 -2.78 56.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.789 1.636 . . . . 0.0 114.568 176.925 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.99 147.54 48.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.307 0.958 . . . . 0.0 111.125 176.99 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -84.99 154.32 22.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 113.719 -177.565 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.97 -34.6 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.639 0.776 . . . . 0.0 110.674 168.536 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.21 -45.42 79.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.034 -1.041 . . . . 0.0 112.675 170.845 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.93 -36.17 75.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.268 0.485 . . . . 0.0 111.91 178.236 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.63 -46.39 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.93 -1.106 . . . . 0.0 111.35 171.255 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.16 -35.97 82.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.357 -0.84 . . . . 0.0 112.545 176.214 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.25 92.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.937 0.895 . . . . 0.0 112.536 174.19 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -61.97 -40.71 96.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.123 0.969 . . . . 0.0 112.269 173.775 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -35.91 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.075 0.95 . . . . 0.0 111.373 174.471 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -65.33 -46.71 79.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.575 1.08 . . . . 0.0 111.701 173.557 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.27 -31.37 67.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.835 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -86.45 -40.17 15.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.394 1.077 . . . . 0.0 113.317 -179.338 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -129.71 2.22 4.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.571 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.98 20.24 77.9 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 164.503 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.67 119.89 61.63 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 118.956 1.378 . . . . 0.0 109.625 177.9 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.62 138.05 83.29 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.182 2.588 . . . . 0.0 113.045 176.079 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.75 -29.62 77.29 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.956 2.438 . . . . 0.0 113.43 -170.961 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.46 -12.51 60.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.137 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.53 -15.75 28.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.579 1.151 . . . . 0.0 113.267 176.69 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.67 96.77 10.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.088 0.955 . . . . 0.0 112.222 -163.924 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -87.31 103.53 15.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.606 0.762 . . . . 0.0 108.993 172.109 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -96.77 129.31 44.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.711 1.204 . . . . 0.0 111.324 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.4 132.14 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.953 1.301 . . . . 0.0 111.424 -169.132 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -143.03 135.89 27.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.226 173.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.98 34.8 14.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 113.526 -171.152 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.61 -5.37 38.12 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.579 -1.326 . . . . 0.0 115.625 -175.69 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.928 1.864 . . . . 0.0 111.497 -178.43 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -83.52 130.81 35.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.081 0.552 . . . . 0.0 111.08 178.557 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.6 128.07 35.98 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.419 1.087 . . . . 0.0 111.964 -169.545 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.84 136.13 33.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.587 1.155 . . . . 0.0 113.905 -178.82 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.4 -45.01 55.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.237 2.215 . . . . 0.0 114.352 -176.731 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.58 0.72 63.96 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -175.846 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -95.52 152.94 17.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.368 1.467 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -85.82 163.09 18.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.202 0.601 . . . . 0.0 112.294 168.819 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -58.44 -35.6 72.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.702 -0.624 . . . . 0.0 112.35 170.441 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.1 m -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.025 0.93 . . . . 0.0 113.394 173.118 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -63.23 -19.45 64.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.566 1.075 . . . . 0.0 113.486 177.791 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -104.81 6.79 34.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.431 1.892 . . . . 0.0 114.653 172.578 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 56.39 38.31 29.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.014 1.325 . . . . 0.0 114.025 178.868 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.28 137.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.631 1.173 . . . . 0.0 110.653 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -105.65 164.65 11.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.367 1.467 . . . . 0.0 113.835 -177.062 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -58.78 139.61 56.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.583 0.753 . . . . 0.0 112.174 172.856 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 63.78 16.26 9.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.34 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -71.56 154.64 41.3 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.4 1.08 . . . . 0.0 112.224 170.244 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.6 m -117.18 129.16 55.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.279 1.432 . . . . 0.0 109.985 -178.974 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -100.24 159.05 15.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.858 1.663 . . . . 0.0 109.52 172.93 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.69 140.25 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 170.242 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.1 tp -111.11 124.59 52.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.631 1.573 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.28 141.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.354 168.531 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.51 146.91 32.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.9 mtm105 -72.76 -39.95 66.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.259 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 mt -109.36 7.66 25.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -168.999 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -141.39 151.43 43.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.479 1.911 . . . . 0.0 110.752 176.348 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.68 -75.12 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.449 1.5 . . . . 0.0 111.473 -179.123 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 C-N-CA 125.24 1.4 . . . . 0.0 113.266 179.224 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -79.37 137.15 37.19 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.866 0.866 . . . . 0.0 110.426 171.25 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -132.5 163.12 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.691 1.196 . . . . 0.0 111.181 167.36 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.85 142.13 44.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.184 0.994 . . . . 0.0 112.228 177.389 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -119.7 125.87 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.511 1.124 . . . . 0.0 110.715 168.73 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.4 134.69 36.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.94 1.696 . . . . 0.0 110.936 172.653 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -119.51 161.17 21.02 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.094 1.358 . . . . 0.0 111.972 -173.471 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.29 -27.88 69.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.669 -1.269 . . . . 0.0 112.028 172.84 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -67.26 -7.02 20.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.813 1.645 . . . . 0.0 114.758 169.797 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.63 15.36 73.6 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.876 -1.14 . . . . 0.0 115.012 176.866 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -73.25 161.44 30.53 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.829 1.314 . . . . 0.0 111.595 174.428 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m -127.09 84.24 2.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.958 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -78.76 123.05 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.252 1.021 . . . . 0.0 108.677 -172.31 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 p -80.2 135.43 36.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.378 0.535 . . . . 0.0 110.468 168.234 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -127.31 149.65 49.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.643 1.177 . . . . 0.0 110.764 172.795 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.96 119.33 38.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.681 1.192 . . . . 0.0 110.31 174.821 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.64 158.03 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.084 -172.849 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -103.67 152.7 38.93 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.057 0.943 . . . . 0.0 110.535 163.81 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.03 -19.76 50.15 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.205 2.603 . . . . 0.0 115.486 178.064 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.3 p -92.96 0.91 57.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.227 1.811 . . . . 0.0 114.516 175.058 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.68 145.45 56.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.804 1.183 . . . . 0.0 111.538 174.092 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -82.68 161.73 22.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.564 0.746 . . . . 0.0 112.185 -179.06 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.81 -39.57 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.406 -0.809 . . . . 0.0 110.616 176.56 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.12 -33.82 72.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.262 -0.899 . . . . 0.0 113.17 172.648 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.18 -43.72 77.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.785 0.721 . . . . 0.0 110.972 175.03 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.95 -39.42 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 120.688 -1.258 . . . . 0.0 111.75 175.905 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -60.0 -38.46 82.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.972 0.805 . . . . 0.0 112.272 172.908 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 -32.66 64.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.077 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.11 -32.59 74.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.512 1.125 . . . . 0.0 111.9 171.327 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.43 -44.76 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.113 1.365 . . . . 0.0 110.949 170.086 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.37 -38.47 68.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.95 0.9 . . . . 0.0 111.881 175.957 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.23 -20.53 66.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.954 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.06 -42.92 6.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 113.493 174.936 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.83 -8.5 14.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -166.411 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 3.13 65.59 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 177.414 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.8 mt -86.05 118.48 70.53 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 125.55 1.54 . . . . 0.0 109.319 -177.174 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.84 144.32 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.413 2.076 . . . . 0.0 111.782 -177.463 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -48.53 -36.19 30.87 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.41 3.407 . . . . 0.0 116.773 -176.576 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.7 -11.78 60.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.828 1.194 . . . . 0.0 114.007 179.912 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -98.88 -3.48 35.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.724 1.61 . . . . 0.0 113.193 175.495 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -103.04 155.51 18.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.792 1.637 . . . . 0.0 112.573 -177.875 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -128.73 146.08 50.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.502 1.921 . . . . 0.0 108.564 152.593 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -116.81 134.84 54.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.891 0.876 . . . . 0.0 111.479 174.265 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.25 141.74 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.793 1.637 . . . . 0.0 110.428 -178.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.34 118.39 22.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.671 1.188 . . . . 0.0 110.683 167.716 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.62 46.79 21.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 170.492 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.11 89.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.368 1.461 . . . . 0.0 116.613 -177.535 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.96 129.03 55.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.644 1.722 . . . . 0.0 111.22 177.138 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -73.66 130.74 40.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.247 0.476 . . . . 0.0 110.673 167.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -86.85 114.47 23.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.87 0.868 . . . . 0.0 109.741 178.449 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.73 154.16 20.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.569 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.37 139.01 58.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.424 0.689 . . . . 0.0 112.132 -176.772 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.57 -18.8 22.91 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.136 1.827 . . . . 0.0 115.086 -179.521 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -81.28 173.49 12.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.951 1.375 . . . . 0.0 112.333 -178.277 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -124.16 161.63 25.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.101 1.36 . . . . 0.0 113.506 -176.001 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 mt -61.4 -37.74 84.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.061 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 p -60.51 -30.56 69.81 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.2 1.4 . . . . 0.0 113.796 174.447 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -64.89 -18.44 65.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.323 0.965 . . . . 0.0 112.698 177.147 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -112.83 13.98 19.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.99 2.116 . . . . 0.0 112.841 176.307 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.1 m120 55.89 33.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.376 1.47 . . . . 0.0 114.877 176.558 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.41 135.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.23 1.012 . . . . 0.0 109.292 172.999 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -134.12 175.24 9.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 111.758 -178.114 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -44.83 133.2 6.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.377 1.471 . . . . 0.0 112.585 173.961 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 57.94 30.67 19.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.272 1.829 . . . . 0.0 113.658 176.164 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -75.49 153.94 37.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 164.88 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -117.13 117.33 29.3 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.248 1.019 . . . . 0.0 111.818 -179.747 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -104.26 164.85 11.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.516 2.326 . . . . 0.0 110.998 178.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -120.09 136.67 54.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.712 1.205 . . . . 0.0 111.965 175.709 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.4 tp -91.87 134.04 35.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.853 1.261 . . . . 0.0 110.05 167.225 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.53 147.39 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.911 2.084 . . . . 0.0 109.048 173.848 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.72 129.86 56.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.633 1.573 . . . . 0.0 111.204 -175.249 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -76.57 -40.0 50.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.102 0.961 . . . . 0.0 113.361 -173.967 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 mt -92.09 19.7 6.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.394 1.477 . . . . 0.0 113.073 -168.792 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -143.4 132.27 22.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.989 2.116 . . . . 0.0 109.414 179.08 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.39 -144.75 39.71 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.557 0.617 . . . . 0.0 114.632 175.801 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.801 1.667 . . . . 0.0 112.619 -177.075 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -107.02 146.8 30.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 113.612 174.513 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.63 162.88 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.406 1.482 . . . . 0.0 109.464 160.141 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.48 135.71 53.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.652 1.181 . . . . 0.0 111.624 -175.33 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.49 112.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 110.654 -175.554 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.94 128.82 44.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.038 2.135 . . . . 0.0 113.345 -170.387 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 p -97.73 159.94 14.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.528 1.531 . . . . 0.0 112.54 177.536 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -77.51 4.17 11.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 114.466 176.862 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.8 p -128.84 33.3 4.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 177.235 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.02 52.48 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 162.383 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -115.19 141.98 47.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.705 1.753 . . . . 0.0 112.142 177.967 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -125.28 111.46 15.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.257 1.023 . . . . 0.0 109.877 169.715 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.23 129.57 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.112 1.365 . . . . 0.0 109.244 -176.605 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 m -89.12 137.25 32.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.007 0.923 . . . . 0.0 109.762 170.857 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.14 163.56 15.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 112.311 174.532 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -115.21 122.55 46.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.259 1.424 . . . . 0.0 110.471 163.536 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.97 167.4 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.237 1.415 . . . . 0.0 112.356 -173.817 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -110.06 155.29 41.97 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.592 157.233 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.97 -19.22 14.98 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.173 3.249 . . . . 0.0 115.795 170.763 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -84.56 -7.79 59.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.31 1.844 . . . . 0.0 114.618 174.92 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -69.88 138.85 52.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.92 1.236 . . . . 0.0 111.601 -178.614 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 p -77.59 157.1 30.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.317 1.047 . . . . 0.0 112.191 178.425 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.7 -29.83 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.783 -1.198 . . . . 0.0 111.789 176.918 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -61.48 -37.87 85.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.622 -1.299 . . . . 0.0 113.094 166.656 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -68.99 -33.06 73.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.269 0.628 . . . . 0.0 112.174 174.341 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.07 -46.14 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 119.415 1.007 . . . . 0.0 111.116 170.472 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.39 -38.5 84.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.889 0.768 . . . . 0.0 112.001 173.5 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.26 70.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.654 1.182 . . . . 0.0 113.323 176.225 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -76.94 -33.76 57.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.767 1.227 . . . . 0.0 112.411 176.516 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.8 mm -62.74 -45.81 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.415 0.686 . . . . 0.0 110.59 165.224 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.03 -41.78 92.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.468 0.576 . . . . 0.0 112.01 176.682 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.18 -51.84 63.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.123 0.874 . . . . 0.0 112.687 179.169 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.08 -19.52 17.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -170.901 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -112.9 -13.41 13.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.009 1.277 . . . . 0.0 114.326 176.866 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.11 10.39 84.18 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.021 -1.049 . . . . 0.0 115.323 -179.755 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.1 mt -80.19 115.62 55.84 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.119 1.367 . . . . 0.0 109.051 -176.277 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.62 140.44 56.71 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.7 2.267 . . . . 0.0 111.864 -174.908 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.12 -27.65 29.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.19 2.593 . . . . 0.0 112.507 -165.692 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.02 -14.3 62.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.972 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -95.23 -17.77 21.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 171.318 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.58 136.36 35.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.794 1.179 . . . . 0.0 112.447 -173.637 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -118.46 136.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.749 1.22 . . . . 0.0 109.732 157.719 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.08 136.39 53.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.841 1.256 . . . . 0.0 111.972 -179.199 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.3 mt -132.22 139.49 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.536 1.535 . . . . 0.0 110.015 -172.673 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -136.27 130.97 33.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 111.354 170.768 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.91 43.59 10.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.1 1.36 . . . . 0.0 114.614 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -0.12 84.35 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 116.941 -2.033 . . . . 0.0 117.086 177.357 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.0 138.92 53.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.469 2.135 . . . . 0.0 112.541 -177.6 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.63 133.2 34.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.269 1.427 . . . . 0.0 111.435 177.711 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.07 135.04 34.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -167.684 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -73.72 148.71 42.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.971 1.709 . . . . 0.0 112.467 173.399 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -76.74 -34.99 58.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.604 1.562 . . . . 0.0 113.351 -176.217 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 16.64 11.89 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.315 1.286 . . . . 0.0 116.315 -178.483 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -118.61 163.87 16.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.195 1.798 . . . . 0.0 111.345 -177.878 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 p -107.02 163.24 13.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.762 1.225 . . . . 0.0 113.358 173.422 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.72 -39.13 70.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.41 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 p -71.16 -31.01 67.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 175.058 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -61.61 -38.66 88.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.588 1.54 . . . . 0.0 111.613 170.969 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -82.99 0.96 42.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 171.303 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 49.81 45.82 24.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.672 1.589 . . . . 0.0 113.844 -176.653 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -91.81 117.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.669 1.588 . . . . 0.0 107.996 176.101 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.81 168.48 9.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.341 1.456 . . . . 0.0 111.997 -171.942 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -52.1 145.23 10.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.65 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 59.75 16.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.217 2.207 . . . . 0.0 116.12 -179.033 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -67.38 156.06 37.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.156 0.982 . . . . 0.0 112.558 168.662 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.9 m -112.29 128.85 56.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.485 1.114 . . . . 0.0 111.104 173.188 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.28 165.39 13.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.257 2.623 . . . . 0.0 108.829 177.32 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -117.11 145.71 43.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.322 1.049 . . . . 0.0 111.671 176.274 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -120.65 124.93 46.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.505 1.522 . . . . 0.0 109.657 176.581 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.58 136.12 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.535 1.534 . . . . 0.0 108.536 176.429 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.12 135.0 42.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.029 0.931 . . . . 0.0 111.027 179.997 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -82.11 77.67 8.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.286 1.434 . . . . 0.0 109.253 169.018 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.67 -26.47 68.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -172.231 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -68.41 -13.2 62.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 173.699 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.86 75.12 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.476 1.989 . . . . 0.0 116.84 -175.394 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 119.996 1.898 . . . . 0.0 115.719 179.679 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 ttp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.35 137.05 37.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.401 0.681 . . . . 0.0 112.007 173.097 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -136.14 162.25 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.469 1.507 . . . . 0.0 111.001 169.64 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.23 151.56 40.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.288 173.884 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.64 119.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.657 1.183 . . . . 0.0 109.417 176.758 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -123.35 136.7 54.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.723 1.209 . . . . 0.0 113.057 -171.879 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -82.24 136.1 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 111.075 165.195 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.22 -27.39 67.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.706 1.202 . . . . 0.0 114.24 -166.289 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -115.61 18.38 15.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.891 1.677 . . . . 0.0 113.162 177.688 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.13 -152.08 5.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.663 1.125 . . . . 0.0 115.236 -171.384 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -83.57 161.63 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.231 2.213 . . . . 0.0 112.997 -164.013 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -98.92 137.25 37.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.554 1.142 . . . . 0.0 111.997 170.46 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.86 136.01 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 127.593 2.357 . . . . 0.0 107.74 168.191 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 m -108.63 136.41 48.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.884 0.874 . . . . 0.0 110.294 176.393 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.42 158.16 42.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.651 0.78 . . . . 0.0 111.841 177.699 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.87 113.8 17.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.771 1.228 . . . . 0.0 108.489 168.899 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.77 167.8 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.153 1.781 . . . . 0.0 110.513 -170.839 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -90.83 148.19 37.71 Favored Pre-proline 0 N--CA 1.449 -0.497 0 O-C-N 121.2 -0.937 . . . . 0.0 111.349 169.035 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.71 -22.48 73.96 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.259 1.973 . . . . 0.0 113.932 178.193 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 p -87.86 5.48 40.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 114.51 175.453 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.84 144.77 38.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.068 0.947 . . . . 0.0 111.289 170.327 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -82.12 148.61 28.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.615 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.82 -35.95 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.756 -0.59 . . . . 0.0 111.989 -174.88 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -72.74 -21.73 60.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.401 -1.437 . . . . 0.0 113.929 175.913 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -76.53 -34.23 58.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.382 -0.824 . . . . 0.0 111.641 169.224 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -60.92 -42.62 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 121.245 -0.909 . . . . 0.0 110.705 168.28 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -57.89 -40.59 80.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.219 0.918 . . . . 0.0 112.698 170.477 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -32.88 74.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 176.426 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.15 -30.11 63.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 112.195 175.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -68.42 -42.88 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 110.879 167.44 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.35 -45.36 91.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.95 0.795 . . . . 0.0 111.406 174.895 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.37 -49.54 75.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.247 0.476 . . . . 0.0 112.031 175.927 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -74.23 -39.27 63.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.841 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -129.35 3.71 5.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -170.772 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.32 -7.0 65.63 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 171.021 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.16 119.51 76.06 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.074 1.437 . . . . 0.0 110.403 -171.649 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.51 137.26 54.2 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.567 2.178 . . . . 0.0 112.786 -179.054 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -50.92 -35.29 49.09 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 124.154 3.236 . . . . 0.0 115.426 178.268 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.94 -24.24 67.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.441 1.496 . . . . 0.0 113.48 176.612 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -100.62 -10.08 21.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.319 1.448 . . . . 0.0 113.059 -178.749 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.47 136.97 33.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.166 1.387 . . . . 0.0 111.107 174.232 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -123.06 123.74 41.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.499 1.519 . . . . 0.0 109.097 166.631 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -108.53 110.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 111.747 -174.769 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.45 137.83 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.449 1.899 . . . . 0.0 109.791 -177.73 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.12 138.18 19.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 170.123 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.15 53.38 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.979 1.312 . . . . 0.0 114.216 172.94 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.31 87.81 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 175.357 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -144.31 148.18 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.236 2.018 . . . . 0.0 112.935 -174.874 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.53 128.82 34.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.014 0.926 . . . . 0.0 110.157 166.678 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -81.14 142.47 33.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.417 0.687 . . . . 0.0 112.353 -171.701 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -76.07 134.53 40.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.972 0.909 . . . . 0.0 112.296 176.183 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -71.84 -29.19 64.14 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.692 1.197 . . . . 0.0 113.184 -171.48 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.69 5.53 61.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.977 1.751 . . . . 0.0 115.9 175.032 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -105.63 177.95 4.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.603 1.701 . . . . 0.0 112.634 174.444 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -107.06 169.49 8.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.595 1.958 . . . . 0.0 112.345 169.967 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.15 -35.11 74.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.649 -0.657 . . . . 0.0 112.685 170.93 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 p -67.92 -32.3 72.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.809 1.243 . . . . 0.0 113.983 178.083 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.06 -21.08 65.92 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.032 0.833 . . . . 0.0 112.796 175.711 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -107.89 8.58 28.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.942 2.097 . . . . 0.0 113.623 173.451 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 54.46 39.87 31.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 174.676 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.1 mt -79.55 131.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 110.854 -178.129 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -94.4 157.15 16.15 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.758 1.623 . . . . 0.0 114.379 -175.865 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -53.98 135.82 42.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.901 1.281 . . . . 0.0 113.505 173.732 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 64.88 20.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.645 1.978 . . . . 0.0 115.28 -173.01 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -68.82 154.32 42.21 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.438 -0.789 . . . . 0.0 111.93 163.161 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.1 m -122.41 123.21 40.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.405 1.482 . . . . 0.0 110.232 179.703 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 mt -92.19 147.59 22.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.003 1.321 . . . . 0.0 110.205 176.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -87.86 120.06 28.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.562 0.745 . . . . 0.0 109.227 169.973 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.1 tp -93.42 120.01 33.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.832 0.853 . . . . 0.0 109.055 168.562 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.46 137.28 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 107.993 171.2 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.21 137.22 32.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.753 -0.592 . . . . 0.0 109.527 173.238 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.66 139.15 39.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.189 1.396 . . . . 0.0 112.087 -176.365 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.1 -41.04 74.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.2 1.0 . . . . 0.0 111.425 -178.642 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -63.42 122.06 15.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.203 1.401 . . . . 0.0 109.497 160.911 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.41 -179.55 23.11 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.908 1.242 . . . . 0.0 113.723 178.489 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.19 179.524 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.728 0.299 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -72.23 135.38 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.873 0.869 . . . . 0.0 110.32 167.714 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -131.0 158.1 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.021 1.328 . . . . 0.0 110.203 173.211 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -117.32 146.54 43.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.234 0.614 . . . . 0.0 112.142 177.235 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.8 132.74 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.189 0.995 . . . . 0.0 110.192 172.523 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -83.12 112.21 19.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.518 0.727 . . . . 0.0 110.984 171.215 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.3 p -67.08 171.12 5.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.776 1.631 . . . . 0.0 113.187 -179.337 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.66 -9.53 44.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -179.626 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -93.24 -9.87 37.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.054 1.342 . . . . 0.0 113.469 170.334 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 -16.42 60.9 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.49 1.995 . . . . 0.0 115.065 -171.879 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.6 154.07 42.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.199 1.5 . . . . 0.0 111.585 177.46 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -85.46 152.6 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.949 0.9 . . . . 0.0 112.369 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.32 148.08 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.862 1.665 . . . . 0.0 109.922 159.197 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.1 m -108.6 129.02 55.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.843 0.857 . . . . 0.0 110.751 179.269 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -116.83 157.58 25.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.992 1.717 . . . . 0.0 111.308 179.534 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -123.77 118.63 27.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.605 1.162 . . . . 0.0 110.923 173.959 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.54 164.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.076 1.75 . . . . 0.0 110.326 -177.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.59 152.37 41.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 O-C-N 120.863 -1.148 . . . . 0.0 109.716 163.809 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.86 -11.2 29.79 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.904 1.736 . . . . 0.0 113.456 176.708 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.2 p -80.27 -7.78 59.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.586 1.954 . . . . 0.0 114.321 170.161 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -77.74 155.51 31.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.794 1.179 . . . . 0.0 113.0 178.228 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -81.19 161.07 24.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.529 1.132 . . . . 0.0 112.994 -177.386 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.52 -30.53 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.508 -0.745 . . . . 0.0 111.372 170.1 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.93 -33.43 74.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.578 -1.326 . . . . 0.0 113.893 173.429 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -62.08 -41.82 98.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 110.788 172.0 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.36 -46.75 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 121.519 -0.738 . . . . 0.0 110.462 175.445 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -58.85 -42.72 90.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 175.841 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.71 -36.53 82.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.471 0.708 . . . . 0.0 112.11 178.478 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.86 -25.21 58.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 113.599 174.453 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.15 -48.48 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 109.88 166.15 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.6 -40.34 75.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.444 1.02 . . . . 0.0 111.612 177.429 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.29 -30.45 50.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 113.77 177.332 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.64 -39.98 8.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.696 1.599 . . . . 0.0 113.76 176.827 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -119.79 -8.39 9.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -161.483 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.72 -18.5 34.26 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.994 1.958 . . . . 0.0 117.994 169.67 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 36' ' ' ILE . 3.6 mp -70.09 124.86 91.53 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 120.503 2.152 . . . . 0.0 110.559 -176.647 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.12 144.79 88.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.352 2.035 . . . . 0.0 113.369 178.542 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -48.81 -36.26 33.05 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.539 3.493 . . . . 0.0 116.475 179.737 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -68.77 -21.2 64.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.064 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -105.11 3.9 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.533 1.533 . . . . 0.0 113.31 -177.229 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.88 141.65 29.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.691 1.197 . . . . 0.0 110.858 170.18 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -120.23 134.04 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.459 1.104 . . . . 0.0 110.508 156.435 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.9 138.24 45.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.212 1.405 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.3 136.54 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.357 1.463 . . . . 0.0 110.801 -177.201 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.01 137.54 26.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.175 1.39 . . . . 0.0 110.844 168.282 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.5 39.61 9.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.591 1.157 . . . . 0.0 113.988 -174.098 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 -13.83 4.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.842 1.687 . . . . 0.0 116.372 -174.922 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -84.9 137.19 33.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.559 1.544 . . . . 0.0 111.507 -175.489 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -73.29 126.76 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 122.947 0.499 . . . . 0.0 110.165 170.397 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.28 121.33 32.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.982 0.913 . . . . 0.0 110.166 -179.587 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.89 146.2 26.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -168.682 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.16 -25.63 67.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.497 1.519 . . . . 0.0 114.537 -166.982 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.31 0.92 72.86 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.23 -1.317 . . . . 0.0 116.147 174.896 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -116.63 163.91 15.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.869 1.834 . . . . 0.0 113.307 -169.501 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -101.91 162.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 112.482 172.158 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.96 -30.15 68.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.482 -0.761 . . . . 0.0 112.783 172.982 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.3 m -65.77 -31.21 72.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.653 1.181 . . . . 0.0 113.448 172.917 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -65.0 -17.48 64.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 120.486 1.493 . . . . 0.0 112.99 174.98 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -111.01 5.04 20.0 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.986 2.114 . . . . 0.0 113.309 172.881 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.22 44.02 28.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.512 1.925 . . . . 0.0 114.707 -179.598 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.04 143.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.402 1.481 . . . . 0.0 111.355 -179.62 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -133.36 170.85 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.781 1.632 . . . . 0.0 114.151 -178.206 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -39.99 129.19 2.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.573 2.749 . . . . 0.0 114.207 177.976 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 62.4 mt-10 60.02 17.94 7.17 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.802 2.041 . . . . 0.0 115.592 170.979 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -69.94 146.99 50.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.474 152.784 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.9 m -107.75 129.8 55.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.795 1.638 . . . . 0.0 111.547 -174.69 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.88 154.41 18.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.148 1.779 . . . . 0.0 111.185 175.753 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -110.78 152.46 26.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.892 1.277 . . . . 0.0 111.572 172.478 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -130.06 135.2 47.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 110.877 -171.499 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.98 137.88 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.134 1.773 . . . . 0.0 110.308 178.843 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 tp -85.64 137.85 32.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 111.559 174.337 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -90.07 139.45 30.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.909 1.684 . . . . 0.0 111.997 172.043 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.35 7.05 9.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.614 1.566 . . . . 0.0 114.608 -174.996 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -132.09 107.96 8.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.057 1.343 . . . . 0.0 112.323 -176.482 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.66 -16.98 11.19 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.324 1.916 . . . . 0.0 116.528 170.618 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.751 2.12 . . . . 0.0 114.356 178.63 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.166 0.032 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -101.36 136.68 40.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.426 1.491 . . . . 0.0 111.866 -177.196 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.83 174.79 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.087 1.355 . . . . 0.0 109.457 162.077 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -114.28 162.14 16.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 111.654 170.599 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.46 134.79 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.65 1.18 . . . . 0.0 108.749 165.568 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.85 155.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.485 1.514 . . . . 0.0 114.273 174.346 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.7 m -118.09 146.7 43.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.824 2.05 . . . . 0.0 109.954 -174.874 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.74 -19.74 62.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.207 -0.933 . . . . 0.0 113.516 179.022 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -67.95 -19.52 64.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.156 1.783 . . . . 0.0 114.966 171.057 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -12.52 40.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.888 1.709 . . . . 0.0 114.86 -174.159 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.3 145.47 55.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.066 1.433 . . . . 0.0 111.065 176.962 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -147.73 148.74 31.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.312 0.645 . . . . 0.0 112.516 171.196 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.2 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.436 1.894 . . . . 0.0 111.685 179.16 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 p -92.35 146.7 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.752 1.221 . . . . 0.0 111.439 165.873 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -131.66 140.69 49.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.808 1.243 . . . . 0.0 111.433 179.883 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -95.66 120.02 35.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.143 0.977 . . . . 0.0 110.9 178.01 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.64 155.11 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.237 1.415 . . . . 0.0 112.121 -175.125 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -117.6 163.07 25.57 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 110.152 165.889 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -56.01 -19.22 25.39 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.413 2.742 . . . . 0.0 116.112 -175.571 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -96.88 -6.88 34.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.133 1.773 . . . . 0.0 115.097 -178.968 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 137.15 58.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 120.417 1.462 . . . . 0.0 110.986 177.44 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p -79.03 161.56 26.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.725 -0.609 . . . . 0.0 112.065 178.27 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.05 -33.98 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.165 -0.96 . . . . 0.0 110.891 174.001 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -71.77 -27.4 62.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.118 -0.989 . . . . 0.0 113.371 175.661 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -67.56 -40.6 84.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.248 0.931 . . . . 0.0 111.38 167.529 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.43 -43.21 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 121.089 -1.007 . . . . 0.0 111.561 174.562 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.64 -42.4 78.83 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.123 0.874 . . . . 0.0 112.853 172.213 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.67 69.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.164 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -69.72 -41.97 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.176 0.99 . . . . 0.0 111.428 174.106 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.07 -40.54 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 110.946 171.091 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.89 -43.68 91.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.818 0.847 . . . . 0.0 112.57 175.809 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.09 -53.25 32.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.307 0.958 . . . . 0.0 111.689 174.616 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -73.11 -24.29 60.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -169.683 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -125.77 6.42 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 178.635 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.64 81.8 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.624 1.41 . . . . 0.0 116.624 166.792 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 16.9 tt -117.73 115.48 37.12 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.244 1.418 . . . . 0.0 112.366 -160.345 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 52.1 Cg_exo -64.43 138.81 61.93 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.515 2.144 . . . . 0.0 114.611 -172.501 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.5 -26.93 47.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 124.123 3.216 . . . . 0.0 114.397 171.987 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.2 -17.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.884 1.674 . . . . 0.0 114.868 170.615 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -122.85 3.56 9.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.986 1.714 . . . . 0.0 114.863 173.249 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -88.9 143.72 26.68 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.625 1.557 . . . . 0.0 112.258 -178.871 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -128.39 147.48 50.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.382 1.073 . . . . 0.0 109.603 151.218 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.3 127.95 51.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.314 1.446 . . . . 0.0 111.391 -178.315 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mt -129.57 130.03 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.879 1.671 . . . . 0.0 109.938 -173.013 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -123.9 126.34 46.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.713 1.605 . . . . 0.0 111.281 179.1 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.34 37.79 4.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.981 1.712 . . . . 0.0 114.237 -175.776 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -2.04 85.01 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.217 1.865 . . . . 0.0 116.823 -179.022 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.89 130.92 55.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.966 1.883 . . . . 0.0 112.859 -176.846 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -73.17 129.4 37.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.898 -0.502 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.05 143.51 35.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.574 1.15 . . . . 0.0 113.157 -176.868 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.38 150.97 21.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.828 175.748 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.25 -43.59 32.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -163.94 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.81 -17.4 76.76 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -173.828 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.52 14.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 112.811 -171.708 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -107.61 167.25 10.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.603 1.561 . . . . 0.0 113.368 -179.963 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.05 -44.08 67.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.044 1.337 . . . . 0.0 112.466 176.702 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.1 p -70.1 -31.29 68.78 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.878 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.22 -19.53 66.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.623 1.101 . . . . 0.0 112.976 172.487 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -103.18 1.15 32.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.02 1.728 . . . . 0.0 114.72 171.631 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m120 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 174.654 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.22 130.39 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.113 0.965 . . . . 0.0 110.842 -176.122 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -115.86 166.65 11.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.72 1.608 . . . . 0.0 113.406 -175.656 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -49.83 143.02 8.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.536 2.334 . . . . 0.0 114.971 -173.619 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 60.6 -4.62 0.12 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.571 2.748 . . . . 0.0 116.944 179.323 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -69.73 163.1 26.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.317 0.962 . . . . 0.0 112.185 169.141 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 t -121.39 148.93 43.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.374 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.0 154.74 19.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.963 1.705 . . . . 0.0 109.957 170.371 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.05 119.84 40.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.089 -1.007 . . . . 0.0 109.039 175.518 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.23 132.74 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.752 0.821 . . . . 0.0 110.203 171.778 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.95 168.13 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.836 1.254 . . . . 0.0 111.489 -179.697 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -72.36 163.39 28.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.867 1.267 . . . . 0.0 113.622 177.447 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -93.89 159.64 15.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.321 1.448 . . . . 0.0 111.312 158.542 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.84 133.9 25.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.981 0.912 . . . . 0.0 110.28 170.981 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 57.76 9.56 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.304 1.842 . . . . 0.0 115.194 -179.565 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 -9.67 83.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -168.777 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 119.654 1.727 . . . . 0.0 114.481 -176.993 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -129.17 153.95 47.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.947 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -140.1 161.19 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.904 1.682 . . . . 0.0 110.486 174.348 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.54 146.64 46.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 110.317 -179.687 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.54 121.88 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.819 -178.455 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.1 123.42 33.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.291 1.836 . . . . 0.0 111.591 -178.619 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.8 p -87.73 170.96 10.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.187 1.395 . . . . 0.0 112.319 174.151 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.35 -20.51 64.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.45 -1.406 . . . . 0.0 114.034 -177.955 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -80.56 -1.89 43.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.888 1.275 . . . . 0.0 113.25 169.592 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.12 -1.22 87.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.02 1.771 . . . . 0.0 115.099 -179.607 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -67.37 139.13 57.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.845 1.822 . . . . 0.0 110.013 177.045 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 m -117.07 93.05 4.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.308 1.043 . . . . 0.0 110.527 -174.93 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tp -75.22 146.68 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 123.833 0.853 . . . . 0.0 111.165 -179.488 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.8 p -113.0 138.37 49.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.244 1.417 . . . . 0.0 111.49 -177.009 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.72 156.5 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.068 1.347 . . . . 0.0 111.499 -172.347 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -115.35 125.36 53.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.034 1.334 . . . . 0.0 109.885 170.139 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.71 167.82 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.431 1.892 . . . . 0.0 111.177 -164.979 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -107.96 151.38 41.23 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.799 0.84 . . . . 0.0 109.509 165.533 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.09 -22.53 73.31 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.381 2.054 . . . . 0.0 113.247 173.076 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.2 p -83.7 -0.51 51.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.736 2.014 . . . . 0.0 114.823 172.204 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -83.81 152.6 24.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.916 1.234 . . . . 0.0 112.927 -178.845 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.36 150.01 23.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.719 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.1 -33.73 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.026 177.553 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.5 -50.0 60.77 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 112.057 167.529 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -72.82 -31.22 64.66 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.787 -0.57 . . . . 0.0 112.374 -178.275 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.86 -44.9 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 121.089 -1.007 . . . . 0.0 111.267 170.33 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.97 -36.12 83.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.342 -0.849 . . . . 0.0 112.907 174.735 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.93 82.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 174.586 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -67.6 -32.3 72.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.357 1.063 . . . . 0.0 112.328 174.197 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -71.73 -39.67 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.811 171.963 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -58.42 -37.96 76.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.105 0.866 . . . . 0.0 111.629 172.707 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.6 -48.38 75.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 113.329 179.542 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.64 -57.39 3.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 177.617 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.97 -7.28 23.5 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -164.826 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.09 78.5 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.601 1.091 . . . . 0.0 114.799 174.314 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.91 119.11 68.49 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 124.863 1.265 . . . . 0.0 108.855 -179.142 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.17 127.3 22.68 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.981 2.454 . . . . 0.0 112.593 178.997 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.17 -27.94 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.88 3.054 . . . . 0.0 115.965 178.453 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.61 -21.49 66.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.755 1.222 . . . . 0.0 113.218 173.803 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -92.85 -12.29 31.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.661 -1.274 . . . . 0.0 114.14 172.283 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -88.98 106.49 18.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.44 1.018 . . . . 0.0 112.055 -173.121 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -98.95 116.85 32.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.38 1.472 . . . . 0.0 109.567 170.417 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.71 129.54 54.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.991 0.916 . . . . 0.0 111.839 -169.697 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.59 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.347 1.859 . . . . 0.0 110.917 -176.737 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.43 136.16 19.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.495 1.518 . . . . 0.0 112.07 171.396 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 47.73 16.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.068 1.347 . . . . 0.0 113.068 -179.089 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.17 -9.65 3.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.302 2.382 . . . . 0.0 116.297 -176.676 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -94.8 135.04 36.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.451 1.626 . . . . 0.0 110.765 -176.381 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -84.12 131.69 34.76 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.795 0.438 . . . . 0.0 109.894 171.034 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -94.79 136.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 122.993 0.517 . . . . 0.0 111.381 -168.589 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.61 130.12 37.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 111.548 179.567 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.89 -37.97 54.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.247 1.819 . . . . 0.0 114.425 -176.609 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.19 -2.46 83.3 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.917 -1.491 . . . . 0.0 116.166 -178.932 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -103.03 167.33 9.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.967 1.883 . . . . 0.0 111.816 178.827 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 p -96.04 162.65 13.46 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.061 0.944 . . . . 0.0 113.395 -179.778 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -56.81 -43.3 80.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.337 0.655 . . . . 0.0 112.438 172.572 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.2 p -69.4 -24.56 63.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.667 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.0 -29.03 70.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 120.302 1.41 . . . . 0.0 112.573 172.7 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.21 9.44 39.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.308 1.443 . . . . 0.0 113.966 172.994 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.66 41.76 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.0 113.247 -176.783 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.78 114.92 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.497 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -90.73 162.96 14.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.966 1.707 . . . . 0.0 110.87 179.401 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -55.86 145.97 23.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.081 -1.012 . . . . 0.0 113.227 176.017 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 57.73 31.32 20.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.887 1.675 . . . . 0.0 114.989 -174.348 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.5 m -83.05 153.04 25.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.924 -1.11 . . . . 0.0 112.8 169.911 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.5 m -104.6 131.21 52.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.608 1.563 . . . . 0.0 111.017 169.973 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -114.54 165.65 12.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.542 1.937 . . . . 0.0 110.599 174.644 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -114.07 132.42 56.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.859 -1.15 . . . . 0.0 111.911 179.264 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -107.35 122.0 45.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.05 1.74 . . . . 0.0 109.463 174.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.63 140.67 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.625 . . . . 0.0 108.474 172.007 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tp -92.12 155.88 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.267 0.627 . . . . 0.0 111.272 178.575 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -126.0 151.41 47.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 111.452 161.419 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.12 143.98 36.84 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.509 0.723 . . . . 0.0 111.81 -177.542 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -133.56 -36.73 0.96 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.214 1.806 . . . . 0.0 112.288 178.687 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 159.96 34.72 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.078 1.323 . . . . 0.0 112.789 165.252 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.804 -175.638 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.56 135.39 33.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.962 0.505 . . . . 0.0 110.358 172.572 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.95 151.14 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.655 1.182 . . . . 0.0 110.682 176.029 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -96.21 132.0 42.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.48 0.712 . . . . 0.0 111.526 177.611 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.0 125.13 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.021 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.76 135.05 54.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.158 1.383 . . . . 0.0 111.56 -172.396 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 p -76.36 160.39 29.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.974 -1.079 . . . . 0.0 111.738 174.897 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.95 -14.53 62.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.905 -1.122 . . . . 0.0 112.767 167.922 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -82.0 -6.56 59.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 114.368 165.956 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 16.14 57.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.548 1.547 . . . . 0.0 116.174 172.817 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -93.66 146.03 24.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.346 1.458 . . . . 0.0 110.064 176.33 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -127.52 142.98 51.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -168.609 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.66 148.57 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.262 1.825 . . . . 0.0 110.721 169.679 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -103.82 124.0 48.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.373 1.069 . . . . 0.0 111.136 176.272 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -109.21 141.68 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.648 1.179 . . . . 0.0 111.489 174.117 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -96.87 118.32 33.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.98 1.712 . . . . 0.0 110.004 172.24 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.78 176.61 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.234 1.814 . . . . 0.0 112.774 -169.949 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.97 155.93 78.87 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 124.729 1.212 . . . . 0.0 111.951 161.442 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.4 -20.17 47.17 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.034 2.489 . . . . 0.0 116.166 -179.125 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.2 p -79.26 -3.8 47.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.671 1.988 . . . . 0.0 114.893 175.628 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -74.25 143.3 45.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.689 1.131 . . . . 0.0 112.416 177.724 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.3 p -81.1 155.81 26.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 112.341 178.675 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -34.89 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.467 -0.77 . . . . 0.0 110.904 171.508 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.02 -43.22 95.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.326 0.967 . . . . 0.0 112.663 169.954 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -61.69 -40.58 95.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.524 1.056 . . . . 0.0 112.538 174.288 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.83 -44.06 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.706 0.802 . . . . 0.0 111.679 176.637 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -59.83 -43.32 94.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.749 1.159 . . . . 0.0 111.836 173.492 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.65 83.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.257 0.623 . . . . 0.0 112.482 175.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -68.17 -38.22 81.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.381 -0.825 . . . . 0.0 111.74 172.889 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.05 -32.84 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.25 173.855 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -66.84 -43.65 83.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.626 1.557 . . . . 0.0 111.791 168.695 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.26 -33.8 72.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.726 0.811 . . . . 0.0 112.747 178.494 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -85.14 -51.09 6.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.209 1.404 . . . . 0.0 114.542 176.947 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -110.62 -12.49 14.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.498 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.4 7.08 83.06 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 177.058 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 mt -90.5 117.18 67.8 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 125.562 1.545 . . . . 0.0 110.049 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.61 142.4 77.27 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.476 2.117 . . . . 0.0 112.906 179.954 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.45 -30.25 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.176 1 C-N-CA 125.366 4.044 . . . . 0.0 117.327 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.23 -10.66 59.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 178.608 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.8 -18.95 16.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.232 1.413 . . . . 0.0 113.203 176.922 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.09 137.9 36.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 178.594 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -121.47 134.95 55.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.978 1.711 . . . . 0.0 109.59 171.352 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.95 139.22 46.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.174 0.989 . . . . 0.0 111.369 -175.908 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 109.843 -179.3 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -140.95 142.98 34.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.638 1.175 . . . . 0.0 111.563 174.259 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.18 34.89 4.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.004 1.322 . . . . 0.0 114.272 -178.506 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 7.63 87.23 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -179.272 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -123.86 149.17 46.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.4 1.6 . . . . 0.0 112.933 175.091 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -80.94 151.24 28.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.152 0.581 . . . . 0.0 112.1 176.381 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -114.07 152.97 30.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.483 1.113 . . . . 0.0 111.899 -170.186 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -125.45 131.03 52.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.694 1.197 . . . . 0.0 111.823 -169.565 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -41.29 -37.11 0.91 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.426 2.69 . . . . 0.0 115.779 -177.757 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.38 -11.35 85.59 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.358 1.456 . . . . 0.0 116.063 -176.595 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -99.58 173.86 6.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.7 1.75 . . . . 0.0 112.558 -177.164 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -109.19 163.26 13.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 113.517 175.089 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.5 -34.67 69.31 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.542 -0.724 . . . . 0.0 112.765 174.24 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -57.61 -39.39 76.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.166 0.987 . . . . 0.0 113.108 170.905 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.38 -13.68 62.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.822 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -121.55 13.32 10.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.344 1.457 . . . . 0.0 114.244 177.072 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 60.66 41.73 14.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 173.845 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.18 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 169.293 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -122.85 172.88 8.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.557 1.943 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -62.5 130.64 46.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.662 1.185 . . . . 0.0 112.688 -176.717 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 11.4 mp0 58.43 24.84 12.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -169.999 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.8 m -60.51 153.95 22.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.111 -1.618 . . . . 0.0 113.257 170.868 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -113.75 130.67 56.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.576 1.15 . . . . 0.0 111.291 169.574 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.97 138.46 54.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.815 2.446 . . . . 0.0 108.224 -176.795 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -101.89 136.71 41.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.742 0.817 . . . . 0.0 111.506 -172.938 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.46 121.25 44.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.847 2.059 . . . . 0.0 109.379 -176.908 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.47 125.38 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.599 1.56 . . . . 0.0 109.664 177.068 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.4 tp -79.48 99.06 7.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 166.07 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -81.4 33.61 0.36 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.478 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.16 -23.13 24.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.728 1.211 . . . . 0.0 113.425 -177.011 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt-85 -134.24 154.16 51.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.351 1.86 . . . . 0.0 111.603 -175.375 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 119.57 1.41 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.467 1.508 . . . . 0.0 113.346 -177.336 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.047 1.784 . . . . 0.0 113.184 179.879 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -95.8 125.14 40.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 111.566 179.657 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.01 163.21 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 111.062 171.927 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -115.22 146.14 41.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.441 0.696 . . . . 0.0 111.693 175.455 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.76 128.81 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.812 1.245 . . . . 0.0 110.235 175.432 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -124.64 143.67 50.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.325 1.45 . . . . 0.0 114.132 -178.423 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -103.31 156.83 17.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.38 1.472 . . . . 0.0 113.823 177.194 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.54 -5.99 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.236 1.814 . . . . 0.0 114.083 176.956 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -115.51 14.05 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.427 1.891 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.29 44.71 7.35 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.424 1.329 . . . . 0.0 116.424 165.366 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -114.42 135.61 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.489 1.116 . . . . 0.0 109.989 161.912 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -117.48 141.83 47.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.04 139.38 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.764 2.025 . . . . 0.0 108.688 -174.136 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 m -107.44 128.97 54.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.66 1.184 . . . . 0.0 109.588 173.156 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.65 146.24 49.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.262 1.025 . . . . 0.0 112.262 -176.493 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -104.58 115.6 30.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 109.782 174.499 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.1 152.59 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.282 1.433 . . . . 0.0 112.051 -168.874 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.49 145.02 29.19 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.259 1.024 . . . . 0.0 110.855 170.002 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.46 -28.48 64.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 115.316 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.37 -12.94 61.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.455 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -77.91 147.97 34.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.975 1.261 . . . . 0.0 113.738 -165.363 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -97.21 163.96 12.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.639 1.576 . . . . 0.0 113.073 -170.328 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.87 -39.61 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 O-C-N 120.714 -1.241 . . . . 0.0 112.65 -164.534 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.66 -36.47 80.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.256 -0.903 . . . . 0.0 112.361 175.803 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.56 -31.37 72.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.233 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.56 -38.51 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.048 -1.032 . . . . 0.0 111.213 174.15 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.29 -35.47 73.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.25 -0.906 . . . . 0.0 112.327 169.266 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.58 65.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.872 1.269 . . . . 0.0 113.781 174.359 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.7 -32.38 72.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.059 0.944 . . . . 0.0 111.839 170.935 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.07 -45.46 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.631 1.172 . . . . 0.0 110.498 172.027 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -56.83 -39.98 75.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.703 0.801 . . . . 0.0 112.183 174.96 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -64.74 -18.06 64.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -103.09 -54.15 2.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.684 1.194 . . . . 0.0 113.839 172.818 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -107.87 -1.55 20.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.117 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.63 8.54 72.25 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.87 -1.144 . . . . 0.0 115.82 173.437 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.38 118.7 72.69 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 125.373 1.469 . . . . 0.0 108.976 -179.144 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.17 141.18 81.71 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.483 2.122 . . . . 0.0 112.801 -179.385 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.27 -24.59 43.56 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.67 2.913 . . . . 0.0 113.607 -171.404 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.79 -15.8 62.69 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.064 -1.023 . . . . 0.0 113.241 173.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.94 -2.39 50.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 112.301 176.763 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -103.34 142.52 34.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.577 1.151 . . . . 0.0 113.012 -174.206 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -120.38 139.57 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.084 2.153 . . . . 0.0 109.023 157.245 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.47 133.74 55.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 110.758 171.969 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.42 135.35 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.167 1.387 . . . . 0.0 109.741 -170.006 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -142.81 137.87 29.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.989 1.316 . . . . 0.0 112.268 176.932 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.72 50.42 3.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.711 1.604 . . . . 0.0 114.314 175.467 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 10.26 85.85 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.154 -1.914 . . . . 0.0 117.744 179.184 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.73 145.07 51.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.869 2.335 . . . . 0.0 112.897 177.923 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -79.74 127.8 32.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 109.699 169.005 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 120.93 18.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.876 0.871 . . . . 0.0 111.304 -174.791 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.05 122.91 25.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.924 179.127 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.15 132.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.402 0.681 . . . . 0.0 109.724 175.357 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.04 -4.25 60.76 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.32 1.438 . . . . 0.0 115.379 -167.148 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -104.88 166.28 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.037 1.419 . . . . 0.0 110.87 166.604 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -104.85 171.21 7.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.724 1.21 . . . . 0.0 112.956 -177.176 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -60.04 -38.13 81.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.263 -0.898 . . . . 0.0 112.686 168.994 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -60.78 -35.08 75.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.581 1.153 . . . . 0.0 112.719 174.868 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -66.61 -9.66 37.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -124.16 11.63 8.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.56 1.544 . . . . 0.0 114.311 176.717 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 54.2 37.48 27.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -175.914 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 133.0 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.815 -1.178 . . . . 0.0 108.189 171.458 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.52 177.33 7.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.05 1.74 . . . . 0.0 111.423 -176.134 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -47.95 132.59 15.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.608 -1.307 . . . . 0.0 111.091 165.911 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.91 14.9 8.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.911 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -70.14 137.57 51.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.873 -1.142 . . . . 0.0 110.28 162.643 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -109.23 127.48 54.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.852 1.261 . . . . 0.0 110.188 179.169 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -108.47 150.69 27.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.376 1.871 . . . . 0.0 110.223 178.793 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -99.0 129.68 45.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.192 0.597 . . . . 0.0 110.245 171.081 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -94.62 132.97 38.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.242 1.417 . . . . 0.0 109.206 167.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 136.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.533 1.533 . . . . 0.0 109.389 176.027 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.14 141.59 29.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.246 1.019 . . . . 0.0 112.029 -173.976 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 -95.49 -24.96 16.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.51 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.62 27.66 2.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.028 1.331 . . . . 0.0 112.804 -172.807 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -145.27 123.45 12.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.816 1.646 . . . . 0.0 109.708 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.73 127.6 0.94 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.761 1.172 . . . . 0.0 112.059 -167.247 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.24 1.4 . . . . 0.0 113.122 -173.571 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -96.99 140.8 30.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.766 0.826 . . . . 0.0 111.963 -178.648 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -136.92 161.22 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 172.528 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.11 121.14 41.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.507 1.123 . . . . 0.0 111.327 179.513 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.41 120.65 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.42 1.088 . . . . 0.0 109.666 175.652 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.51 138.6 46.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.995 1.318 . . . . 0.0 112.604 -175.755 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -96.52 151.2 19.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.722 1.209 . . . . 0.0 111.631 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -57.31 -35.71 70.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.897 -1.127 . . . . 0.0 112.939 -179.518 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -78.49 0.93 24.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.993 2.117 . . . . 0.0 115.294 176.777 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 25.45 10.74 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 164.041 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -89.96 148.57 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.321 1.56 . . . . 0.0 109.985 166.34 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -125.8 120.93 31.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.387 1.075 . . . . 0.0 109.682 171.214 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.41 110.74 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.936 1.694 . . . . 0.0 107.643 179.944 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -88.91 112.44 23.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 109.18 -177.354 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.6 144.35 38.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.357 1.063 . . . . 0.0 111.103 -175.987 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -97.87 131.15 44.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.296 1.046 . . . . 0.0 110.461 162.047 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.91 161.14 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.979 1.711 . . . . 0.0 111.087 -172.739 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 20' ' ' SER . 58.6 tt0 -105.72 146.82 33.58 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.298 1.439 . . . . 0.0 109.396 172.471 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.29 -28.57 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.188 2.592 . . . . 0.0 114.647 173.481 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 8.6 m -81.4 -4.79 56.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.067 2.147 . . . . 0.0 115.132 176.435 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -65.26 137.25 57.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.13 1.332 . . . . 0.0 110.848 177.917 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -74.99 157.32 35.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.124 0.57 . . . . 0.0 110.975 164.542 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.66 -30.33 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 121.483 -0.761 . . . . 0.0 110.964 167.128 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.67 -38.62 88.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.913 -1.117 . . . . 0.0 113.284 168.923 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -70.0 -35.59 74.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.804 1.184 . . . . 0.0 111.964 173.698 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.97 -43.05 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.179 -0.951 . . . . 0.0 110.975 171.596 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -63.35 -34.75 78.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 112.913 173.515 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.91 70.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 173.843 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.95 -40.32 79.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.484 170.558 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.55 -38.4 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.654 0.782 . . . . 0.0 110.985 173.996 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -60.16 -46.5 89.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.443 1.02 . . . . 0.0 111.11 170.427 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.02 -39.88 91.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.789 0.722 . . . . 0.0 112.466 178.396 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -76.56 -46.67 25.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.952 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -115.54 -5.33 12.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.872 1.669 . . . . 0.0 114.496 -168.753 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.75 8.02 84.05 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.81 -1.181 . . . . 0.0 115.21 179.764 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.08 120.9 79.91 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.417 1.608 . . . . 0.0 110.297 -173.22 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.98 132.06 42.71 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.437 2.092 . . . . 0.0 112.665 179.01 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -56.46 -27.46 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.496 2.797 . . . . 0.0 116.062 -177.557 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.18 -25.35 63.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.095 0.958 . . . . 0.0 112.907 174.655 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -96.09 -1.01 49.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.769 2.028 . . . . 0.0 113.337 -176.779 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.35 142.43 36.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.541 1.136 . . . . 0.0 111.493 -176.272 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -136.88 133.63 36.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 111.064 164.331 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 137.54 32.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.88 0.872 . . . . 0.0 110.919 174.949 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -128.29 138.89 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.16 1.784 . . . . 0.0 111.066 -172.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -152.65 147.27 25.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.558 1.543 . . . . 0.0 110.943 166.53 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 33.59 13.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 113.908 -178.284 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.06 1.92 43.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.0 1.286 . . . . 0.0 115.885 -174.525 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -108.49 142.27 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.117 1.767 . . . . 0.0 111.357 -176.631 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -73.79 136.1 43.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 111.314 169.801 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.21 136.42 32.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.409 1.099 . . . . 0.0 110.868 174.506 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -77.55 142.84 38.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.309 1.444 . . . . 0.0 110.767 177.641 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -82.93 -38.43 22.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -159.693 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.72 -5.59 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.997 0.759 . . . . 0.0 114.997 174.449 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -85.59 153.9 22.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.694 1.198 . . . . 0.0 111.142 177.143 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.5 p -110.01 159.48 17.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.339 1.056 . . . . 0.0 113.763 -168.374 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.26 -48.26 80.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.803 -174.899 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 p -70.94 -24.98 62.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.378 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.542 1.064 . . . . 0.0 111.78 170.789 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -79.25 2.65 20.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.08 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 48.38 45.47 20.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.275 1.83 . . . . 0.0 114.044 -174.976 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -84.99 138.17 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.706 1.603 . . . . 0.0 107.712 169.859 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -134.23 174.59 10.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.193 1.397 . . . . 0.0 110.884 -168.456 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -50.03 146.68 4.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 113.04 169.091 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 64.1 17.31 10.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.214 1.406 . . . . 0.0 114.48 177.263 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -79.5 150.14 31.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.561 1.145 . . . . 0.0 113.143 177.875 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -118.46 134.92 54.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.005 1.322 . . . . 0.0 111.677 174.295 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -134.13 160.33 38.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.661 1.984 . . . . 0.0 111.39 -177.519 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -107.38 149.69 27.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.442 1.097 . . . . 0.0 112.467 178.705 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -127.09 124.83 40.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.277 1.831 . . . . 0.0 109.835 177.239 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.65 148.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.561 1.144 . . . . 0.0 111.424 174.353 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -111.76 126.28 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.962 0.887 . . . . 0.0 112.615 -171.858 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -94.95 57.49 2.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 128.435 2.694 . . . . 0.0 110.297 -179.692 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 mt -77.32 137.98 39.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.827 1.251 . . . . 0.0 110.93 -176.288 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 mtp-105 -123.4 -20.78 5.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.373 1.469 . . . . 0.0 113.693 177.265 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.67 -158.95 31.68 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 119.363 0.983 . . . . 0.0 111.805 -164.383 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 C-N-CA 125.417 1.484 . . . . 0.0 113.342 175.453 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 119.203 -0.427 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -89.62 141.47 28.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.89 0.876 . . . . 0.0 111.049 169.859 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt -131.67 160.46 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.247 1.419 . . . . 0.0 110.985 166.273 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -120.73 138.21 54.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.623 1.169 . . . . 0.0 111.906 -173.948 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.15 125.72 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.878 1.271 . . . . 0.0 109.174 173.753 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -82.48 116.02 21.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.493 1.117 . . . . 0.0 109.422 168.744 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -76.72 179.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 113.505 -175.467 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.67 -29.86 70.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.317 . . . . 0.0 112.941 -179.294 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -92.9 6.45 47.73 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.581 1.952 . . . . 0.0 113.867 172.366 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.8 15.36 80.86 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.86 -1.15 . . . . 0.0 115.77 176.694 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -75.71 145.45 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.229 1.515 . . . . 0.0 108.868 168.49 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -81.35 134.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.063 0.847 . . . . 0.0 110.335 165.157 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.89 133.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.68 0.792 . . . . 0.0 110.027 159.512 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -94.21 142.09 27.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.539 1.536 . . . . 0.0 109.568 177.632 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -134.67 136.88 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.365 1.066 . . . . 0.0 110.897 172.25 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.33 123.19 29.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.687 1.195 . . . . 0.0 108.896 164.94 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.35 167.78 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.566 1.946 . . . . 0.0 110.865 -172.722 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -115.35 148.45 40.85 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.206 1.403 . . . . 0.0 110.906 169.17 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.74 -21.03 71.24 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.114 2.543 . . . . 0.0 113.84 -179.569 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 p -82.97 -5.16 58.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.271 2.629 . . . . 0.0 115.039 176.543 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -74.46 140.7 44.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.753 1.16 . . . . 0.0 111.8 179.324 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -79.09 155.58 28.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.499 0.72 . . . . 0.0 112.691 172.741 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.57 -39.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.292 0.637 . . . . 0.0 112.032 -177.909 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.9 -37.59 82.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.383 1.073 . . . . 0.0 113.226 178.594 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -71.44 -22.7 61.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.612 0.765 . . . . 0.0 112.793 175.964 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -79.86 -42.29 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.914 0.779 . . . . 0.0 110.521 169.567 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -60.16 -31.86 70.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.112 -0.993 . . . . 0.0 113.522 175.547 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.62 99.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.571 0.748 . . . . 0.0 112.806 171.742 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.49 -34.89 76.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.878 0.871 . . . . 0.0 112.238 173.823 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.06 -37.17 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 121.24 -0.913 . . . . 0.0 111.198 172.487 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -61.15 -35.38 76.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.41 1.459 . . . . 0.0 111.163 169.756 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.65 -34.0 66.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.293 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -93.04 -29.51 15.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 178.946 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -115.49 -17.01 11.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.939 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 5.77 88.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 172.685 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.97 128.62 40.6 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 110.846 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -62.18 144.42 95.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.544 2.163 . . . . 0.0 113.842 179.762 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.61 -43.48 33.56 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.209 3.272 . . . . 0.0 116.099 -175.048 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -74.63 -11.48 60.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.051 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.74 -11.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.565 1.146 . . . . 0.0 112.604 172.509 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -86.62 128.58 35.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.683 1.193 . . . . 0.0 111.239 178.819 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -114.61 121.37 43.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.005 1.322 . . . . 0.0 108.626 165.671 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.48 127.3 54.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.613 1.165 . . . . 0.0 111.246 -175.401 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -115.08 136.43 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.78 1.632 . . . . 0.0 111.273 -176.762 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -132.97 115.96 15.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.66 1.984 . . . . 0.0 110.003 173.891 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 50.98 6.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.39 1.476 . . . . 0.0 114.033 -174.864 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 -1.0 70.54 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 117.302 1.681 . . . . 0.0 117.302 179.401 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -113.51 143.63 44.2 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.811 1.805 . . . . 0.0 112.158 -176.509 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -84.62 138.63 32.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.795 1.238 . . . . 0.0 112.58 -176.457 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.66 124.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.391 1.076 . . . . 0.0 111.379 176.912 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -119.52 150.58 40.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.274 1.43 . . . . 0.0 113.613 -177.599 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.7 159.72 3.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.344 2.658 . . . . 0.0 115.036 -168.553 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.52 -17.64 8.09 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.029 1.776 . . . . 0.0 115.917 170.518 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -94.26 160.93 14.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.332 1.453 . . . . 0.0 111.226 168.944 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -95.29 165.86 12.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.88 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -52.14 -36.19 50.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.023 0.529 . . . . 0.0 112.391 167.882 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -71.39 -25.87 62.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 176.903 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.37 -24.75 60.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.793 173.902 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.9 -4.13 50.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.327 1.451 . . . . 0.0 113.73 166.803 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 48.31 51.14 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.091 1.757 . . . . 0.0 113.445 -172.209 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.94 93.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.116 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.56 172.01 12.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 113.335 -173.893 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -44.64 130.71 6.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.342 1.457 . . . . 0.0 111.791 166.534 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 60.15 27.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.132 1.773 . . . . 0.0 114.637 177.484 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -68.51 150.44 48.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.93 -1.106 . . . . 0.0 112.803 171.247 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -110.43 123.78 50.52 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.114 1.366 . . . . 0.0 110.526 173.849 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.43 158.22 17.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.863 2.065 . . . . 0.0 109.836 172.644 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -117.1 132.91 56.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.729 0.812 . . . . 0.0 110.538 172.823 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.4 tp -98.25 132.25 43.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.297 1.439 . . . . 0.0 109.548 173.698 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.71 167.08 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.356 1.862 . . . . 0.0 109.601 169.082 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.59 141.41 51.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.135 -0.978 . . . . 0.0 111.506 173.422 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -90.02 112.56 24.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 176.025 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 mt -107.06 125.87 51.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.19 1.396 . . . . 0.0 111.204 -171.423 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.35 160.97 43.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.283 1.433 . . . . 0.0 113.52 -174.522 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 -164.49 1.53 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.233 0.92 . . . . 0.0 113.614 160.702 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.767 -1.574 . . . . 0.0 113.313 -177.925 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptt? . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.781 -0.152 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.37 138.7 31.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.442 1.097 . . . . 0.0 111.313 177.524 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 168.6 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.701 1.6 . . . . 0.0 110.996 168.999 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -123.47 153.63 40.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.362 1.065 . . . . 0.0 111.803 177.227 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.98 126.24 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 124.798 1.239 . . . . 0.0 110.168 174.234 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -102.22 159.06 15.73 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 111.597 175.935 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -150.32 160.2 43.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.929 1.691 . . . . 0.0 110.294 -176.36 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.69 -10.59 48.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.676 -1.265 . . . . 0.0 113.968 -178.237 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.8 p -79.81 -6.85 58.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.438 1.495 . . . . 0.0 113.953 167.963 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.37 5.91 86.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.409 1.48 . . . . 0.0 116.23 173.16 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 140.77 29.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.517 1.658 . . . . 0.0 110.455 174.512 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.1 m -104.6 113.46 27.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.395 0.998 . . . . 0.0 110.588 -176.557 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 mt -87.5 139.23 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.156 1.382 . . . . 0.0 109.165 178.698 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -110.07 134.67 51.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.643 0.777 . . . . 0.0 110.047 169.85 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -126.12 151.54 47.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.144 1.378 . . . . 0.0 110.749 175.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -121.27 112.93 19.23 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.44 153.51 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.942 1.697 . . . . 0.0 112.194 -162.703 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -77.13 146.68 75.41 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.775 170.224 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -54.57 -38.1 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.232 2.621 . . . . 0.0 115.519 -178.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -106.28 31.54 5.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.934 1.693 . . . . 0.0 112.621 175.445 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -68.6 158.58 33.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.494 -1.379 . . . . 0.0 111.629 166.206 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.5 p -110.58 153.81 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.029 1.332 . . . . 0.0 112.864 -170.333 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.35 -35.28 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -170.113 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.76 -27.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 121.083 1.765 . . . . 0.0 112.673 175.598 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.2 -37.18 38.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.532 0.733 . . . . 0.0 111.825 174.396 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.89 -38.22 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.813 -1.18 . . . . 0.0 111.939 172.724 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -59.36 -37.92 79.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.062 -1.024 . . . . 0.0 112.57 168.821 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.41 76.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 174.109 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.27 -39.77 94.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.679 1.127 . . . . 0.0 112.467 170.938 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.36 -39.14 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.522 1.129 . . . . 0.0 110.622 174.716 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -62.93 -42.95 99.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.593 1.088 . . . . 0.0 111.685 173.177 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.07 -33.98 76.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.714 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -89.73 -40.92 12.2 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.279 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -114.31 -20.09 11.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.889 1.676 . . . . 0.0 114.902 -173.434 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.03 62.7 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 178.399 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -86.12 122.56 72.47 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 119.138 1.469 . . . . 0.0 110.442 -172.792 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -63.2 141.22 81.68 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.923 2.416 . . . . 0.0 113.738 -179.631 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.16 -30.05 64.96 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.786 2.99 . . . . 0.0 114.937 -169.628 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.93 -26.65 61.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.884 1.22 . . . . 0.0 112.691 177.52 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -78.41 -19.09 54.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.743 1.217 . . . . 0.0 112.799 175.745 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.05 139.59 38.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.164 0.893 . . . . 0.0 112.337 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -128.1 124.59 37.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.897 1.679 . . . . 0.0 109.798 162.847 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.51 137.55 44.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 0.0 111.103 179.408 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.2 138.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.591 1.556 . . . . 0.0 110.209 -176.949 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.75 125.78 17.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 111.092 174.257 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.29 40.24 13.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 172.845 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.47 8.57 87.42 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -176.871 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.48 125.94 53.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.37 1.868 . . . . 0.0 111.214 174.412 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -82.33 127.06 32.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.41 1.005 . . . . 0.0 110.211 167.277 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.96 137.45 35.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.334 0.653 . . . . 0.0 111.336 -170.7 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.83 140.95 29.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.703 1.201 . . . . 0.0 112.888 -177.186 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.8 -1.56 2.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.767 1.627 . . . . 0.0 114.704 -178.154 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.8 15.74 21.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.367 2.413 . . . . 0.0 116.041 -178.302 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -133.29 166.38 22.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.848 1.824 . . . . 0.0 114.393 -173.077 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -97.19 156.25 16.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 113.833 176.783 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.26 -37.6 80.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.202 1.001 . . . . 0.0 112.457 171.479 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -67.83 -33.91 75.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 114.013 177.087 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.79 -31.08 71.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.805 1.184 . . . . 0.0 112.164 170.75 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -86.39 -0.35 55.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.715 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.02 37.43 26.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.946 1.703 . . . . 0.0 114.349 -174.826 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -81.43 111.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 171.058 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -98.53 175.3 6.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.614 1.566 . . . . 0.0 111.976 -176.422 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -54.42 146.57 15.59 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 112.753 168.104 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 57.58 20.99 6.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.458 1.903 . . . . 0.0 114.778 -173.679 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 m -70.94 145.8 49.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.793 -1.817 . . . . 0.0 111.906 172.254 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 m -110.55 111.8 23.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.586 1.154 . . . . 0.0 110.407 174.01 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.65 161.15 18.63 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.373 1.469 . . . . 0.0 110.412 170.71 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -117.37 150.68 38.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.479 1.111 . . . . 0.0 110.262 166.108 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.4 tp -126.7 128.55 46.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.217 2.207 . . . . 0.0 110.029 -178.055 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.12 144.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 176.189 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.18 136.62 32.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.494 0.718 . . . . 0.0 111.155 173.652 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -114.79 114.06 25.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 108.818 173.927 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.89 153.2 29.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.681 1.592 . . . . 0.0 109.863 -179.694 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -60.97 131.56 51.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.841 0.856 . . . . 0.0 109.999 171.224 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -135.61 20.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -163.575 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.482 174.334 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.41 140.72 37.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.693 0.797 . . . . 0.0 111.018 172.777 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.85 157.67 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.211 1.004 . . . . 0.0 109.522 159.511 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -117.84 147.73 42.78 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.403 1.081 . . . . 0.0 111.073 179.742 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.83 128.27 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.65 0.78 . . . . 0.0 110.108 176.852 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -91.19 130.75 37.04 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.891 0.876 . . . . 0.0 111.196 173.894 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -85.28 167.47 15.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.684 1.194 . . . . 0.0 113.005 177.213 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.18 -15.0 62.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.006 -1.059 . . . . 0.0 113.55 178.7 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -103.92 17.97 22.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.585 1.954 . . . . 0.0 113.063 171.609 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.68 88.72 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 166.845 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -74.59 142.63 44.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.509 1.654 . . . . 0.0 110.618 178.036 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -95.18 117.17 29.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.859 0.863 . . . . 0.0 110.061 168.433 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.096 1.759 . . . . 0.0 109.243 169.368 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -120.87 124.85 46.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.305 1.442 . . . . 0.0 109.896 174.262 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -124.1 162.25 23.94 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.482 1.513 . . . . 0.0 112.721 -172.392 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -114.83 128.67 56.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.187 1.795 . . . . 0.0 109.994 173.181 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.31 160.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.21 1.804 . . . . 0.0 111.81 -175.884 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -101.59 156.44 35.18 Favored Pre-proline 0 N--CA 1.45 -0.44 0 C-N-CA 123.805 0.842 . . . . 0.0 110.615 158.307 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.88 -19.84 20.65 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.324 2.683 . . . . 0.0 115.348 169.444 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -91.48 -0.7 57.65 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.144 2.178 . . . . 0.0 115.27 176.003 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.14 148.93 50.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.896 1.225 . . . . 0.0 111.199 166.888 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.3 p -84.99 159.79 20.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.686 0.794 . . . . 0.0 112.823 175.973 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.5 -33.47 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.773 -0.58 . . . . 0.0 110.368 171.091 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -70.19 -26.78 64.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.915 -1.115 . . . . 0.0 113.62 175.099 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -69.34 -38.42 78.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.881 -1.137 . . . . 0.0 111.175 167.912 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.21 -42.6 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.357 0.98 . . . . 0.0 111.629 173.64 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.93 -41.74 78.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 112.798 171.611 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.04 88.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 176.654 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -63.05 -34.58 77.88 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.207 1.003 . . . . 0.0 111.815 174.049 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.68 -35.54 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.978 1.311 . . . . 0.0 111.841 172.518 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.16 -37.16 86.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.563 1.074 . . . . 0.0 112.105 173.758 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.25 -40.99 98.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.551 0.741 . . . . 0.0 112.885 172.992 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -71.49 -59.86 2.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.64 1.176 . . . . 0.0 113.018 177.32 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -116.5 -6.04 11.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.126 1.37 . . . . 0.0 114.248 -162.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.87 11.04 85.83 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.928 -1.108 . . . . 0.0 115.798 176.864 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.33 121.36 84.39 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.795 1.298 . . . . 0.0 109.509 -178.101 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -64.12 136.41 51.9 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.554 2.169 . . . . 0.0 113.043 -179.421 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -51.54 -31.45 39.77 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 124.491 3.461 . . . . 0.0 115.796 174.365 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.73 -11.86 59.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 174.753 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.31 -6.73 23.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.415 1.486 . . . . 0.0 113.046 171.845 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.28 127.89 36.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.821 1.248 . . . . 0.0 111.994 178.386 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -101.26 131.92 47.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 147.98 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.21 145.56 31.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.438 1.095 . . . . 0.0 111.695 172.369 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mt -135.59 136.78 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.914 1.685 . . . . 0.0 110.118 -172.879 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -138.47 134.0 33.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.748 1.619 . . . . 0.0 110.742 170.412 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.97 45.73 8.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.413 1.485 . . . . 0.0 113.362 -178.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.89 61.09 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.967 1.27 . . . . 0.0 116.046 -179.039 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -109.5 128.93 55.53 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.784 1.634 . . . . 0.0 110.796 -178.334 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -80.32 122.39 26.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 110.675 179.342 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.22 139.05 31.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.443 1.497 . . . . 0.0 111.832 -170.672 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.6 156.49 17.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.827 1.651 . . . . 0.0 112.368 -178.979 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.73 -32.83 64.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.409 -1.432 . . . . 0.0 113.424 -169.064 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.74 34.19 3.19 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.28 1.419 . . . . 0.0 115.485 -174.992 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -139.08 154.31 48.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.145 1.778 . . . . 0.0 111.902 -173.91 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -90.42 164.92 14.11 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 112.64 171.084 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.88 -36.22 69.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 169.782 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 p -65.12 -34.67 78.96 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 175.37 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -66.81 -14.77 63.03 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.716 1.144 . . . . 0.0 113.651 178.303 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -111.13 2.1 17.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.061 1.745 . . . . 0.0 114.146 172.535 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.84 43.47 31.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.605 1.548 . . . . 0.0 112.992 -173.813 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.52 119.17 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.402 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -103.9 162.91 12.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.59 1.156 . . . . 0.0 113.12 -171.641 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -51.33 141.09 15.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.739 1.216 . . . . 0.0 112.94 174.053 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.39 14.82 4.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -174.832 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.1 m -66.24 145.15 56.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.225 -1.547 . . . . 0.0 112.77 171.932 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -101.05 136.02 41.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.256 1.422 . . . . 0.0 110.582 167.242 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.5 166.13 15.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.3 2.24 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -127.16 150.69 49.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.979 1.312 . . . . 0.0 111.35 -179.012 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.18 147.75 44.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.501 1.12 . . . . 0.0 112.508 176.477 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.62 150.6 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.422 -176.057 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.43 127.56 33.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.446 1.498 . . . . 0.0 112.556 177.948 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -95.36 139.49 31.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.702 1.601 . . . . 0.0 112.439 173.778 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.85 174.92 8.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.153 1.781 . . . . 0.0 112.405 -170.032 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 58.54 31.99 21.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.259 2.224 . . . . 0.0 115.792 179.538 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.37 -9.1 67.62 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.873 1.225 . . . . 0.0 114.774 174.849 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 C-N-CA 125.773 1.654 . . . . 0.0 112.114 171.176 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 119.561 -0.257 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -125.78 155.15 41.5 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.172 1.389 . . . . 0.0 113.786 174.344 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -140.89 170.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 127.206 2.202 . . . . 0.0 110.483 172.221 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -122.17 150.53 42.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.98 0.912 . . . . 0.0 112.409 179.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.97 133.42 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.374 1.47 . . . . 0.0 109.556 175.401 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.67 128.21 56.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.696 179.859 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 p -85.16 163.91 18.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.159 1.384 . . . . 0.0 111.948 175.913 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -64.02 -20.07 65.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.302 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -77.58 -13.5 59.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.318 1.417 . . . . 0.0 113.02 171.977 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.5 -13.64 39.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.354 1.931 . . . . 0.0 114.543 -176.642 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -64.9 141.37 58.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.84 1.256 . . . . 0.0 111.854 -175.214 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -108.56 150.36 27.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.79 1.236 . . . . 0.0 111.507 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 mt -136.05 126.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.538 1.935 . . . . 0.0 108.165 179.1 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -89.29 128.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.996 0.918 . . . . 0.0 110.919 175.192 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -118.18 142.98 46.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.206 1.402 . . . . 0.0 112.293 178.055 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -97.99 129.29 44.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.649 1.58 . . . . 0.0 109.791 173.681 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.46 174.22 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.526 1.53 . . . . 0.0 111.977 -171.385 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 53.8 mt-10 -109.93 157.09 38.72 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.356 1.462 . . . . 0.0 109.569 164.064 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.13 -27.93 58.38 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.826 2.351 . . . . 0.0 114.592 174.888 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -98.79 6.14 47.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.766 2.827 . . . . 0.0 114.497 -179.881 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 18.5 t0 -68.43 155.56 39.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.936 -1.103 . . . . 0.0 112.29 -177.326 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.2 p -96.2 149.87 21.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 113.415 -171.948 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.44 -37.16 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 123.628 0.771 . . . . 0.0 111.411 -178.896 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -66.58 -26.78 67.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.233 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -77.67 -35.81 51.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.114 0.87 . . . . 0.0 111.249 172.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.43 -43.28 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.758 0.708 . . . . 0.0 110.688 170.292 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.04 -39.85 95.01 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.269 0.94 . . . . 0.0 113.535 174.548 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.33 80.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.744 0.702 . . . . 0.0 112.791 173.465 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.52 -30.82 64.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.94 -1.1 . . . . 0.0 112.623 175.315 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -66.28 -41.65 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.944 0.897 . . . . 0.0 110.468 169.289 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.05 -41.74 79.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.227 1.376 . . . . 0.0 111.599 171.263 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.96 -19.25 65.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 179.461 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -114.25 -27.93 7.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.356 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -118.94 -20.45 8.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.988 1.315 . . . . 0.0 113.38 -172.497 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 5.84 82.92 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 173.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.4 tp -85.17 123.35 73.46 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.668 1.734 . . . . 0.0 111.044 178.359 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 54.4 Cg_exo -63.07 145.46 93.98 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.0 113.685 -178.54 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 78.2 Cg_exo -57.61 -35.49 98.81 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.843 2.362 . . . . 0.0 116.254 -173.443 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.5 -22.53 66.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.837 176.627 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.94 4.15 50.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.113 1.365 . . . . 0.0 113.227 178.506 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -110.49 134.15 52.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.124 1.369 . . . . 0.0 113.319 -177.683 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -116.39 131.75 56.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.716 2.006 . . . . 0.0 109.211 162.315 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.67 131.11 55.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.718 0.807 . . . . 0.0 110.432 177.408 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.11 131.86 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.975 1.31 . . . . 0.0 110.586 -172.835 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -150.2 133.87 16.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.249 1.02 . . . . 0.0 110.827 173.865 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 41.67 22.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.535 1.134 . . . . 0.0 112.993 -171.733 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 -13.73 1.83 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.908 1.718 . . . . 0.0 116.974 -176.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.58 131.68 36.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.158 1.479 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 117.27 17.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 163.773 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.03 124.06 27.25 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.537 0.735 . . . . 0.0 110.998 -171.377 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.92 137.06 38.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.197 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.91 -31.49 71.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.953 1.701 . . . . 0.0 113.294 -174.615 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.42 0.62 68.48 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.873 -1.515 . . . . 0.0 116.766 178.046 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mtt85 -111.31 171.74 7.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.048 1.924 . . . . 0.0 113.914 -174.905 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.7 p -104.05 164.51 11.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.36 1.464 . . . . 0.0 113.681 176.575 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.41 -35.59 72.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.842 0.857 . . . . 0.0 112.407 167.746 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -66.17 -34.1 77.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.149 0.979 . . . . 0.0 113.637 175.195 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.54 -20.41 66.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.052 0.842 . . . . 0.0 112.899 175.793 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.32 4.45 24.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 114.077 174.291 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 53.47 39.6 30.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.0 114.659 -177.608 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -83.06 109.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.053 -1.029 . . . . 0.0 108.784 177.613 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -93.65 167.0 11.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.506 1.122 . . . . 0.0 114.027 178.816 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -54.23 143.97 21.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -177.853 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 63.45 6.9 2.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -175.185 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -64.95 152.67 42.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.016 0.826 . . . . 0.0 111.783 170.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.5 m -112.96 125.88 54.88 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.397 1.079 . . . . 0.0 110.456 -179.285 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.34 155.3 20.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.018 1.727 . . . . 0.0 110.257 179.552 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -107.36 130.74 54.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.492 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -91.29 133.71 35.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.823 1.249 . . . . 0.0 110.503 172.31 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.44 150.07 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.763 2.025 . . . . 0.0 107.88 166.397 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -92.16 160.78 15.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.769 -1.207 . . . . 0.0 113.415 -177.61 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 ttm105 -114.38 137.56 51.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.46 1.904 . . . . 0.0 110.248 169.695 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.81 162.46 26.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.183 2.193 . . . . 0.0 110.245 -171.735 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -68.08 119.08 12.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.015 -1.053 . . . . 0.0 110.168 173.634 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 14.96 74.43 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.781 -1.011 . . . . 0.0 115.072 -168.298 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.337 1.922 . . . . 0.0 113.277 -179.265 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.2 137.6 32.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.478 0.711 . . . . 0.0 111.335 172.853 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.59 155.21 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 111.068 169.836 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.93 127.73 55.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.06 1.344 . . . . 0.0 109.904 176.284 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.23 126.0 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.611 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -127.56 123.9 36.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.845 1.258 . . . . 0.0 113.218 -172.648 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.2 p -74.94 159.91 31.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.738 1.215 . . . . 0.0 112.894 -178.878 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.7 tp -57.48 -32.64 67.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.122 -0.986 . . . . 0.0 113.242 168.478 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -70.9 -12.0 61.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.449 1.5 . . . . 0.0 114.097 173.954 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.07 59.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.823 1.678 . . . . 0.0 115.657 175.293 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.45 147.6 35.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.252 1.421 . . . . 0.0 109.941 174.43 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -136.72 142.53 43.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.379 1.071 . . . . 0.0 111.578 -172.546 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.64 143.53 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 112.318 172.536 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -110.36 127.85 55.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.266 1.427 . . . . 0.0 111.394 177.739 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -132.71 144.99 50.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.177 1.391 . . . . 0.0 110.926 -177.604 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -94.83 124.89 39.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.008 1.323 . . . . 0.0 109.845 172.841 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.34 162.97 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.106 1.762 . . . . 0.0 111.099 -175.223 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.02 147.81 39.16 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 124.202 1.001 . . . . 0.0 109.926 174.31 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.63 -23.87 69.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.805 1.67 . . . . 0.0 116.074 -166.471 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 m -80.91 -3.99 53.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.558 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.01 145.02 53.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 113.576 178.656 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -77.65 152.33 33.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.926 0.89 . . . . 0.0 112.339 177.45 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.71 -28.87 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.965 -0.459 . . . . 0.0 110.939 174.333 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.17 -48.46 78.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.073 0.949 . . . . 0.0 113.003 170.146 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -65.69 -30.08 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.873 -177.267 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.98 -43.68 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.306 1.042 . . . . 0.0 111.724 174.118 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.01 -33.95 71.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.953 1.251 . . . . 0.0 112.638 174.083 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.23 -32.89 74.41 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 172.26 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -33.25 64.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.715 0.806 . . . . 0.0 111.948 171.72 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.08 -42.2 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 119.742 1.155 . . . . 0.0 110.884 174.919 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.95 -38.13 89.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.98 0.809 . . . . 0.0 111.687 172.832 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.73 -43.22 84.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.141 -0.975 . . . . 0.0 113.396 176.632 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -83.26 -40.6 19.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.525 1.53 . . . . 0.0 114.296 -174.342 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -127.51 2.23 6.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.514 1.526 . . . . 0.0 114.194 -172.543 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.08 -21.54 11.76 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.679 1.431 . . . . 0.0 116.679 164.915 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -66.41 127.71 93.46 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 119.117 1.459 . . . . 0.0 110.55 -175.521 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.47 148.76 85.59 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.064 2.51 . . . . 0.0 113.971 176.351 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.08 -29.76 81.72 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.732 2.288 . . . . 0.0 113.243 176.462 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.65 -11.53 59.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.001 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -106.96 6.42 29.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.038 1.335 . . . . 0.0 113.581 -177.139 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -123.61 148.01 46.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.895 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -113.58 139.22 49.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.677 1.591 . . . . 0.0 109.477 165.135 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.47 130.96 56.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.565 1.546 . . . . 0.0 110.658 174.805 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 135.34 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.532 1.533 . . . . 0.0 109.891 -178.553 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -146.12 139.96 26.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.586 1.555 . . . . 0.0 110.983 173.778 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.37 28.13 1.57 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.338 1.455 . . . . 0.0 114.79 -175.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.99 18.66 78.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.937 -1.48 . . . . 0.0 116.218 -176.417 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -134.24 158.82 42.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.685 1.743 . . . . 0.0 113.03 174.757 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.55 139.86 42.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.409 0.683 . . . . 0.0 112.719 179.923 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.22 136.83 35.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.638 1.575 . . . . 0.0 110.897 168.339 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -136.89 136.14 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.127 0.971 . . . . 0.0 112.514 -173.123 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.04 -27.88 3.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.177 2.991 . . . . 0.0 118.145 -170.155 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.98 73.96 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -177.838 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -118.72 173.69 6.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.595 1.558 . . . . 0.0 113.74 -173.666 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -104.02 163.28 12.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.433 1.493 . . . . 0.0 114.079 -172.725 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -57.4 -38.2 73.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.551 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 m -60.19 -38.74 84.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.276 1.03 . . . . 0.0 113.438 171.074 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -65.74 -21.43 66.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.325 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -104.52 8.96 35.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.573 1.549 . . . . 0.0 113.767 174.334 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 56.13 46.81 20.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.069 1.347 . . . . 0.0 113.692 178.804 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -84.3 147.29 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 109.893 173.457 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -143.23 175.65 9.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.921 2.088 . . . . 0.0 113.234 -169.841 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -49.81 137.25 16.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.97 0.908 . . . . 0.0 112.25 173.004 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 54.73 34.21 21.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.073 1.349 . . . . 0.0 113.967 -179.352 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -71.95 134.29 45.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.081 -1.637 . . . . 0.0 111.089 172.364 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 m -98.17 117.34 32.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.553 170.646 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.88 133.59 48.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.195 1.798 . . . . 0.0 108.158 176.159 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -97.72 134.97 40.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.038 0.535 . . . . 0.0 110.961 -179.132 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -119.97 127.23 52.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.542 1.937 . . . . 0.0 110.496 -171.057 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.29 132.0 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.494 1.118 . . . . 0.0 111.384 -173.902 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.02 106.93 3.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.131 1.372 . . . . 0.0 109.994 168.412 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 43.6 ptt85 -87.17 26.66 1.15 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.768 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -109.66 10.39 24.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.824 2.05 . . . . 0.0 112.749 169.16 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -135.53 158.49 44.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.961 2.105 . . . . 0.0 110.585 -179.12 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.42 68.18 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 176.281 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-N 118.928 1.364 . . . . 0.0 113.292 -176.292 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.498 0.189 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -86.05 141.88 29.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.603 0.761 . . . . 0.0 111.345 167.201 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.2 pt -134.73 153.04 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.768 1.227 . . . . 0.0 110.752 167.249 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.98 126.79 52.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.534 0.734 . . . . 0.0 112.899 -169.505 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.8 t -114.76 116.71 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.292 1.037 . . . . 0.0 110.795 -172.977 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.49 148.32 30.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 111.892 -179.588 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -130.25 163.27 27.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.8 1.24 . . . . 0.0 112.539 174.584 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.7 tp -56.92 -34.53 68.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.667 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -78.94 6.9 8.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.355 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.21 8.47 74.74 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 120.473 -1.392 . . . . 0.0 115.024 -179.868 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -90.49 118.88 30.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.839 1.656 . . . . 0.0 109.654 176.914 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -105.52 132.72 51.33 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.61 1.164 . . . . 0.0 111.446 -168.399 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -99.19 137.23 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.208 1.803 . . . . 0.0 110.052 -175.487 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -98.36 127.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.116 172.097 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -109.99 137.76 47.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.971 0.908 . . . . 0.0 110.874 170.674 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -96.52 109.04 21.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.496 1.518 . . . . 0.0 107.655 170.138 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.89 158.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.318 1.447 . . . . 0.0 112.15 -170.735 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -117.66 150.74 47.42 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.668 168.214 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.97 -29.91 56.52 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.738 2.292 . . . . 0.0 115.815 -178.101 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -75.6 -4.15 38.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.263 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.61 135.36 54.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.855 1.207 . . . . 0.0 110.489 175.272 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.5 p -77.45 157.3 30.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.9 0.48 . . . . 0.0 111.265 172.536 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.83 -33.04 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.572 -0.705 . . . . 0.0 111.409 173.557 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.68 -44.64 85.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.042 0.937 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -70.05 -34.95 73.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.201 0.601 . . . . 0.0 112.17 177.043 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.02 -41.97 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 120.971 -1.081 . . . . 0.0 111.474 172.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.09 -34.44 78.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.159 -0.963 . . . . 0.0 112.779 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.9 82.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.58 0.752 . . . . 0.0 112.611 174.366 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.61 -42.15 91.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.818 1.247 . . . . 0.0 111.852 173.687 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -42.99 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.521 1.128 . . . . 0.0 111.124 172.859 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.46 -43.43 96.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.118 0.967 . . . . 0.0 111.956 176.839 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.51 -34.63 78.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.565 0.621 . . . . 0.0 112.546 179.277 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -76.66 -50.78 12.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 174.67 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -107.96 -8.44 15.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -164.462 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.85 70.68 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.657 1.117 . . . . 0.0 115.512 175.28 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.93 124.41 32.99 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 126.407 1.883 . . . . 0.0 108.553 175.527 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.53 147.18 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.614 2.209 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -46.44 -41.8 23.06 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 124.295 3.33 . . . . 0.0 116.518 -175.722 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.75 -0.68 16.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.93 1.696 . . . . 0.0 115.246 179.911 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -109.06 -2.51 18.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.609 1.964 . . . . 0.0 113.269 166.516 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.2 151.97 21.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.251 1.421 . . . . 0.0 111.436 172.419 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -141.93 117.78 10.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.937 1.695 . . . . 0.0 109.695 164.755 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 tp -116.53 120.27 38.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.7 1.2 . . . . 0.0 111.481 -170.589 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.97 133.25 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 111.817 -167.702 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -118.15 110.1 17.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.205 2.202 . . . . 0.0 110.107 172.885 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.88 52.9 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.298 1.439 . . . . 0.0 114.208 179.294 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.53 -13.56 57.85 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.664 1.602 . . . . 0.0 116.929 -178.962 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -104.84 140.76 37.65 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.581 2.191 . . . . 0.0 112.948 -175.906 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -67.88 127.0 31.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.298 0.639 . . . . 0.0 110.942 167.204 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -71.57 132.59 44.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 111.311 175.502 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.65 127.01 36.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.639 1.576 . . . . 0.0 111.921 -172.47 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.69 -25.59 66.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -166.295 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 -7.21 83.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 178.728 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -95.88 165.39 12.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.532 1.666 . . . . 0.0 112.506 -177.466 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -98.63 157.88 15.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.788 1.635 . . . . 0.0 112.476 172.422 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.51 -36.62 69.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.251 0.62 . . . . 0.0 112.138 170.238 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 p -61.93 -40.7 96.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.86 1.264 . . . . 0.0 113.64 174.123 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.6 -19.74 60.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.269 0.94 . . . . 0.0 113.27 179.087 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -83.9 -5.69 59.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 162.918 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 51.09 50.47 19.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.741 1.616 . . . . 0.0 112.867 -171.709 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -88.78 131.89 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.165 1.386 . . . . 0.0 108.329 170.059 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -121.0 176.29 5.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.822 1.649 . . . . 0.0 111.83 -173.578 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -50.26 138.4 16.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.515 1.126 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 59.26 21.99 10.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.714 2.006 . . . . 0.0 115.484 174.107 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -72.3 157.43 37.7 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.479 1.512 . . . . 0.0 112.951 174.017 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -112.43 137.99 49.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.638 1.175 . . . . 0.0 112.56 -173.286 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.78 163.97 26.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 109.99 174.298 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -118.42 135.39 54.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.821 0.848 . . . . 0.0 110.846 173.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.461 1.504 . . . . 0.0 110.303 176.557 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.95 144.21 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.398 1.879 . . . . 0.0 109.08 179.488 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -86.45 146.7 26.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.68 0.752 . . . . 0.0 112.794 175.277 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -134.53 62.05 1.66 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.437 1.895 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.44 131.71 41.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.208 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -62.71 134.22 55.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.226 0.61 . . . . 0.0 112.21 -170.506 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.59 131.37 10.33 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.211 166.342 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.399 1.476 . . . . 0.0 113.453 177.099 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.44 148.95 30.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.444 1.098 . . . . 0.0 111.255 173.079 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -140.8 154.19 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.748 1.219 . . . . 0.0 111.517 161.467 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -98.63 146.76 25.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.679 1.192 . . . . 0.0 111.186 166.86 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.62 116.47 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.078 1.351 . . . . 0.0 109.656 171.567 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.97 148.25 22.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.864 1.666 . . . . 0.0 111.528 177.741 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -111.29 158.05 19.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.186 0.994 . . . . 0.0 111.787 178.119 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.72 -21.16 66.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.889 -1.132 . . . . 0.0 112.126 169.142 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.4 p -76.85 1.48 17.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.759 1.624 . . . . 0.0 113.794 170.992 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.04 74.06 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 120.814 -1.179 . . . . 0.0 115.379 173.043 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -93.3 160.07 14.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.358 1.863 . . . . 0.0 109.985 178.791 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -132.7 121.72 23.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.873 0.869 . . . . 0.0 110.464 173.373 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -103.23 144.83 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.089 2.156 . . . . 0.0 108.451 178.789 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 p -119.23 138.64 52.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.016 0.926 . . . . 0.0 112.221 174.627 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -131.48 155.86 46.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 111.907 -177.477 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -109.79 123.98 50.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.082 1.753 . . . . 0.0 109.644 163.327 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.66 163.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.929 2.091 . . . . 0.0 110.653 -169.564 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -96.09 148.63 34.82 Favored Pre-proline 0 N--CA 1.45 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 111.934 166.453 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 -14.22 40.14 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.914 2.409 . . . . 0.0 113.862 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -92.63 -3.47 54.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.405 2.282 . . . . 0.0 115.271 172.838 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.97 137.3 53.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.249 1.386 . . . . 0.0 111.029 178.152 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -69.56 157.52 37.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.37 0.605 . . . . 0.0 111.933 174.549 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.22 -34.21 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 120.962 -1.086 . . . . 0.0 111.004 171.357 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.91 -49.27 78.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.206 0.912 . . . . 0.0 112.342 169.515 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.93 -38.06 89.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.945 0.898 . . . . 0.0 112.411 179.706 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.94 -41.87 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.504 -0.748 . . . . 0.0 111.623 175.095 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 57.9 mtpt -61.57 -37.27 83.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.396 0.998 . . . . 0.0 112.0 172.57 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.09 68.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.171 0.988 . . . . 0.0 113.54 173.857 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -70.34 -35.33 73.54 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.828 -1.17 . . . . 0.0 111.711 170.656 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.85 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.364 1.066 . . . . 0.0 110.981 170.587 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -55.2 -49.67 71.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.394 0.997 . . . . 0.0 111.811 175.064 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.99 -36.07 76.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.883 0.873 . . . . 0.0 113.244 179.117 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -84.02 -44.42 14.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -112.04 -10.82 13.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.718 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.95 24.11 70.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 176.414 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -107.09 114.11 61.69 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.205 1.402 . . . . 0.0 108.152 176.418 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.58 147.09 72.17 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.542 2.828 . . . . 0.0 114.238 175.86 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -25.95 40.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.929 2.419 . . . . 0.0 113.377 -169.676 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.4 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.393 1.077 . . . . 0.0 113.878 174.263 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.45 -11.48 29.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.461 1.505 . . . . 0.0 113.269 175.508 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 75.5 mt-30 -99.68 142.74 30.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.791 1.237 . . . . 0.0 112.476 -175.054 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -132.86 138.03 46.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.894 0.878 . . . . 0.0 110.989 158.528 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.69 144.59 30.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.466 1.106 . . . . 0.0 111.956 177.555 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.9 mt -132.7 135.19 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.141 1.776 . . . . 0.0 110.58 -179.055 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.05 139.71 19.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.904 1.282 . . . . 0.0 111.68 174.262 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 37.52 11.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.681 1.193 . . . . 0.0 114.184 -179.318 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -11.66 7.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.201 1.858 . . . . 0.0 116.475 -174.013 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -78.08 133.15 37.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.858 1.829 . . . . 0.0 110.528 178.415 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -79.38 128.69 33.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 160.419 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.68 137.85 35.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.828 0.851 . . . . 0.0 111.413 -167.533 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.42 137.25 44.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.912 1.285 . . . . 0.0 113.029 -170.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -50.71 -30.83 14.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.021 2.128 . . . . 0.0 115.618 -174.93 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -11.13 85.41 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.06 -1.411 . . . . 0.0 116.17 -179.405 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -105.92 168.02 9.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.944 1.872 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -113.56 161.94 16.78 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 113.102 -176.704 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -52.21 -47.12 65.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.737 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.9 p -64.72 -27.57 69.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 179.461 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -66.52 -32.03 73.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.468 1.031 . . . . 0.0 111.88 177.527 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.6 11.51 17.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.701 1.6 . . . . 0.0 113.959 172.239 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 59.54 32.81 21.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -179.087 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -82.4 122.38 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.625 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -114.08 173.2 6.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.052 1.741 . . . . 0.0 112.426 177.626 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -46.71 137.34 7.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.606 1.563 . . . . 0.0 114.297 172.367 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 56.81 15.32 2.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.295 2.238 . . . . 0.0 116.128 -175.251 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -63.92 153.0 38.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.366 -1.459 . . . . 0.0 111.604 170.275 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -106.06 123.8 48.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.253 1.021 . . . . 0.0 110.199 172.497 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.81 164.51 11.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.913 1.685 . . . . 0.0 110.139 172.292 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -113.22 147.43 37.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.828 0.851 . . . . 0.0 111.134 168.49 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.7 tp -120.99 127.09 51.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.555 1.942 . . . . 0.0 109.971 178.628 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.97 133.57 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.827 1.651 . . . . 0.0 109.579 170.937 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.5 tp -100.66 110.32 22.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.88 1.672 . . . . 0.0 109.11 172.692 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -74.82 116.37 15.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.099 0.408 . . . . 0.0 110.244 174.102 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.43 -47.41 8.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.234 1.014 . . . . 0.0 111.812 179.7 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -67.42 -50.07 61.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 118.388 0.54 . . . . 0.0 111.919 -179.148 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.31 7.41 78.65 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 -179.648 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 113.999 -174.991 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.198 0.047 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -84.76 129.06 34.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.029 0.932 . . . . 0.0 110.866 174.178 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.51 168.56 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.222 1.409 . . . . 0.0 110.988 173.385 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.78 147.31 47.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.233 1.013 . . . . 0.0 112.659 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.69 130.58 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.622 1.169 . . . . 0.0 110.726 176.194 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -87.25 113.98 23.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.157 0.983 . . . . 0.0 110.762 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -74.95 179.55 4.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.338 1.855 . . . . 0.0 113.669 -172.917 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -65.6 -21.63 66.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.906 -1.121 . . . . 0.0 113.207 178.233 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p -88.82 -3.48 58.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.939 1.296 . . . . 0.0 113.227 176.357 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.43 -2.02 86.15 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.554 1.55 . . . . 0.0 115.29 -173.803 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -65.11 144.8 56.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.816 1.808 . . . . 0.0 109.907 173.52 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.0 m -97.34 124.49 41.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 172.982 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 pt -110.33 144.51 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.45 1.5 . . . . 0.0 111.885 177.627 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -92.99 132.86 36.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 111.099 179.293 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -121.33 152.74 38.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.652 1.581 . . . . 0.0 111.43 170.598 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -129.28 108.4 10.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 108.687 178.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.1 161.02 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.752 1.621 . . . . 0.0 112.625 -162.062 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -92.65 140.78 23.95 Favored Pre-proline 0 N--CA 1.449 -0.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.455 173.91 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.85 -21.67 34.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.541 2.828 . . . . 0.0 116.488 174.898 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -90.54 2.86 55.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 174.554 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -72.19 146.1 47.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.817 1.19 . . . . 0.0 111.151 172.586 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -83.35 165.05 19.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 112.98 177.889 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.58 -34.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.241 -0.912 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.62 -39.08 86.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.875 1.216 . . . . 0.0 113.252 171.14 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -63.44 -34.25 77.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.63 0.65 . . . . 0.0 112.273 175.516 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.47 -45.82 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 123.268 0.627 . . . . 0.0 111.331 175.427 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -57.77 -42.36 83.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 112.664 178.506 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.64 70.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 177.823 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -83.4 -33.07 25.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.793 1.237 . . . . 0.0 112.031 -179.859 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -41.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 171.154 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.72 -39.17 65.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.078 1.351 . . . . 0.0 112.685 178.526 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.39 -11.32 60.84 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -175.86 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -125.13 -30.34 3.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 175.732 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -96.64 -15.12 21.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.082 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 19.86 77.17 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 174.757 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.95 118.82 56.22 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 109.916 -174.107 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.86 145.68 97.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.877 2.385 . . . . 0.0 113.218 175.715 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.08 -25.74 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.986 2.458 . . . . 0.0 113.711 -164.513 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 -22.78 57.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.279 -0.888 . . . . 0.0 112.888 175.194 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.93 -26.4 34.07 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 174.509 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.56 135.57 50.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 111.377 177.53 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -125.05 117.4 23.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.868 1.667 . . . . 0.0 108.82 168.242 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 tp -108.78 126.54 53.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.004 1.322 . . . . 0.0 110.363 -175.207 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -115.84 138.43 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 111.525 -169.35 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -145.89 136.49 24.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 111.196 167.236 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.4 8.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 0.0 113.926 -169.659 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.26 10.51 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.233 1.873 . . . . 0.0 116.412 -177.113 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -91.14 140.21 30.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.275 1.537 . . . . 0.0 110.823 179.0 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -78.62 127.86 32.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.139 0.495 . . . . 0.0 111.276 172.644 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.24 143.21 31.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.065 1.346 . . . . 0.0 110.875 -178.105 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -106.5 135.43 48.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.43 1.092 . . . . 0.0 111.431 -162.223 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.7 -55.42 5.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.217 1.807 . . . . 0.0 115.023 -164.648 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.21 -5.73 87.05 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 -175.655 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -88.3 158.3 18.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.278 1.539 . . . . 0.0 111.083 -178.601 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -103.27 157.43 17.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.355 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.78 -38.54 72.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.821 0.848 . . . . 0.0 113.138 -179.56 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -71.68 -21.28 61.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.98 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.97 -29.16 70.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.752 1.615 . . . . 0.0 111.952 170.137 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -92.26 6.1 48.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.705 1.602 . . . . 0.0 113.887 174.161 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 25.4 t-20 53.49 38.63 28.51 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.477 1.511 . . . . 0.0 114.857 -173.853 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.4 129.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.993 0.917 . . . . 0.0 108.733 172.752 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -131.1 177.17 7.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.225 1.81 . . . . 0.0 110.816 177.641 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.29 146.14 3.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.288 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.266 32.1 mt-10 61.15 24.38 14.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.635 2.374 . . . . 0.0 115.819 -177.446 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -76.71 149.8 36.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.538 1.135 . . . . 0.0 112.289 166.093 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -123.01 124.48 43.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.215 1.406 . . . . 0.0 111.282 176.72 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.42 162.02 15.08 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.192 2.197 . . . . 0.0 110.119 -178.209 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -120.53 132.78 55.34 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.052 -1.03 . . . . 0.0 111.048 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -103.09 132.0 49.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.807 1.243 . . . . 0.0 110.393 177.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.89 169.26 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.217 1.807 . . . . 0.0 110.596 174.231 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -106.83 167.13 10.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 111.728 -177.94 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -75.43 138.42 41.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.243 1.017 . . . . 0.0 111.965 171.234 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -131.83 53.75 1.97 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.813 2.445 . . . . 0.0 109.566 174.866 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -76.27 147.73 38.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.409 -1.432 . . . . 0.0 111.131 -177.202 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.72 136.73 41.53 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.637 -0.664 . . . . 0.0 112.498 174.284 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.184 1.373 . . . . 0.0 113.534 -178.378 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -85.02 147.0 26.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.788 0.435 . . . . 0.0 111.681 172.97 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.45 178.25 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.167 2.187 . . . . 0.0 109.775 167.402 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -119.29 150.31 40.33 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.459 1.104 . . . . 0.0 111.719 168.847 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -128.28 126.81 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.136 1.374 . . . . 0.0 108.928 169.47 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.4 143.12 51.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.119 1.368 . . . . 0.0 114.604 -177.459 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -108.46 151.82 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.757 1.623 . . . . 0.0 112.801 -179.363 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.64 -24.98 68.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.375 1.47 . . . . 0.0 112.703 179.641 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -81.72 11.79 4.49 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.332 1.453 . . . . 0.0 114.086 171.451 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.33 45.02 11.81 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.394 0.997 . . . . 0.0 114.693 165.229 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -118.6 148.97 42.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.425 1.09 . . . . 0.0 110.536 163.371 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -134.18 139.28 45.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.167 0.987 . . . . 0.0 110.083 172.534 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.2 150.82 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 0.0 111.513 172.765 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 140.88 29.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.691 1.197 . . . . 0.0 109.45 168.868 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -132.32 135.86 46.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.746 0.818 . . . . 0.0 110.972 179.506 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -99.07 123.38 43.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.036 0.935 . . . . 0.0 111.307 177.65 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.13 161.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.894 1.677 . . . . 0.0 112.994 -169.681 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.23 149.87 42.12 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.059 0.944 . . . . 0.0 110.179 161.334 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.18 -27.68 23.34 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.561 2.841 . . . . 0.0 115.607 174.312 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.6 p -72.77 -9.05 58.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 175.183 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.08 131.01 44.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.163 1.347 . . . . 0.0 112.129 -177.443 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -78.27 157.01 29.38 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.822 2.049 . . . . 0.0 113.099 174.914 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mm -56.59 -41.24 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.248 -178.611 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -67.98 -30.84 70.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.755 1.616 . . . . 0.0 112.837 179.253 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -76.2 -32.15 58.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.755 0.707 . . . . 0.0 112.506 174.527 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.56 -44.26 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 119.338 0.972 . . . . 0.0 111.049 168.885 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.17 -34.63 76.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.856 173.861 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.586 0.754 . . . . 0.0 112.521 174.086 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.22 -37.15 84.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.216 -0.928 . . . . 0.0 112.168 174.327 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.89 -40.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.111 1.365 . . . . 0.0 111.527 174.076 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -58.17 -45.49 87.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.202 1.001 . . . . 0.0 111.516 174.464 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.02 -40.84 98.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.608 -0.682 . . . . 0.0 112.821 176.073 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -80.19 -33.33 38.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -173.844 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -123.7 -6.07 8.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.044 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 4.91 90.41 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.37 -1.457 . . . . 0.0 115.551 177.096 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -74.82 120.78 83.21 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 125.507 1.523 . . . . 0.0 110.166 -175.058 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -59.37 142.99 99.84 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.579 2.186 . . . . 0.0 113.555 -175.467 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.99 -32.36 35.23 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.127 2.551 . . . . 0.0 113.419 -165.336 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.84 -11.82 60.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.228 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -94.78 -0.37 54.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.975 1.31 . . . . 0.0 114.272 -177.569 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -99.6 118.28 35.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.879 1.271 . . . . 0.0 112.196 -174.271 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -97.65 130.57 44.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 159.499 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -110.16 139.66 45.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.496 1.118 . . . . 0.0 110.988 177.648 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -130.27 136.55 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.863 1.665 . . . . 0.0 110.948 -178.273 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.63 138.09 35.83 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.754 1.622 . . . . 0.0 111.916 167.901 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 42.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.047 1.739 . . . . 0.0 113.584 -175.274 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.5 65.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.875 177.859 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -103.49 141.87 35.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.804 1.802 . . . . 0.0 112.617 -179.351 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.83 129.13 34.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.613 0.765 . . . . 0.0 110.346 171.612 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -85.79 130.6 34.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.309 1.044 . . . . 0.0 111.684 -167.552 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.22 132.35 36.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.534 1.534 . . . . 0.0 112.894 -171.286 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.78 127.94 34.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.424 176.519 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.69 -12.48 46.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.604 2.049 . . . . 0.0 115.778 -169.559 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -90.89 167.62 12.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.894 1.847 . . . . 0.0 112.872 175.211 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.9 p -113.75 170.11 8.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.15 1.78 . . . . 0.0 112.457 178.584 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.82 -33.06 74.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.748 -1.22 . . . . 0.0 112.184 176.803 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 m -63.42 -25.63 68.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 172.364 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.08 -41.08 97.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.878 1.217 . . . . 0.0 111.37 174.265 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -99.3 1.02 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -174.077 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 52.97 52.67 13.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.899 1.28 . . . . 0.0 112.536 -174.695 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.28 137.29 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.455 1.102 . . . . 0.0 108.138 171.224 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -127.93 176.76 7.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 113.026 -166.566 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -60.1 132.84 55.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.513 -0.742 . . . . 0.0 111.038 176.188 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 39.5 mt-10 57.96 18.15 4.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.411 2.284 . . . . 0.0 115.13 -175.262 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -62.9 151.7 38.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.745 165.345 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -110.79 127.59 55.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.569 1.148 . . . . 0.0 110.571 177.106 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.53 147.81 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.23 1.812 . . . . 0.0 109.849 171.723 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -103.97 136.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.741 0.816 . . . . 0.0 109.777 174.372 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -116.66 123.64 47.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.742 1.617 . . . . 0.0 110.135 -177.906 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.08 133.02 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.92 1.288 . . . . 0.0 109.984 178.723 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.4 131.43 36.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.061 1.344 . . . . 0.0 111.412 -174.876 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -83.08 -31.38 27.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.701 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.0 tp -132.36 83.3 2.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 111.121 -171.983 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -135.69 38.75 2.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.569 1.947 . . . . 0.0 110.559 172.958 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.01 -168.87 26.88 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.514 1.531 . . . . 0.0 114.163 -174.847 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 127.133 2.301 . . . . 0.0 114.222 -179.041 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -97.13 139.26 33.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.126 1.37 . . . . 0.0 110.916 172.799 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.9 pt -129.51 168.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.014 1.326 . . . . 0.0 110.548 168.475 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -117.15 150.71 38.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.356 1.062 . . . . 0.0 111.602 176.637 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.05 135.36 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.077 0.951 . . . . 0.0 109.607 171.273 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -119.26 127.72 53.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.424 1.49 . . . . 0.0 111.998 178.582 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -78.14 165.27 24.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.144 1.378 . . . . 0.0 112.884 178.138 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.1 -1.0 . . . . 0.0 111.559 167.869 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p -76.5 12.27 1.32 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.843 1.657 . . . . 0.0 114.189 172.371 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.26 1.45 57.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.357 1.456 . . . . 0.0 116.631 171.429 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.92 132.23 42.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.919 1.86 . . . . 0.0 109.174 177.066 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -116.44 129.16 56.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 110.35 -179.514 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.6 pt -127.76 151.44 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 -172.837 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.4 p -91.92 150.01 21.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.037 0.935 . . . . 0.0 111.499 173.304 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -135.83 146.56 47.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.799 1.24 . . . . 0.0 109.996 166.814 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -109.34 126.34 53.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.039 0.923 . . . . 0.0 111.825 167.142 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.66 168.27 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 110.63 -165.058 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -113.83 150.96 44.26 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 111.56 167.015 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -53.29 -23.75 24.56 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.695 2.93 . . . . 0.0 115.896 172.197 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -87.04 -0.9 57.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.0 2.12 . . . . 0.0 115.239 175.988 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.51 151.18 25.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.742 1.156 . . . . 0.0 112.588 175.515 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -92.36 158.22 16.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.866 1.666 . . . . 0.0 113.312 -175.47 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -63.34 -30.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.016 -1.053 . . . . 0.0 112.71 -179.793 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -69.99 -28.14 65.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 121.236 1.835 . . . . 0.0 113.526 173.668 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -69.24 -43.6 73.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.253 -0.904 . . . . 0.0 110.508 169.486 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.45 -45.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.468 -0.77 . . . . 0.0 111.741 172.714 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.81 -39.11 90.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.229 0.922 . . . . 0.0 112.464 176.305 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.8 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -69.57 -32.8 71.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.56 1.144 . . . . 0.0 112.241 172.278 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -66.12 -46.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 123.751 0.821 . . . . 0.0 110.141 168.524 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.68 -37.94 74.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.02 0.928 . . . . 0.0 112.351 176.974 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.06 -42.78 81.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 177.859 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -98.24 -28.96 13.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.297 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -114.51 -12.02 12.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.642 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.02 13.02 83.03 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 174.698 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -78.27 123.89 85.81 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 118.918 1.359 . . . . 0.0 109.61 -177.217 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.65 128.18 12.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.402 2.068 . . . . 0.0 112.924 -175.542 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.37 -30.32 42.74 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.457 3.438 . . . . 0.0 116.738 -179.781 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.12 -26.87 69.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.829 1.195 . . . . 0.0 112.895 174.532 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -98.91 -11.3 21.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 173.758 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.6 119.41 20.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.856 1.207 . . . . 0.0 112.563 179.106 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -111.46 118.62 36.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.949 1.7 . . . . 0.0 109.223 170.281 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.408 HD22 HD12 ' A' ' 50' ' ' LEU . 1.2 tt -110.81 124.98 53.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.114 0.965 . . . . 0.0 110.589 -171.847 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.9 mt -127.9 141.89 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.046 1.738 . . . . 0.0 110.127 -176.345 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -142.61 137.58 30.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.759 1.223 . . . . 0.0 110.306 168.531 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.44 48.75 10.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.648 1.179 . . . . 0.0 114.007 179.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.9 20.71 68.88 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 179.963 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -132.19 133.08 43.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.682 1.993 . . . . 0.0 110.539 -178.495 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.45 142.19 31.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.416 0.687 . . . . 0.0 111.083 177.936 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 43' ' ' LEU . 13.8 mt -107.0 126.18 51.98 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.919 0.887 . . . . 0.0 111.554 -170.788 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.0 141.42 28.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.664 1.185 . . . . 0.0 113.71 -175.07 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.1 -30.69 62.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.772 2.429 . . . . 0.0 115.966 -169.914 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.35 -7.35 59.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.705 1.621 . . . . 0.0 116.225 -179.53 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -83.81 158.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 110.218 174.465 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -99.5 162.5 12.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.159 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.9 -40.4 69.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.605 -0.685 . . . . 0.0 112.532 174.64 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -67.58 -27.4 66.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 174.771 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.51 -26.56 68.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.455 1.48 . . . . 0.0 112.523 171.01 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -102.03 12.89 36.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.73 1.612 . . . . 0.0 113.294 174.238 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 58.96 22.01 9.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.972 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.61 125.62 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 122.144 0.973 . . . . 0.0 110.151 -175.902 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -119.42 171.14 8.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.272 2.229 . . . . 0.0 111.446 -176.866 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -52.46 146.79 9.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.383 1.073 . . . . 0.0 113.28 -177.314 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.38 22.1 7.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.479 1.912 . . . . 0.0 115.024 174.604 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -74.16 150.1 40.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.703 1.201 . . . . 0.0 110.528 164.281 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.6 m -110.12 117.83 34.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.777 1.231 . . . . 0.0 109.935 174.8 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.08 159.87 14.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.429 1.091 . . . . 0.0 110.371 174.63 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -111.73 135.13 52.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.343 1.057 . . . . 0.0 111.029 -176.592 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -111.4 138.86 47.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.74 1.216 . . . . 0.0 109.708 175.537 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.01 146.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 125.456 1.502 . . . . 0.0 108.107 167.903 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.37 136.14 33.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 171.516 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -93.09 141.42 28.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.402 -0.811 . . . . 0.0 110.338 162.062 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.85 155.23 25.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.686 0.794 . . . . 0.0 111.71 -175.184 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -143.32 7.44 1.55 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.002 1.721 . . . . 0.0 113.687 -172.5 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 177.42 44.75 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.724 2.107 . . . . 0.0 111.778 176.333 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.461 -1.188 . . . . 0.0 113.562 -179.958 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -98.66 137.75 36.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.884 -176.433 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.26 161.66 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.467 1.107 . . . . 0.0 111.029 167.011 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.9 115.98 23.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.305 1.042 . . . . 0.0 110.616 179.344 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.5 t -105.73 106.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.646 1.178 . . . . 0.0 110.334 -175.308 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -83.04 138.54 33.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.69 1.596 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -122.94 152.92 40.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.583 1.553 . . . . 0.0 111.37 169.579 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.91 -10.64 54.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -166.363 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.7 p -75.05 -5.24 43.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.373 1.469 . . . . 0.0 114.031 169.91 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.68 90.67 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.962 1.267 . . . . 0.0 113.888 -168.057 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.67 138.65 40.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.285 1.542 . . . . 0.0 110.413 169.255 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -138.02 112.54 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.091 0.956 . . . . 0.0 110.606 -178.284 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -76.12 124.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.634 1.174 . . . . 0.0 108.792 -178.747 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.6 m -92.33 119.98 32.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.433 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 tp -129.1 133.71 47.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.271 0.628 . . . . 0.0 112.401 -166.248 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -94.43 119.75 33.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.853 1.261 . . . . 0.0 110.678 174.154 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.22 153.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.645 1.978 . . . . 0.0 111.406 -170.973 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.55 153.58 37.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 124.096 0.958 . . . . 0.0 110.776 167.752 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.97 -27.83 46.78 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.372 2.714 . . . . 0.0 114.33 167.839 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -86.47 -9.39 56.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.631 1.972 . . . . 0.0 114.608 178.373 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.08 148.56 50.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.211 1.369 . . . . 0.0 110.888 175.522 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -89.07 161.29 16.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 113.245 175.838 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.15 -36.78 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.443 -0.786 . . . . 0.0 111.707 172.916 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -59.78 -40.41 88.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.878 0.871 . . . . 0.0 112.777 171.121 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.09 -40.74 91.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.399 0.68 . . . . 0.0 112.096 175.826 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.93 -44.74 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.644 173.729 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.85 -37.73 83.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.368 0.985 . . . . 0.0 112.42 174.953 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.25 81.83 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.479 0.711 . . . . 0.0 112.164 175.393 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.27 -37.5 83.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.989 0.915 . . . . 0.0 111.961 175.437 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.99 -29.72 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.599 1.159 . . . . 0.0 112.547 174.469 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -70.91 -43.98 67.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.771 1.169 . . . . 0.0 111.403 172.419 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -64.84 -26.09 68.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 113.266 174.606 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.56 -64.66 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.989 1.315 . . . . 0.0 112.985 169.786 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -120.58 0.69 10.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -164.403 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.28 9.42 86.82 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 120.637 -1.289 . . . . 0.0 115.792 176.736 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.4 123.44 87.82 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 118.658 1.229 . . . . 0.0 109.222 -176.312 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.64 126.36 18.11 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.488 2.126 . . . . 0.0 112.668 -177.104 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -54.7 -32.81 77.5 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.612 2.875 . . . . 0.0 115.826 -176.874 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.63 -25.54 65.79 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.86 1.209 . . . . 0.0 113.244 175.594 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.94 -15.34 36.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 176.882 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -77.73 115.86 17.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.657 1.117 . . . . 0.0 111.629 -178.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -105.54 108.52 20.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 109.311 168.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -103.6 132.53 49.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.217 1.407 . . . . 0.0 110.965 -173.497 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.6 mt -129.31 139.62 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.12 1.768 . . . . 0.0 111.054 -168.994 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.527 1.131 . . . . 0.0 111.252 166.224 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.65 49.13 21.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.418 1.487 . . . . 0.0 113.504 -179.636 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -11.36 18.88 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.291 1.424 . . . . 0.0 116.419 178.68 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -100.9 140.65 34.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.811 1.806 . . . . 0.0 111.665 179.156 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.05 151.8 41.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.815 0.446 . . . . 0.0 110.854 168.894 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 mt -109.13 140.29 42.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.157 0.983 . . . . 0.0 110.928 -176.256 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -102.57 140.07 37.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 113.409 -171.756 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.44 -29.5 70.56 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.851 1.66 . . . . 0.0 113.972 -163.751 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.17 -5.6 88.87 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.794 1.664 . . . . 0.0 116.55 177.175 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.08 159.8 15.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.435 1.617 . . . . 0.0 112.946 -174.858 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -93.29 162.91 13.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.403 1.481 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.66 -36.93 82.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.224 -0.922 . . . . 0.0 112.245 171.554 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -68.57 -24.15 64.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 175.007 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -58.93 -43.66 91.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.91 1.687 . . . . 0.0 111.197 168.098 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -90.36 11.01 22.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.431 1.492 . . . . 0.0 113.793 -177.137 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 55.93 33.6 22.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.217 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -77.48 131.18 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 121.243 -0.911 . . . . 0.0 108.848 177.648 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -125.82 176.76 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 0.0 111.986 -171.23 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -43.75 135.15 4.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.052 1.741 . . . . 0.0 112.675 167.189 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.79 32.95 15.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.145 1.778 . . . . 0.0 114.316 176.703 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -70.39 142.76 52.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.554 -0.716 . . . . 0.0 111.792 170.147 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -100.8 123.94 45.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.534 1.134 . . . . 0.0 108.537 170.991 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -119.19 165.21 14.5 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.737 2.015 . . . . 0.0 110.378 178.14 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -124.43 144.2 50.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.403 1.081 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 tp -133.51 131.2 39.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.253 1.421 . . . . 0.0 110.408 -178.885 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.26 157.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.68 138.91 31.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.489 0.716 . . . . 0.0 111.636 175.946 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -71.41 144.89 49.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.147 . . . . 0.0 112.829 176.701 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.21 136.44 50.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.34 1.456 . . . . 0.0 110.293 167.174 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 55.63 30.38 15.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.943 1.697 . . . . 0.0 115.058 177.755 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.87 9.05 78.6 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.571 1.558 . . . . 0.0 116.692 -170.649 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 126.046 1.784 . . . . 0.0 111.446 -174.402 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -76.17 144.61 40.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.275 1.03 . . . . 0.0 111.161 172.915 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.42 161.31 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.007 1.323 . . . . 0.0 110.014 158.774 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -112.59 143.19 44.19 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 111.942 178.129 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.758 1.223 . . . . 0.0 109.461 172.074 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -109.0 143.28 38.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.843 1.257 . . . . 0.0 113.27 178.556 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 p -102.19 151.81 21.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.579 1.152 . . . . 0.0 111.678 167.474 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.66 -33.54 74.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.231 1.412 . . . . 0.0 110.81 169.353 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.1 p -68.75 -2.54 9.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.581 1.553 . . . . 0.0 114.613 173.382 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 15.64 27.1 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 162.729 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -99.46 144.62 28.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.396 1.598 . . . . 0.0 111.005 178.397 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -119.66 113.62 20.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.679 1.191 . . . . 0.0 110.201 172.096 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.45 129.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.596 . . . . 0.0 109.747 -176.389 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -91.09 136.9 32.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.209 1.003 . . . . 0.0 111.755 174.203 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.25 158.06 28.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.329 1.451 . . . . 0.0 111.469 172.907 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -115.93 130.01 56.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.584 1.154 . . . . 0.0 110.366 162.834 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.49 160.84 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.306 1.442 . . . . 0.0 112.564 -170.34 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -114.03 152.28 45.62 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.819 1.248 . . . . 0.0 109.385 161.213 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.19 -21.73 67.38 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.597 1.532 . . . . 0.0 116.081 -175.804 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -81.48 2.5 28.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 172.92 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.64 130.41 43.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.722 1.147 . . . . 0.0 110.878 174.035 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 p -76.91 162.47 27.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.893 0.877 . . . . 0.0 113.123 -177.947 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.22 -42.28 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 120.796 -1.19 . . . . 0.0 110.292 177.324 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -67.3 -31.01 71.02 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.911 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -72.33 -40.54 67.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.253 -0.905 . . . . 0.0 112.513 171.321 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.45 -39.9 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 119.639 1.109 . . . . 0.0 111.398 175.032 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.88 -36.33 78.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.276 0.943 . . . . 0.0 112.466 170.625 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.82 -28.47 60.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.38 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.88 -33.71 72.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.99 1.268 . . . . 0.0 111.467 169.584 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.48 -45.36 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 110.37 168.599 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.34 -43.36 74.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.763 1.165 . . . . 0.0 111.506 172.149 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.8 -27.15 68.55 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.496 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -96.68 -36.06 10.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 173.286 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -117.17 -6.79 11.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -166.742 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.44 36.37 62.92 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 120.236 1.38 . . . . 0.0 115.352 171.269 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.97 125.99 22.26 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.898 1.679 . . . . 0.0 110.176 179.446 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.61 155.33 35.56 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.382 2.055 . . . . 0.0 112.711 -172.862 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.29 -36.51 57.39 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.476 2.784 . . . . 0.0 115.223 179.044 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.61 -3.68 16.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 177.486 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.9 -3.81 21.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.192 1.397 . . . . 0.0 114.324 170.656 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -97.62 154.59 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.369 0.986 . . . . 0.0 112.855 -172.533 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -128.37 132.6 48.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.096 2.158 . . . . 0.0 108.642 156.219 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -111.83 143.44 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.399 1.079 . . . . 0.0 111.711 175.023 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.37 129.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.541 1.536 . . . . 0.0 110.613 -178.553 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -139.49 138.18 36.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.718 1.607 . . . . 0.0 110.578 171.916 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.25 45.7 9.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.181 1.393 . . . . 0.0 113.462 -178.68 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.62 -6.7 10.92 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.731 1.634 . . . . 0.0 117.092 -177.15 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.52 135.47 33.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.501 2.15 . . . . 0.0 112.311 -176.768 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -79.59 116.86 20.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.997 0.919 . . . . 0.0 108.771 168.959 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.3 133.41 33.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -164.961 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -104.75 156.5 17.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.8 1.64 . . . . 0.0 113.347 -177.623 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.05 153.14 34.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.22 1.408 . . . . 0.0 113.084 -171.641 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.92 -16.7 60.76 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.716 2.103 . . . . 0.0 115.57 178.712 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -78.44 165.42 23.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.024 1.329 . . . . 0.0 112.238 171.09 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -112.83 168.3 9.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.986 1.714 . . . . 0.0 112.313 168.798 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.69 -35.41 66.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.584 0.754 . . . . 0.0 112.622 172.338 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -68.45 -28.34 66.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.026 1.33 . . . . 0.0 113.287 175.325 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.02 -41.88 58.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.048 0.84 . . . . 0.0 111.832 176.992 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -82.88 -10.01 59.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.06 1.344 . . . . 0.0 114.426 175.898 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.259 66.0 m-80 63.87 58.77 1.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.022 2.129 . . . . 0.0 115.285 -179.697 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.8 127.72 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.876 1.67 . . . . 0.0 109.099 166.825 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -110.5 174.77 5.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.181 1.792 . . . . 0.0 113.005 175.034 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -46.73 132.89 11.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.246 1.819 . . . . 0.0 112.407 175.616 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 61.59 20.08 10.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.536 1.934 . . . . 0.0 114.9 177.184 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -63.89 148.94 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.2 -0.937 . . . . 0.0 112.455 167.159 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -104.69 128.99 52.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.435 1.094 . . . . 0.0 110.622 172.027 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.38 162.37 17.22 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 109.368 173.329 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -120.23 148.31 43.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.069 0.948 . . . . 0.0 111.402 177.747 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -126.98 131.91 50.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.469 1.908 . . . . 0.0 109.832 -174.386 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.58 139.2 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.228 1.411 . . . . 0.0 109.356 175.828 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.94 127.78 44.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.833 1.253 . . . . 0.0 110.212 -177.111 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -73.34 -25.24 60.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -165.844 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.3 mt -101.46 30.9 3.99 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.859 1.209 . . . . 0.0 113.606 -168.567 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -127.68 40.41 3.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.111 1.364 . . . . 0.0 114.211 -167.268 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.22 165.29 29.11 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.07 -1.019 . . . . 0.0 115.32 177.126 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 C-N-CA 126.444 1.973 . . . . 0.0 114.034 -176.496 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -81.92 130.87 35.21 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.878 0.871 . . . . 0.0 110.902 171.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 pt -135.27 168.43 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.458 1.503 . . . . 0.0 110.933 172.252 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.89 153.8 33.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.695 0.798 . . . . 0.0 112.713 -179.353 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.56 132.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 109.814 171.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -90.23 127.51 36.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.311 1.444 . . . . 0.0 110.718 169.549 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -89.48 175.93 7.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.05 1.34 . . . . 0.0 112.873 -179.451 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.4 -37.11 79.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.258 1.423 . . . . 0.0 113.177 -177.473 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.8 p -79.14 -0.19 30.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.703 . . . . 0.0 113.707 174.018 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.33 89.5 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.004 -1.06 . . . . 0.0 115.071 179.924 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.14 155.92 38.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.105 1.452 . . . . 0.0 110.586 169.825 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -106.38 142.1 36.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.504 1.122 . . . . 0.0 111.094 171.635 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.02 148.89 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.524 1.53 . . . . 0.0 110.844 166.641 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.8 m -96.76 136.82 36.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.896 1.278 . . . . 0.0 110.527 175.514 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.55 149.62 42.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.105 1.762 . . . . 0.0 110.843 176.101 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -123.23 107.11 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 110.07 175.68 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.46 162.86 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.096 1.759 . . . . 0.0 110.817 -176.596 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.11 148.99 39.13 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.103 168.96 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.81 -26.07 64.61 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.449 2.099 . . . . 0.0 114.542 173.31 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p -75.4 -4.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.813 2.045 . . . . 0.0 115.354 174.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.38 151.75 32.63 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.729 1.15 . . . . 0.0 112.177 173.415 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 p -82.93 164.37 20.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.292 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.1 -34.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.777 -1.202 . . . . 0.0 111.184 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.07 -36.69 77.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.186 -0.946 . . . . 0.0 112.642 173.513 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -59.76 -40.04 86.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.536 -0.728 . . . . 0.0 111.84 169.472 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.56 -43.04 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.695 0.798 . . . . 0.0 111.751 175.19 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.36 -40.58 78.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.438 1.017 . . . . 0.0 112.27 173.013 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.86 85.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.87 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -69.75 -32.7 71.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.051 0.94 . . . . 0.0 112.883 173.879 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.69 -41.98 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 110.9 171.131 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.9 -38.21 84.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.124 0.875 . . . . 0.0 111.721 176.342 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.32 -32.6 68.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -179.515 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -114.39 -19.61 11.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -179.261 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -123.73 -4.61 8.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.015 1.734 . . . . 0.0 114.708 175.831 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.4 11.02 85.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 117.983 1.953 . . . . 0.0 117.983 161.57 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.41 128.4 59.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 120.417 2.108 . . . . 0.0 110.042 177.288 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.65 141.2 78.58 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.26 1.973 . . . . 0.0 113.253 176.014 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.83 -32.05 44.95 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.375 3.384 . . . . 0.0 116.345 177.611 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.13 -24.29 65.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 174.241 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.48 -12.19 19.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 178.152 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.03 120.56 23.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.495 0.589 . . . . 0.0 111.558 175.614 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -99.65 122.03 42.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.358 1.063 . . . . 0.0 108.624 159.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.97 132.34 54.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.845 0.858 . . . . 0.0 111.724 178.703 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -124.16 142.0 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.153 1.781 . . . . 0.0 110.684 -177.097 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -139.25 138.24 36.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.238 1.415 . . . . 0.0 110.558 166.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 46.35 14.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.135 1.374 . . . . 0.0 113.553 179.567 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.36 2.92 64.36 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.854 -1.525 . . . . 0.0 116.727 178.834 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -121.49 144.7 48.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.172 1.986 . . . . 0.0 113.081 179.19 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -70.39 143.75 51.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.201 1.4 . . . . 0.0 111.641 173.491 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -106.61 139.87 40.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.612 1.565 . . . . 0.0 110.703 177.516 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -110.18 136.93 48.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.594 -165.428 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.03 -35.46 66.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.888 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.12 -4.23 89.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 -175.333 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -106.52 166.38 10.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.966 1.306 . . . . 0.0 112.173 -172.816 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -106.53 161.65 14.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.864 1.266 . . . . 0.0 112.994 -179.577 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.59 -35.31 75.79 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.408 -0.808 . . . . 0.0 112.351 175.659 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.9 m -60.04 -33.85 72.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 169.986 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.66 -23.84 66.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.762 1.165 . . . . 0.0 112.598 174.769 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -103.28 4.77 36.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.45 1.9 . . . . 0.0 114.409 177.558 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.9 t30 56.6 30.24 17.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.168 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.67 136.41 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.963 1.305 . . . . 0.0 109.286 -178.985 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.2 173.35 11.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.354 1.461 . . . . 0.0 112.474 -159.749 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.48 134.63 40.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 111.612 176.778 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 63.37 10.54 4.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.059 2.144 . . . . 0.0 116.679 -171.818 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -68.43 146.32 53.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.773 -1.829 . . . . 0.0 111.144 168.055 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -116.04 115.99 27.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 112.371 -174.201 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -83.24 156.43 23.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.659 1.184 . . . . 0.0 110.946 172.109 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -119.56 133.27 55.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.076 1.35 . . . . 0.0 109.218 172.702 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 tp -97.82 138.83 34.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.165 1.386 . . . . 0.0 110.929 175.873 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.28 144.74 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.738 1.615 . . . . 0.0 108.705 167.362 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 tp -86.83 133.61 33.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.054 0.942 . . . . 0.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -87.53 129.42 35.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.746 0.819 . . . . 0.0 111.168 168.081 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -130.94 -42.31 1.11 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.768 2.027 . . . . 0.0 110.452 177.179 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -67.18 160.52 26.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 112.478 167.422 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.51 -161.3 48.23 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.755 1.169 . . . . 0.0 114.431 -179.663 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 C-N-CA 126.78 2.133 . . . . 0.0 114.786 -173.489 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -88.5 136.88 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.479 1.111 . . . . 0.0 111.505 179.37 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -132.01 165.93 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.105 1.362 . . . . 0.0 109.506 159.456 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -119.85 145.38 46.71 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.461 1.105 . . . . 0.0 110.795 179.491 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.61 121.46 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.186 0.995 . . . . 0.0 109.502 176.863 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.9 149.69 21.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.526 1.931 . . . . 0.0 110.333 170.02 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -134.43 159.79 39.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -157.808 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.96 -20.32 66.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.802 1.241 . . . . 0.0 113.532 173.15 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -86.9 10.45 16.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.588 1.555 . . . . 0.0 113.933 168.64 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.44 17.52 80.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.046 1.308 . . . . 0.0 115.804 164.108 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 158.92 30.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.449 1.5 . . . . 0.0 112.563 178.146 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -96.02 141.14 29.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.949 0.899 . . . . 0.0 110.283 172.549 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 pt -122.29 149.37 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.471 1.508 . . . . 0.0 111.062 167.676 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 p -82.67 152.54 25.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 168.055 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.8 145.84 45.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.14 0.976 . . . . 0.0 111.092 170.287 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -107.65 113.59 26.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.133 1.373 . . . . 0.0 110.371 177.696 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.81 159.57 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.401 1.481 . . . . 0.0 112.088 -173.972 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.69 145.11 34.39 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.719 1.207 . . . . 0.0 109.614 166.697 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.72 -14.98 8.54 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.413 2.742 . . . . 0.0 116.489 173.441 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -117.4 23.39 11.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.19 2.196 . . . . 0.0 113.473 176.988 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.96 151.02 47.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.008 -1.058 . . . . 0.0 112.638 170.95 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -85.58 159.29 19.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 111.848 172.809 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.99 -33.35 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.924 171.125 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.72 -40.13 86.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.132 -0.98 . . . . 0.0 112.958 172.468 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -68.96 -42.24 76.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.346 0.659 . . . . 0.0 111.191 175.224 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -59.18 -45.92 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 118.786 0.721 . . . . 0.0 111.091 175.061 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -63.23 -39.33 94.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.959 0.904 . . . . 0.0 112.617 176.658 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.55 82.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.698 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -67.59 -38.77 84.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.741 1.216 . . . . 0.0 112.335 175.451 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -66.82 -40.05 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 111.184 172.291 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -56.88 -45.22 82.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.723 0.809 . . . . 0.0 111.45 172.576 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.64 -48.42 74.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.214 1.37 . . . . 0.0 112.544 177.43 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -78.12 -32.76 50.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -171.517 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.34 -22.69 11.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.108 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.53 24.24 59.04 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 120.297 1.408 . . . . 0.0 114.48 -175.08 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -95.98 116.64 66.34 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 117.501 -1.237 . . . . 0.0 109.114 -179.974 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -59.96 135.58 63.98 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.914 2.409 . . . . 0.0 113.325 -174.922 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -56.29 -32.54 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.216 2.611 . . . . 0.0 116.317 -171.753 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -69.81 -15.13 63.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.795 1.18 . . . . 0.0 113.824 -179.458 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -103.97 -4.18 23.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.953 1.701 . . . . 0.0 113.363 -175.348 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.53 142.37 30.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.163 -0.961 . . . . 0.0 111.803 -178.086 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 -126.34 131.94 51.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.197 1.399 . . . . 0.0 109.677 163.127 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.0 129.79 56.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.568 1.147 . . . . 0.0 112.191 177.538 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.66 136.44 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.538 1.935 . . . . 0.0 110.263 176.843 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.88 120.89 16.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.669 1.988 . . . . 0.0 109.829 -179.947 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.63 40.11 23.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.846 1.259 . . . . 0.0 114.24 -178.147 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.02 57.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.879 1.704 . . . . 0.0 116.415 -175.747 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.32 146.59 29.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.3 1.84 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -84.45 137.17 33.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.146 -0.971 . . . . 0.0 111.761 178.631 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -91.07 146.49 23.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.644 1.177 . . . . 0.0 111.067 174.483 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.69 138.78 41.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.395 1.078 . . . . 0.0 111.547 -174.143 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.21 155.65 6.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.955 1.702 . . . . 0.0 113.076 177.627 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.55 6.7 60.85 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.9 1.714 . . . . 0.0 114.373 -179.614 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -143.09 168.22 20.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.956 1.702 . . . . 0.0 112.17 -177.239 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -111.24 170.57 8.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.015 1.726 . . . . 0.0 114.385 -170.841 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -52.34 -40.66 62.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 112.853 172.427 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -65.65 -36.73 84.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.413 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -67.91 -24.72 65.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.366 -0.834 . . . . 0.0 112.801 178.784 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -102.89 1.67 34.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.269 1.428 . . . . 0.0 113.929 174.502 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.58 47.89 23.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.292 1.437 . . . . 0.0 113.639 -175.84 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -91.89 127.47 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.461 1.904 . . . . 0.0 107.951 174.424 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -121.63 166.84 13.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.171 0.988 . . . . 0.0 113.303 -170.518 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.91 123.85 3.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.672 2.389 . . . . 0.0 113.292 179.965 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 48.2 mt-10 63.88 22.44 13.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.378 1.871 . . . . 0.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.7 m -61.02 149.67 36.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.148 -0.97 . . . . 0.0 112.81 164.245 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.6 m -103.63 129.59 50.94 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.936 1.294 . . . . 0.0 111.393 169.07 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.89 162.43 14.02 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.957 2.103 . . . . 0.0 110.018 170.825 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -116.27 142.22 47.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.317 1.047 . . . . 0.0 111.267 170.705 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.7 tp -121.15 131.32 54.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.988 2.115 . . . . 0.0 110.807 -176.762 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.38 164.59 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.359 1.463 . . . . 0.0 111.64 173.074 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.11 137.55 32.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.914 1.286 . . . . 0.0 111.73 -177.405 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -82.31 80.27 8.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.747 1.619 . . . . 0.0 110.811 176.88 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.6 mt 61.14 -56.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.601 2.76 . . . . 0.0 116.187 -176.406 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -79.65 123.01 27.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.549 1.94 . . . . 0.0 111.685 -176.853 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.01 24.58 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.183 1.373 . . . . 0.0 114.299 -179.122 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.156 1.836 . . . . 0.0 112.882 -174.645 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 109 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.14 141.12 33.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.577 0.351 . . . . 0.0 111.368 171.994 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.3 pt -133.98 158.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.041 168.614 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -115.85 138.59 51.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.265 1.026 . . . . 0.0 110.758 -178.748 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.77 118.67 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.103 0.961 . . . . 0.0 108.752 176.075 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -100.24 130.54 46.37 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.87 1.668 . . . . 0.0 111.599 -177.066 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -72.78 162.5 29.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.214 0.605 . . . . 0.0 111.04 164.619 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.17 -18.82 60.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.015 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -86.62 -11.54 51.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.598 1.559 . . . . 0.0 114.855 173.583 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.84 5.08 57.67 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -179.95 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.8 136.92 43.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.056 1.428 . . . . 0.0 110.256 174.675 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.6 m -105.89 131.95 52.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.76 0.824 . . . . 0.0 112.242 -178.842 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.8 mt -106.04 121.97 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.874 1.67 . . . . 0.0 107.292 164.331 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 134.36 38.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.347 0.659 . . . . 0.0 110.001 175.519 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.17 160.47 27.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.946 1.299 . . . . 0.0 110.914 178.873 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -117.83 125.34 50.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.803 1.241 . . . . 0.0 110.022 165.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.48 167.83 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.424 1.49 . . . . 0.0 111.786 -167.68 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -112.73 154.21 44.85 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 124.555 1.142 . . . . 0.0 110.987 165.48 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 -21.82 21.53 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.635 2.89 . . . . 0.0 115.149 168.282 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.4 p -84.02 -11.01 57.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.314 2.246 . . . . 0.0 115.25 175.021 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -70.12 140.81 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.942 1.246 . . . . 0.0 111.742 179.353 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -77.66 155.51 31.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.556 1.143 . . . . 0.0 112.073 176.952 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.47 -32.37 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.665 -0.647 . . . . 0.0 111.132 173.555 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -70.41 -33.12 70.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.669 1.122 . . . . 0.0 113.167 173.348 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.4 -38.15 86.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.093 1.315 . . . . 0.0 112.147 169.594 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.93 -43.52 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.055 0.843 . . . . 0.0 111.545 171.911 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -60.62 -41.33 94.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.934 0.788 . . . . 0.0 112.872 172.804 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -38.51 86.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.569 0.748 . . . . 0.0 112.513 177.039 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.64 -37.69 87.32 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.865 0.866 . . . . 0.0 111.607 172.922 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 -45.89 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.016 0.926 . . . . 0.0 111.134 171.896 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.96 -43.31 81.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.335 0.971 . . . . 0.0 111.938 177.34 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.84 -24.37 67.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.905 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -112.34 -21.06 11.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 178.716 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -126.98 -0.25 6.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.69 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.03 -21.37 9.98 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 117.329 1.691 . . . . 0.0 117.329 167.321 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.49 120.11 70.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.298 1.549 . . . . 0.0 109.745 -175.742 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.01 153.43 52.34 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.416 2.077 . . . . 0.0 112.867 -176.368 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.89 -33.31 50.84 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 124.261 3.307 . . . . 0.0 116.816 -175.148 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -22.34 61.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.687 1.13 . . . . 0.0 113.708 177.559 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -83.84 -7.59 59.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.85 -1.156 . . . . 0.0 113.246 175.937 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.81 136.22 41.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.353 1.061 . . . . 0.0 113.308 -175.52 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -117.36 140.03 50.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.129 1.771 . . . . 0.0 109.718 158.143 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.86 130.14 50.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.639 1.576 . . . . 0.0 110.251 179.56 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.7 mt -126.9 140.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.827 1.651 . . . . 0.0 110.134 -175.541 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -142.16 133.83 26.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.471 1.108 . . . . 0.0 111.467 166.721 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 42.5 12.82 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.609 1.964 . . . . 0.0 114.989 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.69 7.59 87.91 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.505 1.526 . . . . 0.0 115.856 179.599 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -117.67 124.75 49.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.597 1.698 . . . . 0.0 111.312 177.73 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -80.18 126.21 30.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.294 0.637 . . . . 0.0 110.156 170.046 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.6 mt -86.16 132.23 34.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -160.805 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.3 130.9 35.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.892 1.277 . . . . 0.0 113.679 -173.501 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -32.51 69.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.183 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.07 -0.27 85.51 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.604 1.573 . . . . 0.0 116.136 176.425 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -106.8 176.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.184 1.492 . . . . 0.0 111.619 177.263 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -126.24 162.26 25.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.866 1.666 . . . . 0.0 112.664 -169.422 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.64 -36.87 74.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.696 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -59.76 -32.77 70.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.963 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.2 -18.81 63.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.279 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -113.75 10.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.672 1.989 . . . . 0.0 113.695 177.983 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 59.77 27.39 16.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.403 1.481 . . . . 0.0 114.791 179.707 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -75.21 128.26 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.038 -1.039 . . . . 0.0 109.277 178.987 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.06 -179.97 4.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.529 1.932 . . . . 0.0 111.154 -174.782 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -54.82 145.04 20.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.977 -1.077 . . . . 0.0 113.067 177.155 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.17 18.71 9.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 115.211 175.867 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -78.75 159.07 28.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.611 1.565 . . . . 0.0 112.109 171.314 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -120.96 135.5 55.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.503 1.521 . . . . 0.0 110.948 -178.131 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.72 159.34 22.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.797 2.039 . . . . 0.0 109.396 172.912 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -111.37 139.05 47.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.897 0.879 . . . . 0.0 112.114 176.202 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -112.29 125.84 54.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.135 1.774 . . . . 0.0 110.951 -176.24 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -124.21 137.03 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.746 1.618 . . . . 0.0 108.991 176.926 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 150.46 20.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.426 0.69 . . . . 0.0 112.182 -178.256 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -86.05 130.61 34.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 157.757 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.3 mt -91.13 28.7 1.55 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -155.843 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -135.04 157.45 46.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.981 2.112 . . . . 0.0 111.927 171.73 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.99 -144.11 3.89 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.964 1.745 . . . . 0.0 113.172 178.68 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.338 1.447 . . . . 0.0 113.403 -177.717 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -93.75 135.11 35.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.69 1.196 . . . . 0.0 111.5 170.807 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.27 152.1 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.801 1.24 . . . . 0.0 111.381 167.421 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -106.81 138.89 42.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.803 -177.545 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.78 122.35 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.431 1.892 . . . . 0.0 108.54 175.604 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -114.8 146.66 40.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 112.57 -177.103 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -111.44 161.3 16.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.006 1.322 . . . . 0.0 113.892 -179.02 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.95 -31.42 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.13 0.972 . . . . 0.0 113.037 176.856 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -96.71 25.62 5.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.509 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.33 17.78 73.05 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.799 1.48 . . . . 0.0 116.799 160.061 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -83.21 134.59 34.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.076 1.438 . . . . 0.0 109.03 169.145 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -111.97 128.76 56.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.903 0.881 . . . . 0.0 109.117 166.746 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.72 134.22 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.539 1.936 . . . . 0.0 108.017 179.892 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -113.75 120.27 40.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.886 0.874 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.9 mt -111.44 130.61 55.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.206 1.003 . . . . 0.0 111.179 -175.165 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.68 110.61 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.18 1.392 . . . . 0.0 109.756 173.724 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.16 174.0 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.631 1.972 . . . . 0.0 112.682 -168.192 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -114.65 149.53 42.46 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.727 . . . . 0.0 110.097 168.115 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.89 -6.75 18.87 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.455 2.77 . . . . 0.0 114.993 -175.778 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -86.39 -3.18 58.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.918 2.087 . . . . 0.0 114.623 171.894 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -70.38 141.14 52.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.238 -0.913 . . . . 0.0 111.276 171.284 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -84.2 160.75 20.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.826 0.85 . . . . 0.0 112.341 174.704 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.52 -31.98 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 112.345 177.559 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -70.87 -25.01 62.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.626 1.557 . . . . 0.0 113.251 172.56 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -70.73 -40.78 72.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.745 -1.222 . . . . 0.0 111.521 166.581 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.07 -45.28 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 118.626 0.648 . . . . 0.0 110.804 176.118 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -57.23 -41.36 79.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.385 0.993 . . . . 0.0 112.937 174.231 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.21 74.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 176.129 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.98 -23.19 55.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.521 1.128 . . . . 0.0 112.818 175.63 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.68 -48.58 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.511 1.524 . . . . 0.0 110.706 164.345 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -36.81 68.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.801 1.24 . . . . 0.0 111.816 176.868 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -57.09 -27.05 61.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.842 1.257 . . . . 0.0 114.273 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -99.95 -43.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.695 1.198 . . . . 0.0 112.907 177.202 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -105.85 -17.86 14.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -166.531 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.91 15.79 80.79 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.768 1.067 . . . . 0.0 115.768 -179.821 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.45 121.82 66.88 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 118.73 1.265 . . . . 0.0 109.609 -177.718 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.1 Cg_exo -61.68 141.83 92.16 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.822 2.348 . . . . 0.0 114.293 -178.742 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -51.57 -31.74 41.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.502 3.468 . . . . 0.0 116.822 -178.024 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.46 -23.22 61.02 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.15 1.341 . . . . 0.0 113.834 177.971 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -88.99 -5.97 57.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.866 1.266 . . . . 0.0 112.387 178.345 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.87 132.53 42.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.013 1.725 . . . . 0.0 111.492 175.285 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -127.99 120.45 27.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.33 1.052 . . . . 0.0 109.433 164.43 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.56 131.76 43.86 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 109.865 -174.976 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -123.33 134.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.719 1.607 . . . . 0.0 110.668 -173.007 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -123.84 120.69 33.34 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.417 1.087 . . . . 0.0 110.148 167.666 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.6 47.75 8.57 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.193 1.397 . . . . 0.0 114.319 -177.648 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 -0.78 68.26 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 117.119 1.607 . . . . 0.0 117.119 -178.601 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -103.38 133.92 47.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 120.265 2.033 . . . . 0.0 112.181 176.728 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -73.31 133.26 43.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.095 0.958 . . . . 0.0 111.924 176.976 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.56 137.31 32.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.379 1.472 . . . . 0.0 110.951 177.242 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.55 130.22 54.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.634 1.174 . . . . 0.0 113.926 -169.166 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.72 -39.69 3.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.231 3.013 . . . . 0.0 115.973 -169.855 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.74 -16.34 68.35 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -179.789 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.77 152.75 22.24 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.546 1.673 . . . . 0.0 111.911 -175.354 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -86.38 159.95 19.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.672 0.789 . . . . 0.0 112.59 179.563 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -55.44 -36.57 66.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.718 -0.614 . . . . 0.0 112.428 171.061 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -63.79 -34.8 78.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 172.858 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -65.58 -15.25 62.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.704 -1.248 . . . . 0.0 113.435 174.209 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.12 8.51 23.88 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.767 1.627 . . . . 0.0 114.241 173.246 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t30 51.25 40.28 25.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.727 1.211 . . . . 0.0 113.885 -174.84 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.51 122.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.261 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -117.21 171.66 7.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.337 1.855 . . . . 0.0 111.072 -177.029 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -46.19 139.49 4.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.691 1.196 . . . . 0.0 112.92 172.525 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 61.92 15.81 7.51 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.3 m -77.82 152.28 33.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.759 -1.838 . . . . 0.0 112.466 170.957 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 m -113.53 134.9 54.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.875 1.27 . . . . 0.0 112.265 178.829 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.78 160.05 28.17 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.024 1.329 . . . . 0.0 109.941 166.062 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -111.49 145.21 39.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.846 1.258 . . . . 0.0 110.651 -175.564 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.9 tp -107.76 114.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.562 1.145 . . . . 0.0 109.764 179.498 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -94.52 134.95 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.313 1.445 . . . . 0.0 108.444 169.0 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.17 131.15 55.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.634 0.773 . . . . 0.0 112.259 -177.157 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -122.67 64.67 0.96 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.826 1.65 . . . . 0.0 111.204 -172.937 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.46 154.22 40.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.377 1.071 . . . . 0.0 112.392 -177.591 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.02 154.14 42.32 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.723 1.609 . . . . 0.0 112.771 -178.789 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.31 161.08 26.93 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.227 2.346 . . . . 0.0 112.225 -177.565 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.373 1.463 . . . . 0.0 114.441 -174.762 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.76 151.59 48.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.214 1.37 . . . . 0.0 113.222 174.885 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -138.57 161.97 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.696 1.998 . . . . 0.0 110.191 176.417 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.25 153.46 28.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.204 1.002 . . . . 0.0 110.351 175.865 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.52 123.39 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 110.155 176.215 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -89.46 117.21 28.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.162 2.185 . . . . 0.0 110.237 176.252 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -80.63 165.5 21.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.126 1.371 . . . . 0.0 112.962 -176.894 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.27 -32.7 71.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.796 1.238 . . . . 0.0 113.618 -178.416 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -79.87 -11.86 59.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.485 1.514 . . . . 0.0 113.258 178.35 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 9.82 49.09 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.276 1.417 . . . . 0.0 115.602 176.856 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -85.04 171.0 12.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.376 1.588 . . . . 0.0 111.565 170.935 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -130.89 144.89 51.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 110.847 178.075 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.2 pt -124.03 154.75 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.066 1.746 . . . . 0.0 111.225 169.245 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -116.06 116.48 27.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.272 1.829 . . . . 0.0 109.926 -175.376 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -122.53 147.26 46.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 112.165 -172.818 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.51 144.69 25.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.637 0.775 . . . . 0.0 112.189 174.26 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -153.64 170.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.706 2.403 . . . . 0.0 109.799 -170.949 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -135.04 156.29 78.46 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 124.844 1.258 . . . . 0.0 110.611 168.034 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -53.1 -37.47 79.45 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.942 2.428 . . . . 0.0 116.068 -177.88 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.44 7.45 19.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.965 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.4 142.24 30.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.876 1.271 . . . . 0.0 112.903 -172.898 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -78.07 150.27 33.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -171.504 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.17 -30.3 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.383 174.703 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -53.83 -40.43 66.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.526 -1.359 . . . . 0.0 112.973 167.293 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -72.32 -25.84 61.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.97 0.805 . . . . 0.0 112.938 177.525 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.79 -47.61 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.066 168.185 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -65.1 -32.18 73.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.819 -1.176 . . . . 0.0 113.55 -178.727 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.08 71.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.323 -0.861 . . . . 0.0 113.028 171.133 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -74.28 -35.82 63.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.206 -0.934 . . . . 0.0 111.599 171.716 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.99 -35.95 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.055 -1.028 . . . . 0.0 111.274 169.466 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.01 -36.35 83.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.812 -1.18 . . . . 0.0 112.552 173.208 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.05 -48.23 53.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 112.537 174.349 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -71.17 -37.83 72.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.772 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -123.76 -2.83 8.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.175 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.03 -3.65 79.41 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 173.416 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.97 125.33 80.16 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 119.122 1.461 . . . . 0.0 110.418 -168.494 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.05 128.73 23.68 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 174.167 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.37 -25.72 74.32 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.114 2.543 . . . . 0.0 116.914 -174.258 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -72.33 -9.48 58.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 176.277 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.53 -9.32 14.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.83 1.252 . . . . 0.0 113.037 170.104 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.66 142.79 33.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.342 1.057 . . . . 0.0 111.479 166.862 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -133.72 155.18 50.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.086 -1.009 . . . . 0.0 110.616 154.49 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -116.17 143.16 45.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.04 1.336 . . . . 0.0 112.186 -179.509 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -124.05 138.41 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.923 1.689 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.94 130.29 27.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.062 1.345 . . . . 0.0 112.404 167.841 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.21 45.6 12.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.136 1.774 . . . . 0.0 113.11 -175.957 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.08 -7.57 15.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.088 1.804 . . . . 0.0 117.128 -177.311 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -87.49 127.93 35.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 120.214 2.007 . . . . 0.0 111.023 175.978 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -80.28 131.59 35.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.562 0.619 . . . . 0.0 110.843 168.762 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.86 125.07 31.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.419 -0.801 . . . . 0.0 111.78 -173.282 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.66 127.5 33.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.887 0.875 . . . . 0.0 109.596 159.229 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.88 -26.21 43.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -158.395 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.29 -11.36 75.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.284 0.945 . . . . 0.0 115.19 176.433 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -73.25 160.42 31.93 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.381 1.091 . . . . 0.0 111.688 173.15 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -92.42 163.34 13.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.25 1.42 . . . . 0.0 113.149 172.833 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.25 -41.59 60.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.703 0.801 . . . . 0.0 112.258 172.197 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.6 p -73.91 -22.48 59.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.811 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -66.84 -17.37 64.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.804 1.638 . . . . 0.0 112.878 169.926 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.01 3.15 38.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.878 1.671 . . . . 0.0 113.314 169.892 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 48.88 44.8 22.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.998 1.719 . . . . 0.0 113.285 178.699 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.5 92.68 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 108.388 179.833 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -83.38 166.23 18.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.684 1.594 . . . . 0.0 111.548 177.186 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 58.14 -114.53 0.78 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.801 1.641 . . . . 0.0 113.481 169.864 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -137.83 143.12 40.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.052 1.341 . . . . 0.0 111.743 177.141 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -150.18 161.84 41.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.721 1.608 . . . . 0.0 111.842 -178.584 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 t -107.69 140.65 40.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.36 1.064 . . . . 0.0 111.09 164.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.33 140.42 40.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.903 1.681 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -92.79 123.14 35.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.604 -0.685 . . . . 0.0 110.489 178.445 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.46 120.92 29.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.739 1.216 . . . . 0.0 109.414 176.732 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.81 151.83 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 110.74 171.62 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -118.68 137.89 53.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.431 1.092 . . . . 0.0 110.637 -169.478 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.67 82.79 1.92 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.815 1.646 . . . . 0.0 109.064 -177.532 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.29 -6.13 44.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -169.893 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -114.82 101.52 9.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.706 1.602 . . . . 0.0 112.098 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 153.0 52.11 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.807 -0.558 . . . . 0.0 112.336 165.326 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 125.751 1.644 . . . . 0.0 114.16 178.537 . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -85.29 134.12 34.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.318 1.047 . . . . 0.0 111.165 168.536 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -131.63 166.17 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 124.468 1.107 . . . . 0.0 110.909 166.128 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.68 156.96 28.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 110.803 167.416 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.9 t -132.67 131.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.625 1.17 . . . . 0.0 109.266 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -105.5 122.06 45.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.471 1.508 . . . . 0.0 110.702 170.689 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -68.59 177.72 2.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.361 1.065 . . . . 0.0 112.845 177.039 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -55.39 -27.28 46.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 170.828 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -97.71 11.55 36.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.244 1.418 . . . . 0.0 113.232 175.674 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.35 6.83 71.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.801 1.191 . . . . 0.0 115.574 176.959 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -65.56 129.14 38.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.469 1.635 . . . . 0.0 109.881 177.576 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -100.11 119.19 37.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.647 0.737 . . . . 0.0 111.452 -170.474 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.78 143.25 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.966 2.106 . . . . 0.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -112.63 130.07 56.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.549 1.54 . . . . 0.0 110.446 177.527 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.84 155.57 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.841 1.256 . . . . 0.0 112.791 -179.542 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -106.07 126.4 52.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.617 1.567 . . . . 0.0 109.023 163.599 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.29 149.2 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 111.257 -177.138 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.5 145.22 29.27 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.239 175.731 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -61.97 -28.94 81.27 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.2 1.933 . . . . 0.0 116.893 -171.287 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 m -100.93 9.58 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.018 1.327 . . . . 0.0 114.062 176.066 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -79.17 156.63 28.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 169.39 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -83.22 156.04 23.37 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.288 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.71 -29.99 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 121.342 -0.849 . . . . 0.0 110.999 169.142 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.13 -45.12 52.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.983 164.03 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 175.447 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.07 -44.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 120.223 1.374 . . . . 0.0 110.627 169.195 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -60.58 -36.15 77.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.564 1.075 . . . . 0.0 112.502 173.497 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.99 82.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 172.909 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -73.32 -31.86 64.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.892 0.877 . . . . 0.0 113.109 173.263 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.9 -39.29 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.341 -0.85 . . . . 0.0 110.681 169.947 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.69 -37.47 87.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.115 0.87 . . . . 0.0 111.973 170.781 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.53 -46.43 89.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.764 1.166 . . . . 0.0 112.812 173.801 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -72.71 -41.34 65.37 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.931 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.25 -6.64 4.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -167.353 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.41 73.21 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.726 1.148 . . . . 0.0 115.457 -179.373 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.12 125.19 91.94 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 0.0 108.608 -179.653 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.46 142.28 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.405 2.07 . . . . 0.0 113.293 -177.423 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.62 -25.22 74.04 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.311 2.674 . . . . 0.0 115.153 176.632 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -82.33 -7.66 59.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.34 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -106.64 13.73 27.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.877 1.671 . . . . 0.0 113.393 -177.679 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -142.91 138.93 30.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.159 -0.963 . . . . 0.0 113.128 -172.87 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -131.45 130.39 42.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.552 1.541 . . . . 0.0 109.157 169.744 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -91.33 132.58 36.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.033 0.933 . . . . 0.0 111.935 -173.231 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -121.97 133.42 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.752 2.021 . . . . 0.0 110.379 -175.675 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -158.5 143.59 16.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 112.724 176.88 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.53 50.95 10.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.237 1.815 . . . . 0.0 114.267 172.628 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.61 3.44 78.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.904 1.24 . . . . 0.0 115.53 178.112 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -130.0 154.94 46.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.939 1.696 . . . . 0.0 112.109 -170.118 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -97.08 130.76 44.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.8 1.24 . . . . 0.0 109.819 169.303 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.73 146.3 31.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.99 0.916 . . . . 0.0 110.843 174.057 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.11 178.86 4.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.135 169.628 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -87.27 -44.2 11.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.24 -1.537 . . . . 0.0 113.675 -174.144 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 22.38 3.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.239 1.4 . . . . 0.0 116.298 -172.906 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -129.4 171.63 12.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.969 1.707 . . . . 0.0 111.463 -179.122 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.4 p -106.81 167.75 9.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.737 1.215 . . . . 0.0 114.077 -174.372 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.0 -47.26 71.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.63 0.772 . . . . 0.0 112.171 175.098 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.9 p -77.05 -23.26 52.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.257 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.79 -28.56 64.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.503 1.501 . . . . 0.0 112.696 169.701 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -102.08 17.15 23.98 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.543 1.537 . . . . 0.0 114.28 178.334 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.18 26.41 15.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 172.004 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.83 128.43 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.338 1.055 . . . . 0.0 111.003 -174.34 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -91.16 157.37 17.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.664 1.186 . . . . 0.0 112.412 171.744 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -58.28 149.58 24.02 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.66 174.714 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.25 14.85 7.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.835 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -69.91 147.45 50.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.954 -1.091 . . . . 0.0 112.086 168.743 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.8 m -107.19 126.77 52.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.693 173.791 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.71 149.91 20.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.341 1.456 . . . . 0.0 110.093 172.498 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -116.32 153.4 32.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 112.733 178.083 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 mt -106.34 140.44 39.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.152 1.381 . . . . 0.0 109.453 159.774 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.55 144.47 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.419 1.088 . . . . 0.0 112.681 -175.513 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.12 -37.4 83.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.032 1.333 . . . . 0.0 114.055 -170.942 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -62.75 -18.65 62.95 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.788 1.235 . . . . 0.0 113.18 177.487 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -131.9 60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.58 2.352 . . . . 0.0 110.387 179.43 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -77.84 54.46 1.27 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 112.365 -177.467 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.28 -147.55 44.35 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.094 1.33 . . . . 0.0 113.633 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.819 1.676 . . . . 0.0 112.82 -174.783 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -80.8 137.71 36.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.293 1.037 . . . . 0.0 112.187 177.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.97 165.2 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.251 1.42 . . . . 0.0 111.33 169.277 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -112.21 142.33 44.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.137 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.79 130.7 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.158 1.383 . . . . 0.0 108.737 167.08 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -125.27 138.25 54.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.083 1.353 . . . . 0.0 112.656 -173.681 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -98.35 173.07 7.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.593 1.157 . . . . 0.0 113.258 -173.284 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.34 -16.62 64.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 176.075 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -88.82 1.6 55.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.466 1.106 . . . . 0.0 112.937 171.192 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.77 4.9 88.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.13 1.347 . . . . 0.0 114.721 -177.072 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.47 129.39 39.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.248 1.524 . . . . 0.0 109.492 175.348 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 m -104.48 136.71 43.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.381 177.252 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.98 131.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.178 1.791 . . . . 0.0 108.075 176.742 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -89.82 140.3 29.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.029 0.931 . . . . 0.0 110.1 173.025 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 mt -128.95 169.57 14.49 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.423 1.489 . . . . 0.0 110.338 163.297 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -131.22 140.72 49.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 163.228 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.06 170.73 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.215 2.206 . . . . 0.0 110.122 177.977 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -89.74 158.68 44.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 111.951 170.709 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.29 -20.36 31.75 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.056 2.504 . . . . 0.0 115.277 169.488 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -93.56 -3.05 53.46 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.75 1.62 . . . . 0.0 115.156 176.047 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.21 154.9 41.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.725 -1.235 . . . . 0.0 111.661 170.504 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -91.31 162.25 14.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.086 0.955 . . . . 0.0 112.437 175.57 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -63.94 -29.11 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 121.317 -0.864 . . . . 0.0 111.661 173.466 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.38 -41.57 85.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.695 -1.253 . . . . 0.0 113.022 167.466 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -65.07 -30.06 70.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.183 0.901 . . . . 0.0 111.946 174.362 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.8 -45.76 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 119.515 1.052 . . . . 0.0 111.104 172.046 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.11 -40.6 85.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.139 0.881 . . . . 0.0 112.527 175.759 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -30.04 71.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.973 0.909 . . . . 0.0 113.429 177.039 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -80.19 -35.73 35.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.157 0.983 . . . . 0.0 113.154 173.998 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mm -59.13 -39.52 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.207 0.912 . . . . 0.0 110.646 167.595 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.25 -44.33 97.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.221 0.919 . . . . 0.0 111.986 171.298 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.76 -33.42 75.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.17 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 18.3 ptpt -99.66 -45.26 5.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 173.113 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -91.82 -14.58 29.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.817 1.644 . . . . 0.0 114.653 -176.251 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.23 85.59 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 179.05 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -85.68 122.26 73.19 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.958 1.379 . . . . 0.0 109.443 -176.268 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.84 136.71 67.87 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.327 2.018 . . . . 0.0 112.921 177.115 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -49.63 -35.92 39.29 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.408 3.405 . . . . 0.0 114.707 176.674 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.97 -32.11 65.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.503 1.521 . . . . 0.0 114.106 174.464 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -90.63 -12.55 36.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.751 1.22 . . . . 0.0 113.065 -178.547 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.71 129.08 35.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.103 0.961 . . . . 0.0 111.013 -177.901 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -115.75 117.47 30.35 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.969 1.308 . . . . 0.0 109.32 165.211 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -103.61 125.77 50.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.832 1.253 . . . . 0.0 111.955 -178.169 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.28 135.01 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.126 1.771 . . . . 0.0 109.637 -173.056 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -132.29 128.06 36.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.43 1.092 . . . . 0.0 110.66 174.261 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.74 33.58 6.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.021 1.328 . . . . 0.0 114.284 -171.101 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 18.6 75.58 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -176.594 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -114.59 135.39 54.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 111.613 168.805 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.25 129.29 34.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.644 0.778 . . . . 0.0 111.202 178.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.3 154.31 20.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.879 0.871 . . . . 0.0 112.294 -175.96 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.0 177.94 8.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.706 0.802 . . . . 0.0 111.811 170.622 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -92.09 -52.3 4.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.019 -1.05 . . . . 0.0 112.929 -177.633 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.54 33.08 4.25 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.515 1.531 . . . . 0.0 115.367 -170.589 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -129.31 152.73 48.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.274 1.537 . . . . 0.0 110.917 179.34 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 p -87.02 163.25 17.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -168.693 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.05 -36.19 74.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 168.438 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -64.18 -40.39 96.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.091 0.956 . . . . 0.0 112.685 173.743 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -64.2 -22.94 67.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 177.511 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.4 3.72 29.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.152 1.781 . . . . 0.0 115.203 176.339 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 53.62 49.28 19.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.054 1.297 . . . . 0.0 113.853 -177.12 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.8 mt -93.34 127.6 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.034 1.334 . . . . 0.0 109.183 176.591 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -124.43 166.73 15.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.774 1.63 . . . . 0.0 112.492 -176.497 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -51.35 131.33 28.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.274 1.83 . . . . 0.0 112.739 -179.03 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 63.1 15.85 8.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.489 2.316 . . . . 0.0 116.066 -178.552 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -72.97 158.61 35.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.51 -0.744 . . . . 0.0 110.929 162.901 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -122.62 134.64 54.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 -171.9 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.38 153.15 26.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.623 1.569 . . . . 0.0 110.213 170.08 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -97.23 142.32 29.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.225 0.61 . . . . 0.0 110.47 171.202 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.12 124.39 52.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.199 1.4 . . . . 0.0 109.534 172.534 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.39 154.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.658 1.183 . . . . 0.0 110.544 169.572 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.3 mt -118.94 174.41 6.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.449 1.5 . . . . 0.0 111.85 -171.25 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.8 mtt-85 -96.99 141.17 30.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.888 1.275 . . . . 0.0 111.191 -179.062 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.6 mt -133.52 -17.07 2.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.03 1.332 . . . . 0.0 113.91 -165.687 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.27 146.76 49.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.938 1.695 . . . . 0.0 110.952 -172.201 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.93 22.11 61.99 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.848 0.737 . . . . 0.0 114.493 -173.712 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 C-N-CA 127.362 2.411 . . . . 0.0 110.099 -164.146 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -85.12 138.55 32.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 112.042 -175.915 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.5 pt -137.2 165.93 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.201 1.4 . . . . 0.0 111.17 165.85 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -122.28 148.84 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.893 1.277 . . . . 0.0 111.872 175.866 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.99 123.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.978 1.311 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 66' ' ' THR . 56.6 mtmt -103.0 127.1 50.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.403 1.481 . . . . 0.0 110.861 176.705 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -109.05 134.69 51.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.409 1.484 . . . . 0.0 109.658 -179.021 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.58 -1.63 16.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -171.79 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -68.76 -5.2 19.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 114.064 161.732 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.73 32.33 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.636 1.589 . . . . 0.0 114.259 -175.239 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -122.22 127.29 49.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.248 1.419 . . . . 0.0 112.351 -173.376 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -107.56 144.21 34.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.274 1.43 . . . . 0.0 110.747 178.24 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mt -130.84 128.22 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.12 1.768 . . . . 0.0 108.562 -179.948 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.6 m -90.26 137.26 32.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.302 164.838 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.13 150.24 50.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 111.853 177.054 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.09 130.74 44.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.647 1.179 . . . . 0.0 110.404 161.31 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.47 -179.98 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.702 2.401 . . . . 0.0 109.955 -177.932 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.11 160.16 69.78 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.245 -0.91 . . . . 0.0 111.271 166.464 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.05 -25.28 36.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.004 2.469 . . . . 0.0 115.889 178.159 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -98.4 9.9 42.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 113.885 177.414 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.41 145.18 41.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.139 0.976 . . . . 0.0 111.137 177.784 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -89.04 153.08 21.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 112.725 -176.361 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.8 -39.26 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.467 -0.771 . . . . 0.0 111.748 176.112 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.08 -38.92 93.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.751 173.63 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -70.82 -33.58 70.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.734 1.152 . . . . 0.0 112.732 176.991 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.68 -44.55 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 120.961 -1.087 . . . . 0.0 111.307 169.388 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -63.1 -34.62 77.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.352 -0.842 . . . . 0.0 112.486 173.998 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.69 78.3 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.401 1.081 . . . . 0.0 112.779 176.392 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.81 -43.49 98.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.06 0.944 . . . . 0.0 110.905 171.311 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.62 -39.02 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.027 0.931 . . . . 0.0 111.465 175.108 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -68.04 -48.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.245 0.93 . . . . 0.0 112.959 175.278 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.5 -36.14 82.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.9 1.227 . . . . 0.0 112.37 -179.239 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -77.73 -45.29 25.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.91 1.284 . . . . 0.0 113.786 179.736 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -133.13 6.23 3.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -170.553 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.9 8.18 87.75 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 162.557 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -82.94 122.24 77.83 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 119.958 1.879 . . . . 0.0 109.464 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -63.61 128.49 22.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.682 2.254 . . . . 0.0 113.576 -176.625 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -57.29 -22.09 47.35 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.14 3.226 . . . . 0.0 116.905 -178.776 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.58 -21.5 52.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.061 1.3 . . . . 0.0 113.141 172.174 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.2 -31.63 23.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.9 1.28 . . . . 0.0 112.115 172.831 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.02 143.13 55.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 113.044 177.719 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -137.59 143.45 41.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.625 1.57 . . . . 0.0 109.909 154.159 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.71 136.54 50.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.543 1.137 . . . . 0.0 111.262 -176.182 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.62 133.24 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 126.33 1.852 . . . . 0.0 110.903 -179.558 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -130.4 118.7 21.6 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 111.009 172.412 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.35 50.62 9.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.909 1.684 . . . . 0.0 113.142 -173.524 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.32 -10.3 22.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.909 1.719 . . . . 0.0 116.752 -178.566 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -96.87 127.6 43.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.815 1.808 . . . . 0.0 111.368 -178.369 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.76 129.17 34.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 110.851 177.752 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.19 150.94 23.03 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.873 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -101.71 139.62 37.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.571 1.548 . . . . 0.0 112.321 -178.581 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.53 -31.92 69.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -162.712 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.6 74.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 -176.014 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -92.22 165.46 13.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.202 1.001 . . . . 0.0 113.145 -169.215 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.4 p -103.61 157.67 16.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.85 1.66 . . . . 0.0 113.322 -173.54 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.43 -41.93 90.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.077 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 p -69.83 -31.87 69.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.103 0.961 . . . . 0.0 113.138 175.429 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.68 -8.28 46.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.119 1.367 . . . . 0.0 113.585 172.755 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -114.91 4.93 14.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.724 2.01 . . . . 0.0 114.532 165.922 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 55.23 42.99 29.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.653 . . . . 0.0 114.597 -177.94 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.67 138.91 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.14 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -126.51 164.83 20.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.542 1.537 . . . . 0.0 111.873 -177.3 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -60.28 138.19 57.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.242 -0.912 . . . . 0.0 112.309 179.459 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 64.31 28.63 13.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.469 1.907 . . . . 0.0 115.021 -170.594 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -75.14 147.24 40.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.425 -1.422 . . . . 0.0 112.365 166.459 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HE2' ' A' ' 6' ' ' LYS . 13.5 m -110.22 132.32 54.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.769 1.228 . . . . 0.0 110.534 169.715 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -112.4 158.67 19.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.474 1.51 . . . . 0.0 110.547 172.221 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -101.69 139.33 37.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.622 0.769 . . . . 0.0 109.766 169.069 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.12 110.8 22.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.785 1.634 . . . . 0.0 109.24 174.628 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -106.09 150.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.509 1.124 . . . . 0.0 110.512 176.604 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.2 mt -98.87 136.57 38.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.531 0.732 . . . . 0.0 110.218 174.819 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -127.09 69.15 1.27 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -176.303 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.88 152.02 35.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.98 1.312 . . . . 0.0 114.325 -166.573 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -118.23 -41.04 2.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.268 2.227 . . . . 0.0 112.764 176.219 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.16 -179.95 25.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.283 1.897 . . . . 0.0 114.011 179.741 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.757 1.646 . . . . 0.0 113.723 -177.096 . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -105.23 140.27 38.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.465 0.706 . . . . 0.0 110.768 -175.145 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -131.91 160.55 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.093 1.357 . . . . 0.0 110.211 172.741 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -115.1 145.42 42.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.476 1.111 . . . . 0.0 110.918 176.641 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.56 115.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.818 0.847 . . . . 0.0 109.849 173.434 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.2 136.66 33.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.921 1.288 . . . . 0.0 111.073 177.73 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 p -95.63 165.43 12.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 112.369 175.89 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.0 mt -76.41 1.8 15.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.148 1.379 . . . . 0.0 113.49 165.938 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -116.29 29.18 8.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.474 2.71 . . . . 0.0 111.833 179.613 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 0.59 50.86 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 169.412 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -91.34 146.76 23.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.348 1.574 . . . . 0.0 110.906 -177.941 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.4 m -124.17 122.04 36.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 168.933 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.85 139.45 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.287 1.835 . . . . 0.0 109.946 177.856 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.8 m -103.44 133.52 48.36 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 170.087 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.3 mt -129.61 133.92 47.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.604 1.161 . . . . 0.0 112.09 179.641 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -99.72 104.1 15.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.825 1.65 . . . . 0.0 110.71 175.799 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.35 168.79 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.756 2.422 . . . . 0.0 112.656 -166.749 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -103.22 159.22 29.98 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 121.227 -0.921 . . . . 0.0 110.856 161.734 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.93 -23.89 62.08 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.177 1.918 . . . . 0.0 113.826 173.207 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -83.73 1.46 42.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.827 2.451 . . . . 0.0 115.137 178.246 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 132.64 46.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 120.701 1.591 . . . . 0.0 110.631 169.798 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -76.87 162.82 27.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.519 -0.738 . . . . 0.0 111.88 177.324 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.25 -37.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 121.544 -0.723 . . . . 0.0 110.374 172.476 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -70.31 -31.94 69.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 176.807 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -59.84 -45.72 91.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.341 0.973 . . . . 0.0 111.537 169.792 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.2 -41.22 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.666 0.666 . . . . 0.0 110.949 178.512 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.25 -44.96 95.37 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.292 0.951 . . . . 0.0 113.091 175.085 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.75 69.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.905 0.882 . . . . 0.0 113.311 177.032 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -74.87 -32.43 61.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.052 1.341 . . . . 0.0 112.326 173.418 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.93 -39.15 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.139 . . . . 0.0 110.706 168.456 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -57.8 -51.82 67.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.976 1.262 . . . . 0.0 111.772 173.076 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.05 -30.97 71.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.305 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -89.31 -47.02 8.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.903 1.281 . . . . 0.0 114.22 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -117.26 -12.98 10.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.795 1.638 . . . . 0.0 114.14 -166.516 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 31.94 24.0 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.279 1.272 . . . . 0.0 116.279 171.682 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.16 117.5 51.5 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 109.295 177.7 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 143.94 99.49 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.52 2.146 . . . . 0.0 113.955 178.425 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.72 -30.95 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.151 2.567 . . . . 0.0 113.423 -172.276 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.02 -12.79 61.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.41 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -105.72 10.96 32.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.574 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.6 122.27 43.54 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.414 1.461 . . . . 0.0 111.985 177.936 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 mtt-85 -93.53 126.11 38.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 108.127 158.746 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -106.98 133.39 51.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.722 0.809 . . . . 0.0 110.531 170.67 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.43 138.2 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.977 1.711 . . . . 0.0 110.358 -173.436 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -143.56 143.22 31.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.607 1.163 . . . . 0.0 110.813 166.09 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.94 45.15 18.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.847 1.259 . . . . 0.0 113.644 179.805 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.13 5.9 63.33 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 117.517 -1.713 . . . . 0.0 116.976 178.344 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.07 148.09 47.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.618 2.209 . . . . 0.0 112.222 179.122 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -74.69 144.89 43.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.789 0.836 . . . . 0.0 110.629 171.766 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -105.52 146.25 29.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.441 1.096 . . . . 0.0 111.534 -176.377 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.51 136.36 41.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.183 1.393 . . . . 0.0 112.986 -174.032 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.27 -29.28 70.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.117 2.167 . . . . 0.0 114.377 -170.895 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.66 6.81 44.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.778 1.18 . . . . 0.0 115.867 176.301 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -122.45 168.16 12.45 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.389 1.876 . . . . 0.0 111.998 -173.815 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -118.06 164.69 14.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.596 1.958 . . . . 0.0 112.936 -175.985 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.52 -41.32 80.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.456 -0.778 . . . . 0.0 111.98 173.692 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.1 p -60.53 -33.94 73.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.802 1.241 . . . . 0.0 113.733 175.074 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.01 -25.57 59.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.998 0.919 . . . . 0.0 113.383 -179.422 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -90.97 -4.84 56.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.818 1.247 . . . . 0.0 113.638 165.461 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 53.05 46.13 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.809 2.044 . . . . 0.0 113.436 -172.986 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.3 126.37 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.78 1.632 . . . . 0.0 108.1 174.182 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.04 175.61 5.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.886 1.274 . . . . 0.0 112.152 -169.269 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -44.56 149.23 0.41 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.541 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.3 17.09 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.419 2.288 . . . . 0.0 115.411 176.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -79.99 149.01 30.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.066 1.346 . . . . 0.0 112.653 176.198 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -109.62 121.72 45.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.416 177.652 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.52 163.38 12.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.433 1.893 . . . . 0.0 109.586 174.063 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.03 130.59 53.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.73 0.812 . . . . 0.0 110.752 -176.984 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.04 135.33 37.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.834 1.254 . . . . 0.0 110.147 173.606 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.39 127.6 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.196 1.398 . . . . 0.0 108.536 169.927 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.92 126.14 30.36 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.792 -1.193 . . . . 0.0 111.058 176.844 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -64.08 -26.03 68.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.805 2.042 . . . . 0.0 113.269 -178.775 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.41 4.48 17.94 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.228 1.411 . . . . 0.0 113.935 176.378 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.28 166.61 23.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.663 1.985 . . . . 0.0 109.764 176.25 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.96 31.33 69.73 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.331 -0.856 . . . . 0.0 114.989 178.858 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.574 1.559 . . . . 0.0 113.081 179.081 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.2 0.048 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -89.51 131.69 35.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.641 1.176 . . . . 0.0 110.828 171.73 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.13 143.32 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.033 0.933 . . . . 0.0 112.821 166.888 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.96 156.42 17.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.965 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -131.04 134.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.085 1.354 . . . . 0.0 109.659 167.687 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -84.69 117.89 24.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.753 1.221 . . . . 0.0 110.048 164.745 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.4 p -76.58 173.89 11.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.036 1.335 . . . . 0.0 112.666 179.445 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.01 -20.68 66.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.859 -1.151 . . . . 0.0 113.443 179.295 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.4 p -102.47 16.64 25.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.971 1.708 . . . . 0.0 113.792 169.751 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.84 2.91 87.11 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.474 1.511 . . . . 0.0 116.361 169.676 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.74 146.01 51.82 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.943 1.371 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -94.45 98.12 10.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.038 0.935 . . . . 0.0 110.604 177.739 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.6 pt -89.49 158.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 169.327 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -121.7 140.89 51.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.574 0.75 . . . . 0.0 112.005 176.023 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.41 142.61 40.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.984 1.314 . . . . 0.0 110.624 171.961 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.16 115.92 31.62 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.773 168.501 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.7 m -149.37 168.82 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.676 1.59 . . . . 0.0 112.032 -169.513 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -103.83 154.56 37.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.64 1.576 . . . . 0.0 111.204 166.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -55.2 -23.74 38.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.543 2.162 . . . . 0.0 114.584 169.356 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -82.55 -5.97 59.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.961 1.704 . . . . 0.0 115.036 175.803 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.72 144.3 55.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.911 1.232 . . . . 0.0 112.261 175.897 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.4 p -78.83 159.82 27.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.375 0.67 . . . . 0.0 111.615 178.873 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.56 -25.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.354 -0.841 . . . . 0.0 111.328 168.815 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -73.1 -39.75 65.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 120.713 -1.242 . . . . 0.0 112.444 175.138 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -61.49 -41.99 98.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.045 171.916 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.78 -49.6 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.895 1.278 . . . . 0.0 111.249 175.082 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -59.81 -39.32 84.61 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.368 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.3 -37.97 86.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.54 0.609 . . . . 0.0 112.549 176.616 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.354 -0.841 . . . . 0.0 113.2 174.681 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.63 -41.02 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.135 0.88 . . . . 0.0 110.843 168.089 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -58.13 -36.46 72.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.898 0.772 . . . . 0.0 112.495 178.071 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.17 -40.23 95.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.616 1.098 . . . . 0.0 113.117 175.799 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.98 -21.85 22.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -175.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.9 -9.07 3.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.272 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.51 4.81 66.14 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 120.39 -1.444 . . . . 0.0 116.313 173.014 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 tt -83.16 124.4 76.33 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.107 1.363 . . . . 0.0 111.543 -178.855 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.36 139.12 80.94 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.914 2.41 . . . . 0.0 113.672 -178.307 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -50.34 -35.6 44.8 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.422 3.415 . . . . 0.0 116.095 -179.449 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -20.56 63.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.711 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -88.03 -17.97 30.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 112.946 175.097 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.46 125.66 30.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.683 0.793 . . . . 0.0 110.765 -178.679 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -116.27 115.45 25.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.129 1.371 . . . . 0.0 107.657 166.212 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.77 135.21 47.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.463 1.105 . . . . 0.0 111.56 -171.748 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.46 138.77 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.517 1.527 . . . . 0.0 110.741 -174.612 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -134.96 125.67 27.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 110.606 168.895 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.85 45.84 11.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.66 1.184 . . . . 0.0 113.559 -179.044 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -16.02 7.56 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.173 1.844 . . . . 0.0 116.381 -175.812 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -85.76 134.32 33.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.562 1.681 . . . . 0.0 111.562 -175.842 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -75.77 131.86 40.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.138 0.975 . . . . 0.0 111.184 174.291 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.32 115.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.563 1.145 . . . . 0.0 110.936 -178.588 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.05 138.13 31.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.722 0.809 . . . . 0.0 113.116 -173.854 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.29 121.64 13.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.929 174.836 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.09 -13.25 49.0 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.374 1.464 . . . . 0.0 115.22 -175.584 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -81.05 171.01 15.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.065 1.933 . . . . 0.0 111.118 164.857 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -111.97 163.0 14.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.683 1.593 . . . . 0.0 112.723 174.056 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.7 -38.06 71.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.585 0.754 . . . . 0.0 112.845 173.921 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -63.67 -29.17 70.44 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 177.114 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.05 -20.16 65.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.832 1.196 . . . . 0.0 113.062 -177.52 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.28 7.59 25.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 113.134 174.755 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.56 42.57 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 113.93 -175.391 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.11 99.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.377 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -89.33 171.0 10.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.139 1.376 . . . . 0.0 112.177 -179.334 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -41.9 135.84 2.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.999 1.719 . . . . 0.0 112.842 168.32 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 49.2 mt-10 60.88 22.3 12.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.26 2.224 . . . . 0.0 115.579 -179.408 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -64.54 159.18 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.148 -0.97 . . . . 0.0 112.33 162.835 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -116.37 128.84 55.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.727 1.211 . . . . 0.0 111.152 168.503 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.77 158.58 15.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.069 1.748 . . . . 0.0 110.458 168.415 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -113.66 139.57 48.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.22 167.35 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.3 tp -97.91 131.22 44.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.719 1.207 . . . . 0.0 109.787 167.614 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.32 177.2 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 126.7 2.0 . . . . 0.0 109.706 167.818 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.77 150.7 24.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.743 -1.223 . . . . 0.0 113.601 -176.596 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.31 131.05 48.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.777 1.631 . . . . 0.0 110.96 168.292 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.5 116.4 30.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.663 0.785 . . . . 0.0 111.246 179.323 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -160.46 155.81 25.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.406 1.482 . . . . 0.0 113.101 -174.992 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.51 150.47 50.8 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.104 0.859 . . . . 0.0 114.556 -172.834 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.99 -1.45 . . . . 0.0 111.12 -178.959 . . . . . . . . 0 0 . 1 . 117 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -93.06 145.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.216 0.916 . . . . 0.0 112.756 178.668 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.11 166.37 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.798 1.639 . . . . 0.0 109.703 166.953 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -123.7 148.54 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.936 . . . . 0.0 111.277 -179.094 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.82 131.13 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.851 0.86 . . . . 0.0 110.017 175.558 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -122.08 139.26 53.93 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.988 2.115 . . . . 0.0 112.139 -171.69 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 p -107.16 156.68 18.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.023 1.329 . . . . 0.0 113.22 173.746 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.3 -33.84 75.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.304 1.042 . . . . 0.0 113.18 178.402 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -89.11 5.13 45.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.463 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.37 24.36 10.31 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 159.764 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -86.44 134.98 33.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.654 1.227 . . . . 0.0 108.724 163.622 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m -125.38 136.23 53.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.709 1.203 . . . . 0.0 109.286 169.89 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.23 149.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.994 1.318 . . . . 0.0 111.677 179.721 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.359 1.063 . . . . 0.0 110.69 174.167 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.33 147.96 52.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.154 0.981 . . . . 0.0 111.577 169.85 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -105.21 123.68 48.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.11 1.364 . . . . 0.0 109.519 175.592 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.97 162.43 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.911 1.685 . . . . 0.0 112.458 -163.705 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -113.4 143.17 28.82 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 127.886 2.474 . . . . 0.0 110.105 174.574 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.64 -32.1 82.11 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.383 2.055 . . . . 0.0 115.613 -175.041 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 p -79.96 -2.39 43.74 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.273 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.78 140.23 58.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.66 1.573 . . . . 0.0 111.579 177.883 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -83.21 151.47 25.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.161 0.984 . . . . 0.0 112.892 176.869 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.58 -37.34 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 111.216 -179.664 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.47 -31.68 72.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 176.158 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -68.97 -43.6 74.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.589 -0.694 . . . . 0.0 110.365 174.844 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.51 -35.62 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.591 176.912 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.54 -39.9 92.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.832 1.651 . . . . 0.0 112.775 171.664 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.42 64.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 174.266 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -77.04 -34.27 57.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.4 -0.813 . . . . 0.0 112.147 170.345 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.8 -35.35 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.224 1.01 . . . . 0.0 110.821 168.982 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -63.53 -33.94 76.69 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.22 -0.925 . . . . 0.0 112.548 171.735 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.47 -35.76 60.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.501 -1.374 . . . . 0.0 113.561 173.96 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -67.5 -44.75 77.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.726 1.21 . . . . 0.0 113.111 174.66 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -135.7 -2.82 2.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -161.396 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.04 -9.68 37.72 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 120.109 -1.62 . . . . 0.0 116.814 170.71 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.04 121.68 83.72 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.723 1.609 . . . . 0.0 111.109 -179.447 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 58.1 Cg_exo -62.97 138.15 66.4 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.514 2.143 . . . . 0.0 113.177 -179.117 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 36.5 Cg_exo -52.8 -35.31 69.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.498 3.465 . . . . 0.0 116.438 -176.919 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.89 -16.76 63.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.282 1.401 . . . . 0.0 113.474 176.331 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.13 -3.09 48.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.432 1.493 . . . . 0.0 112.947 174.372 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -94.22 118.25 31.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.592 179.287 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -108.13 122.26 46.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.076 1.35 . . . . 0.0 109.556 169.99 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -114.42 131.16 56.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.278 1.031 . . . . 0.0 112.425 -172.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.93 134.74 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.756 1.622 . . . . 0.0 110.238 -173.769 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -157.18 139.62 14.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.699 1.599 . . . . 0.0 110.893 176.596 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.64 51.47 16.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.549 1.54 . . . . 0.0 113.516 -179.626 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 6.8 66.61 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.268 1.414 . . . . 0.0 116.254 175.23 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -142.68 162.03 36.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.14 1.47 . . . . 0.0 112.378 -168.427 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.55 143.94 31.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.391 1.076 . . . . 0.0 112.282 176.313 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -95.42 124.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.937 1.295 . . . . 0.0 110.986 173.214 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -100.17 140.75 33.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.896 1.278 . . . . 0.0 113.189 -174.931 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -38.14 73.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.871 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.12 90.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.268 -1.295 . . . . 0.0 116.328 -175.271 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -107.23 166.25 10.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.588 1.555 . . . . 0.0 111.854 -176.807 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -98.95 161.15 13.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.486 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.0 -38.55 68.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.337 0.655 . . . . 0.0 111.985 170.41 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -67.36 -36.32 81.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.447 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -59.81 -35.74 75.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 112.086 172.799 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.99 6.76 43.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.068 1.347 . . . . 0.0 114.187 175.595 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 54.96 37.09 28.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 113.759 177.117 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.08 106.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.435 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -94.17 173.56 7.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.314 1.845 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -50.8 147.29 5.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.011 1.324 . . . . 0.0 113.046 176.807 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 63.31 6.42 2.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.243 1.817 . . . . 0.0 115.551 177.924 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -65.56 143.99 57.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.327 0.967 . . . . 0.0 112.597 178.89 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -105.36 128.76 53.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.801 1.24 . . . . 0.0 110.4 173.246 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.59 148.99 28.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.579 1.952 . . . . 0.0 109.612 175.429 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -102.48 135.04 44.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 110.804 179.714 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 116.84 27.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.04 1.736 . . . . 0.0 110.198 -176.947 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.06 131.05 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.135 1.774 . . . . 0.0 108.792 173.65 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.52 108.22 18.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.716 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -57.48 138.26 55.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.067 1.747 . . . . 0.0 112.205 -167.842 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.87 153.91 35.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.358 1.063 . . . . 0.0 112.35 -172.896 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -85.37 151.14 24.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.349 1.46 . . . . 0.0 112.016 -175.966 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.12 74.0 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.262 1.265 . . . . 0.0 116.262 -179.996 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.439 1.495 . . . . 0.0 113.879 179.884 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -97.62 142.58 29.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -178.895 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -134.15 168.89 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.121 1.768 . . . . 0.0 110.885 168.71 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -111.07 147.05 35.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.562 1.145 . . . . 0.0 112.997 175.169 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.47 121.37 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.752 1.221 . . . . 0.0 109.958 167.613 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -104.21 139.13 39.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.542 1.537 . . . . 0.0 112.834 -179.369 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -113.53 163.79 14.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.981 1.713 . . . . 0.0 113.775 -178.098 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -64.15 -22.66 67.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.054 1.342 . . . . 0.0 113.704 -169.84 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -77.31 2.11 16.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.571 2.348 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 2.08 90.55 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.062 -1.024 . . . . 0.0 114.829 -178.554 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -83.5 154.37 23.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.524 1.53 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 m -140.99 138.76 33.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.33 1.452 . . . . 0.0 109.867 174.457 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.9 pt -114.22 151.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.144 1.378 . . . . 0.0 111.799 174.05 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -93.94 134.61 36.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.533 1.133 . . . . 0.0 109.751 169.83 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.25 147.42 41.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.28 1.432 . . . . 0.0 111.565 173.426 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -98.86 122.45 42.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.1 1.36 . . . . 0.0 110.363 169.995 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.85 155.95 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.854 1.662 . . . . 0.0 112.134 -170.466 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -97.52 148.71 34.83 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 110.735 164.632 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.33 52.9 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.753 2.302 . . . . 0.0 113.99 174.447 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -100.04 1.84 42.78 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.475 1.91 . . . . 0.0 114.776 175.856 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -69.75 138.05 52.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 120.262 1.392 . . . . 0.0 111.065 174.047 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p -83.6 167.0 17.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.595 1.158 . . . . 0.0 112.353 178.583 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -61.19 -35.9 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.094 -1.004 . . . . 0.0 112.364 -172.154 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.54 -27.73 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.538 -1.351 . . . . 0.0 113.808 178.019 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -69.08 -38.92 79.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.442 0.697 . . . . 0.0 111.658 176.546 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.84 -41.75 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.269 176.29 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.97 -41.43 82.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.854 0.752 . . . . 0.0 112.562 176.138 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.87 78.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.763 0.825 . . . . 0.0 112.596 174.636 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -62.96 -29.06 70.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.468 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.9 mt -71.0 -39.66 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.753 1.221 . . . . 0.0 111.196 171.044 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -63.84 -42.15 97.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.964 1.257 . . . . 0.0 111.599 174.584 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.56 -24.18 66.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 177.97 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -109.19 -24.97 10.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.858 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -129.77 -7.5 4.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.152 1.381 . . . . 0.0 113.526 -179.979 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.12 10.85 85.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.498 -1.376 . . . . 0.0 115.844 173.336 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.11 114.04 58.64 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 125.871 1.668 . . . . 0.0 109.065 -178.753 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.15 148.84 92.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.909 2.406 . . . . 0.0 112.314 177.148 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.09 -38.29 39.84 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.465 2.777 . . . . 0.0 115.681 178.637 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.69 -7.87 37.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.308 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -93.9 -10.2 34.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.036 -1.04 . . . . 0.0 113.436 169.984 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -98.22 134.8 40.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.184 1.356 . . . . 0.0 113.045 -166.368 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -115.46 133.04 56.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.5 1.12 . . . . 0.0 109.52 151.089 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.52 115.94 27.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.959 1.304 . . . . 0.0 111.535 -177.139 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.94 136.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 125.652 1.581 . . . . 0.0 110.98 -174.081 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -130.9 126.3 35.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.233 1.413 . . . . 0.0 111.453 167.535 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.24 37.98 16.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.929 1.292 . . . . 0.0 113.469 178.248 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.95 89.86 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -179.686 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -108.95 141.9 40.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.67 2.235 . . . . 0.0 110.643 170.944 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -76.66 142.19 40.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.522 0.329 . . . . 0.0 110.261 168.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.45 117.74 19.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 121.573 -0.704 . . . . 0.0 111.831 -176.772 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.59 129.69 40.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.178 0.991 . . . . 0.0 112.487 177.839 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.48 145.41 51.93 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.994 0.902 . . . . 0.0 112.615 179.491 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.09 -16.07 18.44 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.373 1.463 . . . . 0.0 115.091 -172.868 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -82.64 168.15 17.57 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.903 1.851 . . . . 0.0 111.508 173.299 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -116.02 167.08 11.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.069 1.348 . . . . 0.0 113.281 -178.336 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.9 mt -58.01 -40.96 82.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.946 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 p -66.56 -30.78 71.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 177.074 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -66.58 -23.57 66.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.658 1.117 . . . . 0.0 112.242 174.262 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.08 5.85 48.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 114.831 172.843 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.81 33.98 21.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.737 1.215 . . . . 0.0 114.094 -179.389 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -84.42 121.07 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.621 1.169 . . . . 0.0 109.264 179.731 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -111.7 171.05 7.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.873 1.669 . . . . 0.0 112.851 -176.191 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -47.27 135.92 9.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.281 1.433 . . . . 0.0 112.733 173.051 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 60.59 17.97 7.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.503 1.921 . . . . 0.0 115.789 -176.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 149.52 48.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.4 -1.437 . . . . 0.0 111.943 167.865 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -103.0 131.59 49.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.203 1.001 . . . . 0.0 111.613 173.944 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -107.66 148.39 29.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.457 1.903 . . . . 0.0 108.536 167.148 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -111.31 125.55 53.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.03 1.332 . . . . 0.0 110.084 -178.083 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.0 tp -103.15 125.98 50.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.221 1.408 . . . . 0.0 109.9 -179.102 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.44 134.49 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.644 1.578 . . . . 0.0 109.227 175.468 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.47 128.03 35.53 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.481 1.112 . . . . 0.0 111.18 -178.376 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -73.64 -62.85 1.34 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.028 1.331 . . . . 0.0 112.786 -179.52 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.97 105.61 8.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 109.881 -178.342 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -147.46 149.03 31.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.927 1.691 . . . . 0.0 111.05 166.895 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.49 144.2 4.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.418 1.485 . . . . 0.0 113.718 175.129 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.428 1.489 . . . . 0.0 113.371 -179.968 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 119 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -126.89 142.99 51.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.865 -178.862 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.2 170.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.013 1.325 . . . . 0.0 111.26 171.068 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -126.39 127.85 46.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.667 1.187 . . . . 0.0 110.983 -178.014 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -105.16 112.31 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.455 1.102 . . . . 0.0 110.665 179.902 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -86.09 117.7 25.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.722 2.409 . . . . 0.0 111.24 -177.953 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -72.5 149.43 44.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.227 0.611 . . . . 0.0 110.549 171.803 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.6 tp -68.85 -20.96 64.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.106 -0.996 . . . . 0.0 112.114 174.08 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -80.44 -29.49 37.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.525 1.53 . . . . 0.0 114.87 177.096 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.09 -62.01 0.2 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 170.562 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -74.73 166.61 23.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.412 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p -107.93 148.32 29.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.715 1.206 . . . . 0.0 112.893 165.639 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -122.78 112.14 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 126.602 1.961 . . . . 0.0 107.906 -175.17 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -83.24 130.28 35.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.185 0.994 . . . . 0.0 111.039 -176.183 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.95 142.81 51.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.37 1.068 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -93.4 127.63 39.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.799 0.84 . . . . 0.0 109.787 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.89 156.56 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.083 1.753 . . . . 0.0 110.341 -173.447 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.34 158.73 31.43 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.308 -0.87 . . . . 0.0 108.915 160.015 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.73 -12.02 19.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.952 1.768 . . . . 0.0 114.788 171.841 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 p -81.46 -7.92 59.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.18 1.792 . . . . 0.0 115.19 170.339 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.3 131.29 46.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 120.357 1.435 . . . . 0.0 110.821 175.492 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -72.49 155.12 40.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.187 0.995 . . . . 0.0 110.866 170.574 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -61.83 -30.18 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 172.39 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.79 -47.16 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.721 1.208 . . . . 0.0 112.514 166.497 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.18 -28.5 63.25 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.424 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.37 -47.86 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 119.9 1.227 . . . . 0.0 110.952 168.474 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.26 -38.29 76.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.381 0.991 . . . . 0.0 112.091 174.284 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.41 77.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.195 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -71.12 -27.87 63.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.976 0.911 . . . . 0.0 113.052 173.586 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -72.19 -45.9 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.597 1.159 . . . . 0.0 110.26 168.491 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.13 -38.1 70.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.209 1.003 . . . . 0.0 112.28 176.524 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.8 -57.02 14.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 177.632 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -88.26 -28.66 20.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.777 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -107.21 -11.32 15.62 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.572 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.48 83.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 177.902 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -82.08 120.14 76.65 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.632 1.216 . . . . 0.0 109.853 -170.273 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.59 145.37 37.26 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.968 1.779 . . . . 0.0 112.597 -173.868 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 -22.5 57.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.485 2.79 . . . . 0.0 114.524 -168.744 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.77 -5.2 56.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.843 1.257 . . . . 0.0 114.153 175.799 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -108.14 -10.42 15.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.599 1.959 . . . . 0.0 113.048 174.874 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.66 147.15 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.29 1.436 . . . . 0.0 112.184 179.492 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.03 127.41 32.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.122 1.769 . . . . 0.0 110.041 166.824 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.88 134.96 54.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.154 1.382 . . . . 0.0 111.71 -175.82 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.72 144.81 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.164 1.785 . . . . 0.0 110.453 -173.16 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -150.68 131.28 13.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.393 1.077 . . . . 0.0 111.042 167.512 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.38 41.31 20.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.115 1.366 . . . . 0.0 114.036 179.04 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.81 -3.45 50.18 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.645 1.593 . . . . 0.0 116.167 -176.511 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -89.18 128.51 35.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.461 1.63 . . . . 0.0 110.314 178.165 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -89.59 109.83 20.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.894 1.678 . . . . 0.0 108.95 179.588 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.2 mt -85.47 133.74 34.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 112.733 -162.211 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.53 139.27 38.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.349 1.06 . . . . 0.0 113.146 -176.934 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.68 -36.37 24.81 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.473 2.709 . . . . 0.0 115.072 -170.224 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 -11.74 78.85 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.178 -1.346 . . . . 0.0 115.983 -175.988 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.58 156.41 21.61 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.593 1.696 . . . . 0.0 111.019 177.54 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -101.08 159.06 15.55 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.262 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.78 -37.47 66.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.259 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -68.09 -30.06 69.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.548 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -70.19 -25.35 63.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.638 1.108 . . . . 0.0 111.93 174.129 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -89.58 9.28 27.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.885 1.274 . . . . 0.0 113.985 167.999 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 23.3 m-20 58.96 18.96 6.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.669 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.06 136.11 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.698 1.199 . . . . 0.0 110.432 -175.357 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.7 170.07 8.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.684 1.594 . . . . 0.0 112.451 -177.802 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 150.25 12.5 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.383 1.073 . . . . 0.0 112.713 168.726 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 60.58 25.93 15.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.407 1.483 . . . . 0.0 114.278 176.057 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -79.64 147.47 32.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.516 1.126 . . . . 0.0 112.534 175.765 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -101.29 122.15 43.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.864 1.266 . . . . 0.0 109.302 165.711 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.09 160.0 20.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.916 2.487 . . . . 0.0 108.394 -179.638 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -117.91 146.68 43.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.357 -1.464 . . . . 0.0 113.317 -171.819 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -128.56 137.48 51.75 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.125 2.17 . . . . 0.0 110.45 -178.624 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.03 143.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.119 2.168 . . . . 0.0 108.238 174.466 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.68 137.57 39.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.424 -0.797 . . . . 0.0 110.148 172.615 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -110.72 111.33 22.44 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.409 1.084 . . . . 0.0 110.871 -178.925 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -111.49 159.2 18.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.805 1.642 . . . . 0.0 111.513 174.213 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -57.52 -38.84 75.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.589 1.155 . . . . 0.0 113.29 -178.396 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.93 157.86 14.82 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.664 1.602 . . . . 0.0 114.671 177.218 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 C-N-CA 125.89 1.71 . . . . 0.0 113.303 179.602 . . . . . . . . 0 0 . 1 . 120 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -89.53 141.88 28.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.544 0.737 . . . . 0.0 112.023 176.716 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -135.18 159.83 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.316 1.447 . . . . 0.0 109.904 160.097 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.57 150.88 34.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.38 1.072 . . . . 0.0 112.037 -178.92 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.56 134.14 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.938 1.295 . . . . 0.0 110.518 178.359 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.63 134.39 52.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.938 1.695 . . . . 0.0 111.691 173.676 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -90.79 170.28 10.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 113.337 178.182 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.8 mt -64.83 -29.65 70.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.206 -0.934 . . . . 0.0 112.119 169.126 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.11 5.57 9.8 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.387 1.875 . . . . 0.0 114.051 169.77 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.56 0.19 72.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.149 1.833 . . . . 0.0 115.882 174.819 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -64.17 144.68 56.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.545 1.938 . . . . 0.0 110.923 -177.452 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.4 m -110.47 122.13 46.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.445 1.498 . . . . 0.0 110.799 -177.402 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.0 mt -123.6 144.48 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.976 1.71 . . . . 0.0 108.789 -175.691 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -113.9 137.17 52.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.611 1.164 . . . . 0.0 110.427 174.087 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.58 144.87 46.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.408 1.083 . . . . 0.0 111.731 176.969 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -103.31 111.25 23.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.126 1.77 . . . . 0.0 109.272 175.225 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.41 176.44 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.196 1.798 . . . . 0.0 112.27 -166.02 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.23 150.14 69.01 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 109.776 162.138 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.41 -25.84 59.62 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.301 2.667 . . . . 0.0 116.904 -179.465 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m -89.8 2.63 54.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.367 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -72.74 143.88 47.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.966 -1.084 . . . . 0.0 111.755 -179.692 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -75.34 150.54 38.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.316 -0.865 . . . . 0.0 112.882 -176.181 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.44 -34.27 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.578 0.751 . . . . 0.0 110.864 171.483 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.34 -46.15 83.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.974 0.909 . . . . 0.0 112.722 171.668 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -70.4 -36.57 74.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 175.788 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.66 -40.49 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.027 -1.045 . . . . 0.0 111.521 175.218 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.43 -32.85 74.01 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.0 112.538 173.554 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.66 85.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.386 -0.821 . . . . 0.0 113.009 171.469 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -63.27 -33.67 76.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.211 -0.931 . . . . 0.0 112.017 173.886 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.56 -40.66 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.493 1.117 . . . . 0.0 111.189 171.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.29 -40.95 87.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.95 0.796 . . . . 0.0 111.799 176.327 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.34 -32.86 72.75 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.138 0.881 . . . . 0.0 113.349 177.633 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.04 -52.92 5.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.357 1.063 . . . . 0.0 113.802 178.899 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -102.61 -14.03 16.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -170.519 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.7 4.97 85.95 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.3 mt -79.33 126.24 81.68 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 119.027 1.414 . . . . 0.0 108.996 178.435 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.69 132.91 26.21 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.58 2.187 . . . . 0.0 111.806 -176.896 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.58 -30.04 26.97 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 125.25 3.967 . . . . 0.0 117.253 -176.513 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.24 -23.27 64.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.167 1.348 . . . . 0.0 113.235 176.36 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -89.42 -4.59 57.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.49 1.516 . . . . 0.0 113.74 170.783 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -93.29 141.68 28.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.655 -1.278 . . . . 0.0 111.001 178.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -133.21 135.34 44.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.045 1.338 . . . . 0.0 111.069 164.16 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.2 mt -111.95 145.69 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.26 1.424 . . . . 0.0 112.339 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -129.61 137.26 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.346 1.858 . . . . 0.0 110.116 177.055 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -135.27 128.24 31.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.281 1.433 . . . . 0.0 111.187 168.178 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.4 43.68 15.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 173.286 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.54 4.51 87.52 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.896 1.712 . . . . 0.0 117.085 -177.563 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -106.67 122.56 46.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.555 1.542 . . . . 0.0 110.337 177.198 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -70.76 134.41 47.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 163.5 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.5 147.46 23.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.909 1.283 . . . . 0.0 110.429 -176.758 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.93 146.0 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.694 1.197 . . . . 0.0 112.399 179.786 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.14 -33.52 70.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.14 1.776 . . . . 0.0 114.271 -165.991 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.25 14.11 23.63 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.378 1.466 . . . . 0.0 116.658 -178.741 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -130.42 171.98 12.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.763 1.781 . . . . 0.0 111.571 -179.381 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -106.75 165.29 11.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 113.23 -177.605 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.64 -37.84 68.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 174.24 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -69.44 -23.62 63.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.777 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -70.0 -19.55 63.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 120.237 1.38 . . . . 0.0 112.924 174.274 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -111.32 14.29 21.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.331 1.452 . . . . 0.0 113.901 177.072 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 58.6 36.78 25.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.331 1.453 . . . . 0.0 114.221 176.786 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.4 mt -82.3 140.36 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.7 1.2 . . . . 0.0 109.519 175.859 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -128.13 -177.62 4.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.845 1.658 . . . . 0.0 112.39 -169.67 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.71 128.1 35.37 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.299 -0.876 . . . . 0.0 111.348 176.645 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 46.1 mt-10 59.04 20.32 8.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.047 1.739 . . . . 0.0 115.026 178.156 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -56.6 146.67 24.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.95 0.9 . . . . 0.0 111.836 167.634 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.9 m -109.06 129.9 55.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.163 0.985 . . . . 0.0 110.923 175.884 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -108.93 152.56 24.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.975 2.11 . . . . 0.0 109.914 177.918 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -104.73 136.87 43.43 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 110.283 169.919 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.1 137.94 45.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.615 1.966 . . . . 0.0 110.042 177.792 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.75 132.95 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.424 1.889 . . . . 0.0 108.506 178.987 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 tp -82.96 127.55 33.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.031 0.933 . . . . 0.0 109.603 168.289 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 -126.27 100.76 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.488 1.515 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.4 mt -86.86 -42.29 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.643 0.777 . . . . 0.0 111.144 175.211 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -70.0 150.53 46.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.045 1.738 . . . . 0.0 113.765 -178.106 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.35 29.89 74.56 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.423 1.011 . . . . 0.0 115.481 173.14 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.515 1.531 . . . . 0.0 113.288 -179.255 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.405 -0.331 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 121 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -116.36 148.15 40.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.414 1.086 . . . . 0.0 111.79 170.501 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.75 159.14 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.771 1.228 . . . . 0.0 110.73 168.454 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -103.84 153.57 20.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.961 0.905 . . . . 0.0 111.577 179.586 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.43 134.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.95 1.3 . . . . 0.0 108.661 173.375 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -125.48 144.61 50.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.165 0.986 . . . . 0.0 112.598 -178.799 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -95.36 164.49 12.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.994 1.318 . . . . 0.0 112.502 178.834 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.12 -26.85 68.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.333 -0.854 . . . . 0.0 112.928 169.975 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -70.08 -6.96 37.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.796 1.238 . . . . 0.0 113.932 170.925 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.37 -2.6 74.63 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.97 1.748 . . . . 0.0 115.432 176.515 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -78.39 137.14 37.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.646 1.223 . . . . 0.0 111.024 -178.301 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 m -105.62 149.95 25.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 -179.36 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.41 144.98 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 128.921 2.889 . . . . 0.0 107.299 179.692 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -115.47 136.04 53.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 109.374 168.834 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.7 mt -123.74 149.98 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.692 1.197 . . . . 0.0 111.872 175.841 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.61 126.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.733 1.613 . . . . 0.0 109.77 175.293 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -145.35 161.41 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.815 1.246 . . . . 0.0 113.717 -169.572 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -109.04 151.59 42.01 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 123.855 0.862 . . . . 0.0 110.455 157.916 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.46 -28.77 65.67 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.354 2.702 . . . . 0.0 116.022 179.83 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 p -81.01 -1.48 44.1 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.944 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.97 135.77 57.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.84 1.2 . . . . 0.0 110.397 170.883 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -76.87 156.45 32.14 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.758 -0.589 . . . . 0.0 111.453 177.219 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.73 -36.01 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.165 -0.96 . . . . 0.0 110.699 174.238 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.45 -47.35 84.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.239 1.016 . . . . 0.0 113.108 169.443 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.69 -23.4 65.29 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 176.863 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -80.4 -41.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.857 1.263 . . . . 0.0 111.685 174.028 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -61.19 -32.26 72.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.949 -1.094 . . . . 0.0 111.909 170.392 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.97 78.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 169.028 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.23 -32.36 73.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.895 1.225 . . . . 0.0 112.818 174.229 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.12 -51.44 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 119.325 0.966 . . . . 0.0 110.465 166.726 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -58.14 -38.61 76.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.689 0.796 . . . . 0.0 112.224 -179.973 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -55.55 -32.4 62.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.118 1.367 . . . . 0.0 114.477 -178.169 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -113.25 -27.11 8.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 177.967 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.16 -14.82 14.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -178.576 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.99 8.78 83.41 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 116.066 1.187 . . . . 0.0 116.066 177.518 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -74.68 125.38 89.66 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 110.256 -174.295 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 Cg_endo -63.17 118.7 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.729 2.953 . . . . 0.0 112.955 -174.127 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 80.7 Cg_exo -61.3 -25.88 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.238 2.625 . . . . 0.0 116.538 -172.67 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.72 -5.68 42.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.611 1.096 . . . . 0.0 112.678 176.801 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -117.33 0.99 12.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.604 1.962 . . . . 0.0 113.178 175.489 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.76 137.4 32.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.721 1.208 . . . . 0.0 110.91 173.435 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -122.38 131.38 53.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 108.845 167.352 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.9 mt -108.85 127.24 53.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.459 176.534 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.61 130.66 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.412 1.485 . . . . 0.0 110.628 -175.194 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -150.85 144.24 24.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.749 1.619 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.76 29.3 3.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.666 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.1 88.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.92 1.248 . . . . 0.0 116.211 -175.135 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -109.26 147.02 33.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.205 1.802 . . . . 0.0 111.727 176.795 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -80.43 139.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 160.693 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.1 139.09 31.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.216 0.606 . . . . 0.0 112.034 -174.125 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.88 123.99 32.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.706 1.602 . . . . 0.0 112.62 -173.25 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.89 -36.86 18.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.464 1.906 . . . . 0.0 114.645 -177.43 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.41 2.56 88.01 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.534 1.54 . . . . 0.0 116.243 -179.2 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -112.7 170.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.174 1.79 . . . . 0.0 111.155 -178.282 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -103.17 164.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.497 . . . . 0.0 113.431 -176.371 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.11 -35.94 72.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.356 -0.84 . . . . 0.0 112.524 168.425 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -67.58 -27.68 67.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 175.804 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.79 -24.09 67.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.959 1.254 . . . . 0.0 113.116 172.125 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -103.14 8.03 38.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.08 1.352 . . . . 0.0 113.0 175.367 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 54.04 38.26 28.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.833 1.253 . . . . 0.0 113.086 179.42 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.73 136.42 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 109.619 179.474 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.57 169.4 13.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.369 1.468 . . . . 0.0 112.838 -171.21 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -43.69 127.37 4.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.866 1.666 . . . . 0.0 112.625 170.773 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.25 23.4 13.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.157 1.783 . . . . 0.0 115.175 177.676 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -64.2 153.47 37.85 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.261 -0.9 . . . . 0.0 110.564 158.915 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -118.79 137.86 53.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.623 1.169 . . . . 0.0 110.164 169.981 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.08 165.12 13.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.635 1.974 . . . . 0.0 110.653 176.862 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -106.97 139.85 40.71 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.407 -0.808 . . . . 0.0 110.997 171.074 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.03 119.66 39.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.744 1.217 . . . . 0.0 109.282 171.081 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.69 132.01 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.933 1.693 . . . . 0.0 108.662 179.569 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 mt -104.89 149.23 25.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.105 0.962 . . . . 0.0 112.418 -175.183 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -84.45 124.09 30.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.883 0.873 . . . . 0.0 109.602 167.676 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 mp -109.13 99.29 8.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.951 1.3 . . . . 0.0 109.645 177.836 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -120.89 17.8 11.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.618 1.567 . . . . 0.0 113.554 -174.335 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.85 -15.43 71.45 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.925 1.25 . . . . 0.0 116.16 -173.715 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.22 1.867 . . . . 0.0 115.055 171.923 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.45 139.47 31.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.851 178.449 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.84 167.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.212 1.405 . . . . 0.0 109.554 164.565 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.56 144.87 47.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.633 1.173 . . . . 0.0 111.122 178.943 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.66 121.61 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.148 -0.97 . . . . 0.0 111.168 177.686 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -81.02 118.44 22.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.028 0.931 . . . . 0.0 110.568 172.249 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -83.27 173.2 11.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.165 1.786 . . . . 0.0 112.586 -178.819 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.79 -6.92 35.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.551 -1.343 . . . . 0.0 114.563 -173.87 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -103.02 9.03 38.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.723 2.009 . . . . 0.0 113.521 172.079 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.0 -15.48 6.36 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 120.289 -1.507 . . . . 0.0 115.255 -178.597 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -53.67 132.59 41.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.755 . . . . 0.0 110.105 165.958 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -109.84 129.95 55.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.19 0.596 . . . . 0.0 111.543 179.098 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.48 149.36 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.177 1.391 . . . . 0.0 111.803 -178.84 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 p -83.64 144.96 29.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.731 1.212 . . . . 0.0 111.476 170.479 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -128.3 155.92 43.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.868 1.267 . . . . 0.0 111.58 167.381 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -112.08 120.21 41.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 0.0 109.96 171.72 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.96 170.17 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.909 1.684 . . . . 0.0 111.257 -173.375 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.65 155.49 81.15 Favored Pre-proline 0 N--CA 1.449 -0.487 0 O-C-N 121.093 -1.004 . . . . 0.0 112.164 167.908 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.63 -21.22 37.86 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.113 3.209 . . . . 0.0 116.932 -174.486 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 p -84.92 -7.71 59.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.1 1.76 . . . . 0.0 114.809 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -67.12 136.96 55.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.102 1.319 . . . . 0.0 111.841 176.447 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 p -83.6 154.99 23.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.825 0.45 . . . . 0.0 111.323 168.731 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.86 -29.35 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -167.423 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.79 -31.03 71.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.727 -1.233 . . . . 0.0 112.746 176.304 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -65.13 -36.88 85.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.659 0.784 . . . . 0.0 110.851 177.196 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.21 -44.04 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.863 1.265 . . . . 0.0 109.716 178.857 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.3 -34.93 78.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 112.267 176.206 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.93 63.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 171.124 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -74.93 -30.96 61.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.843 -1.161 . . . . 0.0 112.868 170.795 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -67.3 -43.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 110.369 167.632 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.7 -40.97 69.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.692 1.133 . . . . 0.0 111.722 174.808 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.62 -15.86 61.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.257 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -108.09 -24.26 11.64 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.576 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -131.93 -8.38 3.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.954 1.302 . . . . 0.0 113.608 -170.549 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.1 59.65 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.277 1.417 . . . . 0.0 116.616 168.289 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 tt -78.74 126.25 82.84 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 118.941 1.371 . . . . 0.0 112.053 -176.624 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.05 147.12 95.72 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.858 2.372 . . . . 0.0 114.051 179.723 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -51.96 -41.15 65.33 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.358 2.705 . . . . 0.0 115.773 -176.769 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.95 -11.02 60.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -178.433 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -94.2 -2.45 52.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.801 1.64 . . . . 0.0 113.375 174.136 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -102.46 127.51 49.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.659 1.183 . . . . 0.0 111.74 -176.945 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -121.13 126.18 49.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.796 1.238 . . . . 0.0 111.211 176.06 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.35 115.36 20.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.825 1.25 . . . . 0.0 110.88 -171.452 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -106.88 140.98 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.603 1.561 . . . . 0.0 110.673 173.405 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -146.72 126.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.963 2.105 . . . . 0.0 110.704 176.22 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.2 41.6 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 0.0 114.318 -174.003 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.27 -4.31 26.42 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.023 1.773 . . . . 0.0 115.899 -175.251 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -93.85 136.86 33.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.779 1.79 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -79.5 133.5 36.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 169.788 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -86.09 101.68 13.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.408 1.083 . . . . 0.0 109.161 178.863 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -88.08 154.91 20.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.42 1.488 . . . . 0.0 113.252 -171.558 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.98 136.53 50.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.52 -0.737 . . . . 0.0 110.547 179.602 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.24 4.94 89.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.155 -0.965 . . . . 0.0 115.511 -178.451 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.87 157.13 16.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.014 1.726 . . . . 0.0 109.371 163.913 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.4 p -100.77 161.19 13.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.473 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.1 mt -53.9 -40.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.977 0.511 . . . . 0.0 112.203 169.957 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 p -69.65 -30.15 67.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.529 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -59.65 -28.24 67.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.254 1.843 . . . . 0.0 112.986 170.242 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.15 5.11 44.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.032 1.333 . . . . 0.0 114.122 174.018 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 51.68 38.99 24.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.804 1.642 . . . . 0.0 114.629 -174.359 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.93 128.25 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.654 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -129.27 162.52 27.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.695 1.598 . . . . 0.0 111.234 -176.067 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 132.1 52.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.818 1.247 . . . . 0.0 110.176 167.849 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.75 54.36 1.31 Allowed 'General case' 0 N--CA 1.449 -0.497 1 C-N-CA 132.055 4.142 . . . . 0.0 110.038 8.667 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -56.31 145.71 26.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.559 1.544 . . . . 0.0 114.587 -173.721 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.0 m -97.79 142.37 29.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 109.701 163.361 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.69 148.64 45.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.177 1.791 . . . . 0.0 110.528 172.296 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -110.7 128.08 55.57 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.371 1.069 . . . . 0.0 111.324 -179.567 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.1 tp -90.57 135.63 33.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.796 1.238 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.57 157.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.528 1.131 . . . . 0.0 110.207 163.014 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.26 129.88 35.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.854 0.862 . . . . 0.0 110.795 -176.472 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -88.12 137.38 32.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.112 2.165 . . . . 0.0 111.947 -178.857 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -133.95 149.95 51.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.3 1.44 . . . . 0.0 113.266 -162.251 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -154.2 163.22 40.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.213 1.405 . . . . 0.0 113.392 173.049 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.3 176.39 54.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.974 1.273 . . . . 0.0 114.535 173.108 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.428 1.489 . . . . 0.0 114.525 172.154 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 123 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -81.63 135.25 35.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.975 0.51 . . . . 0.0 110.993 171.702 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 156.7 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 111.29 163.756 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -110.37 142.86 41.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 -170.898 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.12 107.36 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.93 1.292 . . . . 0.0 109.714 177.564 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.87 131.65 37.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.069 1.348 . . . . 0.0 112.135 -175.491 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 p -89.61 154.71 19.76 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.762 0.791 . . . . 0.0 111.505 168.528 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.7 mt -77.54 -6.63 54.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.655 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -138.48 -11.14 1.4 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.927 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -114.74 0.57 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.084 1.311 . . . . 0.0 114.812 -169.549 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -69.54 149.17 48.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.894 1.277 . . . . 0.0 112.5 -167.761 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -109.76 116.24 31.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 159.26 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.84 130.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.894 1.277 . . . . 0.0 109.56 -174.1 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -92.53 132.86 36.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.493 0.717 . . . . 0.0 109.519 169.424 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.88 145.61 51.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.525 1.13 . . . . 0.0 111.057 173.63 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -121.45 105.37 10.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.692 1.997 . . . . 0.0 110.019 -175.389 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.18 165.43 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 113.172 -169.604 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.89 151.16 54.51 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.836 1.254 . . . . 0.0 113.639 176.652 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -56.18 -20.04 29.72 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 124.646 3.564 . . . . 0.0 116.607 172.823 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.4 p -102.98 7.61 39.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.266 1.826 . . . . 0.0 114.499 -178.762 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -81.87 146.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.995 175.039 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 p -89.66 156.29 18.67 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.819 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.03 -29.62 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 120.987 -1.07 . . . . 0.0 112.217 -178.858 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.93 -43.84 86.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.925 1.239 . . . . 0.0 112.25 168.698 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.19 -36.1 74.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.0 111.842 177.22 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.84 -48.0 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 118.997 0.817 . . . . 0.0 110.782 171.586 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.68 -41.24 90.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.966 0.803 . . . . 0.0 112.204 176.754 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.46 78.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.93 0.892 . . . . 0.0 113.313 176.329 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -73.02 -32.48 65.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.831 -1.168 . . . . 0.0 112.211 175.866 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.84 -39.86 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.989 1.315 . . . . 0.0 110.886 168.659 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.65 -43.56 93.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.43 1.014 . . . . 0.0 111.675 173.669 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.69 -39.53 94.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.795 -0.565 . . . . 0.0 112.476 176.725 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -76.03 -51.77 11.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -179.733 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -108.01 -11.78 15.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.601 1.561 . . . . 0.0 115.172 -170.298 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.43 87.05 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.335 1.425 . . . . 0.0 115.819 -179.589 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -77.22 120.2 80.63 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.936 1.294 . . . . 0.0 109.81 -171.218 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.07 136.2 34.17 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.284 1.989 . . . . 0.0 112.163 -174.981 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.76 -34.59 65.49 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 124.001 3.134 . . . . 0.0 115.803 -177.371 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -65.32 -16.63 63.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.885 1.221 . . . . 0.0 113.711 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -92.05 -15.38 27.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.241 1.016 . . . . 0.0 113.148 175.852 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.1 112.23 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.754 1.161 . . . . 0.0 113.129 -170.1 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -91.48 120.21 32.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.521 0.729 . . . . 0.0 109.908 158.55 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.6 mt -107.88 133.73 51.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.108 1.363 . . . . 0.0 111.201 174.967 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.91 135.31 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.295 1.438 . . . . 0.0 110.012 -175.078 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.44 137.04 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.325 1.05 . . . . 0.0 110.915 169.757 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 37.51 4.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 113.933 -175.167 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.93 10.83 81.07 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -177.398 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -112.41 134.46 53.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.621 1.569 . . . . 0.0 111.704 -177.124 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -74.31 127.39 32.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.076 1.351 . . . . 0.0 110.43 172.774 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.81 158.48 16.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.85 0.86 . . . . 0.0 112.85 -171.796 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -109.44 145.19 36.58 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.916 1.686 . . . . 0.0 111.796 178.481 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.99 -31.93 68.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -163.845 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.88 -6.27 87.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.778 1.18 . . . . 0.0 115.244 178.695 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -85.5 159.0 20.03 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.833 1.316 . . . . 0.0 111.697 176.978 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 p -109.45 163.32 13.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.859 1.664 . . . . 0.0 112.859 -177.827 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -55.39 -47.52 75.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.608 0.763 . . . . 0.0 112.394 179.972 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -63.03 -34.94 78.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 178.733 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.38 -25.92 68.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.81 1.186 . . . . 0.0 113.327 175.738 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -96.37 8.81 43.07 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 114.073 171.778 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 53.76 38.1 27.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.204 1.366 . . . . 0.0 113.095 -175.06 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.74 125.3 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.5 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -125.09 172.91 9.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.592 1.957 . . . . 0.0 110.403 -174.575 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -52.57 138.71 27.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.369 0.986 . . . . 0.0 112.21 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.68 28.73 17.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.295 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.9 m -74.12 153.96 39.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.785 -1.197 . . . . 0.0 111.313 163.693 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -119.47 127.36 52.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 111.252 175.543 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.34 169.37 8.84 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.166 2.586 . . . . 0.0 110.074 177.083 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.551 1.14 . . . . 0.0 112.269 172.564 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.1 130.37 50.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.924 1.69 . . . . 0.0 110.579 177.161 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.86 135.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.094 1.358 . . . . 0.0 109.122 172.317 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.83 127.66 42.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.483 0.713 . . . . 0.0 112.26 -178.148 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -58.9 152.05 20.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.166 0.986 . . . . 0.0 112.153 173.604 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.07 161.37 29.48 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.785 1.234 . . . . 0.0 113.104 -171.112 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 52.53 25.17 3.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.958 2.503 . . . . 0.0 115.352 177.547 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.18 -13.14 62.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.704 1.145 . . . . 0.0 115.177 -174.53 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.692 1.615 . . . . 0.0 112.694 -178.396 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.622 -0.228 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 124 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -92.43 131.75 37.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.436 1.095 . . . . 0.0 111.148 177.925 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.21 159.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.058 1.343 . . . . 0.0 111.843 176.98 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.63 144.44 43.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.319 1.048 . . . . 0.0 112.093 175.211 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.37 122.54 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.749 1.22 . . . . 0.0 109.987 171.914 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -94.41 139.22 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.673 1.989 . . . . 0.0 110.51 179.226 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -104.77 153.11 21.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.53 0.732 . . . . 0.0 111.527 174.017 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.49 -35.19 73.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.497 1.119 . . . . 0.0 112.954 -174.782 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -89.07 15.2 9.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 175.857 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 20.66 37.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 163.814 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.7 tttm -85.02 155.76 21.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.353 1.077 . . . . 0.0 110.166 166.568 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.2 m -130.88 128.91 41.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.491 0.717 . . . . 0.0 110.238 170.007 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.94 139.3 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 126.904 2.082 . . . . 0.0 107.822 -176.39 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.3 m -117.14 136.11 53.26 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 109.823 174.994 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.51 147.88 52.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.498 1.119 . . . . 0.0 112.009 178.764 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.08 122.3 47.28 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.895 1.278 . . . . 0.0 110.6 170.449 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.39 166.94 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.483 2.313 . . . . 0.0 111.29 -165.682 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -96.84 152.17 38.26 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 121.061 -1.024 . . . . 0.0 111.703 169.321 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.08 -22.22 54.73 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.72 2.28 . . . . 0.0 114.048 168.798 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -86.36 -2.38 58.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.767 1.627 . . . . 0.0 114.705 173.965 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -73.2 139.48 46.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.812 1.642 . . . . 0.0 112.516 -178.281 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -81.97 141.44 33.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.724 1.61 . . . . 0.0 111.835 -175.539 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -55.39 -41.99 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.409 1.084 . . . . 0.0 112.609 -177.473 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.71 -26.9 67.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 176.464 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -81.51 -37.09 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.119 0.968 . . . . 0.0 112.256 173.724 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.95 -39.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.206 -0.934 . . . . 0.0 110.582 172.952 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -63.06 -36.75 84.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.238 -0.914 . . . . 0.0 112.641 170.59 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.62 81.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 173.933 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.62 -35.33 79.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.295 -0.878 . . . . 0.0 112.414 169.164 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.3 -30.95 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.834 0.854 . . . . 0.0 111.509 174.815 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -67.22 -46.21 74.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.622 1.555 . . . . 0.0 111.452 171.162 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -43.62 80.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.392 1.477 . . . . 0.0 112.309 175.595 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -87.26 -35.83 18.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -173.274 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.93 -11.0 6.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.993 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.05 38.22 19.7 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 173.223 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 125.71 27.11 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.342 1.457 . . . . 0.0 109.553 172.126 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -62.5 139.14 74.67 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.798 2.332 . . . . 0.0 113.346 173.575 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -52.13 -28.68 34.08 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 124.49 3.46 . . . . 0.0 115.426 175.13 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -58.45 -32.05 68.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.799 1.64 . . . . 0.0 113.089 172.59 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -97.9 -17.19 19.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.75 1.62 . . . . 0.0 113.134 -179.624 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -82.68 137.28 34.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 112.223 177.635 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -125.38 145.26 50.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.575 1.15 . . . . 0.0 109.449 159.509 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 tp -124.01 127.85 48.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 110.48 -167.993 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -118.57 135.52 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.323 1.449 . . . . 0.0 110.642 -171.072 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -125.54 110.26 13.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.456 1.103 . . . . 0.0 109.483 169.117 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 57.24 5.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.833 1.253 . . . . 0.0 113.087 -174.425 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.44 -15.21 1.58 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -176.588 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -79.01 120.31 23.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.475 2.138 . . . . 0.0 110.112 177.896 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -83.91 127.08 33.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.051 0.54 . . . . 0.0 110.688 175.149 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -88.27 159.28 18.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.114 0.966 . . . . 0.0 113.459 -169.028 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.06 145.27 30.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.567 1.947 . . . . 0.0 111.704 179.46 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -67.92 -26.12 65.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -167.196 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.19 -14.28 59.16 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 -175.355 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -77.29 165.09 24.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.728 1.264 . . . . 0.0 112.169 -178.79 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -107.46 160.45 15.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.381 1.073 . . . . 0.0 112.617 172.552 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.91 -39.55 68.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.531 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 p -66.3 -30.13 70.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.005 1.322 . . . . 0.0 114.348 175.111 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -67.79 -22.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.82 1.191 . . . . 0.0 112.094 176.468 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -102.66 3.68 37.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.776 1.631 . . . . 0.0 113.806 173.004 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.96 38.51 28.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.197 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.43 127.81 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 168.325 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -129.74 177.0 7.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 112.986 -167.209 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -53.46 119.7 5.17 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.63 1.572 . . . . 0.0 110.646 175.032 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 60.28 35.7 20.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.451 1.5 . . . . 0.0 114.266 -175.501 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 m -73.42 143.78 46.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.406 -0.809 . . . . 0.0 110.204 155.322 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 m -110.86 125.47 53.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.88 1.272 . . . . 0.0 109.578 174.999 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.4 164.57 12.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.748 1.619 . . . . 0.0 110.317 173.267 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -118.48 134.35 55.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.741 1.216 . . . . 0.0 110.567 177.268 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -93.2 135.21 34.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.469 1.108 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.17 137.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 177.304 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.67 113.4 25.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 109.663 174.725 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.96 100.18 7.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.821 1.248 . . . . 0.0 109.81 -174.91 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.7 150.97 22.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.797 0.839 . . . . 0.0 111.713 -177.574 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -87.42 -25.38 23.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.904 1.682 . . . . 0.0 112.639 166.771 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.63 -166.38 37.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.704 1.145 . . . . 0.0 114.261 177.94 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.756 1.646 . . . . 0.0 112.428 -177.382 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -76.39 140.14 41.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.178 0.591 . . . . 0.0 111.533 177.885 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.27 163.88 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.414 1.086 . . . . 0.0 110.342 155.592 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.634 1.174 . . . . 0.0 110.501 174.723 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.53 132.71 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.14 1.376 . . . . 0.0 108.223 167.713 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -126.62 130.85 51.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.142 0.977 . . . . 0.0 112.559 -179.193 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 p -83.87 167.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.715 1.606 . . . . 0.0 112.937 178.287 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.14 6.86 1.13 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 166.087 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -110.39 6.05 21.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.207 1.803 . . . . 0.0 112.851 168.389 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.98 4.25 71.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.974 1.273 . . . . 0.0 115.479 -178.618 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.28 122.09 17.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.911 1.355 . . . . 0.0 109.548 176.451 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m -95.79 136.27 36.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.118 0.967 . . . . 0.0 110.702 176.624 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.99 135.17 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.898 1.679 . . . . 0.0 108.178 171.263 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -96.69 139.73 32.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.074 1.35 . . . . 0.0 111.233 176.045 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.2 mt -131.1 137.57 49.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.811 0.845 . . . . 0.0 111.63 172.314 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -84.64 118.35 24.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.675 1.19 . . . . 0.0 108.913 164.212 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.23 167.05 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.131 1.372 . . . . 0.0 112.682 -177.236 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -119.02 153.64 52.91 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 125.84 1.656 . . . . 0.0 109.607 163.024 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.42 -17.08 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.635 2.223 . . . . 0.0 115.962 178.163 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 p -87.35 -1.33 57.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.006 1.723 . . . . 0.0 115.595 172.79 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.77 131.48 50.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.772 -1.205 . . . . 0.0 110.117 173.647 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -74.99 152.69 38.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.805 0.842 . . . . 0.0 112.337 178.232 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -57.23 -40.54 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.441 0.696 . . . . 0.0 111.041 174.631 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -66.28 -37.09 84.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.273 1.029 . . . . 0.0 113.124 175.279 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -67.9 -41.35 82.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.366 0.985 . . . . 0.0 111.563 175.344 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.26 -38.34 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.477 175.483 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.71 -39.73 94.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.85 1.205 . . . . 0.0 112.755 172.606 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.41 -33.91 76.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 174.75 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -65.64 -42.86 90.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.825 1.25 . . . . 0.0 111.544 170.413 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.91 -36.2 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 119.054 0.843 . . . . 0.0 111.16 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -62.14 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.063 -1.023 . . . . 0.0 111.442 171.116 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -65.68 -36.31 83.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.634 -1.291 . . . . 0.0 113.557 177.411 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -84.68 -31.03 24.35 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 -176.544 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -126.18 -10.88 6.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -176.749 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.54 86.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 120.439 1.472 . . . . 0.0 116.315 177.999 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.25 119.6 72.53 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.685 1.194 . . . . 0.0 109.59 -171.589 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.65 138.45 83.45 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.665 2.244 . . . . 0.0 112.837 179.289 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.3 -33.97 57.93 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.71 2.94 . . . . 0.0 115.521 179.527 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.98 -4.62 45.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 114.376 177.936 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.85 -13.26 15.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.281 1.833 . . . . 0.0 112.925 172.999 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.89 151.8 27.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.432 1.493 . . . . 0.0 111.005 173.831 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -141.55 144.03 34.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.323 1.049 . . . . 0.0 109.457 154.655 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.602 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -132.37 139.4 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.334 1.853 . . . . 0.0 110.522 -177.519 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -144.61 132.08 20.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.823 1.649 . . . . 0.0 110.855 172.326 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.51 36.64 7.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.179 1.392 . . . . 0.0 114.743 -179.809 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.57 -8.47 58.92 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.491 1.52 . . . . 0.0 115.902 -177.027 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.31 140.77 29.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 120.222 2.011 . . . . 0.0 111.002 177.572 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -78.16 140.85 38.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.65 -0.656 . . . . 0.0 111.564 168.437 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.6 mt -91.57 106.73 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.721 1.208 . . . . 0.0 110.435 -178.116 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -108.39 145.09 35.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.034 1.334 . . . . 0.0 111.912 -168.994 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.31 143.07 53.74 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.32 1.048 . . . . 0.0 112.249 -176.75 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.18 -1.74 40.59 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 179.972 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.52 175.23 5.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.038 2.135 . . . . 0.0 112.961 174.445 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 p -115.89 166.63 11.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.957 2.103 . . . . 0.0 112.544 173.375 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.79 -38.97 67.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.601 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -67.34 -27.28 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 175.174 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -70.42 -11.41 60.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.833 1.197 . . . . 0.0 112.982 172.912 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -112.03 5.08 18.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.368 1.867 . . . . 0.0 114.509 176.532 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 56.9 40.83 28.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.048 1.295 . . . . 0.0 113.233 -176.283 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -82.92 121.45 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.166 -0.959 . . . . 0.0 109.198 175.471 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -100.06 155.87 17.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.711 1.604 . . . . 0.0 111.959 -175.888 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -38.73 132.32 1.21 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.603 1.961 . . . . 0.0 113.168 164.07 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 59.98 20.3 9.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.186 2.194 . . . . 0.0 115.837 -178.815 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -68.74 156.23 38.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.948 -1.095 . . . . 0.0 113.403 169.726 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.0 m -98.31 121.38 40.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 109.813 168.672 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.51 133.44 38.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 108.288 165.186 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -87.54 130.59 34.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.029 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 tp -110.74 135.44 51.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.055 1.342 . . . . 0.0 109.176 172.393 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 m -133.32 166.11 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.006 1.722 . . . . 0.0 110.457 174.047 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.5 mt -117.09 121.41 41.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.948 1.299 . . . . 0.0 110.811 -172.088 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -62.91 -21.88 66.34 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.906 1.282 . . . . 0.0 114.063 -178.783 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.27 3.35 53.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.413 1.485 . . . . 0.0 113.936 178.323 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -130.57 135.86 48.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.144 1.778 . . . . 0.0 111.288 179.082 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.04 -22.35 0.08 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.491 1.044 . . . . 0.0 115.619 -179.953 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.981 1.277 . . . . 0.0 113.927 174.16 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.68 140.89 30.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.032 0.933 . . . . 0.0 110.591 174.111 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -131.07 171.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.666 1.586 . . . . 0.0 110.017 165.005 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -123.71 151.66 42.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.761 0.824 . . . . 0.0 110.531 170.15 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -131.26 125.14 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.618 172.986 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -74.58 122.43 23.13 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.172 0.989 . . . . 0.0 108.75 169.485 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -77.87 172.55 13.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.545 1.138 . . . . 0.0 112.671 -172.322 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tp -71.9 -21.55 61.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.409 170.606 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -84.15 4.57 29.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.871 2.068 . . . . 0.0 114.117 172.248 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.47 79.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.864 1.211 . . . . 0.0 115.635 178.011 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -90.48 -178.1 5.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.749 171.539 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -120.64 131.63 54.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.995 1.318 . . . . 0.0 109.436 169.181 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -112.88 136.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.046 0.938 . . . . 0.0 110.793 169.058 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -90.13 138.14 31.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.519 1.128 . . . . 0.0 110.033 176.814 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.24 143.28 42.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.772 0.715 . . . . 0.0 112.443 173.832 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -87.65 130.15 34.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.592 1.157 . . . . 0.0 110.232 165.754 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.76 159.65 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.944 1.697 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -99.21 141.27 22.56 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.62 165.435 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.81 -34.08 83.7 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.173 1.915 . . . . 0.0 113.988 173.965 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 p -74.61 -0.25 17.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 176.975 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -75.17 149.41 38.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.319 1.418 . . . . 0.0 112.277 175.964 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -84.58 165.3 18.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.955 0.902 . . . . 0.0 112.988 176.242 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.57 -31.12 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.555 168.614 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -65.89 -35.91 81.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.663 1.574 . . . . 0.0 111.882 174.13 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.37 -42.65 68.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.909 177.888 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -37.05 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.248 0.931 . . . . 0.0 111.967 176.739 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.231 0.923 . . . . 0.0 112.461 171.494 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.017 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -80.17 -23.27 41.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.701 1.2 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.14 -38.48 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.648 1.579 . . . . 0.0 110.663 167.522 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.47 -40.74 87.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 111.597 172.52 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.26 -27.79 48.92 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.719 1.207 . . . . 0.0 114.255 172.622 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.07 -49.86 4.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.281 1.433 . . . . 0.0 113.838 -178.722 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -105.77 -6.84 18.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.264 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.44 11.38 79.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 115.918 177.225 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.86 119.0 70.38 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.094 1.358 . . . . 0.0 109.271 -177.296 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.15 149.19 81.87 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.805 2.337 . . . . 0.0 113.485 -179.725 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.38 -25.72 48.78 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.003 2.469 . . . . 0.0 114.37 -164.507 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.27 -23.08 54.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.238 -0.914 . . . . 0.0 113.318 175.771 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -80.41 -21.61 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.156 0.889 . . . . 0.0 111.617 -179.912 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -77.37 125.43 29.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.872 1.269 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -109.83 112.82 25.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.329 1.452 . . . . 0.0 108.773 159.92 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -90.06 139.06 30.98 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 110.976 176.72 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -128.73 138.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 109.473 -177.867 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -148.62 136.52 20.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.7 1.2 . . . . 0.0 111.195 171.329 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.33 44.65 12.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 114.679 169.279 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 2.61 90.08 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.95 1.738 . . . . 0.0 117.342 178.051 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -125.67 138.54 53.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 120.266 2.033 . . . . 0.0 112.667 179.988 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.69 113.72 20.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.624 1.17 . . . . 0.0 109.378 173.728 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.9 108.43 6.71 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.264 1.426 . . . . 0.0 111.293 -173.843 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -88.59 149.82 23.38 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.465 1.106 . . . . 0.0 111.82 179.745 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.17 166.05 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.76 1.624 . . . . 0.0 113.256 173.221 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.29 -9.86 75.37 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 120.981 -1.074 . . . . 0.0 115.378 -178.855 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -128.06 160.71 31.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.258 1.423 . . . . 0.0 113.297 -178.158 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -97.07 163.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.575 -174.554 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.55 87.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.601 0.76 . . . . 0.0 111.583 176.028 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 p -59.11 -47.34 85.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.243 1.817 . . . . 0.0 112.841 171.033 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -64.42 -35.6 81.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.914 179.269 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -80.8 -3.4 50.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 172.601 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 59.75 49.34 8.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.376 1.87 . . . . 0.0 114.394 -175.811 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.9 141.04 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.419 1.488 . . . . 0.0 108.989 169.875 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -135.2 172.58 12.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.557 1.143 . . . . 0.0 112.165 -166.588 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.06 130.25 45.28 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.483 1.113 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 45.5 mt-10 56.59 18.83 3.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.566 1.946 . . . . 0.0 115.95 -173.738 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -61.75 133.24 55.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.511 -1.368 . . . . 0.0 110.151 161.837 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -95.96 121.67 37.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.571 0.748 . . . . 0.0 110.156 172.867 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.32 165.43 12.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.258 1.823 . . . . 0.0 109.988 172.402 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -129.17 151.21 50.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 111.796 179.258 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.3 tp -121.09 131.92 54.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.018 1.327 . . . . 0.0 111.769 -178.899 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.81 166.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.538 1.935 . . . . 0.0 110.16 164.773 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -104.66 166.06 10.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.862 -1.149 . . . . 0.0 114.009 -170.802 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -116.39 147.66 41.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.013 2.125 . . . . 0.0 110.521 160.124 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.96 129.62 47.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.734 1.214 . . . . 0.0 112.251 178.535 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -79.03 168.91 19.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.502 1.521 . . . . 0.0 111.308 170.322 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.11 177.25 20.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.651 1.12 . . . . 0.0 115.161 -177.999 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.778 1.656 . . . . 0.0 113.55 -176.926 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -105.17 149.49 25.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.645 0.778 . . . . 0.0 113.08 179.951 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.2 158.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 110.25 167.402 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -116.85 122.72 45.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.628 1.171 . . . . 0.0 111.13 -174.241 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.91 107.31 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.776 1.23 . . . . 0.0 109.68 -176.196 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 148.25 27.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.854 1.662 . . . . 0.0 112.511 178.468 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -124.06 154.82 39.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.324 1.45 . . . . 0.0 112.174 166.329 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 tp -71.1 -19.09 62.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.832 -1.167 . . . . 0.0 113.032 173.867 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -69.36 -0.03 5.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.26 1.424 . . . . 0.0 113.955 164.299 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.35 14.49 71.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.412 1.482 . . . . 0.0 114.776 172.162 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -92.44 143.93 25.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.414 1.086 . . . . 0.0 110.256 177.181 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.0 m -122.46 120.09 32.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.289 1.036 . . . . 0.0 109.346 169.535 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.6 125.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.951 1.301 . . . . 0.0 108.482 -179.837 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -89.98 130.2 36.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.861 0.864 . . . . 0.0 109.33 176.719 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 164.39 12.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.093 1.357 . . . . 0.0 111.823 178.214 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -125.01 112.09 16.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.381 1.873 . . . . 0.0 108.996 172.002 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.03 164.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.57 1.948 . . . . 0.0 112.042 -164.56 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -121.24 153.29 58.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.728 1.611 . . . . 0.0 110.249 165.837 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.24 -28.11 69.65 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 0.0 114.378 173.853 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -88.61 10.48 20.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.416 1.886 . . . . 0.0 114.899 178.407 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -81.78 150.66 27.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.584 -1.323 . . . . 0.0 111.891 168.489 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -86.62 159.24 19.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 112.603 -179.013 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.83 -31.55 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 120.989 -1.069 . . . . 0.0 111.681 171.48 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.21 -41.92 89.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.271 -0.893 . . . . 0.0 112.117 170.338 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -66.7 -39.48 88.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.96 . . . . 0.0 112.357 176.009 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.32 -46.78 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 119.753 1.161 . . . . 0.0 111.108 174.029 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.34 -35.36 77.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.681 -0.637 . . . . 0.0 112.487 173.939 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.74 72.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.117 0.967 . . . . 0.0 113.52 176.798 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.58 -41.46 88.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.757 0.823 . . . . 0.0 111.364 172.833 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.79 -37.54 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.323 1.049 . . . . 0.0 111.193 172.77 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -61.01 -36.59 79.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.357 1.063 . . . . 0.0 111.832 174.411 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.38 -58.15 3.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.832 1.196 . . . . 0.0 112.013 173.038 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -61.22 -45.97 92.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.224 0.92 . . . . 0.0 113.17 -174.354 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -108.83 -4.85 16.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.288 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.49 10.33 75.18 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 174.11 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -89.81 121.2 69.21 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 119.277 1.539 . . . . 0.0 109.013 -175.986 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.93 148.16 69.79 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.583 2.188 . . . . 0.0 111.619 178.315 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.78 -35.37 69.09 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.427 2.751 . . . . 0.0 116.329 -171.566 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.33 -14.52 63.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 179.419 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -95.15 -12.25 26.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.024 1.33 . . . . 0.0 112.793 175.295 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -91.63 149.45 21.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.108 1.363 . . . . 0.0 112.724 -178.155 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -134.66 149.56 50.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.194 1.398 . . . . 0.0 110.552 149.022 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -118.68 117.53 29.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.666 1.186 . . . . 0.0 110.112 179.155 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mt -117.67 119.21 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.81 1.244 . . . . 0.0 110.105 -175.909 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -122.05 136.12 54.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.246 1.418 . . . . 0.0 109.7 175.614 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.64 42.39 11.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.945 1.298 . . . . 0.0 113.567 178.901 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.0 11.4 78.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.429 1.49 . . . . 0.0 116.748 178.709 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.0 147.96 51.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.113 1.957 . . . . 0.0 112.143 -176.827 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -74.59 143.66 44.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.148 1.379 . . . . 0.0 111.989 178.102 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.32 131.99 45.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.05 1.34 . . . . 0.0 110.513 175.609 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -102.79 140.43 37.08 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.628 1.571 . . . . 0.0 113.265 -174.436 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -63.27 -18.61 63.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.934 1.694 . . . . 0.0 115.23 -171.596 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.6 -11.77 84.4 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.043 178.167 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -113.59 177.96 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.622 1.711 . . . . 0.0 113.879 -169.76 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 p -114.88 167.72 10.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.831 2.052 . . . . 0.0 113.426 178.567 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.16 -37.53 72.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.717 -0.614 . . . . 0.0 112.376 171.13 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -65.85 -34.12 77.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 113.699 178.897 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.02 -1.05 . . . . 0.0 112.073 173.625 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -93.78 4.19 54.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.069 1.348 . . . . 0.0 113.907 176.397 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.28 31.33 18.34 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.078 1.351 . . . . 0.0 113.757 177.335 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.03 107.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 109.187 -175.268 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -81.17 171.17 15.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.137 0.975 . . . . 0.0 112.831 -177.911 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 148.14 16.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.206 1.002 . . . . 0.0 112.97 169.243 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 55.1 30.67 14.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.919 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -75.12 143.99 43.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.715 -0.615 . . . . 0.0 111.849 166.517 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -106.34 136.76 45.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.806 1.642 . . . . 0.0 110.274 171.469 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.75 161.69 35.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.122 1.369 . . . . 0.0 111.69 172.978 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -96.19 132.86 41.17 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.119 0.968 . . . . 0.0 111.343 175.317 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.15 113.35 25.56 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 160.986 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.73 132.04 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.956 1.302 . . . . 0.0 108.801 179.185 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.4 124.25 39.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.721 0.409 . . . . 0.0 110.101 174.356 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -67.74 159.55 29.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.982 1.313 . . . . 0.0 114.435 -168.657 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -84.22 167.96 16.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.959 1.704 . . . . 0.0 111.893 169.702 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 47.67 46.09 18.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.886 2.074 . . . . 0.0 115.58 168.712 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.48 -4.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 177.339 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-N 120.254 2.027 . . . . 0.0 114.205 179.755 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -100.71 135.0 42.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.362 1.465 . . . . 0.0 111.983 -171.825 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.96 155.91 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.478 1.511 . . . . 0.0 111.454 173.189 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -108.82 157.38 18.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 112.563 -171.611 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.49 136.33 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.273 1.429 . . . . 0.0 109.043 172.362 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -117.49 133.16 56.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.589 1.155 . . . . 0.0 111.994 170.33 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -82.06 159.42 23.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 112.42 178.626 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.68 -29.58 68.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.783 0.833 . . . . 0.0 112.121 167.692 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -72.57 -10.75 60.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.084 1.354 . . . . 0.0 114.232 173.232 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.08 12.36 52.43 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.448 1.499 . . . . 0.0 116.069 172.078 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -94.58 143.61 26.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.278 1.539 . . . . 0.0 111.173 178.792 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 m -105.39 142.11 35.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.766 1.226 . . . . 0.0 111.593 177.684 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.1 mt -127.36 138.7 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 127.835 2.454 . . . . 0.0 108.828 177.089 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.3 m -112.05 124.89 53.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.08 1.352 . . . . 0.0 110.346 177.241 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 pp -139.58 165.45 27.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.953 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -121.64 142.27 50.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.366 1.066 . . . . 0.0 113.043 -178.177 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.93 165.52 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 127.351 2.26 . . . . 0.0 110.99 -176.431 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -87.72 150.96 49.41 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 110.368 160.353 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.96 -13.09 17.26 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 124.092 3.195 . . . . 0.0 116.564 -178.668 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 p -105.56 -2.46 23.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.179 2.591 . . . . 0.0 114.578 -178.545 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.98 163.84 21.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.823 0.738 . . . . 0.0 112.153 175.357 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -98.81 162.28 13.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -172.94 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.7 mm -59.21 -35.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 177.396 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.53 -30.58 69.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.245 -1.534 . . . . 0.0 113.656 173.763 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -62.96 -36.32 83.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.272 1.396 . . . . 0.0 111.559 173.722 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.5 t -65.11 -46.64 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.599 172.852 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -59.88 -36.16 76.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 113.034 176.66 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.35 71.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.369 1.068 . . . . 0.0 112.948 175.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.83 -28.1 61.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.111 0.869 . . . . 0.0 113.058 173.711 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.79 -44.77 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.472 1.109 . . . . 0.0 110.561 166.222 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -58.1 -43.9 87.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.365 0.984 . . . . 0.0 112.008 174.587 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.78 -38.0 66.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 176.288 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.66 -47.9 10.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.55 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -102.37 -15.47 16.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.103 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.07 86.98 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.991 -1.068 . . . . 0.0 115.025 -174.395 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -82.52 122.12 78.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 118.636 1.218 . . . . 0.0 109.325 -175.818 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.41 137.13 35.72 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.568 2.179 . . . . 0.0 112.646 -173.315 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.0 -31.29 43.34 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.337 3.358 . . . . 0.0 115.711 176.952 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -64.13 -13.14 45.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 176.167 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -116.49 18.29 15.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.557 1.543 . . . . 0.0 112.613 179.405 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -119.95 139.39 52.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.24 1.816 . . . . 0.0 112.056 178.916 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -130.21 124.51 32.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.902 1.281 . . . . 0.0 110.03 163.004 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.57 151.87 21.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 112.625 178.79 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -131.22 144.46 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 110.314 -173.912 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -136.95 127.14 26.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.595 0.758 . . . . 0.0 111.689 162.288 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.43 44.72 5.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 114.115 -176.151 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.5 -9.99 65.85 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 -179.67 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -96.04 128.96 43.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.631 2.215 . . . . 0.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.21 142.59 57.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 111.666 172.941 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 mt -111.66 141.0 45.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.641 1.576 . . . . 0.0 112.215 -175.449 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.64 125.81 45.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -170.565 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -50.98 -35.47 33.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.079 2.152 . . . . 0.0 115.35 -169.612 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.42 -7.06 80.03 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.346 1.45 . . . . 0.0 116.009 -177.213 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -92.97 156.51 16.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.281 1.541 . . . . 0.0 112.558 -177.76 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -83.23 154.97 23.93 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.668 0.787 . . . . 0.0 111.928 177.14 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.18 -31.85 67.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.37 -0.831 . . . . 0.0 111.701 169.281 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -67.97 -24.74 65.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 171.611 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.97 -24.5 64.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.659 1.572 . . . . 0.0 112.284 171.466 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.17 -2.21 37.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.767 1.627 . . . . 0.0 113.671 168.656 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t30 48.23 47.07 19.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.439 2.296 . . . . 0.0 115.275 -173.023 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -92.73 123.04 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.593 1.157 . . . . 0.0 109.554 178.972 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -116.47 -175.72 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.335 1.854 . . . . 0.0 112.668 179.423 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -48.53 151.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -172.505 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 62.66 7.74 2.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.392 2.277 . . . . 0.0 115.856 173.223 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -65.41 150.7 47.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.601 1.561 . . . . 0.0 111.912 167.626 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -115.68 113.26 23.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.138 0.975 . . . . 0.0 110.397 174.053 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.95 152.5 33.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.709 1.204 . . . . 0.0 109.887 168.948 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -111.26 155.56 22.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.374 0.67 . . . . 0.0 109.757 169.748 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 tp -125.61 142.62 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.766 1.226 . . . . 0.0 110.862 -176.39 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.34 132.04 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 109.607 167.038 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.87 171.63 9.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.254 1.022 . . . . 0.0 113.642 -179.815 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -134.11 66.64 1.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.093 2.157 . . . . 0.0 110.136 170.596 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -76.55 152.34 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.428 1.091 . . . . 0.0 112.159 179.972 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -115.84 149.37 38.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.471 1.909 . . . . 0.0 111.846 -170.381 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.95 47.29 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 175.948 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.216 1.865 . . . . 0.0 113.893 177.546 . . . . . . . . 0 0 . 1 . 129 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -113.47 134.64 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.226 1.411 . . . . 0.0 112.143 -167.192 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.87 167.8 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.511 1.524 . . . . 0.0 111.717 178.29 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.94 137.87 54.56 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 111.598 -171.457 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.35 119.79 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.574 1.15 . . . . 0.0 109.534 179.235 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -89.63 144.86 25.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.448 1.099 . . . . 0.0 111.655 173.547 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p -100.22 155.37 17.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.181 0.992 . . . . 0.0 110.763 167.131 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.47 -27.5 68.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.801 -1.187 . . . . 0.0 111.21 168.064 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -73.84 4.62 5.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.555 1.942 . . . . 0.0 114.239 173.892 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.19 19.46 52.86 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 166.195 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.57 155.94 17.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.376 1.47 . . . . 0.0 110.624 170.694 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 m -124.21 131.03 53.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.288 1.435 . . . . 0.0 110.001 164.21 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.76 127.38 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 125.618 1.567 . . . . 0.0 109.519 -176.967 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -94.53 125.57 39.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.67 1.188 . . . . 0.0 110.979 175.914 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.95 156.09 32.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 112.244 -176.817 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.92 124.8 33.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 110.628 178.959 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.65 -178.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.655 1.982 . . . . 0.0 111.821 -168.573 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.59 152.35 46.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.888 2.075 . . . . 0.0 110.292 162.949 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.04 -18.79 45.24 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.03 2.486 . . . . 0.0 115.738 174.914 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 p -86.17 -4.53 59.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 115.376 173.475 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -74.5 150.83 39.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.297 0.953 . . . . 0.0 111.688 174.443 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 156.09 19.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.693 1.597 . . . . 0.0 113.601 -173.43 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.64 -32.47 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.532 -0.73 . . . . 0.0 111.1 170.763 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -56.21 -43.74 78.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.479 1.112 . . . . 0.0 113.077 167.749 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.9 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 112.696 176.481 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.57 -45.32 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.381 -0.825 . . . . 0.0 111.19 173.151 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.47 -34.6 75.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.834 0.743 . . . . 0.0 112.513 173.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.62 78.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.041 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -65.94 -44.21 85.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.218 0.917 . . . . 0.0 111.486 171.744 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.16 -39.61 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.753 0.821 . . . . 0.0 111.374 176.855 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.83 -40.83 80.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.779 1.232 . . . . 0.0 111.735 172.761 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.09 -51.41 46.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.872 0.76 . . . . 0.0 112.887 174.837 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -72.71 -35.08 67.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.079 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -114.93 -16.46 11.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -174.279 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.69 49.27 18.96 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.533 -1.355 . . . . 0.0 113.914 -178.965 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.27 122.07 28.3 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.864 1.666 . . . . 0.0 108.691 -179.438 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -62.4 139.15 75.27 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.508 2.139 . . . . 0.0 112.32 179.349 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.9 -34.89 93.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.115 2.543 . . . . 0.0 115.019 -176.565 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.42 -22.1 65.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.4 1.0 . . . . 0.0 113.597 175.931 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -87.62 -8.49 56.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 113.383 173.396 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.07 139.05 31.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 110.838 177.309 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ptt85 -132.07 135.4 46.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.932 0.893 . . . . 0.0 111.318 157.856 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.21 145.07 40.54 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.935 1.694 . . . . 0.0 111.949 -171.803 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -132.14 136.2 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.628 1.571 . . . . 0.0 110.503 -176.281 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -139.12 130.53 27.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 110.118 165.913 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 39.1 64.22 0.83 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.517 1.927 . . . . 0.0 114.283 175.694 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -16.27 7.65 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.239 1.876 . . . . 0.0 116.611 178.231 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -107.72 134.33 50.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.477 1.638 . . . . 0.0 112.017 -174.176 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -82.51 141.72 32.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.764 0.826 . . . . 0.0 110.235 169.157 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -102.95 128.16 49.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.302 -162.323 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -89.5 125.09 35.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.771 1.629 . . . . 0.0 112.461 179.331 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.13 -37.87 3.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 128.789 2.836 . . . . 0.0 114.765 178.335 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.55 -12.39 63.9 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.77 -1.572 . . . . 0.0 116.37 179.701 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -98.78 166.86 11.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.311 2.056 . . . . 0.0 112.912 -175.643 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -98.65 161.24 13.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.137 0.975 . . . . 0.0 112.742 170.522 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.0 -43.14 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.957 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 p -65.49 -34.64 78.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.193 0.997 . . . . 0.0 113.586 174.502 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.54 -18.09 64.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.047 0.84 . . . . 0.0 113.19 173.179 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.7 7.34 43.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.358 1.863 . . . . 0.0 114.888 168.977 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.8 t30 59.61 33.28 21.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.328 1.451 . . . . 0.0 114.613 179.666 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.5 mt -88.92 125.58 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.743 -1.223 . . . . 0.0 110.026 178.934 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -124.07 171.31 9.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.674 1.59 . . . . 0.0 112.827 -173.14 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -46.17 140.99 3.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.727 1.611 . . . . 0.0 113.007 172.172 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.37 18.97 8.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -176.904 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.83 141.58 55.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 119.932 -1.73 . . . . 0.0 111.876 170.658 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.3 m -97.14 131.93 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.634 0.773 . . . . 0.0 109.276 162.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 162.23 17.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.77 2.028 . . . . 0.0 109.847 172.975 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -116.17 143.55 45.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.766 0.826 . . . . 0.0 110.653 174.503 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.55 140.96 47.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.115 1.766 . . . . 0.0 109.691 171.665 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.52 135.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.303 1.441 . . . . 0.0 108.983 169.337 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.76 135.31 36.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.472 1.509 . . . . 0.0 109.864 172.102 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.37 144.7 56.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.791 0.836 . . . . 0.0 112.616 174.035 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.57 157.0 17.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.223 1.809 . . . . 0.0 112.955 -175.006 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 47.67 39.3 9.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.098 2.159 . . . . 0.0 112.657 -175.285 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.59 22.53 0.85 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.14 2.305 . . . . 0.0 117.675 -165.604 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.07 2.271 . . . . 0.0 111.244 178.266 . . . . . . . . 0 0 . 1 . 130 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 130 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -106.7 146.19 31.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 112.781 175.168 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.09 162.79 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.273 1.429 . . . . 0.0 110.234 163.353 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.61 133.14 56.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.257 1.023 . . . . 0.0 111.227 -175.116 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.7 118.3 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 174.916 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.25 118.59 29.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.304 1.442 . . . . 0.0 110.874 177.905 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -73.65 166.51 23.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.948 1.299 . . . . 0.0 112.587 -179.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.5 -31.64 70.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.293 -0.879 . . . . 0.0 112.087 167.56 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -72.83 3.35 5.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.634 1.573 . . . . 0.0 114.152 171.42 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.47 -10.97 57.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.36 1.933 . . . . 0.0 116.53 167.117 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -75.88 156.5 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.775 1.288 . . . . 0.0 111.28 175.924 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 p -99.21 145.18 27.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.723 0.773 . . . . 0.0 111.946 168.327 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 98.8 mt -118.08 121.64 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.409 1.883 . . . . 0.0 107.044 172.272 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 m -89.37 128.64 35.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.494 1.117 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -123.44 142.7 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 112.006 -177.862 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.39 126.64 52.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.034 1.734 . . . . 0.0 111.491 -179.38 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -152.14 169.87 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.12 2.168 . . . . 0.0 112.497 -167.971 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -114.11 159.0 37.98 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.729 1.612 . . . . 0.0 111.594 164.741 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.36 -18.49 59.35 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.444 2.762 . . . . 0.0 116.799 -171.926 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -96.56 7.46 46.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.139 1.775 . . . . 0.0 114.211 176.755 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -77.97 147.74 34.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.311 -0.868 . . . . 0.0 112.082 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -77.56 152.6 33.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.039 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.3 mm -66.6 -30.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.936 -1.103 . . . . 0.0 110.907 169.523 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.57 -43.44 62.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 165.11 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -65.85 -36.91 84.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.872 0.76 . . . . 0.0 112.934 176.015 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.29 -46.47 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.402 0.547 . . . . 0.0 110.787 173.808 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.21 -33.93 74.1 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.507 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.51 84.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.98 0.912 . . . . 0.0 112.594 172.079 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -68.02 -28.22 67.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.583 1.153 . . . . 0.0 113.41 173.045 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.0 -39.75 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.93 0.786 . . . . 0.0 111.134 167.372 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -59.84 -38.38 81.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.27 1.395 . . . . 0.0 112.618 177.164 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.27 -25.73 62.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.157 1.783 . . . . 0.0 115.092 178.927 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -134.31 -17.11 2.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -176.096 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -109.01 -20.42 13.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.416 1.086 . . . . 0.0 113.231 172.93 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.99 86.4 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 174.775 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -72.98 125.37 91.12 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 119.828 1.814 . . . . 0.0 109.176 176.41 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.44 130.8 37.33 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.339 2.026 . . . . 0.0 111.598 175.959 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.59 -34.54 53.07 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.673 2.915 . . . . 0.0 115.808 -177.506 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.68 -17.83 65.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.389 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -93.06 -13.43 28.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.511 1.525 . . . . 0.0 113.042 174.365 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.65 128.87 34.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.617 -176.588 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -88.44 145.05 25.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.776 0.83 . . . . 0.0 109.007 153.923 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.2 tp -121.12 126.84 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.918 0.887 . . . . 0.0 109.321 165.791 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.31 139.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.906 1.682 . . . . 0.0 109.496 -178.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -144.39 137.52 27.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.976 1.31 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 47.48 11.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.235 1.414 . . . . 0.0 114.143 179.455 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.77 9.88 86.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.686 1.613 . . . . 0.0 116.83 175.216 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -140.71 153.64 46.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.616 1.708 . . . . 0.0 113.094 -176.357 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -75.96 153.22 36.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.405 1.082 . . . . 0.0 112.057 177.402 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 mt -111.4 159.7 17.77 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.313 1.845 . . . . 0.0 111.392 174.618 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.11 169.27 8.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.717 1.607 . . . . 0.0 111.108 168.862 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -94.98 -31.69 13.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.637 -1.289 . . . . 0.0 113.48 -166.698 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 27.29 1.88 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.534 1.54 . . . . 0.0 115.666 -176.704 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -125.36 170.28 11.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.946 1.698 . . . . 0.0 110.537 -175.444 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -114.13 158.64 21.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.623 1.569 . . . . 0.0 111.679 174.801 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.3 mt -53.45 -42.97 67.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.285 1.034 . . . . 0.0 113.708 -173.107 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 p -66.62 -27.64 67.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 176.076 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -65.45 -31.16 72.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.19 1.359 . . . . 0.0 112.081 175.998 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.82 8.78 41.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.156 1.382 . . . . 0.0 114.122 175.398 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.82 35.24 21.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.33 1.052 . . . . 0.0 113.02 -174.554 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.52 102.19 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 175.683 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.14 165.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.847 1.259 . . . . 0.0 111.289 -178.915 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -56.52 152.81 11.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.521 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 62.91 4.38 1.47 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.066 2.147 . . . . 0.0 116.221 -175.647 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -65.4 156.68 31.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.339 1.055 . . . . 0.0 113.701 178.121 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -119.47 128.97 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.738 1.615 . . . . 0.0 111.16 177.9 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.15 158.93 26.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.505 2.322 . . . . 0.0 110.083 -177.904 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -116.88 123.69 47.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.24 -176.682 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.63 125.25 34.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.064 1.345 . . . . 0.0 109.294 173.508 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.6 t -136.58 157.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.588 1.555 . . . . 0.0 108.694 -175.779 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.21 151.1 19.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.513 -1.367 . . . . 0.0 112.591 -177.716 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -73.34 154.04 40.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.186 0.994 . . . . 0.0 112.773 173.549 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -63.62 -36.15 82.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.55 1.54 . . . . 0.0 113.351 -174.212 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -128.42 157.05 42.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.452 1.901 . . . . 0.0 110.14 170.605 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.22 -18.19 3.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.453 1.501 . . . . 0.0 115.447 178.036 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.366 1.46 . . . . 0.0 114.051 -178.725 . . . . . . . . 0 0 . 1 . 131 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.63 0.252 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 131 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.45 144.57 33.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 112.136 170.842 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.16 153.25 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.931 1.292 . . . . 0.0 110.335 158.415 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.82 146.86 23.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.586 0.754 . . . . 0.0 111.46 168.386 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.32 129.66 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.779 1.232 . . . . 0.0 108.498 167.687 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.82 148.3 50.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -177.581 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -90.48 161.19 15.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.53 1.132 . . . . 0.0 112.4 174.427 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.62 -24.89 65.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.797 -1.189 . . . . 0.0 113.064 176.182 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -79.73 3.76 18.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.054 1.741 . . . . 0.0 114.18 166.804 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.44 59.35 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 161.09 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -80.64 111.8 17.41 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.092 1.946 . . . . 0.0 111.195 -177.289 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -100.57 144.6 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.154 1.382 . . . . 0.0 111.895 -178.271 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.21 161.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.991 2.116 . . . . 0.0 111.463 171.738 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -102.81 146.19 28.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.652 1.581 . . . . 0.0 111.08 167.676 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 tp -132.57 147.14 52.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.679 1.592 . . . . 0.0 111.121 176.48 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.85 119.21 38.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.967 1.307 . . . . 0.0 110.912 177.519 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.44 160.81 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.476 1.51 . . . . 0.0 112.494 -171.626 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -111.75 151.42 43.41 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 123.814 0.846 . . . . 0.0 110.673 162.526 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -10.41 11.33 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.02 2.48 . . . . 0.0 117.092 -177.185 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -94.98 -2.89 49.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.18 1.792 . . . . 0.0 115.196 175.564 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.89 133.33 53.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 179.332 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.2 p -81.83 163.34 22.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.725 1.21 . . . . 0.0 113.063 174.901 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.51 -43.09 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 112.122 -164.88 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.12 73.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.051 -1.031 . . . . 0.0 113.325 -178.63 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.69 -38.01 86.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.862 1.265 . . . . 0.0 112.085 171.844 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.45 -39.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.204 1.002 . . . . 0.0 112.068 175.59 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -58.79 -37.31 76.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.957 1.253 . . . . 0.0 112.482 171.552 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.47 86.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 174.072 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.3 -37.23 77.19 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.656 0.782 . . . . 0.0 112.093 170.834 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.21 -34.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.486 1.115 . . . . 0.0 111.693 176.991 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.19 -38.94 92.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.247 1.385 . . . . 0.0 112.013 172.148 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.73 -33.03 74.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.169 0.895 . . . . 0.0 112.881 174.19 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -75.11 -47.64 27.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.503 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.17 -4.58 6.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -166.05 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.5 21.51 74.93 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.4 1.455 . . . . 0.0 115.995 173.663 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.93 116.66 61.28 Favored Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 125.735 1.614 . . . . 0.0 108.898 177.64 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.51 146.02 95.48 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.275 2.65 . . . . 0.0 114.497 -179.134 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.83 -33.43 71.09 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 124.125 3.217 . . . . 0.0 115.672 -178.658 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.49 -7.01 34.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.215 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -103.53 -6.6 21.58 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.298 1.839 . . . . 0.0 112.824 174.98 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -102.51 124.47 48.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.065 1.346 . . . . 0.0 112.927 -172.426 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -104.5 125.26 50.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.84 1.256 . . . . 0.0 109.048 159.465 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -107.41 130.56 54.8 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.281 1.032 . . . . 0.0 111.664 179.114 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.48 140.27 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.938 1.695 . . . . 0.0 111.155 -175.646 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -136.33 131.95 35.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.619 1.168 . . . . 0.0 112.736 167.574 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.21 44.62 4.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.882 1.673 . . . . 0.0 113.346 -170.897 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.45 -6.49 60.74 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 178.903 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -99.94 135.87 40.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 120.802 2.301 . . . . 0.0 111.604 177.053 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -72.73 134.94 45.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.054 0.542 . . . . 0.0 109.906 170.724 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -75.55 123.91 26.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.458 0.703 . . . . 0.0 110.983 -174.249 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.2 136.65 32.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 113.419 -174.483 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.44 144.76 55.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -169.445 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.49 -12.1 41.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.773 1.654 . . . . 0.0 114.849 -171.042 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -79.52 163.24 24.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.91 1.355 . . . . 0.0 111.653 167.151 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 p -109.77 169.23 8.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.466 1.907 . . . . 0.0 111.943 178.606 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.06 -34.7 63.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.183 -0.948 . . . . 0.0 112.832 171.712 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -66.4 -22.17 66.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.01 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.8 -17.97 64.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.558 1.526 . . . . 0.0 113.081 173.42 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -117.5 11.52 13.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.653 1.581 . . . . 0.0 112.75 -179.534 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.8 t30 54.57 41.87 31.66 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.341 . . . . 0.0 113.408 -179.93 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -85.62 124.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.895 1.278 . . . . 0.0 108.57 176.624 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.59 -178.77 4.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.005 1.722 . . . . 0.0 111.71 179.604 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -46.99 127.85 10.6 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.954 1.701 . . . . 0.0 113.947 -175.914 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 51.3 mt-10 62.08 25.31 15.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.812 2.445 . . . . 0.0 114.849 176.886 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -55.78 155.31 6.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.012 1.325 . . . . 0.0 112.393 160.169 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -115.45 118.93 34.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.521 1.129 . . . . 0.0 111.061 170.992 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.54 152.29 18.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.638 1.575 . . . . 0.0 109.642 171.793 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -109.16 132.06 54.48 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.923 0.889 . . . . 0.0 109.666 179.331 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.68 120.14 41.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.43 136.29 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.836 1.254 . . . . 0.0 109.138 173.022 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.04 132.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.216 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -79.13 -24.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.891 0.876 . . . . 0.0 112.439 171.309 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 tt -152.9 135.52 15.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.27 1.428 . . . . 0.0 109.683 167.988 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -145.94 143.27 29.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.195 1.798 . . . . 0.0 110.147 167.232 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.4 -172.57 41.58 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.144 0.402 . . . . 0.0 113.422 -175.25 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.661 1.6 . . . . 0.0 114.159 -177.116 . . . . . . . . 0 0 . 1 . 132 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 132 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.2 133.34 35.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.088 0.404 . . . . 0.0 110.429 174.016 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.62 167.01 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 125.635 1.574 . . . . 0.0 111.351 174.029 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -123.83 151.95 42.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.718 1.207 . . . . 0.0 112.092 174.527 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.88 133.21 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.89 174.853 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -119.63 132.9 55.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.576 . . . . 0.0 112.806 -175.426 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -90.36 161.03 15.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 111.684 166.542 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.12 -36.33 79.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.637 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -82.34 -1.31 49.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.641 1.176 . . . . 0.0 114.067 174.586 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.17 1.03 29.89 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.439 -1.756 . . . . 0.0 117.024 160.268 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -64.31 139.46 58.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.082 1.941 . . . . 0.0 110.016 177.588 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -118.27 127.36 53.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.2 1.0 . . . . 0.0 111.608 -172.962 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -104.52 132.88 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.083 1.353 . . . . 0.0 108.189 170.09 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -104.3 129.11 52.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.312 1.445 . . . . 0.0 108.38 170.426 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -130.1 147.51 51.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.206 0.912 . . . . 0.0 112.215 179.568 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 120.56 41.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.007 1.323 . . . . 0.0 108.696 164.811 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.24 156.3 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.08 1.352 . . . . 0.0 112.105 -172.918 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.93 144.19 27.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 124.374 1.07 . . . . 0.0 109.659 169.652 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -56.14 -23.66 45.83 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.785 2.324 . . . . 0.0 114.942 174.749 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 m -79.32 -8.73 59.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.045 2.138 . . . . 0.0 115.8 177.907 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.54 148.07 49.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.468 1.485 . . . . 0.0 111.015 173.173 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -86.55 156.27 20.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.469 0.707 . . . . 0.0 111.938 169.599 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.43 -32.96 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 169.832 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.08 -45.83 75.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.717 1.207 . . . . 0.0 112.836 168.107 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -73.39 -33.01 64.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.764 0.711 . . . . 0.0 112.838 178.936 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.4 -40.81 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.25 -0.906 . . . . 0.0 111.297 171.621 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -57.35 -40.22 77.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.65 1.114 . . . . 0.0 112.071 170.716 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.02 87.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 177.64 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -65.57 -32.52 74.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.886 1.275 . . . . 0.0 112.554 175.625 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.44 -38.97 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.378 1.471 . . . . 0.0 111.535 170.827 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -63.55 -41.7 98.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.85 1.205 . . . . 0.0 110.769 174.386 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.0 -37.45 87.46 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.808 0.731 . . . . 0.0 112.458 176.533 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -73.75 -59.53 2.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.587 1.155 . . . . 0.0 113.51 177.258 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -110.98 -0.56 16.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -169.792 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.32 -6.12 65.25 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 174.318 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.78 122.23 84.15 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.746 1.218 . . . . 0.0 109.78 -174.821 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.37 139.42 38.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.552 2.168 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.86 -23.77 61.86 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.493 2.795 . . . . 0.0 114.066 -169.711 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.92 -25.6 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 113.297 174.932 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -85.44 -36.72 20.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.848 0.749 . . . . 0.0 112.051 167.921 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -57.88 137.45 56.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.81 1.186 . . . . 0.0 112.468 -176.53 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -134.21 133.29 40.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.214 1.406 . . . . 0.0 109.412 160.292 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.56 132.4 44.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.099 0.96 . . . . 0.0 109.811 178.321 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.06 131.1 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 109.704 179.004 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -147.51 131.02 16.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.42 178.696 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.93 46.67 12.4 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.419 1.488 . . . . 0.0 113.046 -167.314 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.26 -15.8 1.86 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.287 1.899 . . . . 0.0 116.666 -178.495 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.17 144.61 25.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.612 1.565 . . . . 0.0 111.337 -175.568 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.55 131.64 36.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.133 0.973 . . . . 0.0 111.324 171.523 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 mp -93.07 145.35 24.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.078 1.351 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -110.63 144.26 39.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.229 1.812 . . . . 0.0 111.55 -176.42 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -77.77 -28.58 50.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -157.124 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.53 13.35 22.93 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -175.866 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -129.24 157.06 42.9 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.254 1.822 . . . . 0.0 112.121 -168.59 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -84.41 160.12 20.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -174.692 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -61.64 -37.44 84.0 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.305 -0.872 . . . . 0.0 112.522 177.417 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -59.46 -34.3 72.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.222 1.409 . . . . 0.0 114.452 172.323 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -65.93 -28.68 69.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.235 1.014 . . . . 0.0 112.985 -177.994 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -94.91 3.33 55.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.115 1.766 . . . . 0.0 114.041 172.493 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 54.12 48.75 20.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.446 1.498 . . . . 0.0 113.163 -176.037 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.8 mt -74.28 139.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 166.27 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -130.33 168.92 16.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.221 1.408 . . . . 0.0 111.559 -174.209 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -54.59 149.76 10.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.482 -0.761 . . . . 0.0 111.128 165.497 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.43 23.83 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.976 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 m -91.33 145.47 24.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.557 -1.339 . . . . 0.0 112.134 174.522 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.0 m -110.25 129.57 55.71 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.91 1.284 . . . . 0.0 110.594 169.681 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -102.98 146.64 28.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.191 1.797 . . . . 0.0 109.884 172.009 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -101.7 138.56 38.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.612 -0.68 . . . . 0.0 109.677 170.765 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.79 117.89 29.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.372 1.469 . . . . 0.0 109.716 -176.531 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.45 163.26 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.914 1.285 . . . . 0.0 111.511 -179.23 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.31 128.3 54.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.752 1.221 . . . . 0.0 111.206 -178.017 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -92.04 119.04 31.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.808 1.643 . . . . 0.0 109.123 170.347 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.22 136.94 52.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.834 1.254 . . . . 0.0 112.062 -167.732 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.7 mmm-85 -119.58 -15.08 9.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.956 2.103 . . . . 0.0 113.533 173.28 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.33 -161.46 54.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.78 1.181 . . . . 0.0 114.465 176.622 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 C-N-CA 126.397 1.951 . . . . 0.0 111.965 -176.502 . . . . . . . . 0 0 . 1 . 133 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 133 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.97 142.04 31.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.271 0.628 . . . . 0.0 111.123 170.364 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -127.26 156.42 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.269 1.028 . . . . 0.0 110.366 154.469 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -115.8 145.99 42.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.62 1.168 . . . . 0.0 111.513 -179.046 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.49 122.05 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.947 0.899 . . . . 0.0 110.703 177.488 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -89.83 129.65 36.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 111.745 175.368 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.3 p -106.65 151.91 24.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.157 0.983 . . . . 0.0 112.728 178.763 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.77 -12.52 60.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 112.897 173.527 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 p -72.93 -4.02 29.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.288 1.435 . . . . 0.0 113.334 163.721 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 47.33 7.15 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.944 1.259 . . . . 0.0 113.225 174.849 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -132.64 162.5 31.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.76 1.624 . . . . 0.0 110.948 -179.791 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.2 m -122.1 119.64 31.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.195 1.398 . . . . 0.0 109.799 169.413 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.31 133.13 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.838 1.255 . . . . 0.0 107.919 172.158 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.9 m -109.93 123.56 49.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.344 1.058 . . . . 0.0 109.046 168.796 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -120.09 131.7 55.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.214 1.006 . . . . 0.0 110.982 -178.42 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -79.6 125.24 29.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.935 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.31 175.96 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 126.844 2.058 . . . . 0.0 112.222 -174.214 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -126.44 146.37 56.27 Favored Pre-proline 0 N--CA 1.448 -0.526 0 C-N-CA 125.497 1.519 . . . . 0.0 110.369 169.639 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.06 -29.51 87.22 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.101 2.534 . . . . 0.0 116.456 -176.933 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.54 -4.48 56.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.699 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.83 156.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.675 1.125 . . . . 0.0 112.921 -177.705 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -93.81 157.08 16.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.056 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.38 -39.98 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.499 0.72 . . . . 0.0 110.94 173.875 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.94 -40.75 96.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.154 -0.966 . . . . 0.0 112.527 175.502 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.21 -35.46 79.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.166 0.586 . . . . 0.0 112.242 175.581 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.59 -47.08 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 119.61 1.095 . . . . 0.0 111.61 173.259 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 37.0 mtmt -60.29 -31.68 70.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.142 0.883 . . . . 0.0 113.325 176.979 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.07 66.77 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.887 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -73.15 -37.0 66.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.321 0.964 . . . . 0.0 111.928 169.908 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.34 -36.14 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 110.91 173.156 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -64.1 -45.15 89.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.298 0.954 . . . . 0.0 111.643 171.032 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.5 -34.79 77.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.361 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.72 -46.07 9.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 179.572 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -114.82 -7.83 12.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -171.462 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.9 8.84 85.08 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.945 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.3 mt -79.73 125.69 81.87 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 118.781 1.291 . . . . 0.0 108.551 -179.954 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.91 137.94 70.67 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.299 1.999 . . . . 0.0 113.415 -175.405 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.78 -18.82 47.54 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.146 2.564 . . . . 0.0 114.48 -168.813 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.48 -15.65 39.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.687 1.195 . . . . 0.0 113.684 172.607 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -97.03 -18.15 19.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.764 1.626 . . . . 0.0 112.859 175.372 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -67.92 141.29 56.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.363 1.065 . . . . 0.0 111.276 168.771 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -132.9 125.27 29.54 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.688 1.195 . . . . 0.0 110.322 160.138 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.6 140.03 36.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.514 1.126 . . . . 0.0 111.692 -179.476 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.55 135.01 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.7 1.6 . . . . 0.0 110.293 177.722 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -127.29 120.91 29.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.897 1.679 . . . . 0.0 109.866 170.29 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.62 51.26 6.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.818 1.647 . . . . 0.0 114.564 175.709 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.97 14.05 83.04 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.125 -1.375 . . . . 0.0 116.227 -179.059 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -122.06 121.35 36.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.972 1.709 . . . . 0.0 111.341 -178.601 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -68.88 137.42 53.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.382 1.073 . . . . 0.0 110.132 169.844 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 mt -99.28 120.81 40.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 111.914 -174.012 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -86.38 147.13 26.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.59 1.556 . . . . 0.0 113.078 179.524 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -72.09 -28.99 63.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -163.064 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 -10.19 86.2 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -179.972 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -87.96 163.76 16.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.849 1.324 . . . . 0.0 112.329 -173.417 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -98.03 161.01 13.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.218 170.663 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.49 -39.95 74.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.798 -0.564 . . . . 0.0 112.359 174.213 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -59.67 -37.19 78.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.184 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.46 -29.2 70.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.816 0.846 . . . . 0.0 113.219 -177.188 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -93.69 5.08 52.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.966 1.306 . . . . 0.0 114.188 177.248 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.25 29.96 18.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.793 1.237 . . . . 0.0 113.202 -171.584 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.67 131.69 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 168.987 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.81 179.11 5.72 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.528 1.531 . . . . 0.0 111.743 -166.031 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.77 127.46 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.311 -0.868 . . . . 0.0 111.206 179.925 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 61.91 29.8 17.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.813 1.645 . . . . 0.0 114.324 -176.458 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -68.69 147.34 51.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.155 -0.965 . . . . 0.0 112.205 167.32 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -111.05 132.63 54.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.543 1.537 . . . . 0.0 110.39 178.259 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.55 155.41 25.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.909 2.084 . . . . 0.0 110.548 176.521 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.05 143.51 33.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 166.924 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.07 127.16 55.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.599 1.56 . . . . 0.0 111.473 175.689 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.96 151.08 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.395 2.278 . . . . 0.0 109.624 178.314 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.0 tp -102.24 136.16 42.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.79 1.236 . . . . 0.0 112.079 179.981 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -128.24 82.52 2.09 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.318 1.847 . . . . 0.0 109.99 178.745 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.66 -25.03 67.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.641 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -69.3 10.51 0.32 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 179.466 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.68 171.39 21.34 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.454 1.026 . . . . 0.0 113.6 167.399 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 C-N-CA 126.113 1.816 . . . . 0.0 112.189 178.604 . . . . . . . . 0 0 . 1 . 134 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -77.46 145.08 37.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.269 1.028 . . . . 0.0 111.61 176.266 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -138.07 170.42 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.002 1.321 . . . . 0.0 110.801 164.299 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -119.59 145.46 46.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.608 1.163 . . . . 0.0 110.972 166.883 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.72 126.82 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 123.805 0.842 . . . . 0.0 109.885 169.44 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -92.15 125.98 37.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.6 1.96 . . . . 0.0 110.784 173.147 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -90.82 172.23 8.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.845 1.258 . . . . 0.0 111.99 -177.286 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.17 -25.84 67.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.731 -1.231 . . . . 0.0 113.49 179.378 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.2 p -87.29 2.53 49.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 113.932 178.181 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.93 1.2 89.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.972 1.273 . . . . 0.0 115.26 178.667 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -71.37 157.04 38.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.094 1.447 . . . . 0.0 111.148 171.015 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.3 m -109.34 147.14 33.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.68 1.192 . . . . 0.0 110.271 169.611 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 pt -125.51 148.23 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.565 1.146 . . . . 0.0 111.502 162.934 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.8 m -111.52 111.06 21.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.31 1.844 . . . . 0.0 110.46 -173.973 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.99 163.02 13.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.107 0.963 . . . . 0.0 112.33 -175.291 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -121.83 105.81 10.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.687 1.595 . . . . 0.0 109.45 177.365 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -125.7 150.99 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.166 1.786 . . . . 0.0 111.322 -168.714 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.26 144.24 66.34 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.612 -0.68 . . . . 0.0 111.083 174.77 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -53.11 -27.28 36.26 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.074 2.516 . . . . 0.0 115.303 174.507 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -114.35 29.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.832 1.253 . . . . 0.0 114.067 173.786 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.55 145.2 52.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.429 -0.794 . . . . 0.0 111.409 161.514 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.5 p -78.2 160.86 27.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.049 0.939 . . . . 0.0 111.537 169.857 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.95 -34.86 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 121.025 -1.047 . . . . 0.0 112.145 173.579 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.42 -31.83 70.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.464 1.106 . . . . 0.0 113.336 172.293 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -78.63 -6.11 54.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.196 -0.94 . . . . 0.0 113.285 175.199 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.65 -39.14 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.443 1.497 . . . . 0.0 111.731 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.9 -40.22 66.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.584 1.153 . . . . 0.0 113.415 178.287 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.31 71.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 175.558 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -78.27 -30.36 48.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.059 0.943 . . . . 0.0 112.769 176.854 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.3 -40.36 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.552 1.141 . . . . 0.0 110.676 173.35 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.2 -47.86 80.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.843 -0.535 . . . . 0.0 111.28 172.591 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.57 -32.97 65.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 114.065 176.593 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -84.91 -53.44 5.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.295 1.038 . . . . 0.0 113.388 179.298 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -122.8 2.19 9.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -166.024 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.24 87.35 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.653 1.121 . . . . 0.0 115.761 170.987 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -68.48 122.31 84.05 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 118.676 1.238 . . . . 0.0 109.622 -174.031 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.82 131.21 28.37 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.267 1.978 . . . . 0.0 112.021 -174.403 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -56.42 -33.69 92.65 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.256 2.637 . . . . 0.0 115.779 -173.128 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.87 -24.36 66.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.859 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.45 -6.02 53.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.923 1.289 . . . . 0.0 113.349 175.676 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -86.17 147.69 26.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.472 1.109 . . . . 0.0 111.404 177.723 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -141.86 143.16 33.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.026 1.33 . . . . 0.0 107.681 156.709 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -101.58 119.74 39.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.045 0.538 . . . . 0.0 110.592 170.796 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -103.66 131.63 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.582 1.553 . . . . 0.0 109.102 175.873 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -133.68 127.62 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.366 1.467 . . . . 0.0 110.336 173.976 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.92 42.27 11.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.647 1.179 . . . . 0.0 113.942 -178.838 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.18 -2.71 69.22 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.019 1.771 . . . . 0.0 116.616 -178.954 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -102.26 135.3 44.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.966 1.707 . . . . 0.0 111.001 -177.21 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -80.72 131.05 35.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.512 0.597 . . . . 0.0 110.633 171.389 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.45 146.67 26.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.578 1.151 . . . . 0.0 111.418 -177.138 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.96 146.61 42.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -165.584 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -32.23 38.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.968 2.107 . . . . 0.0 116.351 -170.416 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.4 -14.06 64.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 118.841 -0.977 . . . . 0.0 115.429 -178.132 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -104.18 158.23 16.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.112 1.456 . . . . 0.0 111.85 -172.068 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -106.93 163.5 12.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.481 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.95 -32.68 68.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.521 0.728 . . . . 0.0 112.922 172.824 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -74.24 -28.93 61.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 173.392 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -64.67 -43.15 94.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.706 1.139 . . . . 0.0 110.782 168.84 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -81.74 0.8 37.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 178.357 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 57.64 45.49 19.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.075 1.35 . . . . 0.0 113.283 175.453 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.89 120.29 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.773 1.629 . . . . 0.0 110.166 -177.337 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -93.31 163.36 13.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.605 1.562 . . . . 0.0 112.658 177.696 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -54.04 147.44 12.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 113.715 -177.816 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.59 15.79 8.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.166 2.186 . . . . 0.0 115.246 -178.335 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -67.14 154.63 40.76 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.793 1.237 . . . . 0.0 112.481 165.132 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -114.81 127.82 55.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.906 1.282 . . . . 0.0 111.34 -178.325 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.11 152.37 27.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.334 1.454 . . . . 0.0 110.128 173.687 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -121.22 148.9 43.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.328 1.051 . . . . 0.0 112.421 -174.353 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.56 135.14 44.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.44 1.496 . . . . 0.0 108.324 161.98 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.98 144.1 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.828 1.651 . . . . 0.0 110.567 -171.418 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.46 151.51 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.231 1.012 . . . . 0.0 113.313 177.522 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 55.65 16.46 1.94 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.474 2.31 . . . . 0.0 116.403 175.875 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -129.16 37.41 4.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.653 1.981 . . . . 0.0 110.21 174.83 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -88.64 -34.86 17.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 0.0 113.409 -174.694 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -173.86 28.9 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.207 0.908 . . . . 0.0 114.048 -176.417 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.85 -2.084 . . . . 0.0 111.007 178.052 . . . . . . . . 0 0 . 1 . 135 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 135 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -100.84 144.63 29.56 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.079 0.552 . . . . 0.0 112.486 171.276 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.51 171.57 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.009 2.123 . . . . 0.0 110.662 172.184 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -113.61 158.08 21.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.876 1.27 . . . . 0.0 112.213 174.012 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 t -134.62 134.54 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.768 1.227 . . . . 0.0 109.68 168.334 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.75 147.72 46.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.596 1.559 . . . . 0.0 112.917 -176.648 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.0 p -116.8 162.35 17.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.335 1.454 . . . . 0.0 113.85 -173.81 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.49 -26.72 68.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.722 1.209 . . . . 0.0 112.8 169.715 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -72.65 1.31 8.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.222 1.409 . . . . 0.0 113.784 168.906 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.31 7.82 88.18 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.515 1.055 . . . . 0.0 115.124 172.47 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -83.47 145.04 29.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.787 1.293 . . . . 0.0 109.832 176.369 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -119.74 133.82 55.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.504 0.722 . . . . 0.0 109.832 167.689 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.1 pt -119.71 161.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.443 1.497 . . . . 0.0 110.732 173.898 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -110.16 150.41 28.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.242 1.417 . . . . 0.0 111.289 176.586 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.74 139.69 32.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.025 0.93 . . . . 0.0 111.795 -178.376 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -107.32 124.82 50.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.479 1.112 . . . . 0.0 110.534 176.518 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 162.79 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.432 1.893 . . . . 0.0 111.395 -166.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -116.83 149.9 44.86 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.632 163.567 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.48 -24.15 51.34 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.228 2.619 . . . . 0.0 115.995 -178.637 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -77.67 -8.23 57.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.811 2.045 . . . . 0.0 114.802 176.621 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.03 143.73 49.03 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.228 0.922 . . . . 0.0 111.946 177.25 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.663 0.785 . . . . 0.0 111.386 177.051 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.29 -33.15 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.05 -1.032 . . . . 0.0 110.736 173.665 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.03 -32.44 72.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.626 -1.296 . . . . 0.0 113.446 173.715 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -70.43 -38.23 74.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.003 0.82 . . . . 0.0 111.487 170.445 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.11 -45.59 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 120.595 -1.316 . . . . 0.0 111.029 170.951 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -64.83 -34.33 78.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.26 175.862 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -28.97 61.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 173.211 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -69.94 -34.38 73.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.357 -1.464 . . . . 0.0 111.308 170.826 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.59 -48.94 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.965 0.906 . . . . 0.0 110.087 168.017 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -52.0 -38.42 56.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.316 1.046 . . . . 0.0 113.017 176.819 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.53 -43.38 68.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.192 0.905 . . . . 0.0 113.258 178.121 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -104.03 -12.84 16.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -175.793 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -116.37 -12.45 11.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.14 1.376 . . . . 0.0 114.413 177.791 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 -1.13 71.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.507 1.527 . . . . 0.0 116.798 176.36 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 mt -95.64 119.11 65.63 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.9 1.68 . . . . 0.0 109.857 -171.479 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -63.15 153.29 74.91 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.477 2.784 . . . . 0.0 115.613 179.38 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -55.22 -33.67 85.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.943 3.095 . . . . 0.0 116.375 -179.05 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.08 -23.67 67.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 120.184 1.356 . . . . 0.0 112.882 175.885 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -92.67 6.75 46.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.027 1.731 . . . . 0.0 112.951 -179.046 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -122.31 136.63 54.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.966 1.706 . . . . 0.0 111.662 -178.508 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -117.79 120.32 37.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.376 1.47 . . . . 0.0 109.63 164.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.76 131.26 49.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.126 0.971 . . . . 0.0 112.42 176.937 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.32 139.77 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 0.0 111.135 -177.166 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -155.66 139.94 16.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.319 1.448 . . . . 0.0 111.22 175.028 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.22 26.43 6.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.815 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.94 -4.33 31.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.475 1.988 . . . . 0.0 115.553 -170.358 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -90.07 151.08 21.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.332 2.253 . . . . 0.0 111.89 -176.011 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -71.02 125.84 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.596 0.759 . . . . 0.0 110.748 166.575 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.84 123.56 30.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.118 0.567 . . . . 0.0 110.018 167.244 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.36 128.47 54.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.112 1.365 . . . . 0.0 112.759 -161.497 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.912 1.685 . . . . 0.0 115.472 -165.47 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.31 3.58 82.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.924 1.249 . . . . 0.0 116.186 179.568 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -105.67 170.77 7.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.558 1.679 . . . . 0.0 111.213 177.433 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.5 p -106.71 164.12 12.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.139 1.376 . . . . 0.0 114.019 179.445 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.41 -37.72 70.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 168.98 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -65.55 -23.41 66.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.51 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -74.44 -12.07 60.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.01 -1.056 . . . . 0.0 113.284 175.558 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.03 0.46 13.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 113.154 170.678 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 44.87 54.39 6.81 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.641 1.977 . . . . 0.0 113.877 -172.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.41 137.44 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.451 1.101 . . . . 0.0 108.933 169.513 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -125.78 170.45 11.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.553 1.541 . . . . 0.0 112.735 -177.489 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -46.22 147.33 1.12 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.879 1.672 . . . . 0.0 114.299 178.892 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.41 4.16 0.91 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -176.989 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -63.62 146.29 54.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.47 -1.394 . . . . 0.0 112.649 172.466 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 m -105.68 123.84 48.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.045 0.938 . . . . 0.0 110.832 172.819 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.15 154.53 17.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.93 1.292 . . . . 0.0 110.534 169.903 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -112.35 139.38 47.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.402 -0.811 . . . . 0.0 110.734 179.539 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -121.02 137.78 54.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.989 1.316 . . . . 0.0 111.462 -173.389 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.86 137.91 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 109.485 167.233 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.82 146.38 25.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 112.306 179.471 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -141.87 53.88 1.49 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.829 2.052 . . . . 0.0 112.281 -165.357 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.09 142.82 43.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.084 1.353 . . . . 0.0 112.378 -175.066 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -87.9 -13.85 40.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.009 1.724 . . . . 0.0 114.458 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 158.91 27.41 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.404 1.002 . . . . 0.0 113.423 172.541 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.336 1.446 . . . . 0.0 112.439 -172.143 . . . . . . . . 0 0 . 1 . 136 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 136 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.26 146.15 27.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 112.697 174.656 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.43 159.61 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.314 1.446 . . . . 0.0 110.109 167.386 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.21 119.82 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.528 0.731 . . . . 0.0 112.001 -175.872 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.13 115.23 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.853 1.661 . . . . 0.0 109.855 -174.454 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.06 112.59 21.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.359 1.464 . . . . 0.0 110.853 177.325 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -75.1 171.52 13.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.912 1.285 . . . . 0.0 112.853 -178.559 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.51 -13.09 60.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 167.526 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p -96.22 5.57 50.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.254 1.822 . . . . 0.0 113.495 172.06 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.42 0.42 46.67 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.9 1.238 . . . . 0.0 115.856 -178.566 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -66.31 148.8 51.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.407 1.883 . . . . 0.0 109.676 174.685 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -115.13 92.89 4.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.213 0.605 . . . . 0.0 110.393 -176.807 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.16 135.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.844 1.258 . . . . 0.0 109.622 -175.887 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.5 m -89.4 141.47 28.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.129 0.972 . . . . 0.0 110.306 178.356 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -137.43 134.44 35.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.19 0.996 . . . . 0.0 111.658 178.017 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -91.31 119.67 31.54 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.344 1.058 . . . . 0.0 110.944 176.66 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 165.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.89 2.076 . . . . 0.0 112.222 -171.456 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -112.25 154.84 44.28 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.741 1.216 . . . . 0.0 110.741 164.181 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.68 -26.78 39.35 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.691 2.261 . . . . 0.0 113.411 164.007 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -76.29 -7.12 54.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.738 2.015 . . . . 0.0 115.444 175.276 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -80.31 143.69 33.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.568 1.531 . . . . 0.0 112.251 -178.184 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -78.04 156.13 30.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.969 1.308 . . . . 0.0 112.115 174.667 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.45 -37.75 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.504 -0.747 . . . . 0.0 111.579 172.954 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.68 -32.61 71.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.992 -1.068 . . . . 0.0 112.934 174.968 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.1 -37.92 84.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.747 -1.22 . . . . 0.0 111.479 173.461 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.37 -44.05 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 118.795 0.725 . . . . 0.0 111.157 170.738 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.41 -40.44 94.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.077 0.853 . . . . 0.0 112.92 174.695 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.78 -33.03 73.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 175.436 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -68.86 -36.62 78.34 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.291 1.036 . . . . 0.0 111.797 171.328 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.57 -43.58 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.162 0.985 . . . . 0.0 110.795 171.294 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.74 -38.21 64.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.68 1.127 . . . . 0.0 112.596 175.647 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.69 -4.74 16.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -179.78 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -132.38 -30.84 1.46 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 170.465 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.39 -9.02 16.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.288 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 8.45 76.2 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.959 1.544 . . . . 0.0 116.959 170.014 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.6 mt -84.58 124.53 73.17 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 119.551 1.675 . . . . 0.0 109.321 177.582 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -62.62 139.81 77.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.396 2.064 . . . . 0.0 112.344 174.354 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.49 -39.83 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.87 3.047 . . . . 0.0 115.737 -177.645 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.67 -12.6 58.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.483 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.83 -5.95 40.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.868 1.267 . . . . 0.0 113.199 172.493 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.06 123.1 43.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 120.23 1.377 . . . . 0.0 112.106 -175.941 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.12 134.07 35.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 0.0 108.949 154.529 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.71 134.92 52.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 109.56 167.858 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -128.66 129.59 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.125 0.97 . . . . 0.0 110.674 -171.177 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.16 141.04 21.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.758 1.223 . . . . 0.0 111.274 174.84 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 44.37 13.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.659 1.584 . . . . 0.0 114.756 171.979 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.94 1.66 74.13 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -179.368 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.45 132.69 54.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.04 1.736 . . . . 0.0 111.408 -179.433 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.72 107.94 18.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.209 1.404 . . . . 0.0 107.227 167.522 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -73.52 144.92 45.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -154.765 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.81 130.29 44.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.011 1.324 . . . . 0.0 113.142 -168.302 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -63.67 -30.63 71.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.177 1.391 . . . . 0.0 114.577 -165.445 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.98 -2.82 90.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.637 1.589 . . . . 0.0 116.01 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -106.53 166.29 10.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.807 1.804 . . . . 0.0 112.345 178.764 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.5 p -111.81 166.28 11.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.911 1.684 . . . . 0.0 113.544 -175.045 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.05 -37.1 71.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.309 -0.87 . . . . 0.0 112.74 172.539 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.0 p -73.51 -32.86 64.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.575 1.15 . . . . 0.0 113.897 175.29 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -59.04 -33.41 70.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.914 1.234 . . . . 0.0 112.469 167.904 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -91.21 4.89 51.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.152 1.781 . . . . 0.0 114.884 174.505 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.17 37.92 29.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 113.952 177.854 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.3 mt -85.66 134.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.482 1.513 . . . . 0.0 110.824 -176.538 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.04 166.27 10.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.301 1.84 . . . . 0.0 113.422 -177.809 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -49.49 139.42 12.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.966 1.706 . . . . 0.0 112.612 170.643 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 58.52 24.13 11.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 176.042 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -72.11 155.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.016 0.926 . . . . 0.0 111.956 168.251 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -107.4 140.02 41.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.09 166.93 23.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 111.96 169.197 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -110.81 147.42 34.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.155 0.982 . . . . 0.0 112.61 -174.297 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.81 125.87 54.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.773 2.029 . . . . 0.0 109.885 177.112 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -129.97 137.6 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.412 1.485 . . . . 0.0 109.64 -179.579 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.1 tp -89.01 133.51 34.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.096 1.359 . . . . 0.0 110.624 179.537 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -73.05 107.42 5.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.087 0.955 . . . . 0.0 108.526 164.977 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -70.39 -7.88 46.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -158.966 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -126.8 9.37 6.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.129 1.372 . . . . 0.0 114.101 174.913 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -28.52 69.76 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.429 1.332 . . . . 0.0 116.429 -171.836 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 119.163 1.481 . . . . 0.0 114.38 175.138 . . . . . . . . 0 0 . 1 . 137 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 137 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.81 148.56 24.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.19 0.905 . . . . 0.0 112.447 174.023 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -135.96 159.63 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.133 1.773 . . . . 0.0 110.822 175.241 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -110.6 139.4 45.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.629 0.771 . . . . 0.0 112.006 179.221 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.93 127.46 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.219 1.408 . . . . 0.0 109.468 174.021 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.73 139.05 49.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.104 1.361 . . . . 0.0 113.336 179.339 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -92.37 163.74 13.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.226 176.353 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -75.07 -6.04 47.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 175.985 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -112.97 28.15 9.03 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.447 1.499 . . . . 0.0 112.506 168.204 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.79 30.0 64.44 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.619 1.408 . . . . 0.0 116.619 160.58 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.14 135.33 36.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.506 1.653 . . . . 0.0 109.543 163.34 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -108.5 133.38 52.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.763 1.225 . . . . 0.0 109.531 171.578 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 132.99 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.194 1.798 . . . . 0.0 108.902 -176.681 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -98.08 133.29 42.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.133 0.573 . . . . 0.0 110.679 175.083 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.49 154.12 34.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.961 1.304 . . . . 0.0 111.386 176.24 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -108.53 127.68 54.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 109.489 172.345 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.63 165.28 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.754 1.622 . . . . 0.0 111.468 -167.34 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -113.7 156.5 43.52 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.253 1.021 . . . . 0.0 109.435 164.791 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -51.47 -31.02 37.32 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 123.277 2.651 . . . . 0.0 115.85 173.552 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -81.19 -1.51 44.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.458 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.67 136.67 39.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.031 1.287 . . . . 0.0 111.731 -175.211 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -86.1 164.42 17.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -168.309 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.84 -40.32 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.598 -0.689 . . . . 0.0 110.554 175.498 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.578 -1.326 . . . . 0.0 113.053 175.992 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.34 -38.69 87.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.507 0.594 . . . . 0.0 111.665 172.745 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.25 -41.59 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.895 173.173 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.96 -39.29 81.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 120.195 1.361 . . . . 0.0 112.417 172.383 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -32.68 70.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.385 1.074 . . . . 0.0 113.111 175.865 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.95 -34.35 73.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 112.792 171.261 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.75 -37.64 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.961 1.304 . . . . 0.0 110.687 171.01 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.18 -46.25 89.78 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.811 -1.18 . . . . 0.0 111.382 170.92 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -57.54 -52.25 66.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.812 0.733 . . . . 0.0 112.333 176.614 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -79.95 -39.78 29.49 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -174.249 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.32 -13.47 9.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -170.204 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 19.2 69.15 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.66 -1.275 . . . . 0.0 116.029 173.227 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.4 125.66 71.31 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 118.948 1.374 . . . . 0.0 110.268 -177.615 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.4 124.1 14.44 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.9 2.4 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.55 -31.03 90.49 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.688 2.259 . . . . 0.0 115.597 -173.713 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -18.89 65.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.926 1.239 . . . . 0.0 114.236 -175.407 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -108.17 2.55 22.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.074 1.35 . . . . 0.0 114.633 178.525 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.81 114.55 21.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.378 0.99 . . . . 0.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -103.06 114.56 28.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.823 1.249 . . . . 0.0 111.249 168.427 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.85 137.21 38.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.767 1.627 . . . . 0.0 112.133 -179.751 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.74 136.78 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.897 1.679 . . . . 0.0 110.392 -171.324 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -137.09 137.06 38.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 110.836 164.054 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.92 42.29 20.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.984 1.313 . . . . 0.0 113.239 -175.857 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.46 -15.53 1.52 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -174.107 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -77.58 123.72 26.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.312 1.556 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -69.27 120.0 14.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.272 0.629 . . . . 0.0 110.371 166.413 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -83.61 146.36 28.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.147 1.379 . . . . 0.0 113.23 -173.518 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.27 138.2 31.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.542 1.537 . . . . 0.0 114.097 -177.223 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.46 -39.92 67.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 114.614 -175.468 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.75 -0.33 89.17 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -174.917 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.19 176.32 5.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.815 1.646 . . . . 0.0 112.066 -173.765 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.4 p -121.34 168.43 11.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.371 1.868 . . . . 0.0 112.899 -173.291 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.06 -30.26 71.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.062 -1.024 . . . . 0.0 112.962 175.012 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.1 p -71.78 -34.24 69.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.872 1.215 . . . . 0.0 112.918 175.842 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.83 -36.15 71.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.081 0.855 . . . . 0.0 112.717 174.09 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -98.11 0.35 45.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.891 1.276 . . . . 0.0 114.103 177.958 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 52.8 45.51 28.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.215 1.406 . . . . 0.0 113.895 -177.928 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.09 102.16 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.938 1.695 . . . . 0.0 108.32 177.891 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.33 170.24 9.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.735 1.614 . . . . 0.0 112.648 -170.638 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 136.86 15.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.88 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 59.89 17.34 6.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.269 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -71.77 150.87 44.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 164.752 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -106.03 123.08 47.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.532 1.533 . . . . 0.0 111.473 -178.634 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.87 160.52 14.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.754 2.021 . . . . 0.0 109.654 172.666 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -118.63 147.12 44.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.883 0.873 . . . . 0.0 111.063 175.857 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -124.39 127.48 47.62 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.275 1.83 . . . . 0.0 110.949 -174.947 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.11 135.03 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.497 1.919 . . . . 0.0 109.206 -177.638 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.05 113.83 27.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.944 0.898 . . . . 0.0 110.162 177.361 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -55.96 -42.84 76.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.57 0.748 . . . . 0.0 112.731 -178.622 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.83 31.94 4.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.016 1.327 . . . . 0.0 113.095 -168.742 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -136.91 21.12 3.05 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.778 1.231 . . . . 0.0 113.383 174.495 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 -179.18 26.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.361 1.458 . . . . 0.0 116.525 173.185 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.516 -179.749 . . . . . . . . 0 0 . 1 . 138 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 138 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -100.36 144.75 28.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.881 0.872 . . . . 0.0 111.342 174.305 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.08 158.7 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.856 1.262 . . . . 0.0 111.28 168.442 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.62 118.79 27.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.964 1.306 . . . . 0.0 111.608 -169.36 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.91 112.76 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 125.465 1.506 . . . . 0.0 110.746 -175.811 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -97.19 134.44 40.51 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.202 1.801 . . . . 0.0 112.974 -174.816 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -108.5 154.01 22.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.914 1.286 . . . . 0.0 112.948 172.506 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.48 -22.23 66.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.967 1.307 . . . . 0.0 114.376 -176.853 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.6 p -85.13 19.18 2.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.694 1.998 . . . . 0.0 113.95 171.473 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.46 89.61 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 167.848 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -81.21 152.94 27.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.987 1.394 . . . . 0.0 110.303 175.762 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -131.67 129.34 40.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.578 1.151 . . . . 0.0 110.192 167.437 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.13 126.8 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.581 1.552 . . . . 0.0 109.519 178.074 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -101.05 142.18 32.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.381 1.072 . . . . 0.0 111.167 176.348 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -137.81 145.05 41.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.34 1.056 . . . . 0.0 111.688 169.684 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -89.49 122.82 33.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.812 1.245 . . . . 0.0 110.233 167.869 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.18 171.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 126.956 2.103 . . . . 0.0 110.955 -174.936 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -110.09 152.3 43.02 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 124.492 1.117 . . . . 0.0 110.048 164.354 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.08 -20.77 70.87 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.75 2.3 . . . . 0.0 113.638 175.271 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 p -76.97 -2.94 36.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.169 1.787 . . . . 0.0 115.05 172.182 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.61 151.0 32.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.144 -1.598 . . . . 0.0 112.786 176.92 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 p -84.79 157.92 20.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.958 0.903 . . . . 0.0 111.984 178.101 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -55.78 -37.87 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 121.539 -0.726 . . . . 0.0 111.906 176.527 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.44 -26.07 67.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.396 -1.44 . . . . 0.0 114.651 176.547 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -66.9 -26.87 67.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.309 -0.869 . . . . 0.0 112.556 173.954 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 t -81.57 -44.63 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.78 0.832 . . . . 0.0 110.281 172.356 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -61.82 -40.31 94.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.946 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.84 66.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 176.725 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.37 -29.28 42.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.74 1.216 . . . . 0.0 112.258 175.133 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.9 mt -62.54 -39.06 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.913 0.885 . . . . 0.0 110.932 165.523 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.95 -41.71 95.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.918 1.236 . . . . 0.0 112.018 172.442 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.86 -51.43 69.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.071 0.85 . . . . 0.0 112.996 177.524 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -78.97 -38.25 37.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -175.476 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -121.65 -0.85 9.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.27 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.46 6.47 88.04 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 170.461 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.38 116.17 66.09 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 109.419 -176.386 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.56 146.24 95.4 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.772 2.314 . . . . 0.0 113.031 177.095 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -46.84 -35.14 17.36 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 124.693 3.595 . . . . 0.0 116.004 179.496 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.12 -7.36 58.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.36 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -98.63 -0.27 43.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.508 1.123 . . . . 0.0 113.378 172.663 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -99.67 153.85 18.76 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.578 1.081 . . . . 0.0 112.877 -170.521 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -135.02 137.43 42.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.126 1.77 . . . . 0.0 109.815 150.075 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.9 tp -127.06 122.38 34.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 110.194 179.69 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 136.32 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.909 1.283 . . . . 0.0 110.586 -170.838 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -131.09 123.02 27.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.713 1.605 . . . . 0.0 110.886 173.748 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 36.93 5.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.37 1.468 . . . . 0.0 114.866 -178.44 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.57 90.49 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.99 1.757 . . . . 0.0 116.421 -176.728 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -99.27 133.0 44.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.604 1.702 . . . . 0.0 111.49 -178.808 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.81 147.1 29.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.068 1.347 . . . . 0.0 110.285 167.65 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -122.88 136.36 54.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.319 1.048 . . . . 0.0 111.948 -162.785 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.85 137.14 43.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.473 1.509 . . . . 0.0 112.507 -175.349 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.98 -30.46 67.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -163.422 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.86 -19.97 64.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -177.653 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -93.11 159.18 15.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.827 1.313 . . . . 0.0 112.062 -168.8 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -85.78 164.08 17.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.546 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.03 -42.07 89.32 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 121.467 -0.771 . . . . 0.0 111.511 171.18 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -73.26 -25.06 60.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 175.735 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -61.59 -21.68 64.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.353 1.433 . . . . 0.0 112.766 165.96 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -106.88 5.93 28.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 114.241 174.602 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 57.61 38.11 27.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.721 1.209 . . . . 0.0 113.695 -177.587 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.7 mt -85.01 135.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.872 1.669 . . . . 0.0 108.235 171.643 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.44 178.12 6.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.368 1.467 . . . . 0.0 112.828 -166.274 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -57.49 137.23 56.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.199 1.0 . . . . 0.0 112.626 175.056 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 57.89 25.68 12.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -173.434 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -63.38 143.27 57.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.428 -1.42 . . . . 0.0 113.748 179.098 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -97.52 131.81 43.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.245 168.352 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.15 155.23 47.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.833 1.653 . . . . 0.0 110.303 176.17 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -118.09 122.79 44.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.111 0.965 . . . . 0.0 110.849 -173.973 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.15 129.64 53.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 110.952 -177.933 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.24 162.1 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.705 1.602 . . . . 0.0 110.779 173.32 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.3 144.42 34.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.796 0.807 . . . . 0.0 111.17 173.706 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -80.0 137.93 36.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 110.275 177.706 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.18 154.69 21.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 111.423 176.33 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 54.51 39.16 30.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.089 1.756 . . . . 0.0 113.448 177.635 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.98 54.89 0.32 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 113.669 -169.761 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.746 1.641 . . . . 0.0 112.226 -175.574 . . . . . . . . 0 0 . 1 . 139 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 tmm? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 139 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -91.19 129.54 37.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.423 1.089 . . . . 0.0 112.73 -164.638 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -129.93 171.2 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.79 1.236 . . . . 0.0 111.324 172.15 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.4 153.27 39.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.899 0.88 . . . . 0.0 110.428 164.709 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.95 128.85 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.111 0.964 . . . . 0.0 109.823 174.174 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -129.7 140.5 51.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.105 1.362 . . . . 0.0 113.856 -168.704 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.9 p -107.23 163.17 13.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.76 1.624 . . . . 0.0 112.901 179.376 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -27.37 69.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.885 -1.134 . . . . 0.0 112.348 169.3 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -65.11 -8.98 19.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 167.802 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 8.59 78.11 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.3 1.428 . . . . 0.0 116.041 172.286 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.34 135.77 37.56 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 119.426 1.613 . . . . 0.0 109.698 174.377 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -126.41 108.27 11.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.289 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.6 tt -96.56 141.0 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 111.6 178.908 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -87.46 133.76 33.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.925 172.791 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -136.84 150.29 48.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 111.822 175.554 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -113.52 128.17 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.341 1.056 . . . . 0.0 109.793 165.008 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 m -133.88 153.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.174 2.19 . . . . 0.0 109.897 -176.188 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -81.53 143.78 51.85 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 120.916 -1.115 . . . . 0.0 111.478 174.303 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.33 -9.72 27.0 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.093 2.529 . . . . 0.0 116.323 -162.528 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -122.68 21.24 10.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.756 1.622 . . . . 0.0 113.139 174.26 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.86 152.3 45.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.886 1.274 . . . . 0.0 112.573 176.01 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.8 p -75.54 147.98 39.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 112.447 178.196 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.62 -37.02 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.271 1.028 . . . . 0.0 110.638 170.277 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.23 -49.52 60.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 112.867 169.604 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -75.57 -24.7 56.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.61 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.89 -43.36 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 120.945 -1.097 . . . . 0.0 110.45 168.654 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.0 -36.1 82.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.38 0.991 . . . . 0.0 112.479 174.051 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.18 81.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 173.816 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -65.42 -37.92 88.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.101 0.96 . . . . 0.0 111.958 171.651 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.46 -36.13 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 111.138 170.457 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -63.72 -42.87 97.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.334 -1.479 . . . . 0.0 111.903 172.648 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.09 -40.16 90.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.958 0.903 . . . . 0.0 113.138 178.513 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -87.65 -38.22 16.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.958 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.01 -12.24 12.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.882 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.84 69.35 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 173.883 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.82 121.27 56.6 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.347 1.459 . . . . 0.0 109.453 -174.212 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.8 Cg_exo -58.82 131.28 41.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.932 2.421 . . . . 0.0 113.689 177.596 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.6 Cg_exo -56.05 -31.15 81.53 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.986 3.124 . . . . 0.0 115.964 -175.986 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.63 -8.62 53.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.106 1.362 . . . . 0.0 113.993 177.073 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -99.65 -9.82 22.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.264 1.425 . . . . 0.0 113.29 171.706 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -95.47 130.02 42.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.848 1.259 . . . . 0.0 111.582 -173.583 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.23 138.99 50.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.648 1.179 . . . . 0.0 109.876 158.748 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.7 mt -113.98 131.95 56.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.306 1.042 . . . . 0.0 110.209 177.942 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 mm -125.54 133.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 110.049 -172.714 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -154.01 144.61 22.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.923 0.889 . . . . 0.0 112.646 176.248 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.66 43.23 12.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 114.426 -177.259 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.99 9.68 85.94 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 174.302 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -144.86 159.12 43.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.398 1.599 . . . . 0.0 114.481 173.872 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.13 135.1 42.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.09 1.356 . . . . 0.0 111.265 175.829 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.85 92.87 9.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.314 1.445 . . . . 0.0 108.675 174.248 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -75.51 156.42 35.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.222 1.011 . . . . 0.0 112.614 176.417 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.78 0.83 33.05 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.877 1.671 . . . . 0.0 115.329 -158.17 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 -4.03 87.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.323 -1.486 . . . . 0.0 115.524 175.445 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -120.67 174.17 6.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.785 1.634 . . . . 0.0 113.517 -173.667 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.9 p -118.43 165.65 13.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.697 2.399 . . . . 0.0 112.579 -179.755 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.23 -39.02 71.86 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.951 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -70.68 -28.2 64.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.694 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -64.83 -32.78 74.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.081 1.309 . . . . 0.0 111.63 172.205 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.8 5.8 48.48 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.865 1.666 . . . . 0.0 114.124 176.025 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 56.23 38.18 29.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.704 1.602 . . . . 0.0 114.919 179.362 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -87.81 128.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.094 1.357 . . . . 0.0 110.227 -178.861 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -136.27 174.89 10.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.386 1.875 . . . . 0.0 112.256 -176.285 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -47.35 142.89 3.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -173.348 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 39.9 mt-10 54.19 34.82 21.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.217 2.207 . . . . 0.0 114.58 -175.537 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -87.75 149.95 23.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.784 1.234 . . . . 0.0 111.198 163.692 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 m -119.57 126.39 51.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.737 1.215 . . . . 0.0 110.126 176.641 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.73 142.64 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.973 1.309 . . . . 0.0 109.623 178.522 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -87.47 138.65 31.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.69 -0.631 . . . . 0.0 110.021 171.923 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -112.96 123.27 49.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.113 1.765 . . . . 0.0 109.085 176.207 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -116.18 128.8 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.013 1.725 . . . . 0.0 108.909 179.639 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.57 134.94 39.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.735 0.814 . . . . 0.0 110.228 178.753 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -85.17 64.88 8.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.098 179.06 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.16 129.44 34.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.898 0.879 . . . . 0.0 110.564 178.757 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.54 -36.15 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.977 2.911 . . . . 0.0 116.975 -166.153 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.43 -24.35 76.43 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.497 1.499 . . . . 0.0 116.251 -176.372 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 126.552 2.025 . . . . 0.0 112.988 174.679 . . . . . . . . 0 0 . 1 . 140 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 140 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -80.69 139.04 36.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 175.703 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -140.27 160.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.54 1.536 . . . . 0.0 110.765 170.028 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -100.1 147.7 25.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.392 1.077 . . . . 0.0 111.71 166.789 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.66 134.08 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.764 1.625 . . . . 0.0 109.284 167.043 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -116.35 154.11 30.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.641 1.577 . . . . 0.0 112.391 177.337 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -125.39 155.54 40.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.284 1.433 . . . . 0.0 112.521 174.47 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.77 -19.52 65.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.597 1.159 . . . . 0.0 112.635 170.569 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -73.43 1.19 10.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.814 1.646 . . . . 0.0 113.659 168.54 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.81 25.69 68.95 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.851 -1.156 . . . . 0.0 114.456 174.813 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -96.01 142.89 27.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.299 1.049 . . . . 0.0 110.449 172.221 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.8 m -115.07 134.0 55.55 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.407 1.483 . . . . 0.0 108.15 172.533 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.1 mt -131.88 134.43 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.469 1.508 . . . . 0.0 107.676 -175.348 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -100.41 132.0 46.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.805 0.729 . . . . 0.0 109.426 168.181 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -119.99 152.8 36.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.289 1.036 . . . . 0.0 111.199 173.611 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -115.47 109.37 17.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.82 1.648 . . . . 0.0 108.82 173.55 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -127.41 169.52 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.697 1.599 . . . . 0.0 112.641 -171.675 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.6 134.44 25.27 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 124.643 1.177 . . . . 0.0 111.053 175.022 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.38 -26.31 34.78 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 124.372 3.381 . . . . 0.0 117.377 -176.461 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 p -80.44 -4.43 53.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 176.124 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -80.8 149.49 29.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.671 1.123 . . . . 0.0 112.843 -176.533 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -81.71 151.02 27.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 112.976 -179.019 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -57.66 -35.41 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 123.524 0.729 . . . . 0.0 111.783 176.963 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -70.58 -25.52 63.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.587 -1.321 . . . . 0.0 113.925 176.64 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -38.1 65.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.0 -1.063 . . . . 0.0 111.837 169.965 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.07 -40.63 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 118.635 0.652 . . . . 0.0 111.33 170.288 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -64.98 -37.56 88.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.914 -1.116 . . . . 0.0 112.112 173.867 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.11 68.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 113.906 173.183 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -68.38 -40.04 81.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.884 1.274 . . . . 0.0 111.44 170.805 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.13 -34.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.125 0.97 . . . . 0.0 111.523 171.698 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -62.98 -41.68 99.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.052 -1.03 . . . . 0.0 111.944 172.019 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.57 -40.98 96.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 112.542 174.677 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -69.85 -51.4 33.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.943 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.67 -6.75 10.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -164.073 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.07 -9.16 73.63 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.324 1.289 . . . . 0.0 116.324 176.502 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -73.51 123.98 89.95 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 119.474 1.637 . . . . 0.0 109.99 -174.663 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.59 142.93 50.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.949 1.766 . . . . 0.0 111.863 177.974 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.32 -32.68 62.45 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 124.084 3.189 . . . . 0.0 116.501 -175.598 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.54 -20.45 66.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.638 1.108 . . . . 0.0 113.467 177.474 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -102.96 9.99 38.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.354 1.462 . . . . 0.0 113.846 175.924 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -106.65 146.9 30.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.287 1.035 . . . . 0.0 110.83 171.839 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -133.28 140.86 47.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.702 1.201 . . . . 0.0 110.246 160.927 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.78 144.26 44.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 112.644 -178.954 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -136.88 137.9 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.745 1.618 . . . . 0.0 109.656 -177.912 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.68 119.88 17.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.058 1.343 . . . . 0.0 110.089 170.836 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.54 41.43 13.17 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.743 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.04 1.82 69.74 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 -176.409 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -83.62 126.67 33.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 109.467 171.471 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -85.49 113.88 22.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.258 1.023 . . . . 0.0 109.143 176.162 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.38 130.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.351 0.66 . . . . 0.0 111.403 -168.675 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.78 140.27 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.77 1.228 . . . . 0.0 113.545 -171.925 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.9 -33.16 64.38 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.749 2.02 . . . . 0.0 114.865 -170.304 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.56 16.58 49.01 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.429 1.966 . . . . 0.0 116.14 179.384 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.68 171.17 11.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.702 1.601 . . . . 0.0 112.146 176.631 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -107.01 161.78 14.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 113.328 -178.008 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.78 -38.05 71.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 174.846 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.4 m -58.51 -34.97 71.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 173.575 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.03 -14.33 62.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.904 0.775 . . . . 0.0 113.066 179.196 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.6 7.61 13.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.827 1.651 . . . . 0.0 113.938 179.279 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 m120 58.29 37.04 26.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 172.841 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 O-C-N 121.32 -0.862 . . . . 0.0 109.53 171.448 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -113.63 162.42 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.844 1.258 . . . . 0.0 111.984 177.161 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 140.51 57.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.12 -0.988 . . . . 0.0 110.949 172.108 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 62.69 17.64 9.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.325 1.85 . . . . 0.0 115.725 -173.662 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -66.49 155.93 36.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.964 -1.085 . . . . 0.0 113.113 172.456 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -111.35 121.52 45.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.797 1.239 . . . . 0.0 110.783 172.198 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.89 160.86 15.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.339 1.856 . . . . 0.0 110.027 177.636 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -119.21 135.73 54.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.12 0.968 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -113.23 133.96 54.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.425 1.89 . . . . 0.0 109.443 178.566 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.97 131.95 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.563 1.545 . . . . 0.0 108.585 174.318 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.71 130.22 52.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.231 1.012 . . . . 0.0 111.75 179.859 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -100.53 151.44 21.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.064 1.746 . . . . 0.0 112.073 -167.632 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.06 -41.87 1.26 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.3 1.44 . . . . 0.0 112.789 179.863 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -72.15 150.67 43.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.448 1.022 . . . . 0.0 112.86 176.619 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.31 -2.94 12.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.52 1.534 . . . . 0.0 116.786 -179.01 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 126.54 2.019 . . . . 0.0 112.099 179.287 . . . . . . . . 0 0 . 1 . 141 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 141 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -86.84 142.3 28.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.606 1.562 . . . . 0.0 110.09 170.881 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.9 pt -132.62 172.61 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.75 1.22 . . . . 0.0 111.404 165.458 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -125.37 151.32 46.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.963 1.305 . . . . 0.0 111.351 173.742 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.48 136.61 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.253 0.621 . . . . 0.0 112.154 170.762 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.38 129.58 55.24 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.229 1.812 . . . . 0.0 112.845 -176.751 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -84.36 176.62 8.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 113.292 -179.351 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.3 -22.93 65.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 177.535 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.9 p -85.83 -0.37 55.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.743 1.156 . . . . 0.0 113.69 170.599 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.94 8.81 86.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.583 1.087 . . . . 0.0 114.492 -177.515 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.57 138.22 50.72 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.951 1.375 . . . . 0.0 109.764 176.232 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -115.68 129.94 56.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 111.541 -176.279 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.07 161.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.757 1.223 . . . . 0.0 110.945 172.451 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -116.37 141.34 48.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.98 0.912 . . . . 0.0 112.944 176.809 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -127.55 149.11 50.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 110.864 -177.345 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -98.56 129.9 45.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.17 0.988 . . . . 0.0 110.322 171.784 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -146.0 165.63 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.602 1.161 . . . . 0.0 113.567 -174.336 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -121.42 158.75 52.73 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 127.093 2.157 . . . . 0.0 111.712 177.687 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.1 -31.4 90.23 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.197 2.598 . . . . 0.0 114.163 173.06 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -87.96 1.4 54.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.049 1.339 . . . . 0.0 114.579 176.799 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.85 155.71 39.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.718 1.144 . . . . 0.0 112.533 -174.369 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 p -119.15 153.63 34.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.058 1.343 . . . . 0.0 113.331 -169.225 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.13 -39.15 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.015 0.926 . . . . 0.0 112.205 -168.262 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -67.83 -32.92 73.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.879 -1.138 . . . . 0.0 112.994 178.81 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -71.0 -36.85 72.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.31 0.644 . . . . 0.0 112.089 172.244 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.56 -44.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.17 -0.956 . . . . 0.0 110.963 171.586 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -61.15 -39.87 91.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 112.673 175.531 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.83 98.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.655 -0.653 . . . . 0.0 112.64 173.748 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.46 -25.99 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 175.235 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.02 -37.73 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.916 1.286 . . . . 0.0 111.693 170.755 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.2 -37.77 88.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.605 1.093 . . . . 0.0 111.575 173.636 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.66 -25.77 67.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 174.766 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -82.26 -62.68 1.56 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.963 1.305 . . . . 0.0 112.598 171.918 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -115.27 0.52 13.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.935 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.66 15.82 79.26 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.803 1.183 . . . . 0.0 115.866 174.585 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.17 121.91 72.56 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 125.086 1.354 . . . . 0.0 108.145 177.396 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 138.79 31.46 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.163 1.908 . . . . 0.0 112.38 -176.165 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -48.53 -36.41 31.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.7 3.6 . . . . 0.0 117.28 -175.399 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.77 -18.47 62.11 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.806 1.185 . . . . 0.0 113.691 -178.705 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -91.45 -8.6 47.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.909 1.284 . . . . 0.0 113.347 173.589 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -91.67 127.77 37.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 111.921 -177.793 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -118.61 123.91 46.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.57 1.148 . . . . 0.0 110.514 163.858 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.85 133.62 42.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.02 0.928 . . . . 0.0 110.773 179.486 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.8 mm -122.99 135.76 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.495 1.918 . . . . 0.0 109.799 -176.739 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -153.07 144.89 23.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.369 1.468 . . . . 0.0 111.094 174.695 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.3 40.27 14.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.604 1.561 . . . . 0.0 113.676 177.114 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.28 4.19 86.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 179.112 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -133.22 162.66 31.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 120.157 1.979 . . . . 0.0 113.991 -178.101 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.98 132.62 42.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 110.628 171.906 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.89 112.84 19.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.281 1.032 . . . . 0.0 108.241 167.23 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.96 149.16 31.07 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.27 1.428 . . . . 0.0 112.728 -172.887 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.6 32.72 0.46 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.539 1.935 . . . . 0.0 114.991 -154.143 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.2 -3.18 15.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.864 1.697 . . . . 0.0 115.659 173.091 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -129.0 156.14 44.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.839 1.656 . . . . 0.0 112.397 -174.07 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -92.79 162.03 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.056 1.342 . . . . 0.0 112.023 179.492 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.18 -34.98 72.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.783 -1.198 . . . . 0.0 113.993 -175.137 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.4 p -69.34 -28.24 66.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.038 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.24 -23.33 64.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.309 0.959 . . . . 0.0 111.913 171.745 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.25 8.71 42.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.503 1.921 . . . . 0.0 113.609 172.993 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 57.22 31.2 19.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 179.44 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 120.147 -1.596 . . . . 0.0 109.813 178.383 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.4 173.28 6.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.621 1.568 . . . . 0.0 112.729 177.803 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 138.29 32.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.068 1.347 . . . . 0.0 114.635 -174.025 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 59.6 18.67 7.27 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.236 2.214 . . . . 0.0 115.686 177.662 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.0 m -64.36 153.81 37.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.704 1.202 . . . . 0.0 112.244 171.135 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -109.85 127.79 54.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.501 1.121 . . . . 0.0 110.177 176.879 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.69 167.34 9.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.173 1.789 . . . . 0.0 109.987 173.142 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -119.08 142.66 47.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.123 -0.986 . . . . 0.0 110.747 175.612 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.69 116.15 27.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.342 1.457 . . . . 0.0 109.761 177.006 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.47 117.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.212 1.405 . . . . 0.0 107.508 170.099 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.27 123.19 28.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.391 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -81.02 60.28 4.14 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.979 0.912 . . . . 0.0 113.122 -173.323 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.9 134.73 57.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 173.895 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 53.3 45.47 28.41 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.361 1.464 . . . . 0.0 113.492 -174.739 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.27 -37.72 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.762 1.172 . . . . 0.0 115.312 176.369 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 126.686 2.089 . . . . 0.0 113.364 175.43 . . . . . . . . 0 0 . 1 . 142 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 142 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -98.85 141.12 32.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.791 0.837 . . . . 0.0 112.858 173.305 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.56 169.87 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.334 1.454 . . . . 0.0 110.825 168.318 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.3 142.28 46.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.341 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.57 129.53 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.613 1.565 . . . . 0.0 108.934 169.763 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.86 125.96 53.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.255 1.022 . . . . 0.0 113.236 -171.181 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -74.55 168.33 19.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.172 1.389 . . . . 0.0 113.704 -172.169 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -60.97 -16.54 43.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.328 1.451 . . . . 0.0 114.258 168.724 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.4 p -94.03 -5.05 48.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.849 1.659 . . . . 0.0 113.061 171.742 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 10.11 82.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.975 1.274 . . . . 0.0 115.281 -178.603 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.14 133.35 39.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.496 1.648 . . . . 0.0 109.592 174.977 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 m -94.8 122.53 37.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.525 1.13 . . . . 0.0 110.351 -177.798 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.2 mt -109.53 125.78 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.866 1.667 . . . . 0.0 109.018 -178.493 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.7 m -81.53 137.67 35.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.291 0.636 . . . . 0.0 110.387 171.482 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.1 mt -128.18 148.19 50.6 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.17 0.988 . . . . 0.0 111.129 159.777 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.75 133.03 38.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.055 0.942 . . . . 0.0 110.933 165.048 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.25 164.6 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.135 2.174 . . . . 0.0 110.499 179.848 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.02 153.56 43.37 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.379 -0.825 . . . . 0.0 110.954 156.306 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.64 -26.47 65.15 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.035 2.49 . . . . 0.0 113.846 172.681 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 m -77.38 -5.97 51.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.12 1.768 . . . . 0.0 114.615 176.781 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.51 148.56 40.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.325 1.421 . . . . 0.0 112.751 179.494 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.97 154.91 19.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.77 1.628 . . . . 0.0 113.429 -175.803 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.98 -32.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 121.116 -0.99 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -58.6 -42.82 89.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.251 1.02 . . . . 0.0 112.017 170.902 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.01 -32.99 72.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 173.147 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.28 -46.77 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.973 1.26 . . . . 0.0 110.913 173.245 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.222 0.919 . . . . 0.0 112.662 175.094 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.23 77.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 113.07 176.372 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.74 -30.09 45.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.123 -0.985 . . . . 0.0 112.798 177.171 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mm -60.93 -44.63 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 110.799 166.657 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -57.02 -33.33 67.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.515 1.052 . . . . 0.0 113.061 175.312 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.29 -14.93 62.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 177.785 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -125.98 -11.64 6.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.048 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -125.29 -7.22 7.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.721 1.208 . . . . 0.0 114.243 176.439 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 -3.39 28.04 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 175.285 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -71.15 123.03 88.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.564 1.682 . . . . 0.0 109.41 -176.86 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.37 130.85 24.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.234 1.956 . . . . 0.0 111.426 179.776 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -49.28 -32.44 25.48 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.626 3.551 . . . . 0.0 116.382 -178.261 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.53 -24.27 67.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.085 1.312 . . . . 0.0 113.853 176.98 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -89.5 -13.58 37.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.796 1.238 . . . . 0.0 113.715 174.248 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.18 135.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.249 0.931 . . . . 0.0 111.619 -176.685 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -118.99 131.36 56.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.654 1.581 . . . . 0.0 109.714 164.83 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -114.97 122.05 45.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.836 0.855 . . . . 0.0 112.217 -177.322 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -114.93 135.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.452 1.901 . . . . 0.0 110.237 -173.656 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -141.68 138.92 32.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.82 1.248 . . . . 0.0 110.377 170.767 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.63 43.21 9.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.035 1.334 . . . . 0.0 113.429 -174.834 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.5 -2.69 76.98 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.802 1.668 . . . . 0.0 117.08 176.866 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -129.2 153.66 47.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.705 1.753 . . . . 0.0 112.683 -174.28 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -79.43 138.45 37.61 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.741 0.817 . . . . 0.0 113.175 -178.622 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -94.02 152.81 18.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.965 1.306 . . . . 0.0 113.087 -179.437 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.86 132.88 36.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.002 1.321 . . . . 0.0 113.015 -177.189 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.45 -39.24 70.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.879 1.272 . . . . 0.0 113.607 -179.367 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.01 5.27 50.17 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -178.008 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -117.89 163.87 15.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.697 1.748 . . . . 0.0 112.78 -173.837 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -100.83 151.36 21.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.27 1.828 . . . . 0.0 112.917 -175.49 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -57.27 -43.19 82.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 112.539 178.96 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -71.31 -26.12 62.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.63 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.47 -26.86 66.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.132 1.333 . . . . 0.0 112.458 175.019 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -87.86 5.46 40.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.421 1.888 . . . . 0.0 114.441 168.516 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 56.16 35.78 26.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 120.528 -1.358 . . . . 0.0 114.582 -174.565 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.98 138.47 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 O-C-N 120.378 -1.451 . . . . 0.0 109.164 172.596 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -129.49 172.79 11.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.209 1.404 . . . . 0.0 112.672 -169.206 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -53.69 129.08 31.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.072 1.349 . . . . 0.0 110.772 172.44 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 47.4 mt-10 65.41 11.48 7.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -174.024 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -62.51 149.33 43.21 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 120.424 1.466 . . . . 0.0 111.657 163.986 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.8 m -115.79 126.77 54.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.307 1.043 . . . . 0.0 111.994 178.982 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.62 156.94 17.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.128 1.771 . . . . 0.0 110.077 171.282 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -108.77 138.24 45.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.246 1.019 . . . . 0.0 110.802 174.549 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.9 tp -103.49 130.53 50.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.6 1.56 . . . . 0.0 109.781 174.971 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.1 t -129.39 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.963 1.705 . . . . 0.0 108.926 177.295 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.6 mt -109.04 155.75 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 112.528 -178.744 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -85.88 156.96 20.31 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.448 1.499 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -134.65 24.36 3.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.11 1.364 . . . . 0.0 113.836 -161.691 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.48 -43.82 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.521 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.73 -1.25 89.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.165 1.364 . . . . 0.0 116.27 -171.432 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.192 1.853 . . . . 0.0 112.878 176.757 . . . . . . . . 0 0 . 1 . 143 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 143 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.65 141.4 28.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.833 0.853 . . . . 0.0 112.079 176.544 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -138.46 167.01 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.686 1.594 . . . . 0.0 109.889 160.117 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -124.82 154.73 40.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.209 1.003 . . . . 0.0 111.851 176.089 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.39 131.13 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.677 0.791 . . . . 0.0 110.807 173.441 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.95 140.33 29.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.818 2.047 . . . . 0.0 110.319 171.635 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -121.31 154.11 36.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.164 0.986 . . . . 0.0 111.004 174.741 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.6 tp -51.13 -38.58 52.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.095 1.758 . . . . 0.0 114.814 -166.22 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 p -73.8 -7.96 54.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.373 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.25 -18.41 36.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.573 1.559 . . . . 0.0 114.127 -177.885 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -62.3 140.4 58.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.978 1.711 . . . . 0.0 111.208 176.548 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.6 p -113.82 159.5 19.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.522 1.129 . . . . 0.0 112.287 172.569 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.81 146.64 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 111.265 172.399 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.0 m -108.84 129.61 55.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 110.215 -176.512 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.41 154.18 34.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.364 1.066 . . . . 0.0 113.209 -174.215 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -109.28 111.27 22.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.327 1.851 . . . . 0.0 109.906 169.525 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.38 169.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.874 1.67 . . . . 0.0 111.776 -175.69 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -130.45 152.68 80.71 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 0.0 110.046 165.745 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.49 -23.17 76.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.387 2.058 . . . . 0.0 114.544 -174.074 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.3 p -73.91 -8.49 56.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 171.001 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -67.84 133.99 50.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.549 1.522 . . . . 0.0 111.175 179.166 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.2 p -70.42 153.34 43.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.681 -0.637 . . . . 0.0 110.995 169.441 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.1 mm -67.65 -27.4 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.707 -1.246 . . . . 0.0 111.71 179.959 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.65 -42.96 84.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.156 165.38 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -66.49 -31.55 72.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 173.121 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.88 -44.16 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 119.828 1.195 . . . . 0.0 110.656 170.186 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -64.09 -33.09 74.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.166 0.894 . . . . 0.0 112.831 173.595 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.75 -31.62 68.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.079 0.952 . . . . 0.0 113.009 173.132 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -72.05 -33.34 67.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.405 1.082 . . . . 0.0 112.687 171.174 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.97 -46.82 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 118.746 0.703 . . . . 0.0 110.055 167.14 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -55.92 -37.64 69.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.545 1.138 . . . . 0.0 112.041 175.156 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.05 -15.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 176.669 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -109.78 -41.93 4.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.182 1.393 . . . . 0.0 113.751 170.99 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -107.25 -13.03 15.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -167.389 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.72 17.35 74.94 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 115.915 175.661 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.57 126.91 54.6 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.075 1.438 . . . . 0.0 109.243 179.35 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.65 134.27 49.94 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.133 2.555 . . . . 0.0 114.101 177.302 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.9 -23.5 21.28 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.592 3.528 . . . . 0.0 117.114 173.973 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.9 -14.29 56.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 173.309 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.19 -40.17 12.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.795 168.761 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.17 147.16 53.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.046 1.339 . . . . 0.0 112.985 175.044 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -133.75 139.34 46.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.416 1.486 . . . . 0.0 110.555 155.865 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.42 135.29 47.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.782 0.833 . . . . 0.0 111.989 176.103 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.3 mt -121.13 131.18 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.717 1.607 . . . . 0.0 109.559 -179.713 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.53 125.67 36.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.41 1.484 . . . . 0.0 110.582 174.539 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.78 48.86 14.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.667 1.187 . . . . 0.0 113.333 -176.556 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 -5.58 41.3 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 179.389 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -104.9 133.3 49.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.823 1.812 . . . . 0.0 111.389 -179.664 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.56 132.26 36.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.938 0.495 . . . . 0.0 109.863 174.444 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -85.89 146.59 26.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.043 0.937 . . . . 0.0 112.333 -173.904 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -83.36 178.79 7.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.766 1.226 . . . . 0.0 111.77 172.866 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -101.93 -31.65 10.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -165.949 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.67 -30.94 25.48 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.096 0.862 . . . . 0.0 114.268 178.795 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -68.89 156.57 38.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.84 1.256 . . . . 0.0 112.339 -177.277 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -101.67 162.69 12.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.292 1.437 . . . . 0.0 114.301 -175.074 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.35 -37.11 64.54 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.205 0.602 . . . . 0.0 112.256 168.889 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -63.69 -42.38 98.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.539 1.536 . . . . 0.0 113.197 172.807 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -64.02 -36.39 83.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.055 0.843 . . . . 0.0 112.372 177.025 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -85.3 -3.63 58.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 172.989 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 t30 56.65 36.51 27.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.424 1.89 . . . . 0.0 114.944 -177.68 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.14 123.75 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.03 -1.044 . . . . 0.0 109.071 -177.372 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.17 169.05 9.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.705 1.202 . . . . 0.0 114.226 -166.932 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -44.32 134.32 5.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.261 1.824 . . . . 0.0 112.572 166.379 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 61.57 12.45 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.273 2.229 . . . . 0.0 116.086 -178.654 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 m -67.29 157.64 33.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.107 -0.995 . . . . 0.0 112.626 174.184 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.8 p -118.45 143.26 46.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.954 1.302 . . . . 0.0 111.937 -179.067 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.46 158.34 34.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 174.138 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -98.92 140.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.796 0.838 . . . . 0.0 110.725 167.987 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.66 130.05 51.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 110.029 169.227 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.77 158.43 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 125.097 1.359 . . . . 0.0 109.757 167.466 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.03 125.22 49.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.722 -0.611 . . . . 0.0 110.641 175.229 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -127.37 100.85 6.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 0.0 110.445 176.046 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.4 153.66 43.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.811 -179.644 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -105.3 -20.68 13.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.675 2.39 . . . . 0.0 111.941 174.304 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.18 -175.53 49.89 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.269 1.89 . . . . 0.0 113.755 177.608 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.338 -1.812 . . . . 0.0 112.979 174.748 . . . . . . . . 0 0 . 1 . 144 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 144 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -87.51 136.84 32.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 169.003 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.49 150.12 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.256 1.022 . . . . 0.0 111.072 166.958 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -93.11 149.28 21.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.52 1.128 . . . . 0.0 111.792 174.862 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.11 122.31 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.251 1.021 . . . . 0.0 110.873 166.193 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 113.81 15.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.974 1.309 . . . . 0.0 109.398 172.919 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -78.59 169.63 17.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.926 1.69 . . . . 0.0 114.21 -171.299 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.14 -22.29 64.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 176.394 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -93.61 -6.51 46.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 113.828 -176.848 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.22 -16.5 45.55 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.039 1.304 . . . . 0.0 115.501 176.414 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.46 170.95 15.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.163 1.482 . . . . 0.0 112.203 170.559 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 m -124.56 132.68 53.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.082 0.953 . . . . 0.0 111.721 174.1 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.0 pt -103.67 156.64 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.445 1.498 . . . . 0.0 110.973 177.177 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.9 m -117.6 129.54 55.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.481 1.113 . . . . 0.0 110.509 174.162 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.75 148.71 34.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.807 1.643 . . . . 0.0 111.195 179.381 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -101.9 119.02 38.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.552 1.141 . . . . 0.0 110.857 173.256 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.28 174.42 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.026 2.13 . . . . 0.0 111.873 -170.073 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.12 158.63 74.65 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 111.241 170.462 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.13 -27.91 31.29 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.698 2.932 . . . . 0.0 115.613 174.002 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -92.84 -2.92 55.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.506 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 150.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.051 1.296 . . . . 0.0 111.67 172.868 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.3 p -89.72 159.19 17.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.915 0.886 . . . . 0.0 112.804 -179.027 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.65 -32.71 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 121.362 -0.836 . . . . 0.0 111.32 169.588 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.32 -34.96 78.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 120.813 -1.18 . . . . 0.0 113.898 174.749 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -69.19 -36.28 77.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.401 0.681 . . . . 0.0 112.149 169.494 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.21 -43.48 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 119.43 1.014 . . . . 0.0 110.863 171.628 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.23 -35.68 81.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.596 1.089 . . . . 0.0 113.233 175.418 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.02 85.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.834 0.743 . . . . 0.0 112.95 172.827 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -68.37 -29.43 68.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.532 1.133 . . . . 0.0 112.708 174.382 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.89 -39.26 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.385 1.074 . . . . 0.0 111.026 168.733 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.69 -35.58 78.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.056 1.298 . . . . 0.0 112.158 174.865 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -64.17 -38.46 91.12 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.528 1.131 . . . . 0.0 113.332 170.705 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -88.94 -31.38 18.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -173.414 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -120.47 -16.03 8.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.384 1.874 . . . . 0.0 114.782 -173.312 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.48 12.9 82.13 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.095 -1.003 . . . . 0.0 115.437 -176.368 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.68 125.07 50.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 119.045 1.423 . . . . 0.0 108.85 -179.389 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.15 149.09 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.491 2.127 . . . . 0.0 112.735 -176.701 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -52.46 -30.37 43.66 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.893 3.062 . . . . 0.0 117.044 -175.49 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -66.73 -14.03 62.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.963 1.256 . . . . 0.0 114.086 177.707 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -98.18 -3.26 38.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.032 1.733 . . . . 0.0 113.551 172.476 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -105.67 119.76 39.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.968 1.258 . . . . 0.0 113.747 -171.768 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -107.74 127.29 53.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 108.605 166.541 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -112.49 124.39 52.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.02 0.827 . . . . 0.0 112.169 -177.004 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.47 138.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.177 1.791 . . . . 0.0 110.107 -177.422 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -134.39 115.47 14.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 109.956 173.171 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.96 50.29 13.92 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 113.489 -172.714 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.82 6.02 71.27 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 179.277 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -112.48 132.97 54.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 110.919 -179.047 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -72.7 129.14 37.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.647 1.112 . . . . 0.0 111.007 174.674 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -92.27 140.97 29.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.421 0.688 . . . . 0.0 111.257 172.889 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -99.44 134.69 41.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.173 1.389 . . . . 0.0 113.051 -169.398 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.0 -30.78 26.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -174.187 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.32 -6.0 84.58 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.048 -179.593 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.78 155.89 17.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.423 2.111 . . . . 0.0 112.4 -178.667 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -91.4 159.98 15.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.797 1.239 . . . . 0.0 111.298 171.613 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.4 -32.94 70.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.205 -0.934 . . . . 0.0 112.693 175.658 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.5 m -58.93 -29.29 67.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.487 1.515 . . . . 0.0 113.951 172.972 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -73.22 -11.72 60.62 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.211 0.914 . . . . 0.0 113.113 176.189 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -119.77 7.81 11.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.826 1.651 . . . . 0.0 113.683 178.153 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 m120 57.7 34.96 25.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.408 1.483 . . . . 0.0 114.755 173.021 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.3 132.54 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.004 1.321 . . . . 0.0 110.715 -176.859 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.36 170.71 7.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.071 1.348 . . . . 0.0 112.188 168.991 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -52.32 149.66 5.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.083 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 59.83 24.55 13.56 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.464 1.905 . . . . 0.0 114.664 174.553 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -71.73 156.44 39.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.864 1.666 . . . . 0.0 111.456 162.947 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.7 m -116.07 124.98 51.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.034 1.333 . . . . 0.0 111.838 177.124 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.41 156.11 16.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.525 1.53 . . . . 0.0 109.858 163.932 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -111.51 129.66 55.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.698 1.199 . . . . 0.0 109.582 170.488 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.5 134.87 33.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.911 0.884 . . . . 0.0 109.299 170.972 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.19 150.45 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.043 2.137 . . . . 0.0 108.391 179.547 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.46 120.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.438 -0.789 . . . . 0.0 111.183 175.438 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -82.98 134.68 35.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.819 1.248 . . . . 0.0 110.278 171.575 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -126.25 -17.46 5.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.646 1.578 . . . . 0.0 113.309 -179.263 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -79.37 3.19 19.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 177.054 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 -23.38 51.64 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.612 1.096 . . . . 0.0 115.505 179.202 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.778 -179.283 . . . . . . . . 0 0 . 1 . 145 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tmm? . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 145 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.71 134.68 42.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.673 0.67 . . . . 0.0 112.678 -170.0 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.49 164.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.728 1.611 . . . . 0.0 112.007 177.291 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.43 141.43 52.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.454 1.102 . . . . 0.0 112.89 174.547 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.68 125.26 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 124.864 1.266 . . . . 0.0 110.045 175.812 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -106.99 144.7 33.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.031 1.732 . . . . 0.0 112.378 178.708 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -98.53 163.95 12.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.394 1.478 . . . . 0.0 113.745 171.729 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.74 -25.26 68.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.184 0.994 . . . . 0.0 112.355 166.547 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.8 p -76.72 0.88 18.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.9 1.28 . . . . 0.0 113.511 171.404 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.08 87.64 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.176 1.37 . . . . 0.0 115.773 174.005 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.92 138.94 32.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.358 1.463 . . . . 0.0 110.493 -177.995 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -120.71 130.18 53.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.822 0.849 . . . . 0.0 111.364 178.398 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 tt -116.26 147.7 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.527 1.531 . . . . 0.0 110.381 173.525 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 t -108.9 146.0 34.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.873 0.869 . . . . 0.0 112.642 173.228 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.95 150.45 51.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.03 1.332 . . . . 0.0 111.521 176.566 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -99.99 128.72 46.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.281 1.432 . . . . 0.0 110.413 168.28 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.04 157.94 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.499 2.32 . . . . 0.0 111.302 -174.677 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -85.13 146.74 45.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.551 168.986 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.59 -21.12 72.53 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.521 2.148 . . . . 0.0 116.49 -165.918 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -119.51 24.65 10.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.095 1.758 . . . . 0.0 113.692 176.555 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -66.19 152.87 43.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.829 -1.169 . . . . 0.0 112.087 170.258 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -81.33 138.42 35.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.755 1.222 . . . . 0.0 110.807 -178.302 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.11 -34.02 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.7 0.8 . . . . 0.0 112.372 -176.495 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.28 -35.2 67.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.56 -1.337 . . . . 0.0 113.748 173.955 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -81.13 -22.87 38.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.369 -0.832 . . . . 0.0 112.707 174.822 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.95 -39.4 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.804 -1.185 . . . . 0.0 110.284 168.271 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -61.61 -33.76 74.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 120.94 -1.1 . . . . 0.0 112.652 170.556 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.77 -27.07 68.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.464 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -78.24 -39.38 40.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.751 -1.218 . . . . 0.0 110.975 174.174 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.63 -40.56 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.431 1.092 . . . . 0.0 110.894 171.135 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -60.34 -47.51 85.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 112.007 172.484 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.95 -39.94 83.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.535 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.74 -52.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 178.825 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -106.53 -6.31 18.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.506 1.123 . . . . 0.0 113.655 -167.165 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 11.57 83.67 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 172.617 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 mt -91.34 123.52 63.86 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 118.887 1.343 . . . . 0.0 109.51 -172.543 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.8 132.45 35.01 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.472 2.115 . . . . 0.0 113.288 -178.796 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -56.54 -24.67 54.62 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.744 2.962 . . . . 0.0 116.41 -179.769 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.46 -13.08 59.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.256 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -96.45 -27.7 14.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.444 1.897 . . . . 0.0 112.047 170.368 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.76 133.67 47.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.991 1.317 . . . . 0.0 111.823 173.421 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.58 127.35 38.86 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.095 1.358 . . . . 0.0 109.511 164.085 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.3 mt -103.46 136.2 43.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.189 0.996 . . . . 0.0 112.495 -177.328 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -124.94 130.58 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.555 1.942 . . . . 0.0 109.589 -178.214 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -140.92 132.56 27.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 110.829 176.313 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.45 44.03 30.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.409 1.084 . . . . 0.0 113.419 -175.514 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.27 5.95 60.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.094 1.33 . . . . 0.0 115.644 -179.253 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -120.41 136.35 54.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.458 1.503 . . . . 0.0 111.38 -171.841 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -72.9 131.28 42.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.315 1.046 . . . . 0.0 110.556 176.892 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.8 mt -88.27 126.06 34.98 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 110.091 177.364 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.25 139.06 36.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 160.291 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.98 -23.57 48.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -161.967 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.45 10.26 37.64 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.982 1.553 . . . . 0.0 116.982 -177.602 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -118.37 162.01 19.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.95 1.875 . . . . 0.0 111.784 175.479 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 162.73 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.978 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.08 -44.58 64.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.78 1.232 . . . . 0.0 112.051 168.927 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 p -69.79 -34.47 73.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 175.62 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.79 -34.85 79.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.828 1.194 . . . . 0.0 112.772 174.232 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -87.38 3.35 47.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.002 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 55.42 44.52 26.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.236 1.814 . . . . 0.0 114.309 178.408 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.21 121.26 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 108.499 175.513 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.05 174.05 7.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 111.761 -173.538 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 134.06 44.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.437 1.095 . . . . 0.0 113.843 -177.177 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.27 10.85 4.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.293 2.237 . . . . 0.0 116.004 -175.61 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -70.96 148.99 47.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.683 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 138.17 51.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.854 1.261 . . . . 0.0 110.003 -177.871 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.7 170.31 14.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 145 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -117.44 145.13 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.425 1.09 . . . . 0.0 112.244 -170.661 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.15 138.13 51.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.728 1.611 . . . . 0.0 111.02 -179.001 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.48 137.01 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.821 1.648 . . . . 0.0 109.185 173.686 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.6 mp -95.74 112.75 24.4 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.101 0.961 . . . . 0.0 108.596 170.065 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -60.22 112.65 2.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.167 0.987 . . . . 0.0 113.403 -167.668 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.1 130.15 42.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.56 1.144 . . . . 0.0 110.418 -178.585 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 58.21 17.14 4.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.933 1.693 . . . . 0.0 114.441 -169.769 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.56 173.45 19.65 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.835 1.683 . . . . 0.0 112.624 176.354 . . . . . . . . 1 1 . 1 . 145 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.737 -1.591 . . . . 0.0 113.854 179.499 . . . . . . . . 0 0 . 1 . 146 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 146 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -89.03 130.38 35.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.786 1.234 . . . . 0.0 111.561 -175.236 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -137.17 168.11 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.894 1.678 . . . . 0.0 110.402 174.623 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -127.04 147.98 50.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.245 178.829 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.17 122.07 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 109.386 173.631 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -101.7 138.01 39.25 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.979 1.711 . . . . 0.0 111.492 178.629 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.1 p -98.63 160.37 14.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.812 1.245 . . . . 0.0 112.812 179.265 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -59.69 -33.47 71.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.626 -0.671 . . . . 0.0 111.382 172.704 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.54 12.13 4.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.136 1.374 . . . . 0.0 113.688 176.817 . . . . . . . . 2 2 . 1 . 146 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.89 24.95 72.91 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.74 -1.225 . . . . 0.0 115.68 169.733 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -94.91 146.32 24.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.465 1.133 . . . . 0.0 108.955 168.805 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -118.49 137.82 52.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 171.302 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 120.68 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.246 1.818 . . . . 0.0 108.884 -177.181 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.93 133.12 35.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 110.599 174.789 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.22 154.67 49.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.283 1.433 . . . . 0.0 111.802 176.936 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -131.88 120.12 22.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.813 0.845 . . . . 0.0 112.471 -179.693 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -145.28 166.41 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.84 2.056 . . . . 0.0 111.056 -174.762 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -88.23 159.99 46.62 Favored Pre-proline 0 N--CA 1.449 -0.491 0 O-C-N 120.965 -1.084 . . . . 0.0 111.019 169.105 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.22 -19.17 40.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.781 2.321 . . . . 0.0 114.556 169.16 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -86.44 -8.41 57.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.348 2.259 . . . . 0.0 115.708 176.28 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.13 151.67 44.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.047 1.294 . . . . 0.0 111.775 173.802 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -81.84 159.39 23.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.354 -0.841 . . . . 0.0 112.571 179.399 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -60.35 -32.74 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.407 -0.808 . . . . 0.0 111.201 170.005 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.77 -36.94 83.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.315 1.046 . . . . 0.0 112.644 175.823 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -59.56 -43.45 93.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.139 0.881 . . . . 0.0 111.743 172.656 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.44 -42.19 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.726 -0.608 . . . . 0.0 111.024 178.373 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.68 -36.7 81.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.88 0.764 . . . . 0.0 112.836 175.176 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.72 78.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 176.766 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.86 -36.71 75.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.113 0.869 . . . . 0.0 112.624 173.256 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.44 -37.92 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.974 0.91 . . . . 0.0 111.042 172.279 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.82 -39.88 95.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.224 0.92 . . . . 0.0 112.111 172.158 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.09 -41.58 77.29 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.537 1.062 . . . . 0.0 113.104 179.689 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -75.66 -44.05 44.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 178.195 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -113.23 -9.14 13.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -170.835 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.9 2.21 90.65 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 120.226 1.376 . . . . 0.0 115.939 177.464 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.01 118.72 74.09 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 109.626 -171.51 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.22 131.76 31.5 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.224 1.95 . . . . 0.0 112.121 -178.415 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.01 -30.54 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.047 3.165 . . . . 0.0 116.068 -176.469 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.05 -27.94 69.25 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.683 1.129 . . . . 0.0 112.573 174.911 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -83.66 -8.38 59.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.867 1.267 . . . . 0.0 113.127 177.189 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -99.27 138.05 36.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.629 1.172 . . . . 0.0 112.878 -173.561 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -126.04 139.36 53.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.836 1.655 . . . . 0.0 109.296 160.735 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -113.49 131.9 55.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.592 0.757 . . . . 0.0 111.627 -175.461 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.9 mm -117.33 138.74 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.192 1.797 . . . . 0.0 110.96 -176.458 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.45 134.43 41.56 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.061 0.944 . . . . 0.0 111.339 163.72 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.27 32.29 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.698 1.599 . . . . 0.0 114.275 -176.813 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.23 -1.5 88.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.641 1.591 . . . . 0.0 116.93 -177.481 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.64 137.61 42.2 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.846 2.058 . . . . 0.0 111.073 -178.859 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.64 142.12 39.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.713 0.688 . . . . 0.0 111.472 177.062 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -103.87 132.31 50.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.507 1.523 . . . . 0.0 110.804 179.363 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.88 138.79 31.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.602 1.561 . . . . 0.0 112.674 -173.794 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -59.6 -31.44 69.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.891 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.78 -5.54 57.32 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.039 1.304 . . . . 0.0 115.813 176.621 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -109.5 171.55 7.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.544 1.672 . . . . 0.0 112.36 -171.906 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -113.19 167.19 10.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.586 1.954 . . . . 0.0 112.082 175.749 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.81 -35.67 71.18 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.614 -0.679 . . . . 0.0 112.228 174.39 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -64.11 -31.85 73.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.687 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.74 -14.02 62.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.393 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -118.46 7.31 11.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.138 2.175 . . . . 0.0 113.975 179.868 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.57 33.11 22.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.585 1.554 . . . . 0.0 114.055 -179.178 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -77.34 135.93 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.606 1.162 . . . . 0.0 110.351 -178.561 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -118.3 179.35 4.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 113.209 -178.346 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -54.22 159.4 1.93 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.972 1.709 . . . . 0.0 113.107 169.376 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 65.8 -4.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.369 1.868 . . . . 0.0 115.161 176.804 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.5 m -59.38 134.57 57.13 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.347 1.459 . . . . 0.0 112.797 178.689 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.9 m -102.79 121.64 42.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.543 1.137 . . . . 0.0 110.212 166.534 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.22 158.31 15.78 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.927 2.091 . . . . 0.0 109.235 173.036 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -111.34 135.6 51.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.594 -0.692 . . . . 0.0 111.08 172.015 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 tp -87.61 130.29 34.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.388 1.075 . . . . 0.0 109.416 170.38 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.25 128.41 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.526 1.53 . . . . 0.0 108.399 170.689 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -84.03 131.34 34.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.94 -0.475 . . . . 0.0 110.315 173.168 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.96 89.86 2.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.276 1.83 . . . . 0.0 110.112 -175.398 . . . . . . . . 2 2 . 1 . 146 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -85.28 151.74 23.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.444 1.098 . . . . 0.0 111.494 -177.988 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -73.76 148.7 42.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.364 1.465 . . . . 0.0 112.238 -179.27 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.19 169.89 42.59 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.042 1.306 . . . . 0.0 115.445 178.638 . . . . . . . . 1 1 . 1 . 146 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.455 -1.747 . . . . 0.0 115.772 -174.349 . . . . . . . . 0 0 . 1 . 147 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 147 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -108.53 133.5 52.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.068 1.347 . . . . 0.0 110.001 -177.577 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 pt -136.45 160.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.792 1.237 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -116.47 146.37 42.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.104 0.962 . . . . 0.0 111.671 -179.387 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.73 121.34 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.588 1.155 . . . . 0.0 110.573 176.461 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -97.37 153.81 17.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.412 1.485 . . . . 0.0 113.16 -179.243 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -121.76 160.35 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.932 1.293 . . . . 0.0 112.21 178.639 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.1 mt -72.99 -12.83 61.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.2 -0.938 . . . . 0.0 112.486 171.248 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -80.04 3.73 19.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.444 1.498 . . . . 0.0 114.02 163.896 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 10.54 83.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.34 1.448 . . . . 0.0 116.244 170.669 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -80.14 165.1 22.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.711 1.756 . . . . 0.0 111.916 174.938 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -135.08 103.41 5.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.569 1.548 . . . . 0.0 109.519 167.234 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mt -79.67 138.32 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.662 1.985 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -104.13 129.23 51.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.07 0.948 . . . . 0.0 110.181 173.205 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.27 149.83 46.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.695 1.198 . . . . 0.0 112.589 -178.568 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.56 108.89 14.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.206 1.402 . . . . 0.0 111.544 -175.844 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.64 170.4 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.921 2.088 . . . . 0.0 112.528 -162.54 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -112.35 151.83 44.05 Favored Pre-proline 0 N--CA 1.448 -0.54 0 C-N-CA 126.058 1.743 . . . . 0.0 110.571 162.832 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.3 -11.47 28.19 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.814 2.342 . . . . 0.0 115.235 179.636 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -93.76 1.63 56.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.059 2.543 . . . . 0.0 115.422 174.432 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -81.92 150.34 27.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.535 1.062 . . . . 0.0 112.616 174.614 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 165.33 12.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.436 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.28 -31.43 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.874 1.269 . . . . 0.0 113.293 -177.271 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.46 -35.66 78.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.805 -1.184 . . . . 0.0 112.744 175.671 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -73.02 -33.26 65.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.941 -0.474 . . . . 0.0 112.14 176.703 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.58 -46.45 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.652 -0.655 . . . . 0.0 110.171 171.978 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.68 -38.79 89.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.608 0.763 . . . . 0.0 112.664 175.599 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.5 94.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.681 0.793 . . . . 0.0 112.679 176.49 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -72.61 -26.55 61.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.388 -0.82 . . . . 0.0 113.173 178.655 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.51 -43.94 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.554 1.141 . . . . 0.0 111.016 164.56 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -58.16 -42.07 85.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.268 0.94 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.82 -20.56 66.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.012 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -100.78 -43.1 6.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.625 1.17 . . . . 0.0 113.767 176.961 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -111.53 -13.69 13.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -169.402 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 32.66 60.04 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 120.105 1.321 . . . . 0.0 115.422 176.802 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.46 118.49 55.5 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 109.24 -179.132 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.06 132.7 40.46 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.559 2.173 . . . . 0.0 113.076 -179.917 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -48.1 -35.13 25.31 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.871 3.714 . . . . 0.0 116.135 178.234 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -66.47 -11.55 52.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.451 1.478 . . . . 0.0 114.677 177.973 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -97.48 -8.66 28.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.129 1.772 . . . . 0.0 114.243 174.04 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -98.4 138.67 35.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.909 1.283 . . . . 0.0 112.29 -172.606 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -137.22 140.66 41.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.276 1.43 . . . . 0.0 110.887 161.589 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -120.03 142.78 48.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 113.033 -170.227 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -130.22 138.28 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.834 1.654 . . . . 0.0 110.356 -177.648 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -125.4 113.69 17.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.47 1.508 . . . . 0.0 110.832 171.01 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.88 53.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.813 1.245 . . . . 0.0 113.708 175.239 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.41 -15.1 19.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.134 1.826 . . . . 0.0 117.239 -177.826 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.79 125.68 32.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 111.278 175.653 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.03 120.23 21.84 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.836 0.854 . . . . 0.0 110.479 172.454 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.78 129.65 34.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.531 1.132 . . . . 0.0 110.358 -177.0 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -122.58 159.86 26.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.23 1.412 . . . . 0.0 111.532 -174.131 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.98 151.1 31.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.105 -0.997 . . . . 0.0 113.52 -163.535 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.38 -8.6 12.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.186 1.85 . . . . 0.0 116.183 -174.336 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -81.48 146.07 30.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.639 1.219 . . . . 0.0 109.225 167.682 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -92.88 159.08 15.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.559 0.618 . . . . 0.0 112.539 177.503 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -54.02 -42.05 68.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.945 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 p -68.25 -25.34 65.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 176.181 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.57 -20.49 62.78 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.392 0.997 . . . . 0.0 112.506 174.56 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -99.76 9.49 42.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.794 2.038 . . . . 0.0 114.121 170.459 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 56.31 32.88 21.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.939 1.295 . . . . 0.0 114.487 -179.529 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.83 135.05 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 109.227 173.458 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -122.97 177.79 5.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.055 1.342 . . . . 0.0 112.783 -177.564 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -51.44 140.92 16.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.334 1.454 . . . . 0.0 113.81 170.87 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 59.75 11.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.972 2.109 . . . . 0.0 115.984 -178.003 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -64.58 146.1 55.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.446 -0.784 . . . . 0.0 111.69 175.092 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.4 m -107.27 125.31 50.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.678 1.191 . . . . 0.0 109.921 175.829 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.18 161.31 14.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.709 2.004 . . . . 0.0 109.273 172.674 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -122.18 134.69 54.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 110.226 175.281 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.1 tp -100.6 133.1 45.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.35 1.86 . . . . 0.0 110.341 178.958 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.21 148.32 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.612 1.565 . . . . 0.0 110.822 170.964 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -126.7 143.07 51.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.19 1.396 . . . . 0.0 112.416 -164.516 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -72.7 -39.23 67.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.942 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.8 mt -102.08 29.5 5.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.305 1.442 . . . . 0.0 114.249 -167.721 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -142.55 161.5 37.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.514 2.326 . . . . 0.0 111.134 178.736 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.85 111.18 2.23 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.927 1.727 . . . . 0.0 112.601 174.475 . . . . . . . . 1 1 . 1 . 147 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.967 1.27 . . . . 0.0 112.19 -171.12 . . . . . . . . 0 0 . 1 . 148 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 148 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -101.4 146.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.455 0.702 . . . . 0.0 111.871 179.818 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.55 169.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.975 1.71 . . . . 0.0 110.216 171.344 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -105.43 150.41 25.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.517 0.727 . . . . 0.0 111.131 161.485 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.77 108.92 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.253 1.021 . . . . 0.0 109.541 172.289 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -87.35 117.29 26.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.076 1.751 . . . . 0.0 109.32 177.521 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 m -77.87 138.21 38.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 166.665 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.29 12.91 0.27 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 179.836 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 p -80.71 -12.75 59.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.917 1.687 . . . . 0.0 112.906 160.442 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -21.01 32.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 127.814 2.626 . . . . 0.0 114.146 -177.534 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -74.34 150.21 40.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.871 1.335 . . . . 0.0 112.442 179.348 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -132.93 155.01 49.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.697 0.799 . . . . 0.0 113.051 179.908 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.8 pt -130.56 156.32 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.361 1.464 . . . . 0.0 111.244 176.103 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -94.99 136.46 35.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.459 1.104 . . . . 0.0 109.254 166.664 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 tp -135.42 149.02 49.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.991 0.916 . . . . 0.0 112.241 178.916 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.02 130.47 55.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.596 0.759 . . . . 0.0 111.076 171.372 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.78 171.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.887 2.475 . . . . 0.0 110.45 -171.227 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -127.17 150.41 72.18 Favored Pre-proline 0 N--CA 1.449 -0.493 0 O-C-N 120.857 -1.152 . . . . 0.0 111.476 176.972 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.79 -22.57 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.312 2.675 . . . . 0.0 116.81 -178.093 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -93.1 2.11 56.88 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 175.299 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -63.35 133.47 54.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 120.404 1.456 . . . . 0.0 110.748 173.195 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -76.95 168.21 20.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.155 0.582 . . . . 0.0 111.645 167.18 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.02 -41.52 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 121.285 -0.884 . . . . 0.0 111.402 170.099 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.25 -30.76 69.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 119.723 1.147 . . . . 0.0 113.739 178.056 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -67.24 -39.71 86.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.841 0.746 . . . . 0.0 111.615 172.46 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.78 -44.14 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.787 174.829 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -58.45 -38.28 77.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.31 0.959 . . . . 0.0 113.131 173.478 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.95 -43.2 79.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.146 0.978 . . . . 0.0 112.184 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.02 -28.74 68.48 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.141 0.976 . . . . 0.0 112.867 175.454 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.56 -46.1 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.044 168.054 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.99 -42.77 85.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.89 1.223 . . . . 0.0 111.455 176.138 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.34 -9.38 11.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 177.325 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -119.18 -47.94 2.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.826 1.25 . . . . 0.0 113.82 -179.068 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -111.99 0.83 16.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 114.178 -176.46 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.37 57.55 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 117.479 1.752 . . . . 0.0 117.479 167.305 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 tt -73.49 122.76 88.41 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 119.702 1.751 . . . . 0.0 111.754 -178.798 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.42 132.62 39.14 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.46 2.107 . . . . 0.0 113.484 -178.979 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.79 -27.2 33.39 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.986 3.124 . . . . 0.0 117.089 -179.811 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -68.88 -21.99 64.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 120.541 1.519 . . . . 0.0 113.19 179.51 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -102.07 11.7 37.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 114.157 173.642 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.37 142.9 32.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.663 1.119 . . . . 0.0 112.007 175.766 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -131.29 142.4 50.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.411 1.485 . . . . 0.0 111.004 159.338 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.51 140.95 48.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.275 1.43 . . . . 0.0 111.965 -176.403 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.44 138.31 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.552 1.941 . . . . 0.0 109.971 -175.555 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -150.88 145.42 25.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.001 1.32 . . . . 0.0 109.624 166.231 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.66 56.04 8.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.26 1.424 . . . . 0.0 114.076 179.895 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.67 -4.52 28.26 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.842 1.686 . . . . 0.0 116.982 172.683 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -132.72 151.03 52.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.628 1.714 . . . . 0.0 113.238 -173.67 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -75.08 136.62 41.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 110.808 173.332 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.34 147.16 23.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.188 0.995 . . . . 0.0 112.763 -170.296 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.91 149.75 21.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.231 1.813 . . . . 0.0 112.748 -167.91 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.43 -28.11 56.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -156.223 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.39 1.07 53.63 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.605 1.574 . . . . 0.0 115.059 175.722 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -92.2 153.36 19.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.321 1.448 . . . . 0.0 111.3 -172.71 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -113.56 158.89 20.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -173.364 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.5 mt -56.33 -40.94 75.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.255 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -61.35 -30.83 70.76 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.423 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.67 -29.07 66.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.494 1.043 . . . . 0.0 112.046 178.616 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.43 5.69 41.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.818 1.647 . . . . 0.0 114.519 177.627 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.7 m120 54.91 33.11 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.527 1.131 . . . . 0.0 113.675 -175.428 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.74 150.55 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.754 1.221 . . . . 0.0 109.798 174.212 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -132.69 162.4 31.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.005 1.722 . . . . 0.0 111.301 -171.447 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -57.85 145.46 35.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.448 0.699 . . . . 0.0 112.31 171.921 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 57.96 25.56 12.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.279 1.832 . . . . 0.0 113.887 177.927 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 97.2 p -81.68 164.24 21.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.047 1.339 . . . . 0.0 111.344 164.748 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.0 m -116.61 125.48 51.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.22 1.408 . . . . 0.0 109.844 177.999 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.31 152.09 21.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.481 1.512 . . . . 0.0 110.084 172.64 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -103.06 135.74 44.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.857 0.863 . . . . 0.0 111.578 177.156 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.8 131.97 54.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.276 1.831 . . . . 0.0 109.998 -179.223 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.2 153.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.133 1.373 . . . . 0.0 110.574 -177.341 . . . . . . . . 2 2 . 1 . 148 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.39 143.25 57.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.918 0.887 . . . . 0.0 110.48 169.463 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -115.73 140.22 49.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.5 1.52 . . . . 0.0 112.562 179.109 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -74.69 164.59 26.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.697 1.999 . . . . 0.0 112.22 176.095 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 54.48 37.3 27.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.132 1.773 . . . . 0.0 114.143 -178.342 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.87 -15.35 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 178.356 . . . . . . . . 1 1 . 1 . 148 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.908 1.718 . . . . 0.0 112.204 178.326 . . . . . . . . 0 0 . 1 . 149 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 111.117 0.043 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 149 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -90.74 148.33 22.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.776 0.43 . . . . 0.0 110.692 172.953 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.38 158.33 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 111.254 160.73 . . . . . . . . 2 2 . 1 . 149 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -95.36 134.21 38.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.15 0.98 . . . . 0.0 111.01 173.136 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.86 114.01 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.537 1.535 . . . . 0.0 108.261 174.603 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -110.45 136.01 50.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.247 1.419 . . . . 0.0 112.36 -173.381 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.0 p -80.65 161.6 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.552 175.591 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.02 -22.95 67.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.174 -0.954 . . . . 0.0 112.435 169.309 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.5 p -79.21 -0.07 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 114.257 171.98 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.66 17.2 66.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.855 1.217 . . . . 0.0 116.015 173.111 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -98.14 135.9 39.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.511 1.524 . . . . 0.0 110.194 177.226 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 m -114.06 130.03 56.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.859 0.864 . . . . 0.0 112.382 -176.064 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.72 142.14 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.55 2.34 . . . . 0.0 107.975 170.818 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 m -108.23 133.84 51.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.902 1.281 . . . . 0.0 109.143 169.301 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 tp -135.54 146.41 48.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 112.552 -174.683 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -100.43 121.41 41.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.192 1.397 . . . . 0.0 111.828 -177.906 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.01 165.63 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.699 2.0 . . . . 0.0 112.189 -170.026 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -121.8 151.97 58.41 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 121.119 -0.988 . . . . 0.0 111.505 168.185 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.22 -24.94 44.07 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.148 2.566 . . . . 0.0 116.471 -179.967 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -83.96 -4.65 58.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 175.459 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.49 140.24 58.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.018 1.281 . . . . 0.0 111.199 176.038 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -78.94 153.25 30.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.287 0.635 . . . . 0.0 111.734 169.999 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.27 -37.13 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 110.822 177.728 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.43 -46.83 88.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.103 -0.998 . . . . 0.0 112.477 175.205 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.0 -27.75 67.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 113.105 176.983 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -69.39 -44.01 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 118.982 0.81 . . . . 0.0 111.461 170.768 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -38.85 79.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.35 0.977 . . . . 0.0 112.375 172.409 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.58 73.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.156 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.95 -40.0 90.93 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.881 1.218 . . . . 0.0 111.93 170.751 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.17 -38.95 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.185 0.994 . . . . 0.0 110.931 175.033 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.28 -42.0 94.49 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.109 0.868 . . . . 0.0 112.434 171.961 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.69 -38.36 86.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.375 -0.828 . . . . 0.0 112.924 178.481 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -75.08 -51.49 13.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.018 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -120.17 4.77 10.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -169.305 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.95 2.22 86.33 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.194 -1.566 . . . . 0.0 116.263 172.289 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -79.63 114.21 43.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.921 1.688 . . . . 0.0 109.34 -177.075 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.97 147.59 91.84 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.051 1.834 . . . . 0.0 113.597 -176.996 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.03 -29.33 66.12 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.251 2.634 . . . . 0.0 114.047 -171.533 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -72.39 -15.33 61.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.936 -1.103 . . . . 0.0 113.332 174.81 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -77.57 -14.69 59.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.053 -1.029 . . . . 0.0 112.497 173.959 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -104.9 118.14 35.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 119.615 1.098 . . . . 0.0 113.324 -163.24 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -93.84 129.19 40.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.202 1.001 . . . . 0.0 108.886 156.693 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.18 123.83 51.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.407 1.003 . . . . 0.0 110.36 174.926 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.37 128.42 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.479 1.112 . . . . 0.0 111.511 -165.002 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -149.75 145.75 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.459 1.504 . . . . 0.0 111.059 177.18 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.67 46.51 11.47 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 174.262 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.42 10.12 82.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.445 1.498 . . . . 0.0 115.991 178.81 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -126.58 132.07 51.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.881 1.672 . . . . 0.0 112.141 -173.243 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -76.47 113.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 159.398 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 mt -74.48 141.56 44.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -167.696 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -83.13 131.35 35.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.352 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.77 -21.36 66.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -176.449 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.52 -4.46 73.4 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.338 1.447 . . . . 0.0 115.325 171.504 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -107.0 176.72 5.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.639 1.72 . . . . 0.0 111.346 179.868 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.4 p -119.47 162.79 18.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.484 1.914 . . . . 0.0 113.44 -171.462 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.73 -34.13 73.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 178.193 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 p -71.37 -24.24 62.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.295 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -63.48 -26.0 68.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 120.273 1.397 . . . . 0.0 111.995 168.118 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -101.95 8.09 41.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.42 1.488 . . . . 0.0 113.874 175.823 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 55.17 31.1 15.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.398 1.479 . . . . 0.0 114.208 176.426 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.75 129.22 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.611 1.164 . . . . 0.0 109.849 -174.336 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.07 161.6 14.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.79 1.236 . . . . 0.0 112.58 177.355 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -45.59 135.68 6.36 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.661 1.584 . . . . 0.0 115.185 177.206 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 58.3 mt-10 65.69 22.11 11.61 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.843 2.457 . . . . 0.0 116.106 178.033 . . . . . . . . 2 2 . 1 . 149 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.8 m -59.78 154.8 17.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.142 1.377 . . . . 0.0 112.841 164.399 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -110.71 105.55 14.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.111 1.365 . . . . 0.0 110.472 176.368 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.66 153.48 17.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.683 1.593 . . . . 0.0 109.681 173.679 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -103.91 138.36 40.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 122.029 -0.419 . . . . 0.0 111.152 171.895 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.24 125.43 49.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.662 1.585 . . . . 0.0 109.061 169.483 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.62 130.65 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.777 1.231 . . . . 0.0 109.246 173.387 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.5 mt -81.76 140.29 34.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.96 0.504 . . . . 0.0 111.873 -175.858 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -75.83 158.02 32.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 112.135 165.541 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -88.34 141.54 28.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.469 1.508 . . . . 0.0 110.305 -179.427 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.02 44.01 25.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.002 1.721 . . . . 0.0 112.965 -175.609 . . . . . . . . 2 2 . 1 . 149 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.46 24.36 13.92 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.795 2.14 . . . . 0.0 114.779 -175.939 . . . . . . . . 1 1 . 1 . 149 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.856 1.693 . . . . 0.0 115.431 -172.963 . . . . . . . . 0 0 . 1 . 150 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -98.08 151.79 19.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.478 0.711 . . . . 0.0 111.422 -179.034 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -136.82 160.06 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.467 1.907 . . . . 0.0 111.335 174.133 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -106.92 149.33 27.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.036 0.935 . . . . 0.0 111.422 170.579 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -127.62 135.45 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.003 1.321 . . . . 0.0 109.155 167.687 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.45 136.76 38.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.411 1.085 . . . . 0.0 113.065 -171.773 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -98.39 144.67 27.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.208 1.403 . . . . 0.0 111.923 175.124 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.06 -29.15 67.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.028 1.331 . . . . 0.0 114.26 -168.858 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -81.53 -15.11 55.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.945 1.698 . . . . 0.0 115.163 176.769 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.92 -32.86 0.88 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 117.961 1.944 . . . . 0.0 117.961 164.299 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -65.75 138.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.427 1.614 . . . . 0.0 112.708 -167.085 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -122.41 142.55 50.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.034 1.334 . . . . 0.0 110.788 175.634 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -136.57 153.99 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.687 1.595 . . . . 0.0 111.058 173.655 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 p -105.95 147.36 28.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 112.241 171.451 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -139.17 154.72 48.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.2 1.4 . . . . 0.0 111.457 169.937 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.23 131.08 57.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.669 1.188 . . . . 0.0 111.16 178.731 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.13 176.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.342 1.857 . . . . 0.0 110.877 -162.309 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -127.44 154.27 77.34 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 125.719 1.608 . . . . 0.0 109.479 176.134 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.49 -34.07 80.45 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.837 2.358 . . . . 0.0 115.251 -178.679 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -97.04 9.77 41.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.453 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -69.06 150.13 47.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.855 0.752 . . . . 0.0 110.749 170.871 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 p -98.14 151.89 19.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.607 1.163 . . . . 0.0 113.768 -168.466 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.75 -37.92 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.164 0.586 . . . . 0.0 111.082 178.749 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -66.47 -32.57 74.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.58 1.082 . . . . 0.0 113.263 175.978 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -72.8 -38.73 67.12 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.297 -0.877 . . . . 0.0 112.215 170.713 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -38.96 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.074 -1.016 . . . . 0.0 111.525 174.073 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.6 -36.86 79.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.582 1.083 . . . . 0.0 112.817 169.492 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -33.17 71.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.599 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -69.63 -35.03 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.596 1.558 . . . . 0.0 111.866 172.103 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.54 -44.65 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 109.961 167.817 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.2 -32.23 73.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.176 0.99 . . . . 0.0 113.012 -179.76 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.21 -37.6 72.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.513 1.052 . . . . 0.0 113.594 171.322 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -106.08 -26.38 11.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.909 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -114.5 -15.59 12.02 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 178.481 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.45 1.91 58.66 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 178.265 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.72 129.14 91.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 118.93 1.365 . . . . 0.0 110.729 -172.334 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -53.93 122.14 10.86 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.826 3.018 . . . . 0.0 113.504 175.93 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.28 -29.67 58.49 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.154 3.236 . . . . 0.0 115.52 -179.791 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.7 -22.16 64.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.783 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -104.28 -8.24 19.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.866 2.066 . . . . 0.0 113.623 178.679 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.96 114.78 12.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.993 0.815 . . . . 0.0 109.644 170.49 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -103.48 119.4 38.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.92 1.288 . . . . 0.0 108.72 170.318 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.99 135.2 54.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.918 1.287 . . . . 0.0 111.441 -175.065 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mt -133.7 136.41 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 -176.778 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.99 121.89 30.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.376 1.47 . . . . 0.0 110.281 172.429 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.63 46.37 8.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.88 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.3 79.29 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 117.434 1.734 . . . . 0.0 117.434 -177.489 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -107.12 130.06 54.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 120.263 2.031 . . . . 0.0 111.076 179.112 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -81.46 136.44 35.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.618 0.644 . . . . 0.0 111.749 179.516 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.17 151.3 23.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.321 1.048 . . . . 0.0 112.532 -175.016 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -124.67 127.95 48.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.349 1.459 . . . . 0.0 112.253 -175.643 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.22 -46.55 65.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.716 2.006 . . . . 0.0 115.162 -165.362 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.4 14.42 23.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.093 1.197 . . . . 0.0 116.093 -176.122 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -117.37 173.09 6.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.579 1.551 . . . . 0.0 111.419 -177.692 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -99.17 167.45 10.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.892 1.277 . . . . 0.0 113.356 -177.675 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.07 -34.01 75.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.35 -0.844 . . . . 0.0 113.015 168.811 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -63.01 -33.56 75.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.835 0.854 . . . . 0.0 113.078 172.917 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.82 -14.93 51.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.951 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.83 6.55 12.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.613 1.565 . . . . 0.0 113.728 176.551 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 56.36 39.18 30.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.601 1.16 . . . . 0.0 113.298 -177.893 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.2 mt -80.09 101.68 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.699 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.69 170.54 12.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.254 1.422 . . . . 0.0 112.396 -175.085 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -49.16 127.26 14.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.83 1.252 . . . . 0.0 112.829 174.172 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 29.7 mt-10 53.05 39.47 29.57 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.104 2.161 . . . . 0.0 115.676 -176.862 . . . . . . . . 2 2 . 1 . 150 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -74.8 159.07 32.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 163.879 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -112.09 130.07 56.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.351 1.461 . . . . 0.0 111.008 175.216 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.91 142.89 33.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.905 1.682 . . . . 0.0 110.571 174.944 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -89.3 137.44 32.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.466 -0.771 . . . . 0.0 110.469 168.136 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.99 134.16 55.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.413 1.485 . . . . 0.0 109.581 173.599 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.54 140.23 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 126.115 1.766 . . . . 0.0 109.24 174.106 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mp -100.83 121.05 41.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.716 1.206 . . . . 0.0 110.288 -177.654 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 mtp-105 -86.62 137.04 32.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 112.965 175.346 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 tp -77.57 134.51 38.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.711 1.204 . . . . 0.0 111.173 177.746 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -106.01 -38.67 6.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.677 1.191 . . . . 0.0 113.191 173.123 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.26 -171.81 48.34 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.004 1.287 . . . . 0.0 116.256 171.817 . . . . . . . . 1 1 . 1 . 150 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 125.215 1.388 . . . . 0.0 113.26 177.877 . . . . . . . . 0 0 . 1 . 151 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 151 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -84.94 135.26 34.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.025 0.53 . . . . 0.0 111.701 174.679 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.73 173.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.007 1.323 . . . . 0.0 110.257 158.414 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -117.71 147.37 43.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.111 1.364 . . . . 0.0 111.69 179.56 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -133.2 136.12 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.909 1.284 . . . . 0.0 109.618 174.959 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -84.38 122.65 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.294 0.638 . . . . 0.0 111.899 172.662 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -70.52 165.34 22.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 112.964 178.93 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.4 -25.03 66.92 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.004 1.322 . . . . 0.0 112.471 166.822 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.5 p -84.09 4.3 30.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.996 1.718 . . . . 0.0 114.186 172.543 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.77 -1.79 88.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.573 . . . . 0.0 116.715 170.441 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -95.65 171.85 8.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.78 1.79 . . . . 0.0 112.5 178.896 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m -100.6 127.46 46.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.729 0.812 . . . . 0.0 112.395 -179.595 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.6 pt -113.76 159.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 111.723 171.332 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.8 p -91.5 148.16 22.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 179.578 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.18 136.73 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.674 1.189 . . . . 0.0 110.592 167.698 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.67 111.64 24.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.065 1.346 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.02 154.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.116 1.766 . . . . 0.0 112.865 -165.375 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.27 149.09 40.6 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.697 -0.627 . . . . 0.0 110.461 164.307 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.99 -16.15 19.72 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.776 2.317 . . . . 0.0 114.609 166.295 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 m -97.77 6.26 48.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.225 1.81 . . . . 0.0 115.457 172.368 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.52 141.85 53.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.267 1.394 . . . . 0.0 111.187 166.705 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.2 p -85.64 165.8 16.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 112.915 173.796 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mm -64.43 -28.78 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.472 -0.767 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.17 -43.74 95.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.719 -1.238 . . . . 0.0 112.434 170.402 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -65.55 -40.87 93.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.233 0.613 . . . . 0.0 111.22 177.901 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.81 -47.51 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.75 0.82 . . . . 0.0 111.027 175.416 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.57 -37.76 87.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.047 0.84 . . . . 0.0 112.469 176.785 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.81 0.732 . . . . 0.0 112.277 175.593 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.13 -30.03 71.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 112.679 175.088 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.8 mt -76.02 -40.82 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.824 1.25 . . . . 0.0 112.162 173.705 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -57.92 -41.16 82.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.569 1.148 . . . . 0.0 111.809 173.746 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.6 -44.25 89.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.919 0.888 . . . . 0.0 112.792 176.969 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -78.91 -46.74 17.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.999 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -115.4 -6.44 12.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -164.516 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.09 55.18 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.684 1.129 . . . . 0.0 115.487 169.391 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.85 114.05 31.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 C-N-CA 125.512 1.525 . . . . 0.0 107.422 172.222 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.12 147.42 95.72 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.672 2.248 . . . . 0.0 113.983 -173.213 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.83 -43.16 48.32 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.819 3.013 . . . . 0.0 115.975 -172.38 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -76.59 -2.95 35.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.871 1.214 . . . . 0.0 113.96 -178.574 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -106.58 -2.21 22.08 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.348 1.859 . . . . 0.0 113.122 176.047 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.24 150.05 22.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.981 1.312 . . . . 0.0 111.095 172.571 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -124.93 128.31 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 108.501 154.427 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.09 125.92 51.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.902 1.281 . . . . 0.0 110.963 -178.981 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.56 136.29 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.796 1.638 . . . . 0.0 110.327 -176.752 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -141.6 132.53 25.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.868 1.667 . . . . 0.0 109.951 172.555 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 42.67 18.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.44 1.096 . . . . 0.0 113.543 -173.991 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 1.88 51.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.987 1.756 . . . . 0.0 116.207 -179.418 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -118.97 147.36 44.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.281 1.833 . . . . 0.0 111.565 -173.538 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -73.42 137.78 44.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.261 1.025 . . . . 0.0 112.516 -179.944 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.2 122.96 37.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.803 1.241 . . . . 0.0 110.841 172.565 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.28 151.87 33.75 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.761 1.624 . . . . 0.0 112.083 -171.561 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -72.02 156.41 39.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.853 1.261 . . . . 0.0 114.269 -165.515 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.48 -29.19 7.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.469 1.985 . . . . 0.0 115.375 179.918 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -86.84 154.25 21.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.915 1.358 . . . . 0.0 112.329 171.565 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -96.42 159.97 14.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 112.989 -177.886 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.74 -40.2 62.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.012 0.925 . . . . 0.0 113.403 179.932 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 p -68.14 -28.97 67.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 175.466 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -67.66 -30.85 70.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.685 1.13 . . . . 0.0 111.731 174.768 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -86.26 3.86 41.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.7 1.6 . . . . 0.0 113.969 171.113 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 53.66 43.76 30.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.497 1.519 . . . . 0.0 114.224 -174.695 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -90.87 126.84 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.142 1.377 . . . . 0.0 108.016 172.819 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -120.2 168.03 11.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.297 1.439 . . . . 0.0 111.74 -173.459 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -49.45 136.7 15.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.872 1.269 . . . . 0.0 113.039 179.141 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 37.0 mt-10 61.12 24.36 14.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.083 1.753 . . . . 0.0 115.526 -176.303 . . . . . . . . 2 2 . 1 . 151 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m -77.6 154.66 32.07 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.079 -1.013 . . . . 0.0 112.358 165.033 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -109.45 135.85 49.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.389 1.476 . . . . 0.0 112.618 -179.154 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -108.74 146.69 33.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.761 2.024 . . . . 0.0 111.077 170.289 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -111.31 149.79 30.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 172.228 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.37 129.14 42.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 110.835 -172.379 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.6 165.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.188 1.795 . . . . 0.0 110.942 169.652 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.13 157.18 19.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.245 1.018 . . . . 0.0 113.152 -177.053 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -125.72 156.99 38.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.218 1.807 . . . . 0.0 115.42 179.558 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt 60.59 -30.53 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 130.868 3.667 . . . . 0.0 120.407 155.759 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -122.6 154.79 37.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.142 1.337 . . . . 0.0 112.308 -165.533 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.27 160.32 25.79 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.498 1.047 . . . . 0.0 112.58 172.523 . . . . . . . . 1 1 . 1 . 151 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 117.691 -1.616 . . . . 0.0 112.933 177.058 . . . . . . . . 0 0 . 1 . 152 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 152 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.0 144.91 25.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.658 1.183 . . . . 0.0 110.584 166.348 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -133.86 155.78 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 110.79 166.194 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -114.32 124.24 51.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.327 1.051 . . . . 0.0 111.27 -174.254 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.05 119.46 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.236 1.015 . . . . 0.0 109.549 174.88 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -94.52 122.1 36.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.447 1.499 . . . . 0.0 111.182 178.484 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -78.64 162.79 25.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.879 0.872 . . . . 0.0 112.12 173.285 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.22 -25.18 65.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.625 0.77 . . . . 0.0 112.425 170.891 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.6 p -86.93 7.84 25.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.109 2.163 . . . . 0.0 114.199 176.209 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.58 8.8 87.5 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.155 1.359 . . . . 0.0 115.893 174.482 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -77.29 138.25 39.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.663 1.185 . . . . 0.0 110.595 178.105 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -102.79 106.38 16.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.594 1.158 . . . . 0.0 110.033 177.128 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.18 117.02 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.904 1.281 . . . . 0.0 108.356 178.062 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.5 m -101.43 117.99 36.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.895 0.878 . . . . 0.0 110.192 -173.093 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 mt -108.62 139.94 42.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.245 1.018 . . . . 0.0 111.845 -173.736 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.57 112.97 25.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.775 1.23 . . . . 0.0 108.441 171.744 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.01 172.0 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.792 -173.852 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -128.59 165.1 33.74 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.191 1.796 . . . . 0.0 108.374 160.791 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.25 -25.14 54.46 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.314 2.009 . . . . 0.0 114.439 176.618 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 p -69.42 -11.63 60.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 172.007 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 134.48 54.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 120.498 1.499 . . . . 0.0 110.827 177.502 . . . . . . . . 2 2 . 1 . 152 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -78.29 159.63 28.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.755 173.208 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.57 -31.63 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.148 -0.97 . . . . 0.0 110.37 169.769 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.2 -38.66 92.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 168.69 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.78 -44.42 93.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.755 1.161 . . . . 0.0 111.757 172.09 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.91 -45.28 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 121.66 -0.65 . . . . 0.0 110.89 175.584 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -63.98 -38.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 175.367 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.92 -39.04 90.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.937 0.79 . . . . 0.0 112.12 177.052 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.77 -36.78 84.52 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.217 1.007 . . . . 0.0 111.828 173.76 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.65 -36.1 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 119.028 0.831 . . . . 0.0 111.449 171.283 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.75 -37.79 88.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 120.212 1.369 . . . . 0.0 111.928 172.475 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.42 -23.26 53.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 176.153 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -81.55 -38.02 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.609 1.564 . . . . 0.0 113.841 172.524 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -132.76 -9.35 3.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -166.346 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.49 86.21 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 177.179 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mm -92.2 119.12 68.34 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.981 1.312 . . . . 0.0 110.244 -176.937 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.52 146.77 93.19 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.277 1.985 . . . . 0.0 114.186 179.82 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.95 -34.13 28.03 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 125.069 3.846 . . . . 0.0 115.65 177.395 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.62 -4.35 26.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 178.213 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -109.88 -1.86 17.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.832 1.653 . . . . 0.0 113.705 173.505 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.7 141.92 33.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.939 1.296 . . . . 0.0 112.164 -173.87 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -133.85 109.03 8.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.474 1.51 . . . . 0.0 109.751 174.826 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.36 132.81 39.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -176.784 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.39 136.89 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.113 1.765 . . . . 0.0 111.433 -173.108 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -139.51 114.52 9.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.284 1.833 . . . . 0.0 110.59 175.061 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.95 42.25 16.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.155 1.782 . . . . 0.0 114.487 177.713 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.89 -9.19 72.98 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.178 1.847 . . . . 0.0 116.292 -178.951 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -92.96 146.73 23.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.807 1.803 . . . . 0.0 111.004 175.297 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -73.04 144.38 47.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 161.135 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.05 112.5 21.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.247 0.619 . . . . 0.0 109.568 165.142 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -74.41 136.4 42.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.358 1.463 . . . . 0.0 111.938 -179.278 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.61 -32.88 73.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.472 1.509 . . . . 0.0 114.752 -166.016 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.87 11.49 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.168 1.366 . . . . 0.0 115.973 -179.649 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -121.05 172.36 8.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 120.151 1.976 . . . . 0.0 113.794 -169.388 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -108.85 159.21 16.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.352 1.861 . . . . 0.0 113.433 177.934 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.51 -41.04 80.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.29 0.636 . . . . 0.0 111.757 169.385 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -58.8 -41.7 87.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.684 173.748 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.43 -29.22 66.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.094 0.861 . . . . 0.0 113.073 179.962 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.43 -0.4 54.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.969 1.308 . . . . 0.0 114.28 167.469 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.8 t30 54.44 45.36 27.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.18 1.392 . . . . 0.0 113.044 -176.441 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.93 120.31 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 108.12 174.982 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -114.29 176.93 4.83 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.786 1.634 . . . . 0.0 111.976 -171.049 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -51.85 145.55 9.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 178.878 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 61.38 16.38 7.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.083 1.753 . . . . 0.0 115.241 176.965 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -71.46 147.36 47.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 175.912 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.7 m -105.47 134.57 48.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.636 1.174 . . . . 0.0 110.443 171.781 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -126.92 159.39 34.16 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.52 2.328 . . . . 0.0 109.732 177.553 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -115.6 140.74 48.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 111.277 -176.859 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.5 tp -117.28 123.0 45.5 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.666 1.187 . . . . 0.0 111.369 -178.428 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -103.37 139.37 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.995 1.718 . . . . 0.0 108.054 166.351 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.5 mt -101.15 143.85 30.75 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.769 -0.582 . . . . 0.0 110.95 165.468 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -114.86 76.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.309 1.444 . . . . 0.0 108.135 168.906 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.44 140.46 58.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.73 0.812 . . . . 0.0 110.185 178.481 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -73.49 143.21 46.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.807 1.243 . . . . 0.0 112.856 -166.154 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -152.49 34.75 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.28 0.943 . . . . 0.0 113.732 -176.3 . . . . . . . . 1 1 . 1 . 152 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 125.694 1.616 . . . . 0.0 112.66 -176.567 . . . . . . . . 0 0 . 1 . 153 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 153 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -89.09 136.84 32.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.923 1.289 . . . . 0.0 112.044 178.352 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.54 166.1 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.868 1.267 . . . . 0.0 110.663 164.966 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -122.31 154.57 37.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.845 1.258 . . . . 0.0 111.964 -178.783 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.57 128.69 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.993 1.317 . . . . 0.0 110.235 173.487 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.59 143.53 43.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.488 1.515 . . . . 0.0 113.398 179.814 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -122.9 157.43 32.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.696 1.598 . . . . 0.0 113.463 177.142 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -68.23 -20.68 64.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -175.041 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -72.98 -6.28 44.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.099 1.36 . . . . 0.0 114.202 168.212 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.93 9.54 57.17 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.876 1.227 . . . . 0.0 115.11 177.537 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -76.64 147.13 37.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.969 1.885 . . . . 0.0 110.988 174.423 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -130.67 130.58 44.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.0 109.143 169.705 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -121.62 131.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.999 1.719 . . . . 0.0 108.999 -168.598 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 131.88 46.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 111.614 177.904 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.11 164.33 17.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.402 1.481 . . . . 0.0 112.62 178.188 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.42 120.02 35.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.353 1.461 . . . . 0.0 109.824 170.527 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -135.8 173.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.649 1.18 . . . . 0.0 111.977 -170.801 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -139.99 146.73 47.94 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.775 1.63 . . . . 0.0 109.077 -178.202 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -57.53 -28.3 80.36 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.027 1.818 . . . . 0.0 116.005 -171.198 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 m -87.4 1.93 51.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.239 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.22 140.13 58.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 120.206 1.366 . . . . 0.0 111.572 175.459 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.17 157.14 20.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.915 1.686 . . . . 0.0 112.254 176.494 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.22 -32.08 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 121.368 -0.833 . . . . 0.0 111.456 172.055 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.17 -45.4 68.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.69 1.596 . . . . 0.0 112.588 169.148 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -72.33 -43.44 64.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.204 1.402 . . . . 0.0 112.443 177.599 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.19 -41.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.046 -1.034 . . . . 0.0 111.898 176.617 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 55.1 mtpt -62.56 -34.49 77.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 174.252 . . . . . . . . 2 2 . 1 . 153 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.64 -38.24 73.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 172.832 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.39 -34.39 75.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.318 1.047 . . . . 0.0 112.155 172.777 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.8 -40.89 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.275 1.43 . . . . 0.0 111.945 172.13 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -62.56 -36.21 81.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 120.166 1.348 . . . . 0.0 112.297 175.776 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.02 -57.24 12.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.686 0.676 . . . . 0.0 111.101 171.375 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -69.45 -37.79 77.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -170.792 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.04 -11.01 10.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -170.809 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.4 7.36 85.1 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.432 1.014 . . . . 0.0 115.306 -179.857 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 mt -81.18 120.43 78.5 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.171 1.388 . . . . 0.0 109.526 -176.561 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.13 133.75 45.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.764 2.309 . . . . 0.0 112.792 -178.846 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 37.6 Cg_exo -51.8 -38.17 66.9 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.574 3.516 . . . . 0.0 115.616 -177.435 . . . . . . . . 2 2 . 1 . 153 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.55 -24.76 67.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 176.403 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -98.01 1.06 47.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.04 1.736 . . . . 0.0 112.859 -176.966 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -93.69 146.81 23.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.975 1.71 . . . . 0.0 110.812 173.683 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -137.57 124.79 21.71 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.813 1.645 . . . . 0.0 109.653 161.596 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.02 133.19 45.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 111.051 -178.753 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -122.38 131.03 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.445 1.898 . . . . 0.0 109.993 -176.242 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -153.04 131.02 11.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 112.082 176.649 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.73 42.65 15.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.722 2.009 . . . . 0.0 115.123 174.605 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.81 15.65 80.98 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.497 178.97 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.26 144.41 49.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.408 1.604 . . . . 0.0 110.931 173.697 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.95 131.9 34.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 160.235 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.84 145.0 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.922 1.289 . . . . 0.0 112.022 -170.475 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -123.18 131.19 53.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 110.853 -168.305 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.38 -35.74 8.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.661 2.384 . . . . 0.0 115.114 -174.519 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.02 -3.0 50.39 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.524 1.535 . . . . 0.0 116.776 -179.682 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.55 168.76 10.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 120.128 1.964 . . . . 0.0 113.785 -176.479 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -120.9 159.11 26.2 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.35 1.86 . . . . 0.0 114.186 -171.309 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.22 -40.99 92.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.871 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -60.22 -38.88 84.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.649 1.18 . . . . 0.0 112.901 176.118 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -73.72 -27.37 61.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.387 1.075 . . . . 0.0 113.208 178.52 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -83.74 4.28 29.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.226 1.41 . . . . 0.0 114.223 169.3 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 56.93 34.45 24.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.75 1.159 . . . . 0.0 113.497 -177.264 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.13 129.59 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 120.762 -1.211 . . . . 0.0 108.806 176.513 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -119.13 174.22 6.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.251 1.82 . . . . 0.0 110.538 -171.147 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.72 150.69 31.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.847 -1.158 . . . . 0.0 111.703 171.491 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.8 18.68 9.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 114.074 -179.219 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -75.52 148.49 38.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.905 -1.122 . . . . 0.0 111.799 173.876 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.14 125.16 53.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.029 1.331 . . . . 0.0 109.691 170.536 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.28 156.57 16.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.172 1.389 . . . . 0.0 109.749 168.466 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -106.42 137.72 43.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.106 0.563 . . . . 0.0 110.26 169.366 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -115.43 131.03 57.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.124 1.37 . . . . 0.0 109.041 177.801 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.23 149.11 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.519 1.128 . . . . 0.0 110.413 168.324 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.55 154.16 19.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.239 1.016 . . . . 0.0 112.013 -172.081 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -121.58 47.95 1.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.064 1.746 . . . . 0.0 112.273 -179.07 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.56 134.68 36.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.553 1.141 . . . . 0.0 111.778 -175.941 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.9 mtp-105 -141.19 -3.15 1.22 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.898 1.679 . . . . 0.0 114.422 178.233 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.66 153.63 8.27 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.492 1.52 . . . . 0.0 114.794 179.944 . . . . . . . . 1 1 . 1 . 153 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 C-N-CA 125.483 1.516 . . . . 0.0 112.666 -177.589 . . . . . . . . 0 0 . 1 . 154 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 121.048 0.451 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 154 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -86.1 137.52 32.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.109 1.363 . . . . 0.0 110.987 172.881 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 165.01 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.052 1.341 . . . . 0.0 111.025 165.734 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -121.44 135.15 55.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.052 1.341 . . . . 0.0 110.981 -178.462 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.24 112.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.228 1.411 . . . . 0.0 109.293 175.543 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 148.93 26.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.692 1.197 . . . . 0.0 111.339 171.317 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -152.17 148.27 27.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.05 1.34 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.96 5.74 2.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.981 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -99.68 36.82 1.71 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.158 1.783 . . . . 0.0 113.55 171.702 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.78 32.99 79.03 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 161.362 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -155.96 167.57 29.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.941 1.296 . . . . 0.0 112.333 179.333 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -122.34 130.29 52.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.273 1.429 . . . . 0.0 108.625 168.923 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.99 128.47 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.913 1.285 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -91.89 137.64 32.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.444 0.697 . . . . 0.0 110.171 175.862 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.09 142.07 51.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.11 0.964 . . . . 0.0 111.555 178.732 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -98.31 111.67 23.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.814 1.246 . . . . 0.0 109.28 170.388 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.99 161.36 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.011 1.724 . . . . 0.0 111.777 -173.11 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.65 144.21 30.95 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.061 0.944 . . . . 0.0 110.894 176.059 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 -36.55 51.69 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.707 2.938 . . . . 0.0 115.853 179.074 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -89.44 8.78 29.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 178.835 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.79 163.15 27.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.51 -1.369 . . . . 0.0 112.525 173.849 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -107.82 154.18 21.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.254 1.421 . . . . 0.0 113.755 -173.23 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.81 -42.88 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 113.227 -170.589 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.28 -33.82 72.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.192 178.242 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -70.36 -9.04 55.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 172.862 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.1 -34.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 111.681 166.271 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.55 -35.6 70.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.331 1.423 . . . . 0.0 112.432 167.356 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.57 74.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 171.378 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.93 -26.32 56.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.947 -1.096 . . . . 0.0 112.567 175.422 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.21 -44.92 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.482 1.113 . . . . 0.0 110.423 167.835 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.2 -39.57 75.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.011 0.924 . . . . 0.0 112.411 178.496 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.37 -28.55 63.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.097 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -102.72 -44.04 5.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.816 1.246 . . . . 0.0 112.944 179.887 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.67 -10.87 18.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.354 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.13 28.25 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 173.115 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.53 123.07 89.07 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.031 1.332 . . . . 0.0 109.111 -178.23 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.8 137.19 71.14 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.313 2.009 . . . . 0.0 112.183 178.865 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -48.12 -33.55 21.45 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 124.508 3.472 . . . . 0.0 116.023 -178.9 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -67.69 -16.41 64.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.266 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -99.4 -4.65 31.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.876 1.27 . . . . 0.0 113.716 175.186 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.83 140.47 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 111.382 -179.21 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -129.55 131.61 46.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.18 1.392 . . . . 0.0 109.425 165.318 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.99 129.62 56.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.897 0.879 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -121.02 126.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 110.976 -177.262 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -138.67 133.56 32.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.049 1.74 . . . . 0.0 110.162 176.989 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.03 39.17 7.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.507 1.523 . . . . 0.0 114.881 175.953 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.42 82.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.809 -1.55 . . . . 0.0 116.658 -178.6 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.22 140.08 38.91 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.14 1.97 . . . . 0.0 112.346 178.739 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.0 113.62 25.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.978 1.311 . . . . 0.0 109.705 169.869 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -76.99 127.66 33.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.322 1.049 . . . . 0.0 112.039 -163.174 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -89.25 142.06 27.98 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.057 1.343 . . . . 0.0 112.48 -170.545 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.31 -13.66 62.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -166.199 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.6 5.54 82.37 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 117.638 -1.646 . . . . 0.0 116.669 176.555 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -117.19 168.47 10.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.089 1.944 . . . . 0.0 115.066 -168.668 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -103.47 158.45 16.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.133 2.173 . . . . 0.0 113.294 178.186 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.94 -39.87 95.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.38 -0.825 . . . . 0.0 112.346 178.648 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.4 p -67.93 -27.51 66.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.93 1.292 . . . . 0.0 114.329 175.303 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.27 -23.73 67.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.646 -1.284 . . . . 0.0 112.572 170.853 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -99.35 7.87 45.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.084 1.754 . . . . 0.0 114.533 169.889 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t30 52.53 35.13 17.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.555 1.542 . . . . 0.0 114.078 -177.32 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -72.27 122.75 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.253 -0.904 . . . . 0.0 108.795 179.036 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -109.46 173.01 6.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.297 1.439 . . . . 0.0 112.515 -178.517 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -53.46 142.44 22.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.202 1.401 . . . . 0.0 113.736 177.462 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 59.75 27.68 17.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 114.614 -178.91 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -66.55 143.12 57.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.06 -1.025 . . . . 0.0 111.899 169.14 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -105.71 133.39 50.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.372 1.069 . . . . 0.0 110.192 163.3 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.96 163.65 22.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.498 1.519 . . . . 0.0 110.577 169.401 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -115.88 132.04 56.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.549 1.14 . . . . 0.0 110.953 -175.526 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.98 133.18 33.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.981 1.312 . . . . 0.0 109.858 171.731 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.48 136.1 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.009 1.724 . . . . 0.0 108.678 167.584 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.51 137.9 31.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.303 1.041 . . . . 0.0 110.993 179.041 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -132.24 102.82 5.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.526 1.13 . . . . 0.0 110.523 179.295 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.75 164.54 15.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.685 1.994 . . . . 0.0 110.538 175.228 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -59.15 128.56 37.8 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.829 1.652 . . . . 0.0 112.949 -178.458 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.78 165.11 27.62 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.842 1.21 . . . . 0.0 114.473 179.182 . . . . . . . . 1 1 . 1 . 154 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.276 1.893 . . . . 0.0 115.172 -172.333 . . . . . . . . 0 0 . 1 . 155 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 155 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -107.37 145.57 32.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.445 1.098 . . . . 0.0 112.151 169.293 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -126.01 151.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 111.502 172.857 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.61 139.72 47.96 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.738 1.215 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.88 109.94 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.778 0.831 . . . . 0.0 110.403 -174.633 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.81 116.12 16.2 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.976 1.311 . . . . 0.0 110.218 175.264 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -93.54 173.24 7.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.895 1.278 . . . . 0.0 113.064 -177.208 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 tp -66.49 -26.9 67.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -171.48 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -68.53 -21.76 64.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 171.306 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.09 -16.2 54.14 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.794 1.188 . . . . 0.0 113.543 -164.434 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -71.35 143.98 50.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 120.023 1.911 . . . . 0.0 111.49 177.306 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.8 m -101.77 125.58 48.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.391 1.077 . . . . 0.0 110.398 175.214 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.51 153.05 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 124.352 1.061 . . . . 0.0 110.739 170.992 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 m -124.74 142.07 51.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.95 1.3 . . . . 0.0 109.982 -174.04 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 tp -140.55 139.18 34.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.217 1.007 . . . . 0.0 112.063 179.517 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.58 125.14 35.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.77 0.828 . . . . 0.0 111.507 168.477 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.8 158.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.893 1.677 . . . . 0.0 110.356 -170.615 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -108.83 147.05 35.06 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.161 0.984 . . . . 0.0 110.88 174.041 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.86 -22.89 55.73 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.112 1.874 . . . . 0.0 113.571 -175.487 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -85.92 24.7 1.23 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 114.66 173.021 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -115.05 165.29 13.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.102 2.161 . . . . 0.0 110.776 169.755 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.8 p -104.08 152.65 21.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.928 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.27 -39.31 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.196 0.999 . . . . 0.0 111.159 175.827 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -61.62 -38.65 88.44 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.237 -0.914 . . . . 0.0 113.391 177.002 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -66.9 -35.99 81.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.544 -0.722 . . . . 0.0 112.132 174.442 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.32 -44.65 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.161 -0.962 . . . . 0.0 111.574 170.876 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -63.13 -39.53 94.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.059 0.845 . . . . 0.0 112.755 177.06 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.8 85.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 112.531 174.871 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -67.8 -41.51 83.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.375 -0.828 . . . . 0.0 112.022 173.105 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -59.91 -24.0 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.962 1.305 . . . . 0.0 112.788 177.727 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -63.7 -26.52 68.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.567 1.076 . . . . 0.0 113.189 174.539 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.01 -31.45 18.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 120.862 -1.149 . . . . 0.0 112.911 171.296 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.98 -42.29 57.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.622 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -129.92 -0.7 4.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.695 1.598 . . . . 0.0 114.709 -177.747 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.71 -14.93 44.88 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.864 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.14 130.14 89.94 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 118.873 1.337 . . . . 0.0 109.625 -175.537 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.09 139.66 85.39 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.951 2.434 . . . . 0.0 112.907 177.888 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.15 -22.41 74.15 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.923 2.415 . . . . 0.0 115.537 -173.854 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.2 -24.79 51.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 121.126 1.784 . . . . 0.0 112.892 171.395 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.4 -22.44 19.65 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.93 1.292 . . . . 0.0 112.745 178.829 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.19 147.46 50.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.709 0.803 . . . . 0.0 110.872 164.425 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -133.11 138.45 46.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.576 0.75 . . . . 0.0 109.918 154.334 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.27 135.43 44.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 174.21 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -125.45 132.85 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 -175.585 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -145.73 146.56 31.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.387 1.875 . . . . 0.0 110.192 179.344 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.7 43.26 9.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.747 1.219 . . . . 0.0 113.898 178.546 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.53 -5.3 78.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.912 1.72 . . . . 0.0 117.277 177.661 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.99 159.02 42.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 121.045 2.423 . . . . 0.0 114.764 -176.719 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -65.75 155.01 37.43 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.432 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.31 137.04 46.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 0.0 111.709 176.832 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.05 131.0 37.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 109.602 165.707 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.88 -30.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -151.972 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.6 8.39 7.44 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.396 -1.224 . . . . 0.0 115.755 -176.169 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -101.41 150.76 22.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.165 1.786 . . . . 0.0 112.298 -173.552 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -70.34 154.91 41.36 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 172.592 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.9 -33.49 73.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.048 -0.408 . . . . 0.0 111.592 171.239 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.4 p -61.2 -37.34 82.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.988 1.315 . . . . 0.0 113.67 172.593 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.03 -19.1 63.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 112.862 -179.93 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -99.8 0.57 41.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.872 1.669 . . . . 0.0 114.043 170.638 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.24 35.66 26.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.916 1.286 . . . . 0.0 113.852 -175.264 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.41 96.17 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.437 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -113.57 164.48 13.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.296 1.838 . . . . 0.0 112.621 -169.728 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 56.3 -93.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.592 2.357 . . . . 0.0 115.497 166.401 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -139.1 40.09 2.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 110.994 -176.32 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.8 m -50.58 140.79 13.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.308 1.443 . . . . 0.0 113.08 179.894 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -112.32 137.98 49.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.383 1.073 . . . . 0.0 111.494 173.94 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.04 163.6 22.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.557 1.943 . . . . 0.0 110.854 -174.87 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -111.74 138.01 48.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.148 0.979 . . . . 0.0 110.471 168.277 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.35 120.06 36.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.703 1.601 . . . . 0.0 108.552 176.389 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.35 155.57 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.979 1.312 . . . . 0.0 111.713 -175.205 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.6 tp -85.4 117.68 24.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.74 1.216 . . . . 0.0 108.115 166.252 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -114.25 122.16 45.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 110.505 -173.789 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.3 mt -142.37 -19.13 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.607 1.963 . . . . 0.0 114.91 -170.899 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -124.37 21.12 8.74 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.373 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.06 -21.52 61.59 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.587 1.089 . . . . 0.0 115.789 -176.013 . . . . . . . . 1 1 . 1 . 155 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.673 1.606 . . . . 0.0 112.565 175.125 . . . . . . . . 0 0 . 1 . 156 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 156 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.89 143.7 30.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.915 0.486 . . . . 0.0 111.5 171.819 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 pt -130.6 162.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.768 1.227 . . . . 0.0 109.145 156.866 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -111.18 144.69 39.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.581 0.752 . . . . 0.0 110.588 175.578 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.93 129.12 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 124.094 0.958 . . . . 0.0 109.431 174.308 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 150.7 42.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.839 1.256 . . . . 0.0 114.189 -177.535 . . . . . . . . 2 2 . 1 . 156 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.5 p -85.61 159.7 19.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.674 0.79 . . . . 0.0 111.027 166.835 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.19 0.35 6.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.479 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -111.83 20.35 17.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.78 2.432 . . . . 0.0 112.503 171.492 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.94 8.92 86.91 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 117.603 -1.665 . . . . 0.0 117.14 161.46 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -80.74 141.88 34.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.134 1.967 . . . . 0.0 109.825 167.195 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -133.59 142.34 48.09 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.137 1.375 . . . . 0.0 112.029 178.3 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.41 158.3 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.694 1.998 . . . . 0.0 111.347 173.396 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 m -101.96 134.59 44.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 109.965 172.906 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.26 145.8 40.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.156 1.382 . . . . 0.0 111.181 168.491 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.0 117.5 34.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.061 1.344 . . . . 0.0 108.892 170.14 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.23 160.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.847 1.659 . . . . 0.0 113.169 -165.903 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -107.83 150.71 40.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 125.248 1.419 . . . . 0.0 111.35 166.755 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.96 -27.04 43.03 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.076 2.517 . . . . 0.0 115.5 174.413 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 p -85.96 -0.87 56.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.393 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.07 131.44 46.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 120.339 1.427 . . . . 0.0 110.61 177.36 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -76.25 171.29 14.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.778 1.231 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.2 -39.8 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.983 171.89 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.02 -40.15 88.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.793 1.237 . . . . 0.0 113.406 172.961 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.5 -45.27 88.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.925 0.784 . . . . 0.0 111.879 173.571 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.18 -40.44 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 121.161 -0.962 . . . . 0.0 111.594 -178.73 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -60.82 -37.15 81.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.491 1.041 . . . . 0.0 112.593 171.691 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.65 74.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 175.176 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.93 -30.35 67.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.287 0.949 . . . . 0.0 112.526 172.956 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.72 -41.8 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.654 1.182 . . . . 0.0 111.362 169.168 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.28 -39.2 82.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.863 0.865 . . . . 0.0 111.493 171.954 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.43 -33.38 75.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.241 1.016 . . . . 0.0 113.706 175.418 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -83.82 -45.62 13.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.838 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -120.41 -15.88 8.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.169 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.45 22.87 71.98 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -179.939 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.8 mt -85.69 121.42 73.3 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 124.674 1.189 . . . . 0.0 108.674 177.796 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.61 137.23 79.03 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.89 2.394 . . . . 0.0 113.056 178.804 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.51 -33.56 68.36 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.567 2.845 . . . . 0.0 116.111 -177.306 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -23.92 65.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.598 1.09 . . . . 0.0 113.252 177.369 . . . . . . . . 2 2 . 1 . 156 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.1 -13.19 59.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 118.995 0.816 . . . . 0.0 112.871 174.32 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -94.43 136.22 34.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.224 1.009 . . . . 0.0 111.06 -174.377 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -122.26 132.51 54.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.735 1.214 . . . . 0.0 109.443 156.1 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.3 mt -106.83 133.23 51.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 110.568 -178.208 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.2 mt -133.11 131.08 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.325 1.45 . . . . 0.0 110.507 -173.442 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -150.13 146.75 27.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.764 1.226 . . . . 0.0 111.547 175.063 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 33.72 4.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.666 1.586 . . . . 0.0 115.027 -178.377 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.02 2.9 90.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 115.974 -179.112 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.89 138.16 50.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.027 1.731 . . . . 0.0 112.244 178.437 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -69.92 137.11 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 122.901 0.48 . . . . 0.0 109.973 159.482 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.94 129.2 35.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.42 0.688 . . . . 0.0 110.679 -176.589 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -103.12 163.39 12.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -165.212 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.69 135.25 56.57 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.145 -0.972 . . . . 0.0 113.172 -170.912 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.82 -8.82 55.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.963 1.744 . . . . 0.0 115.415 178.426 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -77.41 162.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.01 1.324 . . . . 0.0 111.318 176.518 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -120.95 173.19 7.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.688 1.595 . . . . 0.0 112.834 179.84 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.66 -38.16 71.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.851 -0.531 . . . . 0.0 111.849 168.458 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -67.24 -34.15 76.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.137 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -61.87 -37.35 84.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.781 1.173 . . . . 0.0 112.204 177.245 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -96.8 5.21 51.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.246 1.418 . . . . 0.0 114.718 -179.857 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 55.14 53.92 9.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.867 1.667 . . . . 0.0 113.414 -177.309 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -98.29 132.11 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.111 1.364 . . . . 0.0 108.916 179.378 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -125.13 168.42 13.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.628 1.171 . . . . 0.0 112.929 -165.114 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -48.73 129.22 16.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.492 1.917 . . . . 0.0 112.83 178.987 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 97.9 mt-10 62.23 24.28 14.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.17 2.188 . . . . 0.0 115.186 -179.475 . . . . . . . . 2 2 . 1 . 156 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -68.05 152.03 46.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.092 -1.005 . . . . 0.0 111.296 163.084 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -111.89 118.82 36.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.213 1.405 . . . . 0.0 110.811 174.35 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.65 154.7 19.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.468 -179.81 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -107.0 137.09 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.955 0.902 . . . . 0.0 111.344 -178.032 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.92 127.39 55.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.686 1.994 . . . . 0.0 109.992 177.745 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 t -115.78 138.02 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 125.876 1.67 . . . . 0.0 109.276 175.15 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.99 164.46 13.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 -179.912 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -98.98 -35.98 9.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 172.954 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.04 26.25 10.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.836 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -131.58 170.13 15.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.009 1.724 . . . . 0.0 112.492 179.521 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -91.08 1.03 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.401 1.001 . . . . 0.0 114.016 166.765 . . . . . . . . 1 1 . 1 . 156 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 116.639 -2.201 . . . . 0.0 114.816 -177.854 . . . . . . . . 0 0 . 1 . 157 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 157 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -77.98 141.69 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.742 1.217 . . . . 0.0 110.22 167.883 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.1 pt -131.1 162.51 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 111.024 162.299 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -112.48 139.54 47.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.005 1.322 . . . . 0.0 110.317 172.49 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.03 127.53 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.959 0.904 . . . . 0.0 109.799 173.793 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -110.41 127.34 55.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.469 1.508 . . . . 0.0 112.196 -172.713 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -73.49 166.89 22.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.551 1.54 . . . . 0.0 112.566 179.783 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.89 -24.37 67.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.955 -1.09 . . . . 0.0 112.515 169.964 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -81.35 -0.79 42.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.94 2.096 . . . . 0.0 114.033 171.051 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.25 10.34 86.28 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.678 1.609 . . . . 0.0 115.889 172.244 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -83.05 144.04 30.18 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.851 1.26 . . . . 0.0 109.591 171.933 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -124.6 114.42 19.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.201 0.6 . . . . 0.0 111.791 -167.448 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.58 148.37 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.475 1.51 . . . . 0.0 111.624 176.609 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p -96.96 142.68 28.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.286 1.035 . . . . 0.0 111.867 170.506 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -134.99 155.8 50.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.365 1.466 . . . . 0.0 111.105 173.444 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.29 129.64 55.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.669 1.188 . . . . 0.0 111.061 170.751 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.19 170.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.871 2.068 . . . . 0.0 111.204 -170.93 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -120.25 151.32 53.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 167.949 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -55.66 -26.59 56.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.815 2.344 . . . . 0.0 114.755 171.588 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 p -78.83 -8.84 59.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.147 1.779 . . . . 0.0 114.731 174.442 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -81.47 146.66 30.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.174 1.389 . . . . 0.0 112.091 -175.608 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -83.24 151.88 25.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -173.151 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -63.66 -35.29 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 O-C-N 121.529 -0.732 . . . . 0.0 111.834 178.533 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.55 -42.51 92.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.999 -1.063 . . . . 0.0 112.852 170.652 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -69.07 -30.3 68.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.381 -0.824 . . . . 0.0 112.818 175.307 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.44 -38.99 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.94 -1.1 . . . . 0.0 111.485 169.944 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.5 -36.65 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.521 1.055 . . . . 0.0 112.689 171.637 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.08 95.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.728 0.694 . . . . 0.0 112.496 172.082 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -64.1 -32.86 74.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 174.955 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.87 -47.7 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.455 1.102 . . . . 0.0 110.477 170.134 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -55.51 -42.7 74.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.452 -0.78 . . . . 0.0 112.176 179.6 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.55 -14.15 11.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.711 1.604 . . . . 0.0 114.979 -178.394 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.14 -7.51 5.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 171.472 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -120.99 -13.82 8.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 178.333 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.89 65.93 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 120.152 1.342 . . . . 0.0 115.728 172.44 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.29 122.3 25.13 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 125.803 1.641 . . . . 0.0 107.97 175.733 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.68 145.46 51.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.347 2.031 . . . . 0.0 112.591 -175.272 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -48.68 -39.43 38.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 124.168 3.245 . . . . 0.0 116.131 -177.346 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.25 -15.32 33.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.47 1.508 . . . . 0.0 113.948 176.869 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -111.4 9.02 21.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.541 1.936 . . . . 0.0 113.375 179.481 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -109.65 152.42 25.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.43 1.092 . . . . 0.0 113.182 176.563 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -134.64 143.37 47.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.407 2.683 . . . . 0.0 109.225 176.624 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.21 125.99 18.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.952 0.901 . . . . 0.0 113.034 -165.752 . . . . . . . . 2 2 . 1 . 157 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.81 141.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.519 1.928 . . . . 0.0 110.533 -176.731 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -140.62 141.69 35.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.196 1.798 . . . . 0.0 110.237 170.867 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.84 29.14 3.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -175.665 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 -3.55 66.15 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 116.657 1.423 . . . . 0.0 116.657 -175.193 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -108.3 141.94 39.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.068 1.934 . . . . 0.0 112.742 178.734 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.85 148.32 27.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.202 1.001 . . . . 0.0 112.367 -178.001 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.43 146.49 26.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 113.465 -170.555 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.82 133.63 35.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.322 1.449 . . . . 0.0 111.7 171.874 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.72 -34.7 72.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -165.456 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.59 -5.84 86.37 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 178.854 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -96.07 176.91 5.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.003 1.721 . . . . 0.0 111.963 -176.947 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -102.22 168.62 9.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.974 1.31 . . . . 0.0 113.716 178.864 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.01 -34.81 73.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 168.07 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 p -69.95 -28.22 65.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.21 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -64.29 -12.69 44.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.27 1.028 . . . . 0.0 113.495 172.988 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -120.03 6.91 10.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.682 1.593 . . . . 0.0 113.714 174.511 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 50.0 46.36 24.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.386 1.474 . . . . 0.0 113.068 -173.964 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.76 125.06 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.445 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -106.59 167.17 10.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.995 1.318 . . . . 0.0 111.998 -169.555 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -54.6 140.05 36.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.372 -0.83 . . . . 0.0 112.448 173.031 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 57.66 21.58 7.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -175.095 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.4 m -60.99 147.7 42.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.715 -1.24 . . . . 0.0 112.505 167.046 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.1 m -99.32 123.13 43.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.685 1.194 . . . . 0.0 109.625 163.158 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.78 149.9 27.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.643 1.577 . . . . 0.0 109.489 173.271 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -107.42 119.47 39.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.66 1.184 . . . . 0.0 110.625 -176.818 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.81 134.28 34.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.856 1.662 . . . . 0.0 110.968 178.475 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.33 146.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.588 1.555 . . . . 0.0 108.502 177.96 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.13 147.21 23.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.029 -1.045 . . . . 0.0 110.22 176.761 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -135.98 101.41 4.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 110.827 170.628 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.31 163.79 23.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.084 0.945 . . . . 0.0 112.392 -175.006 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -100.53 5.49 44.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.726 2.01 . . . . 0.0 112.944 173.495 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.77 157.97 12.13 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.362 1.458 . . . . 0.0 113.111 176.949 . . . . . . . . 1 1 . 1 . 157 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.186 1.374 . . . . 0.0 115.69 179.749 . . . . . . . . 0 0 . 1 . 158 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.211 0.529 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 158 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 132.35 35.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.587 1.555 . . . . 0.0 109.843 172.442 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.88 168.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.793 0.837 . . . . 0.0 109.668 160.471 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.27 143.79 41.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.341 0.657 . . . . 0.0 110.086 172.37 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.31 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 123.89 0.876 . . . . 0.0 109.688 172.224 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -125.02 144.89 50.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.277 1.031 . . . . 0.0 111.971 175.395 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -88.75 167.33 13.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.807 1.243 . . . . 0.0 112.088 -178.78 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.33 -33.84 74.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.623 -1.298 . . . . 0.0 111.312 169.834 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -74.96 1.93 11.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.287 2.235 . . . . 0.0 114.734 173.541 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.35 79.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 171.202 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -78.6 149.23 33.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.991 1.896 . . . . 0.0 111.723 176.497 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 p -90.92 134.75 34.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.832 1.253 . . . . 0.0 111.84 -177.609 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.59 122.72 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.47 1.908 . . . . 0.0 108.924 179.304 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -93.08 125.82 37.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.405 1.082 . . . . 0.0 110.019 172.929 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.18 154.59 31.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.817 1.247 . . . . 0.0 112.097 -171.631 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -112.77 124.02 51.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.158 1.783 . . . . 0.0 110.668 174.515 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 155.39 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 125.455 1.502 . . . . 0.0 111.107 -176.191 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.02 155.42 37.53 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.931 167.173 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -54.18 -30.8 62.85 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.161 2.574 . . . . 0.0 115.213 179.403 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -94.14 9.44 37.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.79 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.56 137.03 58.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 120.564 1.529 . . . . 0.0 110.282 170.242 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.81 164.04 23.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.053 0.941 . . . . 0.0 111.064 173.208 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.93 -33.83 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.812 171.437 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.73 -37.05 80.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.723 0.809 . . . . 0.0 112.919 171.87 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -68.14 -43.15 78.93 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 119.115 0.87 . . . . 0.0 111.935 174.464 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.86 -44.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.576 -0.702 . . . . 0.0 111.023 178.946 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -59.65 -39.35 84.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.038 173.608 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.21 82.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.26 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.96 -40.83 98.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.057 0.943 . . . . 0.0 111.347 173.518 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.12 -44.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.424 1.09 . . . . 0.0 111.452 175.028 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -54.94 -52.66 62.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.787 1.235 . . . . 0.0 111.652 176.118 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -53.04 -39.37 63.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 112.965 178.606 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -85.35 -35.48 21.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -178.919 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -116.26 -15.58 11.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -167.021 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 19.85 69.21 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 119.678 1.126 . . . . 0.0 115.878 179.195 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -103.26 113.04 66.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.627 1.571 . . . . 0.0 108.463 175.943 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.99 148.55 88.52 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.673 2.248 . . . . 0.0 114.242 -176.311 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.35 -40.19 71.27 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.079 2.519 . . . . 0.0 114.736 178.297 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.2 -13.49 58.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.92 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -104.44 -6.03 21.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.521 1.928 . . . . 0.0 113.364 -175.312 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -98.53 137.53 37.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.77 1.228 . . . . 0.0 112.647 -179.106 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 -119.62 120.27 36.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.935 1.694 . . . . 0.0 109.104 165.439 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.2 134.76 49.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.818 1.247 . . . . 0.0 112.355 -175.59 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.0 140.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.102 1.761 . . . . 0.0 110.92 -177.005 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -138.11 124.27 20.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.944 169.367 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.81 43.85 21.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.149 1.38 . . . . 0.0 112.882 -179.063 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.72 -8.95 3.93 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.619 1.581 . . . . 0.0 116.721 -174.428 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -80.22 131.48 35.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.207 1.803 . . . . 0.0 109.94 176.62 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -76.01 132.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.422 0.555 . . . . 0.0 110.716 170.593 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.2 mt -95.13 99.72 11.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.455 1.102 . . . . 0.0 109.375 176.795 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.66 150.19 21.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 112.698 177.4 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -62.43 151.63 36.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.591 1.557 . . . . 0.0 112.534 -178.419 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 6.75 63.82 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.773 1.177 . . . . 0.0 114.705 179.988 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -133.04 165.22 25.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.226 1.513 . . . . 0.0 111.605 173.732 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -107.89 159.41 16.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 113.8 -170.061 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.24 -44.19 83.6 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.736 0.814 . . . . 0.0 113.094 178.964 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -59.48 -39.1 82.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.827 0.851 . . . . 0.0 113.08 175.225 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.97 -36.62 75.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.628 1.171 . . . . 0.0 112.223 179.42 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.65 2.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 169.729 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.22 20.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.609 1.564 . . . . 0.0 113.461 -178.73 . . . . . . . . 2 2 . 1 . 158 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.99 124.84 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.717 1.207 . . . . 0.0 108.644 175.019 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -120.43 170.79 9.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.015 1.726 . . . . 0.0 110.869 -173.556 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -56.39 136.17 53.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.508 -0.745 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 50.4 mt-10 58.6 23.71 11.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.828 2.051 . . . . 0.0 115.643 -177.621 . . . . . . . . 2 2 . 1 . 158 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.0 m -77.11 157.94 30.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.92 0.888 . . . . 0.0 110.804 157.362 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 m -121.49 130.21 53.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 112.631 -170.963 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.982 1.713 . . . . 0.0 112.135 175.666 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -124.87 153.54 42.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.624 1.57 . . . . 0.0 112.177 175.594 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.1 tp -118.98 134.6 55.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.551 1.54 . . . . 0.0 112.371 -175.681 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.51 151.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.634 1.974 . . . . 0.0 107.841 166.922 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 132.87 34.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.599 -1.313 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 158 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -84.97 26.94 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.606 1.562 . . . . 0.0 114.923 -161.59 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt 54.24 38.29 29.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.589 1.556 . . . . 0.0 113.515 -179.685 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -105.91 -25.46 12.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.54 1.536 . . . . 0.0 113.138 -174.308 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.96 -145.82 7.17 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.04 2.257 . . . . 0.0 112.062 174.985 . . . . . . . . 1 1 . 1 . 158 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.812 -1.549 . . . . 0.0 113.894 177.498 . . . . . . . . 0 0 . 1 . 159 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 159 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -109.9 147.83 32.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.847 0.859 . . . . 0.0 111.148 178.64 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.58 155.21 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 110.688 173.973 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -94.96 137.93 33.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.779 0.832 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.46 109.54 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.191 0.996 . . . . 0.0 108.866 175.322 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -90.68 125.87 35.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 178.939 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -94.56 178.3 5.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.257 1.023 . . . . 0.0 113.172 179.13 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.54 -19.87 58.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.168 1.787 . . . . 0.0 115.667 -177.205 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -87.97 1.09 54.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.523 1.529 . . . . 0.0 113.69 172.473 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.95 40.56 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.687 1.137 . . . . 0.0 114.58 -170.551 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -66.28 142.85 57.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.775 1.787 . . . . 0.0 110.801 176.501 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 m -104.4 131.71 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 111.146 179.575 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.73 139.28 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.148 1.779 . . . . 0.0 108.58 167.057 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -100.45 125.07 46.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.786 0.835 . . . . 0.0 109.844 177.05 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tp -125.26 130.76 52.7 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.784 0.834 . . . . 0.0 111.87 -173.704 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.921 0.867 . . . . 0.0 111.95 174.342 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -143.14 161.02 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 126.866 2.067 . . . . 0.0 111.419 -171.013 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -113.28 152.61 45.3 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 124.521 1.128 . . . . 0.0 109.127 163.391 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.03 -7.47 15.41 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.034 2.489 . . . . 0.0 115.377 179.31 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -93.14 -1.89 55.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.387 1.875 . . . . 0.0 114.631 170.72 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.48 142.07 51.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.926 1.239 . . . . 0.0 111.644 177.974 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -88.92 155.69 19.36 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.421 1.089 . . . . 0.0 113.059 173.511 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.93 -31.73 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 120.876 -1.14 . . . . 0.0 112.59 -178.557 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.89 -30.62 70.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.792 -1.192 . . . . 0.0 112.604 172.966 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.62 -37.25 62.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.075 0.95 . . . . 0.0 111.793 174.383 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.91 -47.74 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 121.51 -0.744 . . . . 0.0 110.436 169.223 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.2 -38.59 91.75 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.461 0.705 . . . . 0.0 112.823 177.211 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.32 -35.31 77.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 175.692 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -68.77 -37.48 79.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.33 1.052 . . . . 0.0 112.246 173.541 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.34 -40.8 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.413 1.085 . . . . 0.0 110.885 171.324 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.48 -46.68 89.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.593 0.633 . . . . 0.0 112.123 174.191 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.66 -34.16 70.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.712 1.205 . . . . 0.0 113.582 177.957 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -81.49 -54.67 5.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 174.816 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -118.02 1.4 12.0 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -163.113 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 6.01 89.37 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 116.454 1.342 . . . . 0.0 116.454 170.113 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.91 116.59 65.51 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 119.193 1.496 . . . . 0.0 109.221 -179.205 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.7 154.15 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.193 1.929 . . . . 0.0 112.908 -175.774 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -67.08 -29.52 39.89 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.278 1.985 . . . . 0.0 114.489 -163.29 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -69.95 -18.7 63.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.601 1.16 . . . . 0.0 113.995 -179.202 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -88.46 -12.48 42.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.115 0.966 . . . . 0.0 112.973 178.961 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -95.67 118.45 32.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.233 1.413 . . . . 0.0 112.354 -170.65 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.77 128.87 46.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.052 1.341 . . . . 0.0 109.225 164.742 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -113.96 138.16 50.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.251 1.02 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.02 139.88 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.179 1.792 . . . . 0.0 110.199 -172.501 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -127.84 112.74 15.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.764 1.626 . . . . 0.0 110.459 177.094 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 42.56 21.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.501 1.12 . . . . 0.0 113.846 -176.29 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.87 -9.64 51.36 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.13 -1.372 . . . . 0.0 116.499 -175.565 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -87.19 127.54 35.15 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 120.894 2.347 . . . . 0.0 111.747 176.722 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -79.88 129.41 34.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.142 0.577 . . . . 0.0 111.369 -178.254 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.97 143.2 26.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.305 1.042 . . . . 0.0 112.409 -174.25 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.13 149.95 39.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.631 1.972 . . . . 0.0 111.385 -177.35 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.27 10.54 14.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -164.979 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.91 12.25 62.44 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.34 1.448 . . . . 0.0 115.301 179.218 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -145.08 161.49 39.31 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 113.918 -173.306 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -101.67 163.7 12.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.525 1.93 . . . . 0.0 113.335 -179.374 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.76 -44.94 49.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.441 1.097 . . . . 0.0 113.748 -178.779 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 p -69.43 -25.74 64.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 177.808 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -68.09 -29.48 68.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.571 1.078 . . . . 0.0 111.284 171.614 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -91.34 2.25 56.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.01 1.724 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 t30 58.38 33.16 22.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -175.61 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.6 mt -77.0 136.36 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 109.042 173.229 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.53 171.42 14.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.188 1.795 . . . . 0.0 111.474 -172.099 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -47.54 135.0 11.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.261 1.424 . . . . 0.0 114.597 179.785 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 63.36 12.96 6.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.209 1.804 . . . . 0.0 115.191 175.797 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 163.8 21.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.608 1.163 . . . . 0.0 112.545 170.776 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -115.99 131.85 56.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.44 1.496 . . . . 0.0 111.782 -178.561 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -106.92 157.16 17.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.153 1.781 . . . . 0.0 110.334 165.117 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -113.55 142.5 45.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.284 171.414 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.28 132.33 53.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.005 1.722 . . . . 0.0 109.576 -174.445 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.44 124.13 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.389 1.476 . . . . 0.0 108.558 178.514 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.19 136.07 44.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.66 0.784 . . . . 0.0 111.989 -173.022 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -68.47 118.63 11.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.889 1.276 . . . . 0.0 110.807 171.117 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.4 tp -75.94 -46.72 28.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.917 0.887 . . . . 0.0 112.87 -172.227 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -83.1 40.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 112.066 175.622 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.14 -14.78 81.55 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.76 1.647 . . . . 0.0 115.806 -171.67 . . . . . . . . 1 1 . 1 . 159 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.861 -1.522 . . . . 0.0 113.054 -177.195 . . . . . . . . 0 0 . 1 . 160 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.839 -0.06 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 160 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -83.9 138.67 33.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.033 1.333 . . . . 0.0 110.603 173.868 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 pt -144.61 170.88 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.322 1.849 . . . . 0.0 111.051 170.549 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.99 150.83 51.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.003 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.9 133.97 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.969 174.691 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -112.61 137.91 50.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.36 2.264 . . . . 0.0 111.595 179.387 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -113.15 155.36 25.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.394 1.478 . . . . 0.0 113.747 177.747 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.4 -35.71 81.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.046 1.338 . . . . 0.0 113.17 -175.829 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -78.86 7.95 6.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.47 1.108 . . . . 0.0 113.725 172.803 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.71 3.72 42.96 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.184 -1.342 . . . . 0.0 116.398 160.787 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -86.8 147.11 25.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.065 1.932 . . . . 0.0 112.34 -176.184 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -121.68 130.54 53.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.372 1.469 . . . . 0.0 109.272 174.5 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.68 131.9 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.343 1.457 . . . . 0.0 109.662 -174.825 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.2 m -93.18 134.22 35.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.976 1.31 . . . . 0.0 109.72 174.987 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.0 mt -126.63 144.96 50.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.953 1.301 . . . . 0.0 110.805 176.318 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -124.05 92.82 3.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.05 1.34 . . . . 0.0 109.365 -175.554 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.0 171.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.06 1.744 . . . . 0.0 112.995 -164.992 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -93.26 157.63 38.52 Favored Pre-proline 0 N--CA 1.45 -0.468 0 O-C-N 121.453 -0.779 . . . . 0.0 112.196 173.529 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.47 -13.05 19.12 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.33 2.687 . . . . 0.0 115.417 166.39 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -91.43 -7.68 49.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.918 2.087 . . . . 0.0 114.687 175.086 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 131.63 48.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.348 1.431 . . . . 0.0 110.351 174.797 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -71.97 158.41 36.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.159 -0.338 . . . . 0.0 110.812 173.202 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.46 -28.42 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 121.314 -0.866 . . . . 0.0 111.363 173.918 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.39 -44.74 95.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.163 1.347 . . . . 0.0 112.461 167.304 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -62.61 -40.26 96.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.378 0.99 . . . . 0.0 111.805 176.024 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.75 -46.14 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.245 0.618 . . . . 0.0 110.748 174.545 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 41' ' ' GLN . 37.6 mtpt -62.21 -37.98 87.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.23 1.012 . . . . 0.0 113.101 177.018 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.88 63.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.058 0.943 . . . . 0.0 113.342 175.218 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -83.24 -34.17 25.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.934 -1.104 . . . . 0.0 112.241 174.357 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.74 -40.87 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.131 0.973 . . . . 0.0 110.543 164.977 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.39 -41.75 98.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.03 -1.044 . . . . 0.0 112.754 173.456 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.41 -37.93 85.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 113.23 176.828 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.08 -42.67 15.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.611 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -117.29 -6.44 11.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -165.953 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.33 12.36 72.63 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.438 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.87 125.28 84.29 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.032 1.333 . . . . 0.0 109.241 -176.645 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.04 125.43 16.45 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.691 2.261 . . . . 0.0 112.869 179.013 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.54 -30.51 45.0 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.224 2.616 . . . . 0.0 116.314 177.743 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.25 -15.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.212 1.369 . . . . 0.0 114.246 177.079 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -96.03 -22.22 17.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.631 1.173 . . . . 0.0 112.707 171.324 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 77.4 mt-30 -79.71 120.73 24.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.361 0.982 . . . . 0.0 111.331 -170.253 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -118.18 123.8 46.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.365 0.666 . . . . 0.0 110.447 158.338 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.81 137.43 32.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.735 0.814 . . . . 0.0 109.278 165.58 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.14 147.77 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 113.174 -172.967 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -157.98 141.9 15.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 169.838 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 47.27 22.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.375 1.47 . . . . 0.0 114.678 173.629 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 1.71 60.9 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.171 1.843 . . . . 0.0 116.085 -179.467 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -116.56 146.27 42.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.219 1.51 . . . . 0.0 112.994 -171.759 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -76.53 132.02 39.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.689 1.196 . . . . 0.0 109.084 165.532 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -80.57 135.83 36.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.42 0.554 . . . . 0.0 110.206 172.382 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -90.46 125.27 35.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.362 1.065 . . . . 0.0 113.047 -170.492 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -29.54 2.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.78 2.032 . . . . 0.0 115.544 -178.985 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.27 -22.89 61.98 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.319 1.288 . . . . 0.0 116.319 177.291 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.29 162.59 15.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.008 1.404 . . . . 0.0 111.291 -176.092 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -105.5 162.37 13.53 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.427 1.491 . . . . 0.0 112.39 -178.58 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.26 -39.87 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.007 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.2 p -69.11 -24.38 64.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 176.391 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -67.68 -23.17 65.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.411 1.46 . . . . 0.0 112.221 174.779 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -102.01 8.16 41.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.415 1.886 . . . . 0.0 113.316 170.475 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m120 56.53 27.06 11.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.694 1.998 . . . . 0.0 115.213 -177.595 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.39 104.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.615 -1.303 . . . . 0.0 109.201 -175.302 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.14 172.57 9.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.511 1.124 . . . . 0.0 113.614 -176.897 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -47.58 140.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.461 1.905 . . . . 0.0 113.672 177.036 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 35.0 mt-10 65.01 15.92 10.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.681 2.393 . . . . 0.0 114.811 176.72 . . . . . . . . 2 2 . 1 . 160 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -76.36 143.47 40.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.792 1.237 . . . . 0.0 112.364 168.966 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -97.82 140.15 32.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.422 1.489 . . . . 0.0 110.782 172.238 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.1 mt -117.74 155.34 30.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.782 165.354 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -94.35 143.75 26.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.195 0.598 . . . . 0.0 111.321 168.073 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -113.35 133.25 55.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.098 1.759 . . . . 0.0 110.598 176.958 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.86 133.48 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.813 1.245 . . . . 0.0 109.668 172.87 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -91.74 112.35 24.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.851 0.86 . . . . 0.0 109.143 173.302 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -79.91 64.3 4.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.468 1.907 . . . . 0.0 112.117 -179.574 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.79 164.48 12.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.274 2.229 . . . . 0.0 110.941 167.796 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -130.32 165.28 22.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.748 1.219 . . . . 0.0 112.385 -179.453 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.33 -152.29 11.9 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.669 1.128 . . . . 0.0 113.185 177.512 . . . . . . . . 1 1 . 1 . 160 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 117.701 -1.61 . . . . 0.0 113.003 176.325 . . . . . . . . 0 0 . 1 . 161 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 161 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -83.49 139.71 32.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.481 0.712 . . . . 0.0 112.669 174.302 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.04 168.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 110.209 161.644 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -117.08 156.87 26.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.291 1.036 . . . . 0.0 112.48 176.442 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.1 t -133.6 133.63 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.815 1.246 . . . . 0.0 109.535 171.749 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.63 128.83 55.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.925 1.69 . . . . 0.0 111.811 173.65 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -73.88 172.54 11.39 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.03 0.932 . . . . 0.0 113.168 178.892 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.53 -25.13 6.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.212 2.205 . . . . 0.0 114.45 169.869 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -104.82 8.13 34.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.154 1.781 . . . . 0.0 113.989 176.597 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.47 7.64 88.35 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.814 1.197 . . . . 0.0 115.564 175.074 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.39 131.87 46.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.343 1.571 . . . . 0.0 109.396 173.665 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 m -102.71 134.07 46.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.921 0.889 . . . . 0.0 111.566 -174.745 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.69 142.52 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 125.193 1.397 . . . . 0.0 110.762 172.156 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -95.91 139.17 32.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.906 1.282 . . . . 0.0 110.134 171.863 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 133.93 46.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.725 1.21 . . . . 0.0 110.86 173.508 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -101.7 108.99 20.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.383 1.473 . . . . 0.0 108.961 175.698 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.81 163.43 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 125.817 1.647 . . . . 0.0 112.11 -166.927 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -104.91 154.23 38.8 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 125.027 1.331 . . . . 0.0 113.009 -178.811 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -73.17 -21.44 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.404 2.07 . . . . 0.0 116.088 -162.62 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.1 m -95.95 6.53 48.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.95 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.23 139.59 50.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.992 0.901 . . . . 0.0 110.738 169.704 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -70.91 158.81 35.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.181 0.993 . . . . 0.0 111.669 -179.697 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.92 -28.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 121.251 -0.906 . . . . 0.0 111.295 172.427 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.46 -47.61 84.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.945 -1.097 . . . . 0.0 112.624 168.073 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -63.32 -36.06 82.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.247 -0.908 . . . . 0.0 112.717 174.442 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.34 -42.26 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 119.415 1.007 . . . . 0.0 111.002 174.465 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.29 -34.89 72.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 174.08 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.01 71.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 173.584 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.642 -1.286 . . . . 0.0 113.274 173.701 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -70.54 -43.16 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.745 1.218 . . . . 0.0 110.826 168.761 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -62.32 -40.81 97.55 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.243 1.017 . . . . 0.0 111.679 177.784 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.13 -38.6 58.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.94 0.896 . . . . 0.0 112.789 171.145 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -79.08 -55.23 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 178.122 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -115.62 1.03 13.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -163.563 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.54 8.66 63.48 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 174.406 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 119.93 76.31 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.706 1.603 . . . . 0.0 108.955 -179.228 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.76 146.74 61.15 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.208 1.938 . . . . 0.0 111.107 -178.843 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.69 -27.45 60.51 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.544 2.163 . . . . 0.0 113.347 -169.01 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.89 -12.01 59.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.526 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -108.75 8.49 26.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.643 1.577 . . . . 0.0 114.222 173.158 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.08 99.36 9.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.705 -1.247 . . . . 0.0 110.896 176.818 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -98.72 97.62 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.406 1.082 . . . . 0.0 109.886 168.492 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 mt -82.18 119.87 24.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.224 0.61 . . . . 0.0 111.747 -175.912 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -109.42 139.25 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.443 1.897 . . . . 0.0 110.381 179.413 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.99 121.83 16.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.1 1.76 . . . . 0.0 110.333 173.631 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.61 40.6 8.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -179.885 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.52 3.29 90.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 117.057 1.583 . . . . 0.0 117.057 -177.456 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.36 149.48 29.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 111.562 178.148 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -87.94 139.35 30.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.878 0.871 . . . . 0.0 111.144 174.422 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -102.16 135.36 43.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.533 1.133 . . . . 0.0 111.049 176.111 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.99 144.59 35.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.8 1.24 . . . . 0.0 113.554 -169.493 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.2 -31.09 71.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.166 1.386 . . . . 0.0 113.86 -173.891 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.5 11.53 18.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.54 1.543 . . . . 0.0 115.915 173.499 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.15 167.79 18.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.494 2.147 . . . . 0.0 111.999 177.756 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -113.22 162.19 16.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.215 1.806 . . . . 0.0 112.196 -176.695 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.93 -39.36 68.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 178.476 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -69.17 -28.09 66.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.655 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.26 -20.68 66.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 120.038 1.29 . . . . 0.0 112.782 174.996 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -103.35 2.55 34.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.31 1.844 . . . . 0.0 114.191 177.602 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 55.59 35.56 25.43 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.174 1.389 . . . . 0.0 113.95 -177.702 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.4 mt -78.55 110.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.881 -1.137 . . . . 0.0 109.125 -179.141 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -102.74 160.34 14.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.459 1.104 . . . . 0.0 113.551 -175.519 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -18.03 121.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 129.691 3.197 . . . . 0.0 116.614 172.656 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 54.5 mt-10 63.17 23.07 13.71 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 115.845 177.296 . . . . . . . . 2 2 . 1 . 161 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -66.51 157.9 31.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.991 0.917 . . . . 0.0 112.766 162.38 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -119.02 132.21 56.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.93 1.692 . . . . 0.0 111.521 175.994 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.14 153.39 18.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.605 169.354 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -128.22 147.73 50.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 -176.069 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -115.57 142.9 46.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.403 1.881 . . . . 0.0 109.027 167.859 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.76 157.25 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -163.547 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.52 152.75 44.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.477 1.511 . . . . 0.0 112.97 171.621 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 57.58 -17.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 129.78 3.232 . . . . 0.0 118.624 173.299 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.27 92.74 3.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 108.982 172.066 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -116.41 -21.34 9.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 113.231 175.728 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.04 -158.53 32.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.166 1.841 . . . . 0.0 114.086 166.848 . . . . . . . . 1 1 . 1 . 161 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.965 1.745 . . . . 0.0 115.569 176.22 . . . . . . . . 0 0 . 1 . 162 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -85.83 140.52 30.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.354 1.061 . . . . 0.0 113.421 -175.691 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -136.5 162.09 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 110.72 161.566 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -123.2 147.7 46.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.206 1.002 . . . . 0.0 111.918 -177.018 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 126.0 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.304 1.041 . . . . 0.0 110.679 -179.265 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -90.98 117.87 29.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.036 1.734 . . . . 0.0 111.488 -179.355 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -91.16 156.23 18.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.655 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.17 -21.58 66.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.472 1.509 . . . . 0.0 112.834 170.658 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.5 p -79.44 -1.13 35.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.077 1.751 . . . . 0.0 113.904 172.305 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.13 19.46 55.5 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.515 -1.159 . . . . 0.0 115.853 170.276 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -114.77 163.65 15.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.283 1.433 . . . . 0.0 111.321 173.465 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -112.86 120.79 42.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.728 0.811 . . . . 0.0 109.686 167.815 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.0 pt -100.71 149.1 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.789 1.236 . . . . 0.0 111.02 179.564 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -106.85 138.06 43.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.059 1.344 . . . . 0.0 111.321 -177.499 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.71 158.78 39.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.202 1.801 . . . . 0.0 111.541 -178.92 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -116.36 128.48 55.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.145 1.378 . . . . 0.0 109.973 170.873 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.47 161.65 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.967 1.707 . . . . 0.0 111.803 -173.767 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -98.42 148.99 35.29 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 123.796 0.838 . . . . 0.0 110.414 161.1 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.21 -31.5 76.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.829 2.353 . . . . 0.0 114.849 172.911 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.5 m -76.85 -4.07 41.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.952 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -69.97 144.83 52.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.025 1.284 . . . . 0.0 111.814 178.109 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -89.61 151.26 22.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.854 0.862 . . . . 0.0 113.121 -178.888 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.47 -37.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.377 1.071 . . . . 0.0 111.531 -174.311 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.6 -33.29 75.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.647 1.112 . . . . 0.0 113.113 176.779 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -72.15 -36.21 69.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.072 -1.018 . . . . 0.0 112.025 173.934 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.17 -43.18 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.219 -0.925 . . . . 0.0 110.978 169.824 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -59.02 -41.88 88.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.204 0.911 . . . . 0.0 112.457 171.887 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.35 70.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.349 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.75 -33.97 58.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 112.468 173.181 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.69 -38.03 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 111.256 171.222 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -58.63 -37.21 75.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.693 1.197 . . . . 0.0 112.573 178.754 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.91 -20.16 64.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.21 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.73 -43.15 8.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.338 1.455 . . . . 0.0 113.495 175.748 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.58 4.91 7.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.258 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.62 -17.33 4.42 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 118.832 2.293 . . . . 0.0 118.832 161.52 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.75 128.99 91.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 120.108 1.954 . . . . 0.0 110.218 179.019 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.69 147.12 68.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.252 1.968 . . . . 0.0 112.329 178.321 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.16 -36.83 37.46 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 124.21 3.273 . . . . 0.0 116.097 -178.57 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -66.7 -30.22 70.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 113.673 177.155 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.86 -18.07 24.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.283 0.947 . . . . 0.0 113.476 175.962 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -68.62 138.1 54.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.829 0.741 . . . . 0.0 111.032 171.473 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -123.56 122.32 37.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.14 1.376 . . . . 0.0 108.45 164.576 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.34 125.8 48.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.457 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 137.26 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.467 1.107 . . . . 0.0 110.746 -173.323 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -147.16 140.9 25.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.169 1.388 . . . . 0.0 110.693 169.784 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 45.88 17.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.973 1.309 . . . . 0.0 113.549 -176.767 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.38 61.07 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 177.971 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -128.6 140.89 51.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.742 1.771 . . . . 0.0 112.364 179.604 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -77.14 130.15 36.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 176.033 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -80.98 128.09 33.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.958 1.303 . . . . 0.0 110.742 178.184 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.86 145.55 29.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.32 1.448 . . . . 0.0 113.48 -177.819 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.02 -25.2 66.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.055 1.742 . . . . 0.0 114.208 -169.696 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.07 -0.94 70.52 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.544 1.545 . . . . 0.0 116.152 -175.752 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -98.29 -175.4 3.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.076 1.438 . . . . 0.0 112.091 179.126 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.5 p -123.02 169.08 11.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.529 1.932 . . . . 0.0 112.316 172.659 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.49 -39.03 92.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.103 0.561 . . . . 0.0 111.754 175.176 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.9 m -59.96 -47.74 84.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.502 1.121 . . . . 0.0 113.804 172.045 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -71.47 -12.16 61.25 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.482 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -100.94 4.37 42.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.738 1.615 . . . . 0.0 114.69 166.435 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.8 t30 56.15 45.86 22.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.315 1.416 . . . . 0.0 113.461 -179.181 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.12 108.08 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 108.781 178.055 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -94.6 171.02 9.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.957 1.703 . . . . 0.0 112.491 179.474 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.19 149.84 5.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.376 1.47 . . . . 0.0 113.978 175.32 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.352 10.0 pt-20 54.29 24.25 4.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.335 2.254 . . . . 0.0 116.051 -175.323 . . . . . . . . 2 2 . 1 . 162 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -73.61 148.26 43.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.803 0.841 . . . . 0.0 111.643 165.709 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -110.37 119.32 38.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.459 1.103 . . . . 0.0 110.8 172.419 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.6 mt -100.47 152.46 20.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.122 1.769 . . . . 0.0 110.896 177.644 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -102.69 136.95 41.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 177.995 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.25 124.95 47.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 109.694 172.055 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.11 145.83 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.377 1.871 . . . . 0.0 109.718 175.242 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 tp -92.0 143.05 26.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.471 1.109 . . . . 0.0 111.641 178.497 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -94.52 123.61 38.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.999 1.32 . . . . 0.0 110.651 165.532 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.9 -62.62 1.48 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.564 0.745 . . . . 0.0 111.797 178.123 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.05 157.59 34.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.603 1.161 . . . . 0.0 112.927 172.519 . . . . . . . . 2 2 . 1 . 162 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.5 155.75 25.87 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.811 1.196 . . . . 0.0 112.212 179.675 . . . . . . . . 1 1 . 1 . 162 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.935 -177.389 . . . . . . . . 0 0 . 1 . 163 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 163 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -95.55 135.92 36.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.127 0.571 . . . . 0.0 111.518 171.417 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -117.77 174.96 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.149 1.379 . . . . 0.0 110.102 166.67 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.37 144.56 42.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.931 0.893 . . . . 0.0 111.482 170.48 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.35 126.69 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 124.95 1.3 . . . . 0.0 108.442 168.53 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -127.81 141.89 51.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.074 0.95 . . . . 0.0 112.669 -168.584 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.7 p -129.24 153.59 47.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.673 1.189 . . . . 0.0 113.567 -179.632 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.93 -15.32 62.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.842 1.257 . . . . 0.0 112.855 173.286 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -68.71 -1.06 6.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.403 1.481 . . . . 0.0 114.036 164.351 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 31.11 9.74 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 161.371 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.48 139.67 52.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 111.76 178.435 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 m -113.61 120.63 41.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.628 1.571 . . . . 0.0 109.27 169.894 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.0 133.79 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.909 1.684 . . . . 0.0 108.882 -176.906 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 p -87.87 137.9 31.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.503 0.592 . . . . 0.0 109.866 167.993 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.73 134.32 42.86 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.777 0.831 . . . . 0.0 111.197 -177.092 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -104.28 113.42 26.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.045 1.338 . . . . 0.0 111.461 -175.849 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.64 161.23 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.313 1.845 . . . . 0.0 111.837 -165.94 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -108.57 149.19 39.08 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 166.963 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.0 -21.9 28.65 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.428 2.752 . . . . 0.0 114.803 171.535 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -78.34 -12.55 60.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.32 1.848 . . . . 0.0 114.704 175.596 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.45 139.67 51.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.559 1.072 . . . . 0.0 111.316 -177.556 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -74.6 154.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.588 1.155 . . . . 0.0 111.392 173.187 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 mm -62.53 -30.55 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 121.293 -0.879 . . . . 0.0 110.976 173.963 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.18 -45.26 93.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.983 -1.073 . . . . 0.0 113.289 169.052 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -67.35 -36.35 81.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 112.118 176.696 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.22 -43.59 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 121.145 -0.972 . . . . 0.0 111.3 172.562 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.45 -36.4 80.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.009 0.822 . . . . 0.0 112.136 173.459 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.82 84.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.914 0.885 . . . . 0.0 113.315 173.906 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -66.93 -35.49 80.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.125 1.37 . . . . 0.0 112.636 173.758 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.0 -43.28 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.551 1.141 . . . . 0.0 110.644 171.591 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.65 -46.4 90.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.795 1.18 . . . . 0.0 111.213 173.026 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.69 -41.98 78.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.714 0.688 . . . . 0.0 112.082 -178.981 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.58 -44.3 14.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -178.085 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -108.22 -11.48 15.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.611 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.49 12.91 83.38 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.675 1.125 . . . . 0.0 115.615 178.402 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 112.45 54.56 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.018 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.32 157.68 41.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.232 1.955 . . . . 0.0 113.509 -173.234 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -66.09 -21.85 55.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.472 2.114 . . . . 0.0 115.614 -162.379 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.09 -21.35 54.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.995 0.918 . . . . 0.0 113.139 176.763 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.61 -29.15 20.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.979 0.912 . . . . 0.0 111.89 179.215 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.96 143.53 56.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 112.186 179.662 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -134.94 124.04 24.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.739 1.615 . . . . 0.0 109.466 166.633 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.27 128.18 54.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.027 1.331 . . . . 0.0 112.664 -168.204 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.3 mt -129.79 133.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.351 1.46 . . . . 0.0 110.335 -176.045 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -146.05 142.57 28.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.014 1.326 . . . . 0.0 111.312 170.737 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.73 41.28 17.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.014 1.326 . . . . 0.0 112.909 -171.181 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.5 -5.87 34.29 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.809 1.671 . . . . 0.0 116.45 179.174 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -115.27 148.08 39.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.145 1.972 . . . . 0.0 112.08 -172.728 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.58 140.8 46.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.165 0.586 . . . . 0.0 111.175 176.144 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.03 140.4 32.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.082 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.78 121.17 44.51 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.154 1.381 . . . . 0.0 112.386 -171.513 . . . . . . . . 2 2 . 1 . 163 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -40.49 -35.54 0.46 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.479 3.111 . . . . 0.0 117.749 -176.698 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.99 82.95 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.855 1.216 . . . . 0.0 115.421 179.621 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -91.9 166.35 12.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.077 1.439 . . . . 0.0 111.005 177.761 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 p -106.17 165.16 11.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.454 1.102 . . . . 0.0 113.64 178.708 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -57.54 -40.03 77.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.35 0.66 . . . . 0.0 112.351 172.082 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 p -66.36 -32.58 74.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 174.008 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.08 -42.57 89.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.162 1.346 . . . . 0.0 111.808 174.745 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -80.71 2.81 24.45 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 173.402 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 55.17 43.84 28.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.452 1.501 . . . . 0.0 113.651 177.412 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.5 132.25 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.13 1.772 . . . . 0.0 108.142 174.142 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.69 172.55 11.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.479 1.512 . . . . 0.0 111.398 -169.107 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -55.12 135.62 49.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.536 0.734 . . . . 0.0 112.858 177.507 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.45 13.69 6.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -176.022 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -76.45 160.36 29.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.026 167.189 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -110.11 139.11 45.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.192 1.397 . . . . 0.0 111.831 -177.459 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 135.41 47.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.353 1.861 . . . . 0.0 109.098 166.3 . . . . . . . . 2 2 . 1 . 163 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -99.7 125.45 45.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.787 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.7 tp -117.13 135.88 53.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.485 1.514 . . . . 0.0 110.752 -175.835 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.55 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.372 1.869 . . . . 0.0 109.778 165.255 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.44 143.07 27.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.026 0.93 . . . . 0.0 112.111 170.421 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -85.54 54.54 3.15 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.969 1.308 . . . . 0.0 114.185 174.02 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.47 -32.8 63.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.904 1.282 . . . . 0.0 114.162 -173.517 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -67.63 -14.26 62.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.051 1.34 . . . . 0.0 113.789 175.345 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.73 1.55 75.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.782 2.134 . . . . 0.0 114.997 169.001 . . . . . . . . 1 1 . 1 . 163 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.845 -1.53 . . . . 0.0 112.463 171.844 . . . . . . . . 0 0 . 1 . 164 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 164 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -107.82 147.67 30.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.131 0.972 . . . . 0.0 111.988 -178.622 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.69 165.76 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.757 1.623 . . . . 0.0 111.182 172.35 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -126.3 141.01 52.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 110.775 175.462 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.17 124.99 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.432 1.093 . . . . 0.0 109.358 170.939 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -107.87 132.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.615 2.366 . . . . 0.0 110.374 -174.39 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -107.53 155.89 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.525 1.13 . . . . 0.0 113.52 179.154 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.69 -12.1 56.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.967 1.307 . . . . 0.0 113.77 170.588 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -87.37 3.93 45.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.051 2.141 . . . . 0.0 113.529 170.024 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.71 16.42 77.48 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.744 -1.223 . . . . 0.0 115.756 172.568 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -92.21 145.26 24.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.439 1.096 . . . . 0.0 110.421 174.906 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 m -118.28 125.24 49.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.49 1.116 . . . . 0.0 109.141 171.42 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -113.79 112.41 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 107.608 -172.339 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -102.42 123.66 46.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.979 0.912 . . . . 0.0 110.867 -173.423 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.36 149.49 52.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.41 1.084 . . . . 0.0 112.263 -171.828 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -92.09 136.32 33.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.961 0.904 . . . . 0.0 110.101 168.196 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -145.5 158.22 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.335 -179.728 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.79 160.39 26.16 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.713 -0.617 . . . . 0.0 109.38 157.569 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.56 -16.09 22.7 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.651 2.234 . . . . 0.0 115.682 173.236 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -89.3 -3.82 58.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.45 1.9 . . . . 0.0 115.27 174.546 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.77 139.81 58.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.647 1.112 . . . . 0.0 109.419 167.505 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -81.9 164.36 21.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.9 0.857 . . . . 0.0 112.353 173.174 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.1 -32.61 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.527 -0.733 . . . . 0.0 110.307 169.287 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.25 -39.18 82.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.291 169.632 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -57.74 -42.51 84.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 121.35 1.886 . . . . 0.0 112.263 172.796 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.59 -41.28 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 121.3 -0.875 . . . . 0.0 111.202 177.209 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.715 1.143 . . . . 0.0 113.382 173.992 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.3 69.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.988 0.915 . . . . 0.0 112.743 173.133 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.07 -38.71 69.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.639 1.176 . . . . 0.0 112.361 171.057 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.73 -46.89 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 119.445 1.021 . . . . 0.0 110.553 171.159 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -49.85 -47.58 51.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.305 1.442 . . . . 0.0 112.881 178.302 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.23 -17.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.997 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -97.23 -54.54 3.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.551 1.14 . . . . 0.0 111.741 174.002 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -95.03 -14.11 24.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -165.042 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.58 19.5 79.71 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -178.507 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.78 126.64 34.69 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.314 1.845 . . . . 0.0 108.87 179.622 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 73.1 Cg_endo -73.13 143.82 36.52 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.934 2.423 . . . . 0.0 112.962 -176.792 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.8 Cg_exo -57.39 -33.28 96.0 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.441 2.761 . . . . 0.0 115.759 -177.113 . . . . . . . . 2 2 . 1 . 164 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -72.59 -11.04 60.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 120.001 1.273 . . . . 0.0 114.379 -177.817 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -102.84 10.08 38.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -175.84 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -144.45 151.8 39.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.699 -1.25 . . . . 0.0 113.271 -175.308 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -127.47 148.06 50.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.215 2.206 . . . . 0.0 109.926 -179.794 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.43 145.49 41.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.506 1.122 . . . . 0.0 111.855 179.213 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.8 139.4 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.538 1.935 . . . . 0.0 110.714 179.553 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -143.24 132.67 23.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.525 1.53 . . . . 0.0 111.782 171.016 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.92 38.86 9.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.282 1.433 . . . . 0.0 114.67 173.733 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.2 -21.86 26.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.27 1.891 . . . . 0.0 115.992 -176.613 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -80.97 135.9 35.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.389 1.594 . . . . 0.0 111.365 179.596 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.8 151.31 37.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.467 0.576 . . . . 0.0 109.603 155.306 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -119.41 129.46 54.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.016 0.927 . . . . 0.0 111.597 -171.962 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.7 130.49 39.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.046 1.338 . . . . 0.0 112.689 -176.066 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -45.03 -32.8 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.094 2.558 . . . . 0.0 116.539 -177.53 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.77 3.24 84.09 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.794 1.664 . . . . 0.0 116.489 -178.404 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -116.5 164.08 15.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 120.356 2.078 . . . . 0.0 113.756 179.956 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -93.49 162.74 13.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.026 1.33 . . . . 0.0 113.501 177.796 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.4 -39.61 67.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.463 0.705 . . . . 0.0 112.448 169.103 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.6 p -64.28 -31.46 72.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.187 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.25 -17.28 62.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.33 1.052 . . . . 0.0 113.408 177.092 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -110.82 10.29 22.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.236 1.814 . . . . 0.0 113.697 176.053 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.43 41.9 28.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.926 1.291 . . . . 0.0 112.388 176.603 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.2 mt -90.9 120.66 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.69 1.596 . . . . 0.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -97.13 -179.56 4.57 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.717 1.607 . . . . 0.0 112.904 -178.533 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -54.79 155.03 4.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.243 1.417 . . . . 0.0 112.513 167.814 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 59.95 21.45 10.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.183 1.393 . . . . 0.0 114.384 171.11 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -75.37 136.01 40.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -96.29 130.2 43.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.797 0.839 . . . . 0.0 109.748 163.435 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -113.22 155.78 24.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.853 2.061 . . . . 0.0 109.936 174.588 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -106.75 144.27 33.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.454 1.102 . . . . 0.0 111.139 175.966 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.5 139.61 40.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 112.242 -178.686 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.84 133.16 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.522 1.529 . . . . 0.0 109.329 172.575 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.28 143.17 42.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 111.853 -178.655 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -99.85 82.88 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.994 1.718 . . . . 0.0 110.977 177.761 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.3 mt -107.42 142.13 37.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.629 1.171 . . . . 0.0 112.321 -171.458 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -68.44 152.55 45.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.216 1.407 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.81 173.33 45.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.085 1.802 . . . . 0.0 113.972 172.263 . . . . . . . . 1 1 . 1 . 164 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 C-N-CA 125.567 1.556 . . . . 0.0 114.706 -176.917 . . . . . . . . 0 0 . 1 . 165 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 165 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -86.88 137.9 32.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.74 0.816 . . . . 0.0 111.7 172.081 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.9 149.77 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.637 1.175 . . . . 0.0 111.217 171.002 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -100.73 139.34 36.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.847 0.859 . . . . 0.0 112.692 -177.869 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.46 125.54 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.83 1.252 . . . . 0.0 109.826 173.456 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -84.8 117.74 24.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.384 1.074 . . . . 0.0 109.395 169.306 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -80.83 -174.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 112.696 -178.126 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.92 -21.63 66.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.379 -1.451 . . . . 0.0 113.743 -174.498 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -99.33 6.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.885 2.074 . . . . 0.0 113.412 174.098 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.6 1.64 66.67 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.777 -1.202 . . . . 0.0 115.231 -175.743 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.35 142.96 50.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.468 1.634 . . . . 0.0 109.825 172.647 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -93.27 126.85 38.6 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.647 0.658 . . . . 0.0 111.191 174.879 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.66 153.19 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.832 1.253 . . . . 0.0 109.577 163.705 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -120.76 125.51 47.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 110.22 -175.461 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.93 146.1 35.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.594 1.158 . . . . 0.0 111.667 -178.61 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.04 120.33 39.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.93 1.292 . . . . 0.0 109.732 173.47 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.38 164.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.179 1.392 . . . . 0.0 112.206 -171.332 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.11 155.37 45.59 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.24 1.016 . . . . 0.0 111.008 163.93 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.74 -27.85 28.07 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.941 3.094 . . . . 0.0 117.24 177.0 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -90.01 8.82 30.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.136 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.1 148.13 49.13 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 120.957 1.708 . . . . 0.0 111.27 165.147 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -102.82 165.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.179 0.991 . . . . 0.0 113.357 177.172 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -59.81 -33.38 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.311 1.044 . . . . 0.0 111.835 -175.912 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.54 -35.39 72.23 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.794 1.238 . . . . 0.0 112.817 174.153 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -74.94 -39.81 61.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.558 0.743 . . . . 0.0 111.733 176.454 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.26 -47.46 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.349 0.66 . . . . 0.0 109.94 174.756 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.98 -39.89 83.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.322 0.649 . . . . 0.0 112.653 174.819 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.78 81.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.621 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -70.28 -34.3 72.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 119.976 1.262 . . . . 0.0 112.461 173.519 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.02 -36.04 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.76 0.824 . . . . 0.0 111.511 171.846 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.18 -37.12 85.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.153 -0.967 . . . . 0.0 112.406 172.251 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.61 -42.31 61.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.406 1.003 . . . . 0.0 113.442 177.371 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -88.71 -27.35 21.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -174.311 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -131.53 -8.34 3.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 113.264 -173.306 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.25 1.93 90.49 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 165.154 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 tt -86.86 127.19 60.81 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 119.483 1.642 . . . . 0.0 110.938 177.491 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.87 144.58 98.65 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.02 2.48 . . . . 0.0 114.167 178.877 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.11 -38.01 49.35 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.497 3.465 . . . . 0.0 114.657 177.556 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.11 -10.67 60.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.101 1.761 . . . . 0.0 114.763 178.764 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.83 2.36 29.97 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.522 1.529 . . . . 0.0 113.33 170.424 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -97.51 141.32 30.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.661 1.184 . . . . 0.0 111.676 176.051 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -129.48 128.78 43.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.446 1.498 . . . . 0.0 108.316 164.512 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.91 129.4 56.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.606 0.762 . . . . 0.0 111.42 -169.14 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 mm -125.16 128.53 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 125.516 1.526 . . . . 0.0 110.83 -172.942 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -130.71 129.25 42.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.922 1.289 . . . . 0.0 111.414 176.213 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.42 37.48 6.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 113.867 -178.013 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.6 33.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.745 2.117 . . . . 0.0 116.665 -175.169 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.28 137.77 32.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.708 1.754 . . . . 0.0 111.516 -179.109 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -68.01 131.7 45.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.576 0.626 . . . . 0.0 111.024 165.445 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.07 110.09 18.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.457 1.103 . . . . 0.0 110.036 173.744 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -87.63 158.9 18.75 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 113.111 179.547 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.32 144.53 30.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.954 1.301 . . . . 0.0 111.685 -172.074 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.85 4.66 87.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.424 1.487 . . . . 0.0 114.824 -175.539 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -101.5 147.85 25.89 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.431 1.893 . . . . 0.0 111.104 174.989 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 p -83.05 162.75 21.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.178 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -55.69 -38.86 70.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.44 -0.787 . . . . 0.0 111.84 166.527 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.6 p -66.51 -33.67 76.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 175.912 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -62.54 -28.03 69.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 120.327 1.421 . . . . 0.0 112.438 173.083 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.6 5.73 47.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 114.781 174.588 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 59.36 31.16 20.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.145 1.378 . . . . 0.0 113.821 178.028 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.48 135.71 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.442 -1.411 . . . . 0.0 109.603 176.086 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -131.97 170.3 15.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.077 1.351 . . . . 0.0 112.927 -171.317 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -52.32 130.94 32.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.47 1.508 . . . . 0.0 111.559 177.084 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 59.39 17.04 5.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 116.12 -173.627 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -67.75 149.74 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.284 -1.51 . . . . 0.0 111.167 163.223 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.5 m -111.81 142.21 44.47 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.306 1.442 . . . . 0.0 110.255 176.844 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.57 158.85 42.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.045 1.338 . . . . 0.0 111.188 172.867 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -95.77 136.4 36.24 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.401 1.08 . . . . 0.0 111.537 176.191 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.31 131.13 43.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.523 1.129 . . . . 0.0 108.749 155.119 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.36 154.15 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.669 1.588 . . . . 0.0 110.429 170.229 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 tp -72.86 124.0 24.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.092 0.957 . . . . 0.0 111.103 -174.325 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -87.66 138.24 31.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.953 0.901 . . . . 0.0 110.14 172.242 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.24 146.92 41.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.826 1.25 . . . . 0.0 112.183 -171.544 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -148.31 164.6 33.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.93 1.692 . . . . 0.0 112.954 176.383 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 158.47 53.19 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.71 1.147 . . . . 0.0 114.259 177.198 . . . . . . . . 1 1 . 1 . 165 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.983 1.754 . . . . 0.0 115.81 -178.139 . . . . . . . . 0 0 . 1 . 166 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 166 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -78.74 132.75 37.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.491 0.716 . . . . 0.0 111.197 174.784 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.7 pt -133.52 163.7 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.91 1.284 . . . . 0.0 111.226 166.929 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -118.68 143.56 46.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.182 0.993 . . . . 0.0 111.324 174.764 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.59 113.45 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 109.883 176.266 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -96.01 130.16 43.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.358 1.463 . . . . 0.0 111.76 -175.216 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.4 p -78.08 161.91 27.07 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.865 0.866 . . . . 0.0 111.535 172.119 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.99 -41.5 83.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.927 -1.108 . . . . 0.0 111.867 175.704 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -81.84 15.72 2.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.159 1.383 . . . . 0.0 113.512 175.751 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.91 74.47 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 117.228 1.651 . . . . 0.0 117.228 161.138 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.41 136.4 36.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.552 1.676 . . . . 0.0 108.976 170.456 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -110.72 114.88 28.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.808 0.813 . . . . 0.0 111.653 179.032 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.5 mt -79.81 128.13 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.091 1.356 . . . . 0.0 107.868 171.201 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -94.53 131.95 39.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 167.118 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.78 149.87 51.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 111.653 177.053 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.36 118.33 27.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.836 1.254 . . . . 0.0 109.351 173.297 . . . . . . . . 2 2 . 1 . 166 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.11 161.56 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 112.2 -163.531 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -82.01 147.45 57.89 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 169.894 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.51 -24.87 55.45 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.791 2.327 . . . . 0.0 114.167 168.863 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 p -91.32 1.67 56.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.416 1.886 . . . . 0.0 115.079 176.637 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 136.43 56.49 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.202 1.365 . . . . 0.0 110.281 172.741 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -71.95 158.59 35.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.913 0.885 . . . . 0.0 111.999 173.674 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.85 -30.98 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.651 -1.281 . . . . 0.0 110.807 169.03 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.8 -46.99 81.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.787 1.235 . . . . 0.0 112.37 166.804 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -63.45 -39.95 95.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.756 0.707 . . . . 0.0 112.219 173.535 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.19 -45.68 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.038 1.29 . . . . 0.0 111.361 177.959 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -59.72 -39.68 85.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.337 0.971 . . . . 0.0 112.01 173.409 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.43 80.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 177.072 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -67.59 -34.25 76.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.576 1.08 . . . . 0.0 112.516 173.57 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.44 -39.54 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.912 1.285 . . . . 0.0 111.383 172.898 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.05 -45.51 92.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.214 0.915 . . . . 0.0 111.025 171.418 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.26 -39.74 95.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.542 1.137 . . . . 0.0 113.727 176.744 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -83.14 -41.03 18.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.629 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -118.57 -9.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -171.022 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.33 6.81 87.42 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.55 1.068 . . . . 0.0 115.745 178.291 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mt -78.98 118.52 72.95 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 119.093 1.446 . . . . 0.0 109.545 -175.842 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.78 134.11 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.355 2.036 . . . . 0.0 111.859 -176.785 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -63.62 -25.71 69.31 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.445 2.763 . . . . 0.0 114.049 -171.626 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.49 -29.27 67.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.631 1.105 . . . . 0.0 113.207 172.476 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -95.67 -11.65 26.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.508 1.123 . . . . 0.0 113.129 -179.53 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.8 138.02 35.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.206 0.912 . . . . 0.0 112.224 179.278 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -129.6 133.87 47.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.507 1.523 . . . . 0.0 108.298 160.649 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.91 132.84 55.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.283 1.033 . . . . 0.0 110.532 -175.929 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -120.78 138.24 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.562 1.945 . . . . 0.0 109.28 -173.366 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -133.3 127.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.387 0.675 . . . . 0.0 110.765 166.286 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.9 52.08 13.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.317 1.447 . . . . 0.0 112.867 -177.175 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.18 8.06 64.45 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 179.03 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -123.49 131.46 53.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.901 1.85 . . . . 0.0 112.632 -177.322 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.74 134.71 39.09 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 112.222 -179.32 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 mt -96.45 151.75 19.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.681 1.592 . . . . 0.0 112.667 -174.905 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 137.94 42.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.728 1.611 . . . . 0.0 112.575 -179.087 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.76 -42.37 71.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.887 2.075 . . . . 0.0 114.87 -169.086 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.57 82.39 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -175.821 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -88.95 154.03 20.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.811 1.806 . . . . 0.0 111.658 -178.804 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 p -98.46 160.74 14.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 176.204 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.79 -34.92 73.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.897 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.8 p -68.35 -27.53 66.33 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.539 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -69.42 -27.6 65.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 119.634 1.106 . . . . 0.0 111.855 175.459 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -92.06 7.38 42.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 114.464 172.259 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.76 32.97 20.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.719 1.607 . . . . 0.0 113.95 179.976 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.43 144.2 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 120.792 -1.193 . . . . 0.0 110.996 -179.27 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.71 162.84 19.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.665 1.586 . . . . 0.0 111.764 -174.963 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -61.51 143.1 56.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.446 -0.784 . . . . 0.0 111.82 174.593 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.04 12.54 6.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.495 1.918 . . . . 0.0 115.719 -171.45 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -64.19 132.42 50.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.174 -1.579 . . . . 0.0 111.326 173.876 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -92.7 118.93 31.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 170.209 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -99.14 160.22 14.42 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.897 2.079 . . . . 0.0 108.691 169.338 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.2 139.64 50.99 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.348 1.059 . . . . 0.0 110.568 179.863 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.69 128.12 54.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.87 1.268 . . . . 0.0 109.918 178.626 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.88 142.99 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.939 1.696 . . . . 0.0 108.098 175.906 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.84 146.9 23.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.53 93.76 4.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.643 1.577 . . . . 0.0 109.767 174.753 . . . . . . . . 2 2 . 1 . 166 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.33 126.64 34.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.547 1.539 . . . . 0.0 109.505 -179.661 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.5 -50.05 55.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.664 1.186 . . . . 0.0 112.915 -173.032 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.94 -44.31 55.85 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.203 0.906 . . . . 0.0 111.046 170.368 . . . . . . . . 1 1 . 1 . 166 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.814 1.673 . . . . 0.0 113.865 -178.758 . . . . . . . . 0 0 . 1 . 167 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 167 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -92.88 145.69 24.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 175.989 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.7 pt -135.26 168.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.269 1.828 . . . . 0.0 110.335 163.349 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.69 145.23 48.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.578 1.151 . . . . 0.0 111.743 175.041 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.73 129.81 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.08 0.952 . . . . 0.0 110.778 167.863 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -114.21 141.15 47.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.395 1.878 . . . . 0.0 110.774 179.242 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -121.84 158.63 28.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 113.144 -176.101 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.884 1.674 . . . . 0.0 113.909 172.683 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.8 p -84.51 7.06 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.634 1.174 . . . . 0.0 113.589 171.654 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 2.8 89.67 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 168.468 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -73.45 153.99 40.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.846 1.823 . . . . 0.0 111.521 165.84 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -131.18 130.99 43.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.808 1.243 . . . . 0.0 108.984 162.397 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.49 138.59 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.659 1.584 . . . . 0.0 109.974 -175.517 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -93.98 134.55 36.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.618 1.167 . . . . 0.0 110.958 177.253 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 143.0 51.16 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.354 1.462 . . . . 0.0 112.048 -176.82 . . . . . . . . 2 2 . 1 . 167 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -105.86 119.17 38.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.2 1.4 . . . . 0.0 110.466 176.243 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.64 159.72 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.642 1.577 . . . . 0.0 112.381 -169.531 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -110.45 156.19 40.79 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 124.208 1.003 . . . . 0.0 110.202 161.592 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.97 -18.78 37.1 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.061 2.507 . . . . 0.0 114.791 171.15 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.1 p -83.7 -11.67 56.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.986 1.714 . . . . 0.0 115.07 174.808 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -71.24 142.84 50.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.913 1.233 . . . . 0.0 111.354 -177.181 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -80.31 152.33 29.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.19 -0.944 . . . . 0.0 113.32 177.243 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.48 -31.4 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 112.113 176.385 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -72.73 -17.5 61.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 120.397 -1.439 . . . . 0.0 113.776 173.335 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -81.1 -38.33 27.45 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.726 1.21 . . . . 0.0 111.508 168.787 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.63 -45.12 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.396 -0.815 . . . . 0.0 110.958 169.057 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.4 -34.83 78.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.112 0.965 . . . . 0.0 113.098 175.284 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.88 78.58 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.477 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.36 -35.59 77.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.397 1.479 . . . . 0.0 112.446 177.171 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.64 -45.67 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.667 169.994 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.96 -42.64 90.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.629 1.172 . . . . 0.0 112.563 177.783 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -63.04 -44.69 95.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.842 1.201 . . . . 0.0 113.046 179.697 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.51 -46.69 53.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.805 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -111.76 -13.39 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -170.727 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.9 40.86 20.19 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.905 1.23 . . . . 0.0 114.377 177.457 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.53 117.41 54.45 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.312 1.445 . . . . 0.0 108.925 179.986 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.45 135.69 62.78 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.891 2.394 . . . . 0.0 113.26 -179.431 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.83 -36.38 73.74 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.76 2.973 . . . . 0.0 115.187 179.008 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.1 -13.35 62.14 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 177.287 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -96.81 -11.67 24.6 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.036 1.335 . . . . 0.0 113.452 174.444 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -90.19 135.35 33.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.11 1.364 . . . . 0.0 112.004 -177.285 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -129.23 121.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.566 1.546 . . . . 0.0 109.25 166.37 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.19 136.0 53.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.367 1.067 . . . . 0.0 112.568 -169.064 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.72 137.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.779 1.632 . . . . 0.0 111.242 -167.939 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -125.16 117.87 24.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.841 1.656 . . . . 0.0 111.426 173.972 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.84 42.48 12.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.452 1.501 . . . . 0.0 113.772 -176.834 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.61 5.48 68.52 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 -176.514 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -100.61 140.53 34.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.56 1.68 . . . . 0.0 111.354 174.196 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.56 126.06 35.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.167 0.987 . . . . 0.0 111.884 -172.717 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -86.88 148.12 25.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.987 1.315 . . . . 0.0 112.074 -177.049 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.16 155.95 36.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.993 1.717 . . . . 0.0 113.361 178.699 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.9 -7.51 56.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.92 1.688 . . . . 0.0 114.671 -172.69 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 1.66 86.62 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -178.511 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -130.84 162.41 29.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.712 1.605 . . . . 0.0 113.361 -172.196 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.8 p -95.01 157.83 15.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.432 1.493 . . . . 0.0 112.427 175.366 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.54 -38.67 66.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.704 1.202 . . . . 0.0 113.278 -174.133 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 p -62.47 -27.96 69.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 115.106 174.794 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -68.16 -17.87 64.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 120.107 1.321 . . . . 0.0 112.304 179.039 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -97.2 -2.25 43.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 172.048 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 54.93 40.05 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.949 1.7 . . . . 0.0 114.695 -175.401 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -78.59 137.97 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.863 1.265 . . . . 0.0 109.174 172.943 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.48 178.77 4.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.673 1.989 . . . . 0.0 112.075 -175.156 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.2 150.35 43.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.648 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 63.73 14.3 8.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.518 1.927 . . . . 0.0 115.137 177.518 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -70.6 150.15 46.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 112.8 177.812 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -111.3 121.54 45.53 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.902 1.281 . . . . 0.0 110.523 175.057 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -104.56 152.86 21.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.551 1.54 . . . . 0.0 109.89 175.012 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -108.38 134.93 50.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.482 0.713 . . . . 0.0 110.613 178.378 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.5 tp -112.13 125.97 54.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 109.93 -176.82 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.31 137.83 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.917 1.687 . . . . 0.0 108.541 173.655 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.57 141.65 46.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.279 1.032 . . . . 0.0 111.354 -175.631 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -77.32 90.23 3.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.151 0.98 . . . . 0.0 110.469 170.819 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.1 tp -58.98 -27.05 65.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.453 1.101 . . . . 0.0 113.939 -177.315 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -103.12 7.61 38.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.104 1.762 . . . . 0.0 113.948 175.536 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.97 31.49 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.213 1.863 . . . . 0.0 117.148 -174.091 . . . . . . . . 1 1 . 1 . 167 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.793 1.663 . . . . 0.0 115.949 -174.768 . . . . . . . . 0 0 . 1 . 168 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 168 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -102.7 141.69 35.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.575 0.625 . . . . 0.0 111.986 172.929 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.96 163.3 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.554 1.142 . . . . 0.0 110.756 167.361 . . . . . . . . 2 2 . 1 . 168 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -107.76 147.01 31.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.053 0.941 . . . . 0.0 112.936 -176.23 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.99 135.11 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 109.996 159.37 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.3 153.54 29.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 111.047 177.924 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -128.71 172.24 11.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.96 1.304 . . . . 0.0 112.524 -174.807 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.65 -37.49 63.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.089 1.756 . . . . 0.0 114.592 -176.48 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -79.54 1.57 25.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.155 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 -7.9 63.32 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.503 1.525 . . . . 0.0 114.598 -175.3 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -64.23 143.06 58.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.999 1.32 . . . . 0.0 111.119 176.473 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -126.53 154.99 43.08 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.929 -174.357 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.59 142.05 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 108.536 171.397 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.4 m -109.08 130.25 55.48 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.744 1.217 . . . . 0.0 110.86 -179.585 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 mt -121.16 136.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.076 0.95 . . . . 0.0 110.721 -173.39 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -88.29 124.58 34.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.311 1.045 . . . . 0.0 109.884 171.776 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.58 164.57 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.854 1.261 . . . . 0.0 112.932 -171.985 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -107.31 153.63 41.05 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.663 156.152 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -59.22 -22.03 62.87 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.771 2.314 . . . . 0.0 113.797 174.679 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -82.11 -6.08 58.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.5 1.52 . . . . 0.0 114.809 176.127 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.7 141.7 56.56 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.692 1.133 . . . . 0.0 110.731 175.531 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -85.55 160.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 177.724 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -36.77 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 121.836 -0.54 . . . . 0.0 110.717 176.294 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -73.68 -29.44 62.3 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.675 -1.266 . . . . 0.0 113.855 176.095 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -63.66 -39.44 94.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.735 -1.228 . . . . 0.0 111.513 166.542 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -74.4 -38.45 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.923 0.889 . . . . 0.0 111.64 -177.761 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.28 -34.18 74.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.478 1.036 . . . . 0.0 112.408 170.368 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -34.59 73.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 169.81 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.72 -31.27 72.17 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 120.374 1.443 . . . . 0.0 112.58 171.166 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -69.01 -42.18 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.443 1.097 . . . . 0.0 111.055 170.417 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.92 -37.58 79.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.013 -1.054 . . . . 0.0 112.109 172.89 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.14 -22.01 66.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.078 1.351 . . . . 0.0 113.512 175.579 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -110.07 -21.45 12.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.617 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -136.78 -5.19 1.96 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.254 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 16.67 72.33 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 120.803 -1.186 . . . . 0.0 115.79 177.914 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.11 125.27 81.96 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.991 1.316 . . . . 0.0 109.416 -179.13 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.67 132.91 48.2 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.912 2.408 . . . . 0.0 112.28 179.442 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.92 -30.19 92.46 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.144 1.896 . . . . 0.0 114.747 -178.33 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.02 -19.04 64.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 113.626 175.739 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -83.2 -17.96 40.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.346 1.059 . . . . 0.0 112.652 175.411 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.39 118.92 30.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.575 1.15 . . . . 0.0 112.809 -168.827 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -90.82 134.77 34.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.398 1.079 . . . . 0.0 109.163 156.793 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -115.43 136.52 53.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.82 0.848 . . . . 0.0 110.173 167.388 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -133.0 126.49 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.222 1.009 . . . . 0.0 111.451 -167.878 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -149.0 140.02 22.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.838 1.655 . . . . 0.0 111.107 179.114 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.69 49.5 13.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.511 1.524 . . . . 0.0 114.983 174.741 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.85 5.14 78.83 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 178.299 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm -124.73 136.07 53.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.845 1.658 . . . . 0.0 110.825 -173.511 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.86 129.65 34.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 159.421 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -86.23 146.09 26.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.089 0.556 . . . . 0.0 112.408 -164.085 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.38 139.61 33.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.65 1.58 . . . . 0.0 112.413 -172.511 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -71.23 -27.77 63.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -158.605 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 -6.65 85.63 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.798 1.189 . . . . 0.0 115.464 177.291 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.6 mmm-85 -85.09 160.2 20.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.183 1.393 . . . . 0.0 111.978 -179.61 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.6 p -93.13 165.4 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.91 1.284 . . . . 0.0 113.35 175.742 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.31 -28.03 69.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.1 -1.0 . . . . 0.0 112.543 165.717 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -70.38 -35.84 73.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.785 1.234 . . . . 0.0 114.161 171.655 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -58.21 -29.44 65.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.253 1.388 . . . . 0.0 113.126 172.318 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -106.34 8.72 31.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.534 1.534 . . . . 0.0 114.385 178.203 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 53.77 34.87 20.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.466 1.506 . . . . 0.0 114.543 178.611 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.96 99.58 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 120.349 -1.469 . . . . 0.0 108.637 179.971 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -94.18 172.32 8.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.912 1.285 . . . . 0.0 112.483 -179.74 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -49.86 139.59 13.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.855 1.262 . . . . 0.0 113.787 179.591 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 60.87 10.27 2.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -176.18 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -63.91 151.16 43.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.772 -1.205 . . . . 0.0 111.782 168.037 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.8 m -114.25 132.22 56.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.42 1.088 . . . . 0.0 110.638 174.585 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.87 160.36 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 109.582 167.411 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -99.77 140.76 33.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.708 0.803 . . . . 0.0 109.572 167.916 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.8 tp -123.72 116.64 23.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.078 2.151 . . . . 0.0 108.845 -173.437 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.01 139.37 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.574 1.15 . . . . 0.0 109.877 -174.436 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.34 134.55 33.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.494 0.718 . . . . 0.0 110.946 177.168 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -63.05 149.03 46.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.569 1.148 . . . . 0.0 111.067 170.067 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.64 161.53 28.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.215 1.006 . . . . 0.0 111.892 -179.897 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 53.04 33.32 14.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.932 1.693 . . . . 0.0 114.8 171.836 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.69 -5.83 56.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.959 1.742 . . . . 0.0 116.544 -170.737 . . . . . . . . 1 1 . 1 . 168 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-N 119.53 1.665 . . . . 0.0 114.508 -178.727 . . . . . . . . 0 0 . 1 . 169 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 169 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -75.56 149.04 38.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.032 0.533 . . . . 0.0 111.228 169.23 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.16 170.88 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.68 1.992 . . . . 0.0 110.516 167.538 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -125.37 149.98 47.63 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.55 1.54 . . . . 0.0 109.916 172.348 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.77 126.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 110.211 172.876 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -80.71 115.81 20.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 109.763 170.907 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.6 p -62.41 178.12 0.44 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.1 2.16 . . . . 0.0 113.654 -176.968 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -68.49 -4.83 16.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 174.322 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 p -129.7 22.77 5.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.814 2.046 . . . . 0.0 113.172 -175.431 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.11 -22.06 3.82 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.787 1.66 . . . . 0.0 116.348 173.452 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -64.72 145.96 55.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.727 1.764 . . . . 0.0 110.842 173.99 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -105.42 130.26 53.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.034 0.834 . . . . 0.0 111.702 -178.846 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -105.76 151.74 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.92 1.688 . . . . 0.0 112.021 174.62 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 p -101.59 140.29 36.08 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.077 1.751 . . . . 0.0 111.619 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.6 mt -143.3 158.95 43.19 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 113.12 175.056 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -113.47 124.36 52.22 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.921 2.088 . . . . 0.0 111.031 177.105 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.09 164.28 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 125.847 1.659 . . . . 0.0 111.189 -174.619 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -113.28 147.56 37.66 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 124.291 1.037 . . . . 0.0 111.182 169.815 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -53.83 -27.72 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.327 2.684 . . . . 0.0 116.542 -176.646 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.3 p -85.41 -2.03 57.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 177.836 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.15 147.24 52.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.096 1.316 . . . . 0.0 112.158 177.592 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -82.65 160.87 22.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.167 0.987 . . . . 0.0 112.452 176.556 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.9 -33.15 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 121.581 -0.699 . . . . 0.0 111.894 172.818 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.07 -32.16 73.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 120.9 -1.125 . . . . 0.0 113.045 175.597 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -68.35 -40.69 81.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 118.674 0.67 . . . . 0.0 111.339 174.785 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -63.05 -45.02 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 122.987 0.515 . . . . 0.0 111.048 174.125 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.67 75.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 176.339 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.77 83.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.346 0.658 . . . . 0.0 112.487 173.933 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.08 -30.19 69.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.062 0.945 . . . . 0.0 113.512 175.025 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -66.47 -49.08 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.968 0.907 . . . . 0.0 110.56 168.3 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -56.92 -38.65 73.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.812 1.187 . . . . 0.0 112.109 179.05 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.61 -22.87 47.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.355 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -125.47 -5.7 7.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 176.958 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -123.37 -6.3 8.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 176.87 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.93 1.34 39.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 116.589 1.396 . . . . 0.0 116.589 171.386 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -90.35 126.21 57.36 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.662 1.585 . . . . 0.0 111.366 179.833 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.74 153.7 33.93 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.244 1.963 . . . . 0.0 113.303 -170.453 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -66.3 -27.37 48.07 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.984 1.789 . . . . 0.0 116.082 -160.282 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.17 -8.02 58.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.613 1.097 . . . . 0.0 113.581 -179.868 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -89.08 -13.97 37.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 113.435 166.775 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.34 126.65 35.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -173.264 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -123.36 124.09 42.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 109.255 171.759 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 tp -113.66 134.51 54.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.586 1.154 . . . . 0.0 112.24 -166.67 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.72 141.69 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.536 1.935 . . . . 0.0 109.512 -176.568 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -130.51 130.9 44.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 109.935 166.969 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.04 51.35 7.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.764 1.626 . . . . 0.0 114.19 172.358 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.86 87.14 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.294 1.426 . . . . 0.0 116.53 179.542 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -127.08 124.58 39.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.719 1.76 . . . . 0.0 111.347 -171.951 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -68.37 142.41 55.46 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.759 0.824 . . . . 0.0 110.878 175.24 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -105.88 139.42 40.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.41 1.084 . . . . 0.0 111.129 175.586 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -97.18 154.57 17.29 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.532 1.533 . . . . 0.0 112.176 175.842 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.84 -24.25 59.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.985 1.314 . . . . 0.0 113.591 -176.582 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.62 9.7 54.38 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.588 1.566 . . . . 0.0 116.219 178.682 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -130.44 166.38 20.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.661 1.731 . . . . 0.0 113.057 -175.124 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -102.26 164.77 11.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.339 1.456 . . . . 0.0 113.581 178.149 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.49 -34.85 69.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 171.886 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.5 m -66.31 -37.66 85.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.216 1.006 . . . . 0.0 113.439 173.495 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -64.51 -10.75 27.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.27 0.941 . . . . 0.0 113.398 173.9 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.24 3.16 15.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.205 1.402 . . . . 0.0 114.06 171.293 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 53.05 43.27 31.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.28 1.432 . . . . 0.0 112.728 -176.41 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt -89.19 129.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.269 1.428 . . . . 0.0 108.217 175.823 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -121.96 179.42 4.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -163.461 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -45.07 129.17 7.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.11 1.764 . . . . 0.0 112.914 175.092 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.54 25.17 13.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.367 1.867 . . . . 0.0 115.258 176.287 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -60.36 143.43 53.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.959 0.904 . . . . 0.0 111.498 168.517 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -103.59 129.09 50.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.007 0.923 . . . . 0.0 109.675 166.164 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.94 158.69 19.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.867 1.667 . . . . 0.0 110.458 178.046 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -115.48 127.22 55.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.903 1.281 . . . . 0.0 110.272 179.354 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -98.97 139.06 35.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.381 1.072 . . . . 0.0 110.579 177.151 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.3 145.32 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 109.62 178.312 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.31 129.57 38.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.103 0.961 . . . . 0.0 109.976 175.609 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -66.63 122.1 16.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.633 -0.667 . . . . 0.0 110.093 170.913 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.4 -17.3 11.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.158 1.783 . . . . 0.0 112.868 -173.142 . . . . . . . . 2 2 . 1 . 169 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -116.0 147.34 41.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.804 1.642 . . . . 0.0 112.39 -172.337 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.16 79.88 0.11 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.24 1.4 . . . . 0.0 114.211 179.918 . . . . . . . . 1 1 . 1 . 169 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.428 1.489 . . . . 0.0 112.756 171.676 . . . . . . . . 0 0 . 1 . 170 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.19 133.33 36.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.806 0.843 . . . . 0.0 112.289 -169.748 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.4 pt -121.78 155.69 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.931 0.893 . . . . 0.0 110.896 163.278 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.6 115.07 29.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.57 0.748 . . . . 0.0 111.177 179.214 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -90.84 122.24 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.096 1.358 . . . . 0.0 108.711 175.729 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -104.39 141.35 36.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.343 1.057 . . . . 0.0 110.755 170.371 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -114.19 161.68 17.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.526 1.13 . . . . 0.0 113.158 -173.428 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.64 -20.9 61.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 168.547 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -68.87 -0.36 5.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 161.517 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.16 -2.57 83.8 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.006 1.765 . . . . 0.0 116.404 166.05 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 13' ' ' ILE . 56.4 pttt -91.63 160.9 15.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.347 1.574 . . . . 0.0 113.442 -176.356 . . . . . . . . 2 2 . 1 . 170 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -99.0 146.16 26.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.6 1.16 . . . . 0.0 110.646 161.927 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 ' HE3' ' A' ' 11' ' ' LYS . 1.2 mt -134.91 142.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 127.054 2.142 . . . . 0.0 108.687 173.752 . . . . . . . . 2 2 . 1 . 170 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -95.05 139.11 31.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.953 0.797 . . . . 0.0 110.426 171.284 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 tp -131.25 139.76 49.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.76 1.224 . . . . 0.0 111.681 178.085 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -96.12 110.44 22.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.563 1.145 . . . . 0.0 111.234 177.921 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.78 167.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.563 1.545 . . . . 0.0 112.374 -173.541 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.0 150.28 40.18 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 124.915 1.286 . . . . 0.0 109.811 162.522 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.15 -30.24 59.9 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.222 1.948 . . . . 0.0 113.955 167.029 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -83.91 3.25 34.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 176.062 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.12 128.22 35.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.969 1.259 . . . . 0.0 110.978 175.972 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 m -71.1 146.42 49.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.354 1.462 . . . . 0.0 110.26 173.424 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -56.39 -34.26 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.253 -0.904 . . . . 0.0 112.918 -176.741 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.93 -42.58 90.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.65 1.114 . . . . 0.0 113.661 172.064 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.64 -33.69 66.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.185 0.994 . . . . 0.0 111.345 179.733 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.86 -43.67 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 121.126 -0.984 . . . . 0.0 111.037 171.211 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.9 -35.53 80.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.362 -0.836 . . . . 0.0 113.013 174.1 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.86 67.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 173.792 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 112.144 171.414 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.68 -45.66 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.35 1.06 . . . . 0.0 110.649 171.195 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -52.47 -39.18 60.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.584 1.084 . . . . 0.0 112.954 178.059 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.72 -43.01 80.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.578 1.151 . . . . 0.0 113.448 -178.352 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -97.41 -26.87 14.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 178.871 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -99.2 -20.9 16.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.711 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.36 81.87 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.894 1.225 . . . . 0.0 115.273 -174.153 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.41 120.44 66.51 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 126.092 1.757 . . . . 0.0 109.154 -177.695 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.99 140.55 95.84 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.654 2.236 . . . . 0.0 112.802 178.137 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.58 -31.3 86.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.426 2.084 . . . . 0.0 113.048 -179.16 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.55 2.37 6.5 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 179.289 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -106.27 -14.62 15.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.288 1.835 . . . . 0.0 113.671 173.911 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -94.88 139.35 31.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.755 1.222 . . . . 0.0 112.681 -167.187 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -120.97 129.38 53.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.28 1.032 . . . . 0.0 110.09 160.07 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.5 mt -98.68 147.16 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.722 1.209 . . . . 0.0 110.906 178.413 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -137.14 125.14 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.442 1.097 . . . . 0.0 111.567 -170.964 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -147.23 149.68 33.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 111.916 174.314 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.33 40.97 19.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.977 1.311 . . . . 0.0 112.802 -171.841 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.34 -11.53 12.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.857 1.694 . . . . 0.0 116.607 179.602 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.29 147.57 40.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.025 1.912 . . . . 0.0 112.312 -172.957 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.15 142.46 47.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 111.227 175.236 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.9 mt -101.01 135.82 41.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.925 1.29 . . . . 0.0 111.842 -168.569 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -92.59 152.62 19.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.792 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.87 -19.6 61.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.7 1.6 . . . . 0.0 113.916 -167.641 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.43 2.11 88.21 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -178.861 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.79 161.59 24.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.525 1.53 . . . . 0.0 112.002 -170.328 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.7 167.59 10.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.037 0.935 . . . . 0.0 113.327 174.845 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -37.45 72.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 170.394 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -65.8 -35.95 82.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.156 0.982 . . . . 0.0 112.602 174.533 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -68.19 -15.94 63.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.605 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -104.79 7.06 34.47 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.419 1.888 . . . . 0.0 114.225 168.993 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 m120 51.98 49.01 21.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.955 1.702 . . . . 0.0 114.006 -178.778 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.79 117.0 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.989 1.315 . . . . 0.0 109.058 176.36 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -96.66 165.9 11.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.017 1.727 . . . . 0.0 112.355 -179.237 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -60.92 144.48 52.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.839 0.828 . . . . 0.0 111.817 171.963 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 65.2 8.77 5.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.626 1.97 . . . . 0.0 114.875 -177.433 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 m -74.7 150.48 39.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 111.427 168.881 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -107.89 133.88 51.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.413 -179.416 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.77 148.07 38.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.973 1.309 . . . . 0.0 111.342 179.184 . . . . . . . . 2 2 . 1 . 170 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.15 160.13 14.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.266 -0.896 . . . . 0.0 112.894 -166.172 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -127.43 135.72 50.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.845 2.058 . . . . 0.0 109.324 177.174 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.67 153.23 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.939 1.295 . . . . 0.0 110.265 163.528 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.93 141.29 38.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.773 1.229 . . . . 0.0 111.43 175.921 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -85.53 43.43 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.971 1.709 . . . . 0.0 112.729 -175.186 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.78 147.68 51.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 112.594 -173.201 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -100.72 151.67 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.399 1.479 . . . . 0.0 113.869 -170.505 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 175.47 46.38 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.116 1.341 . . . . 0.0 114.692 177.453 . . . . . . . . 1 1 . 1 . 170 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 127.415 2.436 . . . . 0.0 114.414 177.008 . . . . . . . . 0 0 . 1 . 171 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 171 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -88.08 142.84 27.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.757 1.223 . . . . 0.0 111.368 174.023 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.45 161.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 123.636 0.774 . . . . 0.0 110.905 157.141 . . . . . . . . 2 2 . 1 . 171 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -102.36 151.04 22.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.771 1.228 . . . . 0.0 111.141 175.397 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 t -132.9 125.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.856 1.262 . . . . 0.0 109.753 175.264 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -99.5 139.04 35.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.574 1.549 . . . . 0.0 113.321 178.554 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -96.54 164.26 12.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.154 1.382 . . . . 0.0 113.372 -177.625 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.29 -3.43 7.98 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.996 1.318 . . . . 0.0 114.431 168.859 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.6 p -107.49 4.26 25.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.203 2.201 . . . . 0.0 113.313 177.158 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.11 13.24 82.31 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 177.784 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -85.51 151.53 23.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 110.583 172.653 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -117.08 137.67 52.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 109.975 166.39 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.82 159.44 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.785 1.634 . . . . 0.0 110.684 171.976 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.5 m -122.48 126.7 48.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.432 1.093 . . . . 0.0 110.818 -174.966 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.15 148.63 42.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.24 1.416 . . . . 0.0 111.62 -178.225 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -93.33 132.5 37.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.79 1.636 . . . . 0.0 110.525 169.051 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.5 157.15 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.122 1.769 . . . . 0.0 111.574 179.55 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -97.97 153.88 37.99 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.502 156.957 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.74 -22.28 52.21 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.074 2.516 . . . . 0.0 114.319 174.676 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -75.82 -14.28 60.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.714 2.005 . . . . 0.0 114.855 173.884 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.07 143.55 57.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 120.29 1.405 . . . . 0.0 110.683 -179.538 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.8 p -83.17 163.52 20.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.926 0.87 . . . . 0.0 112.348 173.422 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.5 mm -55.86 -37.79 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.52 0.728 . . . . 0.0 111.174 169.123 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.17 -26.21 60.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.697 -1.252 . . . . 0.0 114.275 174.208 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -64.39 -41.7 96.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 120.331 1.423 . . . . 0.0 110.656 165.186 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.31 -42.49 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 119.385 0.993 . . . . 0.0 111.538 175.845 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.26 -42.97 82.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.048 1.294 . . . . 0.0 112.47 172.382 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.29 66.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.119 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -68.73 -40.66 79.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.471 1.109 . . . . 0.0 111.592 170.61 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mm -58.77 -35.47 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 119.025 0.83 . . . . 0.0 111.991 171.881 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -64.61 -36.7 85.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.714 1.143 . . . . 0.0 112.51 173.561 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.98 -46.09 72.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.413 173.907 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -66.86 -48.01 70.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.786 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -123.87 -8.69 7.81 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.718 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.24 32.99 41.45 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 120.257 1.389 . . . . 0.0 115.546 177.005 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -116.05 121.23 34.15 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 125.382 1.473 . . . . 0.0 109.177 -178.218 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.72 142.28 35.47 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.646 2.231 . . . . 0.0 113.14 -175.866 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.55 -33.42 30.63 Favored 'Trans proline' 0 N--CA 1.449 -1.117 1 C-N-CA 125.502 4.135 . . . . 0.0 115.255 176.258 . . . . . . . . 2 2 . 1 . 171 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.74 -32.48 52.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.778 1.231 . . . . 0.0 113.515 174.642 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -102.81 7.38 39.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.504 1.521 . . . . 0.0 114.166 -176.899 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -108.09 148.33 29.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.882 1.273 . . . . 0.0 112.738 -178.87 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -129.68 131.82 46.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.243 2.217 . . . . 0.0 109.036 162.339 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.72 127.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.471 0.708 . . . . 0.0 112.12 -179.526 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -121.9 137.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.641 1.976 . . . . 0.0 110.248 -171.871 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.04 141.14 23.9 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.249 1.42 . . . . 0.0 111.384 175.336 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.26 38.42 10.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.405 1.482 . . . . 0.0 113.442 -172.974 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.08 -1.47 69.26 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.771 1.653 . . . . 0.0 116.832 -178.125 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -118.75 151.08 38.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.558 1.543 . . . . 0.0 112.163 -171.786 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -77.37 141.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 111.626 176.476 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.39 131.48 46.29 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.878 1.271 . . . . 0.0 110.926 -179.247 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.68 132.97 45.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.425 1.49 . . . . 0.0 111.991 179.861 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.45 -19.61 65.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -166.623 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.12 -14.38 57.63 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 177.671 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -82.2 155.95 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.606 1.703 . . . . 0.0 111.862 -175.11 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -89.75 163.74 14.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.507 1.123 . . . . 0.0 112.849 173.868 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.25 -41.52 84.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.535 -0.728 . . . . 0.0 112.053 176.666 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.3 m -67.29 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.045 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -71.07 -12.5 61.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 120.301 1.409 . . . . 0.0 113.514 170.151 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -114.12 15.2 18.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.31 1.844 . . . . 0.0 113.231 170.541 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 57.98 22.15 8.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.02 1.328 . . . . 0.0 114.472 -178.938 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.84 131.24 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 120.456 -1.402 . . . . 0.0 110.496 -174.832 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.79 175.26 8.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.429 1.892 . . . . 0.0 112.692 -174.88 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -42.78 134.32 3.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.456 2.302 . . . . 0.0 114.529 177.964 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 59.89 28.96 18.53 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.763 2.025 . . . . 0.0 114.497 175.475 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -66.68 157.41 32.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 111.835 165.41 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -116.67 117.57 30.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 171.273 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -100.36 165.38 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.637 1.975 . . . . 0.0 109.624 174.438 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -126.4 130.54 50.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.348 1.059 . . . . 0.0 110.199 179.086 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -102.67 114.45 28.7 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.227 1.411 . . . . 0.0 110.235 -178.675 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.26 140.72 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 175.576 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -104.89 150.96 24.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.318 1.047 . . . . 0.0 111.828 -177.553 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -81.49 145.06 30.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.685 1.194 . . . . 0.0 112.346 176.406 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.49 -32.46 2.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -178.969 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.07 -25.56 65.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.61 1.096 . . . . 0.0 113.154 -171.914 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.1 -20.99 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.833 1.683 . . . . 0.0 115.23 177.814 . . . . . . . . 1 1 . 1 . 171 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.273 1.892 . . . . 0.0 114.598 -179.242 . . . . . . . . 0 0 . 1 . 172 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 172 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -97.75 142.29 29.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.751 0.82 . . . . 0.0 112.404 177.09 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.0 pt -133.12 158.84 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.731 169.484 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.95 142.47 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.508 0.723 . . . . 0.0 111.367 -176.092 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.41 131.03 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.848 1.259 . . . . 0.0 108.817 174.34 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -126.83 139.44 53.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.115 -167.961 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -94.85 154.04 17.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.779 0.832 . . . . 0.0 111.661 164.651 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.58 -26.88 68.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.603 -0.686 . . . . 0.0 112.657 171.039 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.2 p -70.93 -1.83 13.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.232 1.813 . . . . 0.0 115.506 168.277 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.64 4.24 63.94 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 170.746 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -72.74 139.88 47.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.53 1.665 . . . . 0.0 109.99 174.186 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -126.22 135.21 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.677 1.191 . . . . 0.0 110.714 -179.936 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.0 mm -120.55 135.84 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.697 1.999 . . . . 0.0 108.749 174.402 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -109.42 130.16 55.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.26 176.764 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -113.05 169.06 9.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.754 1.622 . . . . 0.0 112.459 -178.887 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -126.78 121.88 33.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.375 1.47 . . . . 0.0 110.57 170.244 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.4 m -145.68 177.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.485 1.914 . . . . 0.0 112.146 -165.839 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -135.01 154.88 79.42 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.8 1.64 . . . . 0.0 110.489 174.189 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -56.0 -29.83 75.49 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.636 2.891 . . . . 0.0 116.562 177.427 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 p -90.88 3.14 55.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.961 1.704 . . . . 0.0 114.459 175.672 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -69.16 140.7 54.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 179.027 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -75.46 149.6 38.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 111.507 -177.74 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -63.65 -31.16 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 O-C-N 121.679 -0.638 . . . . 0.0 111.032 172.872 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.49 -46.56 83.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.073 -1.017 . . . . 0.0 113.135 168.796 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.8 -39.06 76.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.61 1.095 . . . . 0.0 111.932 178.049 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.68 -41.81 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 O-C-N 121.111 -0.993 . . . . 0.0 111.616 173.732 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -66.53 -36.6 83.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.333 -0.854 . . . . 0.0 112.051 173.287 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.07 69.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 174.236 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.73 -35.42 74.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.458 1.503 . . . . 0.0 112.347 174.005 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.99 -39.52 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.287 0.635 . . . . 0.0 110.331 171.311 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.43 -41.83 85.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.021 0.828 . . . . 0.0 112.382 172.682 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.0 -41.96 79.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.885 0.766 . . . . 0.0 112.791 174.671 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -50.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.014 1.326 . . . . 0.0 113.945 179.508 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.04 -16.13 12.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -165.686 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.24 78.81 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 116.392 1.317 . . . . 0.0 116.392 173.424 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.15 127.96 47.16 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 119.663 1.732 . . . . 0.0 109.13 172.809 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -55.58 150.66 42.3 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.487 3.458 . . . . 0.0 115.882 -175.186 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.79 -29.85 68.52 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.275 2.65 . . . . 0.0 114.579 -170.031 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -19.86 63.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 120.476 1.489 . . . . 0.0 113.471 175.111 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -89.97 -5.98 56.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.603 1.161 . . . . 0.0 113.008 175.528 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -78.82 74.82 5.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.807 -178.225 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 131.28 37.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.953 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.86 139.14 39.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.641 1.577 . . . . 0.0 110.31 -178.582 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.7 mt -126.23 134.27 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.82 1.648 . . . . 0.0 110.214 -171.817 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -142.61 127.25 18.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.844 1.658 . . . . 0.0 109.725 171.908 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.53 36.86 14.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -176.549 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.93 0.18 32.8 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.229 1.395 . . . . 0.0 115.873 -173.429 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.81 138.86 31.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.514 1.926 . . . . 0.0 109.577 176.237 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -90.51 133.54 34.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.559 0.744 . . . . 0.0 110.776 174.262 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.21 119.42 23.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.267 -0.896 . . . . 0.0 111.897 -174.817 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.8 126.14 45.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.427 1.891 . . . . 0.0 111.935 -170.893 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.93 -28.92 54.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -163.45 . . . . . . . . 2 2 . 1 . 172 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.598 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -84.27 -178.44 6.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 112.27 -176.789 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 p -119.05 166.54 12.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.351 1.86 . . . . 0.0 112.527 173.738 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -61.11 -38.16 85.32 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 120.751 -1.218 . . . . 0.0 114.279 179.819 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 p -64.8 -26.66 68.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.739 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -59.86 -16.78 31.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 173.139 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -117.11 6.19 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.446 1.899 . . . . 0.0 114.423 179.231 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 54.69 49.43 18.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.987 1.315 . . . . 0.0 113.446 -176.646 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.49 134.21 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.217 1.407 . . . . 0.0 108.414 174.103 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.05 178.74 6.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.863 1.665 . . . . 0.0 111.951 -170.776 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -47.21 126.97 10.07 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.738 1.215 . . . . 0.0 113.482 169.9 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 63.57 9.39 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.94 2.096 . . . . 0.0 116.602 -175.868 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m -58.96 142.35 51.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.93 1.241 . . . . 0.0 112.164 171.759 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.1 p -105.78 129.27 54.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.755 1.222 . . . . 0.0 112.078 -178.059 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -107.56 141.63 38.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.48 1.912 . . . . 0.0 108.855 177.543 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -124.54 165.3 18.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.967 1.307 . . . . 0.0 111.266 -168.797 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -149.89 152.98 35.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.965 -1.084 . . . . 0.0 112.287 -178.64 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.21 119.68 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.373 1.469 . . . . 0.0 107.969 173.176 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.05 -35.37 80.52 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.523 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -63.55 -31.43 72.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 173.38 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.75 -34.98 62.6 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.148 0.579 . . . . 0.0 111.408 173.253 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -62.02 -26.09 68.04 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.314 0.961 . . . . 0.0 113.238 168.455 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.13 1.23 56.65 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.276 1.417 . . . . 0.0 115.793 169.23 . . . . . . . . 1 1 . 1 . 172 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-N 119.704 1.752 . . . . 0.0 113.134 178.397 . . . . . . . . 0 0 . 1 . 173 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 173 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.06 140.08 36.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.435 0.694 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -134.89 161.25 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.091 1.756 . . . . 0.0 110.055 175.88 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 129.89 56.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.966 0.906 . . . . 0.0 110.516 174.141 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.72 125.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.813 0.845 . . . . 0.0 109.201 170.037 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -97.88 127.6 43.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.292 1.437 . . . . 0.0 110.793 175.623 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -88.03 158.41 18.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.222 0.609 . . . . 0.0 111.119 171.096 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.94 -18.62 65.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.253 -0.904 . . . . 0.0 113.176 178.597 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -93.77 9.93 35.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.058 1.743 . . . . 0.0 113.935 173.571 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.36 -12.38 61.69 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 165.928 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.41 142.86 58.27 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.679 1.239 . . . . 0.0 111.092 -177.857 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -113.15 124.45 52.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.013 1.325 . . . . 0.0 110.035 174.875 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -118.84 107.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.696 1.598 . . . . 0.0 108.456 -174.325 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -78.8 118.42 20.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.445 0.566 . . . . 0.0 109.813 174.799 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.93 139.31 46.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.295 1.038 . . . . 0.0 111.586 177.528 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.5 120.54 35.92 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.646 1.179 . . . . 0.0 109.291 169.887 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.74 157.08 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.695 1.998 . . . . 0.0 110.861 -174.01 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.79 141.48 22.87 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 121.32 -0.863 . . . . 0.0 110.988 175.891 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.13 -23.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.632 2.888 . . . . 0.0 116.532 177.361 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -92.74 -1.12 57.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.599 1.56 . . . . 0.0 114.933 178.312 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -70.85 153.48 42.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.483 1.038 . . . . 0.0 112.34 177.029 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -98.56 162.33 13.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.927 1.291 . . . . 0.0 111.42 170.514 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.31 -34.77 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 113.481 -173.087 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -63.05 -40.28 97.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.94 -1.1 . . . . 0.0 112.475 -176.924 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.85 -21.13 65.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.955 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.48 -42.77 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.876 0.762 . . . . 0.0 110.57 171.534 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -59.41 -35.16 73.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.075 -1.016 . . . . 0.0 112.733 175.448 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.39 73.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 173.337 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -71.68 -35.3 70.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.559 -1.338 . . . . 0.0 111.94 174.08 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.72 -31.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.178 1.391 . . . . 0.0 111.591 175.529 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.49 -37.02 86.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.273 0.942 . . . . 0.0 112.347 174.488 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.96 -18.36 64.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 173.895 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.9 -64.24 1.17 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.777 1.231 . . . . 0.0 112.415 174.184 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -105.17 -6.03 20.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -168.06 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.59 18.39 79.98 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.757 1.162 . . . . 0.0 115.666 177.49 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.39 123.32 64.32 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 108.729 -178.13 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.6 136.06 73.44 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.728 2.285 . . . . 0.0 113.454 177.056 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.8 -26.77 58.77 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.57 2.847 . . . . 0.0 115.821 -179.958 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.4 -24.56 61.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.548 1.067 . . . . 0.0 113.702 174.315 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -82.18 -35.66 28.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 112.043 173.32 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.42 146.88 53.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.483 1.113 . . . . 0.0 112.708 -179.076 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -135.84 146.35 47.4 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.536 1.935 . . . . 0.0 110.549 159.231 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.91 130.15 56.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.33 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.633 1.573 . . . . 0.0 109.604 176.273 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -125.55 127.96 47.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.651 1.58 . . . . 0.0 109.112 167.73 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.61 49.22 11.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.537 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.96 5.15 57.48 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -178.614 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.1 123.68 49.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.625 1.97 . . . . 0.0 110.155 -179.7 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -77.03 134.44 38.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.749 0.704 . . . . 0.0 111.523 173.936 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.2 mt -97.21 152.33 18.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.791 1.636 . . . . 0.0 112.423 -171.132 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -137.74 139.57 40.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.487 1.915 . . . . 0.0 111.112 -178.039 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.5 -0.21 6.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.812 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.33 -4.28 36.37 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.344 167.562 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -140.36 169.53 17.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.549 1.939 . . . . 0.0 112.189 173.356 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -99.54 164.28 12.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.008 1.723 . . . . 0.0 113.356 -179.265 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.08 -37.85 69.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.057 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 m -59.34 -38.64 80.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.858 0.863 . . . . 0.0 113.129 173.613 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -69.26 -26.17 64.64 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.073 0.949 . . . . 0.0 113.228 -178.97 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -89.47 2.41 54.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.256 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 59.94 37.15 21.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.955 1.302 . . . . 0.0 113.851 -176.629 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.86 134.06 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 123.995 0.918 . . . . 0.0 108.898 175.849 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -125.41 179.74 4.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 112.445 -173.949 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -52.55 138.34 28.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.159 -0.963 . . . . 0.0 111.859 174.057 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 60.53 23.09 12.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.321 1.848 . . . . 0.0 114.258 176.921 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -63.72 133.4 53.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.271 -0.893 . . . . 0.0 111.866 175.995 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -91.7 120.6 32.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.8 0.84 . . . . 0.0 109.671 174.401 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -110.13 143.48 40.15 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.647 1.579 . . . . 0.0 109.507 174.309 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -101.35 120.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.3 1.04 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.17 124.68 32.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.488 173.09 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.4 t -116.66 153.75 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.753 1.621 . . . . 0.0 108.453 171.362 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -131.08 138.8 49.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.141 0.976 . . . . 0.0 112.239 173.0 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 -84.69 119.78 25.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.533 1.133 . . . . 0.0 112.444 -174.487 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 mt -91.51 49.95 1.66 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.1 1.36 . . . . 0.0 112.561 -175.788 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.25 142.39 48.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.95 2.1 . . . . 0.0 110.241 179.101 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.51 -165.48 53.52 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.116 0.865 . . . . 0.0 113.768 -173.834 . . . . . . . . 1 1 . 1 . 173 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 C-N-CA 125.324 1.44 . . . . 0.0 113.531 176.975 . . . . . . . . 0 0 . 1 . 174 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 174 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.29 130.02 45.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.613 0.765 . . . . 0.0 111.056 -176.164 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.18 163.94 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.965 0.906 . . . . 0.0 111.361 177.703 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -118.82 146.11 45.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.941 0.897 . . . . 0.0 111.148 179.743 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.79 117.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.677 1.191 . . . . 0.0 109.91 175.367 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -105.78 145.95 30.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.546 1.538 . . . . 0.0 112.669 -173.895 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -117.77 153.72 32.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 112.919 -175.545 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.55 -35.0 78.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.127 1.371 . . . . 0.0 112.569 178.978 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -70.37 -12.83 61.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.761 1.624 . . . . 0.0 112.966 176.014 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.99 38.26 4.41 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.352 0.901 . . . . 0.0 115.352 169.198 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -111.01 149.25 30.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.252 1.021 . . . . 0.0 109.845 163.77 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -120.93 127.04 51.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.035 0.934 . . . . 0.0 109.746 164.549 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.74 127.76 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.338 1.855 . . . . 0.0 108.615 -179.067 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.0 m -94.19 127.68 40.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.09 0.956 . . . . 0.0 110.037 174.623 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -126.13 155.18 42.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.307 1.443 . . . . 0.0 112.208 -177.316 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -118.17 127.32 53.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.684 1.594 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 m -144.88 153.25 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.307 1.443 . . . . 0.0 111.953 -167.006 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -91.37 150.54 41.52 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.092 164.326 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.46 -24.77 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.503 2.136 . . . . 0.0 114.77 172.571 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -87.59 0.95 54.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 174.742 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.22 141.38 55.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 120.341 1.428 . . . . 0.0 110.414 170.206 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -82.64 164.73 20.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.548 0.739 . . . . 0.0 112.586 176.331 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.35 -33.57 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.429 -0.794 . . . . 0.0 111.101 168.708 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.28 -33.32 74.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.069 -1.02 . . . . 0.0 113.189 174.363 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -66.95 -38.33 85.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.004 0.82 . . . . 0.0 111.46 169.312 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.17 -41.71 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.238 -0.914 . . . . 0.0 111.037 175.23 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.33 -40.29 85.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.487 1.04 . . . . 0.0 112.509 173.174 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.79 90.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.503 0.721 . . . . 0.0 112.574 175.801 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.15 -31.1 71.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 112.957 175.234 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.6 mt -69.02 -46.08 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 110.693 170.325 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.87 -39.26 77.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 119.656 1.117 . . . . 0.0 111.38 175.734 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.44 -20.52 64.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.684 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -104.28 -51.71 3.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 113.186 175.41 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -100.26 -11.98 19.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.027 1.331 . . . . 0.0 114.059 -167.33 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.51 -4.24 78.97 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.891 1.234 . . . . 0.0 115.972 179.401 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.51 122.53 87.4 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.504 1.652 . . . . 0.0 110.499 -171.258 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.0 136.07 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.828 2.352 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -50.6 -31.09 30.47 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 124.304 3.336 . . . . 0.0 116.477 -179.577 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.2 -33.92 71.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.246 1.384 . . . . 0.0 112.713 174.207 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -76.39 -20.03 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.518 -0.739 . . . . 0.0 112.757 176.008 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -91.92 136.44 33.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 120.351 1.432 . . . . 0.0 113.134 -167.972 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -129.76 135.92 49.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.568 1.547 . . . . 0.0 108.871 161.405 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.78 131.02 55.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.946 0.793 . . . . 0.0 112.015 -173.289 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.97 140.91 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.527 1.531 . . . . 0.0 110.902 -171.023 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -122.6 115.47 22.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.934 1.293 . . . . 0.0 110.648 167.945 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.8 47.02 12.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.47 1.508 . . . . 0.0 113.892 177.649 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.46 5.95 86.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 179.956 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -118.82 131.02 56.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 120.447 2.124 . . . . 0.0 112.16 178.564 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.51 135.27 36.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 111.914 -177.241 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -101.57 137.64 39.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.191 1.396 . . . . 0.0 111.21 -177.467 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.69 144.82 25.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.701 1.2 . . . . 0.0 114.145 -171.573 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.45 -35.99 70.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.217 1.807 . . . . 0.0 114.709 -169.327 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -7.78 86.87 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.366 1.46 . . . . 0.0 115.778 -179.575 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -99.73 158.7 15.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.388 1.594 . . . . 0.0 112.706 -177.52 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 p -100.36 163.12 12.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.629 1.572 . . . . 0.0 113.132 -177.528 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.49 -34.96 69.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.534 -0.729 . . . . 0.0 112.35 168.649 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.4 p -71.32 -15.93 62.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 173.441 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -80.27 -30.29 38.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.858 1.208 . . . . 0.0 112.407 168.185 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -99.73 11.59 38.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.09 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 59.03 32.16 21.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.385 1.474 . . . . 0.0 114.162 174.535 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -76.3 139.29 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -176.874 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -118.26 168.59 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.752 1.621 . . . . 0.0 111.981 -177.453 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 162.75 12.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.376 -0.827 . . . . 0.0 112.184 166.036 . . . . . . . . 2 2 . 1 . 174 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 55.65 37.07 28.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.444 1.098 . . . . 0.0 112.798 -178.346 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 t -126.5 147.16 49.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.825 1.65 . . . . 0.0 110.8 -177.162 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.2 m -120.57 125.93 49.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.639 1.175 . . . . 0.0 111.174 -174.111 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.47 166.04 11.55 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.976 2.51 . . . . 0.0 110.106 174.257 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.64 139.33 53.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.932 0.893 . . . . 0.0 111.689 175.568 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.7 tp -97.84 131.96 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.516 1.126 . . . . 0.0 110.597 176.905 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.56 142.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.075 1.75 . . . . 0.0 109.514 175.994 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.5 113.49 27.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.701 1.2 . . . . 0.0 111.922 179.493 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.5 97.98 7.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.957 1.703 . . . . 0.0 110.305 178.214 . . . . . . . . 2 2 . 1 . 174 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.5 134.68 34.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 111.6 -176.882 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -80.97 23.23 0.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.881 2.072 . . . . 0.0 114.661 177.1 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.75 -143.53 7.38 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.761 2.124 . . . . 0.0 110.756 -174.113 . . . . . . . . 1 1 . 1 . 174 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.406 1.955 . . . . 0.0 112.553 172.965 . . . . . . . . 0 0 . 1 . 175 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.374 -0.822 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 175 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.34 142.6 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.251 0.932 . . . . 0.0 111.661 175.131 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.85 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.776 171.579 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -110.2 138.12 47.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.142 0.977 . . . . 0.0 111.197 -177.74 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -129.35 120.18 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 124.276 1.03 . . . . 0.0 109.48 177.751 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.82 130.38 39.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.447 1.499 . . . . 0.0 112.419 -176.293 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -90.73 158.92 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.747 1.219 . . . . 0.0 112.094 173.636 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.78 -18.15 65.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.729 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -81.8 -2.69 51.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 167.223 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.6 70.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.138 1.351 . . . . 0.0 115.923 176.717 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 140.91 55.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.326 1.563 . . . . 0.0 110.593 176.865 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -102.63 109.1 20.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 167.546 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.9 mt -83.55 133.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.67 1.188 . . . . 0.0 108.011 169.21 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -114.23 132.92 55.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.557 1.143 . . . . 0.0 109.657 176.92 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -131.14 134.52 46.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.579 1.151 . . . . 0.0 110.353 -174.809 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -97.87 107.41 19.89 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 174.984 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.57 167.4 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.551 1.94 . . . . 0.0 111.819 -167.642 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -109.89 150.6 41.59 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.782 1.233 . . . . 0.0 110.784 165.551 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -64.22 -14.53 44.31 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.261 2.641 . . . . 0.0 114.03 173.174 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.7 p -86.88 -5.45 59.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.062 1.745 . . . . 0.0 114.628 172.965 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.51 146.41 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.281 0.946 . . . . 0.0 112.01 178.774 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -73.01 153.1 41.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.542 171.21 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.6 mm -54.97 -39.65 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.506 0.722 . . . . 0.0 110.914 171.393 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.46 -36.4 82.67 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.963 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.46 -35.35 77.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.084 1.311 . . . . 0.0 111.938 175.155 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.91 -42.47 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.228 1.011 . . . . 0.0 111.389 174.865 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -57.22 -35.29 69.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 120.058 1.299 . . . . 0.0 112.907 168.96 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -27.78 62.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.307 -0.871 . . . . 0.0 113.077 175.373 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.97 -35.38 74.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 120.024 1.284 . . . . 0.0 112.119 168.971 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.84 -44.2 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.157 0.983 . . . . 0.0 110.465 168.303 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.36 -51.16 65.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.801 1.182 . . . . 0.0 111.33 176.569 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.4 -35.35 80.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.691 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -99.15 -20.04 16.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -176.067 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -119.53 -8.09 10.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 0.0 114.572 -178.618 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.82 5.8 89.51 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 177.14 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -92.11 120.08 67.93 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 119.423 1.612 . . . . 0.0 110.963 -171.057 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.88 137.7 82.3 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.107 2.538 . . . . 0.0 113.068 178.157 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.83 -34.21 98.92 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.821 2.347 . . . . 0.0 114.246 -178.947 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -15.68 62.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.03 . . . . . . . . 2 2 . 1 . 175 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -95.84 -4.86 42.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.558 1.543 . . . . 0.0 112.967 -179.532 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.15 132.76 50.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.686 1.194 . . . . 0.0 112.453 -175.031 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -109.88 128.37 55.3 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.697 1.599 . . . . 0.0 109.02 163.11 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.2 mt -109.24 132.83 53.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.262 1.025 . . . . 0.0 110.696 174.278 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.16 137.52 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 124.908 1.283 . . . . 0.0 110.502 -171.141 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -153.06 139.88 19.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.203 1.401 . . . . 0.0 111.307 170.366 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.5 42.48 26.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.444 1.498 . . . . 0.0 113.903 177.669 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.2 -7.08 39.19 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.539 1.542 . . . . 0.0 115.814 -179.519 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.35 139.2 38.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.067 1.434 . . . . 0.0 111.686 -176.656 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -82.2 125.3 30.76 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.129 164.303 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.0 132.81 34.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.386 1.475 . . . . 0.0 111.294 -172.72 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -96.87 129.15 44.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.531 1.132 . . . . 0.0 112.565 -167.359 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -47.37 -35.15 7.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.809 2.444 . . . . 0.0 116.184 -171.386 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.69 -8.52 69.99 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -179.52 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.79 161.6 19.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.104 1.452 . . . . 0.0 111.196 176.274 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -106.62 160.4 15.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.85 0.86 . . . . 0.0 113.129 177.198 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.98 -37.46 79.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 113.065 -176.79 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 p -64.54 -31.95 73.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.482 1.113 . . . . 0.0 113.891 172.811 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.93 -28.34 69.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.907 1.231 . . . . 0.0 112.25 175.616 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.31 1.31 55.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.226 1.41 . . . . 0.0 114.544 170.95 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 54.88 36.52 26.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.2 1.4 . . . . 0.0 113.84 -174.998 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.5 mt -76.51 111.28 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 120.749 -1.219 . . . . 0.0 108.279 -179.863 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -84.1 163.58 19.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.007 0.923 . . . . 0.0 113.047 -175.169 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -49.18 135.09 17.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.62 1.568 . . . . 0.0 112.823 166.038 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.58 31.2 18.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.576 1.95 . . . . 0.0 115.656 -175.934 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -77.35 162.17 27.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.821 166.243 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -117.1 133.51 55.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.143 1.377 . . . . 0.0 111.535 178.063 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.47 164.49 16.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.793 2.037 . . . . 0.0 110.592 177.04 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -107.57 142.09 38.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.936 0.895 . . . . 0.0 111.278 169.187 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.1 tp -108.95 133.81 52.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.68 1.592 . . . . 0.0 110.285 169.096 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.09 137.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 109.689 171.887 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -86.63 144.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.178 1.391 . . . . 0.0 112.22 -178.926 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -81.07 140.67 34.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.374 168.142 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.02 -42.99 1.84 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.312 1.445 . . . . 0.0 111.543 172.955 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.1 116.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 154.824 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 25.17 61.66 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.223 -162.235 . . . . . . . . 1 1 . 1 . 175 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 125.547 1.546 . . . . 0.0 112.96 177.957 . . . . . . . . 0 0 . 1 . 176 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 176 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -127.62 146.19 50.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.336 1.054 . . . . 0.0 111.122 165.814 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 pt -137.34 172.15 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.354 1.862 . . . . 0.0 110.551 176.11 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -113.84 157.4 22.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.859 1.263 . . . . 0.0 112.419 177.433 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.5 129.93 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.918 1.287 . . . . 0.0 109.604 171.416 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -118.01 127.45 53.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.838 1.655 . . . . 0.0 112.521 -175.062 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -92.08 158.83 15.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.895 1.278 . . . . 0.0 113.665 179.659 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.6 mt -69.82 -16.05 63.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.414 -0.804 . . . . 0.0 112.632 166.406 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.8 p -83.24 21.69 1.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.92 2.088 . . . . 0.0 113.887 171.579 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.63 14.78 81.74 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 166.137 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -111.01 146.21 37.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.971 1.708 . . . . 0.0 111.69 -177.586 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -118.06 142.22 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.824 0.849 . . . . 0.0 109.981 165.302 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.72 157.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.116 1.366 . . . . 0.0 111.336 172.734 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p -92.66 150.34 20.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.95 0.9 . . . . 0.0 112.202 170.529 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp -136.86 133.29 35.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.257 1.023 . . . . 0.0 111.162 173.669 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.57 118.54 36.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.649 1.18 . . . . 0.0 111.679 176.27 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -154.03 171.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.784 2.434 . . . . 0.0 109.794 -173.298 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -115.76 156.94 45.76 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 112.363 168.786 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.0 -19.07 30.84 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.172 2.582 . . . . 0.0 115.893 179.961 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 p -85.29 -6.69 59.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.455 1.902 . . . . 0.0 114.867 174.863 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -80.93 152.26 28.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.767 1.167 . . . . 0.0 113.636 179.927 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -77.63 158.75 29.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.461 1.105 . . . . 0.0 113.885 -178.195 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.35 -29.32 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.622 167.839 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.24 -41.82 80.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 120.858 -1.151 . . . . 0.0 112.095 168.826 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.71 -38.42 86.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.933 0.893 . . . . 0.0 112.807 174.723 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.91 -51.56 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.214 1.006 . . . . 0.0 111.086 173.593 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -37.72 85.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.622 0.769 . . . . 0.0 112.309 179.488 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.06 89.35 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.437 0.695 . . . . 0.0 112.674 176.746 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.84 -35.18 79.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.439 -0.788 . . . . 0.0 112.829 176.656 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.1 mt -63.51 -38.43 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.562 0.745 . . . . 0.0 111.348 172.61 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.36 -46.2 84.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.384 0.538 . . . . 0.0 111.38 173.356 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.04 -47.17 81.58 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.204 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -73.45 -44.29 58.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -174.94 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -124.61 -4.89 7.65 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.683 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.5 3.77 71.37 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 117.479 1.751 . . . . 0.0 117.479 168.496 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -82.74 119.17 73.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-N 119.936 1.868 . . . . 0.0 109.743 -179.44 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.16 144.17 67.97 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.439 2.093 . . . . 0.0 112.616 -179.044 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.55 -35.54 37.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.045 3.163 . . . . 0.0 115.35 178.923 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -70.64 -7.79 46.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.534 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.39 6.79 16.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.295 1.438 . . . . 0.0 114.105 170.139 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.65 137.56 32.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.696 1.134 . . . . 0.0 110.671 172.991 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -126.24 116.98 22.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.75 1.22 . . . . 0.0 109.045 161.695 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.7 mt -105.93 132.31 52.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 111.475 -176.747 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -124.86 141.22 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.654 1.582 . . . . 0.0 110.628 -178.289 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -147.04 131.7 17.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.636 1.574 . . . . 0.0 110.402 168.085 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.6 37.3 15.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.484 1.114 . . . . 0.0 113.794 -178.988 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 -7.45 6.19 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.572 1.558 . . . . 0.0 116.875 -174.018 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.17 139.09 33.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.387 2.094 . . . . 0.0 110.687 172.624 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.6 137.18 42.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 165.755 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -85.61 118.64 25.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.058 0.543 . . . . 0.0 110.379 178.023 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.676 1.591 . . . . 0.0 112.146 -173.145 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.57 -30.86 55.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.219 1.808 . . . . 0.0 115.231 -170.584 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.34 -6.51 86.02 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.679 1.609 . . . . 0.0 116.127 178.996 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -96.1 168.37 10.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.193 1.496 . . . . 0.0 112.591 177.847 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -111.72 157.71 20.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.582 1.953 . . . . 0.0 111.981 177.804 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.33 -38.49 68.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.421 1.088 . . . . 0.0 113.477 -178.866 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 p -66.83 -24.83 66.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 174.443 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.26 -24.2 67.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 120.192 1.36 . . . . 0.0 112.337 173.434 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -103.38 1.97 33.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.537 1.935 . . . . 0.0 114.177 175.205 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 56.44 36.22 27.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.299 1.439 . . . . 0.0 113.487 -173.075 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -78.75 117.88 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 O-C-N 120.619 -1.301 . . . . 0.0 108.746 175.207 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.15 168.81 14.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.562 1.545 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -45.89 141.0 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.379 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 61.53 6.65 1.55 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.644 2.378 . . . . 0.0 116.535 178.158 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -67.44 160.76 26.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.166 1.387 . . . . 0.0 112.02 168.849 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 m -114.81 133.05 56.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.18 1.392 . . . . 0.0 111.065 177.37 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.9 mt -98.21 145.22 26.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.12 1.368 . . . . 0.0 110.204 170.285 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -96.27 130.68 43.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.71 -0.619 . . . . 0.0 109.763 176.889 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.0 tp -116.61 133.23 56.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.68 142.17 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.552 1.941 . . . . 0.0 108.927 178.723 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -71.17 133.71 46.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.482 0.713 . . . . 0.0 110.71 172.316 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -98.72 114.69 27.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.346 1.458 . . . . 0.0 109.957 171.419 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 125.03 22.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.671 1.588 . . . . 0.0 113.368 -169.105 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -136.04 136.2 40.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 112.216 -179.077 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.08 178.9 24.47 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.752 1.168 . . . . 0.0 114.433 -175.066 . . . . . . . . 1 1 . 1 . 176 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.086 1.803 . . . . 0.0 113.937 177.977 . . . . . . . . 0 0 . 1 stop_ save_